{"title": "PDF", "author": "PDF", "url": "https://aaap.memberclicks.net/assets/WPDC/wpdc_2014.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": " \nPROCEEDINGS OF THE S IXTY- THIRD \nWESTERN POULTRY DISE ASE CONFERENCE  \nApril 1 to 5, 2014  \nPuerto Vallarta, Jalisco, Mexico  \n \nMEMORIAS DE LA XXXIX CONVENCI\u00d3N ANUAL  ASOCIACI\u00d3N N ATIONAL DE E SPECIALISTAS EN C IENCIAS A V\u00cdCOLAS  \n1 al 5 de abril de 2014  Puerto Vallarta, Jalisco, M\u00e9xico  \n  \n \n \n \n \n \nPROCEEDINGS OF THE S IXTY- THIRD \nWESTERN POULTRY DISE ASE CONFERENCE  \nAPRIL 1 TO 5, 2014  \nPUERTO VALLARTA, JAL ISCO, MEXICO  \n \nMEMORIAS DE LA XXXIX CONVENCI\u00d3N ANUAL ANE CA \n1 AL 5 DE ABRIL DE 2 014  \nPUERTO VALLARTA, JAL ISCO, M\u00c9XICO  \n   \n \n \n \n                        \n       \n\u00a92014 W estern Poultry Disease Conference  XXXIX CONVENCI\u00d3N ANUAL DE LA ASOCIACI\u00d3N \nNACIONAL DE ESPECIALISTAS EN CIENCIAS AV\u00cdCOLAS  \n \n63rd WESTERN POULTRY DISEASE CONFERENCE  \n \nBENJAM\u00cdN LUCIO MART\u00cdNEZ  \n1942- 2013  \n \n \n \nCon gran admiraci\u00f3n, respeto, aprecio y gratitud, esta Convenci\u00f3n es dedicada a la memoria del Dr. \nBenjam\u00edn Lucio Mart\u00ednez, promotor, fundador y primer Presidente de la ANECA durante los a\u00f1os 1970  a \n1972. Los e statutos de esta naciente Asociaci\u00f3n fueron firmados por los Dres. Benjam\u00edn Lucio Mart\u00ednez, \nArmando Antill\u00f3n Rionda, Hugo Funes Cata\u00f1o, Miguel \u00c1ngel  M\u00e1rquez Ruiz, Jos\u00e9 Villase\u00f1or Michel, \nAlejandro Cuadra Germ\u00e1n y Jes\u00fas Estudillo L\u00f3pez  (q.e.p.d.) . \nEn la Ciudad d e M\u00e9xico, D.F., un d\u00eda 1\u00ba de Febrero de 1942 nace Benjam\u00edn Lucio Mart\u00ednez, quien desde \nmuy joven mostr\u00f3 inter\u00e9s por la Avicultura, criando algunas gallinas en la casa paterna y luego, durante \nalgunos a\u00f1os,  en una peque\u00f1a caseta av\u00edcola, junto con su hermano Sergio (q.e.p.d.) . En 1964 Benjam\u00edn \nLucio termina sus estudios en la entonces Escuela Nacional de Medicina Veterinaria y Zootecnia \n(E.N.M.V.Z.) de la Universidad Nacional Aut\u00f3noma de M\u00e9xico  (U.N.A.M.). La historia profesional y su \nformaci\u00f3n familiar  comienza n simult\u00e1neamente  en 1966, cuando se titula como M\u00e9dico Veterin ario \nZootecnista  y a los pocos d\u00edas  se une en  matrimonio con su novia y compa\u00f1era de estudios, Dra. Eglantina \nZavaleta Beckler  constituyendo una ejemplar uni\u00f3n conyugal  para toda la vida . Al a\u00f1o siguiente (1967) \nambos se hacen acreedores a una beca para realizar estudios en  la Escuela de Graduados de la Universidad de \nCorne ll. En 1969 Benjam\u00edn Lucio obtiene  el grado de Master of Science en el Departamento de Enfermedades \nde las Aves, Colegio de Veterinaria del Estado de Nueva York, E.U.A.  Regresa a M\u00e9xico en abril de 1969, \nlleno de entusiasmo y conocimientos actualizados acerca de las enfermedades de las aves, integr\u00e1ndose al \nequipo de trabajo  de la E.N.M.V.Z., primero como Profesor Adjunto, y medi ante una fruct\u00edfera carrera \ncurricular alcanza la m\u00e1xima categor\u00eda acad\u00e9mica como Profesor Titular C, con la cual se retir\u00f3 de  la \nU.NA.M. en el a\u00f1o de 1986.  Durante esa primera etapa como Profesor en la U.N.A.M. (1969- 1977) , el Dr. Lucio contribuye a \nmoder nizar los elementos de diagn\u00f3stico av\u00edcola con que contaba el prestigiado Laboratorio de Patolog\u00eda \nAviar, que en aquel tiempo funcionaba bajo la direcci\u00f3n del Dr. Alejandro Cuadra Germ\u00e1n, y donde los \navicultores y colegas acud\u00edan desde a\u00f1os atr\u00e1s con aves o muestras para recibir apoyo de diagn\u00f3stico y \nasesor\u00eda t\u00e9cnica.  \nPoniendo al servicio del Laboratorio de Patolog\u00eda Aviar su capacidad , y con la invaluable participaci\u00f3n \nde los  Dres. Armando Antill\u00f3n Rionda (quien casi al mismo tiempo regresaba tambi\u00e9n  de  sus estudios de \nMaestr\u00eda en la Universidad de Connecticut, E.U.A.) y el pr opio Dr. Cuadra, lograron  la transformaci\u00f3n d el \nmencionado laboratorio, que pas\u00f3  a ser  el Departamento de Producci\u00f3n Animal: Aves . Los  esfuerzos  y el \ninter\u00e9s  del Dr. Lucio y los colegas mencionados por elevar el nivel de la educaci\u00f3n en materia de patolog\u00eda \naviar fueron mucho m\u00e1s all\u00e1, al promover y fijar las bases acad\u00e9micas para la creaci\u00f3n de estudios de post -\ngrado, contando por supuesto con el apoyo de distinguidos profesores de la E.N.M.V.Z. y su Director, Dr. \nPablo Zierold Reyes, poni\u00e9ndose en pr\u00e1ctica como primer escal\u00f3n la Especialidad en Patolog\u00eda Av\u00edcola a principios de los a\u00f1os 70\u00b4s , hecho que permiti\u00f3 la transformaci\u00f3n de Escuela a Facultad de Medicina \nVeterinaria y Zoot ecnia. La Especialidad en Patolog\u00eda Av\u00edcola, posteriormente evolucion\u00f3 a Especialidad en \nProducci\u00f3n Animal: Aves, y pronto cobr\u00f3 una reconocida importancia en M\u00e9xico y el extranjero, por lo que no pocos de sus estudiantes proven\u00edan de pa\u00edses de Centro y Su dam\u00e9rica, varios de los cuales al regresar a sus \nlugares de origen fueron piezas fundamentales para el desarrollo de una medicina aviar  de mayor actualidad y \nsustento. El Dr. Lucio desempe\u00f1\u00f3 de manera por dem\u00e1s relevante desde 1973 hasta 1975 el puesto de Jefe del \nDepartamento de Producci\u00f3n Animal: Aves, incorporando nuevos profesores y diversificando las \u00e1reas  y \nt\u00e9cnicas  de diagn\u00f3stico, con lo que el contacto con la Avicultura nacional se increment\u00f3  notablemente, \naprovechando las bases sentadas por los anteriores Jefes del antiguo Laboratorio de Patolog\u00eda Aviar. Dentro de sus grandes m\u00e9ritos durante la jefatura en el Depto. de Producci\u00f3n Animal: Aves est\u00e1 la de haber invitado \na grandes investigadores como profesores invitados, destacando las figuras de los Dres. P. P. Levine y Henry \nE. Adler, entre otros, quienes dejaron conocimientos y disciplina de trabajo, contribuyendo en muchos aspectos a mejorar la calidad de la docencia, investigaci\u00f3n y diagn\u00f3stico.  \nBenjam\u00edn Lucio fungi\u00f3 como Jefe de la Divisi\u00f3n de Es tudios Superiores de la F.M.V.Z. (1976), \npromovi\u00f3 la constante revisi\u00f3n y adecuaci\u00f3n de los planes de estudio de post -grado de la Facultad, \nestimulando la investigaci\u00f3n y divulgaci\u00f3n de los conocimientos mediante publicaciones en revistas \nespecializadas y la organi zaci\u00f3n de conferencias y cursos .   \nCorr\u00eda el a\u00f1o de 1977 cuando el matrimonio formado por Benjam\u00edn y Eglantina consiguieron ser \nbecados nuevamente , pero esta vez por la Universidad de Cornell,  para proseguir estudios de doctorado . \nDurante las dos estancias  como estudiante de post -grado en Cornell, Benjam\u00edn realiz\u00f3  trabajos de \ninves tigaci\u00f3n y tesis bajo la  experimentada direcci\u00f3n del afamado cient\u00edfico av\u00edcola Stephen B. Hitchner, \nabarcando el estudio de algunas infecciones virales. Una vez cumplidos los requ isitos  acad\u00e9micos para \nalcanzar el grado de Doctor en Filosof\u00eda ( PhD),  a principio del a\u00f1o de  1980 el matrimonio Lucio -Zavaleta se \nreintegra a la F.M.V.Z. de la U.N.A.M. continuando sus labores como profesores e investigadores de tiempo completo.  \nEl inter\u00e9s del Dr. Lucio por  abrir nuevos caminos que facilitaran la actualizaci\u00f3n de conocimientos a los \nprofesionales de la Avicultura  se manifiesta de nueva cuenta  al contribuir en la planeaci\u00f3n, organizaci\u00f3n y \npuesta en marcha  de la Especialidad en Producci\u00f3n Animal: Aves bajo el Sistema de Universidad Abierta, \ncon el apoyo y entusiasta colaboraci\u00f3n del grupo de profesores del Departamento de Producci\u00f3n Animal: Aves. Pronto , otras \u00e1reas de la Facultad desarrol laron planes de estudio bajo es e novedoso m\u00e9todo de \nense\u00f1anza tomando como punto de partida la metodolog\u00eda implementada por el  grupo de profesores  citado.  \nDurante los a\u00f1os de 1969 a 1976, y 1980 a 1986 (primero y segundo periodo de trabajo en la U.N.A.M. ), \nel Dr. Lucio fue profesor de Cl\u00ednica de Aves en el nivel de licenciatura, y de Enfermedades de las Aves en los \ncursos de post -grado, contribuyendo a la formaci\u00f3n de numerosos especialistas en Medicina Aviar, muchos de \nlos cuales se integraron como maestros e investigadores a diversas universidades en M\u00e9xico y el extranjero, \nmientras que otros fueron aprovechados por las industrias av\u00edcola y qu\u00edmico -farmac\u00e9utica para cubrir puestos \nde responsabilidad.  \nReconocido desde un principio como profesor e investigador en la U.N.A.M., Benjam\u00edn se aboc\u00f3 al \nestudio de las principales enfermedades virales de las aves dom\u00e9sticas, siendo el primero en  confirmar la  \npresencia de vario s padecimientos  en nuestro pa\u00eds, como la infecci\u00f3n de la b olsa de Fabricio, hepatitis con \ncuerpos de inclusi\u00f3n, s\u00edndrome de b aja de postura, e nfermedad de Newcastle altamente pat\u00f3gena (forma \nviscerotr\u00f3pica)  ocasionada por cepas inusualmente virulentas, como la cepa Chimalhuac\u00e1n.  Abarc\u00f3 muchos \notros temas de importancia para la Avicultura, y fue co-autor de varios libros  sobre enfermedades de las aves.  En el a\u00f1o de 1986, Benjam\u00edn decide renunciar de manera permanente a su trabajo en la U.N.A.M., \naceptando la propuesta de la Universidad de Cornell para ocupar una posici\u00f3n  como Profesor Visitante. Un \na\u00f1o despu\u00e9s es nombrado Investigador Asociado II ( Senior Research Associate II ) en el Departamento de \nMedicina Aviar y Acu\u00e1tica de la Universidad de Cornell, y para 1989 ya es Profesor Asociado, con el encargo \nde investigar acerca de enfermedades significativas de las aves. \nDurante los \u00faltimos a\u00f1os como profesor en la U.N.A.M., Benjam\u00edn l ider\u00f3 un equipo de trabajo integrado \npor los profesores del Depto. de Producci\u00f3n Animal: Aves  de aquellos tiempos, con la finalidad de desarrollar \nun plan para descentralizar las funciones de diagn\u00f3stico e investigaci\u00f3n  de esa instituci\u00f3n , las cuales \u2013 se \npensaba- deber\u00edan quedar  a cargo de un Centro  de Investigaciones Av\u00edcolas , construido en alg\u00fan lugar fuera \nde la Ciudad  de M\u00e9xico, y cerca de alguna zona av\u00edcola. Este fue seguramente el proyecto m\u00e1s ambicioso  del \nDr. Benjam\u00edn Lucio, quien ya percib\u00eda las limitaciones econ\u00f3micas y administrativas de la instituci\u00f3n para \nllevar a cabo estudios d e investigaci\u00f3n de alto nivel. Lamentablemente, e ste proyecto, a pesar de su \nviabilidad, y de la necesidad de investigaci\u00f3n que demandaba (y demanda) la situaci\u00f3n zoosanitaria de la \nAvicultura,  no recibi\u00f3 la comprensi\u00f3n y apoyo indispensables, quedando finalmente, y hasta la fecha, en el \nolvido. La visi\u00f3n y el talento de Benjam\u00edn en este caso, fue completamente desaprovecha da, pero en cambio, \ninici\u00f3 una larga carrera de \u00e9xitos como profesor e investigador en su segunda \u201cAlma Mater\u201d, la Universidad de Cornell.  \nAh\u00ed pudo continuar con investigaciones rel evantes sobre infecciones como anemia i nfecciosa, \nSalmonella E nteritidis, viruela del Canario, viruela de los L oros, infecci\u00f3n por v irus Herpes en Tr agopanes , y \notras, cuyos frutos los comparti\u00f3 con los colegas de varios pa\u00edses mediante sus interesantes conferencias y publicaciones en revistas especializadas de alto nivel.  \nDesde el mes de septiembre de 1998 hasta su jubilaci\u00f3n oficial en marzo del 2010 ocup\u00f3 el cargo de \nDirector de Servicios de Diagn\u00f3stico y Extensionismo Av\u00edcola, en el Laboratorio de Diagn\u00f3stico de Salud \nAnimal del Colegio de Medicina Veterinaria de la Univ ersidad de Cornell, puesto que le permiti\u00f3 una \nestrecha relaci\u00f3n con los avicultores del E stado de Nueva York, E.U.A.  \nDurante su vida, Benjam\u00edn Lucio fue objeto de numerosos y bien merecidos reconocimientos a su labor, \ndestacando la dedicatoria de la XIV Convenci\u00f3n de la ANECA, en abril de 1989, hace exactamente 25 a\u00f1os, \naqu\u00ed tambi\u00e9n, en Puerto Vallarta, Jal.  Otras prestigiadas organizaciones profesionales, como la American \nAssociation of Avian Pathologists y la Weste rn Poultry Disease Conference tambi\u00e9n l e brindaron \nreconocimientos.  Su contribuci\u00f3n a la Avicultura mexicana y Latinoamericana es innegable y de gran \nimpacto.  \nTal como lo mencionan los reconocidos investigadores, Dres. Bruce Calnek y Ton Schat, grandes \namigos de Benjam\u00edn, en el obituario que publicaron en la revista Avian Pathology: \u201cUna muestra verdadera \nde su estatura internacional es su inclusi\u00f3n por la World Veterinary Poultry Association como miembro \ninaugural de su recientemente establecido Sal\u00f3n de Honor (Hall of Honor)\u201d.  \nBenjam\u00edn siempre  estuvo cerca de la ANECA, ya sea como uno de sus  directivos, consejero, \nconferencista, asistente, y tambi\u00e9n como miembro del Consejo de Expresidentes. Siempre foment\u00f3 la armon\u00eda \ny superaci\u00f3n de nuestra Asociaci\u00f3n, creando v\u00ednculos con otras Asociaciones de car\u00e1cter internacional. Su \nfirmeza de car\u00e1cter, su honestidad a toda prueba, la congruencia de sus c onvicciones, su inteligencia,  extensa \ny admirable vida d e trabajo y su bon hom\u00ed a, le caracterizaron siempre como el gran maestro y el gran amigo \nque fue.  \nLa fraternal relaci\u00f3n maestro -alumno fomentada por el Dr. Lucio invariablemente contribuy\u00f3 a \ndesarrollar sinceros v\u00ednculos de amistad y cooperaci\u00f3n, y esta es una de las razones tal vez m\u00e1s significativas por las cuales es recordado con un profundo afecto por muchos distinguidos colegas avipat\u00f3logos . \nResulta  imposible mencionar en detalle tantos aspectos interesantes de la vida de Benjam\u00edn Lucio \nMart\u00ednez, cuyo prestigio como maestro, compa\u00f1ero y amigo caminan a la par de su intachable imagen como \nesposo, padre y abuelo. Benjam\u00edn es, sin lugar a dudas, un ejemplo a seguir y  motivo para reflexionar acerca \nde las razones por las cuales personas tan valiosas como \u00e9l solo pueden expresar todo su potencial en pa\u00edses \ndistintos del nuestro.  \nDesde su traslado a los  E.U.A. Benjam\u00edn vivi\u00f3 en la Ciudad  de Ithaca, N.Y., donde \u00e9l y su esposa \ntuvieron la dicha de estar en cercana convivencia con sus hijas  y nietos, a quienes adoraba.  \nEl Dr. Lucio fallece  de manera inesperada y s\u00fabita el 15 de junio del 2013, en la sala de urgencias del  \nCentro M\u00e9dico de Cayuga, en  Ithaca, N.Y. Le sobreviven su amada esposa Eglantina Zavaleta de Lucio , sus \nhijas Eglantina y Araceli  y sus nietos, familia que orgullosamente encabez\u00f3 y apoy\u00f3 hasta el \u00faltimo  d\u00eda de su \nvida.  XXXIX CONVENCI\u00d3N ANUAL DE LA ASOCIACI\u00d3N \nNACIONAL DE ESPECIALISTAS EN CIENCIAS AV\u00cdCOLAS  \n \n63rd WESTERN POULTRY DISEASE CONFERENCE  \n \nBENJAM\u00cdN LUCIO MART\u00cdNEZ  \n1942- 2013  \n \n \n \nIt is with great admiration, respect, appreciation, and gratitude that this Conference is dedicated to the \nmemory of Dr. Benjamin Lucio Mart\u00ednez, promoter, founder, and first President of ANECA from 1970 to \n1972.  \nThe statutes of this rising Association we re signed by Drs. Benjamin Lucio Mart\u00ednez, Armando Antill\u00f3n \nRionda, Hugo Funes Cata\u00f1o, Miguel \u00c1ngel M\u00e1rquez Ruiz, Jos\u00e9 Villase\u00f1or Michel, Alejandro Cuadra Germ\u00e1n \nand Jes\u00fas Estudillo L\u00f3pez (RIP).  \nBenjamin Lucio Mart\u00ednez was born February 1, 1942 in Mexico City. From a very early age he showed \ninterest in poultry production, raising some hens at his father\u2019s house, and later for several years, in a small henhouse with his brother Sergio (RIP). In 19 64 Benjamin Lucio completed his bachelor\u2019s degree at the \nNational School of Veterinary Medicine and Husbandry (ENMVZ) of the National Autonomous University of Mexico (UNAM). Both his professional and family history started simultaneously in 1966 when he ea rned his \nDVM degree and few days later, married his girlfriend Dr. Eglantina Zavala Beckler, establishing an \nexemplary marriage that lasted a lifetime. A year later (1967) they both earned scholarships to study at the \nCornell Graduate School at Cornell University. In 1969, Benjamin completed his MSc degree in the Poultry Diseases Department of the Veterinary College of the State of New York, USA. He returned to Mexico in April 1969 full of enthusiasm and up- to-date knowledge of poultry diseases, joining the  ENMVZ team; first \nas an Assistant Professor and through a productive CV, reaching the maximum academic category as Professor Type C until he retired from the UNAM in 1986.  During his first stage as Professor at the UNAM (1967 -1977), Dr. Lucio contributed to the \nmodernization of the avian diagnostic elements available in the Avian Pathology Laboratory, whose director \nwas Dr Alejandro Cuadra German, where poultry farmers and veterinarians received diagnostic and technical support.  \nDr. Lucio, along with Dr.  Armando Antillon Rionda (who had recently returned from completing his \nMSc degree at the University of Connecticut, USA) and Dr. Cuadra, transformed the laboratory into the \nPoultry Production Department. Dr. Lucio\u2019s and the other Drs. efforts to increase the avian pathology \neducation level went beyond when they promoted and established the academic principles to create post -\ngraduate degrees with the support of distinguished professors of the ENMVZ and its Dean, Dr. Pablo Zierold \nReyes. The first post graduate degree established was the Avian Pathology Specialty in the beginning of the 70s. This fact transformed the Veterinary Medicine and Husbandry School. After that, the Avian Pathology \nSpecialty evolved into the Animal Production Specialty: Poultry, and s oon was greatly acknowledged in \nMexico and overseas, receiving students from Central and South America, several of which, when they \nreturned back home, became fundamental pieces for the development of a more modern, developed, and sustainable avian medicin e program. From 1973 to 1975, Dr. Lucio\u00b4s contribution  became even more relevant  \nwhen he was head of the Animal Production Department: Poultry, incorporating new professors, diversifying the technical diagnosis areas, and taking advantage of the basis established by the previous heads of the \nDepartment, which greatly increased the contact with the national poultry sector.  \nOne of the great contributions of Dr. Lucio to the Animal Production Department: Poultry was inviting \ngreat international researchers such as Drs. P.P. Levine and Henry E. Adler. Both contributed knowledge and \ndiscipline, which in turn helped to improve the quality of teaching, research, and diagnosis.  \nBenjamin Lucio was also head of the Postgraduate Studies Division of the FMVZ (1976). He promoted \nthe constant review and update of the postgraduate study programs, stimulating research and scientific \nknowledge by disseminating it through scientific journals publications and the organization of courses and \nconferences.  \nIn 1977 Dr. Lucio and his wife Eglantina earned another scholarship from Cornell University to \ncontinue their postgraduate studies. During his two periods as a postgraduate student at Cornell, Dr. Lucio carried out research on various viruses working under the experienced guidance of the famous poultry researcher Stephen B. Hitchner. Once completing their PhD studies, Dr. Lucio and Eglantina rejoined the \nFMVZ of the UNAM as full time professors and researchers in early 1980.  \nDr. Lucio\u00b4s interest in updating the knowledge of poultry professionals led to the planning, organization, \nand creation of the Poultry Production Specialty through the Open University System with the support of the \ngroup of professors of the Animal Production Department: Poultry. Soon other areas of the FMVZ  developed \nstudy plans under that novel teaching method. During 1969- 1976 and 1980- 1986 (first and second periods Dr. \nLucio worked at the UNAM) Dr. Lucio worked as undergraduate professor of Poultry Clinics and as a postgraduate professor of Poultry Diseas es, contributing to the education of numerous specialists in Poultry \nMedicine, several of which became professors and researchers in a number of universities in Mexico and overseas while others worked in the poultry and pharmacology industries.  \nDr. Lucio studied the main viral diseases of domestic poultry, and was the first researcher to confirm the \npresence of several diseases in Mexico, such as infectious bursal disease, inclusion body hepatitis, egg drop \nsyndrome, and viscerotopic velogenic Newcastle Di sease caused by unusually virulent strains such as the \nChimlhuacan strain.  He worked in many other important poultry topics and was co -author of several poultry \ndisease books.  \nIn 1986 he quit his job at the UNAM and started working at Cornell University as a visiting professor. A \nyear later he became Senior Research Associate II in the Department of Avian and Aquatic Animal Medicine, \nand in 1989 became Associate Professor, investigating significant poultry diseases.  \nDuring his last years as professor at the UNAM, he was the head of a work team formed by the \nprofessors of the Animal Production Department: Poultry, which had the objective of developing a plan to decentralize diagnostic and research functions of the Department, which, they thought, had to be in charge of \na Poultry Research Center established somewhere outside Mexico City and close to a poultry production area. This was certainly the most ambitious project Dr. Lucio had, but he already faced some economic and administrative limitations of the Institution to carry out high level research studies.  \nUnfortunately, this project in spite of its viability and the need of research that the animal health \nsituation the poultry production demanded, did not have the support needed, which led to its suspen sion. Dr. \nLucio\u2019s vision and talent were completely wasted. However, he began a successful career in his second \u201cAlma Mater,\u201d Cornell University, where he was able to continue important research of infectious diseases such as Salmonella Enteriditis, canary  pox, parrot pox, Tragopan Herpesvirus, etc. Dr. Lucio shared all the \nknowledge he acquired in this research through interesting conferences and publications in scientific journals \nand specialized magazines.  \nFrom September 1980 until his retirement in Mar ch 2010 he was the Poultry Diagnostic and Extension \nServices Director of the Animal Health Diagnostic Laboratory in the College of Veterinary Medicine at Cornell University, which allowed him to have a close relationship with the poultry producers of the State of \nNew York.  \nDuring his life Benjamin Lucio received several awards and distinctions for his work; one of the most \nimportant being the ANECA dedicatory in its XIV Convention in April 1989 in Puerto Vallarta, Jalisco, \nMexico, exactly 25 years ago. Other prestigious professional organizations such as the American Association of Avian Pathologists and the Western Poultry Disease Conference have also recognized him for his \naccomplishments. His contributions to the Mexican and Latin American poultry production are undeniable  \nand of great impact. As Dr. Bruce Calnek and Ton Schat, important researchers and great friends of Dr. \nLucio, mentioned in the obituary published in the Journal of Avian Pathology , \u201cA real illustration of his \ninternational importance is his inclusion as an inaugural member of the World Veterinary Poultry Association\u2019s recently established Hall of Honor.\u201d  \nBenjamin was always close to ANECA as part of the Board of Directors or as counselor, lecturer, \nassistant, and as a member of the Former Presidents Board.  He always promoted harmony and improvement \nof our association, creating bonds with other international associations. His strong personality, honesty, strength of conviction, intelligence, long and remarkable work life, and kind heart always characterized him as the great teacher and the great friend he was.  \nThe fraternal student -teacher relationship Dr. Lucio promoted, contributed without a doubt to the \ndevelopment of honest bonds of friendship and cooperation, being this one of the main reasons why he is  \nremembered with deep affection by many distinguished avian pathologist colleagues.  \nIt is impossible to mention with great detail all the interesting aspects in the life of Benjamin Lucio \nMartinez, whose prestige as teacher, colleague, and friend parallel his impeccable image as husband, father and grandfather.  \nUndoubtedly, Benjamin is a n example and a reason to think about why people as valuable as him can \nonly express all their potential in a country different from Mexico. Since he moved to the U.S., Benjamin \nlived in Ithaca, N.Y. where he and his wife were close to their daughters and beloved grandchildren.  \nDr. Lucio died unexpectedly June 15, 2013 in the emergency room of the Cayuga Medical Center in \nIthaca, N.Y. He is survived by his beloved wife Eglantina Zavaleta de Lucio, his daughters Eglantina and \nAraceli, and his grandchildren.  He was a proud part of this family, which he led and supported until the last \nday of his life.  \n SIXTY -THIRD WESTERN POULTRY DISEA SE CONFERENCE  \nMEETING DEDICATION  \n \nHUGO MEDINA  \n \n \n \n  \nDr. Hugo Medina was born and raised in Mexico City. He obtained his Doctor of Veterinary Medicine at  \nNational University of Mexico and Master at University of Minnesota and became board certified Diplomat of \nAmerican College of Poultry Veterinarians.  \nDr. Medina began his poultry veterinary career as Production Manager -Veterinarian for San Antonio Farms i n \nMexico then Technical Service Veterinarian for Central Soya, Veterinarian -Manager Health Services for Foster \nFarms, Director of Veterinary Services for Jennio -O, Veterinarian Health Services for Sparboe and finally Director \nof Animal Health for Center Fr esh Egg Farms.  His contributions to the poultry industry included: implementing \nvaccination, biosecurity and hatchery practices to reduce APV incidence; AI Preparedness Manual and reduction of Peritonitis in Table Egg Layers.  He published/presented numerou s papers at  WPDC and ANECA, AAAP -AVMA, \nMinnesota Turkey Growers Conference, Midwest Poultry Federation Convention and in Avian Diseases. He was \nFounder and Chair of State of California Biosecurity Committee, Program Chair of 1994 WPDC -   ACPV workshop \non P oultry Mycoplasma, President of 1995 WPDC -   Program Chair ACPV workshop on Infect ious Bronchitis in \nchickens, Program Chair ACPV workshop on Environmental Effects on Production, President of the Board ACPV \nand Chair of Minnesota Turkey Growers Association's Avian Pneumovirus Committee.  \nDr. Hugo Medina  of Plymouth, Minne sota, died from a rare type of anapl astic thyroid cancer on November 30, \n2012 at age 66. He is survived by his wife of 36 years , Cindy  Hawker -Medina; his brother Roldolfo;  sisters Alicia \nPalero and Patricia Killian ; and nine nieces and nephews, all from Mexico.  \nCenter Fresh Egg Group establi shed a $25,000 \"Dr. Hugo Medina Scholarship Fund for Veterinary Medicine\" \nat Iowa State University. Memorials can be sent to that fund c/o Center Fresh Group, 241 Saint Andrews Way, Sioux Center, Iowa 51250.  \nDr. Hugo Medina's passion for food production an d animal care remained inspirational throughout his carreer. \nHugo Medina was a valued fr iend and colleague. Hugo was a heck of a nice guy. H e left us too soon and will be \nsorely missed.  \n63rd WESTERN POULTRY DISEASE CONFERENCE  \nDEDICATORIA  \n \nHUGO MEDINA  \n \n \n \n \n El Dr. Hugo Medina naci\u00f3 y creci\u00f3 en la Ciudad de M\u00e9xico. Realiz\u00f3 sus estudios de medicina \nveterinaria en la UNAM y una maestr\u00eda en la Universidad de Minnesota. Lleg\u00f3 a ser un diplom\u00e1tico \ncertificado del C onsejo del Colegio Americano de Veterinarios Especialistas en Aves.  \nEl Dr. Medina comenz\u00f3 su carrera en l a avicultura veterinaria como  Gerente de Producci\u00f3n en las \nGranjas San Antonio en M\u00e9xico. Posteriormente ejerci\u00f3 como  MVZ en el \u00e1rea T\u00e9cnica de Central Soya, \nGerente de Servicios de Salud en Foster Farms, Director de Servicios Veterinarios en Servicios \nVeterinarios de Salud de Jennio -O, MVZ de Servicios de Salud en Sparboe y finalmente Director de \nSalud Animal en Center Fresh Egg Farms. Sus contribuciones a la industria av\u00edcola incluyen: \nimplementaci\u00f3n de vacunaci\u00f3n, bioseguridad y pr\u00e1cticas en la incubadora para reducir la incidencia de \npneumovirus aviar ; un manual para la preparaci\u00f3n de IA en aves y la reducci\u00f3n de peri tonitis en huevo \npara consumo. Public\u00f3 y present\u00f3 un gran n\u00famero de art\u00edculos en WPDC y ANECA, AAAP -AVMA, \nConferencia de Productores de Pavo en Minnesota, Convenci\u00f3n de la Federaci\u00f3n Av\u00edcola del Medio Oeste y en Enfermedades Aviares. Fue fundador y preside nte del Comit\u00e9 de Bioseguridad del Estado de \nCalifornia , Director de Programa del seminario de Mycoplasma Aviar, Presidente del WPDC en 1995, \nPresidente del Programa del Seminario de Bronquitis Infecciosa Aviar de  ACPV , Preside nte del \nPrograma del Seminari o Sobre los Efectos del Medio Ambiente en la Producci\u00f3n de ACPV , Presidente \ndel consejo de ACPV y Presidente del Comit\u00e9 del Pneumovirus Aviar de la Asociaci\u00f3n de Criadores de \nPavo.  \nEl Dr. Hugo Medina, de Plymouth, Minnesota, muri\u00f3 de un raro tipo de c\u00e1ncer tiroidal anapl\u00e1stico \nel 30 de noviembre del 2012 a la edad de 66 a\u00f1os. Le sobreviven su esposa por  36 a\u00f1os, Cindy Hawker -\nMedina, su hermano Rodolfo, sus hermanas Alicia Palero y Patricia Killian y nueve  sobrinos, todos en \nM\u00e9xico.  \nEl Center Fresh Egg Gro up estableci\u00f3 la  \u201cBeca  de la Fundaci\u00f3n Dr. Hugo Medina Para Medicina \nVeterinaria\u201d en la Universidad Iowa State.  Memoriales pueden ser enviados a dicha fundaci\u00f3n o al Center \nFresh Group,  241 Saint Andrews Way, Sioux Center, Iowa 51250.  \nLa pasi\u00f3n del Dr. H ugo Medina por la producci\u00f3n de alimentos y el cuidado animal fueron de \ninspiraci\u00f3n durante toda su carrera. Hugo Medina fue valorado como amigo y colega. Era una persona \nextremadamente agradable. Nos dej\u00f3 muy pronto y ser\u00e1 profundamente extra\u00f1ado.  \n \nSPECIAL ACKNOWLEDGMENTS  \n \nThe 63rd Western Poultry Disease Conference (WPDC) is honored to acknowledge the many contributions and \nsupport to the Conference.  The financial contributions provide support for outstanding presentations and to help pay \nfor some  of the costs of the Conference, thus helping us to maintain a relatively low registration fee for an \ninternational conference. More than 3 0 organizations, companies and individuals have  once again  given substantial \nfinancial support. Many companies and or ganizations, including some that also contribute financially, send speakers \nat no expense to the Conference.  We thank all these people, and acknowledge their support and contribution.  \nOnce again, the WPDC is forever grateful to our distinguished contribu tors and supports of the conference who \nare vital in making the conference a success. All our contributors and supporters are listed on the following pages.  \nWe greatly appreciate their generosity and sincerely thank them and their representatives  for supp orting  this year\u2019s \njoint meeting of  WPDC  and ANECA . \n We thank Dr. Ernesto Soto for his enthusiastic willingness to accept the position of Program Chair for this joint \nmeeting of the 6 3rd WPDC  and XXXIX ANECA.  He would like  to than k Rocio Crespo, Richard P.  Chin, Nestor \nLedesma, Julio Arellano , and David Frame for their extraordinary support.  \nMany have provided special services that contribute to the continued success of this conference. For this year\u2019s \njoint meeting, the WPDC and  ANECA have contracted Grup o Destinos (Mexico)  for providing accommodation  and \nregistration  support as well as the web site for the conference. We would like to thank  Ms. Anabel Jim\u00e9nez for her \nexceptional work with our conference.  \nWe thank Dr. David  Frame for editing and producing another outstanding Proceedings of this meeting. Dr. \nFrame is indebted to Mr. Dana Frame f or his meticulous proof reading and formatting of the Proceedings for \npublication. We acknowledge Bruce Patrick (Graphic Communications , Brigham Young University) for providing \nthe illustrations appearing  on the opening page . We express our gratitude to all authors who submitted manuscripts , \nand are especially appreciative of those who  submitted their manuscripts on time.  63rd WPDC CONTRIBUTORS LIST  \n(As of February  21, 2014 ) \n \n \nSUPER SPONSORS \n \nCEVA Animal Health  \nLibourne, France  \n \n \nBENEFACTORS  \n \nAmerican Association of Avian Pathologists  \nJacksonville, FL  \n \n \nPATRONS  \n \nAlltech  \nLexington, KY  \n \nBayer Health care LLC  \nShawnee Mission, KS  \n \nCobb Vantress  \nSiloam Springs, AR  \n \nFoster Poultry Farms , LLC  \nLivingston, CA  \n \nHuvepharma, Inc.  \nNew Oxford, PA  \n \nHygieia Biological Laboratories  \nWoodland, CA  \n \nIDEXX Lab oratorie s, Inc.  \nWestbrook, ME  \n \nMerial  Select Inc.  \nGainesville, GA  \n \nZoetis -  Diagnostics  \nMadison, NJ  \n     DONORS  \n \nAviagen North America, Inc.  \nHuntsville, AL  \n \nCalifornia Poultry Federation, Inc. \nModesto, CA  \n \nCharles River  \nStorrs, CT  \n \nChr. Hansen, Inc.  \nMilwaukee, WI  \n \nCutler Associates  International  \nMoorpark, CA  \n \nDr. G . Yan Ghazikhanian, DVM, PhD, DACPV  \nSonoma, CA  \n \nHy-Line International  \nDallas Center, IA  \n \nMerck Animal Health  \nMillsboro, DE  \n \nPhibro Animal Health  \nFairfield, NJ  \n \nPoultry Health Services , Ltd.  \nAirdrie, AB, Canada  \n \nSunrise Farms  \nCatskill, NY  \n \nVega Farms  \nDavis, CA  \n \nVeterinary Service, Inc.  \nSalida, CA  \n \n     SUSTAINING MEMBERS \n \nAnimal Health International  \nCeres, CA  \n \nArthur A. Bickford, VMD, PhD  \nTurlock, CA  \n \nBioChek USA  Corporation  \nScarborough, ME  \n \nMasakazu Matsumoto, DVM, PhD  \nCorvallis, OR  \n \nPreserve International  \nTurlock, CA  \n \n  \nFRIENDS OF THE CONFERENCE  \n \nCanadian Poultry Consultants, Ltd.  \nAbbotsford, BC, Canada  \n \nDemler Enterprises  \nWasco, CA  \n \nDr. Marion A. Hammarlund, DVM  \nRiverside, CA  \n \nJ.S. West Milling Company \nModesto, CA  \n \nMerrill\u2019s Poultry Farm, Inc.  \nPaul, ID  \n \nRichard Yamamoto, PhD  \nDavis, CA  \n    \n63rd WESTERN POULTRY DISEASE CONFERENCE OFFICERS  \n \nPresident  \nDr. Portia Cortes  \nUSDA APHIS VS  \n10365 Old Placerville Rd, Ste.210  \nSacramento, CA  95827  \n \nProgram Chair  \nDr. Ernesto Soto -Priante  \nLaboratorio Avi -Mex, SA de CV  \nDurango 136 Int. 301- B \nColonia Roma  \nMexico, D.F. 06700, Mexico  \n \nProgram Chair -elect  \nDr. Shahbaz Haq  \nLakeside Poultry Veterinary Services Inc  \nUnit-A, 240 Graff Avenue  \nStratford, ON   N5A  6Y2 \nCanada  Meeting Support Chair  \nDr. Yan Ghazikhanian  \n \n       Proceedings Editor  \nDr. David Frame  \nUtah State University  \nCooperative Extension  \n325 West 100 North  \nEphraim, UT 84627  \n \nSecretary -Treasurer  \nDr. Richard P. Chin  \nCalifornia Animal Health & Food Safety  \nLaboratory System - Tulare  \n18830 Road 112  \nTulare , CA   93274- 9042  \nrpchin@ucdavis. edu \n \n \n63rd WPDC PROCEEDINGS  \n \nThe Proceedings  of the  63rd Western Poultry Disease Conference are not refereed, but are presented as a \nservice and a source of information to those attending the conference and to others who wish to gain some insight as \nto the information presented.  Copies of the 63rd WPDC Proceedings are available in  electronic  format  only.  \n \n Copies of these Proceedings are available from:  Dr. R. P. Chin  \nCAHFS -Tulare  \nUniversity of California, Davis  \n18830 Road 112  \nTulare, CA   93274- 9042  \nrpchin@ucdavis.edu \n \n Price per copy (includes shipping & handling):  Electronic format  only \n      US$2 5.00 for USA shipment.  \nUS$22.00 for AAAP members and orders of 5 or more for USA.  \nUS$2 8.00 for Canada and Mexico.  \nUS$30.00 for all other countries.  \n \n. \n WESTERN POULTRY DISEASE CONFERENCE (WPDC) HISTORY  \n \nYEAR      PRESIDENT   PROGRAM CHAIR   DEDICATION      RECOGNITION  \n \n1st   WPDC \u2013  1952    A. S. Rosenwald    \n2nd  WPDC \u2013  1953    P. D. DeLay   A. S. Rosenwald    \n3rd   WPDC \u2013  1954    C. M. Hamilton   Kermit Schaaf    \n4th   WPDC \u2013  1955    E. M. Dickinson  W. H. Armstrong    \n5th   WPDC \u2013  1956    D. E. Stover   E. E. Jones    \n6th   WPDC \u2013  1957    D. V. Zander   H. E. Adler    \n7th   WPDC \u2013  1958    H. E. Adler   E. E. Jones    \n8th   WPDC \u2013  1959    R. D. Conrad   L. G. Raggi    \n9th   WPDC \u2013  1960    L. G. Raggi   A. S. Rosenwald    \n10th WPDC \u2013  1961    A. S. Rosenwald  D. V. Zander    \n11th WPDC \u2013  1962    D. V. Zander   R. V. Lewis    \n12th WPDC \u2013  1963    R. V. Lewis   Walter H. Hughes    \n13th WPDC \u2013  1964    W. H. Hughes   Bryan Mayeda    \n14th WPDC \u2013  1965    B. Mayeda   R. Yamamoto    \n15th WPDC \u2013  1966    R. Yamamoto   David S. Clark  \n(1st sign of Contributors)    \n16th WPDC \u2013  1967    D. S. Clark   Roscoe Balch    \n17th WPDC \u2013  1968    R. Balch    Richard McCapes    \n18th WPDC \u2013  1969    R. McCapes   Dean C. Young   \n19th WPDC \u2013  1970    D. C. Young    W. J. Mathey  \n  4th Poultry Health Sym. (PHS)     \n  1st combined WPDC & PHS   \n  1st listing of distinguished members  \n20th WPDC \u2013  1971    W. J. Mathey    Ramsay Burdett  \n5th PHS        \n21st WPDC \u2013  1972     R. Burdett    Marion Hammarlund  \n6th PHS        \n22nd WPDC \u2013  1973    M. Hammarlund  G. W. Peterson  \n7th PHS         \n23rd WPDC \u2013 1974    G. W. Peterson   Craig Riddell \n8th PHS       \n24th WPDC \u2013  1975    C. Riddell    Ralph Cooper  \n9th PHS         \n25th WPDC \u2013  1976    R. Cooper    Gabriel Galvan  \n10th PHS         \n26th WPDC \u2013  1977    G. Galvan    Don H. Helfer    Hector Bravo  \n11th PHS        \n27th WPDC \u2013  1978    D. H. Helfer   Art Bickford  \n12 PHS         \n28th WPDC \u2013  1979    A. Bickford  J. W. Dunsing  \n13th PHS       \n29th WPDC \u2013  1980    J. W. Dunsing    G. Yan Ghazikhanian   P. P. Levine  \n14th PHS  \n5th ANECA    Angel Mosqueda T.  \n30th WPDC \u2013  1981    G. Y. Ghazikhanian  Mahesh Kumar   \n15th PHS    \n31st WPDC \u2013  1982     M. Kumar    Robert Schock  \n16th PHS   \n32nd WPDC \u2013  1983    R. Schock    George B. E. West    \n33rd WPDC \u2013 1984    G. B. E. West   Gregg J. Cutler    \n34th WPDC \u2013  1985    G. J. Cutler   Don W. Waldrip   Bryan Mayeda  \n35th WPDC \u2013  1986    D. W. Waldrip   Duncan A. McMartin  J. A. Allen  \n11th ANECA     Jorge Basurto   Mario Padron     A. Tellez -G. Rode  \n YEAR      PRESIDENT   PROGRAM CHAIR   DEDICATION      RECOGNITION  \n \n36th WPDC \u2013  1987    D. A. McMartin  Marcus M. Jensen    \n37th WPDC \u2013  1988    M. M. Jensen   Barry Kelly    A. S. Rosenwald   \n38th WPDC \u2013  1989    B. Kelly    Masakazu Matsumoto  Louise Williams  \n39th WPDC \u2013  1990    M. Matsumoto   Jeanne M. Sm ith  Dean Young \n40th WPDC \u2013  1991    J. M. Smith    Richard P. Chin   A. S. Rosenwald  \n16th ANECA    Martha Silva M .  David Sarfati M.    A. S. Rosenwald  \n41st WPDC \u2013  1992    R. P. Chin    Rocky J. Terry    Marcus Jensen   Henry E. Adler*  \nR. A. Bankowski  \nC. E. Whiteman  \n42nd WPDC \u2013  1993    R. J. Terry    A. S. Dhillon    W. W. Sadler   Royal A. Bagley  \n43rd WPDC \u2013 1994    A. S. Dhillon   Hugo A. Medina   G. B. E. West  \n44th WPDC \u2013  1995    H. A. Medina   David D. Frame    W. M. Dungan*   A. J. DaMassa  \n                   Gabrie l Galvan  \nWalter F. Hughes  \nW. D. Woodward  \nR. Yamamoto  \n45th WPDC \u2013  1996    D. D. Frame    Mark Bland     Don Zander    Pedro Villegas  \n21st ANECA    R. Salado C.    G. Tellez I.     M. A. Marquez   Ben Lucio M.  \nMariano Salem  \nVictor Mireles  \nCraig Riddell \n46th WPDC \u2013  1997    Mark Bland   James Andreasen, Jr.   Bryan Mayeda   Roscoe Balch  \nPaul DeLay  \nJ. W. Dunsing  \nDon Helfer  \nD. E. Stover  \n47th WPDC \u2013  1998    J. Andreasen, Jr.  H. L. Shivaprasad   W. J. Mathey   Marcus Jensen  \nDuncan McMartin  \n48th WPDC \u2013  1999    H. L. Shivaprasad  R. Keith McMillan    \n49th WPDC \u2013  2000    R. K. McMillan   Patricia Wakenell   R. P. Chin    Ralph Cooper  \nRobert Tarbell  \n50th WPDC \u2013  2001    P. Wakenell   Ken Takeshita        Don Bell  \nArt Bickford  \n51st WPDC \u2013  2002     K. Takeshita    Barbara Daft     Hiram Lasher    Bachoco S.A. de C.V.  \n27 ANECA     J. Carillo V.    Ernesto P.  Soto        Productos Toledano S.A.  \n \n52nd WPDC \u2013  2003    B. Daft    David H. Willoughby      Roland C. Hartman  \n53rd WPDC \u2013 2004    D. H. Willoughby  Joan Schrader        G. Yan Ghazikhanian  \n54th WPDC \u2013  2005    J. Schrader   Stewart J. Ritchie   W.D. Woodward  R. Keith McMillan  \n55th WPDC \u2013  2006    S. J. Ritchie   Peter R. Woolcock       M. Hammarlund  \n56th WPDC \u2013  2007    P.R. Woolcock   Bruce Charlton    R. Keith McMillan  M. Matsumoto  \n57th WPDC \u2013  2008    B. Charlton    Rocio Crespo     A. S. Rosenwald*   B. Daft  \n33rd ANECA     M. A. Rebollo F.   Maritza Tamayo S.    A. S. Rosenwald*   Ernesto \u00c1vila G.  \n58th WPDC \u2013  2009    R. Crespo    Victoria Bowes        G.L. Cooper  \n59th WPDC -  2010    V. Bowes    Nancy Reimers    \n60th WPDC -  2011    N. Reimers   Larry Allen        John Robinson  \n61st WPDC -  2012    L. Allen    Vern Christensen    \n62nd WPDC -  2013    V. Christensen   Portia Cortes    V\u00edctor Manuel   A. Singh Dhillon  \nMireles M.*  \n63rd WPDC \u2013 2014    P. Cortez    Ernesto Soto  P. \n39th ANECA    N\u00e9stor Ledezma M.   Ernesto Soto  P. \n64th WPDC \u2013 2015    E. Soto    Shahbaz Haq  \n  \n   *posthumous   \n MINUTES OF THE 6 2ND WPDC ANNUAL BUSINESS  MEETING  \n \nPresident Christensen  called the meeting to order on Mon day, March  25, 2013, at 5:08 PM, at the Holiday Inn \nCapitol Plaza, Sacramento, CA . There were 23 people in attendance.  \n \nAPPROVAL OF 61st WPDC BUSINESS MEETING MINUTES  \n \nThe minutes from the 61st WPDC business meeting were reviewed and a motion was carried to approve them \nas printed in the Proceedings of the 6 1st WPDC.  \n \nANNOUNCEMENTS  \n \nDr. Christensen  acknowledged all the contributors; in particular, Ceva Animal  Health and Zoetis, both of  \nwhich contribut ed at the  Super Sponsor level . In addition, Dr. Christensen  acknowledge d those at the  Benefactor \nlevel, which included the American As sociation of Avian  Pathologists  and Merck Animal Health . He also thanked \nall the contributors for their generous donations. Th e efforts of the current WPDC officers were acknowledged for \ntheir work and participation in the organization of this year\u2019s meeting . \nDr. Christense n remembered those who passed away this year. This included Dr. Don Helfer, program chair in \n1977 and given the Special Recognition award in 1997, Dr. Hiram Lasher, to whom the 2002 conference was \ndedicated, and Dr. Hugo Medina, the program chair in 1994.  \nDr. Patricia Wakenell gave an update on Dr. George West who has Lewy body dementia.  \n \nREPORT OF THE SECRETARY- TREASURER  \n \nDr. R. Chin presented the Secretary -Treasurer report. The 61st WPDC in Scottsdale, AZ, turned out to be a \ngood one. Although there were only 165 registrants, there were contributions of $36,200 with an overall income of \n$77,355.  We were able to keep the expenses to $56,098, thus leaving a net gain of $21,247.  With this additional \nrevenue, currently, WPDC has $98,710 in savings.  \nContributions for this year\u2019s meeting ( 62nd WPDC) are the most we have had for a regular meeting  at $3 9,150. \nWith this outstanding amount of contribution, Dr. Chin predicts that we should com e out about even. One issue, \nWPDC did not meet its hotel guestroom block, thus incurring an additional $5017 for meeting room rental. Dr. Chin \nwill negotiate a lower guestroom block next time we meet in Sacramento.  \n \nREPORT OF THE PROCEEDINGS EDITOR  \n \nDr. Da vid Frame presented the Proceedings Editor report. T he proceedings book this year is obviously thinner \nthan previous years with a total of 50 papers  in the proceedings . Cost was about the same as last year. As in previous \nyears, t he flash drives were spons ored by Zoetis . \n \nFUTURE MEETINGS  \n \nIt was agreed to continue with the current rotation for meeting venues, with three  different locations, i.e., \nMexico, Canada,  and probably Arizona. The meeting will continue to return to Sacramento every other year.  \nIn 2014 , the 6 3rd WPDC wi ll be in Puerto Valla rta, Jalisco, Mexico , at the Sheraton Buganvilias , April 2 -5, \n2014 . ACPV will probably sponsor a workshop on Tues day, April 1, 201 4. (Ed. The WPDC Executive Committee \nmet with ANECA and began organizing next year\u2019s m eeting. A preliminary budget was developed making sure that \nwe would not lose money. The proceedings will be provided only in electronic format.)  \nIn 2015, the 64th WPDC  and ACPV workshop will be back in Sacramento, March 22 -25, 2015.  \nIn 2016, the 65th WPDC and ACPV workshop are  tentatively scheduled to r eturn to Vancouver, BC, Canada in \nlate April.  \n \n \n  \n WPDC EXECUTIVE COMMITTEE  \n \nDr. Christensen  reported that the WPDC Executive Committee nominated Dr. Shahbaz Haq  for Program Chair \nfor the 64th WPDC in 201 5. There were no other nominations  and Dr. Shahbaz  was elected unanimously as program \nchair -elect. Dr. Christensen  nominated the following officers for 201 3-2014: \n Program Chair: Dr. Ernesto Soto  \n President: Dr. Portia Cortes  \nPast-President: Dr. Vern Christensen  \nContri butions Chair : Dr. Yan Ghazikhanian  \nProceedings Editor: Dr. Dav id Frame  \nSecretary -Treasurer: Dr. Rich ard Chin  \nProgram Chair -elect: Dr. Shahbaz Haq  \nNominations for all office rs were closed and all nominees were approved unanimous ly. \n \nNEW BUSINESS  \n \nDr. Shivaprasad made a motion to rename the meeting to \u201cThe A.S. Rosenwald Western Poultry Disease \nConference.\u201d The motion died due to lack of a second.  \nDr. Re imers moved that we establish the A .S. Rosenwald  Extension Lecture position with d etails to be worked \nout by the WPDC E xecutive Committee.  This motion was seconded  and approved unanimously.  It was decided that \nthe program chair would recommend the person for the lecture to the WPDC Executive Committee f or approval.  \nDr. Christensen stated that CE credits will be emailed to everyone by the AAAP /ACPV  office. There were no \nadditional items for discussion.  \nDr. Christensen  turned the presidency over to Dr. Portia Cortes who acknowledged those who helped her \norganize this year \u2019s meeting. She then a djourned the annual business meeting at 5:47 PM. \n AGRADECIMIENTOS  \n \nAgradecemos la colaboraci\u00f3n con el grupo que por parte de la WPDC integraron el Dr. \nRichard Chin, el Dr. Ernesto Soto, la Dra. Roc\u00edo Crespo y el Dr. David Frame, con quienes \ntrabajamos intensamente para hacer posible este evento.  \n \n \nAGRADECEMOS TAMBI\u00c9N  \nA NUESTROS LEALES PATROCINDORES  \n \n\u2022 Alltech  de M\u00e9 xico S.A de C.V.  \n\u2022 Anglo Corp. S.A. de C.V.  \n\u2022 AVEPSA S.A. de C.V.  \n\u2022 Alta T ecnolog\u00eda Industrial para la Salud Animal S.A. de C.V.  \n\u2022 Bayer de M\u00e9xico S.A. de C.V.  \n\u2022 Boehringer Ingelheim Vetm\u00e9dica S.A. de  C.V.  \n\u2022 B.M. Editores  \n\u2022 CEVA S.A. de C.V.  \n\u2022 GSI Cumberland de Mexico S. de R.L. de C.V.  \n\u2022 Diamond V  de M\u00e9 xico S. de R.L. de C.V.  \n\u2022 Eli Lilly y Compa\u00f1\u00eda de M\u00e9 xico, S .A. de C.V. \n\u2022 Investigaci\u00f3n Aplicada S.A. de C.V.  \n\u2022 Laboratorios Sanfer S.A. de C.V.  \n\u2022 Laboratorio Avi-Mex S.A. de C.V.  \n\u2022 Lapisa  S.A. de C.V. \n\u2022 Los Avicultores y su E ntorno S.A. de C.V.  \n\u2022 Lubing Mesoamericana  S.A  de C.V.  \n\u2022 MSD Animal Health \n\u2022 Merial M\u00e9xico S.A. de C.V.  \n\u2022 BFI Innovations Mexico S.A. de C.V.  \n\u2022 Pisa Agropecuaria S.A. de C.V.  \n\u2022 Premezclas de M\u00e9xico S.A. de C.V.  \n\u2022 Secretar\u00eda de Agricultura , Ganader\u00eda, Desarrollo Rural, Pesca y \nAlimentaci\u00f3n (SAGARPA)  \n\u2022 Sistemas Agropecuarios JAT S.A. de C.V.  \n\u2022 Zoetis  M\u00e9xico S. de R.L. de C.V. \n\u2022 Zinpro Nutricion Animal S. de R.L. de C.V.  \n XXXIX CONVENCI\u00d3N ANUAL DE LA ASOCIACI \u00d3N NACIONAL \nDE ESPECIALISTAS EN CIENCIAS AV\u00cdCOLAS A. C. (ANECA)  \nPRESIDENTE  \nNestor Ledesma Mart\u00ednez  \nVICEPRESIDENTE  \nPilar Casta\u00f1eda Serrano  \nVOCAL  \nRoberto Se\u00f1as Cuesta  \nMargarita Arreguin Nava \nTESORERO  \nOtilio Ortiz Garc\u00eda  \nSECRETARIO  \nOdette Urquiza Bravo  \nGERENTE ADMINISTRATIVO  \nJulio Arellano Rodriguez  \nCOMIT\u00c9 TECNICO  \nMaritza Tamayo Salmor\u00e1n  \nCecilia Rosario Cort\u00e9s  \nRub\u00e9n Merino Guzm\u00e1n  \nRELACIONES COMERCIALES  \nJuan Manuel Bustos Flores  \nRam\u00f3n Morales Bello  \nCOORDINADOR DE ASOACIACIONES REGIONALES  \nLuis Arturo Suazo Orozco  \nCOORDINADOR EXPRESIDENTES  \nLuis Arturo Suazo Orozco  \nCOORDINADOR CONVENCI\u00d3N ANECA & WPDC 2014  \nErnesto Soto Priante  HISTORIA DE LA ASOCIACI\u00d3N NACIONAL DE ESPECIALISTAS  \nEN CIENCIAS AV\u00cdCOLAS, A.C. (ANECA)  \n \nCONVENCI\u00d3N  PRESIDENTE  PERIODO  COORDINADOR   \nDEL PROGRAMA  DEDICACI\u00d3N  \n Benjam\u00edn Lucio Mart\u00ed nez 1970 -1972    \n Jose A. Villase\u00f1or Michel  1972 -1973    \nI Alejandro Cuadra Germ\u00e1n  1973 -1974  Alejandro Cuadra   \nII Miguel A. M\u00e1 rquez Ruiz  1974 -1976  Miguel A. M\u00e1 rquez   \nIII Antonio Berna Santos  1976 -1977  Antonio Berna   \nIV Jorge Basurto Bello  1977 -1979  Jorge Basurto   \nV & 29th WPDC  Angel Mosqueda Taylor  1979 -1980  Angel Mosqueda   \nVI Miguel A. M\u00e1rquez Ruiz  1980 -1981  Miguel A. M\u00e1rquez  Alejandro Cuadra Germ\u00e1n  \nVII Luis Villase\u00f1or Michel  1981 -1982  Luis Villase\u00f1or   \nVIII Carlos L\u00f3 pez Coello  1982 -1983  Carlos L\u00f3 pez Coello   \nIX Francisco J. Aranda Torres  1983 -1984  Francisco J. Aranda   \nX Jorge Basurto Bello  1984 -1985  Jorge Basurto   \nXI & 35th WPDC  Jorge Basurto Bello  1985 -1986  Mario Padr\u00f3n  Alfredo T\u00e9llez Gir\u00f3n Rode  \nXII Bernardo Lozano Dubernard  1986 -1987  Bernardo Lozano  Martin B\u00e4 chtod  G\u00f3mez  \nXIII Manuel Golzarri Moreno  1987 -1988  Manuel Golzarri  Felipe Flores Romero  \nXIV David Sarfati Mizrahi  1988 -1989  David Sarfati  Benjam\u00edn Lucio Martinez  \nXV Manuel Venegas Vilchis  1989 -1990  Manuel Venegas  Jorge Basurto Bello  \nXVI & 40th WPDC  Martha Silva Maldonado  1990 -1991  David Sarfati  Arnold S. Ro senwald  \nXVII  Jose A. Varona Beascoechea  1991 -1992  Jose A. Varona  Ernesto Cortes Miranda  \nXVIII  Eduardo Lucio Decanini  1992 -1993  Eduardo Lucio  Armando Antill\u00f3n Rionda  \nXIX Francisco Baez Medina  1993 -1994  Francisco Baez  Jesus Estudillo Lopez  \nXX Hugo Galicia Becerril  1994 -1995  Hugo Galicia  Fernando Galindo Ramirez  \nXXI & 45th WPDC  Ricardo Salado Carvajal  1995 -1996  Guillermo T\u00e9llez  Miguel A. M\u00e1 rquez Ruiz  XXII  Jose A. Varona Beascoechea  1996 -1997  Jos\u00e9 A. Varona  Fabi\u00e1n Uvi\u00f1a Luna  \nXXIII  Guillermo Tellez Isa\u00edas  1997 -1998  Guillermo T\u00e9llez  Carlos Lopez Coello  \nXXIV  Agustin Torres Islas  1998 -1999  Agust\u00edn Torres  Carlos Barra\u00f1\u00f3 n Jaled  \nXXV  Guillermo Luna O rtiz. 1999 -2000  Guillermo Luna  Expresidentes  ANECA  \nXXVI  Maritza Tamayo Salmor\u00e1 n 2000 -2001  Maritza Tamayo  Guadalupe Tijerina Garza     \nJorge Zurita Deja                                   \nErnesto B\u00e4 chtod G\u00f3 mez \nXXVII  Juli\u00e1n Carrillo Valad\u00e9 z 2001 -2002  Ernesto Soto  Carlos S\u00e1 nchez Widman  \nXVIII  Fernando De La Colina Trevi\u00f1o  2002 -2003  Fernando de la Colina  Ricardo Cuetos Collado  \nXIX Sergio Higuera Bonfil  2003 -2004  Sergio Higuera  Jose A. Quintana L\u00f3 pez \nXXX  V\u00edctor M. Petrone  Garc\u00eda  2004 -2005  Victor M. Petrone  Guillermo T\u00e9llez Isa\u00edas \nXXXI  Roberto Se\u00f1as Cuesta  2005 -2006  Roberto Se\u00f1as  Bernardo Lozano Dubernard  \nXXXII  Roberto Santiago  2006 -2007  Roberto Santiago  Alejandro Cuadra Germ\u00e1 n \nXXXIII  & 57th WPDC  Marco Rebollo Franco  2007 -2008  Ernesto Soto  Ernesto \u00c1vila  Gonz\u00e1lez  \nXXXIV  Maritza Tamayo Salmor\u00e1 n 2008 -2009  Maritza Tamayo  Gabriel Uribe  \nXXXV  Luis Arturo Suazo Orozco  2009 -2010  Miguel Angel Zamora  Susano Medina  Jaramillo  \nXXXVI  Luis Arturo Suazo Orozco  2010 -2011 Luis Arturo Suazo  Ram\u00f3n Lopez  Murgu\u00eda  \nXXXVII  Luis Arturo Suazo Orozco  2011 -2012  Luis Arturo Suazo  Angel Mosqueda  Taylor  \nXXXVIII  Nestor Ledesma Mart\u00ed nez 2012 -2013 Nestor Ledesma  Maritza Tamayo  Salmor\u00e1n  \nXXX IX & 63rd WPDC  Nestor Ledesma Mart\u00ed nez 2013 -2014  Ernesto Soto  Benjam\u00edn Lucio Mart\u00ednez  \n 63rd WPDC/XXXIX ANECA  AN\u00c1LISIS MOLECULAR DEL VIRUS DE INFLUENZA AVIAR \nH7N3 DE LOS BROTES PRESENTADOS EN LOS A\u00d1OS 2012 -2013  \n \nMOLECULAR ANALYSIS OF THE AVIAN INFLUENZA H7N3 \nFROM THE 2012-2013 OUTBREAK  \n \nA. Absal\u00f3nA, L. Garc\u00eda -BarreraA, D. Cort\u00e9s -EspinosaA, A. ToscanoB y E. Lucio -DecaniniB \n \nAInstituto Polit\u00e9cnico Nacional. CIBA Tlaxcala. Carr. Est. Santa Ines -Tecuexco mac Km 1.5, Tepetitla, Tlaxcala,  \nM\u00e9xico. Tel. +52 (55) 5729 6000 Ext. 87813  \nBInvestigaci \u00f3n Aplicada S.A. de C.V. M\u00e9xico  \n \nSUMMARY  \n \nAvian influenza virus has taken new significance  worldwide because of continuous outbreaks of different \nvarieties of the high pathogenicity viruses in several countries of  Asia, Africa and America, corresponding to H5N1, \nH7N3, H7N9 subtypes that had been  isolated from both  humans a nd birds. In this work , a phylogenetic analysis  is \npresented based on the HA gene from the strains of  avian influenza H7N3  from the 2012 \u2013 2013 outbreak.  Also, we \nhave anal yzed at a bio -informatic level the main characteristics of the HA protein and compare d it with the official \nvaccine strain. Based on this analysis we tried to give some explanations of the findings in the field about \npathogenesis  and antigenity of the virus.  \n \nRESUMEN  \n \nEl virus de la influenza aviar ha retomado importancia a nivel mundial  por los continuos brotes de variedades \nvirales de alta patogenicidad en diferentes pa\u00edses de Asia, Africa y America correspondientes a subtipos H5N1, \nH7N3, H7N9 que se han presentado en humanos y en aves. En este trabajo se presenta un an\u00e1lisis filogen\u00e9ti co con \nbase a la secuencias del gen HA de las cepas de influenza aviar H7N3 de los brotes que se presentaron en los a\u00f1os \n2012 \u2013 2013.  Adicionalmente, se anal\u00edzan a nivel bioinform\u00e1tico las caracter\u00edsticas principales de la prote\u00edna HA y \nse compara con la cepa vacunal oficial. Con base en este an\u00e1lisis se trata de dar explicaciones a las observaciones de campo sobre la patogenicidad y antigenicidad del virus.  \n \nINTRODUCCI\u00d3N  \n \nEl virus de la influenza aviar ha retomado importancia a nivel mundial por los continuos brotes de variedades \nvirales de alta patogenicidad en diferentes pa\u00edses de Asia, Africa y America correspondientes a subtipos H5N1, H7N3, H7N9 que se han presentado en humanos y en aves.  \nParticularmente en M\u00e9xico en \u00e9l \u00e1rea av\u00edcola, en las \u00faltimas dos d\u00e9cadas se han presentado dos brotes \nimportantes de influenza de alta patogenicidad. En 1994 se present\u00f3 el primer brote de influenza de alta patogenicidad subtipo H5N2 con repercusiones severas para toda la avicultura nacional. El segundo caso sever o de \ninfluenza de alta virulencia, se present\u00f3 el a\u00f1o pasado con un brote de influenza aviar del subtipo H7N3 que afect\u00f3 a \nlas principales zonas avicolas del pa\u00eds ocasionando cuantiosas p\u00e9rdidas  econ\u00f3micas. En el \u00faltimo tercio del 2012 la \nepidemia del brot e de este virus fue controlada; no obstante, en 2013 un nuevo brote de influenza de alta virulencia \ndel mismo subtipo H7N3 volvi\u00f3 a presentarse.  \nAdicionalmente, esta nueva variedad viral de influenza aviar tiene ligeros cambios antig\u00e9nicos con respecto al  \nvirus del 2012 y con respecto al virus vacunal utilizado en la formulaci\u00f3n de la vacuna. Esto le ha conferido la \ncapacidad de evadir la respuesta inmune humoral que induce la vacuna oficial en el hu\u00e9sped; es decir, que los \nanticuerpos que induce la vacuna  tienen menor capacidad de neutralizar al virus de campo de 2013. Por esta raz\u00f3n, \nse ha vuelto necesario el incremento a 4  dosis de vacuna en pollo de engorda para poder disminuir la mortalidad; lo \ncual representa el doble de la dosis que se aplica regular mente para proteger contra un brote de inf luenza aviar de \nalta virulencia.  \n \n \n 63rd WPDC/XXXIX ANECA  RESULTADOS  \n \nPrimeramente, se mencionan las caracter\u00edsticas de los dos principales genes y prote\u00ednas analizadas. La \nhemaglutinina de HA -AV Jalisco tiene un tama\u00f1o de 568 amino\u00e1cidos codificados en un marco de lectura de 1707 \nincluido un cod\u00f3n de t\u00e9rmino no codificante. Por su parte, la hemaglutinina HA -BV CPA tiene un tama\u00f1o de 560 \namino\u00e1cidos codificados en un marco de lectura de 1683 nucle\u00f3tidos incluido un cod\u00f3n de t\u00e9rmino no codificante. \nComo notoriamente se observa, la diferencia en tama\u00f1o entre las dos cepas es de ocho  amino\u00e1cidos (24 nucle\u00f3tidos).  \nPrimeramente se realiz\u00f3 la comparaci\u00f3n de la cepa HA -BV CPA con la cepa HA -AV Jalisco a nivel de nucle\u00f3tidos  \ny de amino\u00e1cidos. En  el anexo 1  de este documento se muestra un alineamiento simple de las dos secuencias de \nnucle\u00f3tidos realizados con la herramienta Blast disponible en l\u00ednea en la web de NCBI.  \nEl resultado de este an\u00e1lisis indica que el gen de la hemaglutinina HA -AV Jalis co tiene alta similitud con el \ngen de la hemaglutinina HA -BV CPA (94%). A nivel de amino\u00e1cidos, el % de similitud es de 96% entre estas cepas \n(Anexo 2). Sin embargo, aproximadamente la mitad de estas diferencias se deben a la inserci\u00f3n de los nucle\u00f3tidos que posees el gen HA -AV de campo en la regi\u00f3n localizada entre los nucle\u00f3tidos 1013 -1065.  \nEn el an\u00e1lisis de antigenicidad de las HA\u2019s se encontraron notables similitudes de ambas entre HA -AV Jalisco \ny HA-BV CPA como se resume en la Tabla 1  de este documento. En esta tabla se muestran los 21 mayores sitios \nantig\u00e9nicos de cada una de ellas, en ambos casos se trata de los mismos amino\u00e1cidos los que participan. Sin \nembargo resaltan dos sitios antig\u00e9nicos, uno de ellos y el de mayor impacto es e l sitio de ruptura de la prote\u00edna HA y \nque es el sitio determinante de virulencia. Este sitio es el que debe modificarse para obtener una de baja virulencia, \npero este hecho disminuye ligeramente la antigenicidad del sitio. El otro sitio de importancia que  se puede observar \nen las figuras 1A y 1B se encuentra alrededor del amino\u00e1cido 90 de ambas prote\u00ednas.  \n \nCONCLUSIONES  \n \nLas prote\u00ednas HA -BV CPA, HA- AV Jalisco y HA -BV Recombinante tienen altos porcentajes de similitud \nentre ellas y perfiles similares de anti genicidad.  \nPor otro lado, en este momento estoy trabajando en entender los extremos 5\u2019 y 3\u2019 del genoma viral. La raz\u00f3n \nde este estudio, se debe a que se ha reportado a que estos extremos son determinantes del nivel de expresi\u00f3n de lo mRNA virales, lo que se traducir\u00eda en un bajo nivel de expresi\u00f3n de prote\u00ednas virales. De igual forma estoy \nrealizando la comparaci\u00f3n de la neuraminidasa de la misma cepa.  \n \nREFERENCIAS  \n \n1. Rice,P. Longden,I. and Bleasby, A. (2000). The European Molecular Biology Open Software Suite \nTrends in Genetics. 16(6):276 \u2014277.  \n2. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. (1990) \"Basic local alignment search \ntool.\" J. Mol. Biol. 215:403- 410. \n 63rd WPDC/XXXIX ANECA  EARLY VACCINATION FOR PROTECTION AGAINST \nSALMONELLA  INFECTIONS OF POULTRY  \n \nLA VACUNACI\u00d3N TEMPRA NA EN LA PREVENCI\u00d3N DE INFECCI\u00d3N  \nPOR SALMONELLA EN LAS AVES  \n \nS. Aehle  \n \nTechnical Manager , Lohmann Animal Health International, Inc.  \n \nRESUMEN  \n \nEl buen manejo de incubadoras y la vacunaci\u00f3n de las gallinas de postura y de las reproductoras son la base de \nun programa de prevenci\u00f3n y control de Salmonella . La vacunaci\u00f3n de las aves en las incubadoras se ha utilizado \nampliamente como una intervenci\u00f3n temprana para reducir la infecci\u00f3n por salmonelas cuando los pollitos son m\u00e1s \nsusceptibles. Muchos estudios han demostrado el beneficio de la vacunaci\u00f3n temprana por medio de varios modos \nde acci\u00f3n, los cuales incluyen la estimulaci\u00f3n de la inmunidad innata tan temprano como 12 horas despu\u00e9s del nacimiento y los efectos de exclusi\u00f3n competitiva. Sin embargo, todas las intervenciones deben trabajar de manera \neficiente junto con las pr\u00e1cticas y operaciones de cr\u00eda actuales para que sean p r\u00e1cticas y econ\u00f3micas.  Se discutir\u00e1 \ninformaci\u00f3n relativa a las ventajas e inquietudes acerca de la vacunaci\u00f3n al d\u00eda de edad en la incubadora con vacunas de Salmonella, las pr\u00e1cticas de incubaci\u00f3n en la aplicaci\u00f3n d e una vacuna viva de Salmonella y el uso \nconcomitante de vacunas vivas de Salmonella y productos para la salud de las aves.  \n \nSUMMARY  \n \nGood hatchery management and vaccination of layers and breeders are the bases of a Salmonella \nprevention and control program.   Vaccination of poultry in the hatchery has been widely used as an early \nintervention to reduce infection by salmonellae when chicks are most susceptible.  Many studies have shown the \nbenefit of early vaccination by several modes of action including stimulation of innate immunity as early as 12 hours after hatch and competitive exclusion effects.  However, all interventions must work efficiently with current \nhatchery practices and operations to be practical and economical.  Information regarding advantages and concerns \nfor day of age hatchery spray vaccination with Salmonella vaccines, hatchery practices in the application of a live \nSalmonella vaccine and concurrent use of live Salmonella vaccines and products for poultry he alth will be \ndiscussed.  \n \n \nHatchlings are highly susceptible to Salmonella with infection by a few organisms resulting in rapid \ncolonization of the intestinal tract (7).  Infection of young birds results in heavier shedding of salmonellae and a \nlonger duration than occurs in older birds. Resista nce to Salmonella infection increases with age with older birds \nrequiring a higher level of salmonellae to become infected ( 6).  It is for these reasons that early vaccination of \npoultry, preferably at da y of hatch, should be used as a critical  intervention to reduce infection by salmonellae when \nchicks are most susceptible.   Passive immunity to progeny chicks has been exploited as an intervention to break the \nchain of infection vertically against salmonellae by vaccinating breeders with a combination of both live and killed  \nSalmonella vaccines (3,5,7). \nLive Salmonella vaccines  are strains of pathogenic bacteria that are weakened and, thus, no longer pathogenic.  \nVaccination with live vaccines is designed to stimulate maximal immunity and provide a first -line of defense that \ndirectly increases the level of resistance to Salmonella infection in the bird.  The mechanism  of resistance can be \ntwo-fold; one provided by the physical presence of the live vaccine organisms causing an exclusionary effect in the \ngut preventing colonization by other salmonellae,  and the other provided by early activation of cell -mediated \nimmune responses  that serve to block pathogens at the gut\u2019s \u201cportal of entry. \u201d  Pathogen pattern recognition \nreceptors  play an important role with toll -like receptors in stimulating early immune responses  (8,11).  V an \nImmerseel et al ( 13) showed early vaccination of chicks with a live Salmonella vaccine stimulated inna te immunity \nas early as 12 h  after hatch .  As a result  of the combination of a competitive exclusion effect and early onset of 63rd WPDC/XXXIX ANECA  immunity , a reduction of  Salmonella in intestinal colonization leads to reduced  fecal shedding into the environment  \n(2,9,10,12) .   \nVaccination with a live Salmonella  vaccine at one d  of age is the best opportunity for earliest colonization by \nthe vaccine when done at the hatchery or at placement.  Live vaccine organisms initially colonize the gut lining and \nprevent colonization by other Salmonella  sp.  Live Salmonella vaccines can be applied en masse using spray \napplication either in a hatchery spray cabinet or with a backpack portable sprayer.  Use of a food -grade  dye in the \nvaccine water  helps to visualize the spray pattern for full coverage of birds to ensure uniform administration of the \nvaccine.  Water stabilizer products are commercially available that neutralize iron and chlorine, and contain dye  that \naids in spray or drinking water application of live vaccines.  Bright lights provide an effective stimulus to encourage \nactive preening and uptake of the vaccine.  \nVaccination of breeders and g ood hatchery management is  a critical component  of a Salmonella prevention and \ncontrol program.  However, vaccination practices and resulting inherent immunity  must work efficiently with \ncurrent hatchery  and medication practices to be practical and economical.  Compatibility with other products used \nduring  the hatching of poultry to support the health of birds  must be considered.  Water stabilizers are often used in \nvaccine mixing water and in drinking water.  Vaccines, such as those used to protect against Newcastle disease \nvirus, infectious bronchitis virus, Marek\u2019s disease virus and coccidiosis, are administered either in ovo or soon after \nhatch.  Antibiotics,  such as gentamicin, are provided either in ovo or soon after hatch, for the prevention of early \nmortality associated with colibacillosis and paratyphoid bacteria .  Concurrent use of live Salmonella vaccines and \nthese  types of products should be investigated for their interference effects or compatibility with live Salmonella  \nvaccines prior to administration to birds  in the hatchery or at placement in the house.  \nVaccination with live Salmonella vaccines has been shown to be usef ul in reducing infections in poultry;  \nhowever , there are limitations with their use.  Live Salmonella vaccines have  the capability of protecting against \nserogroup s B and D, but cross protection against serogroups C and E is moderate ( 1,4).  Combining a vaccination \nprogram with  killed vaccines  to target specific serotypes  is needed for optimal protection against other serogroups , \nwith live vaccines inducing mucosal and cellular immunity and killed  vaccines providing long- lived systemic or \nhumoral immunity .  Including a live Salmonella vaccine in a primary breeder or layer prevention program should \nnot interfere with bacteriological or serological monitoring programs.   Live vaccines should be easily recognized \nand differentiated from wild -type salmonellae either biochemically or serologically.  Live bacterial vaccines are \nsusceptible to antimicrobial agents commonly used in poultry production and this can reduce or even eliminate their  \nefficacy if antimicrobials  are unintentionally left activated in vaccine water before spray or drinking water \nadministration.  Vaccination is not 100% effective; immune -compromised birds may become carrier s and can \npersistently shed the vaccine or wild -type organisms.  Additionally, a heavy burden of salmonellae in the \nenvironm ent can overcome the protective effects of vaccination.  \nA range of interventions should  be implemented in addition to vaccination to control salmonellae in young \npoultry including biosecurity, pest and rodent control, judicious use of antibiotics  and compe titive exclusion with \nprobiotics.  These interventions, if practiced and monitored vigilantly, will effectively reduce the incidence and \nprevalence of salmonellae infections of poultry.  Poultry are an important reservoir for Salmonella and shed and \nspread  are the modus operandi for horizontal transmission of infection to flockmates through contact and \nenvironmental contamination.  Use of a live Salmonella vaccine  to prevent colonization of  the gut early by wild -type \nsalmonellae and to  reduce shedding of the organisms will effectively control spread and the prevalence of \nsalmonellae in poultry.  \n \nREFERENCES  \n \n1. Bailey, J.  S., A. Rolon, C. L. Hofacre, P.  S. Holt, J.  L. Wilson, D. E. Cosby, L.  J. Richardson, and N.  A. \nCox.  Resistance to cha llenge of breeders and their progeny with and without competitive exclusion treatment to \nSalmonella vaccination programs in broiler breeders.  Int. J. Poult. Sci. 6:386- 392. 2007.  \n2. Berchieri, A. Jr. , and P.  A. Barrow.  Further studies on the inhibition of colonization of the chicken \nalimentary tract with Salmonella Typhimurium by pre -colonization with an avirulent mutant strain. Epidemiol. \nInfect.  104(3): 427- 441. 1990.  \n3. Dorea, F., D. J. Cole, C. Hofacre, K. Z amperini, D. Mathis, M.  P. Doyle, M.  D. Lee , and J.  J. Maurer.  \nEffect of Salmonella vaccination of chicken breeders on reducing carcass contamination of broiler chickens in \nintegrated poultry operations. Appl. Environ. Microbiol. 76:7820- 7825.  2010.  \n4. Hassa n, J. O., and R. Curtiss III.  Development and evaluation of oral vaccination program using live \navirulent Salmonella typhimurium  to protect vaccinated chickens against challenge with homologous and \nheterologous Salmonella serotypes. Infect. Immun. 62:5519 \u20135527. 1994.  63rd WPDC/XXXIX ANECA  5. Hassan , J. O., and R. Curtiss  III.  Effect of vaccination of hens with an avirulent strain of Salmonella \ntyphimurium  on immunity of progeny challenged with wild- type Salmonella strains. Infect. Immun.  64:938- 944. \n1996.  \n6. Holt, P. S . Effect of inducted molting on the susceptibility of white leghorn hens to a Salmonella enteritidis  \ninfection.   Avian Dis. 37:412\u2013 417. 1993.  \n7. Inoue, A. Y., J. B. Paiva, E. V. Sterzo, A. Berc hieri, Jr. , and A. Bernardino.  Passive immunity of progeny \nfrom broiler breeders vaccinated with oil -emulsion bacterin against Salmonella Enteritidis.  Avian Dis. 52(4):567-\n571. 2008.  \n8. Keestra, A.  M., M.  R. de Zoete, R  .A. van Aubel, and J.  P. van Putten. Functional characterization of \nchicken TLR5 reveals species -specific recognition of flagellin.  Mol. Immunol. 45:1298 \u2013 1307. 2008.  \n9. McReynolds, J.  L., R. W. Moore, A.  P. McElroy, B.  M. Hargis , and D.  J. Caldwell. Evaluation of a \ncompetitive exclusion culture and Megan Vac1 on Salmonella typhimurium  colonization in neonatal broiler \nchickens. J Applied Poult. Res. 16: 456- 463. 2007.  \n10. Methner, U., A. Berndt , and G. Steinbach.  Combination of competitive ex clusion and immunization using \nan attenuated live Salmonella vaccine strain in chickens. Avian Dis.  45:631- 638. 2001.  \n11. Ruan, W.  K., Y. H. Wu , J. An, and S. J. Zheng. Polymorphisms of chicken Toll -like receptors 4, 15, and 21 \nin different breeds. Poult . Sci. 91:2512\u2013 2516 . 2012.  \n12. Tellez, G., L. R. Bielke , and B. M. Hargis. Alternative Strategies for Salmonella Control in Poultry, \nSalmonella - A Dangerous Foodborne Pathogen, S . M. Mahmoud (Ed.), ISBN: 978 -953-307-782-6, InTech . 2012.  \n13. Van Immerseel F., U. Methner , I. Rychlik, B. Nagy, P. Velge, G. Martin, N. Foster, R. Ducatelle , and P.  A. \nBarrow.  Vaccination and early protection against non host -specific Salmonella serotypes in poultry; exploitation of \ninnate immunity and micr obial activity. Epidem. Infect. 133( 6):959- 978. 2005.  \n14. Zhang -Barber, L., A. K. Turner, G. Martin, G. Frankel, G. Dougan, P. A. Barrow. Influence of genes \nencoding proton- translocating enzymes on suppression of Salmonella typhimurium  growth and colonization. J. \nBacteriol. 179:7186- 7190. 1997.  63rd WPDC/XXXIX ANECA  CONTROL DE BROT ES DE VIRUELA AVIAR EN PARVADAS  \nDE AVES LIGERAS   \n \nREPORT OF CONTROL OF SMALL POX OUTBREAKS  \nIN BREEDING FLOCKS  \n \n \nJ. C\u00e9sar , A. Camacho, E.  Priante , M. Guti\u00e9rrez, D. Mizrahi , y B. Dubernard  \n \nLaboratorio Avi -Mex, S.A. de C.V., Jos\u00e9 I. Bartolache 1862 Piso 1,  \nCol. del Valle, C .P. 03100, M\u00e9xico, D.F.  M\u00e9xico  \n \nSUMMARY  \n \nIn several flocks of a breeding farm , typical signs of small pox (dry pox) were observed. Clinical signs \nwere presented several times in different flocks during a time- span of four year s, in hens between 12 and 16 wk  \nold was causing delays in body weight and laying onset. Virological diagnosis confirmed the presence of the \nsmall pox virus. Despite having a complete vaccination schedule with five  boosters, clinical signs were  \npersistent. An auto -vaccine was elaborated from the isolates taken  in order to substitute the commercial vaccine \nused. The vaccination schedule was also modified. Better results were observed. A year after the changes, \nclinical signs of small pox stopped and the productive performance was back to normal.  \n \nINTRODUCCI\u00d3N  \n \nLa viruela aviar ( VA) es una enfermedad viral de las aves producida por un poxvirus  (genero Avipoxvirus ), \ncuya presentaci\u00f3n cl\u00ednica c ut\u00e1nea  \u00f3 seca, se caracteriza por la aparici\u00f3n de lesiones proliferativas sobre la piel \nde la cresta, barbillas y otras \u00e1reas sin pluma . El virus causal de la VA tiende a persistir en el medio ambiente \ndurante largos periodos y su control se basa fundamentalmente en medidas de bioseguridad (control de \nmosquitos) y la vacunaci\u00f3n ,  existiendo en el mercado  gran va riedad de vacunas  comerciales  simples o \ncombinadas . El presente reporte describe la manera como  se llev\u00f3 a cabo el control de brotes  recurrentes  de VA \nen una granja de aves  ligeras  mediante el uso de una vacuna aut\u00f3gena o autovacuna (AV) , donde hist\u00f3ricamente \nse presentaban brotes de VA  seca, pese a las vacunas y programas de vacunaci\u00f3n empleados .  \n \nMATERIALES Y M\u00c9TODOS  \n \nEl presente estudio se llev\u00f3 a cabo en una granja de aves ligeras  que presentaba brotes  de VA seca de \nmanera recurrente, en cualquier mes del a\u00f1o, principalmente en la \u00e9poca de mayor precipitaci\u00f3n pluvial.  Con la \nfinalidad de evaluar la inocuidad y eficacia de una vacuna experimental aut\u00f3gena (AV) elaborada a partir de un \naislamiento de gallinas  que sufrieron brote de la enfermedad pese a estar debidamente vacunadas , se llev\u00f3  a \ncabo el siguiente dise\u00f1o experimental : \nPrueba 1 . Tres grupo s de 1 00 aves sanas entre 5 y 1 5 semanas de edad sin lesiones de VA , fueron \ninmuniz ados con la AV con un t\u00edtulo  viral de 104.2 DIEP 50/mL por punci\u00f3n en el pliegue del ala a raz\u00f3n de 0.01 \nmL/ave  (Tabla 1) . Los grupo s ten\u00eda n distinta edad  al momento de la vacunaci\u00f3n, as\u00ed como diferente estatus \ninmunol\u00f3gico respecto a VA , ya que se emplearon en ellos  hasta cinco marcas de vacunas comerciales \ndiferentes para su inmunizaci\u00f3n, con t\u00edtulos virales de 104.5 a 104.7 DIEP 50/mL. Con fines comparativos, para \ncada grupo vacunado  con la AV  se dej\u00f3 un  grupo control conformado por 100 aves , vacunadas con las vacunas \ncomerciales  tradicionalmente empleadas en la explotaci\u00f3n. De 3 a 10 d \u00edas despu\u00e9s de  la aplicaci\u00f3n  de la AV , las \n100 aves vacu nadas de cada grupo fueron revisadas para comprobar la evidencia de reacci\u00f3n inflamatoria \ndelimitada en el sitio de aplicaci\u00f3n que indicara una vacunaci\u00f3n adecuada, as\u00ed como la ausencia de efectos \nadversos atribuibles a la vacuna. Las aves en prueba fueron  observadas diariamente hasta que las aves de los \ngrupos control  presentaran lesiones t\u00edpicas de viruela aviar  y hasta los 90 d\u00edas  post-vacunaci\u00f3n (PV) . \nDespu\u00e9s de 10 d\u00edas  de la aplicaci\u00f3n de la AV, las 100 aves revisadas por grupo presentaron reacci\u00f3n \ninflamatoria en el sitio de aplicaci\u00f3n, indicio de una adecuada vacunaci\u00f3n. No se apreci\u00f3 ning\u00fan tipo de \nreacci\u00f3n adversa atribuible a la vacuna en ninguno de los grupos.  En la Tabla 2 se muestra la incidencia de \nlesiones t\u00edpicas de VA ( porcentaje)  en los grupos de a ves vacunadas , as\u00ed como de  su respectivo grupo control . \nPrueba 2.  La AV fue aplicada a un total de 130,000 aves en crianza, bajo un nuevo programa de \nvacunaci\u00f3n contra VA que constaba de  2 dosis  de vacuna:  al d\u00eda de  edad  una vacuna comercial de VA + Marek \naplica ndo en incubadora  por v\u00eda subcut\u00e1nea 0.2 mL/ave , y a la s emana 7 de edad , la AV  con un t\u00edtulo de 104.2 \nDIEP50/mL, aplicada por punci\u00f3n en el pliegue del ala.  63rd WPDC/XXXIX ANECA   \nDe 3 a 10 d \u00edas posteriores a la aplicaci\u00f3n de la AV, 100 aves vacunadas fueron seleccionadas al azar y \nrevisadas para comprobar que la vacunaci\u00f3n se hubiese realizado de forma adecuada, as\u00ed como para verificar la \nausencia de efectos adversos atribuibles a la vacuna. Se dej\u00f3 un grupo de 100 aves sin vacunar con la AV \n(control), y todas las aves fueron observadas d iariamente hasta que las aves del grupo control  presentaran \nlesiones t\u00edpicas de VA y hasta los 90 d\u00edas  PV. \nDespu\u00e9s  de 10 d\u00edas de la vacunaci\u00f3n con  la AV , las 100 aves revisadas al azar presentaron reacci\u00f3n \ninflamatoria en el sitio de aplicaci\u00f3n, indicio de una adecuada vacunaci\u00f3n.  Despu\u00e9s de los 90 d\u00edas  establecidos \ncomo  periodo de observaci\u00f3n, ning\u00fan ave inmunizada con AV  mostr\u00f3 lesiones de viruela, a diferencia del grupo \ncontrol en donde el 96% de las aves present\u00f3 lesiones de VA de mo deradas a severas . \n \nDISCUSI\u00d3N  \n \nLa recurrencia de los brotes de VA en la gra nja donde se llev\u00f3  a cabo el presente estudio  puso en evidencia \nla persistencia del virus causal en el  medio ambiente  y la ineficacia de l as vacunas comerciales empleadas en \nesta explotaci\u00f3n  para su prevenci\u00f3n y control , ya que a pesar de que se hab\u00edan intensificado las medidas de \nbiosegurida d y la a plicaci\u00f3n de m\u00faltiples vacunas de viruela aviar comerciales (hasta cinco) , los cuadros \ncl\u00ednicos de VA seca continuaron presentes , por lo que se opt\u00f3 por utilizar el virus de campo aislado en uno de \nlos brotes a partir de muestras de piel y crestas con lesiones en diferentes estad\u00edos, incluyendo costras, para la \nelaboraci\u00f3n de una AV. Desde la primera prueba a peque\u00f1a escala realizada dentro de la granja, los resultados \nfueron satisfactorios . Los brotes cesaron tan pronto la vacuna aut\u00f3gena fue utilizada como pilar del programa  de \nvacunaci\u00f3n contra VA  conteniendo un t\u00edtulo viral de 104.2 DIEP 50/mL. El programa  de vacunaci\u00f3n tambi\u00e9n fue \nmodificado, reduciendo el n\u00famero de aplicaciones durante la crianza a solo dos : la primera como vacuna \ncomercial aplicada en la incubadora por la v\u00eda subcut\u00e1nea junto con la vacuna de Marek, y la segunda como \nautovacuna aplicada por punci\u00f3n en el pliegue del ala a las 7 semanas de edad . A partir de entonces h an pasado \n12 parvadas co mpletas sin que se haya  presentado un nuevo brote  de VA . \n \nCONCLUSIONES  Y SUGERENCIAS  \n \nDe acuerdo con los resultados obtenidos en las pruebas realizadas, se con sidera que la aplicaci\u00f3n de la \nvacuna a ut\u00f3gena de VA  de gallina  por punci\u00f3n en el pliegue del ala con un t\u00edtulo de 104.2 DIEP 50/mL, es inocua  \ny que es capaz de conferir protecci\u00f3n a las aves contra la infecci\u00f3n de campo ocasionada por el virus hom\u00f3logo \nde VA, que durante a\u00f1os ocasion\u00f3 la aparici\u00f3n de brotes en la granja.  Se sugiere continuar investigando la \neficacia de las vacunas comerciales empleadas en esta empresa, y la pertinencia de redise\u00f1ar las mismas para \nuna mejor prevenci\u00f3n de la viruela aviar en el  \u00e1rea.  \n \nREFERENCIAS  \n \n1. Organizaci\u00f3n Mundial de Sanidad Animal. Viruela Aviar. Manual de las pruebas de diagn\u00f3stico y de \nlas vacunas para los animales terrestres (mam\u00edferos, aves y abejas). Office International des Epizzoties. pp: 580 -\n587. 2013.  \n2. Tripathy , D. N., and W. M. Reed. Pox. In: Diseases of Poultry, 12th ed. Saif, Y. M., A. M. Fadly, J. R. \nGlisson,  L. R. McDougald, L. K. Nolan, and D. E. Swayne, ed. Blackwell Publishing, Ames, Iowa, USA. pp 291 -307. 2008.  \n3. Tripathy, D. N. and W. M. Reed. Pox. In: A Laboratory Manual for the Isolation and Identification of \nAvian Pathogens, 4th ed. Swayne, D. E., J. R. Glisson, M. K. Jackwood, J. E. Pearson, and W. M. Reed, ed. The \nAmerican Association of Avian Pathologists, Pennsylvania, USA. pp 137\u2013 140. 1998.  \n \n \n \nTabla 1.  Edad de las aves y vacunaciones previas contra VA.  \n \nGrupo  No. aves  Vacunas comerciales previas contra VA  \n(edad a la aplicaci\u00f3n)  Edad al recibir la  \nAV \n1 100 1 d\u00eda; 3 semanas  5 semanas  \n2 100 1 d\u00eda; 3, 5 y 8 semanas  10 semanas  \n3 100 1 d\u00eda; 3, 5, 8 y 12 semanas  15 semanas  \n  \n \n 63rd WPDC/XXXIX ANECA   \nTabla 2.  Porcentaje de aves con lesiones de VA por grado y total.  \n \nGrupo  Edad al recibir   \nla AV  Aves con lesiones de VA  \nLeve  Moderada  Severa  Total  \n1 5 semanas  1% 0% 0% 1% \nCtl-1 NA 45% 23% 27% 95% \n2 10 semanas  2% 0% 0% 2% \nCtl-2 NA 35% 40% 23% 98% \n3 15 semanas  2% 0% 0% 2% \nCtl-3 NA 37% 30% 30% 97% \nNA= no aplica por no haberse vacunado  63rd WPDC/XXXIX ANECA  INDUSTRIAL PRODUCTION OF VACCINE H7N3 IN MEXICO  \n \nPRODUCCION INDUSTRIAL DE VACUNA IA H7N3 EN MEXICO  \n \nM. Arreguin -Nava, H. Flores  y J. Delgadillo  \n \nDGSA SENASICA- SAGARPA  \n \nRESUMEN  \n \nDurante el brote de HPAI en M\u00e9xico en 2012 -2013, se tomaron dos decisiones principales: despoblar todas las \ngranjas afectadas y vacunar todas las granjas av\u00edcolas dentro del \u00e1rea perifocal. Dado que no se ten\u00eda disponibilidad \nde la vacuna contra la influen za aviar H7N3 a nivel mundial, M\u00e9xico produjo su propia vacuna. Se ten\u00edan dos \nopciones para el virus maestro: un virus de referencia de Canad\u00e1 (LPAI H7N3) o un LPAI H7N3 aislado de un pato \nen Lerma, M\u00e9xico en 2006. Despu\u00e9s de probar ambos virus, se decidi\u00f3 utilizar el A/pato/2817/2006/H7N3 como el \nvirus maestro. La vacuna se produjo de acuerdo a las regulaciones mexicanas como una vacuna emulsificada inactiva de agua en una base oleosa. La producci\u00f3n industrial d e la vacuna se llev\u00f3 a cabo en tres  laborator ios \ncomerciales seleccionados como apoyo para el Productor Nacional de Biol\u00f3gicos Veterinarios. La producci\u00f3n y el \nuso de la vacuna son controlados por los Servicios Veterinarios Oficiales Mexicanos (SENASICA).  \n \nSUMMARY  \n \nDuring the 2012- 2013 outbreak of HP AI in Mexico, two main decisions were taken: to depopulate all  affected \nfarms , and vaccinate all the poultry farms within the perifocal area. Since there was no availability of H7N3 avian \ninfluenza vaccine worldwide, Mexico produced its own vaccine. There were two c hoices of master seed virus: a \nreference virus from Canada (LPAI H7N3) or a LPAI H7N3 isolated from a duck in Lerma M\u00e9xico in 2006. After \ntesting both viruses, it was decided to use the A/duck/2817/2006/H7N3 as the master seed virus. The vaccine  was \nproduced according to Mexican regulations as an inactivated and emulsified, water in oil based vaccine. The \nindustrial production of t he vaccine was manufactured by three selected commercial laboratories as support to the \nNational Veterinary Biologics  Producer. The production and use of the vaccine is controlled by the Mexican Official \nVeterinary Services (SENASICA).  \nBackground.  During the 2012 -2013 outbreak of HPAI in Mexico, two main decisions were taken: to \ndepopulate all affected farms and vaccinat e all the poultry farms within the perifocal area. Since there was no \navailability of H7N3 avian influenza vaccine worldwide, Mexico produced its own v accine in record time of 30 d . \nThe production and use of the vaccine is controlled by the Mexican Official Veterinary Services (SENASICA). To date, more  than 600 million doses have been produced.  \nPilot batch.  There were two choices of master seed virus (MSV), a LPAI H7N3 r eference virus from Canada \nor a LPAI H7N3 isolated from a duck in Lerma , M\u00e9xico, during active epidemiology surveillance in 2006. After \ntesting both viruses, it was decided to use the A/duck/2817/2006/H7N3 as the MSV. Three concentrations (12%, \n16% and 20%) were prepared as pilot batch for the vaccine from the MSV. The results  were satisfactory for th e 20% \nconcentration vaccine at two and three w eeks post-vaccination: 90% protection in vaccinated animals against HPAI \nfield virus and 90% mortality in challenged controls.  \nThe industrial production of the vaccine was manufactured  by three  selected commercial laboratories as \nsupport to the National Veterinary Biologics Producer (PRONABIVE).  \nProduction parameters.  0.3 mL of WSV dil ution was inoculated in 9 -11 d old chicken  embryos, incubated \nfor 48 h. Mortality at 24 h  post inocula tion was measured, average of all batches were 9.3%. Harvest of alantoic \nfluid was done in sterile conditions. The average  yeal in 12 m  production was 10.31 mL/ harvest embryo.  Titration \nof allantoic fluid was established not to be less than 10\n9.0 DIEP50% /mL. The geometric mean of the b atches \nproduced during 12 m  was 109.8 DIEP50% /mL. BEI solution was used for inactivation, ensuring complete \ninactivation by embryo testing. Sterility test was carried out for all antigen batches.  \nThe vaccine was produced according to Mexican regulations as an Inactivated and Emulsified, water in oil \nbased vaccine. Formulation of emulsion was done in accordance with official protocols, 20% of antigen in total \nemulsion; blending, filling and labeling process was done under offi cial supervision. All batches were satisfactory \nfor sterility, potency and safety tests.  \n 63rd WPDC/XXXIX ANECA  The Animal Health General Direction of SENASICA kept and analyzed all batch records in order to ensure a \nstandardized production of H7N3 vaccines.  63rd WPDC/XXXIX ANECA  REGULACI\u00d3N DE LA PRODUCCI\u00d3N DE BIOPEL\u00cdCULA EN \nSALMONELLA  ENTERICA SEROVARIEDADES ENTERITIDIS Y \nTYPHIMURIUM  \n \nREGULATION OF BIOFILM PRODUCTION IN SALMONELLA \nENTERICA SEROVARS ENTERITIDIS AND TYPHIMURIUM \n \nM. Aya Casta\u00f1edaA, S. SarnackiA, A. GuerraA, M. LlanaA y M.  CerquettiA \n \nAIMPaM- Instituto de Microbiolog\u00eda y Parasitolog\u00eda M\u00e9dica . CONICET -Consejo Nacional de \nInvestigaciones Cient\u00edficas y T\u00e9cnicas. Facultad de Medici na. Universidad de Buenos Aires  \nCorrespondencia: MsC. Mar\u00eda Del Rosario Aya, rosaritoaya@gmai l.com  \nParaguay 2155 piso 12. Ciudad Aut\u00f3noma de Buenos Aires. Argentina. CP1121ABG  \n \nSUMMARY  \n \nSalmonella Enteritidis  and Typhimurium  are currently the most common serovars in human salmonellosis . \nThe outbreaks are associated with consumption of different produce, but poultry products are the most \nfrequently involved. At the present, it is known that the ecological success of S. enterica  to survive in different \nniches is due to the ability to form  biofilms. Here, we studied the involvement of dam gene in biofilm \nproduction in S. Enteritidis and S. Typhimurium strains. The ability to generate biofilms in wild type and mutant \nstrains was analyzed. Also, were determined the expression of curli and cel lulose and the expression of csgA  and \ncsgD  genes by qPCR, in different culture conditions. Our results suggest that changes in gene expression \nrequired for biofilm production are finely regulated with the participation of dam  gene. This study contributes t o \nthe understanding of the regulation of biofilm formation in Salmonella spp. as well as to the design of new \nstrategies to prevent food contamination and humans and animals infections.  \n \nRESUMEN  \n \nActualmente Salmonella Enteritidis y Typhimurium  representan las serovariedades con mayor prevalencia \ne incidencia en las salmonelosis humanas . Los brotes involucran el consumo de diversos alimentos, pero los \nproductos de origen av\u00edcola son los m\u00e1s frecuentemente implicados. El \u00e9xito ecol\u00f3gico de S. ent erica  para \nsobrevivir en diferentes nichos radica en su capacidad de formar biopel\u00edculas. En este trabajo estudiamos la \nparticipaci\u00f3n del gen dam en la producci\u00f3n de biopel\u00edculas en cepas de S . Enteritidis y S. Typhimurium . Para \nesto, se estudi\u00f3 la capacid ad de generar biopel\u00edculas, la expresi\u00f3n de curli  y celulosa y se determin\u00f3 el nivel de \nexpresi\u00f3n de los genes csgD  y csgA  mediante qPCR, en cepas salvajes y mutantes en diferentes condiciones de \ncultivo. Nuestros resultados, sugieren que cambios en la expresi\u00f3n g\u00e9nica, necesarios para la producci\u00f3n de biopel\u00edculas, se regulan de manera fina con la participaci\u00f3n del gen dam. Este trabajo contribuye al \nconocimiento de la regulaci\u00f3n de la formaci\u00f3n de biopel\u00edculas en Salmonella spp y al dise\u00f1o de nuevas \nestra tegias de prevenci\u00f3n de contaminaci\u00f3n de alimentos y de infecciones en animales y humanos.  \n \nINTRODUCCI\u00d3N  \n \nLas serovariedades Enteritidis y Typhimurium de Salmonella enterica son agentes etiol\u00f3gicos de \ninfecciones ent\u00e9ricas en humanos a nivel mundial. Parte del ciclo de vida de Salmonella spp. incluye la \nsupervivencia en el medio ambiente, para luego ingresar al hospedador. Actualmente, se reconoce que parte del \n\u00e9xito ecol\u00f3gico  de S. enterica  para sobrevivir en gran variedad de condiciones ambientales radica en su \ncapacidad de producir biopel\u00edcula s (2,7).  \nEstas dos serovariedades  de S. enterica se han reportado como contaminantes de productos av\u00edcolas \n(principalmente huevos) en el mundo entero. En la industria de producci\u00f3n av\u00edcola y alimentaria, las \nbiopel\u00edculas pueden crear una fuente persistente de contaminaci\u00f3n del producto, dando lugar a graves problemas \nde higiene y a p\u00e9rdidas econ\u00f3micas  (6,10). Interesantemente, en la actualidad se implementan  nuevas estrategias \npara el control de infecci\u00f3n serovar -especificos . Esto se debe a que S.  Enteritidis  (SE) y S. Typhimurium  (ST), \npueden encontrarse en diferentes nichos y su capacidad de colonizaci\u00f3n y permanenci a aparentemente no es la \nmisma  (10). Conocer la regulaci\u00f3n de la formaci\u00f3n de estas comunidades bacterianas , en las distintas \nserovariedades,  permitir\u00eda el dise\u00f1o de nuevas estrategias de control.   63rd WPDC/XXXIX ANECA  Por otro lado, es ahora conocido que la regulaci\u00f3n de diversos factores de virulencia bacterianos, \nincluyendo las biopel\u00edculas, est\u00e1n controlados por una intrincada red de genes en la q ue participan los \ndenominados reguladores globales de genes, de \u00e9stos, el gen DNA adenina metilasa  (dam) es uno de los \nexponentes  (8). Previamente, cepas atenuadas mutantes dam de Salmonella spp. han sido  propuestas como \nvacunas en aves y ganado,  no obstante actualmente no se conoce con claridad el papel que desempe\u00f1a este \nregulador global  de genes  en la producci\u00f3n de biopel\u00edculas.  \nEn este estudio nos propusimos evaluar la participaci\u00f3n de las  metilaciones realizadas por D am en la \nproducci\u00f3n de biopel\u00edculas en SE y S T. Para ello realizamos caracterizaciones fenot\u00edpicas y determinamos la \nexpresi\u00f3n relativa de dos genes ; csgD  principal regulador de la producci\u00f3n de biopel\u00edculas  y csgA  sub-unidad de \nla prote\u00edna m\u00e1s abundante de la matriz extracelular, curli . Previamente estos dos genes fueron descriptos como \ndeterminantes para la producci\u00f3n de estas comunidades bacterianas  (1,5). \n \nMATERIALES Y M\u00c9TODOS  \n \nCepas . Se analizaron  dos cepas  salvajes de cada una de las serovariedades de Salmonella: S E 5694 y ST \n14028 (cepas  de colecci\u00f3n) ; SE ArJEG  y ST SIpE (proveniente s de aislamientos  cl\u00ednicos) . Mutante s carentes del \ngen dam (\u2206dam) fueron construidas a partir de las cepas salvajes mediante mutag\u00e9nesis dirigida ( 3). \nFormaci\u00f3n de biopel\u00edcula . Se desarroll\u00f3 un ensayo fenot\u00edpico para evaluar la habilidad de las cepas para \nformar biopel\u00edcula  en la interfase aire -l\u00edquido (7) y se realiz\u00f3 el ensayo semi -cuantitativo de formaci\u00f3n de \nbiopel\u00edcula  en placas de 96 pozos de policloruro de vinilo ( PVC)  (4). Los experimentos se realizaron en tres \nr\u00e9plicas independientes.  \nExpresi\u00f3n de prote\u00edna curli  y celulosa . Se analiz\u00f3 mediante el estudio del morfotipo  de las colonias \ndesarrolladas en agar conteniendo rojo congo y azul brillante de coomassie (1). La expresi\u00f3n relativa de la \nsubunidad CsgA del curli tambi\u00e9n fue evaluada por PCR en tiempo real  (qPCR) .  \nExpresi\u00f3n relativa de genes csgD  y csgA.  ARN total se extrajo a partir de cultivo s bacterianos en \ncondiciones inductoras  de biopel\u00edcula ; caldo LB sin NaCl a 28\u00ba C, sin agitaci\u00f3n  durante 48  h. La extracci\u00f3n se \nrealiz\u00f3 utilizando Trizol (Life Technologies  Inc). La s\u00edntesis de cDNA a partir de ARN total y la qPCR se \ndesarroll\u00f3 y analiz\u00f3 como previamente  se hab\u00eda estandarizado (9). Los cebadores usados se dise\u00f1aron de \nacuerdo con la informaci\u00f3n de las  secuencia s de ADN de S E str.P125109 y S T str.14028S de la b ase de datos \ndel servidor BLAST (http://blast.ncbi.nlm.nih.gov) , para los genes ARNr16S , csgD  y csgA . Los resultados se \nexpresaron como la media de tres experimentos independientes. Como control de inducci\u00f3n de biopel\u00edculas se \nrealiz\u00f3 el mismo procedimiento en cultivos en estado de vida plant\u00f3nica; agitaci\u00f3n a 37\u00baC durante 20  h en LB \ncon NaCl.   \nIdentificaci\u00f3n de sitios potenciales de metilaci\u00f3n por Dam . Los an\u00e1lisis in silico  se desarrolla ron con el \nsoftware Vector NTI , para identificar sitios de metilaci\u00f3n por la enzima Dam (GATC), en los operones \ncsgDEFG, csgBA  en los genes  bcsA  y AdrA . Los an\u00e1lisis se realizaron con las secuencias gen\u00f3micas Refseq \nNC_011294 de S E y NC_016856.1  de S.T, disponibles en base s de datos del servidor BLAST . \n \nRESULTADOS  \n \nLa formaci\u00f3n de biopel\u00edcula en la interfase aire -liquido se vio reducida o inhibida  en las cepas carentes del \ngen dam, respecto  de sus cepas parentales.  Diferentes intensidades de formaci\u00f3n de biopel\u00edculas fueron \nobservadas en las cepas salvajes, siendo dicha capacidad mayor en las cepas provenientes de aislamientos  \ncl\u00ednicos respecto de las cepas de colecci\u00f3n (Tabla 1, A) . Similares resultados se obtuvieron mediante el ensayo \nsemi -cuantitativo en placas de PVC , en donde l as cepas \u0394 dam mostrar on una disminuci\u00f3n de entre 50 -60% de la \ncapacid ad de formar biopel\u00edcula comparada con su cepa parental. Nuevamente,  las cepas provenientes de \naislamientos cl\u00ednicos mostraron mayor capacidad para formar biopel\u00edcula respecto de las cepas de colecci\u00f3n \n(Tabla  1, B).  \nLos morfotipos  observados en el agar rojo congo, evidenciaron que las cepas carentes del gen dam son \ndeficiente s en la producci\u00f3n de curli  y celulosa. El morfotipo rojo , rugoso y seco  (presencia de curli  y celulosa)  \nfue observado predominantemente en las cepas provenien tes de aislamientos cl\u00ednicos, entre tanto en las cepas de \ncolecci\u00f3n , aunque presentaban un morfotipo similar , el mismo era menos caracter\u00edstico  que el que exhib\u00edan las \ncepas cl\u00ednicas.  El morfotipo liso  y blanco, que indica ausencia de curli  y celulosa, fue observad o claramente \ns\u00f3lo en la cepa S E 5694\u2206 dam, las dem\u00e1s cepas \u2206 dam disminuyeron  en su rugosidad y perdieron parte del  tono \nrojo, pero no se observ\u00f3 el fenotipo liso y blanco (Tabla 1, C).  \nCuando se determin\u00f3 mediante qPCR la expresi\u00f3n del gen central en la regulaci\u00f3n de biopel\u00edcula, csgD,  se \nevidenci\u00f3 una disminuci\u00f3n de alrededor de 60% en las cepas \u2206dam. Las cepas provenientes de aislamientos \ncl\u00ednicos expresa ron 2 a 4 veces m\u00e1s el gen csgD  en relaci\u00f3n a las cepas de colecci\u00f3n. L a mutaci\u00f3n del gen dam \nafect\u00f3  la formaci\u00f3n de biopel\u00edcula y la expresi\u00f3n de csgD  incluso en cepas fuertemente formadoras de \nbiopel\u00edcula , esto fue visto en SEArJEG\u2206dam en donde csgD  se redujo a m\u00e1s de la mitad . Resultados similares 63rd WPDC/XXXIX ANECA  fueron observados para el gen csgA , en donde se observo una dr\u00e1stica disminuci\u00f3n en todas las cepas mutantes \nevaluadas (Tabla 1, D).   \nAn\u00e1lisis bioinform\u00e1ticos revelaron sitios potenciales  de metilaci\u00f3n por la enzima Dam en  genes altamente \nrelacionados con la producci\u00f3n de biopel\u00edculas. Se analizaron los operones csgDEFG y csgBA en los cuales se \nencontraron ocho y tres  sitios  GATC  respectivamente, en la regi\u00f3n codificante y 24 m\u00e1s en el contexto gen\u00e9tico \n(tanto rio arriba com o rio abajo de la ubicaci\u00f3n de los operones). Tambi\u00e9n se analiz\u00f3 la secuencia codificante de \ndos de los principales genes relacionados con la producci\u00f3n de celulosa, bcsA y adrA , en los cuales se \nencontraron 10 y 6 sitios  respectivamente  (Tabla 1, E) . \n \nCONCLUSIONES  \n \nEste estudio se constituye en la primera evidencia de la participaci\u00f3n de la prote\u00edna Dam , en la regulaci\u00f3n \nde la formaci\u00f3n de biopel\u00edculas en S. enterica . Hasta lo estudiado aqu\u00ed , la regulaci\u00f3n parece ser com\u00fan en las \nserovariedades  Enteritidis y Typhimurium. El efecto se estar\u00eda generando posiblemente mediante regulaci\u00f3n \ndirecta del gen csgD o su oper\u00f3n, lo cual tendr\u00eda repercusi\u00f3n en la expresi\u00f3n de genes como csgA  y otros genes \nrelacionados con la producci\u00f3n de celulosa y biopel\u00edc ulas. Estos resultados contribuyen a la descripci\u00f3n de las \nv\u00edas de regulaci\u00f3n en la producci\u00f3n de biopel\u00edculas, lo cual est\u00e1 directamente relacionado con la capacidad de \nvirulencia, la expresi\u00f3n de factores de patogenicidad y la persistencia en diferentes nichos ecol\u00f3gicos de S E y \nST. Las cepas atenuadas mutantes dam de Salmonella, propuestas como vacunas en modelos aviares y bovinos , \ncon deficiente producci\u00f3n de biopel\u00edculas persistir\u00edan menor tiempo en el ambiente y ser\u00edan m\u00e1s susceptibles al efecto de an tibi\u00f3ticos y desinfectantes. Dam  parece ser un nuevo foco de estudio para modelos de erradicaci\u00f3n e \ningenier\u00eda de biopel\u00edculas . \n \nREFERENCIAS  \n \n1. Barnhart M y Chapman MR. Curli Biogenesis and Function. Annu Rev Microbiol. 60:131\u2013 147. 2006  \n2. Costerton JW, Stewart  PS y Greenberg EP . Bacterial biofilms: a common cause of persistent infections. \nScience 284:1318- 1322. 1999. \n3. Datsenko KA y Wanner BL. One -step inactivation of chromosomal genes in Escherichia coli K -12 \nusing PCR products. Proc Natl Acad Sci U S A  97: 6640\u2013 6645. 2000.  \n4. Genevaux P, Muller S y Bauda P. A rapid screening procedure to identify mini -Tn10 insertion mutants \nof Escherichia coli K -12 with altered adhesion properties. FEMS Microbiol Lett. Aug 15;142(1):27- 30. 1996.  \n5. Gerstel U y R\u00f6mling U. The csgD promoter, a control unit for biofilm formation in Salmonella \ntyphimurium. Res Microbiol. Dec;154(10):659- 67. 2003.  \n6. Kumar CG and Anand SK. Significance of microbial biofilms in food industry: a review. Int J Food \nMicrobiol. Jun 30;42(1- 2):9-27. 1998.  \n7. Latasa C y col. Salmonella biofilm development depends on the phosphorylation status of RcsB. J \nBacteriol. Jul;194(14):3708 -3722. 2012.  \n8. Low DA, Weyand NJ y Mahan MJ. Roles of DNA adenine methylation in regulating gene expression \nand virulence. Infect Immun  69: 7197\u2013 7204. 2001.  \n9. Sarnacki SH y col. Dam Methylation Participates in the Regulation of PmrA/PmrB and \nRcsC/RcsD/RcsB Two Component Regulatory Systems in Salmonella enterica Serovar Enteritidis. PLoS ONE \n8(2): e56474. 2013 . \n10. Wales y Davies. A critical rev iew of Salmonella Typhimurium infection in laying  hens. Avian Pathol, \n40:5, 429- 436. 2011.  \n \n(El art\u00edculo completo  ser\u00e1 enviado a publicaci\u00f3n en la revista Food Microbiology. )  \n(The full -length article will be published in Food Microbiology .) \n \n \n  \n \n  \n \n  \n \n 63rd WPDC/XXXIX ANECA  Tabla 1. Resumen de resultados . \n \nCepas.  Se estudiaron 7 cepas: SE 5694 y S T 14028 cepas salvajes de colecci\u00f3n;  SE ArJEG y ST SIpE \nsalvajes provenientes de aislamientos cl\u00ednicos y sus respectivas mutantes carentes del gen dam.  A. Se estableci\u00f3 \nuna escala num\u00e9rica de acuerdo con la intensidad de formaci\u00f3n de la monocapa aire- l\u00edquido, siendo 0 no \nformaci\u00f3n y 4 formaci\u00f3n fuerte de biopel\u00edcula. B.  Los valores se expresan como la relaci\u00f3n entre la densidad \n\u00f3ptica del desarrollo bacteriano medida antes de la coloraci\u00f3n y la densidad \u00f3ptica medida luego  de la \ncoloraci\u00f3n con cristal violeta (biopel\u00edcula). Se normaliz\u00f3 a la cepa salvaje de colecci\u00f3n a la cual se le asign\u00f3 un \nvalor de 100%. C.  Se indica la presencia (+ \u00f3 ++ en caso de morfotipo muy marcado) o ausencia ( -) de curli  y \ncelulosa de acuerdo con los morfotipos visualizados en agar rojo congo. Cuando el morfotipo no es totalmente \ncaracter\u00edstico se indica +/ -.  D. La expresi\u00f3n relativa del gen se informa en porcentaje normalizado a la cepa \nsalvaje de colecci\u00f3n, a la cual se le asign\u00f3 un valor de 100 %. E. Se indica el n\u00famero de secuencias GATC (sitio \nblanco de metilaci\u00f3n por Dam), en la secuencia codificante de los operones y genes estudiados.  \n Cepas  A. \nBiopel\u00edcula \ninterfase \nAire - \nliquido   \n(Escala 0 -4) B. \nEnsayo \nsemi -\ncuantitativo  \nplacas PVC  \n(%)   C. \nMorfotipo en \nrojo congo \n(presencia/ausencia)  D. \nExpresi\u00f3n relativa \nde genes (%)  E. \nPotenciales sitios de metilaci\u00f3n \npor Dam  \n(cantidad de sitios)  \ncurli  celulosa  csgD  csgA  oper\u00f3n \ncsgDEFG  oper\u00f3n \ncsgBA  gen \nbcsA  gen \nadrA  \nS. Enteritidis  \n5694  2 100 + + 100 100 \n8 3 10 6 5694 \u2206dam 0 36 - - 38 6 \nArJEG  4 154 ++ ++ 475 290 \nArJEG  \n\u2206dam 1 79 - +/- 127 43 \nS. Typhi murium  \n14028  3 100 + + 100 100 \n8 3 10 6 14028 \n\u2206dam 0 49 - +/- 39 62 \nSIpE  4 137 ++ ++ 177 150 63rd WPDC/XXXIX ANECA  EFECTO DE UN PROBI\u00d3TICO Y UN COMPLEJO ENZIM\u00c1TICO \nEN LAS VARIABLES PRODUCTIVAS, VELLOSIDADES \nINTESTINALES Y CONTEOS DE COLIFORMES EN \u00cdLEON DE \nPOLLOS DE ENGORDA ALIMENTADOS CON  \nDIETAS SORGO \u2013 SOYA \n \nEFFECT OF A PROBIOTIC AND ENZYME COMPLEX IN PRODUCTION \nVARIABLES, VILLI AND COLIFORM COUNTS IN ILEUM OF BROILERS \nFED SORGHUM \u2013 SOYBEAN DIETS  \n \n \nB. BautistaA, A. L\u00f3pezB, V. G\u00f3mezC, G. Del R\u00edoD, C. RosarioC y G. \u00c1vilaA \n \nACentro  de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola, UNAM,  C.P. 13300,  Ciudad de M\u00e9xico  \nBDupont Animal Nutrition,  C.P. 02300, Ciudad de M\u00e9xico \nCDepartamento de Medi cina y Zootecnia de Aves, UNAM, Ciudad Universitaria C.P. 04510, Ciudad de M\u00e9xico  \nDFacultad de Estudios Superiores Cuautitl\u00e1n, UNAM San Sebast\u00edan Xhala C.P. 54714  \nDirecci\u00f3n de contacto : zacnitec1@hotmail.com  \n \nSUMMARY  \n \nThe purpose of this study was t o evaluate the effect of a probiotic ( Bacillus  subtilis ) and an enzymatic complex \n(xylanase, protease and amylase) in the productive performance, vi lli and total coliform in ileum. T he following \nexperiment w as planned. 780 chicks were  distributed in a completely randomized design with 2x3 fact orial \narrangement (5 replicates / treatment, 26 birds / replicate). The factors were two sorghum \u2013  soy based diets and the \naddition or not of the enzyme complex and probiotic. Performance parameters were evaluated weekly. Samples were taken from the descen ding duodenal loop and the villi length, and lamina propria and mucosa thickness and crypt \nsize were measured. Total coliforms ileal content were quantified. Under handling conditions used, improvements in \nweight gain and body weight as well as reduced tot al coliforms in the ileum with the inclusion of probiotic and \nenzymes in diets for broilers were observed.  \n \nRESUMEN  \n \nSe realiz\u00f3 un estudio con 780 pollos de engorda  distribuidos en un dise\u00f1o completamente al azar, con un \narreglo factorial 2x3 ; los factores  fueron las dietas y la adici\u00f3n o no del probi\u00f3tico y probi\u00f3tico+enzimas. Las \nvariables productivas se evaluaron semanalmente. Se tomaron muestras de duodeno y se realiz\u00f3 el conteo de  \ncoliformes totales en \u00edleon . Se observ\u00f3 mayor (p< 0.05) peso corporal, ganancia de peso, \u00edndice de conversi\u00f3n y \nrendimiento en canal en los animales que consumieron la dieta basal positiva; se observ\u00f3 mayor (p<0.05) peso \ncorporal y ganancia de peso en los pollos de los tratamientos suplementados con los a ditivos.  Se observ\u00f3 diferencia \nestad\u00edstica (p<0.05) en el an\u00e1lisis histol\u00f3gico, con efectos positivos en los pollos que consumieron la dieta basal \npositiva y en los suplementados con probi\u00f3ticos y probi\u00f3ticos+ enzimas. Se observaron menores (p<0.05) conteos \nde coliformes totales en los pollos que consumieron la dieta basal negativa y aditivos .  \n \nINTRODUCCI\u00d3N  \n \nEl rendimiento productivo de los animales depende de la digestibilidad de los nutrientes contenidos en los \nalimentos, as\u00ed como del grado de absorci\u00f3n y utilizaci\u00f3n de los mismos , por lo que es necesario incrementar el \naprovechamiento de los nutrientes por el animal con el prop\u00f3sito de maximizar dicho rendimiento. El objetivo del \npresente estudio, fue examinar la respuesta de los pollos de engorda alimen tados con dietas en base a sorgo \u2013  soya y \nsuplementados con un complejo enzim\u00e1tico y un probi\u00f3tico, en el comportamiento productivo, integridad intestinal \ny microbiota intestinal.  \n 63rd WPDC/XXXIX ANECA  MATERIAL Y  M\u00c9TODOS  \n \nSe utilizaro n dos dietas basales con sorgo \u2013  soya como  ingredientes principales, ambas bajas en energ\u00eda \nmetabolizable. La dieta basal positiva fue una dieta tipo comercial con nutrientes que cubrieron las necesidades  de \nlas aves ; la dieta basal negativa fue reducida en los nutrientes aportados por la matriz e nzim\u00e1tica ( -85 Kcal de EM y \nalgunos amino\u00e1cidos esenciales). Se emplearon dos productos comerciales, un complejo enzim\u00e1tico basado en \nxilanasas, proteasas  y amilasas y un producto probi\u00f3tico basado en tres cepas de Bacillus subtilis . Se utilizaron 780 \npollitos Ross 308 de un d\u00eda de edad en un dise\u00f1o completamente al azar, con un arreglo factorial 2x3. Los factores \nson las dietas (basal positiva y basal negativa) y la adici\u00f3n o no del complejo enzim\u00e1tico y probi\u00f3tico. Se tuvieron 6 \ntratamientos, con 5 r\u00e9plicas por tratamiento de 26 animales cada una. Los tratamientos fueron los siguientes:  \n1) basal positiva   \n2) como 1 + probi\u00f3tico  \n3) como 2 + complejo enzim\u00e1tico   \n4) basal negativa  \n5) como 4 + probi\u00f3tico  \n6) como 5 + enzimas   \nLos par\u00e1 metros productivos se e valuaron semanalmente, al d \u00eda 42 se determin\u00f3 el rendimiento en canal. A los \nd\u00edas 21 y 42 se tomaron muestras de dos cm de l asa descendente de duodeno, las cuales se procesaron con t\u00e9cnicas \nhistol\u00f3gicas de ru tina; se midi\u00f3 la longitu d de vellosidades, espesor de l\u00e1mina propia, espesor de mucosa y tama\u00f1o \nde criptas. Al d \u00eda 42 se tomaron muestras del contenido ileal, para realizar el conteo de coliformes totales. Las \nvariables se analizaron conforme al modelo descrito y la comparaci\u00f3n d e medias por la prueba de Tukey, con una \nsignificancia del 0.05.  \n \nRESULTADOS  \n \nNo se observ\u00f3 diferencia (p>0.05) estad\u00edstica en las variables productivas al d \u00eda 21; al d\u00eda 42, en el factor \ndietas se encontr\u00f3 diferencia estad\u00edstica (p<0.05), siendo la dieta testigo positivo d\u00f3nde se observ\u00f3 mayor peso \ncorporal ( 2481a vs 2603b), ganancia de peso ( 2436a vs 2559b), \u00edndice de conversi\u00f3n ( 1.9b vs 1.81a) y rendimiento en \ncanal (1975a vs 2118b). En el factor aditivos se encontr\u00f3 diferencia est ad\u00edstica (p<0.05) entre el tratamiento testigo \nrespecto a los tratamientos probi\u00f3ticos y probi\u00f3ticos+ enzimas en las variables peso corporal (2508a vs 2549b, 2568b) \ny ganancia de peso (2464a vs 2505b,2524b). En la revisi \u00f3n histol\u00f3gica de duodeno al d\u00eda  21 se observ\u00f3 diferencia \nestad\u00edstica (p<0.05) al factor dieta y aditivos. En la dieta testigo positivo se presentaron mayores valores en las \nvariables longitud de vellosidad (2137.173b vs 1998.757a), espesor de mucosa (2382.897b vs 2262.548a) y tama\u00f1o de \ncriptas (144.758b vs 131.296a); en el factor aditivos se observ\u00f3 mayor espesor de l\u00e1mina propia en el tratamiento \ntestigo (300.797b vs 228.264\u00aa, 2301.646a). En el muestreo realizado al d \u00eda 42 se observ\u00f3 diferencia estad\u00edstica \n(p<0.05) en el factor dieta y aditivos. En el factor dieta, el espesor de l\u00e1mina propia fue mayor en la testigo negativo \n(298.954\u00aa vs 331.161b) y el tama\u00f1o de criptas fue mayor en la dieta testigo positivo (144.314b vs 117.774a). En el \nfactor aditivos se encontr\u00f3 diferencia en el tama\u00f1 o de criptas, siendo el tratamiento probi\u00f3ticos quien present\u00f3 \nmayor tama\u00f1o respecto al tratamiento testigo y probi\u00f3tico+enzimas ( 143.758b vs 126.389a, 122.983a). En el conteo \nde coliformes totales se encontr\u00f3 diferencia estad\u00edstica (p<0.05) al factor diet a, siendo la testigo positivo la que \npresent\u00f3 conteos m\u00e1s altos de coliformes totales ( 6.1655a vs 6.0594b). Se observ\u00f3 diferencia estad\u00edstica al factor \naditivos (p<0.05), siendo los tratamientos suplementados con probi\u00f3ticos o probi\u00f3ticos  + enzimas quienes \npresentaron menores conteos de coliformes totales ( 7.1444b vs 6.2014a, 5.9672a). \n \nDISCUSI\u00d3N  \n \nEn el factor dietas en los d \u00edas 21 y 42 de edad, la diferencia observada en el peso corporal, ganancia de peso y \nrendimiento en canal entre los animales alimentados con las dietas basales positiva y negativa coincide con lo reportado por diversos autores, quienes reportaron mayores gana ncias de peso conforme se aumentan los niveles de \nenerg\u00eda metabolizable en la dieta (1,2,3) . En el factor aditivos, los resultados observados en el peso corporal y \nganancia de peso al d  42 coinciden con lo se\u00f1alado en trabajos anteriores, e n donde  encontraron que los pollos de \nengorda que fueron suplementados con esporas de Bacillus subtilis  en la dieta presentaron mejor desempe\u00f1o \nproductivo comparado con los tratamientos testigo (4,5,6) . Recientemente se public\u00f3  un trabajo  del efecto \ncomplementario entre el uso de Bacillus subtilis  como probi\u00f3tico y complejos enzim\u00e1ticos conteniendo amilasa, \nxilanasa y proteasa,  que se vio reflejado en un mejor desempe\u00f1o productivo en los pollos suplementados con ambos \naditivos\n (7). En el fa ctor aditivos, en duoden o al d \u00eda 21 se observ\u00f3 menor espesor de l\u00e1mina propia en los 63rd WPDC/XXXIX ANECA  tratamientos Probi\u00f3tico y Probi\u00f3tico+ enzimas, Algunos autores  (8) mencionan que el adelgazamiento puede \ndeberse a una disminuci\u00f3n en el tejido conectivo, lo que puede conllevar un efecto ben\u00e9fic o al mejorar la absorci\u00f3n \nde nutrientes. Otros autores  mencionan que la microbiota intestinal disminuye la absorci\u00f3n de nutrientes al \nincrementar el grosor del tracto intestinal (10,11) . Tomando en cuenta que el tiempo de permanencia del quimo en el \nduoden o es corto, de aproximadamente 10 min, un menor espesor de l\u00e1mina propia contribuye  a una mayor \nabsorci\u00f3n de nutrientes en duodeno  (11). En el factor dietas, las diferencias observadas en los dos periodos de \nmuestreo, coincide con  diversos autores quienes se\u00f1alan que la longitud de las vellosidades intestinales y la \nprofundidad de las criptas intestinales depende de la cantidad de sustratos disponibles en el lumen intestinal (12,13) . \nLa reducci\u00f3n en el conteo de coliformes totales en los animales que consum ieron la dieta basal negativa coincide \ncon lo observado anteriormente  en dietas suplementadas con xilanasas, donde las aves que fueron alimentadas con \ndietas reducidas en nutrientes presentaron bajos conteos de coliformes to tales en \u00edleon  (14); lo observado en el factor \naditivos concuerda con lo citado por diversos autores que han reportado una disminuci\u00f3n en las ufc de coliformes y \nclostridium en contenido de \u00edleon y ciegos con la inclusi\u00f3n de Bacillus subtilis  a la dieta de pollos de engorda (4,5) . \n \nREFER ENCIAS  \n \n1. Zorrilla F .F., Cuca G .M., \u00c1vila G .E. Efecto de niveles de energ\u00eda, lisina y prote\u00edna en dietas para pollos \nde engorda en iniciaci\u00f3n. Vet. Mex. 24 (4): 311- 316.1993.  \n2. Leeson S .L., Caston and Summers J .D. Broiler responses to diet energy. Poult . Sci. 75: 529 -535.1996  \n3. Saleh E .A., Watkins S .E., Waldroup A .L. and Waldroup P .W. Effects of dietary nutrient density and \nenergy feeding programs for growing large male broilers chickens. Int. J. Poul t. Sci. 3 : 11 -16.2004 . \n4. Teo A .Y., Tan H .M. Evaluation of the p erformance and intestinal gut microflora of broiler fed on corn -\nsoy diets supplemented with Bacillus subtilis  PB6 (CloSTAT). J. Appl. Poult. Res .16: 296- 303.2007.  \n5. Sen S ., Ingale S .L., Kim Y .W., Kim J .S., Kim K .H., Lohakare J .D., Kim E .K., Ryu M .H., Kwon I .K., \nChae B .J. Effect of supplementation of Bacillus subtilis  LS 1 -2 to broiler diets on growth performance, nutrient \nretention, caecal microbiology and small intestinal morphology. Res. Vet. Sci . 93: 264- 268.2012.  \n6. Walsh M .C., Romero L .F., Indrakumar S .E., Ravindran V. Influence Of  Combinations  Of  A  Direct -\nFed  Microbial  And Exogenous Enzymes On The Growth Performance And Feed Eficiency Of Broilers . Poult. Sci . \nPoultry Science  Association Annual Meeting , Metabolism And Nutrition: Feed Additives Ii. (Abs tracts 169 -179) \nVol.92 (E - Suppl. 1) .2013.  \n7. Romero L .F., Indrakumar S .E., And Ravindran V. Influence  Of  Combinations  Of  A  Direct -Fed  \nMicrobial  And Exogenous Enzymes On Nutrient Digestibility In Broilers At 11 And 21 Days Of Age. Poult. Sci . \nPoultry Science Association Annual Meeting , Metabolism And Nutrition: Feed Additives Ii. (Abstracts 169 -179) \nVol.92 (E - Suppl. 1) .2013.  \n8. Dibner J .J., Kitchell M .L., Atwell C .A., Ivey F .J. The effect of dietary  ingredients and age  on the \nmicroscopic structure  of the gastrointest tract  in poultry. J App Poult Res . 5: 70 -77.1996.  \n9. Ravindran V ., Kornegay E .T., Webb K .E. Effects of fiber and virginamicyn on nutrient absorption, \nnutrient retention and rate of passage in growing swine. J. Anim. Sci . 59: 400- 408.1984.  \n10. Apajalahti J ., Kettunnen A ., Graham H. Characteristics of the gastrointestinal microbial communities, \nwith special reference to the chicken. World Poult. Sci. J . 60: 223-  232.2004.  \n11. Denbow M. Chapter 12: Gastrointestinal anatomy and physiology: In Causey Wh ittow editor. Sturkie\u00b4s \nAvian Physiology 5th edition, Academic Press  229-325.2000 . \n12. Shamoto K ., Yamauchi K. Recovery responses of chick intestinal villus morphology to different \nrefeeding procedures. Poult. Sci.  79: 718-  723.2000.  \n13. Yamauchi K. Review on chic ken intestinal villus histological alterations related with intestinal function. J \nPoult Sci  39: 229 -242.2002 . \n14. Nian F ., Guo Y .M., Ru Y .J., Li F .D., P\u00e9ron A. Effect of exogenous xylanase supplementation on the \nperformance,   net energy and gut microflora of broiler chickens  fed wheat -based diets. Asian -Aust. J. Anim. Sci . \n24(3): 400- 406.2011.  \n15. Fritts C .A., Kersey J .H., Motl M .A., Kroger E .C., Yan F ., Si J ., Jiang Q ., Campos M .M., Waldroup A .L., \nWaldroup P .W. Bacillus subtilis  C-132 (calsporin) improves li ve performance and microbiological status of broiler \nchickens. J App . Poult . Res. 9: 149- 155.2000.  \n 63rd WPDC/XXXIX ANECA  EFFECTS OF DIAMOND V ORIGINAL XPC\u2122 DURING IN  VITRO  \nAND IN VIVO  CLOSTRIDIUM  (NECROTIC ENTERITIS) \nCHALLENGES  \n \nEFECTOS DE DIAMOND V ORIGINAL XPC EN DESAF\u00cdOS IN VITRO E IN  \nVIVO  DE CLOSTRIDIUM (ENTERITIS NECR\u00d3TICA)  \n \nJ. Broomhead, V. Nsereko, E.  Gingerich , and D.  McIntyre  \n \nDiamond V, Cedar Rapids, Iowa, USA  \n \nRESUMEN  \n \nSe investigaron los efectos de XPC sobre el crecimiento de Clostridium  perfringens  (CP) en un modelo \nintestinal in vitro  seguido de un desaf \u00edo con enteritis necr\u00f3tica (NE) en pollos de engorda. Para el estudio in vitro  las \nexcretas frescas de pollos de engorda (fuente de microbiota intestinal), con o sin adici\u00f3n de XPC, se desafiaron con \nCP y se incubaron durante 24 h. XPC aument\u00f3 la producci\u00f3n de \u00e1cidos grasos vol\u00e1tiles y redujo el pH y las \nconcentraciones de CP (P < 0,05). A continuaci\u00f3n, se llev\u00f3 a cabo un desaf\u00edo de pollos de engorda con NE, \nprobando los efectos de la alimentaci\u00f3n con XPC solo o combinado con la virginiamicina (VIR) o la bacitracina. Los pollos de engorda se desafiaron con C P en los d  19, 20, y 21 y luego se calificaron las lesiones de enteritis \nnecr\u00f3tica. Las calificaciones de las lesiones NE fueron menores y el rendimiento de los animales mejor en todos los grupos tratados en comparaci\u00f3n (P < 0,05) a los controles desafiados. Se observaron beneficios acumulativos \ncuando se combinaron XPC y VIR. Los resultados sugieren que XPC puede cambiar la microbiota intestinal para suprimir el crecimiento de CP y lesiones de enteritis necr\u00f3tica de manera preferente.  \n \nSUMMARY  \n \nThe effects  of XPC on Clostridium  perfringens  (CP) growth in an in vitro  intestinal model followed by a \nnecrotic enteritis (NE) broiler challenge were investigated. For the in vitro  study , fresh broiler excreta (intestinal \nmicrobiota source), with or  without XPC addition  was challenged with CP an d incubated for  24 h. XPC increased \nvolatile fatty acid production and reduced pH and CP concentrations ( P < 0.05). A broiler NE challenge was then \nconducted, testing the effects of feeding XPC alone or combin ed with virginiamycin (VIR) or bacitracin. Broilers  \nwere challenged with CP on d  19, 20, & 21 and then scored for NE lesions. NE lesion scores were lower and animal \nperformance better in all treated groups compared ( P < 0.05) to challenged controls. Additive benefits were \nobserved when XPC and VIR  were combined . Results suggest that XPC may shift the intestinal microbiota to \npreferentially suppress CP growth and NE lesions.  \n \nINTRODUCTION  \n \nIn poultry, NE  was first reported in 1961 in England.  The pathogen responsible for this disease was reported to \nbe Clostridium perfringens  (CP), resulting in sudden death. The environment of a healthy gut does not typical \nsupport the growth of CP.  However, when coccid ial infections are present, the intestinal mucosa becomes damaged \nallowing establishment and proliferation of CP.  The subclinical effects are less noticeable but will reduce growth \nand performance of the birds and cause increased condemnations at processin g. Two antibiotic drugs commonly \nused to combat NE are virginiamycin & bacitracin.  Feeding Original XPC has been shown to improve health and \nperformance under several pathogen challenges in poultry, such as Salmonella (1) and coccidia ( E. maxima;  2). \nWith the benefits of Original XPC improving gut health and balancing the immunity, it was hypothesized that \nimprovements should also  be seen during a CP (n ecrotic enteritis) challenge  induced by a mild coccidiosis  \nchallenge . \n  \n \n 63rd WPDC/XXXIX ANECA  MATERIALS AND METHODS  \n \nIn vitro  assay.  The CP utilized was an avian strain isolated from a bird diagnosed with necrotic enteritis . Fresh \nexcreta from six wk old broilers birds fed an organic diet (free from feed additive) was  used as the source of \nintestinal microorganisms.  Fresh excreta was combined with a mineral salts medium (6 g/L), homogenized and \nfiltered; this filtrate was used as the fecal inoculum for the in vitro  model.  Under anaerobic conditions, 0.3 g of a \npredige sted poultry diet (10 replicates) was combined with 30 mL  of fecal inoculum and 0.15 g of treatments (XPC \nor control grain) in a Falcon tube.  Tubes were then challenged with approximately 4.43 log cfu/mL of CP , final \nconcentration . Tubes were incubated for  24 h  at 39\u00b0C, after which the contents were analyzed for VFA by gas \nchromatography.  For enumeration of CP, serial dilutions of the tube contents were plated onto a  CP selective \nmedium consisting of an agar base, and the selective supplement. Plates were incubated at 37oC, under strict \nanaerobic conditions (90% N; 5% H 2; 5% CO 2).  \nIn vivo  study . Four hundred and forty eight  d old male broiler chicks (Cobb x  Cobb 500) were separated into \nseven treatment groups with eight  replicate pens of eight chicks each.  Birds were raised in brooder cages  and \nprovided dietary treatments from 1 \u2013  28 d of age. Treatments include a negative control (NC) group, f ed no additives \nand not challenged with CP , and six groups orally inoculated  with a broth culture containing 108 CFU/mL  of CP on  \n19, 20, & 21 d  of age. The challenged groups were fed either no additives (PC), 1.25 kg/ton ne XPC (XPC), 22 \ng/tonne virginiamycin (VIR), both XPC and  VIR (XPC+VIR),  55 g/ton ne Bacitracin Methylene Disalicylate \n(BMD ), or combination of both XPC and BMD (XPC+BMD).  To initiate the NE  challenge b irds all treatment \ngroup s were orally inoculated at 14  d with ~5000 oocysts of E. maxima . Six h after final CP challenge on  d 21, three  \nbirds/pen were euthanized and NE lesions scoring was conducted . All mortalities through 28 d  were necropsied with \nNE mortalities recorded . Replicate pen body weight and feed consumption was monitored.  \n \nRESULTS  \n \nIn vitro  study results can be found in Table 1. I nclusion of XPC into the fecal inoculum reduced ( P < 0.05) pH \nand increased ( P < 0.05) acetate, propionate, butyrate and total VFA concentrations . Inclusion of XPC also  \nsuppressed growth of CP ( P < 0.05) by 0.65 of a log . \nIn vivo  study results can be observed in Table 2. A significant in crease (P < 0.05) in NE lesions and NE \nmortalities and reduction ( P < 0.05) in performance were observed in PC group compared to NC gr oup. Mortality in \nthe XPC, VIR or  BMD groups plus the combinations were not significantly different from the non- challenged \ncontrols (NC). The addition of XPC, VIR, or BMD into the diets resul ted in a significant reduction (P < 0.05) in NE \nlesions and improved ( P < 0.05) body weight gain and feed conversion during the challenge. The combination of \nXPC with either antibiotic also resulted in a significa nt decrease (P < 0.05) in lesion scores and improvement ( P < \n0.05) in  performance. Additive responses were observed in lesion reduction  and performance improvement when \ncombining XPC with VIR. XPC+VIR treatment resulted in similar ( P > 0.05) lesion score and body weight gain as \ncompared to NC. Additive benefits of reduced mortality and feed conversion were also apparent when XPC was added  to the BMD diet.  \n \nIMPLICATIONS  \n \nResults of this study demonstrate that Original XPC, virginiamycin, or BMD are benef icial in reducing the \nnecrotic enteritis stress caused by CP. Results also suggest that Original XPC can be used in addition to antibiotic \nprograms, particularly during a high challenge, with the potential of an additive  response in reducing necrotic \nenteritis stress.  The in vitro  research provides mode of action direction , in that Original XPC may possess qualities \nthat can shift the intestinal microbial population (demonstrated by VFA increase) to preferentially suppress CP \ngrowth.  \n \nREFERENCES  \n \n1. Ibukic, M., D. Trampel, T. Frana, C. M. Logue, and J. Broomhead. Eval uation of Diamond V Original \nXPC for reducing cecal colonization by Salmonella Enteriditis in layer pullets. In: Proceedings of the 93rd \nConference of Research Workers in Animal Diseases. Chicago, IL. 2012.  \n2. 2. Lensing, M., J. D. Van der Klis, I. Yoon, and D. T. Moore. Efficacy of Saccharomyces cerevisiae on \nintestinal health and productivity of coccidian -challenged laying hens.  Poult. Sci. 91:1590- 1597. 2012.   \n 63rd WPDC/XXXIX ANECA   \nTable 1 .  Effects of Original XPC on volatile fa tty acid (VFA) and Clostridium perfringens  (CP) \nconcentrations in a broiler in vitro  gut model . \n \nParameter  Control  XPC  MSE  \npH 6.59a 6.55b 0.005  \nAcetate (mM)  22.7b 27.2a 0.37 \nPropionate (mM)  13.5b 15.4a 0.19 \nButyrate (mM)  3.02b 4.36a 0.07 \nTotal VFA (mM ) 39.9b 47.7a 0.60 \nCP (log10 CFU/ml)  5.73a 5.08b 0.14 \nab Means in the same row with different superscripts differ at P < 0.05   \nMSE = Mean squared error  \n \nTable 2 . Effects of feeding Original XPC, virginiamycin (VIR), bacitracin (BMD) or combinations on necrotic \nenteritis (NE) lesions, mortality and animal performance during a Clostridium perfringens  challenge . \n \n Treatment  Intestinal NE \nLesion Score1 \n(21d)  NE  \nMortality, % \n(19-28d) Weight Gain, g  \n(14-21d) Feed Conversion  \n(14-21d) \nNC 0c 0b 222a 1.65e \nPC 1.13a 21.9a 144c 3.02a \nXPC  0.58b 9.4ab 188b 2.43b \nVIR 0.54b 6.3ab 195b 2.16cd \nXPC+VIR  0.33bc 6.3ab 201ab 1.98d \nBMD  0.42bc 12.5ab 186b 2.28bc \nXPC+BMD  0.42bc 6.3ab 188b 2.15cd \nMSE  0.10 3.6 6 0.06 \na-e Means in the same column with different superscripts differ at P < 0.0001  \n1 Lesion score is on a scale of 0 -3; 1 = slight mucus covering and loss of tone  \nMSE = Mean squared error; NC = not challenged; PC = challenged, no additive fed  \n 63rd WPDC/XXXIX ANECA  INTERACCI\u00d3N DE LAS ENZIMAS XILANASA, PROTEASA Y \nFITASA -SUPERDOSIS SOBRE LOS PAR\u00c1METROS \nPRODUCTIVOS, RENDIMIENTO EN CANAL Y TIEMPO DE \nTR\u00c1NSITO DE LA DIGESTA EN POLLOS DE ENGORDA  \n \nINTERACTION OF XYLANASE, PROTEASE AND SUPERDOSE PHYTASE \nENZYMES ON PRODUCTIVE PERFORMANCE, CARCASS YIELD AND \nTRANSIT TIME OF THE INGESTION OF BROILER CHICKENS  \n \nTedeschi -Dos Santos TA, Massey O\u00b4Neill HVA, L\u00f3pez -Coello CB, Rubio AJC y Camacho -Fern\u00e1ndez D*C \n \nAAB Vista Feed Ingredients, 3 Woodstock Court, Blenheim Road, Marlborough Bus ines Park,  Marlborough Wilts, \nSN8 4AN, UK  \nBDepartamento de Producci\u00f3n Animal -Aves, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional \nAut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, Distrito Federal, 13209  \nCAB Vista Feed Ingredients, M\u00e9xico  \nAutor para correspondencia: Daniel Camacho Fern\u00e1ndez. Direcci\u00f3n: Maravat\u00edo 311 Col. Claver\u00eda. C. P. 02080 \nM\u00e9xico, D. F., correo electr\u00f3nico: Daniel.Camacho@ abmauri .com .mx \n \nSUMMARY  \n \nTwo thousand eight hundred Ross 308 chickens one day  old were assigned to o ne of eight diets with seven  \nrepetitions of 50 animals. The treatments were: T1: Control; T2: Xylanase; T3: Protease; T4: Phytase superdose; T5: \nXylanase + Protease; T6: Xylanase + Superose; T7: Protease + Superdose; T8: Xylanase + Protease + Superdose. \nProductive performance and carcass yield were registered at 42 d  of age. Transit time of t he ingestion was registered \nat four  periods. Xylanase, protease or superdose  inclusion alone had very little effect on animal performance, but \nimproved carcass yield and weight. When two enzymes were included together, carcass yield and weight as well as performance were improved. The best results were obtained when phytase superd ose + xylanase were included. The \ninclusion of the three enzymes alone only had benefits on performance and carcass yield, compared to the inclusion \nof superdose + xylanase.  \n \nRESUMEN  \n \nCon m\u00e1s frecuencia en la industria del pollo de engorda , el uso de enzim as va convirti\u00e9ndose en una estrategia \nen la producci\u00f3n, para disminuir los costos de producci\u00f3n o aminorar el efecto nocivo de los factores antinutricionales de los macroingredientes. Se asignaron 2,800 pollitos Ross 308 de un d\u00eda de edad a ocho dietas con siete repeticiones con 50 animales. Los tratamientos fueron: T1: Control; T2: Xilanasa; T3: Proteasa; T4: Superdosis  \nde Fitasa; T5: Xilanasa + Proteasa; T6: Xilanasa + Superdosis ; T7: Proteasa + Superdosis  y T8: Xilanasa + Proteasa \n+ Superdosis . A los 42 d\u00edas de edad se registraron los par\u00e1metros productivos y el rendimiento en canal , y en 4 \nper\u00edodos el tr\u00e1nsito de la digesta. La  inclusi\u00f3n de Xilanasa, P roteasa \u00f3 Superdosis  cada  una  por  separado, tuvo  \npoco  efecto sobre el desempe\u00f1o del animal, pero tendi\u00f3 a mejorar el rendimiento y el peso de la canal. Cuando se incluyeron dos enzimas juntas, mejor\u00f3 el rendimiento de la canal, el peso y el desempe\u00f1o; los mejores resultados se \nobtuvieron cuando se incluy\u00f3 la Superdosis  de Fitasa + Xilanasa. La inclusi \u00f3n de las tres enzimas no tuvo m\u00e1s \nbeneficios en el desempe\u00f1o y el rendimiento de la canal, en comparaci\u00f3n con el uso de la  S uperdosis de Fitasa  + \nXilanasa.  \n \nINTRODUCCI\u00d3N  \n \nLas enzimas comercialmente disponibles se han utilizado en la nutrici\u00f3n de monog\u00e1stricos desde finales de los \na\u00f1os ochenta del siglo pasado , siendo usadas rutinariamente en el presente. Las enzimas ex\u00f3genas  mejoran el valor \nnutricional  del ma\u00edz  y en consecuencia  de las dietas basadas en  ma\u00edz y harina de soya  por varios mecanismos  \npotenciales ( 3). La enzima m\u00e1s com\u00fan utilizada en las dietas ha sido la fitasa, con el objetivo de hidrolizar el fitato, 63rd WPDC/XXXIX ANECA  incrementando la absorci\u00f3n de f\u00f3sforo y reduciendo as\u00ed el uso del costoso f\u00f3sforo org\u00e1nico o  inorg\u00e1nico.  El uso de \nsuperdosis de fitas a ha mostrado mejorar  el desempe\u00f1o de los animales al destruir m\u00e1s r\u00e1pidamente el fitato , \nreduciendo p\u00e9rdidas end\u00f3genas e incrementando la absorci\u00f3n de l inositol mejorando el estatus antioxidante de las \naves.  Los polisac\u00e1ridos no almid\u00f3n (NSP) (por sus sig las en ingl\u00e9s) se destacan como  uno de los factores  anti-\nnutricionales. El m a\u00edz, que se a\u00f1ade a la alimentaci\u00f3n  como fuente principal  de energ\u00eda , s\u00f3lo contiene el 1% de NSP \nsoluble s, especialmente arabinoxilanos , en comparaci\u00f3n con  24, 45 y 46% del trigo, cebada y centeno , \nrespectivamente  (1). Sin embargo , aunque el ma\u00edz  es un ingrediente  f\u00e1cil de digerir , hay evidencia que sugiere  la \npresencia de almid\u00f3n  resistente a la digesti\u00f3n , lo que puede limitar  el valor  de la energ\u00eda de ma\u00edz  y en consec uencia  \nde la energ\u00eda de la dieta (2). Se sabe que las enzimas  pueden hidrolizar  polisac\u00e1ridos  que impiden  la digesti\u00f3n de los  \ngranos de almid\u00f3n  y prote\u00ednas , haciendo que estos compuestos sean  disponibles para la digesti\u00f3n  por la acci\u00f3n de  \nenzimas end\u00f3genas  (4). La xilanasa ha sido utilizada con \u00e9xito  en dietas con base trigo , que tienen un  alto contenido \nde arabinoxilanos, siendo efectiva en  reducir la viscosidad  del quimo y la degradaci\u00f3n  de la pared celular . \nRecientemente otras enzimas han sido desarrolladas tales como las proteas as. El valor m\u00e1s aceptado de la inclusi\u00f3n \nde proteasas ex\u00f3genas en dietas de aves , es sobre la mejora en la digestibilidad de la prote\u00edna de los ingredientes de \nla dieta. La falta de comprensi\u00f3n de que los efectos de las proteasas  solas o en combinaci\u00f3n , tienen lugar sobre la \ndigestibilidad de los amino\u00e1cidos individuales, puede acentuar  a\u00fan m\u00e1s , el desequilibrio del perfil de amino\u00e1cidos \nproporcionado a la dieta  (5). Comercialmente m\u00e1s de una enzima puede ser utilizada, siendo con troversial el hecho \nde que el uso  de una primera enzima puede tener un impacto en la respuesta de la inclusi\u00f3n de una segunda y as\u00ed \nsucesivamente.  Aunque cada enzima tiene una actividad enfocada en un diferente sustrato, la respuesta de las \nenzimas no se ha visto que tengan un efecto aditivo. Massey O\u00b4Neill (datos en tr\u00e1mite de publicaci\u00f3n) propone que \nla forma de evaluar el impacto de diferentes en zimas adicionadas en la misma dieta,  es mediante un dise\u00f1o factorial \ndonde cada enzima sea incluida por separado o conjuntamente.  \nEl objetivo de  este estudio fue  evaluar el efecto  de la inclusi\u00f3n de enzimas : fitasa (superdosis), xilanasa y \nproteasa; as\u00ed co mo la combinaci\u00f3n de ellas, sobre los par\u00e1metros productivos , rendimiento en canal y tiempo de \ntr\u00e1nsito de la digesta  en pollos de engorda , mantenidos  en producci\u00f3n hasta los 42 d\u00edas  de edad.  \n \nMATERIAL Y M\u00c9TODOS  \n \nSe utilizaron  un total de 2,800 pollitos Ross 308 de un d\u00eda de edad,  para ocho dietas , con siete repeticiones en \n56 lotes , con 50 animales cada uno. L a dieta control inclu\u00eda fitasa ( \u201cQuantum Blue  5G\u201d\u00ae) a 500 FTU/kg. Se \nincluyeron  xilanasa:  \u201cEconase XT 25\u201d\u00ae (EXT -16,000 B XU/kg), s uperdosis de \u201cQuantum Blue 5G\u201d (SD \u2013 1000 \nFTU/kg adicionales) y proteasa (PRO -15,000 PROT/kg) por separado \u00f3 en combinaci\u00f3n . Los tratamientos \nconsistieron de un dise\u00f1o factorial 2x2x2 con y sin la inclusi\u00f3n de xilanasa, proteasa y fitasa en el conc epto de \nsuperdosis para un total de ocho tratamientos y siete  repeticiones por tratamiento. Los tratamientos fueron los \nsiguientes: T1: Control; T2: Xilanasa (XIL)  100g/ton ; T3: Proteasa  (PRO)  200g/ton ; T4:  Superdosis de Fitasa (SD)  \n200g/ton ; T5: Xilanasa  + Proteasa (XIL  + PRO)  100g/ton  + 200g/ton ; 6: Xilanasa  + Superdosis  (XIL  + SD) \n100g/ton  + 200g/ton ; T7: Proteasa  + Superdosis  (PRO  + SD) 200g/ton  + 200g/ton ; T8: Xilanasa  + Proteasa + \nSuperdosis  (XIL  + PRO  + SD) 100g/ton  + 200g/ton  + 200g/ton . Las dietas se ofrecieron a libre acceso al igual que \nel agua durante todo el experimento.  (\u201cQuantum Blue 5G\u201d es una fitasa producida por el microorganismo  \nEscherichia coli . \u201cEconase XT25 \u201d\u00ae es una xilanasa producida por el microorganismo  Trichoderma  reesei .) \nSe emplearon dietas a base de sorgo +pasta de soya cubriendo los requerimientos que se\u00f1ala la estirpe (Cuadro 1)  en \ntres fases alimenticias . En el Cuadro 1  aparece el an\u00e1lisis calculado de las dietas . \nA los 42 d\u00edas  de edad se registr\u00f3 el consumo de alimento, ganancia de peso corporal, conversi\u00f3n alimenticia y \nmortalidad. A los 21 d\u00edas de edad, se seleccionaron dos aves por repetici\u00f3n se aplic\u00f3 eutanasia por dislocaci\u00f3n \ncervical y se colect\u00f3 la tibia izquierda para l a determinaci\u00f3n de cenizas en hueso. A los 42 d \u00edas de edad dos machos \npor repetici\u00f3n fueron seleccionados y se procesaron en rastro para determinar el peso y rendimiento de la carne de \npechuga y de la canal. Los resultados se analizaron por tratamiento y p or el efecto de la inclusi\u00f3n de cada enzima. El \ntiempo de tr\u00e1nsito de la digesta fue medido a los d\u00edas 21, 28, 35 y 42 d\u00edas de edad. En cada caso se separaron cinco  \nmachos por repetici\u00f3n y colocados en jaulas independientes. Los animales fueron alimentados  con las mismas dietas \nque la repetici\u00f3n de origen incluyendo 2k g/ton de \u00f3xido ferroso. El tiempo de tr\u00e1nsito fue determinado como el \nperiodo comprendido entre el consumo de alimento con \u00f3xido ferroso,  hasta el tiempo en que las heces cambiaron \nde color , de su color original caf\u00e9 a rojo. Despu\u00e9s de esta medici\u00f3n las aves se retornaron al  lote de donde proced\u00edan.  \nAn\u00e1lisis e stad\u00edstico. Los datos  se sometieron a un procedimiento  ANOVA usando el modelo GLM  para un \ndise\u00f1o completamente aleatorizado, proceso de Minitab y el tiempo de tr\u00e1nsito de la digesta fue analizado como \nr\u00e9plicas en el tiempo . Cuando en los efectos fueron encontradas diferencias estad\u00edsticamente significativas, se aplic\u00f3 \nla prueba de Tukey para las medias de los tratamientos. Se tomaron las d iferencias estad\u00edsticas: P<0.05 y P<0.10.  63rd WPDC/XXXIX ANECA     \nRESULTADOS  \n \nLos resultados de los par\u00e1metros productivos y del rendimiento en canal se presentan en el Cuadro 2. Al aislar \nlos efectos de cada  enzima al d\u00eda 42, la S uperdosis de Fitasa  aument\u00f3 el consumo de alimento y la ganancia de peso \ncorporal  (P<0. 15), mientras que con Xilanasa  mejor\u00f3 la conversi\u00f3n alimenticia y tendi\u00f3 a aumentar la ganancia de \npeso corporal  (P<0.10) . Con el uso de la Superdosis aument\u00f3 el rendimiento de la canal y tendi\u00f3 a aumentar  m\u00e1s \ncuando se utiliz \u00f3 junto con Xilanasa  (P<0.15) . En consecuencia, las aves alimentadas con Xilanasa  presentaron \ncanales m\u00e1s pesadas y las alimentadas con la S uperdosis presentaron carne de pechuga m\u00e1s pesada y tendieron \ntambi\u00e9n a tener canales m\u00e1s pesadas.  La inclusi\u00f3n de proteasa tuvo una tendencia a reducir el rendimiento de la \npechuga.  \nLos resultados del tiempo de tr\u00e1nsito de la digesta incrementaron mientras los animales tuvieron m\u00e1s edad. No \nse encontraron diferencias estad\u00edsticamen te significativas entre el grupo control y los grupos tratados a los d\u00edas  21 y \n28. Al d\u00eda  35 la Superdosis \u00f3 la combinaci\u00f3n de Xilanasa y Proteasa tuvieron menor tiempo de tr\u00e1nsito con r especto \nal grupo control. Al d \u00eda 42 el grupo de Superdosis tuvo m\u00e1s ti empo de tr\u00e1nsito que el grupo control. En general , la \ninclusi\u00f3n de S uperdosis  aument\u00f3  el tiempo de tr\u00e1nsito  cuando se incluye en  una dieta que contiene  xilanasa  y \nninguna  mejora adicional  fue obtenida cuando se le incluye con la proteasa.   \nLa inclusi\u00f3n de las tres enzimas juntas tuvo impacto sobre el desempe\u00f1o y rendimiento de la canal en pollos \nalimentados con una dieta de sorgo. Sin embargo, el desempe\u00f1o fue \u00f3ptimo cuando en la dieta se incluyeron dos \nenzimas, pero no hubo respuesta cuando  se incluy\u00f3 una tercera. Particularmente los pollos alimentados con Xilanasa  \nen conjunto con la S uperdosis de Fitasa , presentaron el mejor desempe\u00f1o en la mayor\u00eda de los par\u00e1metros evaluados.  \n \nCONCLUSIONES  \n \nLa inclusi\u00f3n de Xilanasa, Proteasa \u00f3 Superdosis  de Fitasa  cada una por separad o, tuvo  poco efecto sobre los \npar\u00e1metros p roductivos de los pollos, pero tendi\u00f3 a mejorar el rendimiento y el p eso de la c anal. Cuando se \nincluyeron  dos enzimas juntas, mejor\u00f3 el r endimiento de la canal, el p eso y los p ar\u00e1met ros p roductivos ; los mejores \nresultados se obtuvieron cuando se incluy\u00f3 la Superdosis de Fitasa + Xilanasa. La inclusi\u00f3n de las tres enzimas no tuvo m\u00e1s beneficios en los par\u00e1metros p roductivos  y el r endimiento de la c anal, en comparaci\u00f3n con el uso de la  \nSuperdosis de Fitasa + Xilanasa.  \n \nREFERENCIAS  \n \n1. Choct , M. Feed polysaccharides: nutritional roles and effect of enzymes. In : Congreso Latinoamericano \nde Nutrici\u00f3n Animal. San Pedro, p.65- 78. 2010.  \n2.  Slominski,  B. A. A new generation of enzymes for animal feeds. In: Western Nutrition Conference. \nCanada, P.1 -29. 2001.  \n3.  Cowieson, A. J. Factors that affect the nutritional value of maize for broilers. Animal Feed Science and \nTechnology. 119:293- 305. 2005.  \n4.  Bedford,  M. R.  The effects of enzymes on digestion. Journal of Applied Poultry Research. 5:370- 378. \n1996.  \n5.  Romero, L.F. and  P. W. Plumstead . Bio-Efficacy of proteases in poultry and their interaction with other \nfeed enzymes . Aust. Poult. Sci. Symp. 24: 23- 30. 2013.  \n  \n  \n \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA  Cuadro 1 . Composici\u00f3n y an\u00e1lisis calculado de las dietas testigo1. \n \nIngredient es Iniciador  (0-21) Crecimiento  (22-35) Finalizador  (36-42) \nSorg o, % \nPasta de soya, %  \nAceite de soya, %  \nFosfato monoc\u00e1lcico , % \nPiedra caliza, %  \nSal, % \nDL Metionin a, % \nLisina  HCl, %  \nL-Treonina , % \nBicarbonato de Sodio, %  \nOtros, %2 64.0 \n30.9 \n1.53 \n1.03 \n1.06 \n0.31 \n0.29 \n0.36 \n0.09 \n0.10 \n0.33 65.6 \n27.9 \n2.90 \n0.94 \n1.13 \n0.31 \n0.22 \n0.21 \n0.02 \n0.10 \n0.67 69.3 \n22.9 \n4.10 \n0.75 \n1.15 \n0.26 \n0.23 \n0.32 \n0.07 \n0.10 \n0.82 \nNutri mentos \nEM, Kcal/Kg \nProte\u00edna cruda, %  \nLisina, % \nM+C, %  \nTreonin a, % \nCalci o, % \nF\u00f3sforo disponible , % \nSodio,  %  \n3000  \n22.0 \n1.25 \n0.87 \n0.79 \n0.90 \n0.46 \n0.20  \n3100  \n20.0 \n1.05 \n0.76 \n0.68 \n0.90 \n0.44 \n0.20  \n3200  \n18.0 \n1.00 \n0.72 \n0.65 \n0.85 \n0.40 \n0.18 \n1 Tratamientos 2 -8 formula dos con la inclusi\u00f3n de la enzima referente a la dieta \n2 Suplidos por kilogram o de dieta : Hierro  (Sulfato Ferroso ), 60 mg, Manganes o (Sulfato y \u00d3xido de Manganes o), \n120 mg; Zinc (\u00d3xido de Zinc ), 100 mg; Yodo (Yodato de Calci o), 1 mg; Cobre  (Sulfato de Co bre), 8mg; S elenium \n(Selenito de Sodio), 0.3mg, Vitamina A, 9,600 IU; V itamin a D3 3,600 IU; Vitamin a E, 18mg; Vitamin a B12, 15 \nmcg; Riboflavin a, 10 mg; N iacin a, 48 mg; \u00c1cido d-pantotenic o, 18 mg; V itamin a K, 2 mg; \u00c1cido F olico, 1.2 mg; \nVitamin B 6, 4 mg; Ti iamin a, 3 mg ; d-Biotina, 72 mcg \n \n \nCuadro 2 . Resultados promedio de las variables productivas y del rendimiento en canal . \n \n  Par\u00e1metros Productivos  Rendimiento en Canal  \n Consumo\nAlim.,, g  Peso \nCorporal g  Conversi\u00f3n\nAlime., g/g  Peso \nCanal, g  Porcentaje\nCanal, %  Peso Pech., \ng Porcentaje \nPech., %  \nControl  4467ab 2506B 1.783      2079B 77.6B 639 30.8 \nXilanasa  4400ab\u2019 2513AB 1.751  2114AB 78.1AB 657 31.1 \nProteasa  4393b 2508B 1.752  2112AB 78.2AB 650 30.7 \nSuperdosis  4474ab 2509AB 1.784  2107AB 78.3AB 662 31.4 \nXIL+PRO  4430ab 2512AB 1.764  2119AB 78.8AB 643 30.3 \nXIL+SD  4479ab 2549AB 1.758  2150A 79.4A 685 31.9 \nPRO+SD  4495a 2534AB 1.774  2111AB 79.0AB 647 30.6 \nXIL+PRO+S\nD 4483ab 2563A 1.749       2149A 79.2AB 663 30.8 \nP        \nTratamientos  0.021  0.089  0.100  0.079  0.088  0.17 0.42 \nXIL 0.60 0.071  0.011  0.012  0.070  0.12 0.67 \nPRO  0.77 0.37 0.19 0.40 0.13 0.19 0.052  \nSD 0.001  0.011  0.58 0.055  0.019  0.039  0.14 \nABP<0.10  a,b P<0.05 63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N DE UN PROGRAMA CON VACUNA ACTIVA \nTERMOSENSIBLE CEPA MS -H, EN EL CONTROL DE  \nM. SYNOVIAE  EN REPRODUCTORAS PESADAS  \n \nEVALUATION OF A PROGRAM USING THE ACTIVE THERMO-SENSITIVE \nVACCINE (VAXSAFE\u00ae MS) FOR THE CONTROL OF MYCOPLASMA  \nSYNOVIAE IN HEAVY BREEDERS  \n \nE. Camacho,  M. Murillo, E. Soto, D. Sarfati y B.  Lozano  \n \nLaboratorio Avimex , S.A. de C.V. J.I. Bartolache 1862. Colonia del Valle. Delegaci\u00f3n Benito Ju\u00e1r ez. 03100 \nM\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nTo est ablish an effective control of a vian Mycoplasma in breeders is vital, as this can benefit their own \nproductivity as well as that of their progeny. In Mexico, a high percentage of heavy breeders are positive to \nMycoplasma synoviae  (MS) and most of the companies have implemented immunization of fl ocks wi th live \nvaccines. After five years of continuously using an immunization program in breeders, an evaluation was done in \nfour flocks and their progeny. Results indicated that MS was not detected in embryos. Only some of the flocks sero -\nconverted, were posit ive to PCR and presented clinical problems, indicating a field MS contamination. The rest of \nthe progeny did not present any problem. It is concluded that immunization with Vaxsafe\u00ae MS in a continuous \nbreeder program is an excellent tool to avoid vertical transmission of MS.  \n \nRESUMEN  \n \nEn reproductoras es fundamental establecer un control efectivo de la Micoplasmosis aviar ya que esto beneficia \nsu propia productividad y la de su progenie. En M\u00e9xico un alto porcentaje de las reproductoras pesadas se encuentra n positivas a la presencia de MS y la mayor\u00eda de las empresas han implementado la inmunizaci\u00f3n de \nparvadas  con vacunas vivas. Despu\u00e9s de cinco  a\u00f1os de uso continuo de un programa de inmunizaci\u00f3n en \nreproductoras , se realiz\u00f3 una evaluaci\u00f3n de 4  parvadas as\u00ed  como de su progenie. Los resultados indican que el MS \nno fue detectado en la embriones. Solo algunas parvadas de la progenie sero -convirtieron, fueron positivas a PCR y \npresentaron problemas cl\u00ednicos, indicando una contaminaci\u00f3n con MS de campo. El resto de la progenie no present\u00f3 problema alguno. Se concluye que la inmunizaci\u00f3n con Vaxsafe\n\u00ae MS en programa continuo en reproductoras es una \nexcelente herramienta para evitar la trasmisi\u00f3n vertical de MS.  \n \nINTRODUCCI\u00d3N  \n \nLos p rogramas  de prevenci\u00f3n y control de la micoplasmosis aviar con el uso de f\u00e1rmacos antimicopl\u00e1smicos \nhan demostrado sus lim itaciones a lo largo de m\u00e1s de 4 0 a\u00f1os  en los que se han empleado por la avicultura mundial \nde manera intensiva, dando como resultado la perpetuaci\u00f3n del proble ma y una incidencia alta de MS  en parvadas de \nreproductoras, gallinas de postura y pollos de engorda  en M\u00e9xico .  \nEn las parvadas de reproductoras pesadas (RP) es fundamental establ ecer programas efectivos de prevenci\u00f3n   \nde la m icoplasmosis (MG y/o MS ), ya que   afectan su propia productividad y la de su progenie. En M\u00e9xico , en un \nestud io realizado por Soto y col (4)  se observ\u00f3 que el 80% de las reproductoras pesadas se enc ontraban \nserol\u00f3gicamente positivas a MS , por lo que la mayor\u00eda de las empresas i mplementa ron la inmuniza ci\u00f3n de sus \nparvadas con la vacuna Vaxsafe MS con la cepa Termosensible MS-H (Bioproperties, Pty. Ltd.) a los 21 d  de edad \npara prevenir los da\u00f1os econ\u00f3micos asociados con este microorganismo en sus operaciones . \nEs importante enfati zar que la inmunizaci\u00f3n de parvadas con esta vacuna no impide que las aves se infecten \nposteriormente con cepas de campo, pero su importancia radica en que:  Previene que las cepas de campo sean \ntransmitidas verticalmente; p reviene la manifestaci\u00f3n cl\u00ednica en las  reproductoras y en su progenie; p reviene los \nda\u00f1os econ\u00f3micos asociados con este microorganismo  \n 63rd WPDC/XXXIX ANECA  OBJETIVO  \n \nPresentar resultados serol\u00f3gicos y de pruebas de PCR de 4 distintas parvadas de reproductoras  bajo programa \nde inmunizaci\u00f3n  con la vacuna viva termo sensible cepa MS -H contra Mycoplasma synoviae . \n \nMATERIALES Y M\u00c9TODOS  \n \nPara este estudio se valoraron  4 parvada s de reproductora s pesadas  entre  las 3 0 y las 45 semanas de edad , as\u00ed \ncomo  de su progenie.  \nDe cada lote de reproductoras, as\u00ed como de su pro genie, s e realiz\u00f3 un  muestreo con la toma de 100 muestras de \nsueros y 100 hisopos  est\u00e9riles de tr\u00e1quea de cada una de las aves muestreadas , as\u00ed como 10 0 hisopos  est\u00e9riles en \nembr iones picados no nacidos (EPNN ) provenientes de  esas mismas aves reproductoras. L as muestras de hisopos se \nenjuagaron en medio de cultivo de Frey 2X  dentro de tubos de ensayo  y fueron enviados  al laboratorio cl\u00ednico en un \nperiodo no mayor  de 48 h bajo conservaci\u00f3n t\u00e9rmica entre 2\u00b0C y 8\u00b0C . \nSe realizaron  pruebas serol\u00f3gicas  mediante las t\u00e9cnicas de ELISA, Inhibici\u00f3n de la Hemoaglutinaci\u00f3n ( HI) y \nde Aglutinaci\u00f3n en Placa ( AP) de todos los sueros , y se llevaron a cabo pruebas de PCR a partir de la muestras \ntomadas con hisopos traqueales, as\u00ed como de los EPNN en la planta incubadora, provenientes de las mismas claves \nde reproductoras muestreadas . \n \nRESULTADOS  \n \nPrueba s de ELISA . Los resultados obtenidos indican que  los sueros provienen de aves vacunadas normalmente \npresentan niveles entre 600 y 1800. En este  estudio se observa que las aves vacunadas presentaron adem\u00e1s un \ndesaf\u00edo  natural en el campo , ya que los t\u00edtulos obtenidos en las parvadas se encontraron entre 1800 y 13 500.  \nPrueba de HI . Los resultados obtenidos indican que  los sueros provienen de aves v acunadas normalmente presentan \nniveles entre 1:20 y 1:80.  En este estudio se observa que las aves vacunadas presentaron adem\u00e1s un desaf\u00edo natural \nen el campo, ya que los t\u00edtulos obtenidos en las parvadas se encontraron entre 1:320 y 1:640.  Prueba de AP . Los \nresultados obte nidos fueron 100% positivos . Resultados en la prueba de PCR . Las muestras provenientes de hisopos \ntraqueales de las madres resultaron 100% positivas, mientras que las muestras provenientes de los hisopos obtenidos \nde los EPNN resultaron 100% negativas.   \n \nDISCUSI\u00d3N  \n \nMediante las t\u00e9cnicas serol\u00f3gicas empleadas se determin\u00f3 que las cuatro claves de reproductoras vacunadas \ncon Vaxsafe MS que fueron muestreadas entre las 30 y 45 semanas de edad, sufrieron desaf\u00edo de campo con MS  al \njuzgar por los altos t\u00edtulos de anticuerpos circulantes encontrados. As\u00ed mismo, los resultados positivos de las pruebas \nde PCR de hisopos traqueales de esas mismas aves indican  que las aves son positivas a la presencia de MS, ya sea \ncepa vacunal o cepa de campo. No obstante, en ninguna muestra tomada de los EPNN mediante hisopos est\u00e9riles, se \nencontraron resultados positivos  de PCR, lo cual confirma que la vacunaci\u00f3n de las reproductoras con la vacuna \nviva elaborada con la cepa termosensible MS -H, previno la transmisi\u00f3n vertical del MS  de campo , lo que previene \nlas p\u00e9rdidas  econ\u00f3micas  asociadas  con este microorganismo en las aves.    \n \nCONCLUSI\u00d3N  \n \nLa inmunizaci\u00f3n  oportuna  de las aves reproductoras con la vacuna viva elaborada con la cepa termo -sensible \nMS-H, en programa continuo, es una herramienta para prevenir la trasmisi\u00f3n vertical de M S a su progenie y con \nello, propicia r una mejor productividad del pollo de engorda . \n \nREFERENCIAS  \n \n1. Kleven, S. H. and N. Ferguson- Noel . Mycoplasma synoviae Infection. In \u201cDiseases of Poultry\u201d. 1 2th \nedition. Edited by Y.M. Saif, A.M. Fadly, J.R. Glisson, L.R. McDougald , L.K. Nolan and D.E. Swayne. Iowa State \nUniversity Press. pp 845 -856. 2008.  \n2. Glisson, J. Interacciones de las enfermedades respiratorias, XXII Curso Avimex \u201cA ctualidades en Cl\u00ednica \nAviar\u201d . 2011.  63rd WPDC/XXXIX ANECA  3. Morrow, C. Control de la Micoplasmosis Aviar, XXI I Curso Avimex \u201cActualidades en Cl\u00ednica Aviar\u201d.  \n2010.  \n4. Soto, E. Avances en el control de M synoviae en M\u00e9xico, XII Curso Avimex \u201cAsumiendo en reto en la \nprevenci\u00f3n y contr ol de los Complejos Respiratorios de las aves en el nuevo milenio\u201d . 2000.  \n5. Soto, E. Programa de control y erradicaci\u00f3n de M synoviae con el uso de Vaxsafe Ms, X Curso Avimex \n\u201cSalud y productividad aviar\u201d.  1998.  \n6. Scott, P.C.  Desarrollo de una mutante termosen sible de M . synoviae (MS -H) y su aplicaci\u00f3n en campo \ncomo una vacuna activa atenuada, VIII Curso Avimex \u201cBronquitis Infecciosa y problemas respiratorios \nEmergentes\u201d . 1996.  63rd WPDC/XXXIX ANECA  EFFECT OF GENOTYPE SPECIFIC LIVE RECOMBINANT \nNEWCASTLE DISEASE VACCINES ON MORTALITY AND VIRUS \nSHEDDING AFTER CHALLENGE  \n \nEFECTO DE LAS VACUNAS VIVAS RECOMBINANTES DE GENOTIPO \nESPEC\u00cdFICO CONTRA LA ENFERMEDAD DE NEWCASTLE EN LA \nMORTALIDAD Y LA ELIMINACI\u00d3N DEL VIRUS DESPU\u00c9S DEL DESAF\u00cdO  \n \nS. C\u00e1rdenas Garc\u00edaAB, P. MillerA, C. BrownB, and  C. AfonsoA \n \nASouth East Poultry Resea rch Laboratory, Athens, GA, USA  \n BCollege of Veterinary Medicine, University of Georgia, Athens, GA, USA  \n \nRESUMEN  \n \nEn este estudio, dos virus recombinantes lentog\u00e9nicos se generaron mediante la substituci\u00f3n de los genes F y \nHN de la c adena principal de la vacuna LaSota (genotipo II) con los genes F y HN del Virus de la Enfermedad de \nNewcatle NDV virulento de genotipos VIId (de \u00c1frica del Sur) y XIII (de Pakist\u00e1n). Los virus recombinantes fueron \natenuados por la mutaci\u00f3n del sitio de escisi\u00f3n de la prote\u00edna de fusi\u00f3n y fueron bien caracterizados para confirmar \nsu seguridad. Se vacunaron pollitos SPF de un d\u00eda de edad, ya  sea con uno de estos virus o  con la vacuna La Sota y \n14 d  despu\u00e9s de la vacunaci\u00f3n fueron desafiados con sus respectivos virus hom\u00f3logos virulentos (Sud\u00e1frica o \nPakist\u00e1n). Los resultados demuestran que las vacunas experimentales otorgaron una supervivenci a del 100%, \nprevinieron los signos cl\u00ednicos y disminuyeron la excreci\u00f3n del virus en la orofaring e en comparaci\u00f3n con la cepa \nLaSota. Adem\u00e1s, cuando se vacunaron pollos SPF de cuatro semanas de edad con la vacuna experimental que \nexpresa las glicoprote\u00ednas  F y HN del virus genotipo XIII o con la vacuna La Sota 103, 104, 105 or 106, y se \ndesafiaron con el virus virulento de Pakist\u00e1n, la mortalidad despu\u00e9s del desaf\u00edo disminuy\u00f3 en los grupos que recibieron la vacuna hom\u00f3loga al virus de desaf\u00edo, en comparaci\u00f3 n con la vacuna la Sota. En conclusi\u00f3n, los genes F \ny HN hom\u00f3logos a NDV virulento circulante son suficientes para disminuir la diseminaci\u00f3n del virus de desaf\u00edo y \npara reducir la mortalidad de manera m\u00e1s efectiva que la vacuna LaSota.  \n \nSUMMARY  \n \nIn the pre sent study, two lentogenic recombinant viruses were generated by replacing the F and HN genes from \nthe LaSota vaccine backbone (genotype II) with the F and HN genes from virulent NDV of genotypes VIId (from \nSouth Africa) and XIII (from Pakistan).  The reco mbinant viruses were attenuated by mutating the fusion protein \ncleavage site and thoroughly characterized to confirm their safety.  One d old SPF chicks were either vaccinated \nwith one of these viruses o r the LaSota vaccine and 14 d  after vaccination were challenged with their respective \nhomologous virulent virus (South Africa or Pakistan). Results demonstrate that the experimental vaccines conferred \n100% survival, prevented clinical signs, and decreased oropharyngeal virus shedding compared to the LaSota s train. \nAdditionally, when four wk old SPF chickens were vaccinated with the experimental vaccine expressing the F and \nHN glycoproteins from the genotype XIII virus or with the LaSota vaccine at 10\n3, 104, 105 or 106, and challenged \nwith the virulent virus f orm Pakistan, the mortality after challenge was decreased in those groups that received the \nvaccine homologous to the challenge virus, compared to the LaSota vaccine. In conclusion, the F and HN genes \nhomologous to the circulating virulent NDV are sufficie nt to decrease virus shedding of the challenge virus and to \nreduce mortality more effectively than the LaSota vaccine.  \n \nABSTRACT  \n \nNewcastle disease (ND) poses a severe threat to the poultry industry due to its great economic  impact and \nworld -wide distribution  (1).  One of the most important methods to control ND is vaccination  (1), but current \nvaccines have not been able to prevent replication and viru s shedding into the environment  even though it has been \ndemonstrated that the se vaccines, when applied correctly and at the appropriate doses, can protect from disease ( 2). 63rd WPDC/XXXIX ANECA  The commercially available vaccines , such as LaSota and B1 , belong to genotype II and some others such as \nUlster and V4 belong to genotype I, while virulent Newcastle disease viruses (vNDV) currently circulating around \nthe world belong to completely different genotypes such as V, VI, VII and XIII.  Previous studies have demonstrated \nthat vaccines genetically homologous to the challenge vNDV are able to reduce viral excretion in to the environment \n(3,4).  Data also demonstrated th at a reduction in viral shedding after challenge, reduc ed transmission from bird to \nbird (5).   \nIn the present study, two experimental vaccines  were generated by replacing the F and HN genes from the \nLaSota vaccine backbone (genotype II) with the F and H N genes from vNDV of genotypes VIId (from South \nAfrica) and XIII (from Pakistan).  The se viruses were attenuated by mutating the fusion protein cleavage site and \nthoroughly characterize d to confirm their safety.  One d old SPF chick ens were vaccinated with  either one of these \nexperimental vaccines or with the LaSota vaccine and 14 d  after vaccination were challenged with either  vNDV -VII \nor vNDV- XIII (heterologous to LaSota) .  Results demonstrate that the experimental vaccines conferred 100% \nsurvival, prevented clinical signs, and decreased oropharyngeal virus shedding compared to the LaSota vaccine.  \nAdditionally, we tested the effect of homologous vaccines on clinical protection under suboptimal dosage in \ncomparison with the LaSota vaccine.  This \u201csuboptimal\u201d scenario presented here mimics the unfortunate environment that is found in the field in the countries that have endemic v NDV strains circulating.   Here,  four wk \nold SPF chickens were vaccinated with the experimental vaccine expressing the F and HN glycoproteins from \nvNDV -XIII virus or with the LaSota vaccine at 10\n3, 104, 105 or 106, and challenged with vNDV -XIII.  Protection \nagainst the clinical outcome after challenge wa s better in those groups that received the vaccine homologous to the \nchallenge virus when compared to the LaSota vaccine.   \nIn conclusion, the F and HN genes homologous to the circulating v NDV are sufficient to decrease virus \nshedding of the challenge viru s and increased clinical protection  more effectively than the LaSota vaccine.  \n \nREFERENCES  \n \n1. Miller PJ, Koch G. 2013. Newcastle Disease, other Avian Paramyxoviruses and Avian Metapneumovirus \ninfections, p. 89- 138. In Swayne DE, Glisson JR, McDougal LR, Nolan LK, Suarez DL, Nair V (ed.), Diseases of \nPoultry, 13 th ed. Wiley -Blackwell Publishing, Ames, Iowa.  \n2. Dortmans JC, Peeters BP, Koch G. 2012. Newcastle disease virus outbreaks: vaccine mismatch or \ninadequate appli cation? Veterinary microbiology 160:17- 22. \n3. Miller PJ, Estevez C, Yu Q, Suarez DL, King DJ. 2009. Comparison of viral shedding following \nvaccination with inactivated and live Newcastle disease vaccines formulated with wild -type and recombinant \nviruses. A vian Dis 53:39 -49. \n4. Miller PJ, King DJ, Afonso CL, Suarez DL. 2007. Antigenic differences among Newcastle disease virus \nstrains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238- 7246.  \n5. Miller PJ, Afonso CL, El Attrache J, Dorsey KM, Courtney SC, Guo Z, Kapczynski DR. 2013. Effects of \nNewcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Developmental \nand comparative immunology 41:505- 513. 63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N F\u00cdSICA Y SEROL\u00d3GICA DE HOMOGENEIDAD DE \nVACUNAS INACTIVADAS CONTRA LA ENFERMEDAD DE \nNEWCASTLE E INFLUENZA AVIAR MEZCLADAS  \nPOR TRES M\u00c9TODOS DIFERENTES  \n \nPHYSICAL AND SEROLOGICAL EVALUATION OF THE UNIFORMITY OF \nINACTIVATED VACCINES AGAINST NEWCASTLE\u2019S DISEASE AND AVIAN \nINFLUENZA MIXED USING THREE DIFFERENT METHODS  \n \nP. Cascante *, S. Madrigal , G. Rodr\u00edguez , L. Garc\u00eda, V. Marrufo  y D. Lucio  \n \nInvestigaci\u00f3n Aplicada S.A. de C.V.  \n7 Norte No. 416, Col. Centro, Tehuac\u00e1n, Puebla, M\u00e9xico. CP 75700.  \n*rcascante@grupoidisa.com  \n \nSUMMARY  \n \nThe mixing uniformity of emulsified concentrated vaccines against Newcastle\u00b4s disease (ND) and avian \ninfluenza (AI) was evaluated through physical and serological tests. Tests of microscopy, oily phase dispersion and \nstability in a bivalent ND+AI vaccine, in two monovalent vaccines against ND and AI and three mixtures of these \nvaccines (3 different method s) were d one. Serological evaluation in seven SPF birds groups immunized with non-\nmixed and mixed vaccines was made. A lower emulsion vacuole size, and a higher uniformity, as well as a good \nstability, allow for a better contact surface to obtain rapid sub cutaneous tissue absorption with a quicker \nseroconversion and the presence of protecti ve antibodies titters at 14 d  post-vaccination. The use of a bivalent \nvaccine ND+AI, alone, or with a mixture of two monovalent vaccines (mechanically mixed using an electric mixer), resulted in higher protecti ve antibodies titters at 14 d  post-vaccination ( P<0.05) with a lower variation coefficient.  \n \nRESUMEN  \n \nSe evalu\u00f3 la homogeneidad de mezclado de vacunas em ulsionadas concentradas contra enfermedad de \nNewcastle (ENC) e  influenza aviar (IA) mediante pruebas f\u00edsicas y serol\u00f3gicas. Se realizaron pruebas de \nmicroscop\u00eda, dispersi\u00f3n de fase oleosa y estabilidad en una vacuna bivalente ENC+IA, dos vacunas monovalentes contra ENC y IA y tres mezclas de estas vacunas ( tres m\u00e9tod os diferentes). Se re aliz\u00f3 evaluaci\u00f3n serol\u00f3gica en siete  \ngrupos de aves SPF inmunizadas con vacunas sin mezclar y mezcladas. Un menor tama\u00f1o en las vacuolas de emulsi\u00f3n, m\u00e1s homog\u00e9neas y una buena estabilidad permiten una mayor superficie de contacto para obtener una \nr\u00e1pida absorci\u00f3n en el tejido subcut\u00e1neo con una seroconversi\u00f3n m\u00e1s r\u00e1pida, t\u00edtulos de an ticuerpos protectivos a 14 \nd PV. Emplear una vacuna bivalente ENC+IA, sola o con una mezcla de dos vacunas monovalentes (mezcladas \nmec\u00e1nicamente con batid ora el\u00e9ctrica), result\u00f3 en mayores t\u00edtulos de antic uerpos protectivos a los 14 d\u00edas  PV \n(diferencia estad\u00edstica significativa p<0.05), con menor coeficiente de variaci\u00f3n.  \n \nINTRODUCCI\u00d3N  \n \nEn los \u00faltimos a\u00f1os en M\u00e9xico es  com\u00fan  que algunos productores de pollo de engorda, mezcl en vacunas  \nconcentradas fabricadas por diferentes laboratorios contra diferentes ant\u00edgenos como son virus de la enfermedad de \nNewcastle  (ENC) y virus de  influenza a viar (IA). Estas mezclas se realizan con l a finalidad de obtener diversidad \nantig\u00e9nica  en una mayor cantidad de emulsi\u00f3n administr\u00e1ndola en una sola aplicaci\u00f3n subcut\u00e1nea, con  una elevada \nrespuesta inmune en los pollos. El objetivo de este estudio es e valuar  la homogeneidad en el mezclado de vacun as \nemulsionadas concentradas contra E NC e IA por tres  diferentes m\u00e9todos de mezclado, a trav\u00e9s de pruebas f\u00edsicas y \nserol\u00f3gicas.  \n   \n 63rd WPDC/XXXIX ANECA  MATERIAL Y M\u00c9TODOS  \n \nSe realizaron pruebas f\u00edsicas de microscop\u00eda, prueba de dispersi\u00f3n de fase oleosa y prueba de estabilidad de la \nemulsi\u00f3n en una vacuna monovalente contra ENC (VmENC), una vacuna monovalente contra IA (VmIA) y una \nvacuna bivalente  ENC+IA (VbENCIA), as\u00ed como en tres  mezclas por diferentes  m\u00e9todos de VmENC y VmIA: \nmezcla uno  por agitac i\u00f3n en botella ( Vmix1), mezcla dos  por agitaci\u00f3n manual  con cuchar\u00f3n (Vmix2) y mezcla tres  \npor agitaci\u00f3n mec\u00e1nica co n batidora el\u00e9ctrica (Vmix3) . Adicionalmente se vacunaron siete grupos de aves libres de \npat\u00f3genos espec\u00edficos : A (VmENC ), B (VmIA ), C (Vmix1 ), D (Vmix2 ), E (Vmix3 ), F (VbENCIA ) y G (VbENCIA  \n+ Vmix3 ) (Tabla 1) .  \nMezcla por agitaci\u00f3n en botella . En una  botella de vidrio graduada de uno L de capacidad con taparosca de \npl\u00e1stico, se vertieron 500 mL de vacuna monovalente contra ENC y 500 mL de vacuna monovalente contra IA. Se \nagit\u00f3 la botella cerrada de manera manual de forma vigorosa durante cinco m  continuos.  \nMezcla manual con cuchar\u00f3n . En un contenedor de pl\u00e1stico de dos L  de capacidad sin tapa, se vertieron 500 \nmL de vacuna monovalente contra ENC y 500 mL  de vacuna monovalente contra IA. Se mezcl\u00f3 de manera vigorosa  \nempleando un cuchar \u00f3n de pl\u00e1stico durante cinco m  continuos.  \nMezcla mec\u00e1nica con batidora . En un contenedor de pl\u00e1stico de dos L  de capacidad sin tapa, se vertieron 500 \nmL de vacuna monovalente  contra ENC y 500 mL de vacuna monovalente contra IA. Se mezcl\u00f3 empleando una \nbatidora mec\u00e1n ica a 4000 rpm durante cinco m  continuos.  \nPrueba de microscop\u00eda . Con la finalidad de determinar la homogeneidad  as\u00ed como el tama\u00f1o de gota de la \nemulsi\u00f3n, se realiz aron pruebas de microscop\u00eda empleando un microscopio \u00f3ptico convencional en muestras de 6 \nidentificaciones de las vacunas emulsionadas y sus mezclas: A, B, C, D, E y F.  \nPrueba de estabilidad de la emul si\u00f3n. Se realiz\u00f3 la prueba de ruptura y separaci\u00f3n de la emulsi\u00f3n, \nsometiendo los biol\u00f3gicos empleados y sus mezclas a 37 \u00b0C, 4 \u00b0C, y cambios de temperatura de 37 \u00b0C a  4 \u00b0C y \nviceversa, de 4 \u00b0C a 37 \u00b0C, con la finalidad de determinar la estabilidad de cada biol\u00f3gico y sus mezclas.  \nPrueba serol\u00f3gica . Con la f inalidad de determinar el nivel de anticuerpos que estimula la aplicaci\u00f3n de los \nbiol\u00f3gicos incluidos en el protocolo, se realiz\u00f3 la evaluaci\u00f3n de t\u00edtulos de anticuerpos conferidos por la \nadministraci\u00f3n de las vacunas y sus mezclas  en aves de estirpe liger a libres de pat\u00f3genos espec\u00edficos  (Tabla 1) . \n \nRESULTADOS  \n \nEl tama\u00f1o de las vacuolas de emulsi\u00f3n es menor y su homogeneidad es mayor en las vacunas VmENC y \nVbENCIA sin mezclar; respecto a las vacunas mezcladas, la vacuna Vmix1 (mezclada manualmente por agitaci\u00f3n \nen botella) tuvo las vacuolas de menor tama\u00f1o con formaci\u00f3n de grumos m\u00e1s peque\u00f1os y con mayor homogeneidad \nrespecto a Vmix2 y Vmix3. La prueba de dispersi\u00f3 n de fase oleosa mostr\u00f3 que las tres vacunas sin mezclar son \nemulsiones agua en aceite, caracter\u00edstica que  se mantiene en l as vacunas mezcladas . En la prueba de estabilidad las \nvacunas sin mezclar y las vacunas mezcladas tuvieron resultados satisfactorios a 37  y 4 \u00b0C  (Tabla 2) . \nLa prueba serol\u00f3gica para ambos ant\u00edgenos mostr\u00f3 que el grupo G seguido del grupo F tuvieron los t\u00edtulos de \nanticuerpos m\u00e1s altos con menor coeficiente de variaci\u00f3n, siendo los \u00fanicos grupos con t\u00edtulos protectivos para \nambos ant\u00edgen os desde los 14 d\u00edas PV , con diferencia estad\u00edstica significativa ( Comparaci\u00f3n m\u00faltiple de medias \nTukey p<0.05) . \nEl menor tama\u00f1o de vacuolas de emulsi\u00f3n , su mayor homogeneidad, as\u00ed como una buena estabilidad son \ncaracter\u00edsticas f\u00edsicas  que permiten tener una mayor superficie de contacto a fin de obtener una r\u00e1pida absorci\u00f3n de \nlas vacunas en el tejido subcut\u00e1neo  con una seroconversi\u00f3n a t\u00edtulos de anticuerpos  protectivos m\u00e1s r\u00e1pida (14 d\u00edas  \nPV). El uso de una vacuna concentrada bivalente ENC+IA permite obt ener t\u00edtulos de anticuerpos m\u00e1s altos, \nprotectivos a los 14 d\u00edas PV y con menor coeficiente de variaci\u00f3n, emple\u00e1ndola sola o con una mezcla de dos \nvacunas monovalente . \n \nREFERENCIAS  \n \n1. Calnek BW. Diseases of Poultry. M\u00e9xico: El manual moderno, 1995.  \n2. Zavala G. Solid immune system essential for respiratory integrity. Word Poultry Elsevier Supplement. \n14-16. 1998.  \n3. Swayne DE. Perdue LM. Garc\u00eda M. Rivera -Cruz E. Brugh M. Pathogenicity and diagnosis of H5N2 \nMexican avian influenza viruses in chickens. Avian Diseases. 41:335- 346. 1997.  \n4. Garc\u00eda A. Johnson H. Srivastava DK. Jayawardene DA. Wehr DR. Webster RG. Efficacy of inactivated \nH5N2 influenza vaccines agains t lethal A/Chicken/Quer\u00e9taro/19/95 infection. Avian Diseases. 42:248- 256. 1998.  63rd WPDC/XXXIX ANECA  5. Lucio DE. Marrufo VD . Gonz\u00e1lez EME. Evaluaci\u00f3n de vacunas inactivadas contra influenza aviar. \nMemorias de la XXVIII Convenci\u00f3n Anual ANECA y Proceedings of the Fifty- First Western Poultry Disease \nConference. Puerto Vallarta (Jalisco) M\u00e9xico. M\u00e9xico (DF): Asociaci\u00f3n Nacional d e Especialistas en Ciencias \nAv\u00edcolas; 2002: 338- 341. 2002.  \n6. Lucio DE. Actualidades sobre influenza aviar en M\u00e9xico. Memorias del IV Precongreso Cient\u00edfico \nAv\u00edcola IASA; 2004 abril; Ixtapa Zihuatanejo (Guerrero) M\u00e9xico. Tehuac\u00e1n (Puebla): Investigaci\u00f3n Aplicada S.A. \nde C.V. y Asociaci\u00f3n Nacional de Especialistas en Ciencias Av\u00edcolas. 2004.  \n7. Lucio E., Morales A., Ortega R., Rodr\u00edguez A., Absal\u00f3n A. Caracter\u00edsticas de los virus de la enfermedad \nde Newcastle que circulan en M\u00e9xico y sus repercusiones en protecci\u00f3 n y persistencia en las zonas afectadas. \nTehuac\u00e1n, Pue., M\u00e9xico Investigaci\u00f3n Aplicada SA de CV e Instituto de Biotecnol og\u00eda del IPN, Tlaxcala, M\u00e9xico.  \n \n \nTabla 1. Dise\u00f1o experimental.  \n \nIdentificaci\u00f3n de la Muestra  M\u00e9todo de mezclado \nvacunas A y B  Dosis  \nA Vacuna monovalente ENC (VmENC)  ----- 0.2 mL / ave  \nB Vacuna monovalente IA (VmIA)  ----- 0.2 mL / ave  \nC VmENC + VmIA (Vmix1)  Agitaci\u00f3n en botella  0.4 mL / ave  \nD VmENC + VmIA (Vmix2)  Manual con cuchar\u00f3n  0.4 mL / ave  \nE VmENC + VmIA (Vmix3)  Mec\u00e1nico con batidora  0.4 mL / ave  \nF Vacuna bivalente ENC -IA (VbENCIA)  ----- 0.2 mL / ave  \nG VbENCIA  ----- 0.2 mL / ave  \nVmix3  Mec\u00e1nico con batidora  0.4 mL / ave  \nNota:  El grupo G fue vacunado administrando VbENCIA (0.2 mL/ave) por separado de la mezcla  \nVmix3 (0.4 mL/ ave) \n  \nTabla 2. Resultados de la prueba de ruptura de la emulsi\u00f3n.  \n \nIdentificaci\u00f3n de la Muestra  De 37 \u00b0C a 4 \u00b0C  De 4 \u00b0C a 37 \u00b0C  \nA Vacuna monovalente ENC (VmENC)  Negativo  Negativo  \nB Vacuna monovalente IA (VmIA)  Negativo  Negativo  \nC VmENC + VmIA  (Vmix1)  Negativo  Negativo  \nD VmENC + VmIA (Vmix2)  Negativo  Negativo  \nE VmENC + VmIA (Vmix3)  Negativo  Negativo  \nF Vacuna bivalente ENC -IA (VbENCIA)  Negativo  Negativo  \n 63rd WPDC/XXXIX ANECA  REVISITING THE JOHNSON & REID INTESTINAL LESION \nSCORING METHOD FOR COCCIDIOSIS  \n \nREVISANDO EL M\u00c9TODO JOHNSON & REID PARA LA CALIFICACI\u00d3N DE \nLESIONES INTESTINALES PARA COCCIDIOSIS  \n \nH.M. Cervantes \n \nPhibro Animal Health, Watkinsville , Georgia, USA \n \nRESUMEN  \n \nEn 1970 los investigadores de parasitolog\u00eda de aves J. Johnson y W.M. Reid  de la Universidad de Georgia \npublicaron un m\u00e9todo detallado para la calificaci\u00f3n de lesiones dise\u00f1ado para evaluar de manera m\u00e1s uniforme \nlesiones cecales e intestinales causadas por infecciones de una sola especie con seis  especies de Eimeria  de pollos e n \nambientes de laboratorio. Aunque su intenci\u00f3n era estandarizar las t\u00e9cnicas de calificaci\u00f3n de lesiones entre investigadores de parasitolog\u00eda de aves, los veterinarios que trabajan en la producci\u00f3n de aves y las industrias \nav\u00edcolas aliadas adoptaron r\u00e1pi damente el m\u00e9todo Johnson y Reid para el monitoreo rutinario de la coccidiosis en el \ncampo. Sin embargo, la aplicaci\u00f3n actual del m\u00e9todo de la calificaci\u00f3n de lesiones desarrollado por Johnson y Reid \nen 1970 difiere sustancialmente de la publicaci\u00f3n origin al. Esta presentaci\u00f3n destacar\u00e1 la necesidad de calificar las \nlesiones coccidiales de manera m\u00e1s uniforme a nivel de la industria av\u00edcola y se har\u00e1 hincapi\u00e9 en las diferencias \nentre la publicaci\u00f3n original y su aplicaci\u00f3n actual.  \n \nSUMMARY  \n \nIn 1970 Universi ty of Georgia poultry parasitology researchers J. Johnson  and W.M. Reid published a detailed \nlesion scoring method designed to evaluate in a more uniform way intestinal and cecal lesions caused by  single \nspecies infections with six Eimeria  spp. of chickens  in laboratory  settings. Although their intention was to \nstandardize lesion scoring  techniques among poultry parasitology researchers, poultry veterinarians  working for the \nproduction and allied poultry industries quickly adopted the Johnson and Reid Metho d for the routine monitoring of \ncoccidiosis in  the field. However,  the current application of the  lesion scoring  method developed by Johnson and \nReid in 1970 differs substantially from  the original publication. This presentation will highlight the need to score  \ncoccidial lesions more uniformly at the poultry industry level and will emphasize the differences between the \noriginal publication and its current application.  \n \nINTRODUCTION  \n \nIn 1970 poultry parasitology researchers J. Johnson and W.M. Reid from the University of Georgia \nDepartment o f Poultry Science published a lesion scoring method designed to evaluate gross intestinal and cecal \nlesions induced by single species laboratory in fections with Eimeria spp. of chickens  (1).  Although the intent of \ntheir publication was to standardize lesion scoring techniques among poultry parasitology researchers, veterinarians and parasitologists working for the production and allied poultry indus tries quickly adopted the technique for routine \nmonitoring of coccidiosis. H owever, the current interpretation of the lesion scoring technique developed by Johnson \nand Reid in 1970 differs substantially from the original publication  (2). \n \nOBSERVATIONS FROM  THE ORIGINAL PUBLICATION  \n \nThe original publication provides descriptions for the different degrees of severity of lesions for six  species of \nEimeria , namely, E. tenella, E. necatrix, E. acervulina, E. mivati, E. maxima , and E. brunetti.  However, the authors \ncaution readers about the difficulty in scoring the last two species and indicate serious doubts in the usefulness of scoring those species in infections that are not at least moderately severe.   Also, the authors did not produce a \nseparate description  of lesions for E. mivati indicating that the location and type of lesions are similar to those \ncaused by E. acervulina  except for a tendency for lesions to move in a caudal direction with the progression of the 63rd WPDC/XXXIX ANECA  infection.   Other differences noted by the authors were that the lesions are more rounded and that severe congestion \nhad not been observed.  \nThe authors abandoned all attempts to score by species, and instead only record ed the degre e of coccidiosis -\ninduced damage  to four regions of the intestinal tra ct; the regions being the upper, middle , and lower intestine and \nthe ceca.  \nFor E. tenella  and E. necatrix  lesions were scored on d five to seven  post-inoculation in battery trials.   E. \nmaxima  and E. brunetti  lesions were scored six to seven d  post-inoculation.  No time -frame for scoring was given \nfor E. acervulina  or E. mivati .  The authors noted that scoring lesions for E. maxima  is very difficult because the \ndegree of pathogencity  for this species does not always correlate with the severity of the lesions.  The authors noted \nas well that E. brunetti  was the most difficult species to score, in part because light infections do not produce lesions \nand severe infections are seldom seen  in experimental infections.  \nThe authors indicate d that their lesion scoring technique requires a minimum of two but better three people.  \nThe authors re commend examining a minimum of five  birds , or 5% of the total number of birds.  They  mention that \nthe serosal surface of the intestines should be examined for lesions first throughout the length of the intestines under \na strong light.   They also indicate d that a similar examination of the mucosal surface with collection of shallow and \ndeep scrapings for mi croscopic examination should be conducted on only one or two birds and that the second or \nthird person should examine them with the microscope under low and high power.   The authors also recommended \nconducting the lesion scoring \"blindly\" by one person having no knowledge of the treatments.  \nFinally, the authors indicate d that lesion scoring is time consuming and that the maximum number of birds that \nmay be examined in a day by a team of three is 200.  \n \nINCONSISTENCIES  \n \nAlthough the authors stated that they did not include a +5 category for birds dying from the coccidial infection \nbecause these birds may have lesions less severe than those found in some of the surviving birds , in the description \nof lesions for E. tenella , E. necatrix , E acervulina , E. maxima , and E. brunetti  they stated that dead birds are scored \nas +4 ( the highest lesion score by  their method).   \nNo specific mention is made by the authors about the importance of collecting mucosal scrapings from the \nmid-intestine from every bird to be examined  microscopically for the presence of E. maxima  oocysts.  For E. \nbrunetti  the authors report that a +1 score produces no gross lesions and can easily be missed unless mucosal \nscrapings are collected and examined microscopically to identify the parasite.  \n \nOBSERVATIONS FROM EVALUATIONS IN THE FIELD  \n \nThese  observations are based on 18 years of experience by the author conducting lesion scorings for coccidial \ninfections in broiler chickens in the field  by the method of Johnson & Reid.   \nMost people conducting lesion scoring in the field tend to report findings in terms of species rather than \nregions of the intestine, for example, a +2 for E. acervulina  instead of a +2  for the upper region , or a +1 for E. \nmaxima  instead of a +1  for the middle region.  Most evalu ators tend to increase the severity of the infections by one \nlevel, for example, a +2 E. acervulina infection is frequently scored as a +3 even by veterinarians with a good deal \nof clinical experience.  In the author's opinion this may be due to the fact t hat very severe infections (in the +4 \ncategory) are seldom seen in the field due to the routine use of anticoccidials or vaccines designed to prevent clinical \noutbre aks of coccidiosis, if a +4 is never or very seldom found, then a +3 by Johnson & Reid soon  becomes a +4; a \n+2 becomes a +3 and so on.  \nMost individuals conduct the lesion scoring and microscopic examination by themselves although in some \ninstances teams of colleagues work together to assess coccidiosis control at an operation.  In most cases the individuals conducting the lesion scoring session have knowledge of the anticoccidial program prior to the start.  In \nmost cases the individual conducting the lesion scoring session does not examine the serosal surface throughout the \nlength of the intesti nes prior to examining the mucosal surface.  Most reports provide the overall incidence of \ncoccidiosis or the incidence of each coccidial species by age but very few provide the mean lesion score by flock \nand the average lesion score for the entire necrops y session.  In addition, individual s that do not collect mucosal \nscrapings from the mid -intestinal region from every  bird for microscopic examinatio n have been not ed.  \nFinally, the author has observed a well recognized contract -researcher lesion score up t o 2,000 birds in a period \nof approximately three  hours.  \n \n 63rd WPDC/XXXIX ANECA  CONCLUSIONS  \n \nFew if any of us follow the method developed and published in 1970 by Joh nson & Reid as originally \ndescrib ed.  This should be acknowledged when presenting work on coccidiosis inolving lesion scoring \"by the \nmethod of Johnson & Reid\".  \nA recognition of this fact should prompt everyone conducting lesion scoring for coccidial infections in the field \nto study the original manuscript and attempt to adhere to the descriptions of lesions and s cores provided for each of \nthe various species of Eimeria spp. infecting broiler chickens.  \n \nREFERENCES  \n \n1. J. Johnson and W.M. Reid.  Anticoccidial drugs: Lesion Scoring Techniques in Battery and Flo or-pen \nExperiments with Chickens.  Experimental Parasitology 28:30- 36.  1970 . \n2. H.M. Cervantes.  Revisiting Lesion Scoring Techniques for Coccidiosis.  Proc. 150th Annual Meeting of \nthe American Veterinary Medical Association  and 56th Annual Meeting of the American Association of Avian \nPathologists.  2013.  63rd WPDC/XXXIX ANECA  INTERPRETACI\u00d3N DE RESULTADOS DE LA PRUEBA DE ELISA \nPARA DETECCI\u00d3N DE ANTICUERPOS CONTRA VIRUS DE \nINFLUENZA A EN SUEROS DE POLLOS DE ENGORDA CON \nDIFERENTES PROGRAMAS DE VACUNACI\u00d3N  \n \nINTERPRETATION OF ELISA RESULTS FOR THE DETECTION OF \nANTIBODIES AGAINST INFLUENZA A VIRUS IN CHICKEN SERA  \nFROM BROILERS VACCINATED WITH DIFFERENT PROGRAMS  \n \nJ. ChapaA, P. Mu\u00f1ozA, E. Guzm\u00e1nA, B. BautistaA, S. ZimmermanA, P. L\u00f3pezA y C. G\u00f3mezB \n \nAInvestigaci\u00f3n Aplicada S.A. de C.V. 7 norte 416, Colonia Centro, Tehuac\u00e1n, Puebla, M\u00e9xico, CP75700  \nBIDEXX Livestock, Poultry and Dairy. One IDEXX Drive, Westbrook, ME 04092, USA \n \nSUMMARY  \n \nEvaluation of the humoral immune response is performed by quantifying the levels of circulating antibodies. \nSerological methods are relatively easy procedures, rapi d and reproducible, and provide a good estimate of the \nresistance of animal populations against some viruses and bacteria. In Mexico the detection of antibodies against the \nvirus of avian influenza (AI) is routinely performed by testing hem agglutination inhibition subtype specific. The \nELISA developed to measure an tibodies against viruses type A  has the advantage of detecting exposure and  \ndissemination of virus in poultry populations and can be used in surveillance and eradication programs.  \nA study was conducted to determine the values ??S / N in blocking ELISA with broilers serum samples of \ndifferent ages and vaccination programs. Results are presented.  \n \nRESUMEN  \n \nPara evaluar la respuesta a la vacunaci \u00f3n de pollos de engorda de cuatro, cinco y seis  semanas de edad, con \ncuatro d iferentes vacunas inactivadas de influenza aviar , elaboradas con el subtipo H7N3, se utilizaron  las prueba s \nde ELISA indirecta y competitiva de  influenza aviar , as\u00ed como la prueba de HI . Una mayor sensibilidad y menor \nvariaci\u00f3n de los resultados se observaron  en la prueba competitiva.\nLa evaluaci\u00f3n de la respuesta inmune humoral se realiza mediante la cuantificaci\u00f3n de los niveles  de \nanticuerpos circulantes. Los m\u00e9todos serol\u00f3gicos son procedimientos relativamente f\u00e1ciles, r\u00e1pidos y reproducibles, \ny proporcionan una buena estimaci\u00f3n de la resistencia de una poblaci\u00f3n de animales contra algunos virus y \nbacterias. En M\u00e9xico , la detecci\u00f3n de anticuerpos contra el virus de Influenza Aviar (IA) se realiza en forma \nrutinaria mediante la prueba de inhibici\u00f3n de la hemoaglutinaci\u00f3n  (HI),  espec\u00edfica del subtipo , que es una prueba  \nsensible  y tiene aplicaci\u00f3n en el  monitoreo  de parvadas , sin embargo es laboriosa y se requiere contar con los \nsubtipos espec\u00edficos. La prueba de inmunoensayo enzim\u00e1tico ( ELISA ) desarrollada para medir anticuerpos contra \nvirus Tipo  A, tiene la ventaja  de detectar la exposici\u00f3n y diseminaci\u00f3n de  cualquier subtipo de l virus en poblaciones \nav\u00edcolas , por lo que  puede ser usada en program as de vigilancia y erradicaci\u00f3n, as\u00ed como en la evaluaci\u00f3n de la \nrespuesta a la vacunaci\u00f3n.  Productos comerciales de ELISA indirecta  (iELISA) han sido  desarrollados para el uso en \naves domesticas y se ha reportado mayor sensibilidad que la prueba de precipitaci\u00f3n en gel de agar (AGID).  La \nELISA de bloqueo (bELISA) usa un anticuerpo monoclonal que compi te con los anticuerpos del suero  para unirse \ncon el ant\u00edgeno marcado y puede ser usada en varias especies de aves ( 1). En Mexico el virus de IA  H5N2 de baja \npatogenicidad fue detectado por primera vez en 1994 en aves comerciales , y mediante  la vacunaci\u00f3n , que ha sido \nuna d e las estrategi as de la campa\u00f1a, se pudo erradicar al  virus de alta patogenicidad en ese mismo a\u00f1o. \nRecientemente en 2012 debido los brotes de IA causados por el subtipo H7N3 de alta patogenicidad,  se implement\u00f3  \nla vacunaci\u00f3n en algunas zonas del pa\u00eds como parte de las acciones para el control y la  erradicaci\u00f3n del virus. La \nprueba de b ELISA Influenza A, es por lo tanto una herramienta de diagn\u00f3stico para el monitoreo y detecci\u00f3n de la \nexposici\u00f3n de las aves en zonas libres y para la evaluaci\u00f3n de la respuesta a la vacunaci\u00f3n con uno o ambos subtipos.  63rd WPDC/XXXIX ANECA  El objetivo de este trabajo fue evaluar los resultados niveles de anticuerpos inducidos por diversas vacunas \ncontra IA , con las pruebas de iELISA y  bELISA , y determinar cu\u00e1l producto o esquema de vacunaci\u00f3n  resultar\u00eda en \nmayor protecci\u00f3n ante un eventual desaf\u00edo con virus de campo.  \n \nMATERIALES Y M\u00c9TODOS  \n \nMuestras de suero.  Se obtuvieron  12 muestras de suero de cuatro grupos de pollos de engorda de  cuatro, \ncinco  y seis semanas de edad , sumando un total de 144 muestras . Cada grupo proced\u00eda de una parvada vacunada \ndurante las dos primeras semanas de vida, con diferentes productos contra la I A, conteniendo  el virus inactivado del \nsubtipo H7N3 de baja patogenicidad. Los  calendario s de vacunaci\u00f3n y los productos utilizados no fueron revelados \npor el propietario.  \nPruebas  serol\u00f3gicas.  Se realizaron  las prueba s de ELISA  para la detecci\u00f3n de anticuerpos  contra el virus de \nIA, por l os m\u00e9todos  indirecto y de bloqueo (Influenza A) (IDEXX, Westbrook, ME) de acuerdo a las \nrecomendaciones de manufactura.  La prueba de HI se realiz\u00f3 con el ant\u00edgeno H7N3  cepa oficial con cuatro  UHA. \nAn\u00e1lisis estad\u00edstico. Se obtuvieron los valores de estad\u00edstica descri ptiva en el programa XCheck IDEXX\u00ae. y \nse realiz\u00f3 la prueba de correlaci\u00f3n con los resultados de la media geom\u00e9trica de los valores S/P de la prueba \nindirecta y S/N de la prueba competitiva, obtenidos de cada grupo de sueros . \n \nRESULTADOS  \n \nLos resultados de las pr uebas  se resumen en la  tabla 1.  El n\u00famero de muestras positivas fue  mayor en la prueba \ncompetitiva que  en la prueba indirecta, 118 (81. 94%) y 95 (65.97%), respectivamente.  La variaci\u00f3n de los resultados \nde acuerdo al coeficiente de variaci\u00f3n fue mayor en la prueba indirecta (8 9.6%) que en la prueba competitiva \n(44.19%) . Un coeficiente de correlaci\u00f3n de R2 = .7594 fue obtenido al comparar los valores S/P y S/N de las \npruebas.  El t\u00edtulo de anticuerpos promedio de cada grupo obtenido con la prueba indirecta vari\u00f3 de 672 a 2120 en las \naves de cuatr o semanas de edad alrededor de dos  semanas posteriores a la vacunaci\u00f3n (PV), de 1040 a 3 754 en las \naves de cinco semanas (tres  semanas PV) y de 1205 a 3463 en las aves de seis  semanas (4 semanas PV).  La mej or \nrespuesta a la vacunaci\u00f3n determinada por el mayor t\u00edtulo de anticuerpos o valor S/P medido con la prueba indirecta, y el menor valor S/N en la prueba competitiva, fue observada en las aves del G rupo 1 de cinco semanas de edad y \ndel G rupo 3 a las seis semanas.  Para su comparaci\u00f3n se inclu yen los resultados de HI en la T abla1. \n  \nDISCUSI\u00d3N  \n \nLas prueba s de iELISA  y bELISA permite n la semi  automatizaci\u00f3n y la r\u00e1pida realizaci\u00f3n de un gran n\u00famero \nde muestras, pero  el resultado deber\u00e1 de ser interpretado en forma grupal y no individual . Las pruebas indirectas son \nespec\u00edficas de especie, aunque las pruebas comerciales disponibles detectan la respuesta serol\u00f3gica de pollos y pavos ( 2). La prueba competitiva puede ser usada para la detecci\u00f3n de anticuerpos de diversas especies de aves y ha \nsido evaluada en forma experimental y con muestras de aves silvestres ( 1). En este trabajo se evalu\u00f3 la respuesta \nserol\u00f3gica de aves vacunadas con el subtipo H7N3,  obteniendo un mayor n\u00famero de resultados positivos con men or \ncoeficiente de variaci\u00f3n  en la prueba competitiva, comparados con los obtenidos en la prueba indirecta.  La prueba \nde bELISA es una valiosa herramienta de de diagn\u00f3stico serol\u00f3gico para la detecci\u00f3n de aves expuestas al virus de \nIA en zonas libres y para evaluar la respuesta de la parvada a la vacunaci\u00f3n con cualquier subtipo.  \nLa ELISA indirecta ofrece los beneficios de medir los t\u00edtulos vac\u00fanales por parvada y por granja. La b ELISA \nes una herramienta de monitoreo con la sensibilidad y especificidad suficientes para el seguimiento de parvadas en zonas libres de IA.  \n \nREFERENCIAS  \n \n1. Brown J., Luttell M., Berghaus R., Kistler W., Keeler S., Howey A., Wilcox B., Hall J., Niles L., Dey A., \nKutsen G., Fritz K., and Stallknecht D. 2010. Prevalence of antibodies to type a Influenza virus in wild avian species \nusing two serologic assays. J. Wildlife Dis. 46 (3): 896- 911.  \n2.  Swayne D., Senne D. and Suarez D . Avian Infuenza. In: A laboratory manual for the isolation , \nidentification , and characterization  of avian pathogens. 5th. Ed. Edited by D. Swayne, J. Glisson, J. Pearson, W. \nReed, M. Jackwood and P. Woolcock , American Association of Avian Pathologist, Inc, Athens , GA,  2008 . \n 63rd WPDC/XXXIX ANECA   \nEdad S/P S/N Tit. S/P S/N Tit. S/P S/N Tit. S/P S/N Tit.\n4 sem. 0.654 0.336 8.0   0.325 0.480 10.0 0.932 0.392 5.0   0.655 0.418 13.0 \n8 12 6 5 10 5 9 10 0 7 11 6\n5 sem. 1.573 0.227 28.0 0.485 0.482 13.0 1.264 0.295 30.0 0.824 0.322 13.0 \n10 12 10 6 7 6 10 9 9 9 9 6\n6 sem. 0.555 0.373 7.0   0.721 0.426 18.0 1.461 0.244 48.0 1.054 0.386 42.0 \n7 10 3 7 8 8 9 12 11 8 8 7\n* Media G eom \u00e9trica: valores S/P de iELISA, S/N de bELISA y T\u00edtulo Log10 de HI.\n   Resultados positivos: S/P > 0.5 , S/N < 0.6  y  HI > 5.Gpo. 2 Gpo. 4Tabla 1. MG y n\u00famero de muestras positivas en iELISA, bELISA y HI.*\nGpo. 3 Gpo. 1\n \n 63rd WPDC/XXXIX ANECA  RESULTADOS DEL MONITOREO SEROL\u00d3GICO CON LA \nPRUEBA DE ELISA PARA LA DETECCI\u00d3N DE ANTICUERPOS \nCONTRA BRONQUITIS INFECCIOSA E INFECCI\u00d3N DE LA \nBOLSA FABRICIO EN AVES REPRODUCTOR AS \u2013 \nCONSTRUCCI\u00d3N DE L\u00cdNEAS BASE  \n \nMEXICAN SEROLOGICAL BASELINES AND ELISA RESULTS FOR THE \nDETECTION OF ANTIBODIES AGAINST INFECTIOUS BRONCHITIS AND \nINFECTIOUS BURSAL DISEASE FROM DIFFERENT MONITORING \nPROGRAMS IN MEXICAN BREEDERS  \n \nJ. ChapaA, E. Rodr\u00ed guezA, E. Guzm\u00e1nA, S. ZimmermanB, P. L\u00f3pezB y C. G\u00f3mez B \n \nAInvestigaci\u00f3n Aplicada S.A. de C.V. 7 norte 416, Colonia Centro, Tehuac\u00e1n, Puebla, M\u00e9xico, CP75700  \nBIDEXX Livestock, Poultry and Dairy. One IDEXX Drive, Westbrook, ME 04092, USA \n \nSUMMARY  \n \nInfectious bronchitis (IB) and infectious bursal disease (IBD )  are acute contagious viral diseases that typically \naffects young chickens . IBV infections primarily cause respiratory disease, but some strains cause kidney damage. \nBreeder hens affected commonly suffer losses in production and egg quality. IBD causes im munosuppression and in \nsusceptible chickens decreases the response to vaccination and increases sus ceptibility to other infections . \nImmunization of breeders ensures passive immunity in their progeny to protect against early infections.  \nSerological tests ma y help to assess flock health by measuring antibody levels and establishing baselines that \nhelp monitor the prevalence and incidence of IB in breeder flocks , as well as antibody levels against IBD. \nMonitoring results are analyzed using the ELISA tests. Res ults are presented . \n \nRESUMEN  \n \nLas pruebas serol\u00f3gicas permiten evaluar la salud de las parvadas por la medici\u00f3n de los niveles de \nanticuerpos. Con este fin, establecer l\u00edneas base, evaluar la prevalencia e incidencia de BI en parvadas de reproductoras, as\u00ed  como los niveles de anticuerpos contra la IBF, se analizaron los resultados del monitoreo \nserol\u00f3gico con las pruebas de ELISA de 4 6 parvadas alojadas en siete granjas durante los a\u00f1os 2012 y 2013. Se \nobtuvieron los valores promedio y su variaci\u00f3n en diferentes edades , y se establecieron los par\u00e1metros o l\u00edneas base \nde referencia.  \nLa bronquitis infecciosa (BI) y la infecci\u00f3n de la bolsa de Fabricio (IBF) son enfermedades virales agudas y \ncontagiosas que normalmente afectan a las aves j\u00f3venes.  Las infecciones primarias por virus de BI pr oducen \nenfermedad respiratoria y  algunas cepas causan lesiones en ri\u00f1\u00f3n. Las aves de postura y reproductoras com\u00fanmente \nsufren p\u00e9rdidas en la producci\u00f3n y en la calidad del huevo. La IBF en aves susceptibles causa inmunosupresi\u00f3n, \ndisminuye la respuesta a la vacunaci\u00f3n e incrementa la su sceptibilidad a otras infecciones. Para ambas \nenfermedades, l a inmunizaci\u00f3n de reproductoras asegura inmunidad pasiva en la progenie contra infecciones \ntempranas.   \nEl diagn\u00f3stico serol\u00f3gico se basa en la detecci\u00f3n de anticuerpos en el suero contra diversos  agentes \ninfecciosos. La prueba de inmunoensayo enzim\u00e1tico ( ELISA ) es r\u00e1pida, pr\u00e1ctica y sensible,  permit e analizar una \ngran cantidad de sueros, est\u00e1 disponible comercialmente y su costo es relativamente bajo. E n el caso de BI e IBF es \nel m\u00e9tod o de elecci\u00f3n para el monitoreo (1).  \nLa raz\u00f3n m\u00e1s importante para examinar los t\u00edtulos de anticuerpos en las aves es establecer un banco de datos, \nantecedentes o l\u00edneas base,  de tal manera que se pueda detectar un problema temprano efectivamente.  Es importante \nestablecer la correlaci\u00f3n entre lo s t\u00edtulos de las pruebas serol\u00f3gicas y los problemas cl\u00ednicos que presentan las aves. \nSe establece un banco de datos para los rangos normales y se comparan cuando las aves presentan un desaf\u00edo por \nvirus de campo . Cualquier  cambio e n los  t\u00edtulos  normales  puede ser la alerta de un problema potencial, cuando se 63rd WPDC/XXXIX ANECA  presenta un  problema cl\u00ednico  es impo rtante tomar muestras pareadas durante l a fase aguda de la enfermedad y \ndurante la fase de convalecen cia, dos semanas de spu\u00e9s de la aparici\u00f3n del brote  (1,2). \nLa l\u00ednea base es el resumen promedio del comportamiento hist\u00f3rico de los mejores lotes productivamente para \nla cual se establece rangos, de tal manera que si se excede estos par\u00e1metros, en nuevos lotes evaluados, se tiene que \nrevisar el programa sanitario . Se calculan los t\u00edtulos normales para cada agente infeccioso, a determinada edad y por \nagente infeccioso, as\u00ed mismo  se determina si la parvada analizada, difier e de la media de la l\u00ednea base. Los cuadros \nson referencias generales de acuerdo a la experiencia de campo y bajo condiciones de normal es, adem\u00e1s de procesos \nde enfermedad. En este caso la prueba de ELISA puede ayudar a orientar el diagn\u00f3stico  (5). \nLas pruebas serol\u00f3gicas permiten evaluar la salud de las parvadas p or la medici\u00f3n de los niveles de \nanticuerpos. Con este fin, as\u00ed como establecer l\u00edneas base y  evaluar la prevalencia e incidencia de BI, y los niveles \nde anticuerpos contra la IBF en parvadas de reproductoras, se analizan  los resultados del monitoreo serol\u00f3gico con \nlas prueba de ELISA . \n \nMATERIALES Y M\u00c9TODOS  \n \nSe reunieron los resultados obtenidos de  muestras de suero analizados  mediante la prueba indirecta de ELISA . \nLas muestras proced\u00edan de 46 parvadas de reproductoras ligeras de diferentes edades alojadas en siete granjas \nubicadas en la zona del valle de Tehuac\u00e1n, en el estado de Puebla, M\u00e9xico, durante los a\u00f1os 2012 y 2013.  El \nprograma de monitoreo establecido por el productor incluye muestreos a partir del nacimiento de la pa rvada , a las 5, \n10, 14  y 18 semanas de edad, y posteriormente cada seis semanas hasta el fin de su vida productiva.  \nPruebas serol\u00f3gicas.  Se realizaron las pruebas de ELISA indirecta para la detecci\u00f3n de anticuerpos contra los \nvirus de BI e IBF (IDEXX, Westbrook, ME) de acuerdo a las recomendaciones de manufactura y con el uso d el \nprograma XCheck de IDEXX\u00ae.  \nAn\u00e1lisis de los datos . Se utilizaron los valores de la media geom\u00e9trica de l os t\u00edtulos de anticuerpos en el suero \nde las aves , obtenidos en cada resultado , y se construy\u00f3 una tabla din\u00e1mica con el programa de Exel Microsoft\u00ae. Se \nincluyeron datos de la granja  y parvada de procedencia, as\u00ed como la edad de las aves, el a\u00f1o y el mes en que se \ntomaron las muestras . Se calcularon  los valores de estad\u00edstica descriptiva con los resultados de la media geom\u00e9trica \nde las parvadas de cada granja en cada una de las etapas  del monitoreo.  \n \nRESULTADOS  \n \nLos valores de la media y desviaci\u00f3n est\u00e1ndar de los promedios  obtenidos de cada granja con los resultados de \nlas parvadas en cada monitoreo o edad  se presentan en la T abla 1. En el caso de BI los t\u00edtulos promedio variaron \nentre 619 y 4472, siendo los valores individuales m\u00ednimos de 79 y 87 a las dos y cinco semanas de edad \nrespectivamente, y los m\u00e1ximos superiores a 10, 000 en una parvada entre las 24 y 36 semanas de edad. En el caso \nde IBF los  t\u00edtulos promedio variaron de 1567 a 6677, siendo el  valor m\u00ednimo de 48 en aves de cinco  semanas y el \nm\u00e1ximo de 9137 en aves de una semana de edad.  En a mbos casos una diminuci\u00f3n en los t\u00edtulos de anticuerpos se \nencontr\u00f3 en la segunda y quinta semana de edad.  \n \nDISCUSI\u00d3N  \n \nLas pruebas serol\u00f3gicas son usadas rutinariamente para el monitoreo de la respuesta a la vacunaci\u00f3n y para \ndetectar incremento en el t\u00edtulo de anticuerpos atr ibuible a la infecci\u00f3n de campo . El diagn\u00f3stico serol\u00f3gico de la \ninfecci\u00f3n por  virus de BI en aves comerciales es mejor realizado  por la demostraci\u00f3n  de una respuesta ascendente de \nlos anticuerpos en el s uero usando la prueba de EL ISA, que detecta anticuerpos comunes para todos los serotipos \n(3). No se observaron incrementos considerables en los t\u00edtulos , sugestivo s de un brote en la mayor\u00eda de las parvadas;  \n\u00fanicamente , en dos de  la misma granja presentaron t\u00edtulos  al menos el doble del promedio. Esto sugiere una \nprobable exposici\u00f3n al virus de campo.  Considerando tambi\u00e9n que las  aves reciben varias vacunaciones durante el \nper\u00edodo de crianza.  \nLa prueba de ELISA es la m\u00e1 s com\u00fanmente usada para la evaluaci\u00f3n de anticuerpos contra el virus de IBF . Se \npuede establecer un perfil de anticuerpos en las reproductoras que indicar\u00e1  el nivel de inmunidad de la parvada y \ndar\u00e1 informaci\u00f3n para el desarrollo de programas propios de inmunizaci\u00f3n para las reproductoras y su progenie. El \nperfil de a nticuerpos puede ser realizado con el suero colectado de las reproductoras o  de su progenie al d\u00eda de edad, \nsiendo  los t\u00edtulos 60% a 80% menores que en las reproductoras.  Los anticuerpos  trasmitidos de la gallina en la yema \nde huevo pueden  proteger a los p ollos contra infecciones tempranas con el virus de IBF. Las vacunas en emulsi\u00f3n de \naceite pueden  estimular la inmunidad materna  adecuada para proteger a los pollos por cuatro a cinco  semanas , y con 63rd WPDC/XXXIX ANECA  vacunas vivas por uno a tres semanas ( 4). El monitoreo provee  informaci\u00f3n  valiosa  sobre el grado de protecci\u00f3n de \nla progenie durante las primeras semanas de vida.  \n \nREFERENCIAS  \n \n1. Bol\u00edvar  V. Bronquitis Infecciosa, soluciones pr \u00e1cticas. Lafavet C\u00eda. Ltda.  \n2.  Castro N ., Sequeda L ., Cort\u00e9s S . Correlaci\u00f3n entre la l\u00ednea base serol\u00f3gica, histopatolog\u00eda, imagen de la \nbolsa, PCR y secuenciaci\u00f3n viral para la enfermedad de Gumboro en fase de cr\u00eda en ponedoras comerciales . Lebrija, \nSantander. Revista Spei, Domus. N\u00fam.  6-7, 2007 . \n3.  Gelb J. and Jackwood M. Infe ctious B onchitis. In: A laboratory manual for the isolation, identification, \nand characterization of avian pathogens. 5th. Ed. Edited by D. Swayne, et al.  AAAP , Inc, Athens, GA, 2008.  \n4.  Luckert P. and Saif  Y. Infectious bursal disease . In: Diseases of Poultry, 9th ed. B. Calnek, et al Eds . \nIowa State University Press, Ames, Iowa. pp. 648 -663. 1991.  \n5.  Vasquez C. Algunas consideraciones para la interpretaci\u00f3n serol\u00f3gica en ELISA.  \nhttp://engormix.com/MA avicultura/sanidad/art\u00edculos . 27/07/09.  \n \n \nTabla 1. Resultados de los t\u00edtulos de anticuerpos contra los virus de BI e IBF obtenidos en la prueba de ELISA.\n1      2      5      10    14    18    24    30    36    42    48    54    60    66    72    78    \nBI\nMedia 2,794  963     619     2,020  1,941  3,348  4,137  4,360  3,977  4,472  3,679  3,999  3,965  4,126  4,199  4,053  \nDS 1,956  1,075  208     878     1,233  2,323  1,092  1,662  907     840     1,743  1,180  718     1,744  2,215  2,026  \nIBF\nMedia 6,677  3,081  1,567  2,539  2,512  2,821  5,316  5,237  4,926  4,945  3,247  4,209  3,806  5,734  3,943  5,444  \nDS 2,386  2,518  987     691     1,444  24       1,310  449     1,187  1,272  647     2,044  927     1,398  1,429  1,298  Edad en semanas\n \n 63rd WPDC/XXXIX ANECA  EFECTO DE LA DISMINUCI\u00d3N DE PROTE\u00cdNA Y AMINO\u00c1CIDOS \nESENCIALES EN DIETAS SORGO + SOYA TIPO COMERCIAL \nSOBRE LOS PAR\u00c1METROS PRODUCTIVOS EN PAVOS \nNICHOLAS DE 4 A 12 SEMANAS DE EDAD  \n \nEFFECT OF REDUCING PROTEIN AND ESSENTIAL AMINO ACIDS IN \nCOMMERICAL SORGHUM+SOY DIETS ON PERFORMANCE OF NICHOLAS \nTURKEYS 4 TO 12 WEEKS OF AGE  \n \nV. Ch\u00e1vezA*, H. PosadasA, A. CandeloB y R. S\u00e1nche zB \n \nACentro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola Universidad N acional Aut\u00f3noma de \nM\u00e9xico UNAM   \nBFacultad de Medici na Veterinaria y Zootecnia UNAM  \n*E-mail: erico_runy@hotmail.com  \n \nSUMMARY  \n \nGlutamine and glutamic acid are amino acids that have basic functions on the normal functions of the \norganism. The research objective was to evaluate the effect of productive parameters of Nicholas turkeys. The \ntreatments were: T1 - diet according to nutritional needs of Nic holas turkeys and T2 - diet with a 10% reduction of \nprotein and essential amino acids (lysine, methionine and threonine) and addition of 2 kg/ton of AminoGutM R (10% \nglutamine and 10% glutamic acid).  \nStatistical analysis results for weight gain and FCR showed significant ( P<0.05) difference between treatments \nwith a better performance for G roup 1. No significant ( P>0.05) difference was shown for feed intake and carcass \nyield. We conclude that reducing protein and essential amino acids 10% of the requirements for Nicholas turkeys \naffected their performance in weight gain and FCR from 4 to 12  wk of age.  \n \nRESUMEN  \n \nEl objetivo de la investigaci\u00f3n fue evaluar el efect o en los par\u00e1metros productivos de pavos Nicholas, \nalimentados con dietas sorgo + soya tipo comercial con una disminuci\u00f3n del 10% de prote\u00edna y de los amino\u00e1cidos m\u00e1s limitantes (lisina, metionina y treonina) y la sustituci\u00f3n con 0.2% de Aminogut (glutamin a y ac. Glut\u00e1mico al \n10%).  Se utilizaron 324 pa vos, de la estirpe Nicholas de cuatro  semanas de edad, los cuales se distribuyeron \nconforme a un dise\u00f1o completamente al azar en dos  tratamientos con tres  repeticiones de 54 pavos cada una. Los \ntratamientos fu eron: T1. - Dieta seg\u00fan las recomendaciones nutricionales de la estirpe Nicholas y  T2.- Dieta con \nreducci\u00f3n del 10% de prote\u00edna y amino\u00e1cidos esenciales (lisina, metionina y treonina) y adici\u00f3n de 2 Kg/Ton de \nAminoGut\nMR (10% de glutamina y 10% de ac.glut\u00e1mico)  como fuente de nitr\u00f3geno. La dieta experimental, solo \ncomprendi\u00f3 la etapa de desarrollo (semana 5 a 9). En la etapa de finalizaci\u00f3n, se emple\u00f3 la misma dieta sorgo + soya \ntipo comercial para ambos tratamientos. Los  resultados del an\u00e1lisis estad\u00edstico, para ganancia de peso y conversi\u00f3n \nalimenticia indicaron que existi\u00f3 diferencia significativa (P<0.05) entre tratamientos, con una mayor ganancia de \npeso y mejor conversi\u00f3n del T ratamiento 1. En el caso de consumo de alimento y rendimiento en canal, el an\u00e1lisis \nno present\u00f3 diferencia significativa  (P>0.05) entre tratamientos.  \n \nINTRODUCCI\u00d3N  \n \nEl inter\u00e9s econ\u00f3mico de la explotaci\u00f3n actual del pavo, se apoya principalmente en su rendimiento en carne y \nla calidad nutritiva  por el bajo contenido de grasa de su carne (4,5 ). La producci\u00f3n de carne de pavo, al igual que el \nresto de la producci\u00f3n av\u00edcola, sustenta la alimentaci\u00f3n de las aves en granos forrajeros y dependiendo del nivel de \ntecnificaci\u00f3n alcanzado en las explotaci ones, \u00e9ste puede ser proporcionado solamente quebrado y acondicionado con \notras materias primas, o bien, a trav\u00e9s de alimentos balanceados ( 3,11). 63rd WPDC/XXXIX ANECA  La anatom\u00eda y fisiolog\u00eda de los distintos \u00f3rganos y tejidos, difieren entre pavos y pollos y algunas de estas  \ndiferencias deben tomarse en cuenta a la hora de formular raciones.  Las estirpes actuales de pavos comerciales se \ncaracterizan por su amplia pechuga y alto porcentaje de masas musculares, por lo que precisan que la relaci\u00f3n \nprote\u00edna: energ\u00eda, sea mayor q ue en lo pollos durante las primeras semanas de vida  (5,6). Como en todas las especies \ndom\u00e9sticas las necesidades en prote\u00edna y en amino\u00e1cidos esenciales dependen de la edad; Se estima que las \nnecesidades en amino\u00e1cidos entre pavos y pollos son similares, aunque las necesidades de pavos son ligeramente \nsuperiores a las de los pollos en lisina y ligeramente inferiores en metionina  (8,14).  \nTanto la Glutamina como el \u00c1cido Glut\u00e1mico, son amino\u00e1cidos que cumplen funciones primordiales en el \nfuncionamiento normal del organismo y son altamente requeridos en las dietas en per\u00edodos de grandes exigencias \ncomo el crecimiento y desarrollo inicial de las aves, es por esto que se considera un nutriente condicionalmente \nesencial por ser un compuesto producido usualmente en cantidades adecuadas por s\u00edntesis end\u00f3gena, pero que se \nrequiere de forma ex\u00f3gena bajo determinadas circunstancias para cubrir las necesidades fisiol\u00f3gicas de los animales  \n(1,2,7). La glutamina presenta dos grupos amino, esta caracter\u00edstica le confiere una funci\u00f3n de importancia como es \nservir de fuente de nitr\u00f3geno para la s\u00edntesis de amino\u00e1cidos no esenciales y de otros compuestos nit rogenados  (1, 9, \n7,13) . Es por lo anterior que el objetivo de la investigaci\u00f3n fue evaluar el efecto en los par\u00e1metros productivos de \npavos Nicholas, alimentados con dietas sorgo + soya tipo comercial con una disminuci\u00f3n del 10% de prote\u00edna y de \nlos amino\u00e1cidos m\u00e1s limitantes (lisina, metionina y treonina) y la sustituci\u00f3n con 0.2% de Aminogut (glutamina y \nac. Glut\u00e1mico al 10%).  \n \nMATERIALES Y M\u00c9TODOS  \n \nLa investigaci\u00f3n se realiz\u00f3 en el Centro de Ense\u00f1an za, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola \n(CEIEPAv) de la Facultad de Medicina Veterinaria y Zootecnia de la Universidad Nacional Aut\u00f3noma de M\u00e9xico.  \nSe utilizaron 324 pavos, de la estirpe Nicholas de 4 semanas de edad. Los pavos fueron distribuidos al azar, en 6 lotes de 54 animales cada uno, tres  lotes para cada uno de los tratamientos.  \n\u2022 Tratamiento 1. Dieta seg\u00fan las recomendaciones nutricionales de la estirpe Nicholas.  \n\u2022 Tratamiento 2. Dieta con reducci\u00f3n del 10% de prote\u00edna y amino\u00e1cidos esenciales (lisina, metion ina y \ntreonina) y adici\u00f3n de 2 k g/Ton de AminoGut\nMR (10% de glutamina y 10% de ac.glut\u00e1mico)  en la etapa de \ndesarrollo como fuente de nitr\u00f3geno.  \nLos datos de las variables ganancia de peso, consumo de alimento, conversi\u00f3n alimenticia y rendimiento en \ncanal fueron sometidos a un an\u00e1lisis de varianza y comparados mediante pruebas de T de Student a un nivel de \nsignificancia de 5%, para lo cual se empleo el programa estad\u00edstico MENU  (10). \n \nRESULTADOS Y DISCUSI\u00d3N \n \nLos result ados obtenidos en las primeras cuatro semanas (5 -9 de edad) de experimentaci\u00f3n para las variables \nganancia de peso e \u00edndice de conversi\u00f3n indicaron que existi\u00f3 diferencia significativa (P<0.05) entre tratamientos, con una mayor ganancia de peso de 412g en los pavos alimentados de acuerdo a las recomendaciones de la estirpe, \ncon respecto a los pavos que ten\u00edan restricci\u00f3n de prote\u00edna y amino\u00e1cidos y adici\u00f3n de Aminogut. La conversi\u00f3n \nalimenticia fue mejor de 1.47 en pavos alimentados seg\u00fan las recomendaciones comparados con los pavos, que \nten\u00eda n restricci\u00f3n de prote\u00edna y amino\u00e1cidos con adici\u00f3n de Aminogut con una conversi\u00f3n de 1.60.  \nEl an\u00e1lisis estad\u00edstico de la semana 5 a 12 de edad mostr\u00f3 diferencias significativas (P<0.05) entre tratamientos \npara las variables ganancia de peso, conversi\u00f3n al imenticia, consumo de alimento y rendimiento en canal.  \nEstos resultados presentados por Waibel et al. 2000 (12) y Miguel et al. 2007 (7 ) confirman lo ocurrido en el \npresente experimento, ya que, al disminuir prote\u00edna y amino\u00e1cidos en un 10%, la suplementaci\u00f3n con L -glutamina y \n\u00e1cido glut\u00e1mico  no es suficiente para compensar la disminuci\u00f3n de amino\u00e1cidos esenciales (Lisina, Metionina y Treonina). La glutamina y el \u00e1cido glut\u00e1mico tienen diferentes papeles metab\u00f3licos durante el desarrollo, entre los \nque destacan , su papel como sustrato energ\u00e9tico para la r\u00e1pi da proliferaci\u00f3n de enterocitos, f uente de nitr\u00f3geno para \nla s\u00edntesis de nucle\u00f3tidos y como reguladores de la demanda metab\u00f3lica,  incrementando la s\u00edntesis y disminuy endo \nla degradaci\u00f3n de pro te\u00edna  en el m\u00fasculo es quel\u00e9tico de pollos de engorde j\u00f3venes.\n \n \nREFERENCIAS  \n \n1. Ajinomoto. Aminogut\u00ae: Ciencia y practica en la nutrici\u00f3n de lechones: Funciones importantes de la \nGlutamina en la nutrici\u00f3n y en la producci\u00f3n animal. Pork world; 2007. Nov -Dic. P 7-9. 63rd WPDC/XXXIX ANECA  2. Buchman A.  Glutamine: commercially essential of conditionally essential? A critical appraisal of the \nhuman data. Am J Clin Nutr 2001; 74 (1): 25- 32. \n3. Direcci\u00f3n General Adjunta de Planeaci\u00f3n Estrat\u00e9gica y An\u00e1lisis Sectorial. Monograf\u00eda del guajolote o  \npavo. M\u00e9xico: Direcci\u00f3n General Adjunta de Planeaci\u00f3n Estrat\u00e9gica y An\u00e1lisis Sectorial; Dic 2010.  \n4. Fundaci\u00f3n de desarrollo agropecuario FDA, INC. Producci\u00f3n de pavos. Guia t\u00e9cnica 1997. N\u00famero 4. P \n1-3. \n5. L\u00e1zaro R, Mateos G, Latorre M.  Nutrici\u00f3n y alimentaci \u00f3n de pavos de engorde. XVIII Curso de \nespecializaci\u00f3n FEDNA; 2002 Nov 4 -5; Barcelona, Espa\u00f1a.  \n6. Leeson S, Summers JD . Commercial poultry nutrition. 3rd ed. Guelph, Ontario Canada: University Books, \n2005.  \n7. Miguel J, Cortes A, Martinez A Y \u00c1vila E.  Evaluaci\u00f3n de diferentes niveles de inclusi\u00f3n de glutamina en \ndietas para pollos de engorda  [Tesis de Licenciatura]. M\u00e9xico: Universidad Nacional Aut\u00f3noma de M\u00e9xico; 2007.  \n8. Murakami A, Sakamoto M.  Supplementation of glutamine and vitamin E on the morphometry of the \nintestinal mucosa in broiler chickens. Poultry science 2007; 86: 488- 495.  \n9. Newsholme P, Lima M, Procopio J, Pit\u00f3n Curi T, Doi S, Bazotte R, Curi R . Glutamina y glutamato en \nforma de metabolitos vitales.  Braz J Med Biol. Res 2003; 36 (2): 153- 163. \n10. Olivares Se . Paquete estad\u00edstico de dise\u00f1os experimentales FAUANL. 1994. Versi\u00f3n 2.5. Facultad de \nAgronom\u00eda. Universidad Aut\u00f3noma de Nuevo Le\u00f3n.  \n11. Secretaria de Agricultura, Ganader\u00eda, Desarrollo rural, Pesca y Alimentaci\u00f3n SAGARPA. Situaci\u00f3n \nactual y perspectiva de la producci\u00f3n de carne de guajolote (pavo) en M\u00e9xico (2006). Claridades Agropecuarias \n2007; (161): 3 -37. \n12. Waibel P, Carlson C, Brannon J, Noll S.  Identification of limit ing Amino Acids in Methionine and \nLysine -Supplemented Low -Protein Diets for Turkeys. Poult ry Science 2000; 79:1299\u2013 1305 . \n13. Wesley R, Adams R, Stadelman . Effects of Amino Acid restriction and age on weights and meat yields of \nTurkeys. Poultry Science 1981; 60: 1422- 1428.  \n14. Yi F, Allee G, Knight C, Dibner J.  Impact of Glutamine and Oasis hatchling supplement on growth \nperformance, small intestinal morphology, and immune response of broilers vaccinated and challenged with Eimeria \nmaxima . Poultry Science 2005; 84: 283\u2013 293. 63rd WPDC/XXXIX ANECA  RESCUE OF LENTOGENIC ASYMPTOMATIC PERUVIAN \nNEWCASTLE DISEASE VIRUS  \n(NDV- PE18)  \n \nRESCATE DEL VIRUS LENTOG\u00c9NICO ASINTOM\u00c1TICO PERUANO DE \nLA ENFERMEDAD DE NEWCASTLE (RNDV-PE18)  \n \nA. ChumbeA, R. Izquierdo -LaraA, L. TatajeA, F. Falconi -AgapitoB, M. FernandezAB, and V. VakhariaC \n \nALaboratory of Molecular Biotechnology and Genomics , FARVET. ICA, Peru  \nBLaboratory of  Microbiology, FARVET ICA, Peru \nCInstitute of Marine & Environmental Technology. University of Maryland Baltimore. County 701 Eas t Pratt St. \nBaltimore, MD 21202 USA  \n \nRESUMEN  \n \nLa enfermedad de Newcastle (NDV) es responsable de p\u00e9rdidas significativas en granjas de crianza \nav\u00edcola. NDVs lentogenicos  (ICPI de 0.4 a 0.7) son usados como vacunas vivas contra NDV, pero incluso estas \ncepas lentog\u00e9nicas pued en ocasionar sintomas postvacunales indeseables en algunos casos. En 1984, un virus \nlocal de NDV fue aislado y atenuado mediante susesivos pasajes en h uevos libres de pat\u00f3genos (ICPI actual de \n0.42). Con la finalidad de producir un sistema de gen\u00e9tica reversa para este aislado, amplificamos, clonamos y \nsecuenciamos la secuencia completa de este aislado en siete pedazos. La secuenci completa de cDNAde rND V-\nPE18 fue construida entre la ribozima autoclivable hammerhead y el antigenoma de la ribozima del Virus de la \nHepatitis Delta en un vector pCI modificado (pCI/HDV). Los pl\u00e1smidos de soporte fueron construidos a partir del pl\u00e1smido prNDV -PE18, para probar la expresion de \u00e9stos un minigenoma de la proteina verde fluorescente \nmejorada. El virus rNDV -PE18 fue recuperado exitosamente a partir de c\u00e9lulas VERO y ha replicado \neficientemente al menos por 10 pasajes. El test de Patogenicidad mostr\u00f3 que el virus rNDV -PE18 era \ncompletamente avirulento (IPIC=0). As\u00ed rNDV -PE18 es una promisoria candidata a vacuna, especialmente para \npollos de engorde, y un potencial vector para llevar genes for\u00e1neos. Una versi\u00f3n completa de este trabajo ser\u00e1  publicado en breve.  \n \nSUMMARY  \n \nNewcastle disease virus (NDV) is responsible for significant los ses in poultry farms. Lentogenic NDVs \n(ICPI from 0.4 to 0.7) are used as live vaccines against NDV, but even these lentogenic  strains may induce \nundesirable post vaccination symptoms in some cases. In 1984 a local NDV was isolated in Peru (NDV -PE) and \nattenuated by successive passages into SPF eggs (current ICPI of 0.42). With the aim to produce a reverse \ngenetic system for this  isolate, we amplified, cloned and sequenced the full sequence it into seven pieces. A full \nlength cDNA clone of rNDV- PE18 was  constructed between a self -cleaving hammer head ribozyme and \nhepatitis delta virus antigenome ribozyme into a pCI vector (pNDV/HD V). Supporting plasmids w ere \nconstructed from prNDV -PE18;  to prove expression of them a n enhanced green f luoresce protein minigenome \nwas generated. rNDV -PE18 virus was successfully recovered in VERO cells and replicated efficiently during at \nleast 10 passa ges. Pathogenicity test showed rNDV -PE18 was completely avirulent (ICPI=0). Thus rNDV -PE18 \nis a promising vaccine candidate, especially for broilers, and a potential vector to delivery foreign genes. An \nextended version of this work will be published short ly. \n \nINTRODUCTION  \n \nNDV is responsible for significant losses in poultry farms around the world (12,1) . In South America, \nespecially in Peru, where backyard husbandry is a common activity and there exist many informal poultry \nbusinesses with low levels of biosecurity (9). NDV genome organization and virulence factors a re very well \ndescribed (2), thanks to reverse genetics since 1999 when NDV was able to be genetically engineered  (11,10) . \nSeveral groups reported the capacity of NDV to transport exogenous genes an d confer protection to the \nsecondary pathogen  (3,14) .  \nNDV has been  present in Peru since 1970. In the middle 80\u2019s our Laboratory of Microbiology (at \nFARVET) was able to retrieve an NDV (NDV -PE) isolate from the field, which had an intracerebral \npathogenic ity index ( ICPI ) of 0.42. Since then, this was propagated into SPF eggs several times and it has been \ncontinuously used as a live vaccine.  63rd WPDC/XXXIX ANECA  NDV vaccination is very well regulated and obligatory for poultry which include live vaccines (15) . Due to \nour special  farming conditions, the initiative of developing a NDV vehicle which could fulfill our needs was \ndeveloped. With the aim of producing our own recombinant viruses based on this isolate, we developed a \nreverse genetic system for it.  \n \nMATERIAL AND METHODS  \n \nVirus c ulture. NDV -PE virus was obtained from FARVET live vaccine\u2019s master s eed and amplified into \nnine d old  embryonated, specific -pathogen -free (SPF) eggs.  \nSequencing of NDV -PE. Viral RNA was extracted from infected allantoid fluid samples with QIAmp \nMinielute Virus -Spin-Kit (Qiagen).  \nBased on published primers for avirulent NDV LaSota strain (4), NDV- PE isolate was amplified into \nseven pie ces by RT -PCR with a high fidelity Pfx(50) polymerase (Life technologies) with seven pairs of primers \n(Table 1). Each piece was cloned into pGemT -easy vector and sequenced with T7/SP6 primers.  \nConstruction of cDNA encoding rNDV. A modify pCI vector wich i ncluded a hepatitis delta virus \n(HDV) antigenome ribozyme  (pCI/HDV)  was used to construct a full lengh cDNA of rNDV -PE plasmid \n(prNDV- PE). A  fragment of 1677 nucleotides flanked by SpeI and RsrII was synthesized and inserted into \npCI/HDV between NheI and R srII. This synthetic gene includes a self -cleaving hammer head ribozyme (HhRz) \nsequence, a partial leader region, a partial phosphoprotein gene and a partial matrix gene. Several restriction \nsites were included into this synthetic gene to construct prNDV -PE18 by seven subsequent subclonings (Figure \n1). Also a RsrII site present into NDV -PE, was eliminated to ease the cloning of the first fragment of prNDV -\nPE18, this mutation was also used as a genetic marker to identify rNDV -PE18 virus. The 7F -7R product, t he \nfirst piece to be inserted, was reamplifed with 7F and 7R -Rsr primers to include a fragment of HDV antigenome \nribozyme (Table 1).  \nSupporting plasmids pCI -N14, pCI -P15 and pCI -L4 were constructed from prNDV -PE18, with primers \nNfor, Nrev, Pfor, Prev, Lfor  and Lrev (Table1).  \nMinigenomic construction.  To verify that our constructed rescue system works it was designed a \nminigenome between HhRz and HDV which was flanked by the 5\u2019 and 3\u2019 noncoding regions of NDV genome surround the ORF of EGFP, prNDV -Mini (5).  \nTransfection and r ecovery. Transfection was carried out as reported previously for NDV  ( 6,11) . Briefly, \nVero cells were maintained with Minimal Essential Medium (MEM) supplemented with 5% of Fetal Bovine Serum (FBS). Vero cells grown to 80% confluency in 12 well plate dish were transfected with a total amount of \n3.8ug DNA (2ug of prNDV -PE18, 1ug of pCI -N14, 0.6 ug of pCI -P15 and 0.2 of pCI -L4) using Lipofectamine \nLTX/optiMEM (Life technologies). One day after transfected cells were trypsinized and r e-seeded into a flask. \nFive d  later, supernatant was harvest and ultracentrifuge for 12 h  at 28000 rpm. The rNDV- PE18 virus was \nresuspended in 1ml DMEM 5% and inoculated into eight - days SPF eggs. After one blind passage NDV -PE18 \nvirus was recovered and propaga ted at least ten passages into nine d  SPFs eggs.  \nIdentify of genetic markers on rNDV- PE18. RT-PCR plus restriction endonuclease digestion were \nperform ed to identify a mutation made on rNDV -PE18. RTs were made with Transcriptor First Strand cDNA \nSynthesis Kit (Roche) with random hexamers and poly A primers. PCRs were made with Pfx(50) with Primers \nForRsr and RevRsr (Table 1). Digestions were made with RsrII (NewEngland Biolabs).  \nHA and pathogenicity tests. Hemagglutination tests were performed with avian SPF red blood cells (8) .  \nThe intracerebral pathogenicity index (ICPI) was determined in day -old chickens as described by Alexander \n(13).  \n \nRESULTS  \n \nNDV- PE sequence. NDV -PE sequence was very similar to other lentogenic NDV strains, only two \naminoacid changes were not fou nd in any NDV sequence.  \nVerification of helper p lasmids. The correct expression of pCI -N14, pCI -P15 and pCI -L4 was verify by \nthe co -expression of  all of them with prNDV -Mini. Twenty -four h post transfection , the first green cells were \nobserved. In contrast , no green fluorescent protein was seen when prNDV -Mini was transfected  without pCI -L4 \n(Figure 2). These  plasmids were also used to optimize  our transfection protocol for recovery.  \nprNDV- PE18 construct. prNDV- PE18  was assembled from cDNA fragments as shown in Figure 1 \nbetween a self -cleaving hammer head ribozyme and hepatitis delta virus antigenome ribozyme. During its \nconstruction, seven point mutation were created by primers: SacII (2354), MluI (6294 -95) and SnaB I (8352- 54-\n55-57). Nine point mutations were introduced: four of them were to ease to clone the full length, eliminating one \nXhoI site (80G>T), replacing a second XhoI for SacI (100C>G, 105G>C) and destroying a RsrII (2665C>T); and five of them to create P acI (3071C>T, 3078C>A) and AscI (3270A>C, 3272T>C, 3276C>T) to use this \nNDV- PE as vector to introduce exogenous genes.  63rd WPDC/XXXIX ANECA  rNDV- PE18 identification. After one blind passage rNDV -PE18 virus was recovered and pr opagated \nseveral passages into nine d  SPFs eggs. A nalysis of the RT -PCR followed by restriction enzyme pattern \nrevealed the absence of RsrII site in rNDV -PE, as calculated from the sizes of the bands, while RT \u2013PCR \nproducts from wild -type NDV -PE were digested by RsrII (Fig. 2C).  \nHemmaglutination and patho genicity test. The allantoic fluid was harvested 5 days after inoculation and \ngave a positive HA titer from 32 to 128 HA units. ICPI showed NDV -PE18 was completely avirulent (ICPI=0). \nDifferent from NDV -PE, which has an ICPI of 0.42.  \n \nDISCUSSION  \n \nThe rNDV- 18 can be distinguishing from the parental virus, since it possesses genetic tags that were \nintroduced into the cDNA copy. Mutations made on it were identified by RT -PCR and enzyme digestion. A \nrecombinant NDV, derived from the vaccine strain NDV -PE, was g enerated and successfully recovered in \nVERO cells using a polymerase II system, described previously by Li (7). NDV -PE18 virus was amplified and \nreplicated efficiently during at least 10 passages. The rNDV - PE18 resulted to be lentogenic asymptomatic, with  \nless ICPI than the parental virus. The low ICPI may be explained by the introduced mutations in the intergenic \nregions, nevertheless more studies are needed to determine the exact mutations that cause it. This feature might \nresult in fewer side effects in  chickens, making rNDV -PE a promising vaccine candidate for all poultry industry, \nespecially for broilers which are very susceptible  to post vaccination reactions. Besides that, rNDV -PE18, due to \nits characteristics could be a potential vector to delivery foreing genes. rNDV -PE18 was capable of replicating \nin embryonated eggs as good as the parental virus, yielding high titers with s ame cythopatic effects than  NDV-\nPE virus.  \nIn summary, this virus is the first NDV recovered in South America and, due to its low ICPI, can be used \nas a vaccine against NDV. Furthermore, rNDV -PE18 has the potential to be used as a vector for insertion of \ngenes from different pathogens outbreaks leading to a better vaccination programs in the poultry industry to fulfill our needs.  \n \nREFERENCES  \n \n1. Alexander, D. J., E. W. Aldous, and C. M. Fuller. The long view: a selective review of 40 years of \nNewcastle disease research. Avian Pathol. J. WVPA 41: 329 \u2013335. 2012.  \n2. Dortmans, J. C. F. M., G . Koch, P. J. M. Rottier, and B. P. H. Peeters. Virulence of Newcastle disease \nvirus: what is known so far? Vet. Res. 42: 122. 2011.  \n3. Huang, Z., S. Elankumaran, A. S. Yunus, and S. K. Samal. A recombinant Newcastle disease virus \n(NDV) expressing VP2 protein  of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J. \nVirol. 78: 10054\u2013 10063. 2004.  \n4. Huang, Z., S. Krishnamurthy, A. Panda, and S. K. Samal. High -level expression of a foreign gene \nfrom the most 3\u2019 -proximal locus of a recombinant Newc astle disease virus. J. Gen. Virol. 82: 1729\u2013 1736. 2001.  \n5. Jiang, Y., H. Liu, P. Liu, and X. Kong. Plasmids driven minigenome rescue system for Newcastle \ndisease virus V4 strain. Mol. Biol. Rep. 36: 1909\u2013 1914. 2009.  \n6. Krishnamurthy, S., Z. Huang, and S. K. Sam al. Recovery of a virulent strain of newcastle disease \nvirus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology \n278: 168\u2013 182. 2000.  \n7. Li, B. -Y., X. -R. Li, X. Lan, X.- P. Yin, Z.- Y. Li, B. Yang, and J.- X. Liu . Rescue of Newcastle disease \nvirus from cloned cDNA using an RNA polymerase II promoter. Arch. Virol. 156: 979\u2013 986. 2011.  \n8. McGinnes, L. W., H. Pantua, J. Reitter, and T. G. Morrison. Newcastle Disease Virus: Propagation, \nQuantification, and Storage. In: Current Protocols in Microbiology. John Wiley & Sons, Inc. 2005.  \n9. Ortiz, E. J., T. J. Kochel, A. W. Capuano, S. F. Setterquist, and G. C. Gray. Avian Influenza and \nPoultry Workers, Peru, 2006. Influenza Other Respir. Viruses 1: 65\u2013 69. 2007.  \n10. Peeters, B. P. H., O. S. de Leeuw, G. Koch, and A. L. J. Gielkens. Rescue of Newcastle Disease \nVirus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence. J. Virol. 73: 5001\u2013 5009. 1999.  \n11. R\u00f6mer -Oberd\u00f6rfer, A ., E. Mundt, T. Mebatsion, U. J. Buchholz, and T. C. Mettenleiter. Generation \nof recombinant lentogenic Newcastle disease virus from cDNA. J. Gen. Virol. 80 ( Pt 11): 2987 \u20132995. 1999.  \n12. Saif, Y. M., and A. M. Fadly. Diseases of poultry. Blackwell Pub., Ames,  Iowa. 2008.  \n13. Swayne, D. E., and A. A. of A. Pathologists. A Laboratory Manual for the Isolation and Identification \nof Avian Pathogens. Copies available from American Association of Avian Pathologists, University of Pennsylvania. 1998.  \n14. Toro, H., W. Zhao, C. Breedlove, Z. Zhang, V. L. van Santen, and Q. Yu. Infectious Bronchitis Virus \nS2 Expressed from Recombinant Virus Confers Broad Protection against Challenge. Avian Dis. 2013.  63rd WPDC/XXXIX ANECA  15. REGLAMENTO DE CONTROL Y ERRADICACI\u00d3N DE LA ENFERMEDAD DE  \nNEWCASTLE. 2003.  \n \nTable 1 . Primers used in this study. Restriction sites are underlined. Bold sequences are Kozak sequences. \nPosition into NDV sequence are indicated.Capital letters are part of NDV sequences.  \n \nPrimer \nname  Position  Sequence (5'\u21923' )  Restriction site  \n1F (1-24) ACCAAACAGAGAATCCGTAAGTTA  - \n1R (2338- 2363)  GTTT CCGCGG CTGGGTTGACTCCCCT  SacII  \n2F (2343- 2365)  AGTCAACCCAG CCGCGG AAACAG  SacII  \n2R (4943- 4964)  GAGCT GCGGCCGC TGTTATTTG  NotI \n3F (4948- 4968)  AACA GCGGCCGC AGCTCTGAT  NotI \n3R (6276- 6301)  TACA ACGCGT AGTTTTTTCTTAACTC  MluI  \n4F (6288- 6312)  AACT ACGCGT TGTAGATGACCAAAG  MluI  \n4R (8351- 8366)  GCAC TACGTA TTTTGCCTTGTATCTC  SnaBI  \n5F: (8358- 8383)  CAAAA TACGTA ATGGTAAATAATACGGGTAGGACATG SnaBI  \n5R (10024- 10052)  TCA GCTTAGC GAAGATCCGTCCATTAACT  BlpI \n6F (10039- 10071)  CTTCGCTAAGC TGACAAAGAAGTTAAGGAACTG BlpI \n6R (12817- 12844)  GTCT AGGCCT CTTACTCTCAGGTAATAG  StuI \n7F (12833- 12854)  AGAGGCCT AGACAATATTGTCT  StuI \n7R (15159- 15186)  ACCAAACAAAGATTTGGTGAATGACGAG  - \n7R-Rsr (15159-  15186)  gatccggaccg cgaggaggtggagatgccatgccgACCCACCAAACAAA\nGATTTGGTGAATGACGAG  RsrII  \nT7 - TAA TACGA CTCAC TATAG GG - \nSP6 - TTC TATAG TGTCA CCTAA AT  - \nNfor  (122- 140) ggaattc gccaccATG TCTTCCGTATTTGATG  EcoRI  \nNrev  (1591- 1572)  gcggccgc TCAATACCCCCAGTCGGTGT  NotI \nPfor (1887- 1906)  tgaattc gccaccATG GCCACCTTTACAGATGC  EcoRI  \nPrev (3074- 3057)  gcggccgcTTAGCCATTTAGAGCAAG  NotI \nLfor (8381- 8400)  tactagt gccaccATG GCGAGCTCCGGTCCTGA  SpeI \nLrev  (14995- 14976)  gcggccgcTTAAGAGTCACAGTTACTGT  NotI \nForRsr  (2491- 2510)  gatcaaggcagagccaagac  - \nRevRsr  (2736- 2755)  gaaatgttggcacaaccggg  - \n \n \n \n \n  \n \n \n \n \n  63rd WPDC/XXXIX ANECA  Figure 1 . Schematic diagram of rNDV -PE subcloning strategy. Seven subsequent subclonings were made \nto construct rNDV -PE. A modified pCI (SnaBI and NotI site destroyed) was opened between NheI and RsrII  to \ninsert a ~1.6 Kb fragment which included several restriction sites and partial Phosphoprotein and Matrix protein. \nAfter that, first insertion was product from  primers 7F and 7R -Rsr, between StuI and RsrII, since RsrII from \nNDV- PE was destroyed into th e synthetic fragment. The second insertion was product from 6F and 6R primers, \nbetween StuI and BlpI. The third to seventh fragments inserted were products from 5F&5R, 4F&4R, 3F&3R, \n2F&2R and 1F&1R primers, respectively, between sites specified on the sche me.  \nSelf-cleaving hammer head ribozyme (HhRz) and hepatitis delta virus (HDV) antigenome ribozyme are \nrepresented as a dotted and solid squares. Leader and trailer regions are showed with vertical and horizontal \nlines, respectively. (not drawn to scale).  \n \n \n \n \n \n \n \n  \n \n   \n \n \n \n \n  \n \n \n 63rd WPDC/XXXIX ANECA  Figure 2 . Fluorescence microscopy of VERO cells (200x) 36h post -transfection, co -transfected with \nplasmids prNDV -Mini,  pCIneo- NP, pCIneo -P and pCIneo -L (A), whereas no fluorescence was detected in \nnegative control without plasmid pCI -L4 (B). Product from RT -PCR with primers ForRsr and RevRsr, digested \nwith RsrII (lane 2 to 7) and no digested (lane 9 to 14). Samples from lanes 2 to 6 are rNDV -PE18 virus samples \nrecovered and lane 7 was NDV -PE. Lane 1 and 15, Fermentas 100pb marker. Lin e 8, Novagen 50pb marker (C) . \n \n 63rd WPDC/XXXIX ANECA  A FOUR- CYCLE PEN STUDY COMP ARING HISTOLOGICAL \nSCORES OF COCCIDIA VACCINATED BROILERS ON FEEDS \nWITH OR WITHOUT SUPP LEMENTATION OF BACITRACIN \nMETHYLENE DISALICYLA TE OR VIRGINIAMYCIN \n \nUN ESTUDIO DE CORRALES DE CUATRO CICLOS COMPARANDO LAS \nCALIFICACIONES DE LESIONES HISTOL\u00d3GICAS DE POLLOS DE \nENGORDA VACUNADOS CONTRA COCCIDIA, CON ALIMENTOS CON O \nSIN SUPLEMENTACI\u00d3N DE BACITRACINA SALICILATO DE METILO  \nO VIRGINIAMICINA \n \nK. CooksonA, F. HoerrB, S. DavisC, D. BadeD, J. SchaefferA, and M. LaVorgnaA \n \nA Zoetis Poultr y, Durham, NC  \nB Veterinary Diagnostic Pathology, LLC, Auburn, AL  \nC Colorado Quality Research, Wellington, CO  \nD Microbial Research, Inc. Fort Collins, CO  \n \nRESUMEN  \n \nSe vacunaron 540 pollos de engorda in ovo contra coccidia, fueron divididos en uno de tres corrales grandes \nadyacentes que representaban a diferentes tratamientos d e alimentaci\u00f3n hasta los 45 d  de edad, para un total de \ncuatro ciclos de engorda. Las primeras parvadas se iniciaron en virutas de madera frescas y las parvadas siguientes \nse colocaro n en la cama usada.  A intervalo s semanales comenzando en el d siete, se eliminaron al azar 10 aves de \ncada corral.  El an\u00e1lisis histol\u00f3gico se realiz\u00f3 en las secciones del duodeno y el yeyuno de cada muestra intestinal, \nque se identific\u00f3 a ciegas como tratamiento de alimentaci\u00f3n 1, 2 o 3. Todos los alimentos del tratamiento 1 \nconten\u00edan 50g / T BMD, los alimentos del tratamiento 2 conten\u00edan 20 g / t de virginiamicina, mientras que los \nalimentos del tratamiento 3 no conten\u00edan ning\u00fan antibi\u00f3tico. Las pu ntuaci ones de las lesiones por coccidia se \ncomparar\u00e1n entre los tratamientos y sobre los cuatro ciclos.  \n \nSUMMARY  \n \nFive hundred forty  commercial broilers were vaccinated in ovo  for coccidia then divided into one of three large \nadjoining pens, representing diffe rent feed treatments, to 45 d  of age for a total of four growout cycles. The first \nflocks were started on fresh wood shavings, then subsequent flocks were placed on the used litter. At weekly \nintervals starting at d seven , ten birds were randomly removed from each pen. Histological analysis was performed \non duodenum and jejunum sections of each intestinal sample, which was identified blindly as feed T reatment 1, 2 or \n3. Treatment 1 feeds all contained 50g/T BMD, T reatment 2 feeds contai ned 20 g/T Virginiam ycin while T reatment \n3 feeds contained no antibiotic. Coccidia lesion scores will be compared between treatments and over all four cycles.  \n \nINTRODUCTION  \n \nCoccidia vaccination is used by some broiler operations as part of an overall coccidiosis management strategy. \nA study was undertaken to compare various intestinal health parameters of broilers vaccinated for coccidia and fed \ncommercial diets with or without either Bacitracin Methylene Disalicylate (BMD) or Virginiamycin (Stafac) over \nfour consecutive gro wout cycles (Master Study 7 -12-7AMVG, Zoetis). The focus of this paper is on the relative \ncoccidia cycling \u2014based on histological evaluation \u2014in birds on the different feed regimens and the potential impact \nthis may have had on bird performance.  \n  \n 63rd WPDC/XXXIX ANECA  MATERIAL S AND METHODS  \n \nA total of 540 Cobb 500 males were vaccinated in ovo  with Inovocox\u00ae EM1 and placed into a room \ncontaining three  large floor pens (15\u2019x 6\u2019). Each side -by-side pen was started on fresh wood shavings that were \nspray inoculated with a known pathogenic strain of Clostridium perfringens  (CP) (CL -15). All birds received starter \n(0-17d), grower (17- 30d) and finisher feeds (30- 45d) and pens only differed by the following supplementation in \neach diet: BMD at 50g/ton, Stafac at 20g/ton or None. At weekl y intervals, 10 birds were random ly removed from \neach pen and a one inch section of the bottom loop of duodenum and jejunum proximal and including Meckel\u2019s \ndiverticulum were placed in formalin for later analysis. Birds were weighed and feed metered at term ination of each \ncycle (45 d of age). After a two w k downtime, another group of 540 Cobb 500 males were EM1 vaccinated and \nplaced in their respective pens on the built -up litter\u2014for a total of four  consecutive growout cycles.  \nA single section of each tissu e was cut, processed and examined histologically. Scoring of Eimeria  oocyst load \nof duodenum and jejunum was as follows. Individual samples were scored for the presence of E. acervulina  or E. \nmaxima  using a 4 -point lesion score system based on the pathologist\u2019s experience of clinical significance: Normal \n(1), Mild (2), Moderate (3) and Severe (4). E. acervulina  scoring criteria were 1= no clusters; 2= 1 -2 clusters; 3= 3 -4 \nclusters; 4= 5 or more clusters. E. maxima  scoring criteria were 1= 0 -2 coccid ia; 2= 3 -30 coccidia; 3=31- 100 \ncoccidia; 4= >100. A group coccidia index score was also generated for each 10 -bird sample by averaging the \nindividual duodenum and jejunum scores, adding them together and subtracting 2. In this manner, a group of all \nnormal  or 1 scores will generate a total coccidia index baseline score of 0.  \n \nRESULTS  \n \nStatistical analysis was not applied to these results, so differences are descriptive only. Overall, there was very \nlittle coccidia activity a bove baseline levels prior to fou r wk  of age. Over the 4 -cycle period, oocyst produ ction \ntended to be greatest at four and five w k (see Table 1). Numerically, Stafac birds tended to have the highest activity \nof coccidia lesions, followed by Controls and then BMD birds. This can be seen in  average lesions scores, as well as \nin the percenta ge of birds that scored either three or four grade lesions. Because the Eimeria  were speciated in both \nthe duodenum and jejunum sections, the percentage of birds with E. maxima  infections of both duodenum and \njejunum could also be tabulated. Again, the incidence of both sites being infected was highest in Stafac birds followed by Controls and, finally, BMD treatments. Comparing total lesion scores and peak 3 -4 scores by each cycle \n(see Table 2), Stafac bird s tended to show the highest activity levels based on both total scores and percentage of \nbirds with moderate to severe lesion scores. The greatest disparity between Stafac birds and the other two groups \noccurred in coccidia lesion scores in the second  growout cycle. Here, the total coccidia index scores were 4.2 in \nStafac birds (vs. 1.7 in Control and 1.1 in BMD groups) and peak 3- 4 lesion scores reached as high as 70% (vs. 10% \nin Control and 20% BMD groups). This was also the only cycle where Stafac birds  did not have at least 1 point \nlower FCR than the Controls.    \n \nDISCUSSION  \n \nIt was somewhat surprising that such differences in coccidia vaccin e load were seen between these three \ntreatments \u2014especially considering that neither BMD nor Stafac have any mechanism of action against coccidia. \nTherefore, we can only speculate that the differences between treatments were due to either subtle differences in the pen conditions and/or litter environments (pens were place side -by-side in the same building but there we re no \nreplicates) or perhaps differences in the intestinal environments. In fact, significant differences in gut microflora \ndiversity were seen in this study (see Neumann et al paper in these same proceedings) based on PCR analysis. As for \nthe lack of repl ication, accurately measuring performance was not a major goal of this four growout study but we \ndid want to create a larger single living space in an attempt to more closely mimic commercial conditions for each \ntreatment. Still, it is worth noting that Stafac and BMD flocks had at least 1 point lower FCR in each growout cycle \n\u2013with one exception\u2014and the differences were greatest on built -up litter (Cycles 3 and 4). The one exception where \nStafac birds did not perform at least 1 point better on FCR vs. Cont rols was in the second  growout \u2014which also \nhappens to be when coccidia lesions were the most severe in this or any group. While it may be possible for light \ninfections to be missed by sampling only one section of duodenum or jejunum histologically, this scoring technique \nwas able to demonstrate differences in severity of infections that may translate into performance differences. In this particular study, any intrinsic advantages of using Stafac vs. Controls may have been lost in Cycle 2 when coccidia \ncyclin g exceeded a particular threshold.   \n      63rd WPDC/XXXIX ANECA   \nTable 1.  4-Cycle averages of key weekly histological Eimeria  score criteria.  \n \n \nTreatment \nGroup  Lesion Score  \n(average of 4 growout cycles)  Percentage of birds with \nModerate to Severe Lesion \nScores (3 -4) Percentage  of birds with E. \nmaxima  scores >1 in both \nDuodenum & Jejunum  \n4 wks  5 wks  6 wks  4 wks  5 wks  6 wks  4 wks  5 wks  6 wks  \nBMD  0.25 0.48 0.28   5   8 3   0   3   0 \nStafac  1.45 1.15 0.35 30 15 0 25 20 10 \nControls  0.88 0.75 0.28 10 10 3   8   5   5 \n \n \nTable 2.  Key average histological Eimeria  score criteria by growout cycle.  \n \nTreatment \nGroup  Total Coccidia Index Lesion Score             \n(sum of all weeks)  Peak Percentage of Moderate to Severe \nLesion Scores (3 -4) \nCycle 1  Cycle 2  Cycle 3  Cycle 4  Cycle 1  Cycle 2  Cycle 3  Cycle 4  \nBMD  1.2 1.1 1.4 0.4 10 20 10 10 \nStafac  2.9 4.2 2.6 2.3 20 70 40 40 \nControls  1.4 1.7 3.2 1.3   0 10 30 10 \n \n \n 63rd WPDC/XXXIX ANECA  BIODISPONIBILIDAD DE F\u00d3SFORO EN POLLOS DE ENGORDA \nALIMENTADOS CON GRANOS SECOS DE DESTILER\u00cdA CON \nSOLUBLES BAJOS EN ACEITE  \n \nBIOAVAILABILITY OF PHOSPHORUS IN BROILERS FED DISTILLERS \nDRIED GRAINS WITH SOLUBLES (DDGS) LOW IN OIL  \n \nC.A. CortesA, E.S. Ram\u00edrezA, C.C. L\u00f3pezB, M.J. ArceC y G.E. AvilaA \n \nACentro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n av\u00edcola, Facultad de Medicina veterinaria y \nZootecnia, Universi dad Nacional Aut\u00f3noma de M\u00e9xico  \nBDepartamento  de Producci\u00f3n Animal: Aves, Facultad de Medicina veterinaria y Zootecnia, Universidad Nacional \nAut\u00f3noma de M\u00e9xico  \nCUniversidad Michoacana de san Nicol\u00e1s de Hidalgo FMVZ  \n \nSummary  \n \nIn order to evaluate the bioavailability of phosphorus in two samples of low  oil DDGS (A and B) with respect \nto a commercial Mono - phosph ate (FMD) in chickens from 7 \u2013  21 d of age, a study was conducted wi th 210 \nchickens distributed in seven treatments with three replicates of ten  birds each. The bioavailability of phosphorus \nwas estimated by the gradients comparison methodology. The results of ash in tibia and tibia resistance increased \nlinearly (P < 0.01) as dietary phosphorus from FMD or from DDGS increased. By comparing the gradients of ash \npercentage in tibia and resistance in  chickens fed DDGS A or B, with the  gradient of FMD considered 100% \navailable, phosphorus bioavailability were obtained f rom ash in tibia of 72% and 86% and for  tibia resistance of \n87% and 73% in DDGS A and B respectively.  \n \nRESUMEN  \n \nActualmente, la gran mayor\u00eda de las plantas productoras de etanol, remueven el aceite a partir de los solubles \nde destiler\u00eda condensados del ma\u00edz al final del proceso mediante centrifugaci\u00f3n para la obtenci\u00f3n de biodisel, esto \ntrae como consecuencia la gen eraci\u00f3n de un nuevo  co -producto llamados \u201cDDGS extractados en aceite\u201d. Este co -\nproducto tiene menor contenido de grasa y ligeramente mayor concentraci\u00f3n de prote\u00edna y otros nutrientes \ncontenidos en los DDGS convencionales. Sin embargo, el conocimiento sobre la biodisponibilidad de f\u00f3sforo de este \nnuevo ingrediente es escasa. C on la finalidad de estudiar la biodisponibilidad de f\u00f3sforo (Pi) de dos muestras de \nDDGS (A y B) bajos en aceite  (6.54 y 5.39%) , en relaci\u00f3n a un fosfato monodic\u00e1cico (FMD), se realiz\u00f3 un \nexperimento  en pollos de engorda en crecimiento. S e utilizaron 210 pollos machos de 7 a 21 d\u00edas de edad de la \nestirpe Ross 308, distribuidos aleatoriamente en 21 pisos  con siete tratamientos de tres  repeticiones con 10 aves cada \nuno. El contenido de f\u00f3sforo de las muestras de DDGS A y B, se emplearon para el c\u00e1lculo de la cantidad a utilizar \nde DDGS, para cubrir el porcentaje de f\u00f3sforo empleado (0.05 y 0.10%) a partir de una dieta deficiente en f\u00f3sforo (0.14%), las dietas experimentales fueron:  \n1) Di eta basal sorgo -pasta de soya con 0.14% de P i  \n2) Como 1 + 0.05% de f\u00f3sforo de FMD  \n3) Como 1 + 0.10% de f\u00f3sforo FMD  \n4) Como 1 + 0.05% de f\u00f3sfor o a par tir de DDGS A \n5) Como 1 + 0.10% de f\u00f3sfor o a partir de DDGS A \n6) Como 1 + 0.05% de f\u00f3sfor o a partir de DDGS B  \n7) Como 1 + 0.10% de f\u00f3sfor o a partir de DDGS B   \nLos resultados para ganancia de peso,  consumo de alimento , conversi\u00f3n alimenticia y porcentaje de cenizas en tibias  \nmejoraron linealmente (P<0.01)  con la suplementaci\u00f3n de f\u00f3sforo  en la dieta  de FMD o  de DDGS A y B . Los \nporcentajes de cenizas en tibias y el consumo de f\u00f3sforo se explicaron por medio de la ecuaci\u00f3n Y= \n27.614+0.007x\n1+0.005x 2+0.006x 3; en donde  X1 correspondi\u00f3 a l a suplementaci\u00f3n de FMD  como fuente de f\u00f3sforo \n(T1, T2 y T3), X 2 a los DDGS A (T1, T4 y T5)  y X 3 a los DDGS B (T1, T6 y T7). Al comparar las pendientes del \nporcentaje de cenizas de los DDGS A y B con los del FMD considerado como 100% disponible, se obtuvieron                63rd WPDC/XXXIX ANECA biodisponibilidades de f\u00f3sforo de 86% y 72% para los DDGS A  y B respectivamente. Los resultados obtenidos en el \npresente estudio con dos muestras de DDGS bajos en aceite (A y B), con 0.85 y 0.94% de P total, indicaron  una \nbiodisponibilidad de f\u00f3sforo del 86 y 72% respectivamente.  \n 63rd WPDC/XXXIX ANECA  PATHOGENESIS OF TWO VARIANT REOVIRUSES FROM \nCLINICAL CASES OF TENOSYNOVITIS  \n \nPATOG\u00c9NESIS DE DOS VARIANTES DE REOVIRUS DE  \nCASOS CL\u00cdNICOS DE TENOSINOVITIS  \n \nE. Dale, H.  Sellers,  and E. Linnemann \n \nPoultry Diagnostic and Research Center, Department of Population Health, College of Veterinary Medicine, \nUniversity of Georgia , 953 College Station Road, Athens, GA 30602- 4875  \n \nRESUMEN  \n \nDos aislamientos de campo de reovirus antig\u00e9nicamente diferentes se evaluaron para la patogenicidad y la \ninmunosupresi\u00f3n. Los aislamientos proced\u00edan de casos de diagn\u00f3stico en el Sureste de Estados Unidos, y fueron \nantig\u00e9nicamente distintos de las cepas vacunales y entre s\u00ed. El aislamiento de campo 94594 se propag\u00f3 en c\u00e9lulas de \nh\u00edgado de embri\u00f3n de pollo y se titul\u00f3 a una dosi s de desaf\u00edo de 103 TCID50/ave; posteriormente se inocul\u00f3 a trav\u00e9s \ndel cojinete plantar en aves libres de pat\u00f3genos espec\u00edficos de un d\u00eda de edad. Las aves se evaluaron para detectar \nsignos cl\u00ednicos, supresi\u00f3n del peso corporal y lesiones macrosc\u00f3picas e h istol\u00f3gicas.  Se observaron lesiones \nmacrosc\u00f3picas e histol\u00f3gicas compatibles con reovirus. El aislamiento de campo 96139 se propag\u00f3 en c\u00e9lulas de \nh\u00edgado de embri\u00f3n de pollo y se titul\u00f3 a una dosis de prueba de 103 TCID50/ave; posteriormente se inocul\u00f3 a tr av\u00e9s \ndel cojinete plantar en pollos de engorda comerciales de un d\u00eda de edad. La serolog\u00eda se realiz\u00f3 para evaluar la \nprotecci\u00f3n materna. Las aves se evaluaron para detectar signos cl\u00ednicos, supresi\u00f3n del peso corporal y lesiones \nmacrosc\u00f3picas e histol\u00f3gicas. Se observaron supresi\u00f3n de peso y lesiones histol\u00f3gicas consistentes con reovirus.  \n \nSUMMARY  \n \nTwo antigenically distinct reovirus field isolates were evaluated for pathogenicity and immunosuppression.  \nIsolates were from diagnos tic cases in the south e astern United States and were antigenically distinct from vaccine \nstrains and each other.  Field Isolate 94594 was propagated in chicken embryo liver cells and titrated to a challenge \ndose of 103 TCID50/bird, then inoculated via foot pad into one d old spec ific pathogen free birds.  Birds were \nevaluated for clinical signs, body weight suppression, gross and histological lesions.  Gross and histological lesions \nconsistent with  reovirus  were observed.  Field Isolate 96139 was propagated in chicken embryo liver ce lls and \ntitrated to a challenge dose of 103 TCID50/bird, then inoculated via foot pad into one d old commercial broilers.  \nSerology was performed to assess maternal protection.  Birds were evaluated for clinical signs, body weight \nsuppression, gross and hist ological lesions.  Weight suppression and histological lesions consistent \nwith reovirus  were observed . The full length article will be published in Avian Diseases . \n \nINTRODUCTION  \n \nRecognized in commercial poultry  worldwide,  avian reovirus, a non -enveloped double stranded RNA \northoreovirus, causes viral arthritis . It is also associated with many other disease syndromes although it may be \nfound in both sick and healthy birds alike. Infection and clinical disease is highly depe ndent on host \nimmunocompetency and age (young are more susceptible), route of infection, and pathotype of the virus  (1,2). Birds \nmay be infected horizontally via the fecal -oral route in contaminated environments and  via vertical transmission.   \nIn cases of viral arthritis, lameness is observed due to edema of the tarsal and metatarsal  tendon sheath s, hock \nswelling  due to exudate, severe arthritis , and occasionally tendon rupture.  Epicardial petechiae, pericarditis and \nhydropericardium are also co mmonly observed . Although morbidity is high and mor tality is generally low,  stunte d \ngrowth and poor uniformity continue to compromise flock performance even after recovery . In breeders , decreased \negg production, hatchability, and fertility  issues may be ob served , in addition to transmission of the virus to \nprogeny ; all of which may cause  considerable economic losses to producers  (3,4). \n \nViral arthritis in chickens is typically controlled through vaccination of breeders with modified live or \ninactivated vaccines, most often with vaccines derived from the S1133 strain , to provide for transfer of maternal 63rd WPDC/XXXIX ANECA  derived antibodies to progeny  (3). Although some cross protection between the numerous heterologous serotypes  \nmay exist,  protection is not complete and antigenic variants  may cause disease in progeny from vaccinated breeders , \nnecessitating the use of autogenous vaccines for protection.  The Sigma C protein, a minor outer capsid protein, \nencoded on the S1 gene, elicits neutralizin g antibodies and is the target for genetic sequencing and genotyping of the \nvirus  (3). \nSince 2011, a rise in clinical cases of tenosynovitis has occurred in the United States.  Reoviruses  were isolated \nfrom tendons, synovial fluid, livers and hearts in numerous clinical cases of viral arthritis.  Characteristic cytopathic \neffect  in primary chicken embryo liver cell culture s and lesions in specific pathogen free ( SPF)  embryos  were \nobserved . Reverse transcriptase- polymerase chain reaction  (RT-PCR)  amplification of Sigma C with subsequent \nsequencing followed by analysis revealed that the isolates grouped into two unique phylogenetic groups.  Group 1 \nexhibited 48% similarity and G roup 2 showed 80% amino acid similarity with vaccinal strains of reovirus.  The two \ngroups share only 50% amino acid similarity with each other.  Serologic evaluation revealed no neutralization with \nvaccine strain S1133 ant isera and no neutralization of G roup 2 with G roup 1 antisera.  Given the novel nature of the \nisolates and the generally poor correlation between genotype and pathotypes, biological characterization of \nrepresentative isolates from the two genotypes was pursued with in vivo  pathogenicity studies.  \n \nMATERIALS AND METHODS  \n \nGroup 1 pathogenicity and i mmunosuppression study . Isolate 94594 was selected as  a representative isolate \nfrom G roup 1, was  propagated and titrated in primary chicken embryo liver cell culture s, and diluted  to a challenge \ndose of 10 3 TCID50/bird.  Twenty, one d old SPF  chicks we re divided into two groups of ten . One group, designated \nas the negative controls, was sham -inoculated subcutaneousl y with 0.05mL  of sterile PBS in the lef t foot  pad. The \nsecond group of ten  SPF one d old chicks was inoculated subcutaneously with 0.05mL  of 10 3 TCID50 isolate 94594  \nin the lef t foot pad.  Footpad measurements were taken prior to  inoculation and every four d  for the duration of the \nstudy.  Birds were observed daily for development of clinic al signs  and mortality . On d seven post challenge, five  \nbirds from each group were humanely euthanized and necropsied; footpad, hock, and weight measurements were \ntaken along with heart, liver, spleen,  duodenal loop, bursa, thymus, H arderian gland, and ten don samples for \nhistological evaluation.  Birds were carefully examined for the presence of macroscopic lesions and hocks were \nexamined for swelling, hemorrhage and /or rupture.  On d  12 post inoculation , the study was terminated and all \nremaining birds were humanely euthanized and necropsied following the same procedure.  \nBirds challenged with the G roup 1 isolate 94594 exhibit ed a 13% weight suppression compared with the \nnegative controls ; however clinical  signs of tenosynovitis were not observed . Upon necropsy , several challenged \nbirds had pale hearts, hydropericardium, and discolored lesions in the foot pads.  Mild to moderate histological \nchanges consistent with reovirus were seen  first in the epicardium five days post inoculation, and in the tendons and \nepicardium  ten d  post inoculation . Histological ch anges suggest mild disease, however evidence of \nimmunosuppression was not observed during the 14 d duration of the study.   \nGroup 2 pathogenicity and protection s tudy . Isolate 96139 was selected as  a representative isolate from \nGroup 2, was propagated and titrated in primary chicken embryo liver cell culture s, and diluted  to a challenge dose \nof 10 3 TCID50/bird.  Thirty, d old commercial chicks from vaccinated breeders were divided into three groups of \nten. Ten birds were bled for day of hatch serology with IDEXX ELISA to measure maternal antibody protection \nagainst reo virus.  Ten chicks, designated as negative controls, were sham -inoculated subcutane ously with 0.05mL  of \nsterile PBS in the left foot pad.  Ten chicks were inoculated subcutaneously with 0.05mL  of 10 3 TCID50 isolate \n96139 in the left foot pad.  Footpad measurements were taken prior to inoculation and every four d  through \ncompletion of the study.  Birds were observed daily for development of clin ical signs and mortality. On d  14 post \nchallenge all birds were humanely euthanized and necropsied; footpad, hock, and weight mea surements were \nrecorded  along with heart, li ver, and tendon samples taken for histological evaluation.  Birds were examined also for \nany macroscopic lesions and hocks were examined for swelling, hemorrhage and /or rupture.   \nDay of hatch serology revealed  highly variable  (CV of 66.8%)  and overall low levels  (GMT of 385) of \nmaternal antibody to reovirus . Birds challenged with the G roup 2 isolate 96139 failed to develop any overt clinical \nsigns during the course  of the 14 d study.  However, weight suppression was observed in c hallenged birds compared \nwith the negative controls.  Mild to moderate histological changes consistent with reovirus  were observed in the \ntendons and epicardium of the challenged birds.  Although the G roup 2 reovirus  isolate did not exhibit the expected \nlevel of pathogenicity in these re latively unprotected birds, the subtle changes seen histologically and in the growth \nof the birds may indicate development of subclinical disease.  \n  \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Jones, R. C.  and K. Georgian.  1984.  Reovirus -induced  tenosynovitis in chickens: The in\ufb02uence of age at \ninfection.  Avian Pathol 13:441\u2014457.  \n2. Roessler, D. E. and J. K. Rosenberger. 1989. In vitro and in  vivo characterization  of avian  reoviruses.  III. \nHost factors  affecting virulence and persistence. Avian Dis . 33:555\u2014565.  \n3. Jones, R.C.  2008. Viral arthritis. In  Diseases of Poultry , 12th ed . A.M. Fadly,  J.R. Glisson, L. R. \nMcDougald, L.K. Nolan, D.E. Swayne, and Y. M. Saif, eds.  Blackwell Publishing; Oxford, UK , 309- 322. \n4. Van der Heide, L. 2000. The history of avian reovirus. Avian  Dis. 44:638\u2014641.  63rd WPDC/XXXIX ANECA  EFECTO DE LA DIFERENCIA DE TEMPERATURA AMBIENTAL Y \nDEL PISO SOBRE LA GANANCIA DE PESO CORPORAL Y \nMORTALIDAD EN POLLOS DE ENGORDA A LOS ONCE D\u00cdAS  \n \nEFFECT OF ROOM AND FLOOR TEMPERATURE DIFFERENCE ON BOD Y \nWEIGHT GAIN AND MORTALITY IN 11 -DAY-OLD BROILERS  \n \nM. D\u00edaz  y L. Quintana  \n \nDepartamento de Medicina y Zootecnia de Aves, Facultad de Medicina Veterinaria y Zootecnia,  \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico, M\u00e9xico DF  \n \n \nSUMMARY  \n The present field study was carried out in a central state of Mexico during winter  in a natural environment broiler \nchicken farm, in which 60,000 Ross 308 female chicken distributed in six sheds were housed. During a period of 11 \nd, minimum and maximum room and floor temperatures were registered every two hours using an environmental \ndigital thermometer and a surface thermometer (laser). Chickens were weighed three times: at arrival and on d 7 and \n11, and mortality in that period was also registered. The discussion is centered on the importance of measuring the floor temperature as an im portant parameter, which could be even more significant that room temperature and how \ntemperatures variations affect body weight gain and mortality in boiler chickens.  \n \n \nRESUMEN  \n Trabajo de campo realizado  en un estado del centro de la Republica Mexicana,  en el periodo de invierno; en una \ngranja de ambiente natural en aparcer\u00eda de pollo de engorda, en la cual se alojaron 60,000 hembras Ross 308 \ndistribuidas en 6 casetas. Durante un periodo de 11 d\u00edas se midieron las  temperaturas m\u00e1ximas y m\u00ednimas \nambienta les y de piso, cada dos horas, utilizando como instrumento de medici\u00f3n un term\u00f3metro digital ambiental y \nun term\u00f3metro de superficie (laser). Se realizaron cuatro pesajes al pollo: al d\u00eda de llegada, al quinto, s\u00e9ptimo y al \nonceavo d\u00eda de edad  y se hizo u n registro de la mortalidad en ese periodo. La  discusi\u00f3n se centra en la importancia \nde la medici\u00f3n de la temperatura de piso como par\u00e1metro fundamental pudiendo ser \u00e9ste a\u00fan m\u00e1s significativo que \nla temperatura ambiental  y como las variaciones de temper aturas afectan en la ganancia de peso corporal y \nmortalidad en el pollo de engorda.  \n \nINTRODUCCI\u00d3N  \n \nLas gallinas  son animales incapaces de regular su propia temperatura corporal durante los primeros 12 a 14 \nd\u00edas de edad aproximadamente, por lo que esta primera etapa de adaptaci\u00f3n del ave a su nueva morada es cr\u00edtica, \ndebe hacerse mucho \u00e9nfasis en el control de las temperaturas y m\u00e1s en casetas de ambiente natural en zonas fr\u00edas. Generalmente se lleva a cabo la medici\u00f3n de la temperatura ambiental, y se p asa por alto el monitoreo de la \ntemperatura del piso, considerando que la crianza de pollo de engorda se realiza en suelo.  \nEn la crianza de pollo de engorda, la ganancia de peso diario es de las metas m\u00e1s relevantes, de tal manera que, en algunos casos, se  mide la ganancia de peso por hora y el \u00edndice de productividad (IP) de una parvada (6). Que hace \na\u00f1os se propuso un valor de 300 puntos a  la s\u00e9ptima semana, \u00edndice que fue visto como un imposible; mismo valor que en la actualidad ha quedado sobre estimad o con respecto a los nuevos rendimientos obtenidos.  \nLa mortalidad es un par\u00e1metro que diariamente se monitorea para ir evaluando el comportamiento de una \nparvada, sin considerar que no siempre una mortalidad baja es sin\u00f3nimo de futuros buenos resultados.  \n \nOBJETIVO  \n \nDemostrar como la temperatura de piso no es siempre la misma que la temperatura ambiental; cuando aquella \nes menor, genera un enfriamiento del pollo, que repercute en la ganancia de peso.  63rd WPDC/XXXIX ANECA   \nMATERIALES Y M\u00c9TODOS  \n \nEl estudio se efectu\u00f3 en una granj a comercial de tipo aparcer\u00eda, situada en el estado de San Luis Potos\u00ed, la cual \naloja 60,000 pollos de engorda al ciclo (hembras) de la estirpe Ross 308,  distribuidas en 6 casetas de ambiente \nnatural.  \nEl peso y la calidad del pollito son variables que no  se pudieron controlar, por lo que se realiz\u00f3 un pesaje al d\u00eda \nde recepci\u00f3n de 300 pollos por caseta, en el siguiente cuadro se muestra el promedio de peso por caseta (Cuadro 1).  \nSe evaluaron los pollos con el modelo de calificaci\u00f3n de pollito reci\u00e9n nacid o (6). Con el fin de constatar la \ncalidad del pollito recibido, se calificaron 10 pollos por caseta y los resultados promedios se muestra en el siguiente \ncuadro (Cuadro 2).  \nLa calificaci\u00f3n fue de 180, que para algunos autores la calidad del pollo se encuen tra dentro del l\u00edmite inferior \nde \u201cbuena\u201d.  \nSe contabiliz\u00f3 la mortalidad de cada caseta (Cuadro 3) y se realizaron necropsias para saber la causa de la \nmuerte, las cuales fueron: deshidrataci\u00f3n, ascitis, pisados, sin causa aparente, infecci\u00f3n del saco vitel ino y onfalitis.  \n \nRESULTADOS Y DISCUSI\u00d3N \n  \nNo se ha aprovechado al m\u00e1ximo el potencial gen\u00e9tico de las aves, al contar con manejos obsoletos, falta de \nterm\u00f3metros en casetas, altas densidades, mal uso de los f\u00e1rmacos y falta de aislamiento t\u00e9rmico (1), pro vocando un \naumento considerable en el \u00edndice la conversi\u00f3n alimenticia (5).  \nDurante el experimento se efectuaron 4 pesajes, los cuales se realizaron: a la recepci\u00f3n, al quinto, noveno y \nonceavo d\u00eda de edad, con el fin de llevar un control m\u00e1s confiable. Du rante 10 d\u00edas se monitore\u00f3 la temperatura de \npiso con un term\u00f3metro de superficie (l\u00e1ser) y la temperatura ambiental con un term\u00f3metro digital, se registraba las mediciones con intervalos de 2 horas.  En el estudio (Cuadros 4, 5, 6 y 7) se identificaron los rangos m\u00e1ximos y m\u00ednimos, para comparar la relaci\u00f3n de variaciones de temperatura con la falta de ganancia de peso en las aves (4).  \nEl manual de producci\u00f3n (2) indica que la temperatura del piso de la caseta debe ser de 28 a 30\u00b0 C al d\u00eda de \nrecepci\u00f3n, al rededor de 2\u00b0 menos que la temperatura ambiental,  se observa que el primer d\u00eda (Cuadro 4), la caseta 3 \ntuvo una temperatura 5\u00b0 por debajo de lo recomendado, sin embrago, no fue la caseta con mayor mortalidad al final \ndel estudio (Cuadro 3); se debe considerar que las zonas m\u00e1s vulnerables al enfriamiento son la cara y las piernas del \npollo (3).  \nA pesar del aislamiento al techo, no fue suficiente para controlar la variaci\u00f3n de temperaturas ambientales y de \npiso (Cuadro 5), al no tener una cama apropiada;  se observan temperaturas de hasta 15\u00b0C en el piso, mismas que \nenfriaron al pollo y provocaron un alto par\u00e1metro en el \u00edndice de conversi\u00f3n alimenticia (7).  \nPara el s\u00e9ptimo d\u00eda, los pesos que se obtuvieron se encuentran por debajo del est\u00e1ndar (2), por ejem plo: la \ncaseta 1 es la que contaba con los pollos m\u00e1s pesados al d\u00eda de la recepci\u00f3n (Cuadro 4),  por lo que se esperaba un \npeso de 160 gramos en promedio para esta caseta al s\u00e9ptimo d\u00eda y no resultados de 129 gramos, y que present\u00f3 las temperaturas m\u00e1s bajas al quinto y s\u00e9ptimo d\u00eda (Cuadro 5 y 6).  \nAl d\u00eda once de edad (Cuadro 7) se tuvo un d\u00e9ficit de 40 gramos en promedio, lo que indic\u00f3 que existe un \nretraso de 3 d\u00edas con respecto a la ganancia de peso que establece el manual de la estirpe (2). Esta falta d e ganancia \nde peso afecta el d\u00eda en que se esperaba enviar al mercado  a las aves, lo que implica un aumento en el consumo de alimento que directamente se reflejar\u00e1 en los costos.  \nLos resultados de mortalidad (Cuadro 3) para el d\u00eda 11  indica que se esperaban buenos resultados al final del \nciclo, al tener el 0.7% de mortalidad hasta ese momento; par\u00e1metro que se encuentra dentro del rango \u00f3ptimo (2). Las casetas que tuvieron las menores temperaturas durante el estudio, reflejan los menores pesos (Cuadro 7),  cuando \nal inicio eran las que ten\u00edan las parvadas m\u00e1s pesadas (Cuadro 4).  \n \nCONCLUSIONES  \n  \nLa temperatura del piso debe considerarse una herramienta m\u00e1s importante que la temperatura ambiental  y no \ndeber\u00eda existir m\u00e1s de dos grados de diferencia entre amb as. \n \nAGRADECIMIENTOS  \n \nAgradecemos  al MVZ \u00d3scar Flores Flores por su apoyo y  asesor\u00eda en el desarrollo de este estudio de campo.  \n 63rd WPDC/XXXIX ANECA  REFERENCIAS  \n \n1. Agrinews Equipos, 2014. La temperatura, esencial para el rendimiento en granjas av\u00edcolas. Direccion: \nURL: http://agrinews.es/2014/01/14/temperatura -esencial -rendimiento -\navicola/?utm_source=Avicultura+General&utm_campaign=d1a20cb564 -\nCalefacci_n_av_cola_copy_02_1_15_2014&utm_medium=email&utm_term=0_e7b1ab2154- d1a20cb564-\n78403673.  \n2. Aviagen. Ross 308 Broiler Objetivos de  rendimiento. 2012.  \n3. D. Shinder, M. Rusal, J. Tanny, S. Druyan, and S. Yahav, 2007. Thermoregulatory Responses of Chicks (Gallus domesticus) to Low Ambient Temperatures at an Early Age. Br. Poultry Science 86:2200 \u20132209.  \n4. H. van den Brand ,1 R. Molenaar , I. van der Star , and R. Meijerhof, 2010. Early feeding affects resistance \nagainst cold exposure in young broiler chickens. Br. Poultry Science 89 :716\u2013 720 doi: 10.3382/ps.2009-\n00432.  \n5. J. D. May2 and B. D. Lott, 2000. The Effect of Environmental Temperature on  Growth and Feed \nConversion of Broilers to 21 Days of Age. Br. Poultry Science 79:669\u2013 671. \n6. Quintana J.A. Avitecnia manejo de las aves dom\u00e9sticas m\u00e1s comunes. 4\u00aa ed. M\u00e9xico: Trillas, 2011.  \n7. Rolvid Ram\u00edrez, Yngrid Oliveros, Rosanna Figueroa y Valentina Trujil lo, 2005. Evaluaci\u00f3n de algunos \npar\u00e1metros productivos en condiciones ambientales controladas y sistema convencional en una granja \ncomercial de pollos de engorde. Revista Cient\u00edfica, febrero, a\u00f1o/vol. XV, n\u00famero 001 Universidad del \nZulia Maracaibo, Venezuela pp. 49- 56.  \n \n \nCuadro 1.  Peso en gramos a la recepci\u00f3n de los pollos.  \n \n \n \n \n \n \n  \n \n \n \n \n  \n \n \n63rd WPDC/XXXIX ANECA  Cuadro 2.  Modelo de calificaci\u00f3n de pollito reci\u00e9n nacido.  \n \n \n \n \n63rd WPDC/XXXIX ANECA  Cuadro 3.  Porcentaje de mortalidad acumula en los d\u00edas 1, 5, 7 y 11, de las 6 casetas.  \n \n \n \n \n \n \n \nCuadro 4. Pesos, temperaturas m\u00e1ximas, m\u00ednimas y sus diferenciales al primer d\u00eda.  \n \n \n \n \n  \nCuadro 5.  Pesos, temperaturas m\u00e1ximas, m\u00ednimas y sus diferenciales al quinto d\u00eda.  \n \n \n \n63rd WPDC/XXXIX ANECA  Cuadro 6.  Pesos, temperaturas m\u00e1ximas, m\u00ednimas y sus diferenciales al s\u00e9ptimo d\u00eda.  \n \n \n \n \n \nCuadro 7.  Pesos, temperaturas m\u00e1ximas, m\u00ednimas y sus diferenciales al onceavo d\u00eda.  \n \n \n   \n63rd WPDC/XXXIX ANECA  EXPERIMENTAL INDUCTION OF BACTERIAL CHONDROSIS \nAND OSTEOMYELITIS (BCO) IN COMMERCIAL BROILERS \nUSING MYCOPLASMA SYNOVIAE  \n \nINDUCCI\u00d3N EXPERIMENTAL DE CONDROSIS Y OSTEOMIELITIS \nBACTERIANA (COB) EN POLLOS DE ENGORDA COMERCIALES \nUTILIZANDO MYCOPLASMA SYNOVIAE \n \nV. Durairaj  and N. Ferguson- Noel  \n \nPoultry Diagnostic & Research Center , Department of Population H ealth,  \nThe University of Georgia, USA  \n \nRESUMEN  \n \nAunque la condrosis  y la ostiomielitis  bacteriana (COB) se ven com\u00fanmente en pollos de engorda de \ncrecimiento r\u00e1pido,  la COB asociada con Mycoplasma synoviae,  a\u00fan no ha sido reportada. Se ha observado un \naumento en los \u00edndices de COB en pollos infectados con MS y el objetivo de este estudio es investigar  la \npatofisiologia del MS asociado con COB. Se dividieron e n dos grupos , pollos de 45 d\u00edas  de edad - A (n=20)y \nB(n=25), y criados separadamente en dos casetas.  A las tres  semanas de edad, se inocul\u00f3 el G rupo B con MS (con \ngota ocular e Intranasal ), as\u00ed como se aplic\u00f3 la Vacuna IBV +NDV ( por gota ocular). A las seis semanas de edad, los \npollos del G rupo B se reinfectaron con MS (v\u00eda end ovenosa y pediluvios). Diez d\u00edas  despu\u00e9s, se sacrificaron los \npollos y se les practic\u00f3 la necropsia . Se realizaro n evaluaciones tanto morfol\u00f3gica como histol\u00f3gicamente  de las \ncabezas femorales. Los pollos infectados con MS  tuvieron  una mayor incidencia de COB  comparados con los \ncontroles. La MS fue aislada de las cabezas femorales de pollos inoculados.  \n \nSUMMARY  \n \nAlthough bacterial chondrosis and osteomyelitis (BCO) is commonly seen in rapidly growing broilers, BCO \nassociated with Mycoplasma synoviae  (MS) has, so far, not been reported.  We observed increased incidences of \nBCO in MS infected chickens and the objecti ve of this study was to investigate the pathophysiology of MS \nassociated BCO. Forty -five day -old broilers were divided into two groups \u2013  Group A (n=20) and Group B (n=25) - \nand raised in separate colony houses.  At three weeks  of age, G roup B chickens were i noculated with MS (eyedrop \nand intranasal), along with IBV+NDV vaccine (eyedrop). At six weeks  of age, G roup B chickens were boosted with \nMS (in travenous and footpad). Ten d  later, the chickens were necropsied. Morphological and histological evaluation \nof the femoral heads was performed. The MS inoculated chickens had higher incidences of BCO compared to the \ncontrols.  MS was isolated from the femoral heads of inoculated chickens.  \n \nABSTRACT  \n \nBCO (formerly called  femoral head necrosis) causes significant economic losses in the poultry industry and is \na welfare issue. BCO is more commonly seen in rapidly growing broilers  and is caused by many factors including  \nstress, husbandry practices, metabolic problems and infectious pathogen s. Several infectious patho gens have been \nreported to be associated with BCO  although there are no previous reports of BCO associated with MS . In earlier  \nstudies, we observ ed increased incidences of BCO associated with MS and so t he objective of this study was to \ninvestigate the pathophysiology of BCO induced by MS.  Forty -five day -old broilers were divided into two groups -  \nGroup A (n=20) and G roup B (n=25) - and raised in  deep litter system in  separate colony houses  under biosecure \nconditions . Chickens were provided with ad libitum  feed and water.  At two weeks  of age, the chickens were wing \nbanded  and tracheal and blood samples (n=10) were collected  and screened for Mycoplasma gallisepticum  (MG) and \nMS by serum plate agglutination,  hemagglutination inhibition , ELISA , culture and real -time PCR  tests (3). All \nchickens were found be free from MS and MG infection  at that time . At three weeks  of age, the chickens in Group A \nwere inoculated with 100 \u00b5L (50 \u00b5L by eye drop + 50 \u00b5L  by intratracheal route) of MS (K1968  14p) along with \ninfectious bronchitis virus (IBV) and Newcastle Disease Virus (NDV) by eye -drop. The tit er of the MS culture was 63rd WPDC/XXXIX ANECA  1.2 x109 color changing units/mL  (CCU /mL). At six weeks  of age , Group B chickens were boosted with MS (K1968  \n17p) by intravenous route and foot pad injection. At  eight weeks  of age, the chickens were  bled and  human ely \neuthanized using CO 2. Gentle pressure was applied to  the femoral bone to separate it from acetabulum  and s cores \nwere given based on the appearance and lesions on the proximal head of  the femur ( 1,2). Femoral head samples \nwere collected in 10% buffered neutral formalin for histopathological evaluation. The MS inoculated chickens  had \nseverely  eroded growth plate s with hemorrhagic streaks . BCO femoral heads had few irregularly arranged \nchondrocytes in the prehypertrophic and proliferating zone. Hi gher numbers of BCO with severely damaged femoral \nhead were seen in the MS inoculated group.  All blood samples collected at the time of necropsy were serologically \npositive for MS . MS  was isolated  from the femoral head s of inoculated chickens . This is the first report on the \nisolation of  MS from the femoral head in an experimental study . Based on th ese results , BCO can be induced in \nchickens by MS  infection . Further studies need to be condu cted to study mechanism of MS invading the femoral \nhead and causing BCO.  \n \nREFERENCES  \n \n1. Durairaj,  V., F. D. Clark, C.C. Coon,W. E. Huff, R. Okimoto, G. R. Huff, and N. C. Rath.  \n Effects of high fat diets or prednisolone treatment on femoral head separation in  chickens . \nBr Poult Sci. 53:198- 203. 2012.  \n2. Durairaj,  V., R. Okimoto, K. Rasaputra, F.  D. Clark, and N.  C. Rath  Histopathology and serum  clinical \nchemistry evaluation of broilers with femoral head separation disorder.  \nAvian Dis. 42:21 -25. 2009.  \n3. Kleven, S. H. Mycoplasmosis. In: A laboratory manual for the isolation, identification and characterization \nof avian pathogens, 5th ed. L. Dufour -Zavala, D. E. Swayne, J. R. Glisson, J. E. Pearson, W. M. Reed, M. W. \nJackwood, and P. R. Woolcock, eds. American Association of Avian Pathologists, Jacksonville, FL. 59\u2013 64. 2008.  \n \n \n (The full length article will be published in Avian Diseases .) 63rd WPDC/XXXIX ANECA  FIELD INVESTIGATION OF MYCOPLASMA SYNOVIAE \nOUTBREAKS IN COMMERCIAL BROILER BREEDERS IN \nGEORGIA  \n \nINVESTIGACI\u00d3N DE CAMPO DE BROTES DE MYCOPLASMA SYNOVIAE EN \nREPRODUCTORES DE POLLO DE ENGORDA COMERCIAL EN GEORGIA  \n \nV. DurairajA, R. WootenA, P. BlackA, L. ChapelB, and N. Ferguson- NoelA  \n \nA Poultry Diagnostic and Research Center  \nB Georgia Poultry Laboratory Network \nThe University of Georgia  \n \nRESUMEN  \n \nEl Mycoplasma synoviae  (MS) causa p\u00e9rdidas econ\u00f3micas  significativas en la industria av\u00edcola a nivel \nmundial.  En este estudio se detallan las investigaciones de campo de MS que fueron conducidas en cuatro parvadas \nde reproductoras de pollo de engorda comercial en Georgia -  Parvada 1 (34 semanas de edad SE), Parvada 2 (65 \nSE), Parvada 3 (35 SE) y P arvada 4 (44 SE) . Estas parvadas fueron primero reportadas como positivas para MS, \nbasadas en un an\u00e1lisis  serol\u00f3gico  conducido como es recomendado por el Plan Nacional de Mejoramiento Aviar \n(PNMA). Se colectaron hisopos traqueales y muestras de sangre para evaluaci\u00f3n sero l\u00f3gica y an\u00e1lisis  molecular por \nmedio del secuenciado de PCR y ADN de la porci\u00f3n del gen vlha . Bas\u00e1ndose en los resultados, las cuatro parvadas \nse han confirmado como positivos a MS. El an\u00e1lisis del secuenciado revel\u00f3 que estas parvadas fueron infectadas con \ncepas salvajes \u201cS -6\u201d,\u201cS -49\u201d y \u201cS -48\u201d. Investigaciones de campo epidemiol\u00f3gicas y moleculares se deben hacer con \nregularidad para comprender cuales cepas circulan en el campo.  \n \nSUMMARY  \n \nMycoplasma synoviae  (MS) causes significant  economic losses to the poultry industry. MS causes synovitis \nand clinical/subclinical respiratory infections in chickens  and is transmitted both horizontally and vertically.  Vertical \nand horizontal transmission can be prevented by following strict biosecurity measures  and periodic monitoring of \nflocks. Recommendations for m ycoplasma monitoring and surveillance programs in the US are described by the \nNational Poultry Improvement Program ( NPIP ). This field investigation was performed in  four commercial broiler \nbreeder flocks i n Georgia.  Four flocks  - Flock 1 (34 wk  of age -WOA), Flock 2 (65 WOA), F lock 3 (35 WOA) and \nFlock 4 (44 WOA)  - were investigated in this study. All four flocks were reported to be positive for MS based  on the \nserological analysis conducted according to NPI P regulations . In this field investigation study, s amples were \ncollected from both roosters and hens on a random basis. Tracheal swabs were collected for PCR and mycoplasma \nculture.  Whole blood samples were collected and the serum separation was performed.  Serum samples were tested \nby serological tests  such as serum plate agglutination (SPA) test, hemagglutination inhibition (HI) test and ELISA  \n(1). Tracheal swabs were cultured  for isolation and identification of the organism  by the direct immunofluorescence \ntest. Molecular analysis was performed  on the tracheal swabs  by PCR amplif ication a portion of the  MS vlha gene  \nfollowed by sequencing . Based on the results , all four flocks were confirmed to be  positive for MS.  The sequence \nanalysis revealed that F locks  1 and 2 were infected with a wild -type designated \u201cS -56\u201d, and F locks 3 and 4 were \ninfected with \u201cS -49\u201d and \u201cS -48\u201d wild- type strains  respectively . Epidemiological and molecular field investigations  \nand studies  should to be performed on regular basis to understand the circulating mycoplasma strains in the field.  \n \nREFERENCES  \n \n1. Kleven, S. H. Mycoplasmosis. In: A laboratory manual for the isolation, identification and characterization \nof avian pathogens, 5th ed. L. Dufour -Zavala, D. E. Swayne, J. R. Glisson, J. E. Pearson, W. M. Reed, M. W. \nJackwood, and P. R. Woolcock, eds. American Association of Avian Pathologists, Jacksonville, FL. 59\u2013 64. 2008.  \n \n(The full length article will be published in Journal of Applied Poultry Research .) 63rd WPDC/XXXIX ANECA  IMPACT OF MYCOPLASMA GALLISEPTICUM  ON THE \nREPRODUCTIVE ORGANS OF 14 \u2013WEEK OLD SPF CHICKENS  \n \nIMPACTO DEL MYCOPLASMA GALLISEPTICUM EN LOS \u00d3RGANOS \nREPRODUCTORES DE POLLOS SPF DE 14 SEMANAS DE EDAD  \n \nV. Durairaj, M. Franca,  and N. Ferguson- Noel  \n \nPoultry Diagnostic & Research Center, Department of Population Health  \nThe University of Georgia, USA  \n \nRESUMEN  \n \nEl objetivo de este estudio fue evaluar el efecto de Mycoplasma gallisepticum  (MG) en los ovarios y test\u00edculos \nde pollos SPF. Cien pollos SPF fueron separados al azar en dos grupos de 50 pollos por grupo. Los pollos fueron \ncriados en casetas usando el programa est\u00e1ndar de luz para ponedoras. A las 14 semanas  de edad se inocul\u00f3  a uno de \nlos grupos por aerosol con MG (cepa R), y el otro grupo se aplic\u00f3  un placebo tambi\u00e9n por aerosol.  A los diez d\u00edas \npost- inoculaci\u00f3n  se sacrificaron y pesaron. Los test\u00edculos /ovarios se colectaron, pesaron y se preservaron muestras \nen formol neutro amortiguado al 10%. La relaci\u00f3n test\u00edculo /peso corporal (TPC) y ovario / peso corporal (OPC) \ndisminuy\u00f3 en los pollos infectados con MG comparados con los controles. En los ex\u00e1menes histol\u00f3gicos no \nmostraron ning\u00fan cambio signific ativo en los ovarios entre los dos grupos, aunque la espermatog\u00e9nesis fue \naltamente afectada en el grupo infectado con MG.   \n \nSUMMARY  \n \nThe objective of this study was to evaluate the effect of Mycoplasma gallisepticum  (MG) on the ovaries and \ntesticles of SP F chickens.  One hundred SPF chickens (males and females) were randomly divided into two groups of \n50 chickens per group. Chickens were raised in colony houses following a standard lighti ng program for layers. At \n14 wk  of age, one group of chickens was inoc ulated with MG (R strain) by aerosol and the other group was \nadministered a placebo , also by aerosol. At 10 d post inoculation the chickens were euthanized and weighed. The \ntestes/ovary was collected, weighed, and samples preserved in 10% buffered neutral formalin.  The Testes/Body \nweight (TBW) ratio and Ovary/Body weight (OBW) ratio were decreased in MG challenged chickens as compared \nto the controls. On histological examination no differences were observed in ovaries between the two groups \nalthough spermat ogenesis was severely affected in the MG challenged chickens.  \n \nABSTRACT  \n \nMG causes chronic respiratory disease in chickens. MG  can also affect  ovaries  of laying hens causing ovarian \nregression and severe drops  in egg production  (1). The effects of MG on testes  have not yet been described. The \nlong term objective of this research i s to study  the pathophysiological effect of M G on the reproductive organs \n(ovaries and testes ) of broiler breeders. To achieve this goal, a preliminary study in 14 w k old SPF chi ckens was \nconducted to evaluate the pathophysiological effect of MG on the reproductive organs.  One hundred SPF chickens \n(males and females) were  randomly  divided into two groups  (Group A and B)  of 50 chickens/ group. Chickens were \nraised in  deep litter colony houses  with ad libitum  feed and water  following the standard lighting program  for layers . \nAt seven wk of age, all chickens were wing -banded and choanal -cleft swabs and blood samples were collected from  \nfive chickens per group for m ycopl asma screening. The samples collected were tested by serum plate agglutination \ntest (SPA), hemagglutination inhibition (HI) assay, ELISA, culture and real -time PCR. The chickens were found to \nbe free from mycoplasma infections  at that time . At 14 wk  of age , the G roup B chickens  were inoculated  with MG \n(R strain ) by aerosol route  and Group A received MG vaccine diluent as  placebo.  The titer of the inoculum was 7.1 \ncolor changing units/mL (CCU/mL ). Ten days later  the chickens were euthanized, weighed and necropsied. Air sac \nlesions w ere scored and the MG -inoculated  chickens had higher air sac lesion scores  than the control s. The t estes  or \novary was collected, weighed and samples were preserved in 10% buffered neutral f ormalin.  OBW ratio was \ncalculated by dividing the ovary weight by body weight of chickens. Similarly, testes were collected from cockerels, \nweighed and TB W ratio was calculated.  Both OBW and TBW were decreased in MG-inoculated chickens  as 63rd WPDC/XXXIX ANECA  compared  to the  controls . The upper third of trachea was collected in 10% neutral buffered formalin for histological \nevaluation.  The t racheal mucosa thickness was severely increased with lymphocytic infiltration  in the inoculated \nchickens  (Group B).  On histological evalua tion of the ovary , normal follicular maturation was noticed and no \ndifferences were observed  between the two groups.  The m ajority of the testicles of the control group had variable \nspermatogenesis whereas the majority of the testicles of the MG -inoculated  group had no spermatogenesis or had \nrare spermatids and spermatozoa. Based on this study, it can be inferred that t he spermatogenesis  process  occurring \nin the  cockerels was compromised due to MG infection.  Further studies are needed t o investigate the impact of  MG \non spermatogenesis  in broiler breeder males . \n \nREFERENCES  \n \n1. Ferguson- Noel, N., K. Cookson, V. A. Laibinis, and S. H. Kleven. The efficacy of three \ncommercial  Mycoplasma gallisepticum  vaccines in laying hens.  Avian Dis.  56:272- 275. 2012.  \n \n \n(The full length article will be published in Avian Diseases .) \n 63rd WPDC/XXXIX ANECA  REPORTE DE LESIONES EN APARATO REPRODUCTOR DE \nGALLINAS PONEDORAS AFECTADAS POR INFLUENZA AVIAR \nDE ALTA PATOGENICIDAD (H7N3) DE M\u00c9XICO  \n \nREPORT OF LESIONS IN REPRODUCTIVE SYSTEM OF LAYERS \nAFFECTED BY HIGH PATHOGENICITY (H7N3) AVIAN INFLUENZA  \nIN MEXICO  \n \n \nM. EscorciaA, JC Del R\u00edoB, D MarrufoA, E. Mart\u00ednezA, S. Comonfort -D\u00edazA y GM NavaC \n \nADepartamento de Medicina y Zootecnia de Aves . Facultad de Medicina Veterinaria y Zootecnia, UNAM  \nBFacultad de Estud ios Superiores Cuautitl\u00e1n, UNAM  \nCFacultad de Qu\u00ed mica, Universidad Aut\u00f3 noma de Quer \u00e9taro, Quer \u00e9taro, M\u00e9xico \n \nSUMMARY  \n \nIn June 2012, an outbreak caused by a high pathogenicity avian influenza virus (IAAP), subtype H7N3 in \nheavy -type breeding hens farms first, and later in commercial layer farms in Tepatit lan an d Acatic, Jalisco, Mexico \nalarmed  poultry producers and sanitary authorities of the country, initiating monitoring in order to establish the \nsanitary situation of the region. In June 25 of the same year, 51 poultry commercial units had been sampled, having, \nin 14 of them, the presence of signs indicating IAAP; subsequently, the virus presence in this units is confirmed, as \nwell as its dissemination into other poultry areas (OIE 2012 Update on highly pathoge nic avian influenza in animals, \ntype H5 and H7) (5).  \nDespite all the sanitary measur es implemented by the Mexican authorities, this virus has not been eradicated \nfrom the country, bringing with it important production losses caused mainly by a decrease in the laying rate, rather \nthan by the mortality it causes. The present work reports gr oss and microscopic lesions in reproductive system \ndetected in one clinical case of a commercial layer flock which had an AIHP subtype H7N3 outbreak in Mexico.  \n \nRESUMEN  \n \nEn junio de 2012, un brote provocado por un virus de influenza aviar de alta p atogenic idad (IAAP), subtipo \nH7N3, en granjas de reproductoras pesadas primero, y posteriormente en granjas de postura comercial en la s zona s \nde Tepatitl\u00e1n y Acatic, Jalisco -M\u00e9xico,  da la voz de alarma a productores av\u00edcolas y a las autoridades sanitarias del \npa\u00eds inici\u00e1ndose con ello  un monitoreo a fin de establecer la situaci\u00f3n zoo sanitaria de la regi\u00f3n . Para el 25 de junio \nde ese mismo a\u00f1o se hab\u00edan  muestread o 51 unidades av\u00edcolas comerciales, resultando , 14 de ellas , con signos \ncl\u00ednicos susceptibles a IAAP, pos teriormente se confirma la presencia del virus en estas unidades y su diseminaci\u00f3n \nen otras zonas av\u00edcolas , trayendo consigo importantes p\u00e9rdidas de  producci\u00f3n . El presente trabajo reporta las \nlesiones macrosc\u00f3picas  y microsc\u00f3picas a nivel de aparato reproductor detectadas en un caso cl\u00ednico de una parvada \nde postura comercial  que sufri\u00f3 un brote de IAAP, subtipo H7N3 en M\u00e9xico .  \n \nINTRODUCCI\u00d3N  \n \nEn junio  de 2012 , un virus de influenza  aviar, subtipo H7N3 altamente pat\u00f3geno (IAAP ) fue  identificado como  \nla causa del brote de una enfermedad  grave en granjas de ponedoras  comerciales en el estado de Jalisco. Alrededor \nde 22.4 millones de aves resultaron muertas como consecuencia de la infecci\u00f3n o bien por ser sacrificadas preventivamente en las granjas vecinas  (5). El 26 de julio  de 2012,  una campa\u00f1a de inmunizaci\u00f3n  con una vacuna \ninactiva  H7N3  fue implementada en granjas de gallinas ponedoras  en la zona de control  en conjunto con otras \nmedidas [ 2,7\n]. De acuerdo a Kapczynski  y col, y con base a las evaluaciones moleculares que realizaron, el virus \ncausante de este brote present\u00f3 una homolog\u00eda del 97% con virus aislados de aves silvestres de Norteam\u00e9rica en los 8 genes que lo conforman (4 ). 63rd WPDC/XXXIX ANECA  Pese a la inestabilidad antig\u00e9nica q ue presenta el virus de IA, la vacunaci\u00f3n puede ser una herramienta valiosa  \npara el control de la enfermedad en el pa\u00eds, sin embargo,  no proporcion a una protecci\u00f3n absoluta contra la  infecci\u00f3n \nen la  mucosa  del aparato reproductivo,  como sucedi\u00f3 en el presente caso ( 8,9). \nEl objetivo del presente trabajo fue describir las lesiones macrosc\u00f3picas y microsc\u00f3picas observadas en tracto \nreproductor de aves de postura comercial provenientes de parvadas vacunadas y que sufrieron desaf\u00edos de campo \ncon el v irus de IAAP, subtipo H7N3.  \n \nIDENTIFICACI\u00d3N DE CA SOS  \n \nLos casos sospechosos de infecci\u00f3n por el virus H7N3 fueron identificados a trav\u00e9s del reporte del cl\u00ednico \nresponsable de granja en la zona en donde exist\u00eda  reporte y confirmaci\u00f3n previa de casos. A partir del reporte oficial \ndado por las autoridades sanitarias, se mejor\u00f3 la vigilancia cl\u00ednica y se coordin\u00f3 y evalu\u00f3 el reporte de curvas de \nproducci\u00f3n en granjas en riesgo . Se obtuvieron datos  epidemiol\u00f3gicos como historias cl\u00ednicas, fechas de brotes, \nidentificaci\u00f3n de signos cl\u00ednicos y lesiones  y curvas de producci\u00f3n.  \n \nRESULTADOS  \n \nCalidad interna y externa de los huevos producidos por las aves afectadas . Se apreciaron huevos de \ndiferentes tama\u00f1os, cascar\u00f3n fr\u00e1gil, ausencia de alb\u00famina densa, huevos en f\u00e1rfara , cascarones arrugados o \ngranulosos  y yemas peque\u00f1as.  \nLesiones macrosc\u00f3picas observadas . A la necropsia se observaron o varios y oviductos atr\u00f3ficos, presencia de \nexudado caseoso en oviductos, falta de jerarqu\u00eda folicular, fol\u00edculos hemorr\u00e1gicos, pos tura abdominal y peritonitis . \nLesiones microsc\u00f3picas . Se tomaron muestras  a nivel de \u00fatero para estudios histol\u00f3gicos las cuales fueron \nprocesadas en el \u00e1rea de histopatolog\u00eda del Departamento de Medicina y Zootecnia de Aves de la FMVZ -UNAM , \npara su poster ior interpretaci\u00f3n . \nLas lesiones m \u00e1s com\u00fanmente observadas fueron infiltrado linfocitario difuso agudo severo, infiltrado \nheterof\u00edlico  subepitelial difuso agudo moderado y atrofia glandular severa.  \nConforme la infecci\u00f3n fue evolucionando, y a pesar de que la mortalidad de las aves no super\u00f3 el 0.4% , la \ncurva de producci\u00f3n sufri\u00f3 una ca\u00edda del 17% (la parvada ten\u00eda un porcentaje de producci\u00f3n del 95.3% al momento del desaf\u00edo y este p orcentaje cay\u00f3 hasta el  78%). Una vez superada la infecci\u00f3n la curva de prod ucci\u00f3n no se \nrecuper\u00f3.  \nDos semanas posteriores al inicio del brote, s e realiz\u00f3 una segunda toma de muestra para estudios \nhistopatol\u00f3gicos y los resultados revelaron que la mucosa de \u00fatero no se regener\u00f3, por el contrario, esta fue revestida por tejido de cicatrizaci\u00f3n. La mala calidad del huevo, tanto interna como externa no se recuper\u00f3.  \nUno de los principales problemas a los que se enfrentaron los cl\u00ednicos y responsables de granja fue el manejo \nde selecci\u00f3n debido a que las caracter\u00edsticas f\u00edsicas de las aves no nos permit\u00edan diferenciar entre una ave falsa ponedora y una verdadera ponedora, sumado a esto, dentro de las aves ponedoras persist\u00edan las que pon\u00edan huevos \nde mala calidad.  \n  \nDISCUSI\u00d3N  \n \nEl que las vacunas contra IA no eviten la infecci\u00f3n y la diseminaci\u00f3n del virus de campo radica en el hecho de \nque la infecci\u00f3n inicial se produce en las v\u00edas respiratorias, y las vacunas emulsionadas que se utilizan en M\u00e9xico, al \nser aplicadas parenteralm ente, inducen principalmente una respuesta inmune humoral, y no la  inmunidad local, tan \nvaliosa en la neutralizaci\u00f3n del virus de desaf\u00edo. La producci\u00f3n de inmunidad local , tiene como prop\u00f3sito que, ante \nla infecci\u00f3n viral, \u00e9sta act\u00fae como defensa inicial contra los pat\u00f3genos invasores antes de que penetren en el plasma  \n(1,3,6) . \nEl est\u00edmulo antig\u00e9nico en mucosa es un requisito muy importante,  ya que la inmunidad local va asociada a un \npolip\u00e9ptido llamado componente secretor que es derivado de c\u00e9lulas propia s de las mucosas, con esto se entiende \nque haya la evasi\u00f3n, por parte  del virus de IA de desaf\u00edo en aves , a pesar de estar vacunadas y con ello se facilite su \ndiseminaci\u00f3n en el organismo del ave ( 1,3,6 ).  \nLa vacunaci\u00f3n parenteral no evita el desaf\u00edo, por lo tanto, u na vez que el virus de campo es inhalado o \ningerido, y que no ha podido ser neutralizado, a pesar de que las aves sean vacunadas, la presencia de enzimas \nproteol\u00edticas en  las c\u00e9lulas  epiteliales  respiratorias e intestinales provocar\u00e1 que se lleve a cabo el corte de la prote\u00edna \nHA viral lo que permitir\u00e1 su ingreso a la c\u00e9lula, en donde se llevar\u00e1n a cabo m\u00faltiples ciclos de replicaci\u00f3n  y \nliberaci\u00f3n de m \u00e1s virus  infecciosos.  Una vez que se llev\u00f3  a cabo la replicaci\u00f3n viral a nivel de mucosa res piratoria, 63rd WPDC/XXXIX ANECA  en el caso de los virus de alta patogenicidad (AP), \u00e9stos invadir\u00e1n la submucosa de los capilares a nivel respiratorio. \nEl virus replicar\u00e1 dentro de las c\u00e9lulas endoteliales e invadir\u00e1, a trav\u00e9s de la red vascular o linf\u00e1tica, a todos aquellos \ntejidos que posean el receptor viral espec\u00edfico generando una infecci\u00f3n sist\u00e9mica ( 8). \n \nREFERENCIAS  \n \n1. Abbas, A. K., Lichtman, A.H., Pillai, S. Mecanismos efectores de la inmunidad humoral. En: \nInmunolog\u00eda Celular y Molecular. 6\u00aa. ed. Espa\u00f1a: Elsevier  Espa\u00f1a: 2008.  \n2. Acuerdo mediante el cual se activa, integra y opera el dispositivo nacional de emergencia en salud \nanimal, en los t\u00e9rminos del art\u00edculo 78 de la Ley Federal de Sanidad Animal, con objeto de diagnosticar, prevenir, \ncontrolar y erradicar el vi rus de la Influenza Aviar tipo A, subtipo H7N3. ( www.senasica.gob.mx ) \n3. Bienenstock, J. Mucosal and other mechanisms of resistance in the respiratory tract: An overview. In: J. \nMestecky, M.E. Lamm, W. Strober,  J. Bi enenstock, J.P.  Mc Ghee, Ll. Mayer (eds) Mucosal Immunology. 3a. edic. \nElsevier Academic Press, London: 2005.  \n4. Kapczynski, D. R., Patin -Jackwood, M., Guzm\u00e1n, S. F., Ricardez, Y., Spackman, E., Bertran, K., Suarez, \nD.L., Swayne, D.E.. Characterizarion of the 2012 highly pathogenic avian influenza H7N3 virus isolated from \npoultry in an outbreak in Mexico: Pathobiology and vaccine protection. J. Virol. DOI:10.1128/JVI.00666- 13 \n5. Organizaci\u00f3n Mundial de Sanidad Animal (OIE)  2012. Update on highly pathogenic avian influenza in \nanimals (Type H5 and H7). [http://www.oie.int/animal -health -in-the-world/update -on-avian -influenza/2012).  \n6. Peppard, J. V., Kaetzel, C. S., Russell, M. V. Phylogeny and comparative physiology of Ig A. In: J. \nMestecky, Me E. Lamm, W. Strober, J. Bienenstock, J. P. Mc Ghee, Ll. Mayer (eds) Mucosal Immunology. 3a. edic. \nElsevier Academic Press, London: 2005.  \n7. Productora Nacional de Biol\u00f3gicos Veterinarios  Junio 2012:  \nhttp://www.pronabi ve.gob.mx/informes/INFOR123.PDF  \n8. Swayne D. E., Halvorson D. A.. Influenza. In: Y. M. Saif, H. J. Barnes, A.  Fadly, J. R. Glisson, L. R. Mc \nDougald, L. Nolan, D. E. Swayne (eds) Diseases of Poultry. 12a. edic. Iowa State University Press, Ames: 2008.  \n9. Swayne,  S. E., Kapczynski,  D. R (2008) Vaccines, Vaccination, and Immunology for Avian Influenza \nViruses in Poultry. In: Swayne DR (ed) Avian Influenza. Blackwell Publishing, Ames: 2008.  \n \n(Este art\u00edculo ser\u00e1 publicado en su integridad en la revista Avian Pathology .) 63rd WPDC/XXXIX ANECA  CONTROL OF AVIAN MYCOPLASMOSIS  \n \nN. Ferguson- Noel  \n \nDept. of Population Health, Poultry Diagnostic and Research Center  \nCollege of Veterinary Medicine, University of Georgia, 953 College Station Rd.  \nAthens, GA 30602  \n(706) 542- 3068  \nnaolaf@uga.edu  \n \nThe pathogenic avian Mycoplasma spp. (M. gallisepticum, M.  synoviae, M.  meleagridis , and M. iowae ) have \nbeen negatively affecting commercial poultry production for many years. The poultry industry and scientific \ncommunity have made great strides in increas ing the knowledge of the biology of these bacteria (and hence their \ncontrol) since they were first identified, but much is still to be revealed. Avian mycoplasma can evolve rapidly and \nstrains can vary widely in virulence. Despite the current information a nd control options available, costly outbreaks \nof avian mycoplasmosis continu e to occur throughout the world and the varied effects of mycoplasma on poultry \nproduction continue to be identified and described.   \nThe current approaches to MG and MS control include continuous surveillance and quarantine, medication, \nvaccination and/or elimination of infected breeding flocks. To maintain mycoplasma -free flocks it is important to \nuse only negative replacements, use si ngle age farms (isolated if possible), depopulate and disinfect between flocks, \nmaintain good biosecurity and set up monitoring program.  \nElimination of a positive breeder flock is the surest way to eliminate the shed of MG or MS, but this is not \nalways fe asible. Positive flocks should be isolated as much as possible; the eggs and chicks should also be \nsegregated. The presence of persistently infected populations (e.g. backyard birds) ensures  that the biosecurity of \nsurrounding flocks is continually challenged. In situations where negative flocks cannot be adequately isolated and posit ive flocks cannot be eliminated, medication and vaccination become options for mycoplasma control.  \nThe development of antibiotic resistance, cost, regulations and feasibility limit the ability of producers to \ncontinuous ly apply antibiotics to prevent mycoplasma infection, reduce shed of the organisms (vertically and \nhorizontally) and treat clinical signs. Vaccination has better prospects as a long -term control method in these \nsituations.  \nSo the question is  - do mycoplasma vaccines work? And the answer \u2013  yes, no , or sometimes  - depends on how \nsuccess or failure  is judged . It is important to understand the characteristics and limitations of the different vaccines \nand select the safest and/or most efficacious vaccine based on the specific situation and primary concerns \u2013  whether \nthey be preventing clinical signs, protecting progeny, or avoiding vaccine transmission to neighboring flocks.  Most of the currently available mycoplasma v accines can prevent or reduce clinical signs  (depending on the severity \nof challenge ) (2,6). The vaccines do vary in their safety and efficacy ( 1,3). In the event of challenge with a very \nvirulent field strain the most efficacious vacci ne available would be necessary , whereas in a low challenge sit uation \nthis vaccine may be excessive.  \nThe general health of the birds is a factor  in the choice of vaccine, especially in flocks that are under heavy \nchallenge from virulent respiratory viruses or severely immunosuppressed, a safer vaccine would  be preferable to a \nmore efficacious vaccine with some reactivity.  \nSome vaccines can also prevent infection with and  reduce transmission of a field strain  (4,5). The vaccines \nvary in th is ability and if the main goal of the vaccination program is to eventually displace and eliminate a virulent \nwild-type, then a more efficacious vaccine that prevents the field strain from continuing to circulate would be \nimportant.  \nAnother aspect of vaccination that must be taken into consideration is handling and application \u2013 a vaccine \ncannot be expected to behave optimally if it is mishandled. It is difficult to estimate how many \u201cvaccine failures\u201d in the field are actually due to improper handling or app lication so that the birds do not receive a protective dose and \nare in fact never truly vaccinated.  \n \nREFERENCES  \n \n1. Abd-el-Motelib, T.Y., and S.H. Kleven. A comparative study of Mycoplasma gallisepticum vaccines in \nyoung chickens. Avian D iseases 37:981- 987. 1993.  63rd WPDC/XXXIX ANECA  2. Evans, R.D., and Y.S. Hafez. Evaluation of a Mycoplasma gallisepticum strain exhibiting reduced \nvirulence for prevention and control of poultry mycoplasmosis. Avian Diseases 36:197- 201. 1992.  \n3. Ferguson- Noel, N., K. Cookson, V. Laibinis, and S.H. Kleven. The Efficacy of Three Commercial \nMycoplasma gallisepticum Vaccines in Laying Hens. Avian Diseases 56:272 -275. 2012.  \n4. Kleven, S.H., H. -H. Fan, and K.S. Turner. Pen trial studies on the use of live vaccines to displace virulen t \nMycoplasma gallisepticum  in chickens. Avian Diseases 42:300 -306. 1998.  \n5. Turner, K.S., and S.H. Kleven. Eradication of live F strain mycoplasma gallisepticum vaccine using live ts -\n11 on a multiage commercial layer farm. Avian Diseases 42:404 -407. 1998.  \n6. Whithear, K.G., Soeripto, K.E. Harrigan, and E. Ghiocas. Immunogenicity of a temperature sensitive \nmutant Mycoplasma gallisepticum vaccine. Aust Vet J 67:168 -174. 1990.  \n \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n EVALUACI\u00d3N DE UN ADS ORBENTE DE TOXINA T -2 \nEN POLLO DE ENGORDA  \n \nEVALUATION OF A T-2 TOXIN ADSORBENT IN BROILER CHICKENS  \n \n J. FierroA, R. Z\u00fa\u00f1igaA, O. MontalvoA, S. RosasA, J. MedinaA y E. Rodr\u00edguezB \n \nANUTEK S.A. de C.V.  \n \n BInvestigaci\u00f3n aplicada S.A. de C.V.  \n \n7 Norte 416 Tehuac\u00e1n, Puebla. M\u00e9xico, 75700  \njafierro@grupoidisa.com  \n \nSUMMARY  \n \nThe effectiveness of a T -2 toxin adsorbent included in a 2kg/ton concentration in a chicken\u2019s diet was \nevaluated . Eighty four male one-day-old chickens distributed in three  groups of seven  birds with four repetitions \nwere used. The feed was controlled, and the birds had ad libitum  access to water from d 1 to  28, when they were \nslaughtered. T1: control; T2 1800 ppb T2; T3 1800 ppb T2 +  2 kg/ton adsorbent. Results obtained at 14 and 28 d of \nage present significant differences between treatments for weight gain and FCR. Effectiveness of the product based \non weight gain is  74.6%. There were no significant differences found for feed intake.  Also, sever e lesions were \nfound for T.  Inclusion of the adsorbent to the contaminated diet statistically improves animals\u2019 weight. It is \ndemonstrated that the adsorbent at a dose of 2 kg/ton is effective to prevent toxic effects of T2 in broiler chickens.   \n \nRESUMEN  \n \nSe evalu\u00f3 la efectividad de un adsorbente de toxina T2, incorporado a una concentraci\u00f3n de 2 kg/t, en dietas de \npollos. 84 pollos machos de un d\u00eda de edad, distribuidos en tres grupos de siete aves con cuatro  repeticiones; el \nalimento fue contr olado y agua ad libitum  desde el primer d\u00eda hasta el d\u00eda 28 en que fueron sacrificados. T1 control; \nT2 1800 ppb de T2; T3 1800 ppb de T2 + 2 kg/t de adsorbente. Los resultados obtenidos a los 14 y 28 d\u00edas de edad, presentan diferencias significativas entre los tratamientos en ganancia de peso y la conversi\u00f3n alimenticia. La \nefectividad del producto con base en la ganancia de peso es: 74.6%. No se encontraron diferencias significativas en \nconsumo de alimento. Adem\u00e1s se observaron lesiones severas en el T2. L a inclusi\u00f3n del adsorbente a la  \ndieta contaminada mejora estad\u00edsticamente el peso del animal. Se demuestra que el adsorbente a 2 kg/t, es efectivo \npara prevenir los efectos t\u00f3xicos de la T2 en pollo de engorda.  \n \nINTRODUCCI\u00d3N  \n \nLos tricotecenos, son micotoxinas producidas por varios g\u00e9neros de hongos, tales como Fusarium, \nTrichoderma, Myrothecium, Stachybotrys, Cephalosporium.  Son una familia de aproximadamente 150 compuestos \nestructuralmente relacionados (Grove, 1988). Especies del genero Fusarium  son las que m\u00e1s frecuentemente est\u00e1n \nrelacionadas con la presencia de tricotecenos en cereales y sus derivados, pudiendo contaminar la planta y los granos \ndurante el periodo de pre y post cosecha. La toxina T -2 provoca en aves disminuci\u00f3n en el consumo de al imento y \nganancia de peso, lesiones orales, necrosis de los tejidos linfoides, hematopoy\u00e9tico y la mucosa oral, diarrea, \nv\u00f3mito, lesiones en el tracto digestivo, arritmias card\u00edacas, inmunosupresi\u00f3n, da\u00f1os al sistema nervioso, reducci\u00f3n \nen la producci\u00f3n, p eso y calidad de huevos, canibalismo, reducci\u00f3n en la producci\u00f3n de huevo en reproductoras, \nmayores \u00edndices de mortalidad embrionaria precoz en la incubaci\u00f3n, e inhibici\u00f3n de la s\u00edntesis de DNA y prote\u00ednas \n(Morehouse, 1985). La interacci\u00f3n de los tricotecenos con agentes infecciosos ocurre, cuando los mecanismos de \nresistencia dependen de la inmunidad celular (Corrier, et al 1987). Los m\u00e9todos qu\u00edmicos que se han utilizado para \nreducir la contaminaci\u00f3n con micotoxinas no tienen efectos pr\u00e1cticos en la indus tria pecuaria. La Toxina T2 produce \np\u00e9rdidas importantes en el sector pecuario (CAST 2003), motivo por el cual el uso de aditivos antimicotoxinas es de \nmucha importancia, sin embargo la disminuci\u00f3n de la biodisponibilidad de la Toxina T2 es limitada en los  productos \nactuales. Se han desarrollado diferentes tratamientos para mejorar esta caracter\u00edstica. El objetivo fue evaluar el                                                                                                                                           63rd WPDC/XXXIX ANECA \n efecto protector de un adsorbente experimental  del tipo organoaluminosilicato; contra los efectos adversos de 1,800 \nppb de toxina T -2 en pollos de engorda en fase de crecimiento (d\u00edas 1 a 28 de edad).  \n \nMATERIAL Y M\u00c9TODOS  \n \nSe utilizaron 84 pollos de engorda machos de la estirpe comercial Ross, de un d\u00eda de edad y se distribuyeron al \nazar en 3 tratamientos de 7 aves con 4 repeticiones,  con alimentaci\u00f3n controlada y agua ad libitum  durante 28 d\u00edas. \nLas dietas se identificaron  como: 1) dieta control negativo, 2) dieta control positivo con 1,800 ppb de toxina T -2 y \n3) dieta de desaf\u00edo, con el adsorbente a raz\u00f3n de 2 kg/t y 1,800 ppb de toxina T -2. La Toxina T2 se obtuvo de una \ncontaminaci\u00f3n natural, con el hongo Fusarium Sporotrichioides . El alimento fue comercial para pollo de engorda. \nLa concentraci\u00f3n de Toxina T2 adicionada a este alimento se verifico en el laboratorio de Toxicolog\u00eda de Nutek y en \nTrilogy Analytical Laboratory, Washington, MO;  por CG/MS. Las  aves se recibieron y se sometieron a un \nprograma de vacunaci\u00f3n, se pesaron y se registro el peso individual cada semana, hasta el final del experimento. La \nconversi\u00f3n alimenticia y la ganancia de peso se calcul \u00f3 semanalmente. Todos los d\u00edas se realiz\u00f3 una inspecci\u00f3n \nocular de las condiciones ambientales y la salud de las aves. Los animales se sangraron y se sacrificaron el d\u00eda 28 de \nexperimentaci\u00f3n; el h\u00edgado, ri\u00f1\u00f3n, timo, bazo, bols a de Fabricio y molleja fueron retirados y se pesaron  \nindividualmente para obtener su peso relativo : Se obtuvieron muestras para ensayos histopatol\u00f3gicos. Se tomaron \nporciones del intestino delgado (duodeno, yeyuno e \u00edleon) para medir las vellosidades. A las muestras de sangre \ncompleta, se les realizo la biometr\u00eda hem\u00e1tica y del suero se cuantifico la concentraci\u00f3n de xantofilas, vitamina A y \ninhibici\u00f3n de la hemoaglutinaci\u00f3n para la enfermedad de Newcastle. Se retiraron las tibias izquierdas y se analiz\u00f3:  \ncenizas de la tibia, f\u00f3sforo, calcio, manganeso y zinc. La informaci\u00f3n obtenida fue analizada por un ANOVA, \nutilizando el programa estad\u00edstico SYSTAT, por la prueba de Tukey donde se defini\u00f3 la diferencia entre medias. El \nvalor de significaci\u00f3n se bas\u00f3 en  0.05 de probabilidad.   \n \nRESULTADOS  \n \nLos resultados obtenidos a los 14, 21 y 28 d\u00edas de edad, presentan diferencias estad\u00edsticamente significativas \nentre los tratamientos en ganancia de peso y la conversi\u00f3n  alimenticia. La efectividad del producto con base en la ganancia de peso es: 74.6 %. Con respecto al consumo de alimento, no se observaron diferencias estad\u00edsticamente \nsignificativas; pero el error est\u00e1ndar fue menor en el tratamiento de desaf\u00edo.  \n \nTratamientos  Peso en g  Ganancia de peso  Conversi\u00f3n \nalimenticia  Consumo de \nalimento  \nInicial  \nMedias \u00b1 error \nest\u00e1ndar  Final  \nMedias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  \nNegativo  43 \u00b1 0.46 a\n  1556 \u00b1 18.76 a\n  1513 \u00b1 18.87 a\n  1.34 \u00b1 0.017 a\n  2028 \u00b1 20.5 a\n  \nPositivo  43 \u00b1 0.43 a\n  1442 \u00b1 29.49 b\n  1399 \u00b1 29.46 b\n  1.45 \u00b1 0.035 b\n  2035 \u00b1 44.3 a\n  \nDesaf\u00edo  43 \u00b1 0.42 a\n 1527 \u00b1 18.81a\n 1484 \u00b1 18.75 a\n 1.42 \u00b1 0.018 ab\n 2101 \u00b1 16.9 a\n \nMedias con letras diferentes son estad\u00edsticamente significativas.  P<0.05  \n \nLas lesiones por el consumo de la toxina T -2, se observaron a partir de la primera semana.  \nEn  el tratamiento negativo, se observaron 5  aves afectadas  con ulceras , esto se debi\u00f3 al alimento utilizado en \nforma de harina (las lesiones se observan diferentes a la s provoca das por el consumo  de la toxina T -2). En el \ntratamiento positivo, se observaron todas las aves con lesiones orales y 10 de ellas con lesiones de graves a severas , \nen comparaci\u00f3n con el tratamiento de desaf\u00edo  en donde se observaron 2 aves sin lesiones, 24 con lesiones leves y 2 \ncon lesiones severas . \nEl peso relativo de los \u00f3rganos no presento diferencias estad\u00edsticamente significativas, solo num\u00e9ricas. El bazo \ny timo del control positivo se vieron afectados, en comparaci\u00f3n con los otros grupos. Control nega tivo 0.100% \ncontra 0.094% del control positivo en el peso de Bazo y 0.318% contra 0.282% en el peso del timo.  \nEl conteo de gl\u00f3bulos blancos y linfocitos, en sangre completa y la concentraci\u00f3n de vitamina A y xantofilas en \nsuero; presentaron diferencias es tad\u00edsticamente significativas. Adem\u00e1s los pollos del tratamiento con adsorbente y la \ntoxina, presentaron mejor respuesta vacunal, de acuerdo a los resultados de la prueba de HI  para la enfermedad de \nNewcastle.                                                                                                                                             63rd WPDC/XXXIX ANECA \n  \n \n \n \nTratamientos  Gl\u00f3bulos blancos \n103\n/\u03bcL Linfocitos  \n103\n/\u03bcL  Xantofilas  \nmg/L  Vitamina A  \nUI/mL  IH de NC  \n(18 d\u00edas post \nvacunaci\u00f3n)  \nLog2  \n Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  Medias \u00b1 error \nest\u00e1ndar  \nNegativo  83.5 \u00b1 5.06 a\n  72.1 \u00b1 3.34 a\n  12.8 \u00b1 0.47 a\n  31.8\u00b1 1.89 a\n  9.207 \u00b1 0.30 ab\n  \nPositivo  65.10 \u00b14.07 b\n  58.4 \u00b1 3.32 b\n  8.92 \u00b10.70 b\n  21.2 \u00b1 2.17 b\n  8.717 \u00b1 0.29 b\n  \nDesaf\u00edo  75.1 \u00b1 4.00 ab\n  66.2 \u00b1 2.59 ab\n  12.7 \u00b1 0.56 a\n  30.1 \u00b1 0.65 a\n  9.709 \u00b1 0.29 a\n  \nMedias con letras diferentes son estad\u00edsticamente significativas para  (p < 0.05)   \n \nEn los dem\u00e1s resultados del conteo celular solo se presentaron diferencias num\u00e9ricas (monocitos, bas\u00f3filos, \neosin\u00f3filos, neutr\u00f3filos, gl\u00f3bulos rojos, hemoglobina y hematocrito).  \nEn los an\u00e1lisis de minerale s en tibia izquierda , se presentaron diferencias estad\u00edsticas en el porcentaje de \nfosforo y calcio, al igual que en la ceniza, la concentraci\u00f3n de manganeso y zinc no fueron afectados por el consumo \nde la toxina T -2. \nLa integridad intestinal se vio afectad a, principalmente en la parte del duodeno y un poco en yeyuno.  \nEn los an\u00e1lisis histopatol\u00f3gicos, las aves del grupo con micotoxinas presentaron lesiones en lengua, laringe, \nproventr\u00edculo, molleja, h\u00edgado y ri\u00f1\u00f3n.  A continuaci\u00f3n se detallan los resultados:  \nEn el grupo control negativo, no  se observaron lesiones por micotoxinas.  Las aves del gr upo control positivo , \npresentaron en la lengua: estomatitis y glositis erosiva y necr\u00f3tica con presencia de bacterias intralesionales  y en \nlaringes: Laringitis linfocitica moderada a grave difusa.  En el proventr\u00edculo  se observo una  moderada hiperplasia del \ntejido linfoide asociado.  En la molleja se presento una ventriculitis ulcerativa moderada multifocal y  erosiones \ndiscretas, multifocales.  \nEl d iagn\u00f3stico morfol\u00f3gico del h\u00edgado fue una c olangiohepatitis linfocitica moderada, multifocal y una \nesteatosis de leve a moderada difusa.  \nEl ri\u00f1\u00f3n presento una g lomerulopat\u00eda membrana proliferativa moderada difusa con nefritis intersticio \nlinfocitica moderada m\u00faltifocal.  \nEn el gr upo de desa f\u00edo, 6 aves presentaron e stomatitis y glositis erosiva y necr\u00f3tica con presenc ia de bacterias \nintralesionales, adem\u00e1s de laringitis linfocitica moderada a grave difusa.  Solo un ave presento en la zona glandular \ndel proventr\u00edculo acumulo linfoide  asociado.  En el h\u00edgado de 2 aves, se diagnostico colangiohepatitis linfocitica \nmoderada, multifocal y en 5 aves esteatosis leve difusa.  \nLa m olleja  de 4 aves present\u00f3 p\u00e9rdida de soluci\u00f3n de continuidad \u00falcera entremezcladas con abundantes \ncolonias bacterianas y moderado infiltrado heterofilico (Ventriculitis ulcerativa moderada multifocal y erosiones \ndiscretas, multifocales ). \n \nDISCUSI\u00d3N  \n \nLas adsorbentes de micotoxinas deben ser evaluadas \u201cin vivo\u201d para demostrar que son efectivos. Adem\u00e1s de \nprotege r los \u00f3rganos blanco y sistemas de los animales (reducci\u00f3n del rendimiento productivo y de la respuesta \ninmune).  Es muy importante calcular el costo -beneficio que implica la utilizaci\u00f3n de estos productos en la \nelaboraci\u00f3n de alimentos balanceados.  \n \nCONCLUS IONES  \n \nEl adsorbente utilizado a raz\u00f3n de 2 kg/t de alimento para este experimento presento un efecto protector en los \npar\u00e1metros evaluados.  \n \n \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n REFERENCIAS  \n \n1. Corrier DE et al.1987.Vet. Immunol Immunopathol. 1987; 14:11- 21. \n2. Council for Agricultural Science and Technology. 2003. Ames, Iowa, USA. No. 139.  \n3. Grove JF. 1988. Natural Products Reports. 5:187- 209.  \n4. Morehouse LG.1985. Mycotoxins of veterinary importance in the United States. 383- 410.  63rd WPDC/XXXIX ANECA  HOW EFFECTIVE ARE CURRENT COCCIDIOSIS CONTROL \nPROGRAMS?  \n \n\u00bfQU\u00c9 TAN EFECTIVOS SON LOS PROGRAMAS ACTUALES PARA EL \nCONTROL DE LA COCCIDIOSIS?  \n \nS. Fitz-Coy \n \nMerck  Animal Health  \nSalisbury, MD 21801  \n \nRESUMEN  \n \nDespu\u00e9s de 60 a\u00f1os o m\u00e1s, l a industria de la avicultura sigue batallando contra la coccidiosis. La ubicuidad de \nestos par\u00e1sitos se debe a su fecundidad y a la pared de los oocistos. De igual manera, el confinamiento, la \nreutilizaci\u00f3n de la cama, las densidades y los programas profil \u00e1cticos ayudan a su ubicuidad. Antes del uso de las \nsulfas en la d\u00e9cada de los 40s, los avicultores utilizaban remedios caseros para disminuir la severidad de la \ncoccidiosis. Despu\u00e9s de las sulfas, los anticocc\u00eddicos qu\u00edmicos fueron la opci\u00f3n. Eran menos costosos y ten\u00edan \nmenos efectos colaterales; sin embargo, la resistencia se convirti\u00f3 en una norma. Para la d\u00e9cada de los 70s, se \ndescubrieron los ion\u00f3foros, los cuales permitieron a la industria desarrollar programas profil\u00e1cticos efectivos. Durante los 60 s y los 70s, la eficacia entre dos clases de anticocc\u00eddicos era similar (aproximadamente del 80%). De \nlos 90s al 2000s  ocurri\u00f3 una disminuci\u00f3n m\u00e1s marcada en la eficacia de los ion\u00f3foros en comparaci\u00f3n con los \nanticocc\u00eddicos qu\u00edmicos. Para el 2006, la eficacia de los anticocc\u00eddicos parec\u00eda haberse estabilizado.; sin embargo, los ion\u00f3foros siguieron teniendo una eficacia menor que los anticocc\u00eddicos qu\u00edmicos.  \n \nSUMMARY  \n \nAfter 60 or more years the poultry industry is still battling coccidiosis. The ubiquity of these parasites is due to \nfecundity and oocysts wall. Also, confined brooding, re -used litter, densities and prophylactic programs aid in the \nubiquity. Prior t o the use of sulfas in the 1940 s, poultry keepers used home remedies to alleviate coccidiosis \nseverity. Following the sulfas, chemical anticoccidials became the choice. They were less costly with fewer side effects; however, resistance became the norm. By the 1970s, ionophores were discovered; these enabled the industry to develop effective prophyl actic programs. During the 1960- 70s the efficacy between the two classes of \nanticoccidials were similar  (approximately 80%). From 1990s to 2000, there was a more noticeable decline in the \nefficacy of ionophores, compared to the chemical anticoccidials. By 2006, the efficacy of the anticoccidials appeared to have stabilized; however, ionophores remained at a lower efficacy than chemical anticoccidials.  \n \nABSTRACT  \n \nMany improvements  have occurred in  the commercial poultry industry; re-using litter for several flocks of \nchickens, managing feed intake , light intensity and duration during  each grow -out. Some other changes are bird \ngenetics, age at which the birds are market ed and densit ies at which the birds are grown . Also b etter environmental \nconditions inside the houses due to evaporative cooling  and air quality are other major improvements in the \ncommercial industry . Other changes are the removal of roxarsone  (3-Nitro\n\u00ae) from commercial poultry diets , \nexten ded uses of the anticoc cidials , long withdrawal periods  and short lay- out periods between flocks .  \nFor more than 50 years, t he control of c occidiosis has mainly been with the use of in- feed anticoccidials  and \nwith some use of live coccidia vaccines . Shuttle programs and product r otation are quite common and considered \ngood management  practices . But over us e of an  anticoccidial drug in the presence of a moderate coccidia challenge \nmay lead to the development of drug tolerant or even drug resistant strains of coccidia.   \nVaccinating chickens with drug sensitive strains of coccidia has shown great promise; this practice enables the \naddition of drug sensitive strains of coccidia to the population within the house environ;  Mathis et al and Peek and \nLandman,  demonstrated that there are benefits for using Coccivac -B\u00ae or Paracox\u00ae in a rotational program with \nanticoccidials  (2,3) . The data showed sensitivity was restored to Clinacox\u2122 (diclazuril)  or diclazuril and monensin . \nRecently, some commercial poultry companies have used an anticoccidial (ionophore or chemical) following the 63rd WPDC/XXXIX ANECA  administration of a live coccidia vaccine but the drug was not fed until 13 \u2013  21 d or 24 \u2013  28 d of age . The verdict on \nthis practice is not yet out.     \nThe r eview of data from 1960s to 2013 ha s indicated we might not have been good stewards of  managing and \nmaintaining the efficacy of available anticoccidials . For example , the three most commonly used anticoccidials  \n(nicarbazin, salinomycin and monensin)  the drug efficacy at launch was 85 -90%. But after many years of use , the \naverage efficacy against field isolates for monensin and salinomycin is approximately 44% and nicarbazin is 74%. \nThe degradation in efficacy for the two ionophores and nicarbazin is approximately 5 1% and 1 8%, respectively. \nData from anticoccidial sensitivity tests  (AST) for 11 field isolates of E. maxima  from several broiler production \nareas in the US to salinomycin shown considerable variability in susceptibility ; 45% of the isolates resistant,  36% \npartial resistan t and 19% demonstrated some susceptib ility. With no knowledge of new approvals for anticoccidials, \npreserving efficacy of the current drugs should be paramount.  \nBirds immunized with a live coccidia vaccine and grown in commercial houses  on re -used litter were \nchalle nged at 30 d  of age with an isolate compiled from 12 company contract farms. R esults  showed variability in \nthe levels of immunity  to cecal and intestinal species 5% and 38%, respectively.  \nTo maintain the efficacy of the anticoccidial drugs, a more judicio us use of these products is required. This \nshould include using vaccines  and anticoccidials and regular monitoring with ASTs and or necropsy sessions .  \n \nREFERENCES  \n \n1. Personal data.   \n2. Mathis G. and C. Broussard, 2003 XIII Congress of the World Veterinary Poultry Assn.  \n3. Peek , H. W and W. J. Landman, 2006. Avian Dis. 434 -439. Higher incidence of Eimeria spp. field isolates \nsensitive for diclazuril and monensin associated with the use of live coccidiosis vaccination with P aracox -5\u00ae in \nbroiler farms.  \n 63rd WPDC/XXXIX ANECA  DIATOMS AS A NOVEL ADJUVANT FOR VACCINES APPLIED \nVIA THE IN OVO  ROUTE IN POULTRY  \n \nLAS DIATOMEAS COMO UN ADYUVANTE NOVEDOSO PARA VACUNAS \nAPLICADAS A TRAV\u00c9S DE LA RUTA IN OVO  EN AVES  \n \n \nR.A. GallardoA, L. CorbeilA, M. HildebrandB, and M. PiteskyC \n \nADepartment of Population Health and Reproduction, School of Veterinary Medicine, University of California, 1089 \nVeterinary Med icine Dr. VM3B, Davis CA, 95616  \nBMarine Biology Research Division, Scripps Institution of Oceanography, University of California, S an Diego, 9500 \nGilman Dr., La Jolla, CA, 92093  \nCUniversity of California Cooperative Extension, 1089 Veterinary M edicine Dr. VM3B, Davis, CA, 95616  \n \nRESUMEN  \n \nLa inmunizaci\u00f3n in ovo de pollos es una de las tecnolog\u00edas m\u00e1s revolucionarias y que ahorran m\u00e1s trabajo en la \nindustria av\u00edcola moderna. Poco se sabe acerca de los sitios de entrada de ant\u00edgenos en el embri\u00f3n despu\u00e9s de la \ninyecci\u00f3n in - ovo. Sin embargo, la importancia del uso de adyuvantes est\u00e1 bien establecida espec\u00edficamente para las \nvacunas inactivadas y recombinantes. Los adyuvantes se han utilizado en la vacunaci\u00f3n para mejorar la \ninmunogenicidad de la vacuna. Una alternativa innovadora puede ser el uso de las diatomeas, que son microalgas de \nuna sola c\u00e9lula eucariota omnipresente en los h\u00e1bitats acu\u00e1ticos. Se espera que Frustule, la pared celular de s\u00edlice de las diatomeas, proporcione capacidades adyuvantes. La caracter\u00edstica m\u00e1s interesante es que las diatomeas pueden \nproporcionar una plataforma para la expresi\u00f3n de prote\u00ednas inmunog\u00e9nicas y de ese modo actuar como un vector de \nexpresi\u00f3n que proporciona un enfoque de una vacuna novedosa. La diatomea Thalassiosira  pseudonana se pondr\u00e1 a \nprueba para la toxicidad en los hue vos y tambi\u00e9n como un nuevo adyuvante para un ant\u00edgeno viral com\u00fan en las \naves. Los resultados ser\u00e1n discutidos.  \n \nSUMMARY  \n \nThe in ovo immunization of chickens is one of the most revolutionary and labor  saving technologies in modern \npoultry production.  The importance of using adjuvant s is well established specifically for killed and recombinant \nvaccines. Adjuvants have been used in vaccination to improve the vaccine immunogenicity. An innovative alternative may be the use of diatoms, which are single cell  eukaryotic microalgae which are ubiquitous in aquatic \nhabitats. Frustule, the silica cell wall of the diatoms, is expected to provide adjuvant capabilities. The most \nfascinating characteristic is that diatoms may provide an expression platform for immunog enic proteins and in that \nway act as an expression vector providing a novel vaccine approach. The diatom Thalassiosira pseudonana was \ntested for toxicity in embryonated eggs . In a first experiment, five  groups of chickens were created. Three groups  \nreceived 20, 100, or 500ug of diatoms  respectively . One group received Freund\u2019s incomplete adjuvant and the last \ngroup PBS. Results showed that  hatchability, mortality , chick quality , average weights, and uniformities  were not \naffected in the diatom -inoculated groups , strongly suggesting that diatoms do not induce any detrimental or toxic \neffect s. In a second experiment humoral i mmune responses against inactivated Newcastle disease virus (NDV)  will \nbe measured in presence or absence of common adjuvants ( mineral oil or aluminum hydroxide) and diatoms .   \n \nINTRODUCTION  \n \nIn ovo immunization  is one of the most revolutionary technologies performed during the chick\u2019s embryonic \nstage. The procedure consists of  the injection of the appropriate vaccine through the eggshell at 18 d of \nembryonation during the egg transfer to the hatching trays. Almost 200 million  eggs are vaccinated using the in ovo \nroute  in the U.S . annually.  Some in ovo machines inoculate up to 30,000 eggs per hour and also perform the egg \ntransfer, eliminating the need of post hatch vaccination (3, 4). Immune responses can be induced in e mbryos starting  \nat 12 to 14 d of incubation; soon after the emergence of T and B cell progenitors (2,5, 9). Widely known is the ability \nof the in ovo technique to induce immune responses  in embryos inoculated at 18 d of age. Adjuvants have been used 63rd WPDC/XXXIX ANECA  in vaccination to improve the immunogenicity of vaccines especially in killed products. Many of the recombinant \nprotein based vaccines face the problem of being poorly immunogenic creating the need of using adjuvants to boost \nimmune responses (6). So  far tested adjuvants include oil in water emulsions, aluminum hydroxide gel, or aluminum \nphosphate, lipid formulations, and cytokine based adjuvants like type one interferon with aluminum being the most widely used (7).  \nDiatoms are single cell eukaryotic microalg ae present nearly in all water habitats (1). They are very attractive \nas vaccine candidates because they replicate in natural or ar tificial seawater at generally ambient temperature with \nsunlight and minimal nutrients, making inexpensive production feasible. They can also be lyophilized for long- term \nstorage and can be sonicated to produce fine particles and nanoparticles. Frustules, the silica cell wall of the diatoms, \nhave been used for several applications in nanotechnology including drug delivery systems (10) . The diatom silica \nhas been proposed as a substitute for drug delivery vehicles, due to their structural, mechanical, chemical, and \noptical features (10) . These silica shells have a large surface area, nanoscale porosity, and they show biodegradable \ncapabilities. Diato ms could  provide an expression platform and because their cell walls are made of nanostructured \nsilica, they can also act  as an adjuvant (8) New adjuvants are needed in a food animal  production in part because of \nthe shift to less immunogenic recombinant vaccines as opposed to live attenuated vaccines with greater \nimmunogenic potential.  Based on the previously presented information , we tested the d iatom Thalassiosira \npseudonana for toxicity in 18 d embryonated eggs at different concentrations when inoculated  via the in ovo route \nmimicking commercial  procedures.  \n \nMATERIALS AND METHODS  \n \nFive groups of 30 eggs were inoculated with different experimental solutions. Group 1, 2, and 3 were \ninoculated with 500, 100, and 20ug of diatoms in a 200uL  inoculum  respectively . Group 4 was inoculated with \n200uL  of in complete Freund\u2019s adjuvant and Group 5 was inoculated with 200uL  of PBS. Egg weight was me asured \nand averaged in each group . Mortality after inoculation was also recorded. Hatchability  and quality of the chickens \nwas recorded. The quality assessment was developed based on the umbilical cord evaluation. Any crust residue  \nencountered in the umbilical scar was counted and the percentage of chickens with crust y umbilicus  was scored. \nChicken weight and uniformity was calculate d at 1, 3, 5, 7, 11, and 14 d of age.   \n \nRESULTS AND DISCUSSION \n \nEgg weight before inoculation demonstrated similarity in their values . Specifically  averages ranged from \n57.7grs in Group 3 to 58.6grs in G roup 1. No embryo mor tality was noticed after the in ovo inoculation at 18  d of \nembryonation , confirming that the procedure was adequately performed. No major differences in hatchability were \ndetected in the different chicken groups  (Table 1) , even though the hatching on G roup 4 was late compared with the \nother experimental groups. The lowes t hatchability was detected in G roup 2 (100ug of diatoms) and the highest in \nGroup 5 (P BS inoculated). One chick died in Group 4 four d  post hatch.  \nChick quality was measured as explained above. H ighest levels of um bilical scars were detected in G roups 1, \n3, and 4 with 34,4%. Group 2 showed the lowest level with 17,9%  (Table 1) . Low er body weights can be seen in \nGroup 4 during the first 11 days of age, being sta tistically significant until d five  (Table 2) . This demonstrates a \ndetrimental effect of the oil Freund\u2019s adjuvant over the chicken \u2019s first week  of development. This detrimental effec t \nis not seen in any of the groups inoculated with diatoms. Uniformity in the different chicken groups showed  \nstatistically lower levels in Group 4 compared with G roups 1, 2, and 5  (Table 2) . \n \nCONCLUSION  \n \nIn conclusion,  no toxic or detrimental effect s were  identified  in the group o f chickens inoculated at 18 d  of \nembryonation with different concentrations of diatoms.  \nConsidering these results , our next step will be to measure humoral immune responses against inactivated \nNDV adjuvanted with diatoms and compare them with the effect of common adjuvants such as mineral oil and \naluminum hydroxide.    \n   \n \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Dolatabadi, J.E.N., and M. de la Guardia. Applications of Diatoms and Silica Nanotechnology in \nBiosensing, Drug and Gene Delivery, and Formation of Complex Metal Nanostructures. T. Anal. Chem. 30:1538 -\n1548. 2011.  \n2. Dunon, D., J. Salomonsen, K. Skj\u00f8dt, J. Kaufman, and  B. Imhof. Ontogenic Appearance of MHC Class I \n(BF) Antigens During Chicken Embryogenesis. Clin. Develop. Immunol. 1:127 -135. 1990.  \n3. Gildersleeve, R. In ovo Technology Update. Zootec. Int. 73 -77. 1993.  \n4. Gildersleeve, R., C. Hoyle, A. Miles, D. Murray, C. Ricks, M. Secrest, C. Williams, and C. Womack. \nDevelopmental Performance of an Egg Injection Machine for Administration of Marek's Disease Vaccine. J. Appl. \nPoultry Res. 2:337- 346. 1993.  \n5. Houssaint, E., A. Mansikka, and O. Vainio. Early Separation of B and T Lymphocyte Precursors in Chick \nEmbryo. J. Exp. Med. 174:397- 406. 1991.  \n6. Josefsberg, J.O., and B. Buckland. Vaccine Process Technology. Biotech. Bioeng. 109:1443 -1460. 2012.  \n7. Li, S., E. Locke, J. Bruder, D. Clarke, D.L. Doolan, M.J. Havenga, A.V . Hill, P. Liljestrom, T.P. Monath, \nand H.Y. Naim. Viral Vectors for Malaria Vaccine Development. Vaccine 25:2567 -2574. 2007.  \n8. Lincopan, N., M.R. Santana, E. Faquim -Mauro, M.H. da Costa, and A.M. Carmona- Ribeiro. Silica -Based \nCationic Bilayers as Immunoadjuvants. BMC Biotech. 9:5. 2009.  \n9. Reynaud, C., B. Imhof, V. Anquez, and J. Weill. Emergence of Committed B Lymphoid Progenitors in the \nDeveloping Chicken Embryo. EMBO J. 11:4349- 4358. 1992.  \n10. Wang, Y., J. Cai, Y. Jiang, X. Jiang, and D. Zhang. Preparation of Biosilica Structures from Frustules of \nDiatoms and their Applications: Current State and Perspectives. Appl. Microbiol. Biotech. 97:453 -460. 2013.  \n (A full version of this article will be published in Avian Diseases .) \n \nTable 1.  Hatchability and quality in the different experimental chicken groups . \n \nGroup  Hatchability (%)  Quality (umbilical scar \nincidence %)  \n1 (500ug diatoms)  96.6 34.4 \n2 (100ug diatoms)  93.3 17.9 \n3 (20ug diatoms)  96.6 34.4 \n4 (Freund\u2019s incomplete)  96.6 34.4 \n5 (PBS)  100 20 \n \n \nTable 2.  Average body weights (gr)/uniformity (%) in the different experimental chicken groups at different times . \n \n Day 1  Day 3  Day 5  Day 7  Day 9  Day 11  Day 14  \nGroup 1  43.5/100  46.8/96.6  58.9/89.7  75.2/89.7  90.4/75.9  109.9/75.9  135.8/65.5  \nGroup 2  43.7/100  47.3/96  59.9/85.7  74.5/82.1  88.7/75  107.7/75  130.2/67.9  \nGroup 3  42.9/100  47.3/93.1  59.3/79.3  73.2/82.8  88.1/65.6  105/65.5  130.5/62.1  \nGroup 4  41.9/88.9  46.7/75  56.6/64.3  71.6/60.7  87.1/67.9  104/64.3  131.2/64.3  \nGroup 5  43.4/100  47.3/96.7  59.5/90  74.8/86.7  87.8/83.3  111.1/83.3  139.8/80  \n \n 63rd WPDC/XXXIX ANECA  CHANGES IN MANAGEMENT PRACTICES RELEVANT TO \nSALMONELLA  ENTERITIDIS ON U.S. TABLE EGG LAYER FARMS  \n \nL. Garber  \n \nUSDA Animal and Plant Health Inspection Service, Veterinary Services, Centers for Epidemiology and Animal \nHealth, 2150 Centre Ave, Bldg. B, Fort Collins CO 80526  \n \nINTRODUCTION  \n \nSalmonella Enteritidis (SE) is a food -borne pathogen frequently attributed to consumption of improperly \nprepared and/or undercooked eggs.  In 2010, the Food and Drug Administration (FDA) implemented an egg rule to \ncontrol SE on farms producing eggs for the table egg market  (1). The FDA food safety requirements became \neffective on July 9, 2010, through a rule for egg producers having 50,000 or more laying hens. The rule also \nrequired egg producers with fewer than 50,000 but at least 3,000 laying hens to comply with the regulation by July \n9, 2012.  Producers are required to have a SE prevention plan that addresses SE -monitored pullets, biosecurity, \nrodent/pest control, poultry house cleaning and disinfection, and egg refrigeration.  Eggs must be held and \ntransported at or below 45\u00baF beginning 36 h  after time of lay. Testing requirements include testing of the pullet \nenvironment for SE when pullets are  14 to 16 wk  of age . If this environmental test is negative, no additional testing \nof the environment is required until  40 to 45 wk of age.  Testing of the layer house environment is required at 40 to \n45 wk of age and four to six wk  after each molt.  If a positive environmental test occurs, producers must either divert \neggs fo r breaking (or other treatment that achieves at least a 5 -log destruction of SE)  for the life of t he flock or begin \negg testing; four  consecutive negative tests (consisting of 1000 eggs  each) at two wk intervals are required to \ncontinue  producing eggs for the table egg market. Producers who only produce eggs for breaking need only comply \nwith the refrigeration requirements.  Producers who sell all their eggs directly to consumers or have less than 3,000 \nhens are not covered by the rule.  \nThe FDA used information from a 1999 National Animal Health Monitoring System (NAHMS) Layer study in \ntheir assessment of the need for and economic impact of the egg rule.  As practices have changed substantially since \n1999, it was determined that updated  information on practices would be useful to both the industry and government \nagencies.  Therefore,  NAHMS conducted a study in summer 2013 to estimate the prevalence and evaluate risk \nfactors for SE on commercial layer farms, as well as to assess changes in  management practices since 1999 relevant \nto SE control and prevention.   \n \nMATERIALS AND METHODS  \n \n1999 study.  The study design for the NAHMS Layers \u201999 study has been described previously ( 2). Briefly, the \nNational Agricultural Statistics Service (NASS) maintained a list of operations with 30,000 or more laying hens as a \nbasis for estimating monthly egg production.  An operation may have had one farm or multiple farms.  All operations \non the NASS  list in 15 states  (AL,AR,CA,FL,GA,IN,IA,MN,MO,NE,NC,OH,PA,TX,WA ) were eligible to \nparticipate in the study.  All farms were selected for operations having 10 or fewer farms.  If an operation had more \nthan 10 farms, a random sample of farms was selected.  A questionnaire was adm inistered that addressed \nmanagement practices.  Severity of rodent problem on each participating farm was assessed by data collector \nobservation.  Data were weighted to reflect the population of operations with 30,000 or more laying hens in the 15 \nstates.  \nAdditionally, swabs from manure, egg belts, elevators, and walkways  were collected from poultry houses and \nsubmitted to the Agricultural Research Services (ARS) laboratory in Athens, GA for culture.   \n2013 study.  A sample of farms having 3,000 or more laying hens was selected from the FDA list of registered \npremises in 19 states  (AL,AR,CA,FL,GA,IL,IN,IA,MI,MN,MO,NE,NC,OH,PA,TX,WA,WI,New England ). A \nquestionnaire was administered that addressed management practices relevant to SE, such as biosecurity, rodent \ncontrol, molting and vaccination.  No biologic samples were collected.  Producers were asked about  testing for SE in \nthe layer house environment between June 1 , 2012 and May 31, 2013.  Testing may have been by culture, PCR, or \nother rapid tests.  Questions regarding pullet rearing, SE testing and vaccinating were primarily answered by a \ncompany representative while questions relating to day -to-day layer management were primarily answered by farm \npersonnel . Data were weighted to reflect the populati on of farms  with 3,000 or more laying hens in the 19 states. 63rd WPDC/XXXIX ANECA  Only farms with 30,000 or more laying hens were included  in the analysis for comparison to the 1999 study.  Table 1 \nsummarizes the differences in study design for the two  studies.  \n \nRESULTS  \n \nIn the  1999 study, 7.1%  of layer houses were environmentally positive for SE via culture.  In the 2013 study , \n1.0% of flocks tested between June 1, 2012 and May 31, 2013 tested positive for SE.  No flocks from farms with \n<30,000 layers tested positive  and 1.2%  of flocks from larger farms were positive.   \nVaccination of pullets against Salmonella  was rarely performed in 1999 ( 5.4% of farms) whereas nearly all \nfarms did so in 2013 ( 98.7%).  The most common protocol was to give pullets a series of  two live vaccines via spray \nfollowed by a bacterin injection, although many other protocols were used.  For approximately half of the farms, the \nfirst vaccine was administered in the hatchery. In 2013, a n increased percentage of farms monitored SE in pullets, \nroutinely tested for SE in the layer house, and participated in a SE QA program compared to 1999.  \nA higher percentage of farms fed pullets pre/probiotics in 2013 compared to 1999, while a lower percentage of \nfarms gathered eggs by hand  or molted their flo cks. For farms that did molt  in 2013, the most common procedure \nwas to feed an alternative diet rather than to restrict or withhold feed.  There was a significant increase in cage -free \nhousing; 18.7%  of farms had at least one cage-free house in 2013 (11.8% of houses) compared to 0.8% of farm s \n(0.6% of houses) in 1999.  \nMore farms processed eggs on farm  in 2013 compared to 1999, and nearly all stored eggs at <50\u00ba F. Egg racks \nwere more commonly cleaned and/or disinfected before reusing in 2013 compared to 1999.  Producers reported less \nsevere problems with rodents  in 2013 compared to 1999; t raps and sticky tape were a more common rodent control \nmethod and cats were less common.  A higher percentage of producers required employees to use footbaths and \nrequired visitors to park in a restricted area away from the poultry houses  in 2013.  Cleaning and disinfecting \nprocedures for feeders, hoppers, water tanks, and houses were similar in both years. Although we attempted to keep \ndifferenc es in study design between the 2 studies to a minimum, there were some differences which may have had \nan effect on the estimates.  \n \nREFERENCES  \n \n1. Code of Federal Regulations, Title 21, Volume 2, Part 118 Production, storage, and transportation of shell \neggs.  \n2. Garber, L., M. Smeltzer, P. Fedorka- Cray, S. Ladely, and K. Ferris.  Salmonella enterica Serotype \nenteritidis in table egg layer house environments and in mice in U.S. layer houses and associated risk factors.  Avian \nDis. 47:134- 142. 2003.  \n \nTable 1.  Comparis on of 1999 and 2013 NAHMS layer farm studies . \n \n 1999 study  2013 study  \nList frame  NASS  FDA  \nInference population  Operations with 30,000 or more \nlaying hens in 15 states  Farms with 3,000 or more laying hens in 19 \nstates (subset of farms with 30,000 or more \nlaying hens for comparison to 1999 study)  \nTesting  Swabs of layer house environment \ncollected one time by data \ncollector for culture  Producer reported test results for a 1 year \nperiod.  Tests included culture, PCR, and \nother rapid tests  \nRodent assessment  One time d ata collector \nobservation  Producer reported  typical level of problem \nfor a 1 year period  \n 63rd WPDC/XXXIX ANECA  SEROVAR B -  AVIBACTERIUM PARAGALLINARUM ,  \nTHE TRUE PATHOGEN  \n \nSEROVAR B \u2013 AVIBACTERIUM PARAGALLINARUM,  \nEL VERDADERO PAT\u00d3GENO  \n \nA. Garc\u00eda and  D. Fuentes  \n \nLaboratorios Avilab. Porcicultores 80 Tepatitl\u00e1n Jal. Mex. C.P.47693  \npuma_doc@hotmail.com  \n \nRESUMEN  \n \nCoriza i nfecciosa es enfermedad contagiosa que afecta principalmente el aparato respiratorio. El mayor \nimpacto se presenta en parvadas multiedades.  La repercusi\u00f3n econ\u00f3mica en las parvadas, tiende a ser debido al \nincremento en deshechos y a la reducci\u00f3n d e la producci\u00f3n de huevo (10% -  40%).  \nAves de postura comercial de diferentes edades, que hab\u00edan  recibido dos inmunizaciones a c oriza infecciosa, \nfueron afectadas al mismo tiempo con Avibacterium paragallinarum   serogrupos B y C de Page. La producci\u00f3n de \nhuevo disminuyo en un 20% y la mortalidad se elev \u00f3 al doble.  \nAves inmunizadas en laboratorio con diferentes  productores de bacterina de coriza, y desafiadas con \nserogrupo B, fueron afectadas  en diferentes grados de lesi\u00f3n, demostrando no protecci\u00f3n, as\u00ed como no  reactividad \ncruzada entre miembros del mismo serogrupo y que este es  m\u00e1s pat\u00f3geno que los otros serogrupos.  \n \nSUMMARY  \n \nInfectious c oryza is an upper respiratory tract disease in  chickens that can appear in all ages with the major \nimpa ct occurring in multiage flocks.  The economic loss  is due  to the increase in culling and  a drop in egg production \nfrom 75% to 15.7%.  \nLayer birds  of different ages, which have received two doses of c oryza bacterin, were affected at the same time \nwith Page \u2019s serovars  B and C of Avibacterium  paragallinarum . The egg production dropped 20% and the mortality \nincreased two fold.  \nAn experimental vaccine was produced with the autogenous  serovar B. B irds with this vaccine were protected  \nafter challenge ; the birds with the commercial bacterin  (it has two different strain of serovar B) , showed the typical \nsigns of c oryza.  It shows that among the members of this s erovar there is  no cross reactivity and this s erovar is mor e \naggressive than Page\u2019s other s erovars. \nOne of the best ways  to control c oryza  is through the use of  autogenous vaccine . \n \n(Manuscript will be submitted to Avian Pathology .)  \n 63rd WPDC/XXXIX ANECA  GENOMA COMPLETO DE LA CEPA CHIMALHUACAN DEL \nVIRUS DE LA ENFERMEDAD DE NEWCASTLE  \n \nCOMPLETE GENOME OF THE CHIMALHUACAN STRAIN OF THE \nNEWCASTLE DISEASE VIRUS  \n \nL. Garc\u00eda- BarreraA, D. Cort\u00e9s -EspinosaA, A. ToscanoB, E. Lucio -DecaniniB y A. Absal\u00f3nA \n \nAInstituto  Polit\u00e9cnico Nacional. CIBA Tlaxcala. Carr. Est. Santa Ines -Tecuexco mac Km 1.5, Tepetitla, Tlaxcala,  \nM\u00e9xico. Tel. +52 (55) 5729 6000 Ext. 87813. aabsalon@ipn.mx \nBInvestigaci \u00f3n Aplicada S.A. de C.V. M\u00e9xico  \n \nSUMMARY  \n \nNewcastle disease virus continues to be one of the greatest economic losses for Mexican poultry. Last century \nin the early 1970s, an outbreak of this highly virulent virus hit the U.S. and Mexico and other Latin American \ncountries. In one of these outbreaks, a Newcastle disease virus with clearly velogenic pathogenic characteristics was \nisolated. One of these clones that remained frozen since 1992 was completely sequenced and its genetic \ncharacteristics are presented in this paper. The virus belongs to geno type V that is prevalent in Mexico, which is \nvery similar to the  strain Largo/71 isolated in the USA  also in the early 1970s. Phylogenetic analysis suggests that \nthe viruses currently circulating are descended from the Chimalhuacan strain.  \n \nRESUMEN  \n \nEl vir us de la enfermedad de Newcastle contin\u00faa  siendo uno de que mayores p\u00e9rdidas econ\u00f3micas representan \npara la avicultura Mexica. A p rincipio de la d\u00e9cada de los 1970s del si glo pasado, se present\u00f3 un brote de  este virus \nde alta virulencia que afect\u00f3 a M\u00e9xico y USA , adem\u00e1s de otros pa\u00edses de Latinoam\u00e9rica. De uno de estos brotes se \naisl\u00f3 un virus de la enfermedad de Newcastle con caracter\u00edsticas  claramente velog\u00e9nicas de patogenicidad. Uno de \nestos clones mante nido en congelaci\u00f3n desde 1992 fue secuenciado completamente y sus caracter\u00edsticas gen\u00e9ticas se \npresentan en este trabajo. El virus pertenece al genotipo V que es el predominante en M\u00e9xico, con mucha semejanza \na la cepa Largo/71 asilada en USA tambi\u00e9n a in icios de la d\u00e9cada de los 1970s. El an\u00e1lisis filogen\u00e9tico sugiere que \nlos virus que circulan actualmente descienden de la cepa Chimalhuacan.  \n \nINTRODUCCI\u00d3N  \n \nLa enfermedad de Newcastle es una de las causas m\u00e1s importantes de p\u00e9rdidas econ\u00f3micas en la industr ia \nav\u00edcola. La enfermedad es causada por un Paramyxovirus aviar tipo 1 (APMV -1) perteneciente al g\u00e9nero Avulavirus  \ntambi\u00e9n llamado virus de la enfermedad de Newcastle (NDV).  \nEn M\u00e9xico el primer brote de alta patogenicidad del NDV en aves dom\u00e9sticas  se present\u00f3 en la d\u00e9cada de los \n1950s, a inicios de la industrializaci\u00f3n de la avicultura en Am\u00e9rica. Este primer brote de alta patogenicidad fue \nreportado como cepa Quer\u00e9taro/50, que de acuerdo a las recientes clasificaciones pertenec\u00eda al genotipo II. Fue en \nesa \u00e9poca se inici\u00f3 con la vacunaci\u00f3n para la prevenci\u00f3n de la enfermedad utilizando la cepa Lasota. El segundo \nbrote de alta virulencia fue a inicios de la d\u00e9cada de los 1970s cuando se presentaron brotes que afectaron a M\u00e9xico \ny a USA.  \nEsta cepa fue car acterizada por su \u00edndice patogenicidad Intracraneal (ICIP) de 1.9. En el 1980 el gobierno \nmexicano a trav\u00e9s de la Secretaria de Agricultura (SAGARPA; www.sagarpa.gob.mx ) la estableci\u00f3 como cepa de \ndesaf\u00edo referencia. Desde entonces, esta cepa ha sido utili zada para la evaluaci\u00f3n de la efectividad de las vacunas \nque se comercializan actualmente en M\u00e9xico. De igual forma, todas las vacunas importadas contra el NDV de \nacuerdo a las leyes mexicanas, deben ser evaluadas para protecci\u00f3n contra un desaf\u00edo de esta cepa.  \nLa cepa \u201cChimalhuacan/73\u201d desde entonces ha sido transferida a varios laboratorios aunque \ndesafortunadamente no se envi\u00f3 a una colecci\u00f3n apropiadamente. Una al\u00edcuota de la cepa fue transferida a \nInvestigaci\u00f3n Aplicada en 1992, en donde fue replicada y mantenida en nitr\u00f3geno l\u00edquido desde entonces. Al primer \npase de esta al\u00edcuota se le denomin\u00f3 \u201cSemilla maestra \u201d y a partir de esta se ha generado \u201cSemilla de trabajo\u201d.  63rd WPDC/XXXIX ANECA  En este reporte, nosotros presentamos la secuencia del genoma completo de la cepa \u201cChi malhuacan\u201d obtenida \na partir de la amplificaci\u00f3n de la \u201cSemilla maestra\u201d. Adicionalmente, se analizan sus principales caracter\u00edsticas \ngen\u00e9ticas y se compara con el genoma de otras cepas velog\u00e9nicas aisladas en Norte Am\u00e9rica.  \n \nRESULTADOS Y DISCUSI\u00d3N \n \nEl ensamble de las secuencias revela que el genoma de la cepa \u201cChimalhuacan\u201d tiene un tama\u00f1o de 15,192 nt. \nDe igual forma que otros virus de la enfermedad de Newcastle contiene 6 genes que codifican a 6 prote\u00ednas: Nucleoprote\u00edna  (NP), Fosfoprotein a (P), Prote\u00edna de Matr\u00edz (M), Prote\u00edna de Fusi\u00f3n (F) Hemag lutinin a-\nNeuraminidasa  (HN), and RNA polimerasa dependiente de RNA  (L) en sentido 3\u2019 -NP-P-M-F-HN-L-5\u2019. \nLa secuencia del extremo 3\u2019 NCR tiene un tama\u00f1o de 112 nt; mientras que la regi\u00f3n 5\u2019 NCR tiene un tama\u00f1o \nde 199 nt. La regi\u00f3n de inicio de la transcripci\u00f3n gen\u00e9tica  Gene start (GS) del gen NP es AATCTAAAA, P, M, F. \nHN y L. Por su parte la regi\u00f3n de final de transcripci\u00f3n o gene end (GE) tiene secuencias: NP -TTGATGTTTTT; P, \nM, F, HN y L.  \nLas regiones interg\u00e9 nicas comprendidas entre la secuencia GE y GS tiene: 2 nt entre NP/P ;1 nt entre P/M; 1 nt \nentre M/F; 31 nt entre F/HN; y 47 nt entre HN/L.  \nEl porcentaje de G+C del genoma viral es del 46.3% y se observa un decremento del gen NP a L.  \nFilogen\u00e9ticamente , la cepa Chimalhuacan est\u00e1 muy relacionada a la cepa Largo/71 aislada en el estado de \nFlorida. Pertenece al genotipo V, caracter\u00edstico de las cepas aisladas en los \u00faltimos 40 a\u00f1os de brotes ocurridos en \ngranjas av\u00edcolas.  \n \nCONCLUSIONES  \n \nEl virus de la enfermedad de Newcastle, cepa Chimalhuacan tiene un genoma de 15,192 nt. La cepa pertenece \nal genotipo V, y tiene un perfil de amino\u00e1cidos en el sitio de la prote\u00edna de Fusi\u00f3n caracter\u00edstico de los virus velog\u00e9nicos. En cuanto a su uso como cepa de desaf\u00edo en pruebas de constataci\u00f3n de vacunas para el control del \nNDV en M\u00e9xico, esta cepa es ideal debido a su perfil de alta virulencia y a que pertenece  al mismo genotipo de las \ncepas de campo que han circulado en M\u00e9xico durante los \u00faltimos 40 a\u00f1os.  63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N DE LA INFECTIVIDAD DE  METAPNEUMOVIRUS \nAVIAR EN DIFERENTES CULTIVOS CELULARES  \n \nEVALUATION OF THE PERMISSIVENESS OF DIFFERENT CELL \nCULTURES TO THE AVIAN METAPNEUMOVIRUS  \n \n \nK. Gavi\u00f1aABD, L. Padilla -NoriegaAB, H. Ram\u00edrez -MendozaC y J.F. Rivera -Ben\u00edtezC \n \nAInstituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico  \nBDepartamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de \nM\u00e9xico  \nCDepartamento de Microbiolog\u00eda e Inmunolog\u00eda, Fa cultad  de Medicina Veterinaria y Zootecnia, Universidad \nNacional Aut\u00f3noma de M\u00e9xico  \nDAutor corresponsal. Direcci\u00f3n de correo: Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria 3000,  Delegaci\u00f3n Coyoac\u00e1n, CP 04510, Distrito \nFederal, M\u00e9xico. Correo electr\u00f3nico: karagavina@gmail.com.  \n \nSUMMARY  \n \nAvian m etapneumovirus (aMPV) is a paramyxovirus affecting mainly the  respiratory tract of birds.  In vitro  \nreplication is commonly done in the Vero line, however, in this study the permissiveness of ten mammal continuous \nlines and of a primary culture of chicken fibrobalst s to a Mexican isolate of aMPV was determined infecting each \nculture and establishing the  viral yield per Colony Forming Units (CFU). Three highly permissive lines were \nidentified to aMPV: A -72, PK -15 and BGM (~106 CFU/mL ), two moderately permissive: RK -13 and MARC -145 \n(103- 104 CFU/mL ) and the lines LLC -MK2, MDBK, MDCK, Hep -2 and the main cult ure of fibroblasts were not \npermissive. The findings in this study are useful to expand the repertoire of cell lines useful for aMPV isolation, \nwhich in turn will allow us to implement diagnosis techniques.  \n \nRESUMEN  \n \nMetapneumovirus aviar (MPVa ) es un pat\u00f3geno que afecta principalmente el tracto respiratorio de las aves. \nEste virus se a\u00edsla com\u00fanmente realizando m\u00faltiples pases en cultivos hom\u00f3logos, para posteriormente adaptarlo a la \nl\u00ednea celular Vero, por lo que, en este estudio se determin\u00f3 la infectividad de un aislado mexicano de MPVa en otras \n8 l\u00edneas continuas de mam\u00edfero y en un cultivo primario de fibroblastos de pollo. Esto se llev\u00f3 a cabo infectando \ncada cultivo para obtener el t\u00edtulo mediante dosis infectantes en cultivo celular al 5 0% (DICC 50). De esta manera, se \nidentificaron 3 l\u00edneas celulares con t\u00edtulos altos (A -72, BGM y PK -15), mientras que las l\u00edneas RK -13 y MARC -145 \npresentaron t\u00edtulos moderados. Los hallazgos de este estudio permitieron explorar nuevas l\u00edneas celulares para \noptimizar el aislamiento de MPVa, lo que a su vez permitir\u00e1 implementar t\u00e9cnicas de diagn\u00f3stico.  \n \nINTRODUCCI\u00d3N  \n \nMPVa es un pat\u00f3geno que ocasiona rinotraque\u00edtis en pollos y pavos (2),  sin embargo, la infecci\u00f3n puede \ndiseminarse al aparato reproductivo ocas ionando una ca\u00edda en la producci\u00f3n de huevo, as\u00ed como disminuci\u00f3n de  la \nfertilidad en gallos. (7,10)  Adem\u00e1s, en presencia de agentes complicantes como Escherichia coli  se puede producir \nel s\u00edndrome de cabeza hinchada. (7)  MPVa es un miembro de la familia Paramixoviridae , subfamilia Pneumovirinae  \ny se clasifica de acuerdo a sus caracter\u00edsticas gen\u00e9ticas y antig\u00e9nicas en cuatro subtipos denominados A, B, C y D . \n(6,9) La replicaci\u00f3n de este virus in vitro  se lleva acabo en dos pasos, primero se propaga en cul tivos primarios \nhom\u00f3logos, cultivos de \u00f3rganos traqueales o en embri\u00f3n de pollo, y posteriormente, se adapta a la l\u00ednea continua \nVero. (3) Por lo tanto, en este estudio se cuantific\u00f3 la infectividad de MPVa en diferentes cultivos celulares, para \nidentifica r a las l\u00edneas \u00fatiles para el diagn\u00f3stico de este virus.  \n \n \n 63rd WPDC/XXXIX ANECA  MATERIALES Y M\u00c9TODOS  \n \nC\u00e9lulas.  Las c\u00e9lulas empleadas fueron Vero (ri\u00f1\u00f3n de mono verde), LLC -MK 2 (ri\u00f1\u00f3n de mono Rhesus), \nMDBK (ri\u00f1\u00f3n de bovino), MDCK (ri\u00f1\u00f3n de perro), A -72 (carcinoma de perro), MARC -145 (ri\u00f1\u00f3n de feto de mono \nRhesus), Hep -2 (carcinoma de laringe de humano), BGM (ri\u00f1\u00f3n de mono verde), RK -13 (ri\u00f1\u00f3n de conejo), PK -15 \n(ri\u00f1\u00f3n de cerdo), as\u00ed como fibroblastos de embriones de pollo libres de pat\u00f3genos espec\u00edficos de 9 d\u00edas. Los cultivos \ncelulares se mantuvieron en Medio Esencial Modificado por Dulbecco (D -MEM) suplementado con 7% de suero \nfetal bovino (SFB) a 37\u00ba C hasta su uso.  \nVirus.  El virus que se emple\u00f3 en este estudio se obtuvo a partir de un aislamiento de campo de MPVa subtipo \nA, el cual fue sometido previamente a seis pases en cultivo primario de tr\u00e1quea y a seis pases en c\u00e9lulas Vero (aMPV/A/chicken/Mx/Jal/2008 ). \nInfectividad de MP Va en diferentes cultivos celulares.  En este ensayo se llev\u00f3 a cabo la titulaci\u00f3n de la \ninfectividad de MPVa, evaluando la capacidad del virus para producir efecto citop\u00e1tico (ECP) en cada uno de los cultivos celulares empleados, mediante dosis infectantes  en cultivo celular al 50% (DICC\n50), para este fin, cada uno \nde los cultivos se sembraron en placas de 96 pozos (1 x 105 c\u00e9lulas/mL ), se dejaron crecer durante 24 horas y \nposteriormente se infectaron con diluciones decuples seriadas de MPVa, el periodo de adsorci\u00f3n fue de dos  horas, \ndespu\u00e9s el in\u00f3culo se remplaz\u00f3 por MEM suplementado con 1% de SFB y la placa  se mantuvo en incubaci\u00f3n a 37\u00ba C \ndurante tres d\u00edas, despu\u00e9s de este periodo las c\u00e9lulas se lavaron con PBS tres  veces y fueron te\u00f1idas depositando en \ncada pozo 150\u00b5 L de cristal violeta, una vez transcurridos 15 minutos, se realizaron otros tres  lavados con agua \ndestilada y las placas se dejaron secar a temperatura ambiente, por \u00faltimo, se observ\u00f3 al microscopio la formaci\u00f3n \nde ECP y se obtuvo el t\u00edtulo mediante el m\u00e9todo Reed y Muench. (8)   \n \nRESULTADOS  \n \nEvaluaci\u00f3n del ECP en diferentes cultivos celulares infectados con MPVa.  El ECP m\u00e1s evidente se \npresent\u00f3 en las c\u00e9lulas Vero y consisti\u00f3 en la formaci\u00f3n de sincicios peque\u00f1os observables a partir de 18 horas post -\ninfecci\u00f3n, los cuales se volvieron gigantes (de m\u00e1s de 60 n\u00facleos contados al microscopio) despu\u00e9s de 72 horas \npost-infecci\u00f3n, despu\u00e9s de este periodo, las c\u00e9lulas comenzaron a lisarse. Por su parte, las c\u00e9lulas BGM junto con las \nc\u00e9lulas A -72 mostraron un ECP considerable que consisti\u00f3 en sincicios moderados (de 15 a 50 n\u00facleos). En cambio, \nlas c\u00e9lulas PK -15, MARC -145 y RK -13 mostraron redondeamiento, desprendimiento y aparente muerte celular. Por \n\u00faltimo, hubo cultivos en donde no se observ\u00f3 ning\u00fan ECP, en particular en las c\u00e9lulas LLC -MK 2, MDBK, MDCK, \nHep-2 y en los fibroblastos de embri\u00f3n  de pollo.  \nTitulaci\u00f3n de MPVa mediante DICC 50. En este ensayo los t\u00edtulos m\u00e1s altos se obtuvieron en las c\u00e9lulas \nVero, A- 72, BGM y PK -15 (de 2.5 x 106 a 6.3 x 104 DICC 50/ml) y en las c\u00e9lulas MARC -145 y RK -13 t\u00edtulos entre \n3.6 x 104 y 3.1 x 103 DICC 50/ml, mientras que el resto de los cultivos resultaron negativo s, c\u00f3mo puede observarse \nen el C uadro 1.  \n \nDISCUSI\u00d3N  \n \nPara realizar este estudio se utilizaron a las c\u00e9lulas Vero como la l\u00ednea de referencia, pues es en ellas en donde \nse alcanza el t\u00edtulo m\u00e1s alto, esto puede ser debido a que \u00e9stas c\u00e9lulas presentan dos deficiencias en la respuesta de \ni n t e r f e r \u00f3 n  ( I F N ) ,  y a  q u e  p o r  u n  l a d o  t i e n e n  u n  d a \u00f1 o  g e n \u00e9 t i c o  e n  e l  l o c u s  d e  I F N  \u03b2  ( 5 )  y  p o r  o t r o  l a d o ,  s e  h a  \ndemostrado que las c\u00e9lulas Vero tambi\u00e9n fallan en inducir u n estado antiviral debido a una expresi\u00f3n muy baja del \nfacto r regulador de IFN 3 (IRF3). (1)   \nAdem\u00e1s del empleo de las c\u00e9lulas Vero en el diagn\u00f3stico, a nivel experimental se han estado buscando nuevas \nalternativas para lograr la replicaci\u00f3n eficiente de MPVa con t\u00edtulos altos utilizando nuevas l\u00edneas continuas (4), y en este estudio se identific\u00f3 un alto t\u00edtulo de replicaci\u00f3n en las l\u00edneas continuas A -72, PK -15 y BGM, adem\u00e1s de un \nECP notable que consisti\u00f3 en la formaci\u00f3n de sincicios, aunque de un tama\u00f1o  moderado observables a partir de las \n48 horas, sin embargo, cabe mencionar que el virus stock empleado ten\u00eda seis pases previos en las c\u00e9lulas Vero y s\u00f3lo uno en el resto de las c\u00e9lulas, as\u00ed que el t\u00edtulo probablemente se incrementar\u00eda con pases subsecuen tes, por lo se \npueden considerar a estas l\u00edneas como excelentes candidatas para la obtenci\u00f3n de m\u00e1ximos t\u00edtulos virales. Se \nidentific\u00f3 tambi\u00e9n un t\u00edtulo moderado en las l\u00edneas MARC -145 y RK -13. Aunque estas l\u00edneas celulares no son \nbuenas candidatas para el  aislamiento de MPVa, podr\u00edan ser interesantes para el estudio de restricci\u00f3n de hospedero \na este virus. En estas l\u00edneas se observ\u00f3 en cambio redondeamiento y muerte celular. La aparente muerte celular \npodr\u00eda estar relacionada con la inducci\u00f3n de apoptosis , que a su vez es un factor capaz de restringir la replicaci\u00f3n \nviral. Por lo tanto, este estudio contribuye a optimizar el aislamiento de MPVa en l\u00edneas celulares donde se obtienen 63rd WPDC/XXXIX ANECA  t\u00edtulos altos de ant\u00edgeno de referencia con un evidente ECP e inclusive alg unas de ellas son m\u00e1s f\u00e1ciles de mantener \nin vitro  que las c\u00e9lulas Vero.  \n \nREFERENCIAS  \n \n1. Chew, T., R. Noyce, S.E. Collins, M.H. Hancock, L. Mossman. Characterization of the interferon \nregulatory factor 3 -mediated antiviral response in a cell line deficient f or IFN production. Mol. Immunol. 46.  393\u2013\n399. 2009.  \n2.  Cook, J. A. K. Avian pneumovirus infections in turkeys and chickens. Review. Vet. J. 160:118 \u2013125. \n2000.  \n3. Cook, J.K.A., D. Cavanagh. Review: Detection and differentiation of avian pneumoviruses \n(metapneum oviruses). Avian Pathol. 31: 117 -132. 2002.  \n4. Coswing L.T., M.B. Dos santos, H.M. Hafez, H.L. Ferreira, C.W. Arns. Propagation of avian \nmetapneumovirus subtypes A y B using chicken embryo related and other cell systems. J. Virol. Methods. 167: 1- 4. \n2010.  \n5.  Emeny, J.M., M.J. Morgan. Regulation of interferon system evidence that Vero cells have a genetic \ndefect in interferon production. J. Gen. Virol. 43: 247- 252. 1979.  \n6.  Juhasz, K., A. J..Easton. Extensive sequence variation in the atachment (G) prote\u00edna gene of avian \npneumovirus: evidence for two distinc subgroups. J. Gen. Virol. 75: 2873- 2880. 1994.  \n7.  Gough, R. E. Avian pneumoviruses. In: Diseases of poultry, 11th ed. Y. M. Saif, H. J. Barnes, J. R. \nGlisson, A. M. Fadly, L. R. McDougald, and D. E. Swayne, eds. Iowa State University Press, Ames, IA. pp. 308 \u2013\n317. 2003.  \n8.  Reed, L.J., H. Muench. A simple method of estimating fifty percent endpoints.  The American Journal of \nHygiene. 27 (3): 493 -497. 1938.  \n9.  Velayudhan, BT., B. McComb, R.S. Bennet, V.C. Lopes, D. Shaw , D.A. Halvorson, K.V. Nagaraja. \nEmergence of a virulent type C avian Metapneumovirus in turkeys in Minnesota. Avian Dis. 49: 520 -526. 2005  \n10.  Villareal, L.Y.B., P.E. Brandao, J.L. Chac\u00f3n, M.S. Assayag, P.C. Maiorka, P. Raffi, B.S. Saidenberg, \nR.C. Jones, A. J.P. Ferreira. Orchitis in Roosters with Reduced Fertility Associated with Avian Metapneumovirus \nInfections. Avian Dis. 51: 9000 -9004. 2007.  \n \n   \nCuadro 1 . T\u00edtulos obtenidos despu\u00e9s de infectar cada cultivo celular con MPVa.  \n \nCultivo celular  DICC 50/mL \nVero  2.51 x 106 \nA-72 1.99 x 106 \nBGM  1 x 105 \nPK-15 6.3 x 104 \nMARC -145 3.6 x 104 \nRK-13 3.16 x 103 \nLLC -MK 2 Negativo  \nMDBK  Negativo  \nMDCK  Negativo  \nHEP -2 Negativo  \nFibroblastos  Negativo  \n \n 63rd WPDC/XXXIX ANECA  NATIONAL ANTIMICROBIAL RESISTANCE MONITORING \nSYSTEM (NARMS) ON THE FARM FOR POULTRY-  \nPILOT STUDY RESULTS  \n \nSISTEMA NACIONAL DE VIGILANCIA DE RESISTENCIA A LOS \nANTIBI\u00d3TICOS (NARMS) EN LA GRANJA PARA RESULTADOS DE \nESTUDIOS PILOTO EN AVES  \n \nT. GaydosA, C. HofacreA, R. SingerB, R. Berg hausA, V. BaxterA, and P. McDermot tC \n \nAThe University of Georgia - Department of Popu lation Health. Athens, GA, USA  \nBUniversity of Minnesota - Department of Popula tion Health. St. Paul, MN, USA  \nCUnited States Food and Drug Administration - Center for Veterinary Medicine. Laurel, MD , USA \n \nRESUMEN  \n \nLos genes de resistencia a los antibi\u00f3ticos han estado circulando en las bacterias por m\u00e1s de 30,000 a\u00f1os. Los \nprofesionales m\u00e9dicos han combatido la resistencia a los antibi\u00f3ticos desde que se aisl\u00f3 el primer antibi\u00f3tico y se \nprodujo en masa. En 1996 se i nici\u00f3 NARMS para monitorear la susceptibilidad a los antibi\u00f3ticos en los seres \nhumanos, los mercados al por menor, y los animales productores de alimentos. Desde 1996 hasta el 2011 NARMS \nha recolectado m\u00e1s de 107,000 muestras cl\u00ednicas de los seres humanos,  los animales productores de alimentos y los \nmercados de carne al por menor. Estas muestras proporcionaron informaci\u00f3n valiosa acerca de los patrones de \nresistencia a los antibi\u00f3ticos. En 2011, la FDA y el USDA reconocieron que los aislamientos de Salmonel la a partir \nde muestras de plantas de procesamiento no fueron suficientes para un sistema nacional de monitoreo. Un estudio piloto recogi\u00f3 400 muestras de arrastre en botas dentro de las casetas de pollos de engorda y 100 muestras en casetas de pavos para aislar Salmonella  y Campylobacter  y controlar la resistencia a los antibi\u00f3tico s. De las muestras \nrecogidas, 5  % de Salmonella  y 50% de Campylobacter  fueron susceptibles a los antibi \u00f3ticos y 26% de Salmonella  y \n8% de Campylobacter  fueron resistentes a m\u00e1s d e tres antibi\u00f3ticos.  \n \nSUMMARY  \n \nThe genes for antibiotic resistance have been circulating in bacteria for more than 30,000 years. Medical \nprofessionals have combated antibiotic resistance since the first antibiotic was isolated and mass -produced. In 1996 \nNARMS was started to monitor antibiotic susceptibility in humans, retail markets, and food -producing animals. \nFrom 1996- 2011 NARMS collected more than 107,000 clinical samples from humans, food producing animals, and \nretail meat markets. These samples prov ided valuable information about antibiotic resistance patterns.  \nIn 2011 the FDA and USDA recognized that Salmonella isolates from processing plant samples were not \nsufficient for a national monitoring system. A pilot study collected 400 boot sock samples from broiler houses and \n100 samples from turkey houses to isolate Salmonella and Campylobacter  and monitor antibiotic resistan ce. Of the \nsamples collected, 53 % of Salmonella  and 50% of Campylobacter  were pansucceptible to antibiotics and 26% of \nSalmonella and 8% of Campylobacter  were resistant to more than three antibiotics.  \n \nABSTRACT  \n \nThe N ational Antimicrobial Resistance Monitoring System  is an interagency program that tracks antimicrobial \nresistance  in foodborne bacteria from food animals, retail meats , and human clinical cases .  To evaluate the logistics \nand potential value of a pre- harvest component for poultr y monitoring, we conducted a pilot study collecting \nsamples from poultry houses.  During the course of the pilot study 400 boot sock samples  were collected  from 100 \nbroiler houses and 100 samples from 25 turkey houses .  Standard microbiological procedures were used to isolate \nSalmonella and Campylobacter  and test them for susceptibility to a panel of antimicrobials . Of the samples collected \non poultry farms, Salmonella was isolated from 206 (41%) boot socks and Campylobacter  from 391 (78%) boot \nsocks.  Of the isolates obtained , 58.3% of Salmonella  and 47.6% of Campylobacter  were pansusceptible to \nantimicrobials and 16.0% of Salmonella and 11.3% of Campylobacter  were resistant to three  or more antimicrobials .  63rd WPDC/XXXIX ANECA   \nINTRODUCTION  \n \nWhile the most urgent problems of antimicrobial resistance are associated with hospital pathogens (1) a \ncomprehensive strategy to address resistance is incomplete without examining the potential roles of agricultural \nantibiotic use.  In 1996 NARMS was star ted to monitor antimicrobial susceptibility in humans, retail markets, and \nfood- producing animals. From 1996- 2011 NARMS collected more than 206,000  clinical samples from human cases , \nprocessing plant samples, food producing animals, and retail meat markets  (2). These samples provided valuable \ninformation about  antimicrobial resistance patterns and trends over time.    \nFor animal monitoring, NARMS has historically relied on HACCP samples collected by FSIS.  Most of these \nsamples consist  of product specimens collected at the end of processing, and therefore, are not true animal samples.  \nIn addition, data show s that the microbial status of animals changes upon transport such that testing at slaughter may \nnot be a good indicator of on -farm status  (3).  To exami ne the potential value of a pre- harvest component to \nNARMS, a  pilot study was proposed to determine the prevalence of antimicrobial resistant Salmonella and \nCampylobacter  on the farm in commercial poultry.  \n \nMATERIALS AND METHODS  \n \nNARMS isolate collection .  In this study 100 broiler houses and 25 turkey houses were used.  The farms were \nsampled over six months.  On each visit, samples were collected using four  boot socks per house : two boot  socks , \none on each foot, were used for each half of the house. The samples were taken from the area between the feeder \nand drinker lines .  After sampling , the boot socks  were placed into a Whirlpak\u00ae (Nasco)  bag with 100mL of buffered \npeptone water (BPW) and the air removed from the bag. The samples were transported on ice to the diagnostic lab \nfor isolation.  \nSamples were processed for isolation and identification using standard microbiological techniques  (4,5) .  The \nCampylobacter  enrichment broth was Bolton\u2019s broth and the selective agar was Campy -Cefex  (Remel ).  The \nSalmonella  enrichment was tetrathionate -brilliant green broth and iodine . This was  added to the BPW and the \nselective agar was XLT4 agar  (Remel ).  Isolates were sent to the FDA Center for Veterinary Medicine for \nserotyping and susceptibility testing  (6).  \nAntimicrobial minimal inhibitory concentrations (MICs) were determined by broth microdilution according to \nthe Clinical and Laboratory Standards Institute (CLSI) standards (7,8,9)  using a 96 -well microtiter plate (Sensititre , \nTrek Diagnostic Systems, Thermo Fisher Scientific Inc., Cleveland, OH). Salmonella isolates were tested using a \ncustom plate developed for Gram -negative bacteria (catalog # CMV2AGNF) and Campylobacter isolates were \ntested using a custom plate developed f or Campylobacter testing (catalog # CAMPY). CLSI approved interpretive \ncriteria were used when available; otherwise provisional NARMS breakpoints were used  (6). The antimicrobial \nagents tested  with Salmonella were: Amikacin  (AMI), Ampicillin (AMP),  Amoxicillin/Clavulanic Acid  (AUG) , \nCeftriaxone  (AXO),  Chlorampheni col (CHL) , Ciprofloxacin  (CIP) ,  Trimethoprim/sulfamethoxazole  (SXT) , \nCefoxitin  (FOX) , Gentamicin  (GEN) , Kanamycin  (KAN) , Nalidixic Acid  (NAL) , Sulfisoxazole  (FIS) , Streptomycin  \n(STR) , Tetr acycline (TET) , Ceftiofur  (TIO).  The antimicrobial agents tested with Campylobacter  were: \nciprofloxacin (CIP), doxycycline (DOX), erythromycin (ERY), gentamicin (GEN), and meropenem (MER),  \ntetracycline (TET), azithromycin (AZI), clindamycin (CLI), florfenicol (FFN), nalidixic acid (NAL), and \ntelithromycin (TEL).  CLSI interpretive criteria, based on epidemiological cutoff values, are available for: CIP (\u22654 \n\u03bcg/ml), TET (\u226516 \u03bcg/ml), ERY (\u226532 \u03bcg/ml), and DOX (\u22658 \u03bcg/ml). NARMS resistance breakpoints used for oth er \nagents were: >8 \u03bcg/mL for GEN, >16 \u03bcg/mL for MER, >8 \u03bcg/mL for AZI, >8 \u03bcg/mL for CLI, >64 \u03bcg/mL  for NAL, \nand > 16 \u03bcg/mL  for TEL [10].  \n \nRESULTS AND DISCUSSION \n \nOf the samples collected on poultry farms, Salmonella was isolated from 206 (41%) boot socks and \nCampylobacter  from 391 (78%) boot socks. Of the S almonella  isolates 51 (24.8%) Kentucky, 26 (12.6%) Infantis, \n23 (11.2%) Mbandaka, 16 (8.7%) Cubana, 15 (7.3%) Typh imurium, 9 (4.4%) Enteriditis, 9 (4.4%) Alachua, 6 \n(2.9%) Newport, 10 (4.9%) other  serotypes.  Of the Salmonella isolated, 120 (58.3%) were susceptible to all \nantimicrobials tested. Of the antimicrobial resistant isolates, 6 (2.9%) were resistant  to one antimicrobial, 47 \n(22.8%) were resistant to two antimicrobials , 7 (3.4%) were resistant to three antimicrobials , 10 (4.9%) were \nresistant to four  antimicrobials , 16 (7.8%) were resistant to five  or more  antimicrobials .  The individual \nantimicrobial susceptibilities  are shown in Figure 1.  63rd WPDC/XXXIX ANECA  Of the Campylobac ter isolated the species were as follows: 240 (61%) jejuni , 151 (39%) coli.  Of the \nCampylobacter  isolates 186 (47.6%) were susceptible  to all tested antimicrobials , 114 (29.2%) were resistant to one  \nantimicrobial, 47 (12.0%) were resistant to two antimicrobials and 44 (11.3%) were resistant to three  antimicrobials .   \nResistance  to tetracycline was detec ted in 155 (39.6%) isolates, ciprofloxacin in 92 (23.5%)  isolates , nalidixic acid \nin 91 (23.3%) isolates , and azithromycin in 1 (0.3%) isolate  (Figure 2).   \n \nREFERENCES  \n \n1. Prevention, C.f.D.C.a., Antibiotic Resistance Threats in the United States, 2013, 2013.  \n2. Services, D.o.H.a.H., The National Antimicrobial Monitoring System - Strategic Plan 2012 -2016.  \n3. Wesley, I.V., Harbaugh, E., Trampel, D. W., Rivera, F., Rostagno, M. H., & Hurd, H. S., Effect of \npreslaughter events on the prevalence of Salmonella in market -weight turkeys.  Journal of Food Protection, 2006. \n69(8): p. 1785- 1793.  \n4. W.D. Waltman, R.K.G., Salmonellosis , in A Laboratoy Manual for the Isolation, Identification, and \nCharachterization of Avian Pathogens , L. Dufour -Zavala, Editor. 2008, American Association of Avian \nPathologists. p. 3 -9. \n5. J.A. Wagenaar, W.F.J.- R., Campylobacter Infections in Poultry , in A Laboratoy Manual for the Isolation, \nIdentification, and Charachterization of Avian Pathogens , L. Dufour -Zavala, Editor. 2008, American Association of \nAvian Pathologists. p. 27 -30. \n6. Administration, U.S.F.a.D., NARMS 2011 Retail Meat Annual Report \n2012: http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobi\nalResistanceMonitoringSystem/UCM334834.pdf . \n7. Institute, C.a.L.S., Performance Standards for Antim icrobial Disk and Dilution Susceptibility Tests for \nBacteria Isolated from Animals , in Approved Standard- Second Edition 2002, CLSI: Wayne, PA.  \n8. Institute, C.a.L.S., Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for \nBacteri a Isolated from Animals , in Informational Supplement (M31- S1)2004, CLSI: Wayne, PA.  \n9. Institute, C.a.L.S., Performance Standards for Antimicrobial Susceptibility Testing, in Twenty -Second \nInformational Supplement (M100- S22)2012.  CLSI: Wayne, PA.  \n10. Paul S. Mead, L.S., Vance Dietz, Linda F. McCaig, Joseph S. Bresee, Craig Shapiro, and R.V.T. Patricia \nM. Griffin, Food- Related Illness and Death in the United States.  Emerging Infectious Diseases, 1999. 5 (5): p. 607-\n625. \n \n  Figure 1.  The antimicrobials tested with the Salmonella isolates at the left; the number of isolates resistance on \nthe right. Lighter gray bars represent antimicrobial resistant isolate percentages.  \n 63rd WPDC/XXXIX ANECA  Figure 2.  The antimicrobials tested with the Campylobacter  isolates at the left; the number of isolates \nresistance on the right. Lighter gray bars represent antimicrobial resistant isolate percentages  \n \n \n 63rd WPDC/XXXIX ANECA  MULTILOCUS SEQUENCE TYPING (MLST) OF \nCAMPYLOBACTERS TO IDENTIFY POTENTIAL SOURCES \nAND VEHICLES OF COLONIZATION IN TURKEY FARMS  \n \nTIPIFICACI\u00d3N SECUENCIAL MULTILOCAL (TSM) DE \nCAMPILOBACTERIAS PARA IDENTIFICAR FUENTES Y VEH\u00cdCULOS \nPOTENCIALES DE COLONIZACI\u00d3N EN GRANJAS DE PAVOS  \n \nM. Giacomelli and A. Piccirillo  \n \nDepartment of Comparative Biomedicine and Fo od Science, University of Padua  \nViale dell\u2019Universit\u00e0, 16 -  35020 Legnaro (PD), Italy  \n \nRESUMEN  \n \nSe realizo una investigaci\u00f3n molecular en fuentes y veh\u00edculos  potenciales de infecci\u00f3n con Campy lobacter  \nen granjas comerciales de pavos. Se aislaron cepas de C. jejuni y  C. coli  de reproduc toras y su progenie criadas \nen dos diferentes granjas por tres  ciclos de producci\u00f3n consecutivos  y fue ron analizados por medio de la \ntipificacion secuencial multilocal (TSM). Las cepas aisladas de fuentes medioambientales (P.E. Agua de beber, \nantec\u00e1mara y pisos interiores, ratones e insectos), se colectaron  durante los mismos ciclos de producci\u00f3n y \ntambi\u00e9n  fueron analizadas.  La TSM de los C. jejuni y C. coli aislados se realiz\u00f3  de acuerdo con los siete \nesquemas locales empleando los juegos primarios y las condiciones experimentales sugeridas por la base de dato \nde PubTSM de Campilobacter. Se detectaron simi litudes gen\u00e9ticas entre los aislamientos de las reproductoras y \nsu progenie, as\u00ed como entre las aves y algunas de las fuentes mediambientales, principalmente en el agua de \nbeber.  La genotipificaci\u00f3n es una herramienta poderosa, para entender las din\u00e1micas epidemiol\u00f3gicas del \nCampilobacter en granjas de pavos.  \n \nSUMMARY  \n \nA molecular investigation on potential sources and vehicles of Campylobacter  infection in commercial \nturkey farms was carried out.  C. jejuni and C. coli  strains isolated from breeders , their progeny and the growing  \nflocks reared  in two different farms for three  sequential production cycles were analysed by  multilocus sequence \ntyping (MLST). Strains isolated from environmental sources  (drinking water, anteroom and in- house floor, flies, \nAlphitobius diaperinus ), collected during the same production cycles, were also  analysed.  MLST was performed \naccording  to the seven -loci schemes employing the primer sets and the  experimental conditions suggested by the \nCampylobacter  PubMLST  database.  Gene tic similarity was detected between isolates from  breeders and their \nprogeny, as well as between birds and environmental sources, such as flies, Alphitobius diaperinus  and drinking \nwater.  Results of the present study suggest that these environmental sources may be involved in Campylobacter  \ncolonization of meat turkeys.  \n \nINTRODUCTION  \n \nThermophilic campylobacters are among the leading bacterial pathogens involved in human gastroenteritis \nworldwide ( 8). In the European Union, campylobacteriosis has been the most commonly reported zoonotic \ndisease in humans since 2005 ( 6). Members of the Campylobacter  genus naturally colonize a wide range of \ndomestic and wild animals ( 8). Poultry are recognized as the main reservoir of the microorganism and rarely \nshow clinical signs of disease. Particularly, chickens and turkeys carry Campylobacter  at high concentration in \ntheir intestinal tract, determining a high risk of carcass conta mination during the slaughtering process. T he target  \nfor the control of Campylobacter  in poultry  should be the farm;  therefore it is crucial to identify the most \nimportant sources for flock colonization in order to develop intervention strategies ( 2). Although some studies \non the epidemiology of Campylobacter  in poultry production have been carried out, sources and vehicles of \nflock colonization are still poorly understood. In addition, despite the recognized importance of turkeys in the transmission of Campylobacter  and the increased turkey meat production in the last decade, very few studies on \nthe epidemiology of this microorganism have been conducted in this poultry species.  \nIn the present study , we used the MLST method to investigate on the relationships between \ncampylobacters colonizing animals and other sources in the turkey farm environment in order to better \nunderstand which one of them can act as source or vehicle of infection for reared animals.  63rd WPDC/XXXIX ANECA   \nMATERIALS AND METHODS  \n \nStrain collection. C. jejuni (n = 57) and C. coli  strains (n = 78) from different sources were examined in \nthe present study. S trains  were isolated between April 2012 and June 2013 during a longitudinal sampling \ncarried out for three sequential production cycles in  two meat turkey farms (farm A and farm B) located in \nVeneto Region, Northern Italy.  During the first production cycle two flocks per farm were examined, one \ncomposed by progeny of Campylobacter -positive breeders, wh ereas  the second, reared within a different house, \nwas composed by progeny of breeders of unknown Campylobacter  status. Samples  from the farm environment \nwere also collected.  In each farm a target turkey house was selected, where the monitoring continued for th e two \nfollowing production cycles.  Campylobacter  spp. isolation was performed  as previously described ( 7). Water \nsamples were filtered through 0.2 \u00b5m membrane filters ( Sartorius, Goettingen, Germany)  using a vacuum pump  \nbefore processing . \nCampylobacters genotyped  in the present study included strains fro m breeders  (n = 19)  and from growing \nturkeys  (n = 39 ), as well as strains isolated from drinking water  (water line , n = 2;  drinkers , n = 24 ), the \nanteroom (n = 2) and in-house  floor (n = 22) , flies (n = 13) and Alphitobius diaperinus  (n = 12) . They were \nselected in order to represent  each source of isolation  and sampling in both farms.  \nGenotyping . Strains were genotyped by multilocus sequence t yping (MLST) according to the seven loci \nscheme for C. jejuni and C. coli  developed by Dingle et al.  (3,4). DNA was extracted from overnight cultures by \nthermal lysis of the bacterial cells and i nternal fragments of the target genes were amplified by PCR and then \nsequenced using p rimers and reaction conditions suggested by the Campylobacter  MLST database \n(http://pubmlst.org/campylobacter/).  Allele number identification  and sequence type (ST) and clonal complex \n(CC) assignment  for each isolate, were obtained by interrogation of the Campylobacter  MLST database.  \n \nRESULTS  AND DISCUSSION \n \nTwenty -two different STs , 10 in C. jejuni (STs 51, 104, 257, 2116, 2274, 2863, 3102, 2850 , 2863 and \n6941 ) and 12 in C. coli  (STs 825, 829, 832,  1170, 1586, 1628, 1764, 2912, 5150, 5401, 6689 and 6940)  were \ndetected among the 134  strains examined . Five STs  (829, 832, 2116, 2274 and 2863 ) were common to different \nsources. Out of four STs detected among breeders strains, two  (STs 829 and 2863) were  detected also in isolates \nfrom their progeny  and in environmental samples. The occurrence of same STs among breeders and their \nprogeny may suggest the vertical transmission of Campylobacter  spp. However, it should be noticed that these \nSTs were  detected not only in the progeny flocks, but also in tu rkeys of different origin, as well as in \nenvironmental samples , suggesting a different origin of these genotypes , rather than their vertical transmission.  \nOverlapping of STs was observed also between flocks of different origin reared in t he same farms, \nsuggesting the occurrence of cross -contamination between flocks . The finding of STs matching between isolates \nfrom flies captured in one flock and from animals reared in the other flock suggests f lies as responsible for \ncross- contamination between flocks , as previously demonstrated experimentally (10). Also , STs of strains from \nAlphitobius diaperinus  matched those of isolates from growing turkeys  in several instances . Unlike flies, these \ninsects are less likely to be vectors of cross -contamination between flocks reared in the same  farm or source of \nentry of Campylobacter  spp. in the farm, since they live within the poultry house, hiding and persisting over \ntime in cracks and joints of the floor  and walls ( 9). They may rather serve as ongoing reservoirs of \nconta mination within a poultry flock and could be involved in carry- over between subsequent flocks  (1). \nHowever, the latter hypothesis  was not supported by  our study, since  no strains were isolated from any  source \nduring downtime.  \nRegarding water, t he STs of the isolates recovered from the drinkers matched those of the turkey isolates  \non seven of the eight  testing occasions . It is likely that water contamination followed flock infection, since \nprevious studies showed the rapid contamination of water in drinkers in Campylobacter -positive flocks  due to \nfaecal excretion ( 5). Our findings, i.e. the widespread occurrence of turkey -colonizing campylobacters in water \nof drinkers , suggest  that genotypes colonizing turkeys are able to survive in water . Therefore, contaminated \ndrinking water may act as an effective vector in spreading these microorganisms among birds.  However, the role \nof water as source of infection cannot be excluded since in the first production cycle of farm B, campylobacters \nbelonging to the same ST (829) were concurrently isolated from the water line of one poultry house and the \nturkey flock receiving that drinking water.  \nIn the present study, several strain isolated from the environment were genotypically identical to isolates \nrecovered from growing turkey flocks. Although it was not possible to define t he most like ly source of flock \ncolonization  since strains from environmental sources were isolated concurrently with birds , this study  provides \nfurther insight into the possible transmission routes and the epidemiology of C . jejuni and  C. coli  in commercial \nturkey farms . \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Bates, C., Hiett, K.L., and N.J. Stern. Relationship of Campylobacter  isolated from poultry and from \ndarkling beetles in New Zealand. Avian Dis. 48:138- 147. 2004.  \n2. Bull, S.A., Allen, V.M., Domingue, G., J\u00f8rgensen, F., Frost, J.A., Ure, R., Whyte, R., Tinker, D., \nCorry, J.E., Gillard -King, J., and T.J. Humphrey. Sources of Campylobacter  spp. colonizing housed broiler \nflocks during rearing.  Appl. Environ. Microbiol. 72:645- 652. 2006.  \n3. Dingle, K.E., Colles, F.M., Wareing, D.R., Ure, R., Fox, A.J., Bolton, F.E., Bootsma, H.J., Willems, \nR.J., Urwin, R., and M.C. Maiden.  Multilocu s sequence typing system for Campylobacter jejuni. J . Clin. \nMicrobiol. 39:14- 23. 2001.  \n4. Dingle, K.E., Colles, F.M., Falush, D., and M.C. Maiden. Sequence typing and comparison of \npopulation biology of Campylobacter coli  and Campylobacter jejuni . J. Clin. Mi crobiol. 43:340- 347. 2005.  \n5. European Food Safety Authority. Scientific Opinion on Campylobacter  in broiler meat production: \ncontrol options and performance objectives and/or targets at different stages of the food chain. EFSA Journal  \n9:2105. 2011.  \n6. European Food Safety Authority and European Centre for Disease Prevention and Control. The \nEuropean Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food- borne \nOutbreaks in 2011. EFSA Journal 11: 3129 . 2013.  \n7. Giacomelli, M., Andrighetto, C., Lombardi, A., Martini, M., and A. Piccirillo. A longitudinal study \non thermophilic Campylobacter  spp. in commercial turkey flocks in Northern Italy: occurrence and genetic \ndiversity. Avian Dis. 56:693- 700. 2012.  \n8. Humphrey, T., O\u2019Brien, S., and M. Madsen. Campylobacters as zoonotic pathogens: a food \nproduction perspective. Int . J. Food.  Microbiol.  117:237-257. 2007.  \n9. Kaufman, P.E., Burgess, M., Rutz, D.A., and C. Glenister. Population dynamics of manure inhabiting \narthropods under an integrated pest panagement (IPM) program in New York poultry facilities -3 case studies. J. \nAppl. Poult. Res. 11:90- 103. 2002.  \n10. Shane, S.M., Montrose, M.S., and K.S. Harrington. Transmission of Campylobacter jejuni  by the \nhousefly ( Musca domestica ). Avian Dis. 29:384- 391. 1985.  63rd WPDC/XXXIX ANECA  FIRST COMPARISON OF CAMPYLOBACTER JEJUNI  AND \nCAMPYLOBACTER COLI  ISOLATED FROM HUMANS AND \nPOULTRY IN ITALY: PRELIMINARY RESULTS  \n \nPRIMERA COMPARACI\u00d3N ENTRE CAMPYLOBACTER JEJUNI Y \nCAMPYLOBACTER COLI AISLADOS DE HUMANOS Y AVES  EN ITALIA: \nRESULTADOS PRELIMINARES  \n \nM. GiacomelliA, A. PiccirilloA, C. SalataBC, S. BettanelloB, E. De Canale EB, and G. Pal\u00f9 GBC \n \nADepartment of Comparati ve Biomedicine and Food Science, University of Padua,  Viale dell\u2019Universit\u00e0,  \n16 - 35020 Legnaro (P D), Italy  \nBRegional Reference Centre for Gastroenteric Diseases, Microbiology and Virology Unit, Azienda Ospedaliera \ndi Padova, Via Giustiniani, 2 -  35128 Padua, Italy  \nCDepartment of Molecular Medicine, University of Padua,  Via Gabelli, 63 -  35121 Padua, Italy  \n \nRESUMEN  \n \nEl presente estudio fue realizado para evaluar la relaci\u00f3n gen\u00e9tica entre cepas de Campylobacter  jejuni y \nC. coli aisladas de humanos y pollo de engorda, en el norte de Italia. Los aislamientos de humanos fueron \ncolectados de casos cl\u00ednicos de gas troenteritis aguda, mientras que las de los pollos fueron aisladas de pollos de \nengorda en granjas comerciales. La tipificaci\u00f3n molecular f ue llevada a cabo por medio de tipificacion \nsecuencial m ultilocal (TSM) de acuerdo con siete esquemas locales emplean do los juegos primarios y  las \ncondiciones experimentales sugeridas por la base de datos del PubTSM de  Campy lobacter . Una amplia \ndiversidad gen\u00e9tica fue detectada entre las campilobacterias  aisladas tanto de, humanos y pollos, con una \nvariedad mayor en las aisladas en humanos en comparaci\u00f3n con las de los pollos. Un n\u00famero mayor de nuevos  \nalelos y TSs fueron hallados en ambas cepas tanto de humanos como en pollos, mientras que se hall\u00f3 un n\u00famero \nmenor de relaciones gen\u00e9ticas  entre las campilobacterias de humanos y pollos.  A pesar de lo que es \ncom\u00fanmente reportado, de acuerdo a nuestros descubrimientos los pollos no parecen ser una fuente \npredominante de la campilobacteriosis humana.  \n \nSUMMARY  \n \nThe present study was undertaken to evaluate the genetic relationship between  Campylobacter  jejuni and \nC. coli  strains isolated from humans and broilers  in Northern Italy. Human isolates  were recovered  from clinical \ncases of acute gastroenteritis, whereas chicken strains were isolated from broilers in commercial  farms. \nMolecular typing was carried out  by multilocus sequence t yping ( MLST ) according to the seven -loci schemes \nemploying the primer sets and the ex perimental conditions suggested by the Campylobacter  PubMLST \ndatabase.  A wide genetic diversity among campylobacters isolated from both humans and chickens  was \ndetected , with a higher diversity in human isolates compared to chickens. A high number of n ew sequence type s \nwere found  in both human and chicken strains , whereas a low level of genetic relatedness was noticed between \nhuman and chicken campylobacters . Despite what is commonly reported,  according to our findings chicken s \nseem not to be the predominant  source of human campylobacteriosis . \n \nINTRODUCTION  \n \nMolecular typing has been used in source attribution studies to estimate the importance of different \nCampylobacter  reservoirs and to analyse transmission routes for human campylobacteriosis ( 7). Currently \nMLST  represents the method of choice for genotyping of Campylobacter  spp. and it is extensively used for \nsource attribution of human cases, as it allows assessing geographical, temporal and host species -related \nvariation in type ( 1,4).  \nTo our knowledge, genotyping by MLST sequencing has not previously been published from Italian \nCampylobacter  isolates neither in humans nor in chickens, their main reservoir. With the aim to fulfil this lack \nof information, in the present paper we report the firs t results regarding C. jejuni and C. coli  genotypes \nimplicated in human gastroenteritis cases in Italy and their genetic relatedness with chicken isolates.  \n \n 63rd WPDC/XXXIX ANECA   \nMATERIALS AND METHODS  \n \nStrains.  Eighteen human Campylobacter  strains (11 C. jejuni  and 7 C. coli ) and 39 chicken strains (23 C. \njejuni and 16 C. coli ) were included in the study. Human strains were isolated from clinical cases of acute \ngastroenteritis during the routine activity of the Regional Reference Centre for Infectious Diseases in Veneto \nregio n (North -Eastern Italy). Chicken isolates derived from a survey carried out in commercial farms located in \nNorth -Eastern Italy (5 ). Both human and chicken isolates were collected during 2009.  \nMLST.  Genotyping  was performed according to the seven- loci schem es for C. jejuni  and C. coli  \ndeveloped by Dingle et al.  (3,4), employing the primer sets and the experimental conditions suggested by the \nCampylobacter  MLST database (http://pubmlst.org/campylobacter/). Genomic DNA was extracted from \novernight cultures grown on tryptic soy agar (OXOID , Basingstoke, UK ) supplemented with 5% horse blood \n(OXOID) by simple lysis of the bacterial cells. Sequences were aligned  to the alleles in the C. jejuni and C. coli  \nPubMLST database to determine the allele numbers. The sequence type (ST) and the clonal complex (CC) of \neach allelic profile were designated by interrogation of the database. New allele sequences and STs were \nsubmitted to the curator of the Campylobacter  PubMLST database for number designation.  \n \nRESULTS AND DISCUSSION \n \nOut of 57 Campylobacter  strains, 35 different STs were identified  (Table 1) . Among human strains  16 \ndifferent STs were observed , whereas 19 differ ent STs were detected among chicken strains. Overall, 17 STs, \nincluding 6  human and 11 chicken isolates were not previously described. Thi rty-nine isolates grouped into \neight  CCs, while the remaining 19 isolates had STs that could not be assigned to any CC . In detail, 14 STs of \nhuman isolates were grouped into six known CCs, while two  STs did not belong to any CC. Among chicken \nisolates, 13 STs b elonged to 5 known CCs, while six  STs did not belong to any CC. Two CCs, ST -828 CC and \nST-21 CC, predominated and accounted for 22.8% (n = 13) and 21% (n = 12) of all the isolates, respectively. \nST-21 CC, ST -443 CC and ST -828 CC were shared between human and chicken campylobacters, whereas no \noverlapping STs were found.  \nA high genetic diversity was detected among human and chicken C. jejuni and C. coli population \nexamined herein, as widely documented all over the world ( 2,6,8,9). By comparing human and chicken \nCampylobacter  isolates, we also noticed that a higher diversity in CCs was present among human C. jejuni \ncompared to chicken isolates, which is consistent with previously published data ( 2). On the other hand, a larger \nnumber of novel STs unassigned to a defined CC among chicken C. co li compared to human isolates was \nidentified, in accordance with that reported by other studies ( 6,9). In the present study, no human STs were the \nsame as those found in chickens, whereas three CCs were found overlapping between human and chicken \nisolates.  A more evident overlap between human and chicken C. jejuni genotypes has been reported by other \nauthors ( 2,7,8 ).  \nMolecular typing has previously been used to infer the source and the route of transmission of \ncampylobacteriosis in humans and an overlappin g of genotypes in Campylobacter  species infecting humans and \nchickens suggested this food- producing animal as the main source of human infection ( 7,8). In our study, \nCampylobacter  genotypes implicated in human gastroenteritis cases did not show a substantial matching with \nisolates originating from chickens. These preliminary data, therefore, would suggest a weak association between \nhuman and chicken Campylobacter  isolates circulating in Italy. However, m ore data are needed  to further clarify  \ngenotype distribution and population structure of thermophilic Campylobacter  spp. and to identify potential \nsources of human campylobacteriosis in Italy.  \n \nREFERENCES  \n \n1. Ahmed , M.U., Dunn, L., and E.P. Ivanova . Evaluation of current molecular approaches for  \ngenotyping of Campylobacter jejuni  strains. Foodborne Pathog . Dis. 9:375-385. 2012.  \n2. de Haan, C.P., Kivisto, R ., Hakkinen, M., Rautelin, H., and M.L. Hanninen. Decreasing trend of \noverlapping multilocus sequence types between human and chicken Campylobacter jejuni  isolates over a decade \nin Finland. Appl . Environ . Microbiol . 76:5228- 5236.  2010.  \n3. Dingle, K.E., Colles, F.M., Wareing, D.R., Ure, R., Fox, A.J., Bolton, F.E., Bootsma, H.J., Willems, \nR.J., Urwin, R., and M.C. Maiden. Multilocus sequence  typing system for Campylobacter jejuni . J. Clin. \nMicrobiol. 39:14- 23. 2001.  \n4. Dingle, K.E., Colles, F.M., Falush, D., and M.C. Maiden. Sequence typing and comparison of \npopulation biology of Campylobacter coli  and Campylobacter jejuni . J. Clin. Microbiol. 4 3:340- 347. 2005.  63rd WPDC/XXXIX ANECA  5. Giacomelli, M., Andrighetto, C., Rossi, F., Lombardi,  A., Rizzotti, L., Martini M., and A.  Piccirillo. \nMolecular characterization and genotypic antimicrobial resistance analysis of Campylobacter jejuni  and \nCampylobacter coli  isolated from broiler flocks in Northern Italy. Avian Pathol.  41:579-88. 2012.  \n6. Griekspoor,  P., Engvall, E.O., Olsen, B., and J. Waldenstrom. Multilocus sequence typing of \nCampylobacter jejuni  from broilers. Vet . Microbiol . 140:180-185. 2010.  \n7. Kittl, S., Heckel, G., Korczak, B.M., and P.  Kuhnert. Source attribution of human Campylobacter \nisolates by MLST and fla -typing and association of genotypes with quinolone resistance. PLoS One 8 :e81796.  \n2013.  \n8. Sheppard, S.K., Dallas, J.F., Strachan, N.J., MacRae , M., McCarthy, N.D., Wilson, D.J., Gormley, \nF.J., Falush, D., Ogden, I.D., Maiden, M.C., and K.J. Forbes. Campylobacter genotyping to determine the \nsource of human infection. Clin . Infect . Dis. 48:1072- 1078.  2009.  \n9. Wirz, S.E., Overesch, G., Kuhnert, P., and B.M. Korczak. Genotype and antibiotic resistance \nanalyses of Campylobacter  isolates from ceca and carcasses of slaughtered broiler flocks. Appl . Environ . \nMicrobiol . 76:6377- 6386.  2010.  \n \n \nTable 1.  C. jejuni and C. coli  MLST genotypes among human and chi cken isolates. New sequence types are \nshown in bold face.  \n \nSource  Campylobacter  species  CC ST N\u00b0 \nHuman  C. jejuni  ST-257 257 2 \n   6852  1 \n  ST-206 572 2 \n  ST-443 443 1 \n   2361  1 \n  ST-21 6851  1 \n  ST-353 3327  1 \n  NA 6850  1 \n  NA 6856  1 \n C. coli  ST-828 827 1 \n   829 1 \n   854 1 \n   1556  1 \n   2317  1 \n   6853  1 \n   6854  1 \nChicken  C. jejuni  ST-21 50 6 \n   5553  1 \n   6862  1 \n   6863  1 \n   6864  1 \n   6865  1 \n  ST-446 2850  4 \n  ST-443 6867  1 \n  NA 3029  7 \n C. coli  ST-828 2642  2 \n   6866  2 \n   3026  1 \n   6868  1 \n  ST-1150  6877  1 \n  NA 3031  3 \n  NA 5401  3 \n  NA 6859  1 \n  NA 6860  1 \n  NA 6861  1 \nNA = not assigned  \n \n 63rd WPDC/XXXIX ANECA  USO DE UN ESTABILIZADOR PARA CONTRARRESTAR \nEFECTOS ADVERSOS DE COMPONENTES DEL AGUA DURANTE \nLA MEDICACI\u00d3N EN EL AGUA DE BEBIDA  \n \nUSE OF A STABILIZER TO COUNTERATTACK THE ADVERSE EFFECT \nFROM WATER COMPONENTS DURING MEDICATION  \nIN DRINKING WATER  \n \nG. G\u00f3mezA, J. S\u00e1nchezB, N. ChristyB y J. CossC \n \nAAlcer Alimentos S.A. de C.V.  \nBBoehringer Ingelheim Vetmedica S.A. de C.V.  \nCBoehringer Ingelheim Vetmedica S.A. de C.V.  \ndrgabrielalcer@prodigy.net.mx  \nCP.44940  \n \nSUMMARY  \n \nSeveral factors can affect the results expected aft er application of a vaccine and/ or medication  as product \nquality, strength, storage , and application method of the products according to the manufacturer's recommendations.  \nIn the case of vaccination and/ or medication into the drinking water, which is a  commonly used practice in the \npoultry industry, there is a factor of vital importance to  the quality of water.  In the case of  water  supply through \nunderground shaft, the problem is that  water  usually contains  large amounts of dissolved mineral salts that give \nhardness and altering the taste, the absorption and bioavailability of antimicrobials.  To ensure proper operation of \neither a vaccine or an antimicrobial, the quality of water must comply with a pH around 7, hardness less than 300 \nppm and be free of c hlorine and iodine.  \nIn a farm with 250,000 birds applied a water stabilizer, which yielded the appropriate pH, less than 300 ppm \nhardness and elimination of chlorine and iodine. The control group was previously medicated without applying water stabilizer. Since water was obtained under optimum conditions the medication was applied  with antibiotics. \nWe measured minimum inhibitory c oncentrations (MIC) of each group for E. coli, Salmonella Enteritidis , \nStaphylococcus aureus , and Streptococcus uberis after 10 min, one h and two h after the medication. The results \nshowed that by stabilizing the water, CIM is smaller and more uniform for the group when it stabilized the water, \nshowing a statistically significant difference and saving money on medication.  \n \nRESUMEN  \n \nExisten varios factores que pueden afectar los resultados esperados tras la aplicaci\u00f3n de una vacuna y/o \nmedicamento como: la calidad de los productos, la dosificaci\u00f3n, el almacenamiento y la aplicaci\u00f3n de los productos de acuerdo a las recomendaciones d el fabricante. En el caso de la vacunaci\u00f3n y/o medicaci\u00f3n en el agua de bebida, \nla cual, es una pr\u00e1ctica com\u00fanmente utilizada en la avicultura, existe un factor de vital importancia que es la calidad \ndel agua.    \nEn el caso del abastecimiento a trav\u00e9s de po zos subterr\u00e1neos, el problema es que generalmente contienen \ngrandes  cantidades de sales minerales disueltas que le confieren dureza y que alteran el sabor, modifican la \nabsorci\u00f3n y la biodisponibilidad de los antimicrobianos.  \nPara garantizar un adecuado f uncionamiento, ya sea de una vacuna o de alg\u00fan medicamento, la calidad de agua \ndebe cumplir con un pH alrededor de 7, una dureza menor a 300 ppm y estar libre de cloro y yodo.  \nEn una granja de 250,000 aves se aplic\u00f3 un estabilizador de agua, donde se obtuv o, el pH adecuado, dureza \nmenor a 300 ppm y la eliminaci\u00f3n de cloro y yodo. Las casetas que fueron el grupo control fueron medicadas sin \naplicar previamente el estabilizador de agua. Ya que se obtuvo un agua en condiciones \u00f3ptimas se realiz\u00f3 la \nmedicaci\u00f3n con los antibi\u00f3ticos aplicados normalm ente en la granja, se midieron concentraciones m\u00ednimas \ninhibitorias (CMI) de cada grupo para E. coli , Salmonella Enteritidis , Staphylococcus aureus , y Streptococcus uberis  \na los 10 minutos, a la hora y a las dos horas posteriores a la medicaci\u00f3n. Los resultados muestran que al estabilizar el 63rd WPDC/XXXIX ANECA  agua, la CIM es menor y m\u00e1s uniforme para el grupo donde se estabiliz\u00f3 el agua, mostrando una diferencia \nestad\u00edstica significativa y u n ahorro econ\u00f3mico en la medicaci\u00f3n.  \n \nINTRODUCCI\u00d3N  \n \nActualmente la producci\u00f3n av\u00edcola requiere de t\u00e9cnicas de medicaci\u00f3n y vacunaci\u00f3n masiva que permitan al \nproductor inmunizar una gran cantidad de aves en un corto periodo de tiempo.  \nLos procesos de vacun aci\u00f3n y medicaci\u00f3n en el agua de bebida son frecuentemente utilizados hasta el \nmomento. Dado el tiempo y las operaciones necesarias para llevar a cabo este m\u00e9todo, la calidad del agua es el \nfactor m\u00e1s importante a considerar ya que la vacuna o el medicamen to estar\u00e1n en contacto con \u00e9sta por un largo \nperiodo de tiempo. Si el agua no cumple con las m\u00ednimas caracter\u00edsticas fisicoqu\u00edmicas requeridas para llevar a cabo \nla operaci\u00f3n, no se tendr\u00e1 el efecto esperado y las p\u00e9rdidas econ\u00f3micas ser\u00e1n altas.  \nEl probl ema de varias granjas av\u00edcolas es que los pozos subterr\u00e1neos con los que cuentan como fuente de \nabastecimiento generalmente contienen grandes cantidades de sales minerales disueltas que le confieren la caracter\u00edstica de la dureza. La cual no solo altera el  sabor del agua, si no tambi\u00e9n modifica la absorci\u00f3n  y \nbiodisponibilidad de antimicrobianos como tetraciclinas las cuales se quelan en presencia de iones Ca2+ y se \ninactivan; las sulfonamidas que al interactuar con aguas duras se precipitan en las tuber\u00edas ; los \u03b2 -lact\u00e1micos se \ndegradan al contacto con aguas duras inactiv\u00e1ndolos por completo, etc\u2026  \nLa calidad m\u00ednima requerida para asegurar la m\u00e1xima eficiencia de los procesos de vacunaci\u00f3n y medicaci\u00f3n \nest\u00e1n relacionados con los tres par\u00e1metros m\u00e1s importantes: pH, dureza del agua y la presencia de cloro y/o yodo.  \nUn factor determinante en la eficiencia de los procesos de vacunaci\u00f3n y medicaci\u00f3n es el pH. Como todo sistema \nvivo, los virus y las bacterias son sensibles a la desnaturalizaci\u00f3n o desactivaci\u00f3n al encontrarse en un pH fuera del \nrango biol\u00f3gico. De esta manera, el pH ideal para la vacunaci\u00f3n o medicaci\u00f3n es alrededor de 7.0.  \nLa dureza del agua es la presencia de calcio y magnesio, originada por dep\u00f3sitos minerales en el subsuelo. \nEstos iones tienen u na acci\u00f3n quelante en el virus, bacterias e ingredientes activos que son usados en la vacunaci\u00f3n \ny medicaci\u00f3n. La condici\u00f3n ideal en cuando la dureza del agua es <100 ppm sin problemas para la salud del ave \npero pueden ser aceptados como niveles m\u00e1ximos ha sta 180ppm. As\u00ed como la ausencia de cloro y yodo.  \nUn estabilizador de agua es un producto formulado para resolver los retos m\u00e1s dif\u00edciles en los procedimientos \nde vacunaci\u00f3n y/o medicaci\u00f3n masiva, incluso bajo las peores condiciones fisicoqu\u00edmicas del agua, que pueden \nda\u00f1ar la eficiencia de la vacuna o un medicamento.  \nEl estabilizador act\u00faa sobre la dureza presente en el agua elimin\u00e1ndola permanentemente, estabiliza el pH de la \nsoluci\u00f3n hasta lograr la neutralidad, elimina los iones de cloro y yodo permanen temente de la soluci\u00f3n. El presente \ntrabajo se utiliz\u00f3 la prueba de T de Student\u00b4s como an\u00e1lisis estad\u00edstico para encontrar diferencias estad\u00edsticas significativas entre los grupos  (1,2,3).  \n \nMATERIALES Y M\u00c9TODOS  \n \nLa evaluaci\u00f3n se llev\u00f3 a cabo en una granja de 250,000 aves (pollo de engorda), localizada en el valle de \nM\u00e9xico.  Las aves fueron divididas en dos grupos:  \n\u2022 Grupo con estabilizador (A)  \n\u2022 Grupo control sin estabilizador (B)  \nA partir de una muestra de agua proveniente del pozo subterr\u00e1neo se realizaron las siguientes mediciones:  \n\u2022 Examen cualitativo del agua  (5).  \n\u2022 Examen cuantitativo del agua  (6,7,8,9).     \n\u2022 Medici\u00f3n de pH.  \n\u2022 Medici\u00f3n de dureza.  \nA partir de \u00f3rganos se realiz\u00f3.  \n\u2022 An\u00e1lisis bacteriol\u00f3gico.  \nCon una muestra de Colistina, Fosfomicina y Tilvalocina se  realizaron los Conteos M\u00ednimos Inhibitorios (CIM):  \n\u2022 CIM para E. coli.  \n\u2022 CIM para Salmonella Enteritidis . \n\u2022 CIM para Staphylococcus aureus.  \n\u2022 CIM para Streptococcus uberis.  63rd WPDC/XXXIX ANECA  Despu\u00e9s de haber suspendido el suministro de agua subiendo las l\u00edneas entre 1 \u2013  2 h, a Las  aves del grupo A se \nles administr\u00f3 un e stabilizador de agua a una relaci\u00f3n de 0.5 gramos por litro de agua preparando una soluci\u00f3n \nmadre y posteriormente vaci\u00e1ndola en el tinaco.  \nDespu\u00e9s de diez min  se realiz\u00f3 la medicaci\u00f3n de los antibi\u00f3ticos para ambos grupos.  \nDe cada grupo se tomaron 3 muestras de 15 mL cada una en tubos c\u00f3nicos est\u00e9riles, por l\u00ednea del  agua de \nbebida a los 10 min , a la hora y a las dos horas. Las muestras las muestras fueron conservadas en refrigeraci\u00f3n hasta \nque llegaron al laboratori o para su an\u00e1lisis.  \n \nRESULTADOS  \n \nExamen cualitativo del agua: muestra la  presencia de bacterias productoras de gas y mal olor, contaminaci\u00f3n \npor bacterias ent\u00e9ricas en el agua de pozo.  A la recepci\u00f3n de las aves de uno  d, se aisl\u00f3 E. coli de todos los \u00f3rganos \nanalizados.  \nResultados pH . Agua de pozo: 8.2, agua de poz o m\u00e1s estabilizador de agua (6,4).  \nResultados de dureza . Agua de pozo: 425 ppm, agua de pozo m\u00e1s estabilizador de agua: <100 ppm.  \nTabla1 muestra los par\u00e1metros productivos a la s\u00e9ptima semana de edad.  \n \nDISCUSI\u00d3N  \n \nEl grupo con estabilizador de agua (A), tuvo mejores resultados en cuanto a uniformidad y concentraciones \nm\u00ednimas inhibitorias observ\u00e1ndose diferencias estad\u00edsticas significativas al an\u00e1lisis estad\u00edstico  Student\u00b4s t - Test. El \nestabilizador de agua demostr\u00f3 su capacidad para mejorar la calidad de la misma. Al cierre de par\u00e1metros \nproductivos a la s\u00e9ptima semana podemos concluir que las casetas control tuvieron un total de 5.85% de mortalidad, \nmientras que las casetas con el estabilizador de agua obtuvieron un 4.15% de mortalidad, existe un 1.7% de mortalidad a favor del grupo donde se us\u00f3 el estabilizador de agua.  \nEn cuanto a peso el grupo control obtuvo 2,357 kg a comparaci\u00f3n del grupo con estabilizador de agua el cual \nobtuvo 2,551Kg, dando una diferencia de 194 gramos a favor del grupo con estabilizador de agua. El costo de \nmedicaci\u00f3n del grupo control fue de $.46 y del grupo con el estabilizador de agua fue de $.19, siendo este grupo $27 centavos por ave m\u00e1s barato que el  control.  \n \nREFERENCIAS  \n \n1. Sumano  H.L.; Guti\u00e9rrez L.O. Farmacolog\u00eda Cl\u00ednica en aves. Consideraciones sobre el agua desde la \nperspectiva de la industria av\u00edcola. Cap\u00edtulo VII, Departamento de fisiolog\u00eda y farmacolog\u00eda. Facultad de Medicina Veterinaria y Zootecnia. Ed. 3ra. P.p. 317 -338. 20 08. \n2. Ryan KJ; Ray CG. Sherris Medical Microbiology (4th ed. edition). McGraw Hill, 2004.  \n3. Actualidades en Vacunolog\u00eda Aviar. M\u00e9xico D.F. Junio 27, 2008.  \n4. Swayne, D., Glisson, J., Jackwood, M, Pearson, J. and Reed, W. A Laboratory Manual for the Isolation and  \nIdentification of Avian Pathogens. American Association of Avian Pathologist, Inc. Fourth Edition. Kennett Square, Pennsylvania, 1998.  \n5. Norma oficial mexicana nom -127-ssa1-1994, \"salud ambiental, agua para uso y consumo humano- l\u00edmites \npermisibles de calid ad y tratamientos a que debe someterse el agua para su potabilizaci\u00f3n\" modificada en el 2001.  \n6. Norma oficial mexicana nom -092-ssa1-1994, bienes y servicios. m\u00e9todo para la cuenta de bacterias \naerobias en placa.  \n7. Norma oficial mexicana nom -113-ssa1-1994, bien es y servicios. m\u00e9todo para la cuenta de \nmicroorganismos coliformes totales en placa.  \n8. Norma oficial mexicana nom -115-ssa1-1994, bienes y servicios. m\u00e9todo para la determinaci\u00f3n de \nStaphylococcus aureus  en alimentos.  \n9. Norma oficial mexicana nom -111-ssa1-1994, bienes y servicios. m\u00e9todo para la cuenta de mohos y \nlevaduras en alimentos.  \n 63rd WPDC/XXXIX ANECA  PROTECTION OF NEONATAL BROILER CHICKENS \nFOLLOWING IN OVO INJECTION OF \nOLIGODEOXYNUCLEOTIDES CONTAINING CPG MOTIFS \n(CPG -ODN) FORMULATED WITH CARBON NANOTUBES  \nOR LIPOSOMES  \n \nPROTECCI\u00d3N DE POLLOS DE ENGORDA DESPU\u00c9S DE LA APLICACI\u00d3N IN \nOVO  DE OLIGODEOXINUCLE\u00d3TIDOS  (ODN) QUE CONTIENEN MOTIVOS \nCPG (CPG-ODN) FORMULADOS CON NANOTUBOS O LIPOSOMAS  \n \nT. GunawardanaA, M. FoldvariB, T. ZacharA, S. PopowichA, B. Chow -LockerbieA, M. Vaneva IvanovaB, S. TikooCD, \nS. KurukulasuriyaA, P. WillsonC, and S. GomisA \n \nADepartment of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan,  \nSaskatoon, SK, S7N 5B4, Canada  \nBSchool of Pharmacy, University of Waterloo, 200 University Avenue West, Waterloo, ON, N2L 3G1, Canada.  \nCVaccine and Infectious Disease Organization, 120 Veterinary Road, University of Saskatchewan,   \nSaskatoon, SK, S7N 5E3, Canada  \nDVaccinology and Immunotherapy, School of Public Health, University of Saskatchewan,  \nSaskatoon, SK, 7N 5E3, Canada  \n  \nRESUMEN  \n \nPreviamente hemos demostrado que la administraci\u00f3n in ovo  de oligodeoxinucle\u00f3tidos (ODN) que contienen \nmotivos CpG (CpG -ODN) pudo proteger de manera significativa a pollos de engorda reci\u00e9n nacidos contra \ninfecciones por  Escherichia coli o  Salmonella Typhimurim . Los objetivos del presente estudio fueron examinar la \nseguridad y los efectos protectores del CpG -ODN formulado con 2 tipos de nanotubos de carbono (CNTs) o dos \nsistemas de suministro de l\u00edpidos surfactantes (LSC) en pollos de engorda reci\u00e9n nacidos contra septicemia por E . \ncoli. La tasa de supervivencia de los pollos en los grupos que recibieron soluci\u00f3n salina despu\u00e9s de la infecci\u00f3n por \nE. coli fue del 20 al 30%. En contraste, los pollos que recibieron las formulaciones de CpG -ODN tuvieron una  tasa \nde supervivencia del 60 al 80%, lo cual fue significativamente m\u00e1s alto. La carga bacteriana y el puntaje cl\u00ednico \nfueron bajos en los grupos tratados con CNT o LSC -CpG -ODN en comparaci\u00f3n con los grupos que recibieron CpG -\nODN o soluci\u00f3n salina. Esta e s la primera vez que se demuestra que los CpG -ODN formulados con CNT y LSC \ntienen un efecto inmunoprotector contra infecciones por E.coli en pollos de engorda reci\u00e9n nacidos despu\u00e9s de su \nadministraci\u00f3n in ovo.  \n \nSUMMARY  \n \nWe have previously shown that in ovo delivery of  unformulated oligodeoxynucleotides (ODN) containing CpG \nmotifs (CpG -ODN) was able to significantly protect neonatal broiler chickens against Escherichia coli or \nSalmonella Typhimurium  infections. The objectives of this study were to exam ine the safety and immunoprotective \neffects of CpG -ODN formulated with two  types of carb on nanotubes (CNTs) or two types of lipid -surfactant (LSC) \ndelivery systems in neonatal broilers against E. coli septicemia. The survival rate of birds in groups receiv ing saline \nfollowing E. coli infection was 20% to 30%. In contrast, birds receiving CpG -ODN formulations had a significantly \nhigher survival rate of 60% to 80%. Bacterial loads and clinical scores were low in groups treated with CNT - or \nLSC-CpG -ODN compare d to the groups receiving CpG -ODN or saline. This is the first time that CpG -ODN \nformulated with CNT and LSC have been demonstrated to have an immunoprotective effect against an E. coli \ninfection in neonatal broiler chickens following in ovo delivery.  \n 63rd WPDC/XXXIX ANECA  INTRODUCTION  \n \nNeonatal chickens are highly susceptible to diseases since many pathogens enter through mucosal surfaces, and \nthe mucosal immune system is no t fully mature until several wk  post hatch ( 13). Escherichia coli  causes a variety of \ndisease syndromes in poultry including yolk- sac infection, omphalitis, respiratory tract infection, septicemia, and \ncellulitis (19). Vaccines are a well -known method to stimulate the immune system for improved disease protection, \nbut they are not available for all disease agents and are not effective when an immediate protective effect is required. \nHence, these trends point to a need for development of alternative strategies for infectious disease control ( 2).  \nThe vertebral innate immune system identifies pathogen -associated molecular patterns (PAMPs) by pattern \nrecognition receptors (PRRs), inducing immune responses which prevent infections ( 25). Non -vertebral DNA which \ncontains comparatively higher amounts of unmethylated cytosine -phosphodiester -guanine (CpG) dinucleotides than \nvertebral DNA acts as a PAMP. These unmethylated CpG dinucleotides (CpG motifs), are recognized as the molecular pattern that contributes to the immunostimulatory activity of non -vertebral DNA ( 1). Toll- like receptor 9 \n(TLR 9) in mammals, which is a PRR, recognize these unmethylated CpG motifs and initiates immunostimulatory \npathways (1). The context of the unmethylated CpG dinulceotides  including specific flanking sequences are \nresponsible for the extent of immune stimulation ( 23). Synthetic preparations of oligodeoxyneu cleotides containing \nCpG -ODNs  simulating non -vertebral DNA, have shown similar immunostimulatory activity ( 33). This discovery \nhas shown an important preventive immunotherapeutic treatment option which stimulates the host\u2019s immune system. \nStudies have revealed the immunostimulatory action of CpG -ODNs in many vertebral species including mice ( 9), \nfish (20),\n cattle and sheep ( 26), and chickens ( 18, 29). Other than the immunostimulatory action, CpG -ODNs are \nbeing used as vaccine adjuvants due to the ability to activate antigen presenting cells and B cells ( 22). CpG -ODNs \nare also used for cancer therapy due to natural killer cell and cytotoxic T cell activation ( 22). Furthermore, CpG -\nODNs are being used for anti -allergic treatments due to the ability to promote Th1 -type immune respo nse and thus \nsupress Th2 -type allergic responses ( 22). The immunoprotective effect of CpG -ODN against several crucial diseases \nsuch as E. coli (16-18) and Salmonella Typhimurium  (29) bacterial infections, protozoan diseases caused by Eimeria \n(10) and viral diseases such as infectious bursal disease ( 31) and infectious bronchitis ( 11) have been demonstrated \nin chickens.  \nExtending the bioavailability and duration of action of CpG -ODN may increase the therapeutic value. \nUnfortunately, CpG -ODN used in vivo  is rapidly eliminated from the circulation due to adsorption onto serum \nproteins and degradation by serum nucleases ( 24). A possible technique for protecting CpG -ODNs from degradation \nwhile increasing uptake by cells of the immune system, involves liposome encapsulation ( 32) or fusion with \nbiphasic lipid vesicles ( 3). Formulating CpG -ODN with polyphosphazene polymers showed an enhanced protection \nof chickens from E. coli infection (30).  \nNanotechnology can be described as the technology involved in the manufacture, control, manipulation, and \nstudy of structures or devices whose size is of the nanometer scale. Carbon nanotubes (CNTs) exist in two types, single -wall (SWNT) and multi -wall (MW NT). CNTs have been extensively investigated as multipurpose carriers for \ndrug delivery and diagnostic applications. The organic functionalization of CNTs can significantly improve their \nsolubility and biocompatibility profile; as a result, their manipulat ion and integration into biological systems has \nbecome possible. Functionalised CNTs currently hold strong promise as novel systems for the delivery of drugs, \nantigens and genes ( 8). Use of CNTs to enhance uptake of CpG -ODN and increase antiglioma immunity in mice \nhave been reported ( 6) . To our knowledge, CNTs have not been used for formulation of CpG -ODN and delivery in \nchicken embryos. The objectives of t his study were to determine the safety and immunoprotective effects of two \ntypes of CNTs and two types of LSCs in delivery systems formulated with CpG -ODN as immunostimulants in \nneonatal broiler chickens.  \n \nMATERIALS AND METHODS  \n \nDelivery of CpG  ODN formulations by the in ovo route . The objective of this experiment was to enhance \nthe immunoprotective effects of CpG -ODN by formulating with single wall carbon nanotubes (SWNTs) or lipid \nsurfactant composits (LSC) in neonatal birds. Eighteen day old embryonated eggs were injected with 50 \u00b5g of CpG -\nODN formulated with SWNT (SWNT -  CpG -ODN), LSC -CpG -ODN, unformulated CpG -ODN or saline. Each of \nfour groups of embryona ting eggs received either 100 \u00b5L  of formulation or saline by the in ovo  route in the amniotic \ncavity through the air ce ll using 22 gauge needles with one  inch length. Forty embryonating eggs were randomly \nallocated into each of the four groups. After hatching, the groups  of birds were inoculated on d one  of age (which \nwas app roximately 24 h following hatch) with 1\u00d710\n5 or 1\u00d7104 cfu of stationary phase E. coli by the subcutaneous 63rd WPDC/XXXIX ANECA  route in the neck. Half of each group (n=20) were inoculated with 1x105 cfu of E. coli  and the remaining birds \n(n=20) were inoculated with 1x104 cfu of E. coli.  \n Safety of CpG -ODN formulated with CNT or LSC . The objective of this project was to study the safety and \ntoxicity of these CpG -ODN formulations in neonata l broiler chickens until 42 d  post-hatch while being conducted in \ntwo separate experiments. In the first  experiment,  four groups of birds (n=18 for each group) were injected with \nSWNT -CpG -ODN , LSC -CpG -ODN, CpG- ODN or saline by the in ovo.  Birds were examined daily for any clinical \nsigns and mortality. Tissue sections were collected from the gastrointestinal tract (crop, esophagus, proventriculus, \ngizzard, duodenum, jejunum, ileum, and ceca), kidneys, lungs, liver, muscle, trachea and lymph oid organs (spleen, \nbursa, a nd thymus) at 19, 20 and 21 d of incubation and at three, six, and nine d post-hatch for histopathology.    \n \nRESULTS AND DISCUSSI ON \n \nBirds in the first trial that received either CpG -ODN formulated with SWNT or LSC (> 75% surviva l) \nexperienced one -third (0.32; p<0.001) the relative risk of mortality following a lethal dose of E. coli  compared to \nCpG -ODN alone and saline control groups (30% survival). The cumulative clinical score was significantly lower in \nbirds that received CpG -ODN formulated with SWNT or LSC compared to birds that received either CpG -ODN \nalone or saline (p< 0.05 ). Moreover, birds that received CpG -ODN formulated with either SWNT or LSC had a \nsignificantly greater proportion of  lower bacterial loads compared to birds that received CpG -ODN alone or saline \n(p<0.005).  \nNo mortality or clinical signs were detected in any of the embryos or birds following administration of CpG -\nODN formulations throughout d  42 post-hatch in the first safety experiment. No histopathological lesions were \ndiagnosed in any of the organs at any of the time points of embryos or birds throughout d 42 post-hatch in groups \nthat received any CpG -ODN formulation, CpG -ODN or saline.  \nCpG -ODN formulated with CNT or lipid surfactant vesicles was observed to synergistically enhance the \nimmunoprotective efficiency against E. coli infections in neonatal broiler chickens. It is very encouraging to note \nthat CpG -ODN formulations with CNT did not ca use adverse reactions in chicken embryos or neonatal broiler \nchickens.  \n \nREFERENCES  \n \n1. Ahmad -Nejad, P., H. Hacker, M. Rutz, S. Bauer, R.M. Vabulas, and H. Wagner. Bacterial CpG -DNA and \nlipopolysaccharides activate Toll -like receptors at distinct cellular compartments. European journal of immunology \n32:1958- 1968. 2002.  \n2. Al-Ghamdi, M.S., F. El -Morsy, Z.H. Al -Mustafa, M. Al -Ramadhan, and M. Hanif. Antibiotic resistance \nof Escherichia coli isolated from poultry workers, patients and chicken  in the eastern province of Saudi Arabia. \nTropical medicine & international health : TM & IH 4:278 -283. 1999.  \n3. Alcon, V., M. Baca- Estrada, M. Vega- Lopez, P. Willson, L. Babiuk, P. Kumar, R. Hecker, and M. \nFoldvari. Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in \npigs. The AAPS Journal 7:E566- E571. 2005.  \n4. Alcon, V.L., M. Baca -Estrada, M.A. Vega -Lopez, P. Willson, L.A. Babiuk, P. Kumar, and M. Foldvari. \nIntranasal immunization using biphasic lipid v esicles as delivery systems for OmIA bacterial protein antigen and \nCpG oligonucleotides adjuvant in a mouse model. Journal of Pharmacy and Pharmacology 57:955- 961. 2005.  \n5. Azhar, S., S. Akhtar, and M. Munir. Post -Vaccinal Observation of Lymphoid Organs in Broiler Chicks \nInoculated with Hot and Mild Vaccinal Strains of Infectious Bursal Disease Virus. J. Vet. Anim. Sci 2:72 -78. 2012.  \n6. Badie, B., D.C. Zhao, D. Alizadeh, L.Y. Zhang, W. Liu, O. Farrukh, E. Manuel, and D.J. Diamond. \nCarbon Nanotubes Enhance C pG Uptake and Potentiate Antiglioma Immunity. Clin Cancer Res 17:771 -782. 2011.  \n7. Barry, A. Clinical specimens for microbiologic examination. Infectious disease: a guide to the \nunderstanding and management of Infectious Processes. PD Haeprich, ed. Harper and Row, New York:103- 107. \n1972.  \n8. Bianco, A., K. Kostarelos, and M. Prato. Applications of carbon nanotubes in drug delivery. Current \nopinion in chemical biology 9:674- 679. 2005.  \n9. Cho, H.C., B.H. Kim, K. Kim, J.Y. Park, J.H. Chang, and S.K. Kim. Cancer  immunotherapeutic effects \nof novel CpG ODN in murine tumor model. International immunopharmacology 8:1401- 1407. 2008.  \n10. Dalloul, R.A., H.S. Lillehoj, M. Okamura, H. Xie, W. Min, X. Ding, and R.A. Heckert. In vivo effects of \nCpG oligodeoxynucleotide on E imeria infection in chickens. Avian Dis 48:783 -790. 2004.  63rd WPDC/XXXIX ANECA  11. Dar, A., A. Potter, S. Tikoo, V. Gerdts, K. Lai, L.A. Babiuk, and G. Mutwiri. CpG \nOligodeoxynucleotides Activate Innate Immune Response that Suppresses Infectious Bronchitis Virus Replication in  \nChicken Embryos. Avian Diseases 53:261- 267. 2009.  \n12. de Jong, S., G. Chikh, L. Sekirov, S. Raney, S. Semple, S. Klimuk, N. Yuan, M. Hope, P. Cullis, and Y. \nTam. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti -tumor activity of \nsubcutaneously administered CpG ODN. Cancer immunology, immunotherapy : CII 56:1251- 1264. 2007.  \n13. Dibner, J.J., C.D. Knight, M.L. Kitchell, C.A. Atwell, A.C. Downs, and F.J. Ivey. Early feeding and \ndevelopment of the immune system in neonatal poultry. J Appl Poultry Res 7:425 -436. 1998.  \n14. Foldvari, M., and M. Bagonluri. Carbon nanotubes as functional excipients for nanomedicines: I. \npharmaceutical properties. Nanomed -Nanotechnol 4:173- 182. 2008.  \n15. Foldvari, M., and M. Bagonluri. Carbon  nanotubes as functional excipients for nanomedicines: II. Drug \ndelivery and biocompatibility issues. Nanomed -Nanotechnol 4:183- 200. 2008.  \n16. Gomis, S., L. Babiuk, B. Allan, P. Willson, E. Waters, R. Hecker, and A. Potter. Protection of chickens \nagainst a  lethal challenge of Escherichia coli by a vaccine containing CpG oligodeoxynucleotides as an adjuvant. \nAvian Diseases 51:78 -83. 2007.  \n17. Gomis, S., L. Babiuk, B. Allan, P. Willson, E. Waters, N. Ambrose, R. Hecker, and A. Potter. Protection \nof neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine -phosphodiester -\nguanine motifs. Avian Diseases 48:813 -822. 2004.  \n18. Gomis, S., L. Babiuk, D.L. Godson, B. Allan, T. Thrush, H. Townsend, P. Willson, E. Waters, R. Hecker, \nand A. Potter. Protection of chickens against Escherichia coli infections by DNA containing CpG motifs. Infection \nand Immunity 71:857- 863. 2003.  \n19. Goren, E. Observations on experimental infection of chicks with Escherichia coli. Avian pathology : \njournal of the W.V.P.A 7:213- 224. 1978.  \n20. J\u00f8rgensen, J.B., L.- H. Johansen, K. Steiro, and A. Johansen. CpG DNA Induces Protective Antiviral \nImmune Responses in Atlantic Salmon (Salmo salar L.). Journal of virology 77:11471- 11479. 2003.  \n21. Klasing, K.C. Nutritio nal modulation of resistance to infectious diseases. Poultry science 77:1119 -1125. \n1998.  \n22. Klinman, D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4:249- 258. \n2004.  \n23. Krieg, A.M. CPG MOTIFS IN BACTERIAL DNA AND THEIR IMMUNE EF FECTS*. Annual review \nof immunology 20:709- 760. 2002.  \n24. Litzinger, D.C., J.M. Brown, I. Wala, S.A. Kaufman, G.Y. han, C.L. Farrell, and D. Collins. Fate of \ncationic liposomes and their complex with oligonucleotive in vivo. Biochimica et Biophysica Acta ( BBA) - \nBiomembranes 1281:139- 149. 1996.  \n25. Medzhitov, R., and C.A. Janeway, Jr. Decoding the patterns of self and nonself by the innate immune \nsystem. Science 296:298- 300. 2002.  \n26. Nichani, A.K., A. Mena, Y. Popowych, D. Dent, H.G.G. Townsend, G.K. Mutwi ri, R. Hecker, L.A. \nBabiuk, and P.J. Griebel. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. \nVeterinary immunology and immunopathology 98:17- 29. 2004.  \n27. Rampling, A., R. Upson, L. Ward, J. Anderson, E. Peters, and B. R owe. SALMONELLA ENTERITIDIS \nPHAGE TYPE 4 INFECTION OF BROILER CHICKENS: A HAZARD TO PUBLIC HEALTH. The Lancet \n334:436- 438. 1989.  \n28. Saavedra, R., R. Leyva, E.P. Tenorio, M.L. Haces, M. Rodriguez- Sosa, L.I. Terrazas, and P. Herion. \nCpG -containing ODN has a  limited role in the protection against Toxoplasma gondii. Parasite immunology 26:67 -\n73. 2004.  \n29. Taghavi, A., B. Allan, G. Mutwiri, A. Van Kessel, P. Willson, L. Babiuk, A. Potter, and S. Gomis. \nProtection of Neonatal Broiler Chicks Against Salmonella Ty phimurium Septicemia by DNA Containing CpG \nMotifs. Avian Diseases 52:398 -406. 2008.  \n30. Taghavi, A., B. Allan, G. Mutwiri, M. Foldvari, A. Van Kessel, P. Willson, L. Babiuk, A. Potter, and S. \nGomis. Enhancement of immunoprotective effect of CpG -ODN by form ulation with polyphosphazenes against E. \ncoli septicemia in neonatal chickens. Current drug delivery 6:76 -82. 2009.  \n31. Wang, X., P. Jiang, S. Deen, J. Wu, X. Liu, and J. Xu. Efficacy of DNA vaccines against infectious \nbursal disease virus in chickens enha nced by coadministration with CpG oligodeoxynucleotide. Avian Dis 47:1305-\n1312. 2003.  \n32. Wilson, K.D., S.D. de Jong, and Y.K. Tam. Lipid -based delivery of CpG oligonucleotides enhances \nimmunotherapeutic efficacy. Advanced Drug Delivery Reviews 61:233 -242. 2009.  63rd WPDC/XXXIX ANECA  33. Yamamoto, S., T. Yamamoto, S. Shimada, E. Kuramoto, O. Yano, T. Kataoka, and T. Tokunaga. DNA \nfrom bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. \nMicrobiology and immunology 36: 983-997. 1992.  \n \n 63rd WPDC/XXXIX ANECA  ESTUDIO COMPARATIVO DE RESULTADOS SEROL\u00d3GICOS  DE \nCUATRO LABORATORIOS NACIONALES DE LA PRUEBA DE HI \nPARA LA ENFERMEDAD DE NEWCASTLE E INFLUENZA AVIAR \nA PARTIR DE SUEROS  DE POLLO DE ENGORDA  \n \nCOMPARATIVE STUDY OF SEROLOGICAL RESULTS OF THE HI TEST \nFOR NEWCASTLE DISEASE AND AVIAN INFLUENZA FROM BROILER \nSERA FROM FOUR NATIONAL LABORATORIES  \n \nA. Guadarram aA, D. MarrufoA y E. LucioA \n \nA Investigaci\u00f3n Aplicada S.A. de C.V. , 7 Norte 416. Col. Centro. C.P. 75700, Tehuac\u00e1n , Puebla. M\u00e9xico  \nTel. (238) 380 3805  \nCel. 238 388 22 05  \nFax 380 3806  \nE-mail: aguadarrama@grupoidisa.com  \n \nSUMMARY  \n \nBroilers of the Ross lineage, which were kept in isolation units were used. At three wk  of age an emulsified \nvaccine was applied subcutaneously for the prevention of avian influenza and Newcastle disease at a dose of 0.5 mL \nper bird. All birds w ere serologically monitored at three, six, and seven wk of age and sera were sent to four  national \ndiagnostic laboratories where the HI test was performed for avian i nfluenza and Newc astle d isease, differing up to \nsix logarithms  for avian i nfluenza at six and seven wk . Data were analyzed using a factorial tre atment design of four  \nby three ; with statistically significant differences between laboratories and m onitoring.  \n \nRESUMEN  \n \nSe utilizaron  pollos de engorda  de la estirpe Ross , los cuales se mantuviero n en unidades de a islamiento. A las \ntres semanas  de edad  se les aplic\u00f3  una vacuna emulsionada  para la prevenci\u00f3n  de influenza aviar y enfermedad  de \nNewcastle v\u00eda subcut\u00e1nea , a una dosis de 0.5 mL  por ave. Todas las aves se moni torearon serol\u00f3gicamente a las tres, \nseis  y siete  semanas  de edad  y los sueros se envi aron a cuatro  laboratorios  de diagn\u00f3stico  nacionales en  donde s e \nrealiz\u00f3 la prueba de HI para influenza aviar y e nfermedad de Newcastle,  enco ntr\u00e1ndose diferencias de hasta sies  \nlogaritmos para el  caso de influenza aviar a las seis y siete  semanas. Los datos se analizaron por medi o de un dise\u00f1o  \nde tratamientos factorial  de cuatro  por tres ; encontr\u00e1ndose diferencias estad\u00edsticamente significativas entre \nlaboratorios y entre monitoreo . \n \nINTRODUCCI\u00d3N  \n \nLa enfermedad de Newcastle es una de las m\u00e1s importantes infecciones de las aves. Esta se encuentra  \ndistribuida alrededor del mundo y ha sido l a causa de grandes p\u00e9rdidas econ\u00f3micas en la industria av\u00edcola (1). Su \nagente causal es el virus de la enfermedad de Newcastle, un virus que es capaz de infectar alrededor de 240 especies \nde aves y se disemina por medio del contacto directo entre aves enfermas y aves saludables  (2). \nEl virus de la enfermedad de Newcastle (NDV) puede emplearse como un ant\u00edgeno en una variedad amplia de \npruebas serol\u00f3gicas, lo que permite que se utilicen las t\u00e9cnicas de neutralizaci\u00f3n o de enzimoinmunoensayo (ELISA) Y HI para valorar el nivel de anticuerpos en las aves. En la actualidad, la prueba de HI es la m\u00e1s \nampliamente utilizada para la detecci\u00f3n de anticuerpos contra NDV  en las aves (OIE , 2008).  \nLa influenza aviar representa una de las enfermedades infecciosas de mayor importancia no s\u00f3lo en la industria \nav\u00edcola comercial sino tambi\u00e9n en otras especies aviares, mam\u00edferos y humanos ( 3). Los constantes brotes \ndetectados alrededor del mundo en aves comerciales son de gran importancia a nivel econ\u00f3mico, en aves silvestres \nrepresenta un grave problema por la conservaci\u00f3n de las especies . La suceptibilidad al virus de influenza a viar e s \nvariable entre aves comerciales  y aves silvestres . Las Gallineceas  se consideran altamente susceptibles ( 4), mientras \nque, las aves silvestres son reconocidas como reservorios naturales de la enfermedad con variable morb ilidad 63rd WPDC/XXXIX ANECA  dependiendo de la virulencia de la cepa involucrada ( 5). Dependiendo de la especie, la edad y el tipo de ave, los \nrasgos caracter\u00edsticos de la cepa v\u00edrica implicada y los f actores ambientales, la enfermedad  virulenta que afecta a las \naves totalmente susceptibles puede variar desde una muerte s\u00fabita con pocos signos cl\u00ednicos o sin signos aparentes, \nhasta una enfermedad m\u00e1s  caracter\u00edstica con signos cl\u00ednicos variados, que incl uye s\u00edntomas respiratorios, \nsecreciones oculares y nasales, tos, disnea, hinchaz\u00f3n de los senos nasales o la cabeza, cianosis de la piel no cubierta \nde plumas, barbillas y cr esta, signos de descoordinaci\u00f3n, nerviosismo y diarrea (OIE, 2008).  \nCom o todos los  virus de i nfluenza tipo A poseen ant\u00edgenos de la nucleocapside y de la matriz similar , para \ndetectar anticuerpos frente a estos ant\u00edgenos se emplean pruebas de inmunodifusi\u00f3n en gel de agar. En estas pruebas \nse utilizan preparaciones de virus concentradas  que contengan uno o ambos tipos de ant\u00edgeno. No todas las especies \nde aves desarrollan anticuerpos precipitantes demostrables. Los ensayos de inhibici\u00f3n de la hemoaglutinaci\u00f3n tambi\u00e9n se han empleado en la s erolog\u00eda diagn\u00f3stica de ruina, aunque es posible  que esta t\u00e9cnica no detecte algunas \ninfecciones concretas debido a que la hemoaglutinina es espec\u00edfica del subtipo v\u00edrico  (OIE, 2008).  \n \nOBJETIVO  \n \nComparaci\u00f3n de los resultados serol\u00f3gicos obtenidos por medio de la prueba de HI para enfermedad de \nNewcastle  e influenza a viar reportados por 4 laboratorios nacionales.   \n \nMATERIAL Y M\u00c9TODO  \n \nAves . Se utilizaron 13 pollos de engorda de la estirpe Ross de un d\u00eda de edad prov enientes de una empresa de \nC\u00f3rdoba, Veracruz . \nUnidades de aislamiento.  Los 13 pollos se ingresaron al d\u00eda de edad a una unidad de aislamiento  con aire \nfiltrado a presi\u00f3n negativa tipo Horsfall -Bauer,  donde se  les dio agua y alimento a libre acceso.  \nVacuna . Se utiliz\u00f3 la vacuna emulsionada  que conten\u00eda los ant\u00edgenos de influenza a viar y enferm edad de \nNewcastle  a una dosis de 0.5 mL, aplicada v\u00eda subcut\u00e1nea.   \nDise\u00f1o experimental . \n \nActividad  Edad de las aves  \nRecepci\u00f3n de aves Un d\u00eda de edad  \nPrimer muestreo serol\u00f3gico  \nVacunaci\u00f3n con AI+ND  3 semanas  \nSegundo muestreo serol\u00f3gico  6 semanas  \nTercer muestreo serol\u00f3gico  7 semanas  \n Laboratorios.  Las muestras obtenidas se colocaron en diferentes viales, se identificaro n y se enviaron a cuatro \nlaboratorios nacionales  (IA, AV, UN y BI)  \nPruebas . A las muestras de sueros obtenidas por monitoreo se les realizaron las pruebas de HI para \nenfermedad de Newcastle e Influenza Aviar . \nAn\u00e1lisis estad\u00edstico . Se utiliz\u00f3 un dise\u00f1o completamente al azar y un dise \u00f1o de tratamiento factorial de 4 X3 (4 \nlaboratorios  evaluados en 3 monitoreos con 13 repeticiones) . \n \nRESULTADOS  \n \n(Refi\u00e9rase a los gr\u00e1ficos  al fin de l manuscrito.)  \n \nDISCUSI\u00d3N  \n \nLa OIE menciona que la prueba de HI para enf ermedad de Newcastle como para influenza a viar es \nampliamente utilizada para determinar los t\u00edtulos de anticuerpos para estas enfermedades. Por ello, y debido a la \nimportancia de esta prueba, se realiz\u00f3 el trabajo comparativo donde se encontr\u00f3 que si hubo diferencia de los resultados emitidos por lo s diferentes laboratorios para influenza avi ar en el segundo y tercer muestreo serol\u00f3gico.  \nValladares menciona que la prueba de HI ha sido ampliamente utilizada p ara el subtipo H5 del virus de \ninfluenza a viar. Debido a que las propiedades antig\u00e9nicas de la hemoaglutinina pueden modificarse debido a \nmutaciones de punto, la homolog\u00eda entre el ant\u00edgeno de la prueba y los virus de campo es muy importante para \nlograr un nivel adecuado de detecci\u00f3n de anticuerpos. En este estudio, se encontr\u00f3 que hubo una seroconversi\u00f3n 63rd WPDC/XXXIX ANECA  tanto para la enfermedad de Newcastl e como para influenza aviar en aves vacunadas con estos ant\u00edgenos y \ndetectadas por los cuatro laboratorios nacionales. Sin embargo, si se encontr\u00f3 una diferencia en los resultados de \nInfluenza Aviar probablemente asociado a la homolog\u00eda entre los ant\u00edgenos  de las pruebas.  \n \nCONCLUSIONES  \n \nLos diferentes laboratorios reportaron resultados muy similares por suero durante el primer monitoreo tanto en \nla prueba de HI para enf ermedad de Newcastle como para influenza a viar. \nDurante el segundo y tercero muestreo, lo s diferentes laboratorios reportaron resultados muy similares en el HI \nde enfermedad de Newcastle.  \nEl resultado de HI para influenza a viar en el segundo monitoreo fue muy similar en todos los laboratorios, \nexcepto en el grupo identificado como IA A donde l os t\u00edtulos fueron superiores en el 92.3% de los sueros.  \nAl aplicar un factorial de 4X3 con un 95% de confianza se determin\u00f3 que estad\u00edsticamente si hubo un efecto  de \nlaboratorio y de tiempo sobre los resultados evaluados.  \n \nREFERENCIAS  \n \n1. Lancaster J.E. A his tory of Newcastle disease with comments on its economic effects. World Poultry Sci \nJ; 1976, 32:167- 175. \n2. Kaleta E. F., Baldauf C. Newcastle disease in free- living and pet birds. In: Newcastle disease Edited by: \nAlexander DJ. Boston: Kluwer Academic Publishers; 1998,197- 246. \n3. Capua I, Alexander D. J. The challenge of avian influenza to the veterinary community. Avian Pathol ; \n2006, 35:189- 205. \n4. Perkins L.E.L., Swayne D.E. Pathobiology of A/Chicken/Hong Kong/220/97(H5N1) avian influenza \nvirus in seven gal lineceous species. Vet Pathol ; 2001, 38:149- 154.  \n5. Alexander D.J. A review of avian influenza in different  bird species. Vet Microbiol; 2000, 74:3- 13. \n \nGr\u00e1fico 1. Resultados del primer muestreo serol\u00f3gico. HI de enfermedad de Newcastle. Datos expresados en \nLog 2. \n \n \n  \n \n024681012\nS1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 S13T\u00cdTULOS LOG2\nSUEROSIA AV UN BI63rd WPDC/XXXIX ANECA  Gr\u00e1fico 2. Resultados del segundo muestreo serol\u00f3gico. HI de enfermedad de Newcastle. Datos expresados en \nLog 2. \n \n \n \n \n \nGr\u00e1fico 3. Resultados del tercero muestreo serol\u00f3gico. HI de enfermedad de Newcastle. Datos expresados en \nLog 2. \n \n \n \n024681012\nS1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 S13T\u00cdTULOS LOG2\nSUEROS\nIA AV UN BI\n024681012\nS1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S12 S13T\u00cdTULO LOG2 \nSUEROS  \nIA AV UN BI63rd WPDC/XXXIX ANECA  Gr\u00e1fico 4. Resultados del primer muestreo serol\u00f3gic o. HI  de influenza a viar. Datos expresados en Log 2. \n \n \n \n \n \nGr\u00e1fico 5. Resultados del segu ndo muestreo serol\u00f3gico. HI de influenza aviar. Datos expresados en Log 2. \n \n \n \n \n63rd WPDC/XXXIX ANECA   \nGr\u00e1fico 6. Resultados del tercero muestreo serol\u00f3gico. HI de influenza aviar. Datos expresados en Log 2. \n \n \n \n63rd WPDC/XXXIX ANECA  ESTIMACI\u00d3N DE LA FRECUENCIA DE MYCOPLASMA \nGALLISEPTICUM  EN AVES DE TRASPATIO DEL MUNICIPIO DE \nAGUASCALIENTES DIAGNOSTICADO MEDIANTE PCR  \n \nESTIMATION OF MYCOPLASMA GALLISEPTICUM FREQUENCY IN \nBACKYARD POULTRY IN AGUASCALIENTES DIAGNOSED BY PCR  \n \nJ.J. Hern\u00e1ndez- Rangel , L. Medina- EsparzaA, T.  Queza y C. Cruz -V\u00e1zquez  \n \nAInstituto Tecnol\u00f3gico el Llano Carretera Aguascalientes -San Luis Potos\u00ed, Km. 18 El Llano, C.P. 20330, \nAguascalientes, M\u00e9xico lmedinaesparza@yahoo.com.mx . \n \nSUMMARY  \n \nMycoplasma gallisepticum infection affects laying hens by decreasing laying rate, and increasing embryo \nmortality and FCR. The  way of transmission  of this infection makes its control and treatment difficult. The objective \nof the present work was to estimate the frequency of Mycoplasma gallisepticum using PCR in backyard hens. \nTwelve communities of the state of Aguascalientes  were monitored during 12 m. Four hundred eighty  trachea swab \nsamples were obtained. The samples underwent DNA extraction and PCR in final point tests. Tested sequences were \nMg13R and Mg14F; they were run in 2% agarose gel, and observed in a photodocumentator with 185 pb stripes. \n61.2% of the samples (294/480) were positive to Mycoplasma gallisepticum in 83% of the communities. It is \nconcluded that Mycoplasma gallisepticum infection in backyard hens is high, which indicates a high dissemination \nof Mycoplasma gallisepticum in the st udy area.  \n \nRESUMEN  \n \nLa infecci\u00f3n por Mycoplasma gallisepticum , afecta principalmente disminuyendo la postura, aumenta la \nmuerte embrionaria y conversi\u00f3n alimenticia; la formas de transmisi\u00f3n de esta infecci\u00f3n dificulta su tratamiento y control. El objetiv o fue estimar la frecuencia de m icoplasmosis  mediante la t\u00e9cnica de PCR en gallinas de traspatio. \nSe monitoreo durante seis meses, 12 comunidades del estado de Aguascalientes. Se obtuvieron 480 muestras de \nhisopados traqueales. A las muestras se les hizo extracci\u00f3n del ADN y posteriormente las prueb as de PCR en punto \nfinal. Las secuencias probadas fueron la Mg13R y Mg14F, se corrieron en gel agarosa al 2%, posteriormente se observaron en un fotodocumentador con bandas de 185 pb. El 61.2% (294/480) de l as muestras fueron positivas a \nmicoplasmosis, en el 83% de las comunidades. Se concluye que la infecci\u00f3n por m icoplasmosis en gallinas de \ntraspatio es alta, lo que indica una amplia difusi\u00f3n del Mg en la zona de estudio.  \n \nINTRODUCCI\u00d3N  \n \nEl sector av\u00edcola mexicano juega un papel muy importante econ\u00f3micamen te hablando gracias a que participa \ncon el 63.4% dentro de la producci\u00f3n pecuaria nacional, el estado de Aguascalientes es importante en la producci\u00f3n av\u00edcola, ya que, ocupa el cuarto lugar a nivel nacional en cuanto a la producci\u00f3n de carne de pollo con el 9% de la producci\u00f3n total ( 8).  \nActualmente, se establece como una problem\u00e1tica sanitaria la presencia de Mycoplasma gallisepticum  (Mg) y \nMycoplasma synoviae  (Ms), debido a que puede adquirirse la enfermedad mediante transmisi\u00f3n vertical y \nhorizontal, por lo que, es un problema dif\u00edcil de monitorear, debido a la permanencia y cronicidad de este tipo de \nmicroorganismo dentro de las parvadas, por lo que se dificulta su prevenci\u00f3n y detecci\u00f3n r\u00e1pida ( 2). \nLa p\u00e9rdida econ\u00f3mica, causada por el bajo \u00edndice de conversi\u00f3n alimenticia, se observa con la baja en la postura de reproductoras, ponedoras y la muerte embrionaria en huevos infectados ( 5,6).  \nA pesar de las medidas de bioseguridad que ha  adoptado la industria av\u00edcola,  la micoplasmosis aviar, se \nencuentra presente en las granjas av\u00edcolas, de esto surge la necesidad de realizar un estudio inicial, principalmente \nen aves de traspatio, sobre la enfermedad, as\u00ed como, estandarizar una t\u00e9cnica alternativa de diagn\u00f3stico altamente sensible y espec\u00edfica, como la reacci\u00f3n en cadena de la p olimerasa (PCR), y con ello realizar monitoreos peri\u00f3dicos \ny frecuentes, para disminuir el tiempo de diagn\u00f3stico e identificaci\u00f3n del Mg.  63rd WPDC/XXXIX ANECA  El objetivo del presente trabajo fue estimar la frecuencia de Mycoplasma gallisepticum  mediante la t\u00e9cnica de \nPCR en gallinas de traspatio en el estado de Aguascalientes.  \n \nMATERIALES Y M\u00c9TODOS  \n \nEl estudio se realiz\u00f3 en unidades av\u00edcolas de traspatio ubicadas en el estado de Aguascalientes, M\u00e9xico. El \npresente es un estudio epidemiol\u00f3gico de  tipo descriptivo, donde la selecci\u00f3n de las unidades de producci\u00f3n fue \nmediante el m\u00e9todo no p robabil\u00edstico de conveniencia ( 7). \nEl trabajo se dividi\u00f3 en dos fases, primero una fase de campo, la cual se llev\u00f3  a cabo en el per iodo de marzo a \nagosto de 2012, se realiz\u00f3 el muestreo traqueal en gallinas mayores a un a\u00f1o de edad, en cada una de las unidades de \ntraspatio participantes, los muestreos se llevaron a cabo de manera semanal en 45 aves, para tener un gran total de \n480 aves muestreadas dur ante este periodo. Todos los hisopados traqueales obtenidos, fueron colocados en un tubo \nde ensayo, previamente identificados con fecha, unidad y n\u00famero de muestra, en un medio a base de triptosa fosfato \n(DIFCO, BD 260300), se colocaron en hieleras a una t emperatura de 4 \u00baC y debidamente aislados con material \nt\u00e9rmico, posteriormente fueron transportados al laboratorio del Instituto Tecnol\u00f3gico el Llano Aguascalientes, donde \nse procesaron de manera inmediata a su llegada.  \nPosteriormente se llev\u00f3  a cabo la fas e de laboratorio, donde se realiz\u00f3 la extracci\u00f3n de ADN, con el  protocolo \npara la extracci\u00f3n de ADN de c\u00e9lulas en cultivo o tejidos conservados en medio de transporte.  \nLa PCR punto final, se realiz\u00f3 en base al protocolo propuesto por la Organizaci\u00f3n Internacional de Epizootias \n(4), con secuencias o primers espec\u00edficos para Mg: MG14F: 5' -GAG -CTA -ATC -TGT -AAA- GTT -GGT -C-3' y \nMG13R: 5' - GCT -TCC- TTG -CGG -TTA -GCA- AC-3', mismos cebadores utilizados por Jarquin y col.  (3), con el \nprotocolo de reacci\u00f3n modificada de O IE, 2008. La amplificaci\u00f3n se llev\u00f3 a cabo en un termociclador Techne \n(Cambridge) Limited 1995. Los productos obtenidos de \u00e9sta, se corrieron en un gel de agarosa al 2% (Ag\u00fcero y col.  \n2004), el cual se visualiz\u00f3 en un trasiluminador de luz ultravioleta, pa ra observar una banda cuyo peso molecular fue \nde 185 pb que identifica la presencia de ADN de Mg.  \nPara el an\u00e1lisis estad\u00edstico de los presentes datos se emple\u00f3 la form ula descrita por Thrusfield ( 7) para \ndeterminar la frecuencia (F), que se describe como el n\u00famero de instancias, enfermos o atributos relacionados, en \nuna poblaci\u00f3n conocida a un tiempo determinado, sin distinci\u00f3n entre viejos y nuevos casos. Es decir describe el n\u00famero de animales enfermos en relaci\u00f3n con la poblaci\u00f3n en riesgo de desarrollar  la enfermedad:  \n \nF= N\u00famero de individuos enfermos en un punto en particular en el \ntiempo  \nN\u00famero de individuos en la poblaci\u00f3n de riesgo en un punto en \nparticular del tiempo  \n \nRESULTADOS  \n \nAl realizar las primeras pruebas de PCR, los amplicones  se corrieron en un gel de agarosa al 2%, por un tiempo \npromedio de dos horas, agregando un marcador de peso molecular, observ\u00e1ndose las bandas a una altura de 185 pb, con lo cual se confirma la presencia de ADN de Mg , como se puede apreciar en la F igura 1 . \nUna vez realizadas las pruebas se encontr\u00f3 que del tot al de muestras procesadas (480)  294 fueron positivas a \nMg mediante la t\u00e9cnica de PCR, con lo cual se estableci\u00f3 una frecuencia general de 61.25% (294/480). Callison (6) , \nencuentran una frecuencia de 5 2.8% (228/442), esto al desarrollar y validar una PCR tiempo real con sondas \nTaqMan.  \n \nCONCLUSI\u00d3N  \n \nLa frecuencia obtenida en el presente estudio fue de 61.25% (294/480), la cual ser\u00e1 un punto de referencia al \nser este el primer estudio en su tipo para la regi\u00f3n donde se llevo a cabo, aportando datos interesantes para la industria av\u00edcola de Aguascalient es. \n \nREFERENCIAS  \n \n1. Callison S. A., S. M. Riblet, S. H. Kleven, S. Sun, D. L. Suarez,  N. Ikuta,  D. Hilt, And  M. Garc\u00eda,  \nDevelopment and Validation of a Real -Time TaqMan  Polymerase Chain Reaction Assay for the Detection of \nMycoplasma gallisepticum in Naturally Infected Birds. AVIAN DIS, 50: 537- 544. 2006 . 63rd WPDC/XXXIX ANECA  2. Hess M., C. Neubauer, Y,  R. Hackl. Interlaboratory comparison of ability to detect nucleic acid of \nMycoplasma gallise pticum and Mycoplasma synoviae by polymerase chain reaction. AVIAN PATHOLOGY 36 (2): \n127-133. 2007.  \n3. Jarquin, R.,  J. Schultz , I. Hanning,  And S. Ricke. Development of a Real -Time Polymerase Chain \nReaction Assay for The  Simultaneous Detection of Mycoplasma Gallisepticum and Mycoplasma Synoviae Under \nIndustry Conditions. AVIAN DIS, 53(1): 73 -77. 2009.  \n4. OIE. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2008. Chapter 2.3.5. Avian \nMycoplasmosis (Mycoplasma gallisepticum, M. synoviae). 2008 De \nhttp://www.oie.int/eng/normes/mmanual/2008/pdf/2.03.05_%20AVIAN_MYCO.pdf . 10 feb. 2011.  \n5. Papazisi, L., T. S. Gorton,  G. Kutish,  P. F.  Markham,  G. F.  Browning,  D. K.  Nguyen,  S. Swartzell, A. \nMadan , G. Mahairas Y S. J. Geary. The complete genome sequence of the avian pathogen Mycoplasma \ngallisepticum strain Rlow. MICROBIOLOGY. 149: 2307 \u20132316.  2003.  \n6. Sprygin A. V., D. B.  Andreychuk,  A. N. Kolotilov,  M. S.  Volkov , I. A. Runina , N. S. Mudrak , A. V.  \nBorisov , V. N.  Irza, V. V. Drygin And N. A.  Perevozchikova. Development of a duplex real -time TaqMan  PCR \nassay with an internal control for the detection of Mycoplasma gallisepticum and Mycoplasma synoviae in clinical \nsamples from commercial and backyard poultry. AVIAN PATHOLOGY 39(2): 99- 109. 2010.  \n7. Thrusfield, M . Veterinary Epidemiology. 3th edition. Lo ndon, UKD: Blackwell Science. 2007  \n8. UNA. Union Nacional de Avicultores. 2011. De http://www.una.org.mx/index.  17 mar. 2011.  \n \n \n \nFigura 1. Pesaje de muestras positivos  a Mg, observ\u00e1ndose con un peso molecular de 185 pb.  \n \n \n 63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N DE UNA MEZCLA DE MINERALES TRAZA \nORG\u00c1NICOS, \u00c1CIDOS ORG\u00c1NICOS CON Y SIN LA ADICI\u00d3N DE \nENZIMAS EX\u00d3GENAS EN DIETAS SORGO- SOYA PARA \nGALLINAS ISA BROWN  \n \nEVALUATION OF A MIXTURE OF ORGANIC TRACE MINERALS, ORGANIC \nACIDS AND ENZYMES IN SORGHUM-  SOYBEAN DIETS FOR  \nISA BROWN HENS  \n \nV. HerreraA, C. CortesA, R. S\u00e1nchezB y G. \u00c1vilaA \n \nACentro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola -FMVZ \u2013UNAM  \nBSecretaria Administrativa \u2013  FMVZ -UNAM  \nmvzlazaro46@gmail.com  \n \nSUMMARY  \n \nThis study evaluated the addition of two organic trace mineral premixtures, organic acids and the presence or \nabsence of carbohydrase enzymes in diets for l ayers. 360 Isa Brown hens 72 w k old were used, fed with sorghum -\nsoybean based diet s; treatments were: Treatment 1 -Sorghum + soybean basal diet ; Treatment 2 -As 1 + premix 1; \nTreatment 3 -As 1 + Premix 2; Treatment 4 -As 1 reformulated + premix 1 (Premix 1 with enzymes and Premix 2 \nwitho ut enzymes). Results from 10 wk  of experimentation indicated differences (p < 0.05) for: laying percentage \n(77.5c , 81.9a , and 78.9 bc and 80.7ab) egg weight (63.9 b , 64.6a , 63.7by 63.9b g), feed i ntake (109.3b , 113ab , \n110.5b and 118a g) and feed conver sion (2.20b, 2.23b, 2.20b, and  2.32a). It can be concluded that the addition of \ntrace minerals or inorganic minerals, organic acids and growth promoters in sorghum \u2013  soy diets for hens did not \naffect growth performance , but the inclusion of carbohydrases improved yield .  \n \nRESUMEN  \n \nEl presente estudio, se lle v\u00f3 a cabo con la finalidad de estudiar la adici\u00f3n  de una premezcla de minerales traza \norg\u00e1nica, \u00e1cidos org\u00e1nicos y la presencia o ausencia de enzimas carbohidrasas  en la dieta de gallinas postura \n(premezcla 1 y 2) . Se utilizaron 360 gallinas de la l\u00ednea Isa Brown, de 72 semanas de edad y de 55 semanas en \nproducci\u00f3n, alimentadas con dietas a de base sorgo - pasta de soya, los tra tamientos fueron: Tratamiento 1 - Dieta \ntestigo  sorgo + pasta de soya con minerales traza inorg\u00e1nicos y promotor de crecimiento; Tratamiento 2 - Como T1 + \n4kg/ton premezcla  1; Tratamiento 3 - Como T1 + 4kg/ton premezcla 2; Tratamiento 4 - reformulado con premezcla 1 \n4kg/ton.  Los resultados obtenidos en 10 semanas de experimentaci\u00f3n  indicaron diferencias entre tratamientos \n(p<0.05) para; porcentaje de postura,  peso del huevo g consumo de a limento ave/d\u00eda/g  y conversi\u00f3n alimenticia; con \nrespecto huevo sucio, huevo f\u00e1rfara, huevo roto, unidades Haugh,  color  de la yema del huevo y resis tencia del \ncascar\u00f3n no hubo diferencia (P<0.05) entre los tratamientos.  Con los resultados obtenidos en el presente estudio, se \npuede concluir que la adici\u00f3n de minerales traza org\u00e1nicos y \u00e1cidos org\u00e1nicos en una dieta sorgo -soya con minerales \ntraza inorg\u00e1nicos y promotor de crecimiento para gallinas no mejora los par\u00e1metros productivos; sin embargo la \ninclusi\u00f3n de enzimas carbohidrasas en esta premezcla incrementa el comportamiento.  \n \nINTRODUCCI\u00d3N  \n \nLa industria av\u00edcola est\u00e1 continuamente en busca de aditivos para mejorar la eficiencia alimentaria ; entre estos \ncompuestos, los \u00e1cidos org\u00e1nicos son alternativas prometedoras. Los \u00e1cidos org\u00e1nicos suelen inhibir el crecimiento \nde los microorganismos en las raciones y en consecuencia, preservar el equilibri o microbiano en el tracto \ngastrointestinal (TGI) de las aves.  \nPara contrarrestar los efectos negativos de los PNA contenidos en las paredes celulares de los granos y semillas \noleaginosas, se utilizan enzimas ex\u00f3genas, como xilanasas y \u03b2 -glucanasas, las cua les influyen tambi\u00e9n en la  salud \nintestinal.  \n 63rd WPDC/XXXIX ANECA  MATERIAL Y M\u00c9TODOS  \n \nSe utilizaron 360 gallinas, de la l\u00ednea Isa Brown de 72 semanas de edad y de 55 semanas en producci\u00f3n, las \ncuales se alojaron en corrales, con piso de cemento y cama de paja de trigo en una caseta de ambiente natural. Las \naves se distribuyeron   al azar en ocho  grupos de 45 aves cada uno. A las aves se les proporcion\u00f3 un fotoperiodo de \n16 hrs luz x d\u00eda. Adem\u00e1s el alimento y  el agua se ofrecieron a libre acceso durante todo el experimento. Se e mple\u00f3 \nun di se\u00f1o completamente al azar, de cuatro tratamientos con dos  repeticio nes de 45 gallinas cada una. Los \ntratamientos fueron como se se\u00f1ala a continuaci\u00f3n:  \n\u2022 Tratamiento 1  Dieta basal sorgo + soya  \n\u2022 Tratamiento 2  Como 1 + premezcla  1, 4kg/ton (ON  TOP  \n\u2022 Tratamiento 3  Como 1 + premezcla 2, 4kg/ton. (ON TOP)  \n\u2022 Tratamiento 4  Dieta sorgo + soya con menor cantidad de Energ\u00eda Metabolizable (3%),  Prote\u00edna \n(2%) y amino\u00e1cidos esenciales (2%)   1, 4kg/ton.  \nDurante las 10 semanas de experimentaci\u00f3n, se llevaron registro semanales   de porcentaje de postura, peso promedio \ndel huevo, masa de huevo por ave por d\u00eda, consumo de alimento, conversi\u00f3n alimenticia, porcentaje de huevos con \nc\u00e1scara rota y c\u00e1scara en f\u00e1rfara y porcentaje de mortalidad.  Se realizaron  cuatro mediciones de la calidad interna de \nhuevo (a las 2, 5, 7 y10 semanas), coloraci\u00f3n de la yema del huevo, Unidades Haugh y la resistencia a la rotura del \ncascar\u00f3n en fuerza (kg).  \n \nRESULTADOS  \n \nLos resultados obtenidos en 10 semanas de experimentaci\u00f3n indicaron diferencias entre tratamientos (p<0.05) \npara; porcentaje de postura, peso del huevo g, consumo de alimento ave/d\u00eda/g y conversi\u00f3n alimenticia como lo \nmuestra el cuadro 1; en el cuadro 2 con respecto huevo sucio, huevo f\u00e1rfara, huevo roto, unidade s Haugh,  color  de la \nyema del huevo y resistencia del cascar\u00f3n no hubo diferencia (P<0.05) entre los tratamientos.  i \n \nREFERENCIA  \n \n1. L\u00f3pez C.C., Arce M.J., \u00c1vila G.E. Mitos y Realidades del Sistema Digestivo y sus Implicaciones sobre la \nProductividad. Asociac i\u00f3n Espa\u00f1ola de Ciencias Av\u00edcolas. Julio de 2006.  \n2. Piquer FJ. Bases de la utilizaci\u00f3n de complejos enzim\u00e1ticos en nutrici\u00f3n animal: estudio comparativo entre \nespecies. XII Curso de especializaci\u00f3n FEDNA; 1996 noviembre 7 -8; Madrid Espa\u00f1a: Fundaci\u00f3n Espa\u00f1ola  para el \nDesarrollo de la Nutrici\u00f3n Animal,: 1 -7 1996.  \n3. Quiroz M.A., Dibner J.J., Knight C.D. y Gonz\u00e1lez -Esquerra R. Uso de \u00e1cidos org\u00e1nicos como  alternativa \npara el control de la enteritis necr\u00f3tica. Seminario Internacional Novus \u2013  Nra, Santiago de Quer\u00e9taro, M\u00e9xico, Abril \n8, 2005.  \n4. Romero VFJ. Utilizaci\u00f3n de enzima xilanasa y \u03b2 -glucanasas en dietas (sorgo+soya+alfalfa) para gallinas en \npostura. (Tesis de licenciatura) Distrito Federal, M\u00e9xico. Universidad Nacional Aut\u00f3noma de M\u00e9xico; 2003.  \n  \nCuadro 1 . Par\u00e1metros productivos en 10 semanas de producci\u00f3n en gallinas Isa Brown . \n \nTratamiento  % Postura  Peso de Huevo \n(g) Masa de \nHuevo (g)  Consumo de \nalimento (g)  Conversi\u00f3n \nalimenticia \n(kg:kg)  \nDieta testigo  77.5 c  63.9 b  49.5 a  109.3 b  \n 2.20 b  \nOn Top \nPremezcla 1  81.9 a  64.6 a  51 a 113.8 ab  2.23 b  \nOn Top \npremezcla 2  78.9 bc  63.7 b  50.0 a  110.5 b  2.20 b  \nPremezcla 1 \nreformulado  80.7 ab  63.9 b  51.2 a  118.0 a  2.32 a  \nValores con diferente literal en la columna son distintos (P<0.05 ) \n 63rd WPDC/XXXIX ANECA   \nCuadro 2 . Resultados de Unidades Haugh, color de yema y r esistencia del cascar\u00f3n.  \n \nTratamiento  UH Color  Fuerza(kg)  \nDieta testigo  75.2 8.0 1.12 \nOn Top Premezcla 1  82.0 7.7 1.19 \nOn Top Premezcla 2  74.6 8.1 1.16 \nPremezcla 1 \nreformulado  75.0 8.3 1.25 \nValores con diferente literal en la columna son distintos (P<0.05)  \n \n 63rd WPDC/XXXIX ANECA  EFFECT OF COCCIDIA VACCINE ON SALMONELLA \nHEIDELBERG COLONIZATION IN BROILER CHICKENS  \n \nEFECTO DE LA VACUNA CONTRA COCCIDIA SOBRE LA COLONIZACI\u00d3N \nDE SALMONELLA HEIDELBERG EN POLLOS DE ENGORDA \n \nC. HofacreA, L. NewmanB, C. BroussardB, G. MathisC, and R. BerghausA \n \nAThe University of Georgia, Athens, Georgia  \nBMerck Animal Health, Summit, New Jersey  \nCSouthern Poultry Research, Athens, Georgia  \n \nRESUMEN  \n \nExiste una mayor demanda por parte del consumidor de pollo producido sin antibi\u00f3ticos, lo cual se traduce en \nun aumento en el uso de la vacuna contra coccidia en pollos de engorda. Dado que tanto Salmonella como la cepa de \nla vacuna de Eimeria tenella  habitan en el ciego no se ha estudiado si esto tiene un efecto sobre alguno de los \norganismos. Pollitos de engorda de un d\u00eda de edad recibieron una vacuna contra coccidia (Coccivac B\u00ae) o \nsalinomicina (60g/ton) en el alimento y luego la mitad de los pollitos fueron alimentados por sonda con  S. \nHeidelberg.  \nLa prevalencia de S. Heidelberg en las aves vacunadas con Coccivac - B fue 17 % menor que en las aves \ncontrol (control 68.8 % vs 51.3 % Coccivac - B) y un 16% menor que los pollos de engorda tratados con \nsalinomicina (67,5%). Adem\u00e1s de la prevalencia num\u00e9ricamente m\u00e1s baja de S. Heidelberg, los pollos de engorda \nvacunados con Coccivac - B que hab\u00edan sido colonizados con Salmonella, tuvieron una media geom\u00e9trica de MPN \nde S. Heidelberg inferior en su ceca (3.3 ufc / gramo) vs los tratados con salinomicina  (5.5 ufc / gramo) y los \ncontroles (4.3 ufc / gramo).  \n \nSUMMARY  \n \nIn recent years there has been an increase in the use of coccidia vaccine in broilers.  Eimeria tenella  and E. \nnecatrix  have been shown to increase the shed ding of Salmonella.  Since both Salmonella and the vaccine strain  of \nEimeria tenella  inhabit the ceca it has not been studied whether this vaccine use has an effect on the shed ding of \nSalmonella.  Day old male broiler chi cks were given a coccidia vaccine (Coccivac B\u00ae) or salinomycin  (60g/ton) in \nthe feed and then \u00bd of the chicks in each pen were gavaged with S. Heidelberg . \nThe S. Heidelberg  prevalence in the Coccivac- B vaccinated birds was 17% lower than the control birds (68.8% \ncontrol vs. 51.3% Coccivac -B) and 16% lower than the salinomycin treated broilers (67.5%).  In addition to \nnumerically lower S. Heidelberg  prevalence the Coccivac -B vaccinated broilers that had colonized with Salmonella \nhad a lower geometric mean most probable number (MPN) of S. Heidelberg  in their ceca (3.3 cfu/gram) vs. the \nsalinomycin  treated (5.5 cfu/gram) and the control  (4.3 cfu/gram).  \n \nINTRODUCTION  \n \nThe intestine of a chicken is a complex organ that is a balance o f bacteria, viruses, and protozoa.  When a \ncondition occurs to alter this delicate balance, such as coccidiosis , then especially the bacteria component of the \nflora is affected ( 3). Salmonella, although a small part, is a part of the normal bacteria flora of a healthy chicken\u2019s \nintestines.  However, in a human intestine it can result in disease that we call foodborne illness.  \nThe management of all three  parts of this flora is critical to prevent any Salmonella spp. that may be present \nfrom becoming an even l arger part of the normal flora in the ceca.  The two  species of coccidia  that reproduce either \npart or all of their lifecycle in the ceca are Eimeria tenella  and E. necatrix  (4). It has also been well documented that \ndisease caused by E. tenella  and E. neca trix, commonly referred to as coccidiosis , can also result in increased \nSalmonella colonization and shedding ( 1,5). \nThe control of Eimeria  spp. from causing clinical disease can be by in -feed medication, vaccination or a \ncombination of both ( 2). There has been a significant increase in the number of broilers that have been given \ncoccidia vaccines in recent years.  The reasons vary from coccidia resistance to the in -feed coccidiostats , to 63rd WPDC/XXXIX ANECA  attempting to re -establish susceptible (vaccine) strains of Eimeria  in broiler houses , to meeting consumer \npreferences for broilers grown \u201cfree of drugs\u201d.  It is also known that the timing of the coccidia cycle and thus the \ndamage to the intestinal epithelium can be very different between the ionophore anticoccidial drugs and for birds \ngiven a coccidia vaccine at 1 day of age  \nAs previously stated, the disease coccidiosis  caused by E. tenella  and E. necatrix  can result in increased \nSalmonella colonization (1,5). However, what has  not been demonstrated in a controlled study is whether subclinical \ncoccidia infection from a low dose coccidi ostat in the feed or a coccidia  vaccine will have a similar effect on \nSalmonella colonization of broiler ceca.  \n \nMATERIALS AND METHODS  \n \nOne thousand and two hundred male broiler chickens, Cobb x C obb were randomly divided into three  \ntreatments ; 50 chicks per pen with eight  pen-level replicates/treatment.  The control broilers received no coccidia  \nprevention, the coccidia vaccinated broilers received a full dose of Coccivac- B by coarse spray and the salinomycin \ntreated broilers were fed 60 g /ton of salinomycin from day of age to 35 d. Half of the broil er chicks upon placement  \nwere orally gavaged with 3.4 x 105 colony forming  units (CFU) of a nalidixic acid resistant S. Heidelberg . These \nseeders were also tagged.  The remaining birds  in each pen served as contact control or horizontal exposure.  All had \nbedding of soft wood shavings that had been used one time before for a broiler grow out.  This p rovided a \nnatural/more typical coccidia challenge.  \nAt 42 d of age 10 broilers from each pen (5 direct and 5 contact) were humanely euthanized, ceca removed \naseptically and placed into sterile whirl pack bags onto ice for transport.  Salmonella culture was p erformed for \nprevalence of Salmonella using tetrathionate enrichment and XLT -4 agar.  Also, the Salmonella in the ceca were \nenumerated by the most probably number method (MPN) using tetrathionate and XLT -4. \n \nSTATISTICAL ANALYSIS  \n \nDescriptive statistics for continuous variables were reported using the mean and standard deviation.  Because \nthe variances within treatment groups were not homogeneous with respect to pen- level fecal oocyst counts, separate \nnonparametric Kruskal -Wallis tests were used to compare gro ups at each time point.  Pairwise multiple comparisons \nwere performed using a nonparametric Bonferroni procedure to limit the type I error rate to 5% over all \ncomparisons.  Cecal Salmonella MPNs and prevalences were compared between treatment groups and chal lenge \nstatus categories using generalized estimating equations linear and logistic models, respectively, to account for the \ncorrelation between responses of birds from the same pens.  Generalized estimating equations models were \nperformed using robust stand ard errors and an exchangeable working correlation structure.  All statistical testing \nassumed a two -sided alternative hypothesis, and P  < 0.05 was considered significant.  Analyses were performed \nusing commercially available statistical software (Stata vers ion 12.1, StataCorp LP, College Station, TX).  \n \nRESULTS AND DISCUSSION \n \nThe Salmonella challenge was successful as evidenced by 100% of the pens having  drag swabs positive for S. \nHeidelberg  14 d post challenge.  However, by d  42 only 75% of the coccidia vaccinated pens were Salmonella  \npositive vs. 100% positive salinomycin treated pens and 88% of the control pens were Salmonella positive.  Even \nthough these differences were not statistically significant it was consistent with  less Salmonella shedding by t he \ncoccidia vaccinated broilers.  \nThe Salmonella  Heidelberg  prevalence in the Coccivac -B vaccinated birds were 17% lower than the control \nbirds (68.8% positive control vs. 51.3% positive Coccivac -B) and 16% lower than the salinomycin treated broilers \n(67.5% ). Again, these differences were not statistically significant but follow the same pattern  as the Salmonella \nenvironmental positive.  \nSalmonella log 10 MPNs for culture -positive samples are summarized by treatment group and bird challenge \nstatus (dosed or not dosed) in Table 1. In the univariate analysis there was no significant difference between the \nmean Salmonella log 10 MPNs of the treatment groups ( P = 0.774) but the mean log 10 MPN of birds that had been \nindividually dosed was significantly higher than the mean log 10 MPN of birds that had not been individually dosed \n(P = 0.002).  In a multivariable model that contained both treatment and dosing status there was a significant \ninteraction between treatment and challenge status ( P = 0.048), so treatments wer e compared separately by \nchallenge status.  There was not a significant difference between treatments in either birds that were individually \ndosed ( P = 0.737) or in birds that were not individually dosed (P = 0.349).  When comparing birds that were 63rd WPDC/XXXIX ANECA  individua lly dosed to those that were not individually dosed, the birds that were individually dosed had a \nsignificantly higher mean log 10 MPN than birds that were not individually dosed in the control group ( P = 0.004), \nbut not in the Coccivac -B (P = 0.080) or sal inomycin ( P = 0.565) groups.  \n \nCONCLUSION  \n \nIn summary, the Coccivac -B vaccinated and Salmonella challenged broilers had numerically lower Salmonella  \nin their environment, lower Salmonella prevalence in their ceca and had a lower geometric mean Salmonella MPN \nin their ceca ( 3.3 cfu/g ) vs. the salinomycin treated ( 5.5 cfu/g ) and the control ( 4.3 cfu/g ). The results of this study \nconfirm the field stu dy findings of V olkova, et al. ( 7). In their study of sampling 66 commercial broilers flocks in \nthe S. Eastern  U.S., they found that administration of live Eimeria oocyst vaccine to day old broilers was associated \nwith a reduced probability of detecting Salmonella in the flock.  The reason the coccidia vaccine resulted in lower \nSalmonella colonization may  be due to the timing of the Eimeria  lifecycle as it produces ceca epithelial cell damage.  \nAs seen in Figure 1, the oocyst counts in the litter from the Coccivac -B pens were high by d 13 but dropped rapidly \nby d 19 where the salinomycin treated pens had low er levels of Eimeria  oocysts on d  13 and then had peak counts \non d 22 with continued highe r oocyst numbers out to even d 40. \nA second reason for the coccidia vaccinated broilers having lower Salmonella colonization could also be due to \na combination of the  age of the broiler s when exposed to coccidia and also the amount of intestinal damage.  Tellez, \net al. found increased resistance to S . Enteritidis  organ invasion following subclinical coccidial infections ( 6). It \ncould be theorized that the early coccidia exposure with the Coccivac -B in this study resulted in a rapid host \ninflammatory response in the intestine during the same time period that the Salmonella Heidelberg  was colonizing,  \nthus preventing the Salmonel la from colonizing internal organs and/or eliminating the Salmonella  before it could \ncolonize.  \nRegardless of the mechanism it can be concluded from this study that the use of a coccidial vaccine may allow \nthe broiler chicken to be less susceptible to Salmonella Heidelberg  colonization.  \n \nREFERENCES  \n \n1. Arakawa A, Baba E, Fukata T. Eimeria tenella infection enhances Salmonella typhimurium infection in \nchickens. Poultry science. 1981;60(10):2203- 9. Epub 1981/10/01.  \n2. Chapman HD, Cherry TE, Danforth HD, Richards G, Shirley MW, Williams RB. Sustainable coccidiosis \ncontrol in poultry production: the role of live vaccines. International journal for parasitology. 2002;32(5):617- 29. \nEpub 2002/04/12.  \n3. Collier CT, Hofacre CL, Payne AM, Anderson DB, Kaiser P, Mack ie RI, et al. Coccidia -induced \nmucogenesis promotes the onset of necrotic enteritis by supporting Clostridium perfringens  growth. Veterinary \nimmunology and immunopathology. 2008;122(1- 2):104- 15. Epub 2007/12/11.  \n4. Reid M. A diagnostic chart for mine species of fowl coccidia. University of Georgia College of Ag Exper \nStation Bulletin. 1973(Research Report #163).  \n5. Stephens JF, D. B. Barnett, and D. F. Holtman. Concurrent Salmonella typhimurium and Eimeria necatrix  \ninfections in chicks. Poultry science. 1964(43): 352-6. \n6. Tellez GI, M. H. Kogut, and B. M. Hargis. Eimeria tenella or Eimeria adenoides induction of \nmorphological changes and increased resistance to Salmonella enteritidis infection in leghorn chickens. Poultry \nscience. 1994;73(396- 401).  \n7. Volkova VV, Wills RW, Hubbard SA, Magee D, Byrd JA, Bailey RH. Associations between vaccinations \nagainst protozoal and viral infections and Salmonella in broiler flocks. Epidemiol Infect. 2011;139(2):206- 15. \n \n \n \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA  Table 1 . Mean (standard deviation) Salmonella  log 10 MPN in 150 culture -positive ceca samples by treatment \ngroup and challenge status (dosed or not dosed).  \nDosed  Control  Coccivac -B\u00ae Salinomycin  Total  \nNo \n 0.44a (0.81)  0.36a (0.40)  0.74a (0.95)  0.53 (0.80)  \nYes \n 0.79b (0.74)  0.63a (0.79)  0.74a (1.02)  0.72 (0.85)  \nTotal  \n 0.63 (0.79)  0.52 (0.66)  0.74 (0.98)  0.64 (0.83)  \nWithin columns, means with a superscript in common do not differ with a level of significance of 5% over all \ncomparisons.  There were no significant differences between treatment groups for either the birds that were \nindividually dosed or for those that were not individually dosed.  Sample sizes: control not dosed, n = 25; control \ndosed, n = 30; Coccivac -B\u00ae not dosed, n = 17; Coccivac -B\u00ae dosed, n = 24; salinomycin not dosed, n = 25; \nsalinomyci n dosed, n = 29 \n \n \n \n \n 02,0004,0006,0008,00010,00012,00014,00016,00018,000\nDay\n13Day\n16Day\n19Day\n22Day\n25Day\n28Day\n31Day\n34Day\n37Day\n40Figure 1:  Occyst  Counts  \n(E. acervulina/E. tenella)  \nCoccivac-B\u00ae\nIonophore63rd WPDC/XXXIX ANECA  EFECTO DE LA ADICI\u00d3N DE GLUTAMINA + \u00c1CIDO \nGLUT\u00c1MICO EN DIETAS DE POLLO DE ENGORDA SOBRE LA \nINTEGRIDAD INTESTINAL Y  \nEL COMPORTAMIENTO PRODUCTIVO  \n \nEFFECT OF THE ADDITION OF GLUTAMIN + GLUTAMIC ACID ON \nBROILER CHICKENS DIE TS ON INTESTINE INTEGRITY AND \nPRODUCTIVE PERFORMAN CE \n \nMiguel IJA*, V\u00e1zquez DASA, Gomez VGB Hern\u00e1ndez EJC y \u00c1vila GE A  \n \nACentro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola -FMVZ \u2013UNAM  \nBDepartamento de Medicina y Zootecnia de Aves -FMVZ -UNAM  \nCDepartamento  de Morfolog\u00eda -FMVZ -UNAM  \nmvz.jorge.miguel@gmail.com  \n \nSUMMARY  \n \nThe objective of the present study was to evaluate five levels of glutamine + glutamic acid (0 , 700, 1400, 2100 \nand 2800 ppm/t on) in diets for broiler chickens and observe its effects on the intestine integrity and pr oductive \nperformance at 49 d of age.  Eight hundred  Ross chickens distributed in five treatments were used. Results for \ncarcass weight and FCR indicated a significant ( P<0.05) difference. Treatment 2 had a heavier weight compared t o \nTreatments 1 and 5, but similar to T reatments 3 and 4. For FCR, data indicated a better FCR for Treatments 2 and 5 \ncompared to T reatments 1, 3 and 4. For villus height, data showed difference ( P<0.05) between treatments, with a \nhighest height for treatme nt 2 compared to the rest of the treatments.  \n \nRESUMEN  \n \nEl objetivo del estudio fue evaluar cinco niveles de glutamina + \u00e1cido g lut\u00e1mico (0,700, 1400,2100 y 2800 \nppm/Ton) en dietas para pollo de engorda y observar el efecto  sobre la integridad intestinal y el comport amiento \nproductivo a los 49 d de edad. Se utilizaron  800 pollos Ross 308 distribuidos en cinco  tratamientos.  Los resultados \nobtenidos para peso de la canal y conversi\u00f3n alimenticia, indicaron que existi\u00f3 diferencia ( P<0.05) . Con un mayor \npeso de la canal en el tratamiento 2, respecto a los tratamientos 1 y 5, pero similar a los tratamientos 3 y 4. En \nconversi\u00f3n alimenticia los datos obtenidos muestran que se obtuvo una mejor conversi\u00f3n alimenticia en los \ntratamientos 2 y 5 en comparaci\u00f3n a los tra tamientos 1, 3 y 4. Para altura de las vellosidades  intestinales , los datos \nindicaron diferencia (P<0.05) entre tratamientos, con una mayor altura en el tratamiento 2 respecto a los dem\u00e1s tratamientos.  \n \nINTRODUCCI\u00d3N  \n \nLa g lutamina es un amino\u00e1cido que se le  considera como condicionalmente esencial, debido a que el \norganismo si lo sintetiza pero  bajo determinadas situaciones de estr\u00e9s, la cantidad sintetizada es insuficiente para \ncubrir con las necesidades del organism o (1). Investigaciones en cerdos demuestran que la glutamina mejora la \naltura de las vellosidades intestinales, teniendo as\u00ed mayor superficie de digesti\u00f3n y absorci\u00f3n de nutrientes, mejorando la ganancia de peso y conversi\u00f3n alimentici a (3). Con base en estos antecedentes, se realiz\u00f3  el presente \nestudio con el objeto de evaluar el efecto de adicionar un producto a bese de glutamina + acido g lut\u00e1mico en los \nprimeros 21 d\u00edas  de vida en dietas sorgo + p asta de soya para pollos de engorda y su impacto en los par\u00e1metros \nproductivos y la longitu d de las vellosidades intestinales.  \n \n \n \n 63rd WPDC/XXXIX ANECA  MATERIAL Y M\u00c9TODOS  \n \nSe utilizaron 800 pollos de engorda de un d\u00eda de edad, de la estirpe Ross 308 obtenidos de una incubadora \ncomercial. Las aves fueron distribuidas en 25 lotes de 32 pollos cada una (mitad machos y  mitad hembras) alojados \nen una caseta convencional con corrales con piso de cemento y cortinas laterales. Los pollos se distribuyeron \ncompletamente al azar en cinco  tratamientos, cada uno con cinco  repeticiones de 32 aves cada una, durante la etapa \nde ini ciaci\u00f3n de 0 -14 d\u00edas  y la de crecimiento de 15 a 21 d \u00edas de edad recibieron un producto comercial a base de \nglutamina y acido glut\u00e1mico como se describe a continuaci\u00f3n:  \nT1= Dieta sorgo + pasta de s oya \nT2= T1 + 700 ppm de la mezcla de glutamina y acido glut \u00e1mico/ ton  \nT3= T1 + 1400 ppm de la mezcla de glutamina y acido glut\u00e1mico/ ton T4= T1 + 2100 ppm de la mezcla de glutamina y acido glut\u00e1mico/ ton \nT5= T1 + 2800 ppm de la mezcla de glutamina y acido glut\u00e1mico/ ton \nPosteriormente, se ofreci\u00f3 a todos los trata mientos dietas sorgo -soya para finalizaci\u00f3n de los 22 a los 49 d \u00edas de \nedad.  \nDurante el estudio, se llevaron registros de ganancia de peso, consumo de alimento, conversi\u00f3n alimenticia y \nrendimiento de la canal . Para la medici\u00f3n de la longitud de las vellos idades se tomaron muestras de asa duodenal al \nd\u00eda 35 de edad, los fragmentos de intestino fueron procesados mediante la t\u00e9cnica de inclusi\u00f3n en parafina y te\u00f1idos con la t\u00e9cnica de hematoxilina y eosina. Los datos de las variables en estudio, se sometieron  a una an\u00e1lisis de \nvarianza conforme un dise\u00f1o completamente al azar.  \n \nRESULTADOS  \n \nLos resultados de 1- 49 d\u00edas  de experimentaci\u00f3n para peso vivo, peso de la canal y conversi\u00f3n alimenticia se \nencuentran en el Cuadro 1. Los datos obtenidos para peso de la canal y conversi\u00f3n alimenticia, indicaron que existi\u00f3 diferencia (P<0.05) . Con un mayor peso de la canal el trat amiento 2 con respecto del tratamiento 1 y 5, y similar el \ntratamiento 2 al 3 y 4. Para conversi\u00f3n alimenticia los datos obtenidos muestran que se obtuvo una menor conversi\u00f3n alimenticia en los tratamientos 2 y 5 con respecto de los tratamientos 1, 3 y 4. Para peso vivo, los datos no indicaron diferencia (P<0.05) entre tratamientos.  \n \nREFERENCIAS  \n \n1. Bartell, S.M. and A.B. BatalThe Effect of Supplemental Glutamine on Growth Performance, \nDevelopment of the Gastrointestinal Tract, and Humoral Immune Response of Broilers. Poultry Science 86:1940 \u2013\n1947. 2007.   \n2. Kitt, S. J., P. S. Miller,  A. J. Lewis, and R. L. Fischer.  Efffects of glutami ne on growth performance and \nsmall intestine villus height in weanling pigs. Nebraska Swine Rep. Univ. Nebraska, Lincoln.  Pages 29 \u201332, 2002  \n3. Peter J. Reeds, Douglas G. Burrin, Barbara Stoll and Farook Jahoor. Glutamate and Glutamine in \nMetabolism. J. Nutr. 1 30: 978S \u2013982S, 2000.  \n  \nCuadro 1.  Datos obtenidos en pollos alimentados con diferentes niveles de un producto a  base de glutamina y \n\u00e1cido glut\u00e1mico . \n \n \nTratamiento  Peso Vivo  (g) Peso de la Canal (g)  Conversi\u00f3n Alimenticia  \n (Kg:Kg)  \nTestigo  2928 a  2008   b 1.97 ab  \n700 ppm  3125 a  2375   a 1.93 c \n1400 ppm  2966 a  2254  ab 1.98 ab  \n2100 ppm  3000 a  2250  ab 1.99 a \n2800 ppm  2999 a  2159   b 1.93 c \n \nValores con distintas literales son diferentes (P<0.05)  \n \n 63rd WPDC/XXXIX ANECA   \nCuadro 2.  Altura de las vellosidades intestinales (duodeno)   en pollos a los 35 d\u00edas de edad . \n \n \nTratamiento  Altura de las vellosidades \n(\u00b5m)  \nTestigo  751 b  \n700 ppm 905 a  \n1400 ppm  739 b  \n2100 ppm  785 b  \n2800 ppm  800 b  \n \nValores con distintas literales son diferentes (P<0.05)  \n \n \n \n \n FITO -ANTIMICROBIANOS EN LA DESINFECCI\u00d3N  \nDEL HUEVO DE GALLINA  \n \nPHITO-ANTIMICROBIALS IN EGG DISINFECTION  \n \nM. Itza OrtizA*, N. N\u00fa\u00f1ez L\u00f3pezB, R. Rivas CaceresA, J. L\u00f3pez EsparzaC, P. Enrique Lara y LaraD, E. P\u00e9rez EguiaA, \nJ. Mar\u00eda Carrera ChavezA y C. Rodr\u00edguez Alarc\u00f3nA \n \nADepto. Ciencias Veterinarias - Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez. Av. Benjam\u00edn Franklin No. 4651 \nCircuito Pronaf, CP. 32315, Cd. Ju\u00e1rez, Chihuahua ( M\u00e9xico). Tel: 52 (656) 688- 1825  \nBTesista . Estudiante del Programa de Qu\u00edmica. Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez. naielly@live.com  \nCDepto. Qu\u00edmica - Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez. rrivas@uacj.mx ; juan.esparza@uacj.mx  \nDInstituto Tecnol\u00f3gico de Conkal. Km. 16.3 Carretera M\u00e9rida- Motul Conkal, CP. 97345, Yucat\u00e1n, M\u00e9xico. Tel: 52 \n(999) 912- 4133 / Fax: 52 (999) 912- 4135  pedro.lara@itconkal.edu.mx  \n*Autor de correspondencia mateo.itza@uacj.mx  \n \nSUMMARY  \n \nOvotransferrin  present in the albumin is considered a defense mechanism against bacterial contamination of \nthe egg. Some bacteria have evasion mechanisms that can contaminate the egg. The objective of this study is to \nevaluate the phito -antimicrobial activity of organic  extracts of greasewood ( Larrea tridentata), fres h thyme or \nMexican mint ( Plectranthus amboinicus ), and common oregano ( Origanum  vulgare ) on Gram positive and negative \nbacteria of economical impact in the contamination of hen's eggs. The organic extracts w ere prepared at levels of \n30%, 35% and 40% in an ethyl alcohol solution. A total of eight bacteria were studied and were divided in two \ngroups. Data were analyzed using SAS. Differences (P<0.05) were found for extract type, concentration level and \nkind of bacteria. Besides, interaction of extract and level (P<0.04), extract, level and bacteria (P<0.002) were found. \nIt is concluded that L. tridentata  had the highest phito -antimicrobial activity.  \n \nRESUMEN  \n \nLa ovotransferrina presente en la alb\u00famina es considerada un mecanismo de defensa contra la contaminaci\u00f3n \nbacteriana del huevo. Algunas bacterias poseen mecanismos de evasi\u00f3n que pueden contaminarlo. El objetivo del \npresente estudio fue eval uar la actividad fito -antimicrobiana de extractos org\u00e1nicos de La Gobernadora ( Larrea \ntridentata ), Or\u00e9gano orej\u00f3n ( Plectranthus amboincus ) y Or\u00e9gano com\u00fan ( Origanum vulgare ), sobre bacterias Gram \npositivas y negativas de impacto econ\u00f3mico en la contaminaci \u00f3n del huevo de gallina. Los extractos org\u00e1nicos \nfueron preparados en niveles de 30, 35 y 40% en una soluci\u00f3n de alcohol et\u00edlico. Un total de ocho bacterias \nestuvieron bajo estudio y fueron divididas en dos grupos. Los datos se analizaron usado SAS. Se enc ontraron \ndiferencias (P<0.05) sobre el tipo de extracto, nivel de concentraci\u00f3n y el tipo de bacteria. Adem\u00e1s de interacci\u00f3n \ndel extracto y nivel (P<0.04), extracto, nivel y bacteria (P<0.002). Se concluye que la L. tridentata  tuvo una mayor \nactividad fito -antimicrobiana.  \n \nINTRODUCCI\u00d3N  \n \nEl huevo de gallina es un alimento de origen animal, de consumo b\u00e1sico en la alimentaci\u00f3n humana por su \ncomposici\u00f3n nutricional, de manera m\u00e1s espec\u00edfica por su alto valor prote ico (5). El huevo posee mecanismos para \nevitar la contaminaci\u00f3n bacteriana como la cut\u00edcula, cascar\u00f3n, membranas del huevo, as\u00ed como la ovotranferrina \npresente en la alb\u00famina; considerada el principal mecanismo de defensa contra el crecimiento bacteriano, ya que \ncaptura el hierro y evita que las bacterias lo utilice n (17). \nSe sabe que el cascar\u00f3n de huevo esta normalmente cubierto por agentes microbiol\u00f3gicos pat\u00f3genos (bacterias) \nque sin un proceso de desinfecci\u00f3n pueden enfermar al ser humano ; tales como Salmonella Enteritidis  y Salmonella \nTyphimurium  (3). Salmonella  Enteritidis  por ser parte de la biota normal del huevo se puede encontrar tanto en la \nparte interna como en la externa (4). Enterococcus faecalis  a pesar de ser un microorganismo que aparentemente se \nencontraba bajo control ha mostrado en los \u00faltimos a\u00f1os una resistencia y planea colocarse entre los principales \nagentes etiol\u00f3gicos de bacteremias, infecciones urinarias y otros diversos padecimientos  intrahospitalario s (8). 63rd WPDC/XXXIX ANECA  En la actualidad se conoce la resistencia de bacterias a antimicrobianos  o extractos qu\u00edmicos antibacteriales debido \nal uso descontrolado que el ser humano ha tenido.  Existen diversas l\u00edneas de investigaci\u00f3n que est\u00e1n tratando  de \ncontrarrestar mediante medios menos agresivos todo est \u00e9 efecto tan da\u00f1ino  (16). \nLos extractos org\u00e1nicos son mezclas complejas de metabolitos secundarios de f\u00e1cil obtenci\u00f3n, puesto que no \nllevan un proceso tan complejo y contaminante en comparaci\u00f3n a lo s extractos qu\u00edmicos antibacteriales q ue son de \nuso com\u00fan. As\u00ed mismo, dichos metabolitos aparte de ser menos agresivos a la naturaleza en comparaci\u00f3n con los \nproductos  qu\u00edmicos antibacteriales que se usan en la actualidad , son de f\u00e1cil obtenci\u00f3n y pueden s er aislados por \ndiversos m\u00e9todos como la destilaci\u00f3n por arrastre de vapor, por expresi\u00f3n de los frutos o por medio de Soxhlet que \nrepresentan un costo menor, puesto que no necesitan reactivos costosos ni un equipo tan sofisticado  (9). \nLos aceites esenciales de los extractos vegetales cubren un amplio espectro de efectos farmacol\u00f3gicos \nmostrando diversas propiedades como antiinflamatorios, antioxidantes, y anticancer\u00edgenos. Otras actividades biol\u00f3gicas se reportan como biocidas en contra de una amplia gama de microorganismos  (10). \nEl Or\u00e9gano com\u00fan ( Origanum vulgaris ) tiene en los aceites esenciales sus componentes principales, los cuales \nson: timol, carvacrol, pineno, cymol, alfa thuyona, selineno, dipenteno, alfa terpineno; \u00e1cidos polife n\u00f3licos: \u00e1cido \nrosmar\u00ednico, cafeico, urs\u00f3lico, clorog\u00e9nico; flavonoides: apigenol, luteolol, kaempferol, diosmetol y taninos, \nprincipios amargo s (11), los fenoles como el timol y el carvacrol poseen actividad antimicrobiana debido a su \nnaturaleza acida del  grupo hidroxilo, que forma un puente de hidrogeno con un centro enzim\u00e1tico activo (7) y \npresenta actividad antimicrobiana probada en cepas de bacterias Gram -negativas como son: Escherichia coli, \nPseudomona aeruginosa, Salmonella Typhi murium , Salmonella cholerae suis  y Vibrio cholerae , las bacterias \nGram -positivas: Staphylococcus aureus  y Bacillus cereus  presentando diferentes grados de sensibilidad ante esta \nespecie de Or\u00e9gano por el m\u00e9todo semicuantitativo de incorporaci\u00f3n y de disco difusi\u00f3n en agar un a vez separado \nen Cromat\u00f3grafo de gases  (1,6). \nLos extractos alcoh\u00f3licos (etanol y m etanol al 70%) al 6% con polvo vegetal seco (tallos y hojas) de \nGobernadoara ( Larrea tridentata) , presenta una actividad antif\u00fangica contra Aspergillus flavus, Aspergillus niger, \nPenicillium chrysogenum, Penicillium expansum, Fusarium poae y Fusarium moniliform e (13,19).  \nLa presente investigaci\u00f3n espera que mediante el uso de extractos org\u00e1nicos  como agentes antibacteriales \ncontribuya a las investigaciones y conclusiones en usos alternativos a los antimicrobianos que desde hace tiempo se \nhan empleado . De aqu\u00ed que el objetivo del presente trabajo fue evaluar la actividad fito antimicrobiana de los \nextractos sobre  diferentes ba cterias G ram positivas y Gram negativas de impacto econ\u00f3mico en la contaminaci\u00f3n del \nhuevo de gallina.  \n \nMETODOLOG\u00cdA  \n \nToma de muestra.  La Gobernadora ( Larrea tridentata)  fue tomada de un arbusto que se encuentra en el jard\u00edn \ndel Instituto de Ciencias Biom\u00e9dicas de la Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez;  el Or\u00e9gano orej\u00f3n \n(Plectranthus amboincus ) se tom\u00f3 del invernadero del mismo Instituto y el Or\u00e9gano com\u00fan ( Origanum vulgare ) se \ncompr \u00f3 en un supermercado  local , por consiguiente no fue sometido al proceso de  secado (Lachica et al., 1973) . \nPreparaci\u00f3n de los extractos . Larrea tridentata y Plectranthus amboincus  son deshojados manualment e en \nlaboratorio de Microbiolog\u00eda del mismo Instituto . Las  hojas  fueron secadas en una incubadora a 45\u02daC durante  48 \nhoras  (11). La preparaci\u00f3n de los extractos fue al 30, 35 y 40%. U sando una balanza anal\u00edtica y a\u00f1adiendo con ayuda \nde una pipeta alcohol et\u00edlico al 75%  a cada recipiente, para dar un total de nueve tratamien tos (tres de Larrea \ntridentata , tres de  Plectranthus amboincus y  tres de Origanum vulgare ).  \nFase in vitro.  Una vez obtenidos los extractos, se proceder\u00e1 a preparar caldos nutritivos en cajas Petri para \ncultivar las ocho cepas bacterianas que ser\u00e1n usadas para medir la concentraci\u00f3n m\u00ednima i nhibitoria (CMI) con \nrespecto al halo de inhibici\u00f3n del crecimiento de acuerdo a la t\u00e9cnica de Bauer et al. (1966) . \nCepas.  Fueron divididas en dos grupos Gram (+) y Gram ( -). Las cepas Gram (+) son: S treptococcus pyogenes, \nStaphylococcus aureus, Enterococcus faecalis,  Salmonella Gallinarum  y Bacillus subtilis . Las cepas Gram ( -) son: \nKlebsiella oxytoca, Salmonella p -Typhimurium  y Escherichia coli las cuales fueron  incubadas en el cuarto de estufa \nde cultivo bacteriano a una tem peratura de 37 a 38\u00b0C por 24 h . Se estandarizo las concentraciones bacterianas a 50 \nunidades Klett usando un aparato llamado Klett\u00f3metro. Las cajas de Petri con Muller Hinton se llevaron a medio \nest\u00e9ril para inocular las tres repeticiones de cada bacteria por especie, esto  es, se inocularon las 216 cajas de Petri \npara colocar inmediatamente los sensidiscos previamente introducidos en los extractos (7 d\u00edas antes) usando unas \npinzas esterilizadas con alcohol et\u00edlico grado absoluto por flameado.  \nAn\u00e1lisis cromatogr\u00e1fico de gase s. Con los extractos alcoh\u00f3licos de Larrea Tridentata y Plectranthus \namboincus  se realiz\u00f3 el an\u00e1lisis para observar el perfil qu\u00edmico ( 2,11), mientras que para el Origanum  el Carvacrol y \nTimol tienen un efecto sin\u00e9rgico que le da la acci\u00f3n antibacterial ( 14). 63rd WPDC/XXXIX ANECA  An\u00e1lisis e stad\u00edstico.  La variable de respuesta fue la concentraci\u00f3n m\u00ednima i nhibitoria (CMI), halo de \ninhibici\u00f3n del crecimiento bacteriano, fue analizada mediante la prueba no param\u00e9trica de Kruskal -Wallis  (15) \nusando SAS ( 18) y la comparaci\u00f3n de medias usando el m\u00e9todo de Tukey  tom\u00e1ndose como m\u00ednima significativa un \nalfa de 0.05%.  \n \nRESULTADOS  Y DISCUSION \n \nLos resultados encontrados se presentan en el Cuadro 1 . Se puede observar diferencias (P<0.05) sobre el tipo \nde extracto , nivel de concentraci\u00f3n del extracto en la soluci\u00f3n alcoh\u00f3lica, el tipo de bacteria y la interacci\u00f3n del \nextracto y nivel (P<0.04), extracto, nivel y bacteria (P<0.002).  En los tres nivele s de extracci\u00f3n del extracto se \nobservaron diferencias siendo la mayo r cuando la concentraci\u00f3n estuvo al 35%. La Salmonella p_ Typhimurium  \nresult \u00f3 con un mayor CMI; sin embargo aunque en menor grado tambi\u00e9n fueron inhibidas  S. Gallinarum  y E. coli, \ndos bacterias importantes causantes de enteritis, la primera en aves y la seg unda afectando incluso al ser humano.  \n \nCONCLUSIONES  \n \nSe concluye que la Gobernadora ( L. tridentata ) posee una mayor actividad fito  antimicrobiana que el Or\u00e9gano \norej\u00f3n ( Plectranthus amboincus ) y Or\u00e9gano com\u00fan ( Origanum vulgaris ) y puede ser usada en concentraciones del \n35% para limpiar el huevo de gallina.  \n \nREFERENCIAS  \n \n1. Albado Plaus, E., S\u00e1ez Flores, G., Grabiel Ataucusi, S. Composici\u00f3n qu\u00edmica y actividad antibacteriana \ndel aceite esencial del Oreganum vulgare (or\u00e9gano). Revista Medica Herediana (12) :16-19. 2001. En revisi\u00f3n en \nl\u00ednea. Accesado el 3 de febrero del 2011.  \n2. Allen, S. Chemical Analysis of Ecological Materials. Blackwell Scie ntific Publications. London. 1989.  \n3. Arnedo, A., Bellido, J.B., Pac, M.R., Cria do, J., Usera, M.A., Mesanza , I., Gonz\u00e1lez, F., P\u00e9rez, R., \nCort\u00e9s, J.M. Brotes epid\u00e9micos de salmonelosis por consumo de huevos. 1998. En revisi\u00f3n en l\u00ednea. Accesado el 4 \nde abril del 2011. Obtenido de h ttp://www.doyma.es/revistas/ctl_servlet?_f=7012&articuloid=6347 . \n4. CDC (Centros para el control y la prevenci\u00f3n de enfermedades). Consejos para reducir el riesgo de \nadquirir  Salmonella  por el consumo de huevos. Atlanta, GA. 2010. Accesado el 25 de noviembre de 2010. \nObtenido de http://www.cdc.gov/spanish/especialesCDC/SalmonellaHuevos/. \n5. Closa, S., Marchesich, C., Cabrera, M., Morales JC. Composici\u00f3n de huevos de gallina y codorniz. 199 9. \nEn revisi\u00f3n en l\u00ednea. Accesado el 5 de abril del 2011. Obtenido de \nhttp://www.nutricionenmexico.org.mx/alan/1999_2_14.pdf . \n6. Garc\u00eda Luj\u00e1n, C. Actividad antibacteriana de extractos vegetales en cepas hospitalarias de Staphylococcus \naureus con resistencia m\u00faltiple. Universidad Aut\u00f3noma Agraria Antonio Narro. Torre\u00f3n, M\u00e9xico. 2006.  \n7. Garc\u00eda, L. Componentes qu\u00edmicos y su relaci\u00f3n con las actividades biol\u00f3gicas de algunos extractos \nvegetales. Revista Qu\u00edmica Viva. Durango, M\u00e9xico. 2010.  \n8. Garza- Velasco, R., Hern\u00e1ndez- Acosta, K., Mej\u00eda- Ch\u00e1vez, A. Los factores de virulencia y la actual \nimportancia cl\u00ednica de Enterococcus faecalis. 2004. En revisi\u00f3n en l\u00ednea. Accesado  el 31 de marzo del 2011. \nObtenido de http://depa.pquim.unam.mx/bacteriologia/pdfs/ART%CDC -Enterococcus.pdf . \n9. I\u00e1\u00f1ez, E. Agentes Qu\u00edmicos. Tomado del Sitio web para la cons ulta de Microbiolog\u00eda general de la \nLicenciatura en Biolog\u00eda de la Universidad de Granada. 2005. Accesado el 21 de diciembre del 2010. Obtenido de http://www.ugr.es/~eianez/Microbiologia/14agquimicos.htm . \n10. Kalemba, D. and A. Kunicka. Antibacterial and antif ungal properties of essential oils. Curr Med Chem \n10(10):813 -29. 2003.  \n11. Kalra, Y.P. Handbook of reference methods for plant analysis. Soil and Plant Analysis Council, Inc. CRC \nPress, USA: 300 p. 1998.  \n12. Lachica, M., Aguilar, A., y Y\u00e1nez, J. An\u00e1lisis foliar. M \u00e9todos utilizados en la Estaci\u00f3n Experimental \nZaid\u00edn. Anales de Edafolog\u00eda y Agrobiolog\u00eda 32:1033- 1047. 1973.  \n13. Lira Saldivar, R. H. Estado actual del conocimiento sobre las propiedades biocidas de la Gobernadora \n(Larrea tridentata). Tomado de la Revista Mex icana de Fitopatolog\u00eda. Tomo 21(002):214- 222. 2003. Accesado el 3 \nde febrero del 2011. Obtenido de http://redalyc.uaemex.mx/pdf/612/61221217.pdf . 63rd WPDC/XXXIX ANECA  14. Lossa, R. Una composici\u00f3n que contiene carvacrol  y timol para uso como bactericida. Tomada de la \nOficina Espa\u00f1ola de patentes y marcas. Espa\u00f1a. 2004. Accesado el 15 de Marzo de 2011. Obtenido de \nhttp://www.espatentes.com/pdf/2215652_t3.pdf . \n15. Mendenhall, W., and R. J. Beaver. Introduction to linear model and the design and analysis of \nexperiments. In introduction to probability and statistics. W. Mendenhall, ed. Belmont, Duxbury. pp 244\u2011 251. 1994.  \n16. Ojeda, A. El rompimiento de la humanidad con la  naturaleza. Un abordaje desde la dial\u00e9ctica cr\u00edtica. \nTomado de la Revista TECSISTECATL: Econom\u00eda y Sociedad de M\u00e9xico. Volumen 1:4. 2008.  \n17. Rosario, C. Escherichia coli: Generalidades. Departamento de Producci\u00f3n Animal: Aves, FMVZ, \nUNAM. 2006. Accesado el 0 3 de Enero de 2011.  \n18. SAS User\u2019s Guide. Version 9.1 ed. SAS Inst. Inc., Cary, NC. 2004 . \n19. Tequida -Meneses, M., Cortez- Rocha, M., Rosas -Burgos, E. C., L\u00f3pez -Sandoval, S., Corrales -Maldonado, \nC. Efecto de extractos alcoh\u00f3licos de plantas silvestres sobre la inhibici\u00f3n de crecimiento de Aspergillus flavus, \nAspergillus niger, Penicillium chrysogenum, Peni cillium expansum, Fusarium moniliforme y Fusarium poae. 2002. \nEn revisi\u00f3n en l\u00ednea. Accesado el 3 de febrero del 2011. Obtenido de http://www.reviberoammicol.com/2002 -\n19/084088.pdf . \n \n \nCuadro  1. Concentraci\u00f3n m\u00ednima i nhibitoria (mm) de diferentes extractos org\u00e1nicos y nivel de concentraci\u00f3n \n(%) con actividad antimicrobiana sobre bacterias Gram (+) y Gram ( -) de impacto econ\u00f3mico en la contaminaci\u00f3n \ndel huevo de gallina.  \n \n \nLarrea tridentata   \n1.126\u00aa \u00b10.713   \nOriganum vulgaris  0.901b \u00b10.622   \nPlectranthus amboincus  0.436c \u00b10.528   \n   \nnivel 30%  0.763b \u00b10.681   \nnivel 35%  1.008\u00aa \u00b10.745   \nnivel 40%  0.691b \u00b10.592   \n   \n Salmonella p_typhimurium  (-) 1.348a  \u00b10.458  \n Staphylococcus aureus  (+) 1.193ab \u00b10.803  \n Enterococcus faecalis  (+) 0.877bc \u00b10.772  \n Bacillus subtilis  (+) 0.803bc \u00b10.528  \n Streptococcus pyogenes  (+) 0.696c  \u00b10.698  \n Salmonella gallinarum  (+) 0.592c  \u00b10.621  \n Escherichia coli  (-) 0.555c  \u00b10.644  \n Klebsiella oxytoca  (-) 0.500c  \u00b10.429  \nLiterales diferentes entre renglo nes son significativas (P<0.05)  \n(+) G ram positiva; ( -) Gram negativa  \nMedia \u00b1D.E  \n 63rd WPDC/XXXIX ANECA  CARENCIA DE F\u00d3SFORO EN UNA DIETA INICIADOR PARA \nPOLLITA DE REEMPLAZO A CERO SEMANAS DE EDAD  \n \nLACK OF PHOSPHORUS IN A PULLET STARTER DIET AT  \nZERO WEEKS OF AGE  \n \nM. Itza OrtizA*, M. R\u00edos OvandoA, E. P\u00e9rez EguiaA, J. Mar\u00eda Carrera ChavezA, E. Jaramillo  L\u00f3pez   \ny A. Quezada CasasolaA \n \nADepto. Ciencias Veterinarias - Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez. Av. Benjam\u00edn Franklin No. 4651 \nCircuito Pronaf, CP. 32315, Cd. Ju\u00e1rez, Chihuahua ( M\u00e9xico). Tel: 52 (656) 688- 1825  \n*Autor de correspondencia mateo.itza@uacj.mx ; mirna.rios@uacj.mx ; eperez@uacj.mx ; jose.carrera@uacj.mx ; \nejaramil@uacj.mx ; aquezada@uacj.mx  \n \nSUMMARY  \n \nPhosphorus is very important for growth of pullets, essentially on metabolism, development and maintenance \nof bone structure; it is involved in energy and enzymatic reactions, and constitutes the cell wall. This clinical case \noccurred in a pullet commercial farm of the Bovans White lineage. 13,000 day -old pullets were received from the \nhatchery; the day before the starter feed was d eposited in the corresponding silo. Pullets showed the fol lowing \nsymptoms at the sixth d  of age: ruffled feathers, emaciation, prostration and high mortality. A necropsy showed \nnormal organs and fragility was observed in the bones of the ribs, keel and sha nks. Mortality peaked at 69.36 %. The \nanalysis of the feed showed total lack of phosphorus that was confirmed at the food plant. The surviving pullets had \ngrowth below the sexual maturity standard.  \n \nRESUMEN  \n \nEl f\u00f3sforo tiene gran importancia durante el crecimiento de las pollitas, esencialmente sobre el metabolismo, \ndesarrollo y mantenimiento de su estructura \u00f3sea, participa en reacciones energ\u00e9ticas y enzim\u00e1ticas, y como constituyente de la pared celular. El presente caso cl\u00ednico se registr\u00f3 en una granja comercial de pollitas de \nreemplazo de la estirpe Bovans White. Se recibieron 13,000 pollitas de un d\u00eda de edad de la incubadora, el d\u00eda \nanterior el alimento iniciador se deposit\u00f3 en el silo correspondiente. Las pollitas presentaron al sexto d\u00eda de edad los  \nsiguientes s\u00edntomas: pluma erizada, emaciaci\u00f3n, postraci\u00f3n y alta mortalidad. A la necropsia se observ\u00f3 \u00f3rganos normales y fragilidad en los huesos de las costillas, quilla y tarsos. La mortalidad alcanzo el 69.36%. El an\u00e1lisis del \nalimento arrojo carenci a total de f\u00f3sforo que fue corroborado en la planta de alimento. Las pollitas sobrevivientes \ntuvieron un crecimiento inferior al est\u00e1ndar a la madurez sexual.  \n \nINTRODUCCI\u00d3N  \n \nLas funciones del calcio y f\u00f3 sforo son requeridos para las funciones base minerales del tejido \u00f3seo, actividades \nen los tejidos blandos y equilibrio homeost\u00e1tico en el  cuerpo ( 6). El f\u00f3s foro participa en reacciones metab\u00f3licas \nrelacionadas con la transferencia de energ\u00eda y enzim\u00e1tica, como constituyente de la pared celular , est\u00e1 estrechamente \nrelacionado y regulado en parte por la vitamina D ( 2). El f \u00f3sforo es necesario para depositar durante el d\u00eda el calcio \nen los huesos que es retirado durante la noche en numerosos procesos metab\u00f3licos como equilibrio \u00e1cido- base, la \ncapacidad tamp\u00f3n y en procesos de intercambio de energ\u00eda ( 4). Las necesidades de f\u00f3sforo depende de la etapa de \ncrecimiento y la finalidad del mineral es reconstruir el esqueleto y cuando existe una carencia en etapa de \ncrecimiento  se manifiesta en un aumento de la fragilidad \u00f3sea , y en consecuencia, en un aumento de la mortalidad \n(3). Sus fuentes son diversas y se clasifican en org\u00e1nicas (vegetales o animal) e inorg\u00e1nicas (mineral).  \n \nMETODOLOG\u00cdA  \n \nUn total de 13,000 pollitas de la estirpe Bovans  White de tres lotes diferentes fueron recibidas de un d\u00eda de \nedad de la incubadora y fueron alojadas en casetas de piso de cemento , de acuerdo al manual de la Bovans White \n(2012) . La recepci\u00f3n fue de acuerdo a los lineamientos operativos de la empresa que establecen tener un d\u00eda antes almacen ado el alimento tipo iniciador, 15 toneladas, en los silos correspondientes  de la caseta y tres h antes a la \nrecepci\u00f3n programada, 8:00 am, encendidas las criadoras para atemperar la caseta a unos 32\u00baC, un total de 12 \ncriadoras por caseta.  El alimento  y agua se ofreci\u00f3 a libre acceso . \n \nRESULTADOS  Y DISCUSION \n \nLos tres primero d\u00edas post recepci\u00f3n la mortalidad estuvo considerada dentro del est\u00e1ndar con una mortalidad \nde n= 5 a n= 10 en la caseta, sin embargo a partir  del cuarto d\u00eda post recepci\u00f3n la mortalidad se dispar\u00f3 a 39, con \nincrementos mayores llegado a la m\u00e1xima mortalidad a la semana 2 -4 con n= 1,700 (Figura 1).  \nEl saco vitelino se absorbe las primeras 72 horas y tiene la finalidad de alimentar al pollito dur ante este tiempo \n(5). La mortalidad incremento a n= 75 al quinto d\u00eda y paso a m\u00e1s de n= 100 al sexto. El incremento en la mortalidad \nllev\u00f3 a realizar una revisi\u00f3n de la caseta que consisti\u00f3 en un check list  de la limpieza y desinfecci\u00f3n y recepci\u00f3n del \nlote para encontrar alguna causa que estuviera relacionada con el incrementado la mortalidad. Fueron enviadas \nmuestras de pollita s al laboratorio para descartar presencia de alguna bacteria como E. coli, debido que se observ\u00f3 \nun cuadro de colibacilosis  (Figura 2)  al octavo d\u00eda. Los resultados de laboratorio aislaron E. coli, sin embargo se \nconsider\u00f3 que la presencia de la bacteria fue oportunista en este caso y no la causa primaria de la elevada \nmortalidad . Tambi\u00e9n se enviaron muestras de alimento de los silos de la caseta afectada al laboratorio nutrici\u00f3n  de la \nmisma empresa . \nOtros signos observados  fueron pollitas que al doblarle el tarso tuvieron una resistencia muy baja , es \nimportante mencionar que los tarso no se rompieron solamente se doblaban como cart\u00f3n. L as pollitas a los 14 d \u00edas \npresentaron una postraci\u00f3n  similar a un problema de M arek (Figura 3); sin embargo una caracter\u00edstica particular fue \nque caminaban sobre lo s tarsos antes de quedar completamente postradas , este signo puede asociarse a Perosis ( 7) \ndebido a que se observ\u00f3 una inflamaci\u00f3n de las articulaciones tarsianas. Sin emb argo, dicha inflamaci\u00f3n no fue \nperosis, fue originada por el arrastre de la pollita p or no poder soportar su propio peso, y como consecuencia de la \npostraci\u00f3n al no alcanzar el bebedero y comedero el incremento en la mortalidad.  \nSe observ\u00f3  tambi\u00e9n  pollitas muy peque\u00f1as (raquitismos) en relaci\u00f3n de sus contempor\u00e1neas alojadas en la \ncaseta siguiente (F igura 4 ) cuando ten\u00edan casi las tres  semanas de edad . A la necropsia se pudo confirmar la baja \nresistencia de todos los huesos de la pollita  incluyendo las costillas  (7), caracter\u00edstica primaria de un problema de \nraquitismo  asociado a una defic iencia de fosfato c\u00e1lcico y vitamina D3.  \nComo consecuencia del seguimiento al problema la planta de alimento report\u00f3 a los 18 d\u00edas, post inicio del \nproblema, que el bache que fue balanceado y llevado a la granja y colocado en la caseta con el problema no conten\u00eda fosfato de calcio. Un total de 9,018 pollitas (69.36%) con las caracter\u00edsticas mencionadas anteriormente murieron \ncomo consecuencia de la ausencia de f\u00f3sforo en la dieta iniciador.  \nTodo el alimento sin fosfato de calcio fue retirado y distribuido en la granja de gallinas de postura comercial \npr\u00f3ximas a su salida o t\u00e9rmino de su primer ciclo de postura.  A la caseta en crecimiento que report\u00f3 el problema fue \nllevado alimento \u201cnuevo\u201d y las pollitas que sobrevivieron se recuperaron.  \n \nCONCLUSIONES  \n \nLa m ortalidad por ausencia de fosfato de calcio en la dieta iniciador de la pollita de reemplazo incrementa la \nmortalidad y est\u00e1 puede ser tan elevada como el tiempo en que el avicultor detecta el problema. Tomar y enviar \nmuestras de las aves afectadas y del alimento al laboratorio, adem\u00e1s de la necropsia en campo es crucial para un \nbuen diagn\u00f3stico en granja.  \n \nREFERENCIAS  \n \n1. Bovans white management guide. Centurion Poultry, Inc.  2012.  \n2. De Blas, C. y Mateos, G. Nutrici\u00f3n y Alimentaci\u00f3n de Gallinas Ponedoras . Madrid, Espa\u00f1a. Ed AEDOS. \n567 pag.  1991.  \n3. FEDNA, Funaci\u00f3n Espa\u00f1ola para el Desarrollo de la Nutrici\u00f3n Animal. Programas de alimentaci\u00f3n en \navicultura: ponedoras comerciales. Sn. Madrid, Espa\u00f1a. 423 pag.  1994.  \n4. Keshavarz, K. and Nakajima, S. Evaluaci\u00f3n de calcio y fosforo requerida para la \u00f3ptima formaci\u00f3n del \nhuevo. Poultry Science 1998; 79:144- 153. \n5. Noy, Y, Sklan D. Posthatch development in poultry. J Appl Poult Res 1997;  6:344- 354. \n6. Underwood, E. The mineral nutrition of livestock. 3a ed. Wallingford, Oxon. Commonwealth \nAgricultural Bureaux International. Germany, 76 pag. 1999.  7. Woernle. H. Enfermedades de las aves. Acribia, ed. Zaragoza, Espa\u00f1a. 150 pag.  1996.  \n \n \nFigura 1.  N\u00famero de bajas en pollitas de reemplazo de la estirpe Bovans  White de acuerdo a su edad en \nsemanas asociadas a ausencia de f\u00f3sforo en la dieta iniciador.  \n \n \n \nFigura 2. Pollitas de reemplazo de la estirpe Bovans White de 1 -4 semanas de edad con signos cl\u00ednicos \nasociados a una enteritis causada por E. coli (colibacilosis).  \n \n \n \n \n \n \nFigura 3. Pollitas de reemplazo de la estirpe Bovans White de 2 -0 semanas de edad con signos cl\u00ednicos \ndepostraci\u00f3n total asociados a ausencia de f\u00f3sforo en la dieta iniciador.  \n \n \n \n \n \n  \n \n \n  \n \n \n \n \n  \nFigura 4. Pollitas de reemplazo de la estirpe Bovans White de 3 -0 semanas de edad con signos cl\u00ednicos \nasociados a raquitismos por ausencia de fosfato de calcio en la dieta iniciador.  \n \n \n \n USO DE ANTIMICROBIANOS EN LA RECEPCI\u00d3N DE LA \nPOLLITA DE REEMPLAZO  \n \nANTIMICROBIAL USE DURING PULLET RECEIVING  \n \nM. Itza OrtizA, C. Hern\u00e1ndezB, Y. Castillo CastilloC, M. Rios OvandoD, J. Ortiz OrtizA, E. P\u00e9rez EguiaA, J. Mar\u00eda \nCarrera ChavezA y D. Marcela Beristain RuizA \n \nADepto. Ciencias Veterinarias - Universidad Aut\u00f3noma de Ciudad Ju\u00e1rez. Av. Benjam\u00edn Franklin No. 4651 \nCircuito Pronaf, CP. 32315, Cd. Ju\u00e1rez, Chihuahua (M\u00e9xico). Tel: 52 (656) 688- 1825  \n BTesista. Estudiante del Programa de Medicina Veterinaria y Zootecnia. Univer sidad Aut\u00f3noma de Ciudad Ju\u00e1rez  \nCDepto. Ciencias Veterinaria \u2013 Campus Nuevo Casas Grandes, Univer sidad Aut\u00f3noma de Ciudad Ju\u00e1rez \nyamicela.castillo@uacj.mx  \nDInstituto Tecnol\u00f3gic o de Conkal. Km. 16.3 Carretera M\u00e9rida- Motul Conkal, CP. 97345, Yucat\u00e1n, M\u00e9xico. Tel: 52 \n(999) 912- 4133 / Fax: 52 (999) 912- 4135 jortort@yahoo.com.mx \n \nSUMMARY  \n \nAntimicrobial use in pullets is frequent as prophylaxis due to the stress these suffer during transport to the farm \nthat can cause opportunistic bacteria to increase mortality. The aim of this study was to determine the effectiveness \nof three antimicrobial on mort ality during the first three wk  of age of pullets: ceftiofur hydrochloride (T1) equivalent \nto 50 mg ceftiofur, enrofloxacin 10% (T2), a combination of the above (T3) and a negative control (T0). Two hundred pullets were used for each of the four groups. SAS PROC MIXED analyzed the data. Diff erences (P < 0.05) \nin mortality were found by use of antimicrobial, T1 was 5.50 % (N = 11), while for T2 were of 3.03 % (N = 6), T3 \n5.50% (N = 11) and T0 4.0% (N = 8). We conclude that with adequate disinfection the use of antimicrobials may be \nunnecessary . \n \nRESUMEN  \n \nEl uso de antimicrobianos en las pollitas de remplazo es frecuente como profilaxis debido al estr\u00e9s que sufren \nestas durante el transporte a la granja puede originar que bacterias oportunistas incrementen la mortalidad. El objetivo del presente  estudio fue determinar la efectividad de tres antimicrobianos, clorhidrato de ceftiofur (T1) \nequivalente a 50 mg de ceftiofur, enrofloxacina al 10% (T2), una combinaci\u00f3n de las anteriores (T3) y un testigo negativo (T0) sobre la mortalidad durante las pri meras tres semanas de edad de la pollita de reemplazo. Se usaron \n200 pollitas por cada uno de los cuatro grupos. Los datos fueron analizados por PROC MIXED del SAS. Se \nencontraron diferencias (P<0.05) en la mortalidad por uso de antimicrobiano, T1 fue del 5.50% (N=11), mientras \nque para T2 del 3.00% (N=6), T3 del 5.50% (N=11) y para T0 del 4.0% (N=8). Se concluye que realizando una desinfecci\u00f3n adecuada el uso de antimicrobianos puede no ser necesario.  \n \nINTRODUCCI\u00d3N  \n \nLos agentes antimicrobianos act\u00faan mediantes diferentes mecanismos  de acci\u00f3n. Las diversas regiones de \nataque antibacteriano en general son consideradas en la pared bacteriana, membrana bacteriana, interfiriendo con la s\u00edntesis de prote\u00ednas o \u00e1cidos nucleicos en diversos niveles del organoide encargado de su elaboraci\u00f3n. En el ribosoma, act\u00faa un c\u00famulo de agentes, a saber: Aminogluc\u00f3sidos y aminociclitoles, tetraciclinas, cloranfenicol y \nsuced\u00e1neos, lincosamidas y macr\u00f3lidos. Dada la complejidad de este proceso, hay diversos blancos que son \nimpactados por los diferentes agentes antimicrobianos.  \nEl efecto de promotor del crecimiento de los antimicrobianos fueron descubiertos en 1940 cuando se observ\u00f3 \nque los animales alimentados con micelos secos de Streptomyces aureofaciens  que contienen resi duos de \nchlortetraciclina mejoraron el crecimiento de los animales. Los mecanismos de acci\u00f3n de estos promotores del crecimiento est\u00e1n relacionados con la interacci\u00f3n de la microbiota intestinal.  \nEl uso de antimicrobianos durante la recepci\u00f3n es un manejo usado por los avicultores para minimizar la \nmortalidad por bacterias oportunistas que pudieran afectar a las pollitas reci\u00e9n llegadas a granja debido a desinfecciones deficientes o mal manejo en la limpieza y desinfecci\u00f3n del equipo de recepci\u00f3n donde la m ayor \nmortalidad se encuentra entre la primero y segunda semana de vida de la pollita. El objetivo del presente estudio fue 63rd WPDC/XXXIX ANECA  determinar la efectividad de tres antimicrobianos que com\u00fanmente son empleado en la industria av\u00edcola en la \nrecepci\u00f3n de la pollita d e reemplazo.  \n \nMETODOLOG\u00cdA  \n \nLos datos fueron obtenidos en una granja comercial de pollitas de reemplazo de la l\u00ednea gen\u00e9tica Bovans \nWhite, alojadas en piso. La granja se encuentra ubicada en el estado de Yucat\u00e1n, M\u00e9xico, 20\u00b057' 6.82\" N y 89\u00b0 56' 30.69\" O a una altura de 5 m. El clima es del tipo Aw\n0, el m\u00e1s seco de los climas c\u00e1lidos, sub -h\u00famedos de acuerdo a \nla clasificaci\u00f3n de K\u00f6ppen modificada por Garc\u00eda (3 ), con una temperatura anual entre 21.0 y 33.8\u00b0 C ( 4). \nSe utilizaron 800 pollitas del mismo lote de incubadora que fueron alojadas en casetas de piso de cemento a un \nd\u00eda de edad hasta la sexta semana de edad. Todas pollitas fueron recibidas con la vacuna de Marek en incubadora y \nen granja se aplic\u00f3 la vacuna NOBILIS\u00ae CLONE 30+Ma5 al d\u00e9cimo segundo d\u00eda v\u00ed a oral en el agua de bebida. El \nmanejo y alimentaci\u00f3n se realiz\u00f3 de acuerdo a lo recomendado  por la l\u00ednea Bovans White (1 ). \nLas pollitas fueron distribuidas en cuatro tratamientos con 200 pollitas cada uno, donde cada pollita represent\u00f3 \nuna unidad experime ntal. Se utilizaron tres antimicrobianos de amplio aspecto clorhidrato de ceftiofur (T1) \nequivalente a 50 mg de ceftiofur, enrofloxacina al 10% (T2), una combinaci\u00f3n de las anteriores (T3) y un testigo \nnegativo (T0). Los antimicrobianos fueron usados de acuerdo a las recomendaciones del fabricante en el agua de \nbebida por cinco d\u00edas consecutivos desde el primer d\u00eda de recepci\u00f3n. La mortalidad (n) fue registrada a diario \nmientras que el peso corporal (g) se obtuvo por aves hasta el final de experimento.  \nLos datos fueron analizados usando la prueba de chi2 para mortalidad mientras que el peso corporal (g) por el \nPROC GLM del SAS  (8). Las diferencias entre medias fueron determinadas por la prueba de SNK ( 4). \n \nRESULTADOS Y DISCUSION \n \nSe encontraron diferencias (P\u22640.05) entre tratamientos en el peso corporal (g) de las pollitas; sin embargo no \nse encontraron diferencias (P\u22650.05) en la mortalidad en T1 fue del 5.50% (N=11), T2 del 3.03% (N=6), T3 del \n5.50% (N=11) y T0 del 4.0% (N=8). Se observ\u00f3 que la infecci\u00f3n del saco vitelino es la principal causa (55.91%) de \nmortalidad seguida por aspergilosis (38.74%). Las menos frecuentes fueron las ahogadas (0.22%) en el bebedero de la caseta y por corte de pico (0.43%), actividad relacionada al manejo de la cr\u00eda de la pollita de reemplazo.  \nLa falta de una adecuada desinfecci\u00f3n, buen manejo de huevo f\u00e9rtil o un rol de productos en incubadora o \ngranja pueden llegar a propiciar la presencia de E. coli principal bacteria asociada a infecci\u00f3n del saco v itelino ( 7). \n \nCONCLUSIONES  \n \nSe concluye que realizando una desinfecci\u00f3n adecuada el uso de antimicrobianos en la recepci\u00f3n de la pollita \nde reemplazo puede no ser necesario.  \n \nREFERENCIAS  \n \n1. Bovans white management guide. 2012. Centurion Poultry, Inc.  \n2. Dibner  JJ, Richards JD. Antibiotic growth promoters in agriculture: History and mode of action. Poult. Sci. \n2005; 84:634\u2013 643. \n3. Garc\u00eda E. Modificaci\u00f3n al sistema de clasificaci\u00f3n clim\u00e1tica de K\u00f6eppen. UNAM. M\u00e9xico. DF. 1973; 214 \npag. \n4. Itz\u00e1 MF, Garc\u00eda L, Castro F. Consumo de alimento, causa y porcentaje de mortalidad en granjas de postura \ncomercial bajo condiciones clim\u00e1ticas de Yucat\u00e1n, M\u00e9xico. Veterinaria M\u00e9xico. 2006; 37(3):379- 390. \n5. Mendenhall W. Introduction to probability and statis tics; In: Introduction to Linear Model and the Design \nand Analysis of Experiments, Mendenhall, W., R. J. Beaver, (eds.), Belmont(California):Duxbury. 1994; pp: 244-\n251. \n6. Niewold TA. The nonantibiotic  anti-inflammatory effect of antimicrobial growth promoters, the real mode \nof action? A hypothesis. Poult. Sci. 2007; 86:605\u2013 609. \n7. Rosario CC, L\u00f3pez CC, T\u00e9llez IG,  Navarro OA, Anderson RC, Eslava CC. Serotyping and virulence genes \ndetection in Escherichia coli isolated from fertile and infertile eggs, dead -in-shell embryos and chicken with yolk \nsac infection. Avian Dis 2004; 48:791- 802. \n8. SAS User\u2019s Guide. 2004. Version 9.1 ed. SAS Inst. Inc., Cary, NC.  \n 63rd WPDC/XXXIX ANECA   \nCuadro 1.  Peso corporal (g) y mortalidad (n) en la pollita de reemplazo a la sexta semana de edad que fueron \nrecepcionadas con antimicrobianos en el agua de bebida los primeros cinco d\u00edas de edad.  \n \n Testigo  \n(T0) Enrofloxacina 10% (T2)  Clorhidrato de \nCeftiofur* (T1)  Combinaci\u00f3n T1 y \nT2 \nPeso corporal \n(g) 460.0a \u00b147.57  410.0b \u00b112.92  407.0b \u00b16.32  402.0b \u00b124.45  \n \nMortalidad (n)  1.14a \u00b11.21  \n(8/200)  0.85a \u00b11.07  \n(6/198)  1.57a \u00b11.81  \n(11/200)  1.57a \u00b12.44  \n(11/200)  \n*equivalente a 50 mg de ceftiofur  \nLas literales diferentes entre colum nas son significativas (P\u22640.05)  \nMedia \u00b1D.E  \n \n PROTE\u00cdNA MATRIZ DE NEWCASTLE COMO PLATAFORMA \nPARA LA OBTENCI\u00d3N DE PART\u00cdCULAS PSEUDOVIRICAS (VLPS) \nDE FOWL ADENOVIRUS SEROTIPO 4 (FADV -4) GENERADAS A \nPARTIR DE LA FIBRA- 2 \n \nMATRIX PROTEIN OF NEWCASTLE AS A PLATFORM TO OBTAIN \nPSEUDOVIRIC PARTICLES (VLPS) OF FOWL ADENOVIRUS SEROTYPE 4 \n(FADV -4) GENERATED FROM FIBER 2  \n \nR. Izquierdo -LaraA*, A. ChumbeA, A. FigueroaB, L. SaraviaA y M. FernandezAB \n \nALaboratorio de Biotecnolog\u00eda Molecular y Gen\u00f3mica, FARVET SAC., Chincha Alta, Ica, 11141, Per\u00fa \nBLaboratorio de Cultivos Celulares y Virolog\u00eda, FARVET SAC,  Chincha Alta, Ica, 11141, Per\u00fa  \n*Corresponding author: Ray Izquierdo -Lara \nEmail: ray.izquierdo@farvet.com  \n \nSUMMARY  \n \nFadV -4 causes hepatitis to inclusion bodies (HCI) and occasionally hydropericardium syndrome (SHP). \nCurrently, vaccines are not totally effective and can revert. VPLs are good candidates to vaccines. However, FAdV is \na virus that has no viral envelope and has a very complex structure, so that VLPs generation is technically difficult. \nThe objective of the present work was to obtain VLPs in which surface the Fiber -2 protein of the FadV -4 is exposed.  \nIn order to d o that, the Matrix and the Fiber -2 were express ed simulta neously in DF -1 cells. The Fiber -2 was \nmerged in its N -terminal side to the cytoplasmic and trans membrane domain of the Newcastle's NH protein. \nPurified VLPs were evaluated using western blot, which resulted in stripes positive to anti -NDV serum , ~40kDa \ncorrespon ding to the Matrix and the anti Fiber -2 serum, obtaining a stripe of ~55 kDa.  \nVLPs are excellent immunogens, and this is why they can be evaluated as vaccines to control HCI and SHP \noutbreaks.  \n \nRESUMEN  \n \nFowl adenovirus  serotipo 4 ( FAdV -4) causa hepatitis a cuerpos de inclusi\u00f3n (HCI) y s\u00edndrome de \nhidropericardio (SHP) , generando  p\u00e9rdidas en la industria av\u00edcola. Actualmente, las vacunas contra FAdV no son \ntotalmente efect ivas y en ocasiones pueden revertir , por lo que es necesario desarrollar nuevas vacunas para \ncontrol ar esta enfermedad . Por otro lado , los han mostrado ser  excelentes inmun\u00f3genos . Sin embargo, FAdV es un \nvirus sin envoltura, estructuralmente complejo, por lo que generar part\u00edculas pseudov\u00edricas ( VLPs ) de este virus es \nun desaf\u00edo  t\u00e9cnicamente muy dif\u00edcil de realizar . Para superar  este inconveniente,  hemos aprovechado la cualidad  de \nla prote\u00edna Matriz (M) del virus de la enfermedad de Newcastle (NDV) , de tomar parte de la membrana del \nhospedero y formar viriones , para generar VLPs con envoltura  cuya superficie contiene a la prote\u00edna Fibra -2 de \nFAdV -4. Para ello, se expres\u00f3 simult\u00e1neamente en c\u00e9lulas DF -1 la Matriz y la Fibra -2. Esta \u00faltima fusionada en el \nextremo N -terminal a los dominios citoplasm\u00e1tico y transmemb rana de la prote\u00edna HN de Newcastle. Los VLPs \npurificados fueron evaluados por western blot, obteni\u00e9ndose  bandas positiva s a suero anti -NDV de  ~40 kDa \ncorrespondiente a la Matriz, y a suero anti -Fibra2 obteniendo  una banda de ~60  kDa.  \nEste es el primer reporte de la obtenci\u00f3n de VLPs para un adenovirus, dando un paso importante en el \ndesarrollo de la siguiente generaci\u00f3n de vacunas contra FAdV. Sin embargo, estos VLPs necesitan ser probados para \ndeterminar su eficiencia como vacuna contra FAdV -4. \n \nINTROD UCCI\u00d3N  \n \nFowl adenovirus serotipo 4  (FAdV -4) produce  hepatitis a cuerpos de i nclusi\u00f3n (HCI) y s\u00edndrome de \nhidropericardio (SHP) (1); condiciones que han sido reportadas en muchos pa\u00edses del mundo, especialmente en Asia, \ncentro y Suram\u00e9rica (2), causan do p\u00e9rdidas en la industria av\u00edcola . Varias formulaciones de vacunas han sido usadas \nen campo, especialmente las producidas de h\u00edgados afectados, pero ninguna de ellas cumple el criterio de inducir 63rd WPDC/XXXIX ANECA  una respuesta inmune pronta y duradera contra brotes naturales de la enfermedad ( 3). \nFAdV -4 pertenece a la familia Adenoviridae , que se caracterizan  por ser virus icosah\u00e9drico s, sin envoltura y \ncon un genoma de DNA de doble cadena ( 4). En general, la c\u00e1psi de de FAdV contiene 4 prote\u00ednas estructurales \nprincipales: el Hex\u00f3n, el Pent\u00f3n, la Fibra- 1 y la Fibra -2. De estas prote\u00ednas, la prote\u00edna Fibra- 2 juega un rol principal \nen la entrada del virus a  la c\u00e9lula hu\u00e9sped (5). Adem\u00e1s , se ha demostrado que la Fibra -2 es capaz de generar u na \neficiente protecci\u00f3n cuando se usa como prote\u00edna recombinante ( 6). \n Las part\u00edculas pseudov\u00edricas VLPs consisten en un a o m\u00e1s prote\u00ednas estructurales, semejando al viri\u00f3n sin \nincluir el genoma del virus , as\u00ed, generando  potenciales vacunas m\u00e1s seguras sin la necesidad de us ar adyuvante s (7). \nLa prote\u00edna M de v irus de la enfermedad de Newcastle (NDV)  tiene la capacidad de tomar parte de la membrana \ncelular y ensamblar con alta eficiencia viriones vacios cuando es exp resada en c\u00e9lulas aviares (8). Esta caracter\u00edstica \nha permitido  el desarrollo VLPs  que usan como plataforma la prote\u00edna M y los  dominio citoplasm\u00e1tico (DC ) y \ndominio transmembrana ( DT) de las prote\u00ednas F y HN de NDV ( 9). \nEn este trabajo , hemos desarrollado un VLP para FAdV -4, utilizando como la prote\u00edna M y los DC y DT de la \nHN de NDV para incorporar  la prote\u00edna fibra -2 al v irion. \n \nMETODOLOG\u00cdA  \n \nConstrucci\u00f3n de Pl\u00e1smidos que codifican los VLPs . Se realiz\u00f3 un reacci\u00f3n en cadena de la polimerasa con \ntranscriptasa inversa (RT-PCR ) para amplificar el ORF completo de la prote\u00edna M a partir de RNA extra\u00eddo de \nNDV, utilizando los primers : 5\u2019-caatGCTAGC ACCATGGACTCATCTAGGACAATTGGGC -3\u2019 y  5\u2019-\ngaGCGGCCGC TTATTTCTTAAAAGGATTGTATTTGG -3\u2019 (las bases subrayadas corres ponden a los sitios NheI \ny NotI, respectivamente). El ORF  de la  prote\u00edna M  fue insertado en el pl\u00e1smido pcDNA3.1 (Invitrogen\u00ae) entre los \nsitios NheI y NotI , generando el pl\u00e1smido pcDNA3.1/M.  \nEl pl\u00e1smido pcDNA3.1 contiene  los promotores CMV y SV40, donde el primero se usa  para expresar el gen de \ninter\u00e9s, mientras que el segundo expres a el gen de resistencia a la neomicina. Para usar el promotor SV40 para \nexpresar un segundo gen de inter\u00e9s, se amplific\u00f3 a pcDNA3.1/M  con los primers  \n5\u2019-TTGCGTACG CCTGCAGG GCGGGACTCTGGGGTTCGAAATG- 3\u2019 y  \n5\u2019- AATGGCTAAGCGATCGC CCGGGAGCTTTTTGCAAAAGC -3\u2019  \neliminando  el gen de resistencia a la neomicina y colocando los sitios SbfI y AsiSI (bases  subrayad as) a los \nextremos.  Luego  se insert\u00f3 la  Prote\u00edna Verde Fluorescente Potenciada (EGFP ), sintetizada por GeneScript \n(Piscataway, NJ), obteni\u00e9ndose  el pl\u00e1smido pcDNAdual/M -EGFP.  \nLa fibra -2 de FAdV -4 fue fusionad a en su extremo N -terminal a  los DC y DT de la HN de NDV, generando la \nprote\u00edna hnF2. El gen que codifica esta prote\u00edna , fue sintetizado por G eneScript (Piscataway, NJ) . El gen hnF2 fue \ninsertado entre AsiSI y SbfI en el pcDNAdual/M -EGFP , generando el pl\u00e1smido pcDNAdual/M -hnF2.  Un esquema \nde todos los pl\u00e1smidos se muestra en la F igura 1.  \nTransfecci \u00f3n de c\u00e9lulas DF -1. Para encontrar la proporci\u00f3n \u00f3ptima de polietilenimina de 25kDa  (PEI25 ) \n(Sigma -Aldrich) y DNA que debe ser usada para la transfecci\u00f3n de c\u00e9lulas DF -1, 1 y 2 \u00b5g de l pl\u00e1smido \npcDNAdual/M -EGFP fue transfectado  con diferentes cantidades de PEI25 en una placa de 12 pocillo s. La soluci\u00f3n \nde trabajo del PEI25 fue una diluci\u00f3n de  1:1000 (w/v) en agua ultrapura.  \nLa obten ci\u00f3n de VLPs se realiz\u00f3 transfectan do c\u00e9lulas DF -1 con el pl\u00e1smido pcDNAdual/M -hnF2  con la \nproporci\u00f3n \u00f3ptima  de PEI25/DNA , escalada en base al \u00e1rea para flask T -225. Luego de 4h de incubaci\u00f3n las c\u00e9lulas \nfueron lavadas con D -PBS y se les coloc\u00f3 medio DMEM al 5% de suero fetal bovino . \nPurificaci\u00f3n  de VLPs. Se modific \u00f3 el protocolo de  McGinnes et al  (10). Brevemente, el sobrenadante fue \ncolectado  a las 72 y 96 h  post-transfecci\u00f3n  y el debris fue  removido por centrifugaci\u00f3n a 2000 xg por 10 min. Los \nVLPs fueron  ultracentrifuga dos en el rotor type 19 (Beckman) a 18000rpm por 12h . El pellet fue  resuspendido en \nBuffer TNE, cargado sobre  una gradiente discontinua de sucrosa (65% -20%)  y centrifugado  en el rotor SW28 \n(Beckman) a 24000 rpm por 6h. La capa \u201cesponjosa\u201d situada en la interface entre 20% y 65% d e sucrosa, fue \ncolectada, mezclada con 2 vol\u00famenes de 80% de sucrosa y colocada sobre  1ml d e sucrosa al  80%,  luego se coloc\u00f3  \nen la parte superior 3.5ml de  sucrosa al 50% y 2 ml de sucrosa  al 10% . La gradiente fue centrifugada a 38000rpm \npor 18h  en el rotor  SW41 (Beckman) . Los VLPs en la interface de 50% y 10% de sucrosa fueron  colectados y \nconcentrados en una columna amicon de 100kDa. Todas las centrifugaciones fueron hechas a 4\u00b0C.  \nAn\u00e1lisis de prote\u00ednas de los VLPs purificados . La evaluaci\u00f3n de las prote\u00ednas presentes en  los VLPs \npurificados fue evaluada  por Western Blot (WB) . Para ello se realiz\u00f3 un  electroforesis en gel de poliacrilamida con \ndodecilsulfato s\u00f3dico (SDS- PAGE ) de gradiente discontinua ( 5% y 10% ). Luego las prote\u00ednas se transfirieron a una \nmembrana de nitrocelulosa. Se realizaron 2 WB: el primero p ara la detecci\u00f3n de la prote\u00edna M de NDV y el segundo \npara l a detecci\u00f3n de la prote\u00edna hnF2. Para la detecci\u00f3n de la prote\u00edna M se us\u00f3 antisuero de pollo contra NDV 63rd WPDC/XXXIX ANECA  (Charles Rivers) y p ara la detecci\u00f3n de hnF2 se  utiliz \u00f3 antisuero de pollo contra la prote\u00edna fibra -2 de FAdV -4. Para \nambos WB, el anticuerpo secundario fue un anticuerpo de rat\u00f3n contra IgY de pollo conjugado con HRP (Promega).  \n \nRESULTADOS  \n \nOptimizaci\u00f3n de la transfecci\u00f3n . La cantidad \u00f3ptima de DNA/ PEI25 para cada pocillo de una placa de 12 \npocillos fue de 1 \u00b5g de DNA  por 2 \u00b5L de PEI. Esta proporci\u00f3n fue extrapolada para los flask T225 en base al \u00e1rea \n(~60 veces el \u00e1rea de un pocillo de una placa de 12 pocillos). Finalmente cada flask T225 fue transfectado con 60 \u00b5g \ndel pl\u00e1smido  pcDNAdual/M -hnF2 y 120 \u00b5L  de PEI.  \nObtenci\u00f3n de VLPs . Los VLPs recuperados en el sobrenadante de las c\u00e9lulas transfectadas fueron purificados \npor varios pasos de ultracentrifugaci\u00f3n. Luego las prote\u00ednas fueron de tectadas por WB . La prote\u00edna M dio  una banda \nde ~40kDa positiva a  suero anti NDV, c oincidiendo con el tama\u00f1o antes  reportado (11). Por otro lado, la prote\u00edna \nhnF2 result\u00f3 positiva al suero anti Fibra -2, generando una banda de m\u00e1s  de 60kDa. La figura 2 muestra el WB \nrealizado a los VLPs, tanto con suero anti NDV, como con suero anti  Fibra -2. \n \nDISCUSI\u00d3N  \n \nLas prote\u00ednas M y hnF2  fueron encontradas juntas en los VLPs purificados, indica ndo que la incorporaci\u00f3n de \nla prote\u00edna hnF2 en los viriones fue exitosa . El extremo N -terminal de la prote\u00edna hnF2, compuesto de los DC y DT \nde la prote\u00edna HN, tiene la capacidad de interactuar con la prote\u00edna M  (8), lo que explica  la incorporaci\u00f3n eficiente \nla prote\u00edna hnF2 al v iri\u00f3n. \nEl VLP generado tiene un alto potencial inmunog\u00e9nico y s i bien, la \u00fanica prote\u00edna de FAdV -4 incorporada en \nel VLP es la Fibra -2, se espera que la protecci\u00f3n generada contra el virus sea mayor que la protecci\u00f3n obtenida por \nla prot e\u00edna sola. Esto d ebido  principalmente a dos razones: la primera es que los VLPs exhiben una gran repetici\u00f3n \ndel ant\u00edgeno en su superficie , lo que puede inducir una fuerte respuesta inmune de c\u00e9lulas B  (12); la segunda raz\u00f3n \nse debe a que los VLPs presentan un tama\u00f1o similar al de un pat\u00f3geno, lo que les permite ser captados por las \nc\u00e9lulas presentadoras de ant\u00edgeno ( en especial c\u00e9lulas dendr\u00edticas ) y su subsecuente procesamiento y presentaci\u00f3n \nv\u00eda MHC -I y MHC -II (12). \nEn resumen, el presente trabajo es el primero en reportar la obtenci\u00f3n de V LPs para un adenovirus , dando un \npaso importante en el desarrollo de la siguiente generaci\u00f3n de vacunas contra FAdV. Sin embargo, el potencial \ninmunol\u00f3gico de estos VLPs necesita ser probado in vivo, para determinar su eficiencia como vacuna contra FAdV -\n4. \n \nREFERENCIAS  \n \n1. H .  G r g i \u0107 ,  Z .  P o l j a k ,  S .  S h a r i f  a n d  E .  N a g y .  P a t h o g e n i c i t y  a n d  C y t o k i n e  G e n e  E x p r e s s i o n  P a t t e r n  o f  a  \nSerotype 4 Fowl Adenovirus Isolate. PLoS One. 8(10): e77601. 2013.  \n2. Hafez HM. Avian adenoviruses infections with special attention to inclusion body \nhepatitis/hydropericardium syndrome and egg drop syndrome. Pak Vet J, 31(2): 85- 92. 2011.  \n3. Khan, A.A., Sabri, A.N., Mansoor, M.K. and Hussain, I. Hydropericardium syndrome in  \nPakistan: a review. World\u2019s Poult. Sci. J., 8: 647 -654. 2005.  \n4. San M art\u00edn C. Latest Insights on Adenovirus Structure and Assembly. Viruses, 4, 847- 877; \ndoi:10.3390/v4050847. 2012.  \n5. Tan P, Michou AI, Bergelson J & Cotten M. Defining CAR as a cellular receptor for the avian adenovirus \nCELO using a genetic analysis of the two viral Fibre proteins. Journal of General Virology, 82, 1465- 1472. 2001.  \n6. Schachner, A., Marek, A., Jaskulska, B., Bilic, I., Hess, M. Recombinant FAdV -4 \ufb01ber -2 protein  protects \nchickens against hepatitis \u2013hydropericardium syndrome(HHS). Vaccine, \nhttp://dx.do i.org/10.1016/j.vaccine.2013.12.056.  2014.  \n7. Liu F, Ge S, Li L, Wu X, Liu Z & Wang Z. Virus -like particles: potential veterinary vaccine immunogens. \nRes. Vet. Sci., doi:10.1016/j.rvsc.2011.10.018. 2011.  \n8. Pantua H, McGinnes L, Peeples M & Morrison T. Requirements for the Assembly and Release of \nNewcastle Disease Virus -Like Particles. Journal of Virology. DOI: 10.1128/JVI.00726- 06. 2006.  \n9. Morrison T. Newcastle disease virus -like particles as a platform for the development of vaccines for human \nand agricu ltural pathogens. Future Virol. September 1; 5(5): 545\u2013 554. 2010.  \n10. McGinnes L, Pantua H, Laliberte J, Gravel K, Jain S, Morrison T. Assembly and Biological and \nImmunological Properties of Newcastle Disease Virus -Like Particles. Journal of Virology. p. 4513 \u20134523. 2010.  63rd WPDC/XXXIX ANECA  11. Battisti,  A. J., Meng, G., Winkler, D.C., McGinnes, L.W., Plevka, P., Steven, A.C., Morrison  T.G., \nRossmanna  M.G. Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci US A. 109(35): \n13996- 14000. 2012.  \n12. E. Crisci, J. B\u00e1rcena, M. Montoya.  Virus -like particles: The new frontier of vaccines for animal viral \ninfections. Vet. Immunol. Immunopathol. http://dx.doi.org/10.1016/j.vetimm.2012.04.026. 2012.  \n \nFigura 1.  Esquema de clonamiento del pl\u00e1smido que codifica el VLP. El ORF completo de la prote\u00edna M fue \namplificado a partir de RNA extra\u00eddo de NDV e insertado en el pl\u00e1smido pcDNA3.1 entre NheI y NotI, generando \nel pl\u00e1smido pcDNA3.1/M. Para usar el promotor SV40 para expresar un segundo gen de inter\u00e9s, se amplific\u00f3 a \npcDNA3.1/M  eliminando el gen de resistencia a la neomicina y colocando los sitios SbfI y AsiSI a los extremos. \nLuego se insert\u00f3 la EGFP, obteni\u00e9ndose el pl\u00e1smido pcDNAdual/M- EGFP.  La Fibra -2 de FAdV -4 fue fusionada en \nsu extremo N -terminal a los DC y DT de la HN de NDV, generando la prote\u00edna hnF2. El gen hnF2 fue insertado \nentre AsiSI y SbfI en el pcDNAdual/M -EGFP, generando finalmente el pl\u00e1smido pcDNAdual/M -hnF2.   \n \n \n \n \n  \n \n \n  \n \n \n \n \n63rd WPDC/XXXIX ANECA  Figura 2. Western Blot de los VLP purificados. Los VLPs purificados del sobrenadante de c\u00e9lulas \ntransfectadas fueron corridos por SDS -PAGE y luego transferidos a una membrana de nitrocelulosa. Luego las \nprote\u00ednas fueron detectadas por WB. (A) La prote\u00edna M, en el carril 1, dio una banda de ~40kDa posit iva a suero \nanti NDV. En el carril 2 se corri\u00f3 NDV completo como control positivo. (B) La prote\u00edna hnF2, carril 1, result\u00f3 \npositiva al suero anti Fibra -2, generando una banda de m\u00e1s de 60kDa. El carril 2 contiene prote\u00edna Fibra- 2 \npurificada de E.coli como control positivo.   \n \n \n \n  \n \n \n \nINFECTIOUS BURSAL DISEASE (GUMBORO) IS STILL CAUSING  \nPOULTRY PRODUCTION PROBLEMS  \n \nD. Jackwood \n \nFood Animal Health Research Program  \nThe Ohio State University \nOhio Agricultural Research and Development Center  \nWooster, Ohio, USA  \n \nABSTRACT  \n \nEvolutionary forces at work for over half a century have selected for phenotypic changes among infectious \nbursal disease virus (IBDV) strains.  Point mutations and homologous recombination in genome segment A have had \na profound effect on the antigenicity a nd pathogenicity of IBDV.  The reassorting of IBDV genome segments has \ncontributed to changes in pathogenicity among the viruses particularly the very virulent (vv)IBDV. As a result, the \nviruses we are trying to control today are much different than the vir uses that were infecting chicken flocks 50, 25 or \neven five years ago.  Gumboro disease continues to be a problem because vaccines have not kept pace with the \nantigenic changes occurring in these viruses.  We now know that even minor amino acid changes can have profound \neffects on the antigenicity and pathogenicity of IBDV.  Clinical Gumboro caused by the vvIBDV continues to cause \nlosses for poultry producers. Subclinical  IBDV infections and the immune suppression that accompanies them can \nreduce feed efficiency , cause slower  growth rates  and lead to secondary infections.  The inactivated v accine s used to \nproduce maternal immunity  and the  live-attenuated and recombinant HVT -IBD vaccines  used to produce active \nimmunity  in chicks all seem to provide better protection when  their antigenic structure matches that of the field \nviruses.  \n \nINTRODUCTION  \n \nGumboro disease is caused by IBDV.  This virus  is a member of the family Birnaviridae , genus Avibirnavirus . \nThey have a bi -segmented double -stranded RNA genome.  This is important because mutations in RNA viruses \noccur more frequently  than in DNA viruses.  As a result, the antigenic and pathogenic types of IBDV have evolved  \nconsiderably since it was first identified approximately 50 years ago  (5). These viruses  no longer  fit into the two \nantigenic clas ses (classic and variant ) identified in the 1980s.  Numerous  antigenic strains of the serotype 1 viruses \nhave been identified.  In addition,  a wide range of pathogenicity exists from naturally at tenuated to the very virulent \n(vvIBDV) strains  (30). \n \nANTIGENICITY  \n \nTwo serotypes of IBDV have been  identified.  The serotype 1 viruses typically infect chickens and cause \nimmune suppression in that species (5).  Serotype 2 viruses infect numerous avian species including turkeys but thus \nfar no disease has been attributed to the viruses belonging to this serotype (4,2 3,24).  \nApproximately 30 years ago, the serotype 1 viruses were characterized into two antigenic groups known as \nclassic and variant.  Today this is an oversimplification of the antigenic variability we have observed among these \nviruses.  Several antigenic subtypes have been described within the classic virus group; for example the Winterfield \nand Lukert strains (2 2,32) and antigenic drift is largely responsible for the continued emergence of new antigenic \nvariant viruses (14).  \nThe antigenic phenotype of IBDV is determined by the hypervariable sequence region of VP2 (hvVP2) \n(1,3,9,10) . The crystal structure of VP2 identified four loop structures in the hypervariable sequence region that \nwere designated P BC PDE, PFG, and P HI (7). The antigenic characteristics of IBDV are controlled by specific amino \nacids at the apex of these loops (6,2 0).  \nStudies have shown that  several evolutionary mechanisms are used by IBDV to change the amino acids on \nthese loop structures . Amino acid substitution mutations in the P BC and P DE domains have contributed to antigenic \ndrift among IBDV strains (1 4). We examined amino acids 222 and 254 on the variant Del -E strain of IBDV and \nfound that single amino acid mutations at both sites profoundl y affect antigenicity (1 4).  63rd WPDC/XXXIX ANECA  In addition to antigenic drift, the loop structures on VP2 have mutated through homologous recombination.  \nThis is an event that occurs when different strains of IBDV infect the same  host cell. The co -infection provides an  \nopportunity for their genome segments to break and recombine.  When this happens within the hvVP2 region , the \nantigenic structure of the virus can be affected.   \nUsing phylogenetic analysis, two studies on IBDV genome segment A found incongruent phylogeneti c trees \nindicating strong evidence for recombination between vvIBDV and vaccine strains of the virus (11,12) . We \nidentified IBDV that had recombination events in their genomes during a molecular epidemiologic study from 2001 \nto 2011 in commercial chickens from Mexico, Colombia and Venezuela (13). Most of the IBDV identified  had the \ntypical variant or classic amino acid sequences across the hvVP2 region.  However, fifteen viruses identified in \nMexico, six v iruses from Venezuela, and one from Colombia had hvVP2 amino acid combinations characteristic of \nboth classic and variant IBDV strains. The VP2 amino acid sequences in the P BC and P HI loop structures of the \nVenezuela and Colombia viruses were similar to mo st Winterfield  classic viruses while their P DE and P FG loop \nsequences were typical of the Delaware variant strain.  The Mexico viruses had P BC loop sequences that were typical \nof variant IBDV strains but their P DE and P FG loop structures contained amino acids that were similar to Winterfield \nclassic strains.    \n \nPATHOGENICITY  \n \nA wide range of IBDV serotype 1 pathotypes exist in nature.  They have been generally classified into sub -\nclinical (scIBDV), classic virulent (cvIBDV)  and very virulent (vvIBDV) groups (3 0). Although there are some \ncountries that do not have vvIBDV , phylogenetic s tudies  indicate the se highly pathogenic viruses  have spread to \nnearly all poultry producing countries in the world including the United States (8,2 7,29). Phylogenetic studies  also \nindicate that all known vvIBDV are closely related (2 8) however there appears to be some mutations that are \ncreating vvIBDV with unique nucleotide sequences.  These viruses are usually found within a defined geographic \nregion.   \nStudies have shown that amino acids 253 and 284 in VP2 are invol ved in virulence of IBDV (2,2 1,25,31). It \nwas also shown that genome segment B which encodes the viral RNA -directed RNA polymerase was important for \nefficient viral replication and virulence in vivo  (21). The discovery of a natural reassortant of IBDV also \ndemonstrated that genome segment B is important for the pathogenicity of vvIBDV strains ( 19). It appears that more \nthan one molecular det erminant contributes to the virulence of IBDV.   \n \nCONTROL OF GUMBORO  \n \nCurrent vaccination and control strategies used by the poultry industry rely heavily on maternal immunity \nbeing passed to  progeny chicks.  Inactivated commercial vaccines prepared from ant iquated strains of IBDV are \navailable for the production of maternal immunity in breeder flocks but they usually do not fully protect progeny chicks against vvIBDV (1 6). Furthermore, t hese vaccines are also ineffective against newly emerging viruses that \nhave undergone antigenic drift (1 4).   \nLive-attenuated commercial vaccines have been used in young chicks in an attempt to improve protection but \nthey are only marginally effective against the new antigenic types of IBDV and most are not effective against the \nhighly pathogenic vvIBDV (1 8,26). The recombinant HVT -IBD vaccines have improved protection to some IBDV \nstrains but they too are based on a single antigenic type of virus and may not fully protect agai nst evolving IBDV \nstrains.  The increased use and success of autogenous vaccines and recent publications on the molecular basis for \nantigenic drift (1 4) indicate commercial IBD vaccines are not keeping up with the evolution of IBDV.  The spread of \nvvIBDV and ge nome reassorted vvIBDV throughout the world including the  USA , suggests the vaccines used for \nthis acute strain of the virus could perform better  (15,16). A vaccine specifically designed to control vvIBDV is \nneeded.   \nMultivalent vaccines for IBDV exist  and they do a good job protecting against some strains of the virus.  Using \none multivalent vaccine product to p rotect against all possible strains of IBDV however may not be practical \nbecause antigenic change will continue as immunologic selection pressur es drive the evolution of these viruses (1 8). \nThe use of molecular tools to diagnose the IBDV strain s breaking through vaccine immunity  and then genetically \nengineer ing a vaccine to that specific antigenic type of IBDV  is possible  (17). It is likely these designer vaccines \nwill be able to keep up with IBDV evolution and effectively control Gumboro disease long into the future.  \n \n \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Bayliss, C. D., U. Spies, K. Shaw, R. W. Pete rs, A. Papageorgiou, H. Muller, and M. E. G. Boursnell. A \ncomparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a \nvariable region in VP2. J . Gen. Virol. 71:1303- 1312. 1990.  \n2. Boot, H. J., A. H. ter  Huurne, A. A. Hoekman, B. Peeters, and A. Gielkens. Rescue of Very Virulent and \nMosaic Infectious Bursal Disease Virus from Cloned cDNA:  VP2 is not the Sole Determinant of the Very Virulent \nType. J . Virol. 74(15):6701- 6711. 2000.  \n3. Brandt, M, K. Yao, M.  Liu, R. A. Heckert, and V. N. Vakharia. Molecular determinants of virulence, cell \ntrophism, and pathogenic phenotype of infectious bursal disease virus. J Virol. 75:11974- 11982. 2001.  \n4. Chettle, N., R. K. Eddy, and P. J. Wyeth. The isolation of infectio us bursal disease virus from turkeys in \nEngland. British Vet . Journal. 141:141- 145. 1985.  \n5. Cosgrove, A. S. An apparently new disease of chickens -Avian Nephrosis. Avian Dis. 6:385 -389. 1962.  \n6. Coulibaly, F., C. Chevalier, B Delmas, and F. A. Rey. Cryst al structure of an aquabirnavirus particle: \nInsights into antigenic diversity and virulence determinism. J . Virol. 84:1792- 1799. 2010.  \n7. Coulibaly, F., C. Chevalier, I. Gutsche, J. Pous, J. Navaza, S. Bressanelli, B Delmas, and F. A. Rey. The \nBirnavirus crystal structure reveals structural relationships among icosahedral viruses. Cell. 120:761 -772. 2005.  \n8. Eterradossi, N., C. Arnauld, F. Tekaia, D. Toquin, H. Le Coq, G. Rivallan, M. Guittet, J. Domenech, T. P. \nvan d en Berg, and M. A. Skinner. Antigenic and genetic relationships between European very virulent infectious \nbursal disease viruses and an early West Africa isolate. Avian Pathol. 28:36 -46. 1999.  \n9. Eterradossi, N., C. Arnauld, D. Toquin, and G. Rivallan. Critical amino acid changes in VP2 varia ble \ndomain are associated with typical and atypical antigenicity in very virulent infectious bursal disease viruses. Arch . \nVirol. 143:1627- 1636. 1998.  \n10. Eterradossi, N., D. Toquin, G. Rivallan, and M. Guittet. Modified activity of a VP2 -located neutralizing \nepitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus. Arch Virol. \n142:255- 270. 1997.  \n11. He, C -Q., L- Y. Ma, D. Wang, G -R. Li, and N -Z. Ding. Homologous recombination is apparent in \ninfectious bursal dise ase virus. Virol ogy. 384:51- 58. 2009.  \n12. Hon, C -C, T-Y Lam, C -W Yip, R. Wong, M. Shi, J. Jiang, F. Zeng, and F. C. Leung. Phlyogenic evidence \nfor homologous recombination withing the family Birnaviridae. J Gen Vir ol. 89:3156- 3164. 2008.  \n13. Jackwood, D.  J. Molecular epidemiologic evidence of homologous recombination in infectious bursal \ndisease viruses. Avian Dis. 56:574 -577. 2012.  \n14. Jackwood, D. J. and S. E. Sommer -Wagner. Amino acids contributing to antigenic drift in the infectious \nbursal disease B irnavirus (IBDV). Virology. 409:33- 37. 2011.  \n15. Jackwood, D. J., S. E. Sommer -Wagner, B. M. Crossley, S. T. Stoute, P. R. Woolcock, and B. R. Charlton. \nIdentification and pathogenicity of a natural reassortant between a very virulent serotype 1 infectiou s bursal disease \nvirus (IBDV) and a serotype 2 IBDV. Virology. 2011.  \n16. Jackwood, D. J., S. E. Sommer -Wagner, S. T. Stoute, P. R. Woolcock, B. M. Crossley, S. K. Hietala, and \nB. R. Charlton. Characteristics of a very virulent infectious bursal disease virus from California. Avian Dis. 53:592-\n600. 2009.  \n17. Jackwood, D. J. and S. T. Stoute. Multivalent virus -like-particle vaccine protects against classic and variant \ninfectious bursal disease viruses. Avian Dis.  57:41- 50. 2013. \n18. Jackwood, D. J. and S. T. Stoute. Molecular evidence for a geographically restricted population of \ninfectious bursal disease viruses. Avian Diseases. 57: 57-64. 2013.  \n19. Le Nouen, C, G. Rivallan, D. Toquin, P. Darlu, Y. Morin, V. Beven, C. de Boisseson, C. Cazaban, S. \nComte, Y.  Gardin, and N. Eterradossi. Very virulent infectious bursal disease virus:reduced pathogenicity in a rare \nnatural segment -B-reassorted isolate. J Gen . Virol. 87:209- 216. 2006.  \n20. Letzel, T., F. Coulibaly, F. A. Rey, B Delmas, E. Jagt, A. van Loon, and E. Mundt. Molecular and \nstructural bases for the antigenicity of VP2 of infectious bursal disease virus. J . Virol. 81:12827- 12835. 2007.  \n21. Liu, M. and V. N. Vakharia. VP1 protein of infectious bursal disease virus modulates the virulence in vivo. \nVirolo gy. 330:62- 73. 2004.  \n22. Lukert, P. D., J. Leonard, and R. B. Davis. Infectious bursal disease virus:antigen production and \nimmunity. Am. J. Vet. Res. 36:539 -540. 1975.  \n23. McFerran, J. B., M. S. McNulty, E. R. McKillop, T. J. Connor, R. M. McCracken, D.  S. Collins, and G. M. \nAllan. Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys, and ducks: \ndemonstration of a second serotype. Avian Pathol. 9:395- 403. 1980.  63rd WPDC/XXXIX ANECA  24. McNulty, M. S., G. M. Allan, and J. B. McFerran. I solation of infectious bursal disease virus from turkeys. \nAvian Pathol. 8:205 -212. 1979.  \n25. Mundt, E. Tissue culture infectivity of different strains of infectious bursal disease virus is determined by \ndistinct amino acids in VP2. J . Gen. Virol. 80:2067- 2076. 1999.  \n26. Sreedevi, B., L. J. LeFever, S. E. Sommer -Wagner, and D. J. Jackwood. Characterization of Infectious \nBursal Disease Viruses from Four Layer Flocks in the United States. Avian Dis. 51: 845-850. 2007.  \n27. Stoute, S. T., D. J. Jackwood, S. E. Sommer -Wagner, G. L. Cooper, M. L. Anderson, P. R. Woolcock, A. \nA. Bickford, C. G. Senties -Cue, and B. R. Charlton. The Diagnosis of very virulent infectious bursal disease in \nCalifornia Pullets. Avian Dis. 53:321 -326. 2009.  \n28. van d en Berg, T. P. Acute  infectious bursal disease in poultry: a review. Avian Pathol. 29:175 -194. 2000.  \n29. van d en Berg, T. P., N. Eterradossi, D. Toquin, and G. Meulemans. Infectious bursal disease (Gumboro \nDisease). World Trade and Public Health Implications, OIE Scientific and Technical Rev. 19:509- 543. 2000.  \n30. van d en Berg, T. P., D. Morales, N. Eterradossi, G. Rivallan, D. Toquin, R. Raue, K. Zierenberg, M. F. \nZhang, Y. P. Zhu, C. Q. Wang, H. J. Zheng, X. Wang, G. C. Chen, B. L. Lim, and H. Muller. Assessment of genetic, \nantigenic and pathotypic criteria for the characterization of IBDV strains. Avian Pathol. 33:470 -476. 2004.  \n31. van Loon, A., N de Haas, I. Zeyda, and E. Mundt. Alteration of amino acids in VP2 of very virulent \ninfectious bursal disease virus res ults in tissue culture adaptation and attenuation in chickens. J Gen Vir ol. 83 \n(1):121 -129. 2002.  \n32. Winterfield, R. W., A. S. Dhillon, H. L Thacker, and L. J. Alby. Immune responses of white leghorn chicks \nfrom vaccination with different strains of infectious bursal disease virus and in the presence of maternal antibodies. \nAvian Dis. 24:179- 188. 1979.  \n \n 63rd WPDC/XXXIX ANECA  COMPOSTAJE EN SECO DE LA MORTALIDAD DE LA GRANJA \nDE AVES  DE LA  FACULTAD DE MEDICINA VETERINARIA Y \nZOOTECNIA DE LA UNIVERSIDAD NACIONAL AUT\u00d3NOMA  \nDE M\u00c9XIC O \n \nDRY COMPOSTING MADE OUT OF MORTALITY FROM THE  \nPOULTRY FARM OF FMVZ, UNAM  \n \nT. J\u00ednez M\u00e9ndez, \u00c1. Gonz\u00e1lez Ernesto y K. Valle  Valenzuela  \n \nCentro de Ense\u00f1anza Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola, Facultad de Medicina Veterinaria y \nZootecnia, UNAM.  Salvador D\u00edaz Mir\u00f3n s/n. Avenida Tl\u00e1huac, Km 21.5, Colonia Zapotitl\u00e1n, Delegaci\u00f3n Tl\u00e1huac, \nM\u00e9xico D.F. Tel\u00e9fono: 5845- 0029 y 5845- 1530 fax  E-mail: tomas_jinez@hotmail.com  \n \nSUMMARY  \n \nIn order to impact the environment the least possible (air and water), dry composting of mortality from \nCEIEPAv, FMVZ, UNAM was carried out. To do the compos ting, the center has eight  boxes to make com post. The \nprocess lasted 30 d, in which the temperature was moni tored daily during the first wk; from the second w k on, \ntemperatur e was monitored every three d . The maximum temperature registered was 14 8\u00b0F on d three , 134\u00b0 F on d \n14, 94\u00b0F,  on d 23, and 82\u00b0F on d  24. To prepare the compost, a product based on bacteria an d enzymes (COMPOST -\nAID) was used . The product dosage is 2 g/kg of mortality, it is mixed with water and sprayed on the mortality and \nleft for 30 d so that enz ymes and bacteria can transform the solid residues, and at the end of the process we have \nquality  compost.  \n \nRESUMEN  \n \nCon la finalidad de tratar de impactar lo menos posible al ambiente (aire y agua), se realiz\u00f3 el compostaje en \nseco de la mortalidad del CEIEPAv de la FMVZ de la UNAM. Para la realizaci\u00f3n del compostaje el centro cuenta \ncon un \u00e1rea de 8 cajones para la elaboraci\u00f3n de compostas, las cuales est\u00e1n construidas con piso de cemento y una \ncanaleta para recolectar los posibles lixiviados producidos  durante el proceso de compostaje, los muros son de \ntabique y est\u00e1n aplanados con cemento , el techo es de l\u00e1mina galvanizada y se cuenta con una fuente de agua. El \nproceso de compostaje dur \u00f3 30 d\u00edas durante los cuales se registr\u00f3  la temperatura diariamente durante la semana  1 y a \npartir de la semana 2 se tom\u00f3  cada tres d\u00edas . La temperatura m\u00e1xima registrada fue de 148 \u00b0F al d\u00eda  3, de ah\u00ed se \ninicia un descenso de la temperatura al d 14 es de 134\u00b0F y al d\u00eda  18 es de 126\u00b0F al d\u00eda  23 ya es m\u00e1s baja de 94\u00b0F y al \nd\u00eda 24 ya es de 82\u00b0F para  la reali zaci\u00f3n de la composta se utiliz\u00f3  un producto a base de bacterias y enzimas \n(COMPOST -AID\u00ae) la dosis del producto es de 2 gramos por kg  de mortalidad , este es  mezclado con agua y se  \nasperja sobre la mortalidad , se cubre con gallinaza y con material ve getal seco y se deja por 30 d \u00edas para que las \nenzimas y bacterias transformen  los desechos . \n \nINTRODUCCI\u00d3N  \n \nLos residuos s\u00f3lidos comprenden todos los desechos  que provienen de actividades animales y humanas, que \nnormalmente son s\u00f3lidos y que son desechados como in\u00fatiles y superfluos.  Los seres humanos y los animales han \nutilizado los recursos de la tierra para la supervivencia y la evacuaci\u00f3n de residuos. En ti empos remotos, la \nevacuaci\u00f3n de desperdicios  humanos y animales no planteaba un problema ya que la poblaci\u00f3n era peque\u00f1a y la \ntierra era abundante sin embargo a medida que fue creciendo la poblaci\u00f3n hubo la necesidad de producir m\u00e1s \nalimento para m\u00e1s pobla ci\u00f3n y con ello se han generado m\u00e1s residuos. Algunos pa\u00edses sobre todo los desarrollados \nya tiene tiempo que est\u00e1n legislando acerca de estos residuos sin embargo en los pa\u00edses como M\u00e9xico y otros \nparecidos a \u00e9l se inicia una legislaci\u00f3n muy tibia  ya que se ha permit ido algunas minas a cielo abierto  adem\u00e1s de \nconcentraciones excesivas de animales ya sea ganado de leche de carne, cerdos y aves con la consecuente \ngeneraci\u00f3n de desecho s. El termino residuo s\u00f3lido es muy extenso pero en este caso en particular  hablamos de la \ngallinaza y de una alternativas que se puede  hacer para tratar de impactar lo menos al ambiente y poder darle un uso  63rd WPDC/XXXIX ANECA  sustentable , la elaboraci\u00f3n de composta en seco de la gallinaza y la mortalidad es una buena alternativa de manejar \nla mortalidad de una granja sin afectar la salud de las aves sanas y obteniendo adem\u00e1s un producto con valor \nagregado.  \n \nMATERIAL Y M\u00c9TODOS  \n \nLa investigaci\u00f3n se llev\u00f3  a cabo en el C entro de E nse\u00f1anza Investigaci\u00f3n y Extensi\u00f3n en P roducci\u00f3n Av\u00edcola \nde la F acultad de M edicina Veterinaria y Z ootecnia de la U niversidad Nacional Aut\u00f3noma de M\u00e9xico , el cual cuenta \ncon la siguiente infraestruc tura. \n\u00c1rea de compostas . El CEIEPAv cuenta con ocho  Cajones  para la elaboraci\u00f3n de composta  construidos con \ntabique y aplanados  con cemento , con las siguientes dimensiones, 6.5  m de largo, 1.3 m. de ancho y 1.2 m. de alto, \ntecho de l\u00e1mina galvanizada, piso de cemento con un declive del 3%, toma de agua, b\u00e1scula anal\u00edtica con divisiones \nde 0.1g,  term\u00f3metro Taylor con una graduaci\u00f3n que va de - 40 a 160\u00b0F  aspersores manuales, azadones, palas, \ncarretilla, cubetas y  COMPOST -AID. \nPara la elaboraci\u00f3n de la composta se us\u00f3 el producto a raz\u00f3n de 2g  de COMPOST -AID por kg de mortalidad  \ndiluido en agua de l a red p\u00fablica , la composta se inicia colocando una capa de material vegetal seco de 15 cm  de \nalto, se coloca una capa de gallinaza de 10 cm de alto y en seguida se coloca la mortalidad eviscerada, y se asperja a \nla mortalidad con el producto ,se coloca otra capa de gallinaza y finalmente se cubre con una capa de 15 cm de alto \nde material vegetal seco  y se dejo por 30 d\u00edas  al t\u00e9rmino del cual se observo el resultado . \nEl registro de las te mperaturas fue el siguiente: d \u00eda 1- 125\u00b0F, d\u00eda  2-140\u00b0F , d\u00eda 3-146\u00b0F , d\u00eda 4-142\u00b0F , d\u00eda 7-\n135\u00b0F , d\u00eda 8-132\u00b0F , d\u00eda 14-132\u00b0F , d\u00eda 18-126\u00b0F , d\u00eda 21-114\u00b0F , d\u00eda 23-94\u00b0F , d\u00eda 24 ya estaba a temperatura \nambiente  \n \nRESULTADOS Y DISCUSI\u00d3N \n \nLas temperaturas por encima de los 60\u00b0C y el tiempo que duran estas temperaturas eliminan cualquier agente \npat\u00f3geno que este tanto en las heces como en los cad\u00e1veres, el proceso no requiere de control de humedad ni de \nventilaci\u00f3n, \u00fanicamente se forman las capas de heces, mortalidad y sustrato y se deja que act\u00faen las bacterias y enzimas del producto, en este caso la granja cuenta con la infraestructura necesaria para la elaboraci\u00f3n de \ncompostas, pero en caso de no contar con ella se pueden elaborar trincheras o hileras y cubrirlas con pl\u00e1stico en caso \nde que no se cuente con cobertizo,  El proceso de compostaje en seco es una buena alternativa para manejar la \ngallinaza y la mortalidad dentro de las granjas av\u00edcolas, adem\u00e1s de obtener un producto con valor agregado  y algo \nquiz\u00e1 lo m\u00e1s importante es que se impacte lo menos posible al ambiente ya que aunque legalmente no estamos \nobligados a hacerlo \u00e9ticamente s\u00ed.   \n \nFotograf\u00eda 1. Restos de la composta.  \n \n 63rd WPDC/XXXIX ANECA  EXPERIENCES WITH COCCIDIOSIS VACCINE USE IN LAYERS \nIN THE UNITED STATES  \n \nEXPERIENCIAS CON LA UTILIZACI\u00d3N DE LA VACUNA CONTRA LA \nCOCCIDIOSIS EN GALLINAS DE POSTURA COMERCIALES \nEN LOS ESTADOS UNIDOS  \n \nK. Jones  \n \nTechnical Services Veterinarian, CEVA Animal Health  \nkelli.jones@ceva.com  \n \nRESUMEN  \n \nLa coccidiosis existe en la industria de las gallinas de postura a pesar de las pr\u00e1cticas comunes en donde se \nutilizan productos anticoccidianos  y vacunas para combatirla. Este estudio fue de inter\u00e9s en 2013 cuando la \nproducci\u00f3n de una vacuna contra la coccidiosis com\u00fanmente utilizada se vio comprometida, haciendo que el \nproducto escaseara en la industria av\u00edcola de los Estados Unidos. Como una al ternativa, otra vacuna entr\u00f3 al \nmercado durante ese tiempo.  Este hecho, permiti\u00f3 que se hicieran comparaciones de campo entre los dos productos \npor medio del seguimiento de diversos par\u00e1metros, los cuales incluyen el conteo de ooquistes de pollitos criados en \nsuelo y en jaulas. Estos datos ser\u00e1n presentados y demostrar\u00e1n que a pesar de que ambas vacunas indujeron \ninmunidad despu\u00e9s de 21 d\u00edas  de la vacunaci\u00f3n, existieron diferencias definitivas entre las dos vacunas a lo largo del \nestudio.  Esto junto con otras observaciones, indica que una exposici\u00f3n inicial a una dosis m\u00e1s baja de ooquistes \npuede ser mejor que una dosis inicial alta que posteriormente requiera tratamiento qu\u00edmico. Se presentar\u00e1n resultados de este estudio.  \n \nSUMMARY  \n \nCoccidiosis exists in the layer industry despite common practices utilizing anticoccidi als and vaccines to \ncombat it. This study became of interest in 2013 when production  of a commonly utilized  coccidiosis vaccine  was \ncompromised, thus making the product scarce in the industr y. As an alternative, another vaccine entered the U.S. \nmarket during this time. This opportunity allowed for field comparisons to be made between the two products by \nway of monitoring various parameters including oocyst counts from both floor reared and cag e rear ed pullets. This \ndata will be presented and will show that despite the fact that both va ccines induced immunity after 21  d post \nvaccination , there were definite differences observed along the way between the two vaccines. These, along with \nother obse rvations indicate th at a lower initial dose  of oocysts may be better than a high er one  that subsequently \nrequires treatment.  \n \nINTRODUCTION  \n \nCoccidiosis exists in the layer industry despite common practices utilizing anticoccidials  and vaccines to \ncombat it. Anticoccidials are commonly utilized in the industry because they have advantages that include increased \ngrow th rates  and a la ck of post vaccinal reactions. Chemicals attempt to provide a complete kill and shutdown of the \ncoccid ia life cycle, whereas ionophores are designed to allow for leakage with subseq uent immunity to occur. \nPotential disadvantages to these anticoccidials include the development of c hemical resistance (1,5) which can lead \nto severe coccidiosis breaks, s ensiti vity to ionophore toxicity  and d elayed cycling when birds are older .   \nLive non -attenuated vaccines  are administered via a liquid or gel spray application on the first day of life in  the \nhatchery or on the farm . Their mode of action is to initiate immunity  by providing the first low level dose of oocysts \nin a uniform, controlled manner. There are many advantages to coccidiosis vacci nation. For example, vaccine \noocysts remain sensitive to chemicals and can eventually replace more resistant field oocysts . They can also be used \nin organic  and antibiotic free programs. They have also shown to be cost competitive to chemicals/ ionophores. A \nprogram comparison provided by a major la yer producer showed that their a mprolium prevention program costs \nthem $0.03/bird . To vaccinate they s pend $0.035- $0.04/bird. Their a mprolium treatment program, however, \ncommonly costs $0.09/bird + cost of lost birds/eggs.  Disadvantages to coccidiosis vaccination include the fact that 63rd WPDC/XXXIX ANECA  uniform application  uptake is critical, s pray appli cation can wet and chill chicks , live virulent strains can cause post \nvaccinal \u201cstress\u201d, and c ycling is heavily dependent on management .  \n \nCASE REPORT  \n \nDuring 2013, the leading coccidiosis vaccine supplier for the layer industry had production issues thus making \nthe product  extremely scarce in the industry. As a result, another coccidiosis vaccine ent ered the United States \nmarket. During this same time, a large commercial layer company found themselves vaccinating half of th eir pullet \nplacements with  traditional coccidiosis vaccine and the remaining half with the new product. Because of this, there \nwas opportunity to compare both vaccines side by side.  \n \nMATERIALS AND METHODS  \n \nCompany flocks included both cage and floor reared commercial la yer pullets of the same breed. Half of the \nflocks received one commercial vaccine and the remaining half received the other vaccine. The traditional product \nwas applied via 21mL of course water spray at one d  of age in the hatchery, whereas the new vaccine was \nadministered via 25 mL gel droplet  application . Initial uptake of vaccine was assessed by the presence or absence of \nvaccine dye on  the tongue after application. Field obs ervations were recorded.  \nIn addit ion, to monitor the efficacy of the vaccine application and the successful recycling on the farm, regular \noocyst counts on fresh fecal samples were done.  Oocysts in freshly sampled feces re\ufb02ect the current intensity of the \ncoccidial infection present ( 3). Fecal sample periods post coccidiosis vaccination  included : 7 d, 14 d, 21d, and 28 d.  \nRepresentative sample s (60-100g) of fresh  droppings were collected in a Ziploc\u00ae bag using p lastic spoons . \nDroppings were to represent a random  sampling  throughout the house, collected on the routine walk -through.  \nSample bags were labeled with: farm name/flock number/site/house number/sex/age at collection/date of collection. \nSamples were refri gerated until they were sent via  express/overnight delivery on ice to the labo ratory for processing.   \nFecal/cecal samples were all processed in the laboratory and oocyst counts were performed per gram of feces \nusing a modifi cation of a  McMaster counting chamber technique described by  Long  and Rowell  (4). Briefly, using \napplicator sticks, one gram of thoroughly mixed fecal sample was obtained . Sample was then placed in a  15ml \nconic al disposable centrifuge tube. Fecasol\u00ae solution (15 mL) was then added, the tube was capped and the sample \nwas mixed well using a vortex.  Cheesecloth  was then placed in a strainer over a beaker and the mixed samp le was \npoured in the strainer. The cheesecloth was squeezed to get most of the sol ution out. The solution was then poured \nfrom the beaker back int o the conical tube and capped. It was again mixed using a vortex and was loaded into a \nMcMaster slide using a pipette. The slide was allowed to settle for five minutes prior to performing t he counts. Both \nsample processing and oocyst counts were all performed blindly by the same technician for consistency.   \n \nRESULTS  \n \nHatchery o bservations . Liquid spray application required with the traditional product had a tendency to wet \nand chill the chicks  by around 5\u00b0 F compared to the gel droplet application  which only decreased temperature by \n0.8\u25e6F . In addition, liquid application of the traditional product required agitation, as oocysts h ad a tendency to  settle. \nIn comparison, t he gel droplet application  of the new vaccine  did not appear  to wet chicks , and oocysts remained \nsuspended in the gel without agitation. Also, upta ke of the new gel droplet product (based on dyed tongues) was 99-\n100% . \nFloor reared pullets . Both products achieved a vaccine \"take\" indicated by positive oocyst counts at 7  d post \nvaccination. In addition, recycling of oocysts occurred with both products demonstrated by a significant increase \nfrom 7 \u2013  14 d post vaccination and again  from 14 -21 d post vaccination. Oocysts per gram (OPG) of feces peaked at \n21 d post vaccination, as expected , for both products . Immunity developed during this time and infection cleared as \nseen by a decrease in oocyst per gram of feces between 21 -28 d pos t vaccination . Both vaccines appeared to yield \nthe same final result, however, t he path which both products took to achieve this immunity varied tremendously .   \nFor example, the traditional vaccine had much higher 7  d average counts (36,000- 60,000  OPG)  co mpared to the \nnew vaccine  average (2,000 OPG) . This could have been  attributed to a much higher initial dose and a  very fresh \nproduct serial  following the earlier shortage of vaccine supply . In addition to the high counts at 7d, there were also \nreports and  confirmed observations of bloody droppings with accompanying spikes in mortality in flocks that \nreceived the traditional vaccine. The individual farm counts were also interesting, as the new product had much more consistent cycling curves compared with th e traditional product,  in that  there was a nice steady increase \nfollowed by a steady decrease in oocysts per gram  (OPG)  of feces .   63rd WPDC/XXXIX ANECA  Cage reared pullets.  Again, it appeared that both products achieved the final goal of developing immuni ty to \ncoccidiosis, bu t similar  to results from the floor reared pullets, the two curves presented very different ly along the \nway. Like in floor reared birds, 7 d counts of birds vaccinated with the traditional vaccine were extremely high \n(30,000- 90,000 OPG) compared to the new  product (1,000- 2,000 OPG). Some 14 d counts of birds vaccinated with \nthe traditional product were also extremely high (> 250,000 OPG) compared to the new product (26,000 OPG). \nThese traditionally vaccinated high OPG flocks all had to be treated with amprolium prior to 21 d of age due to \nbloody droppings, high morbidity and mortality from 7 -18 d. Additionally, like with the floor reared pullets, \nindividual farm results were more consistent for the new vaccine flocks vs. the traditional vaccine flocks.   \n \nDISCUSSION  \n \nBoth vacc ines appeared to successfully lead to the development of immunity by 21  d for both  cage and floor \nreared layers. This was supported by the decline in oocysts per gram of feces from 21- 28 d. There were, however, \ndistinct differences in cycling curves of the two produc ts. There were much higher  7-14 d counts accompanied by \nbloody droppings and mortality with the traditional vaccin e compared to the new product. There were also high \npeaks and even clinical coccidiosis breaks on some farms vaccinated  with the traditional product. Treatment with \namprolium  was necessary in some cases. It is important to keep in mind that anytime there is a clinical break in a \nflock, there are added costs of medication, pullet mortality, performance loss a nd cost of potential eggs lost.  Because \nof clinical disease plus the  adde d costs for flocks receiving  traditional vaccine, the new vaccine product was the best \nvalue for co ccidiosis control.      \nFor floor reared birds, re -cycling of oocysts is promoted by proper management of litter moisture.  This is \nachieved by adjusting the bird density during brood.  It is suggested to start birds off at a maximum of 0.5 ft2/chick \nfor the first 7d  , a maximum of 0.75 ft2/chick from 7 -12 d and a maximum of 1 ft2/chick from 12-14 d. Keeping \nbirds at these parameters will help to ensure that there is enough oocyst exposure to provide adequate cycling.  \nMois ture is needed for sporulation.  Ideal litter moisture is around 25- 35%. Excessive moisture will yield too many \noocyst s, whereas too little moisture in the barn will yield too few oocysts.  \nFor cage reared birds , it is critical to manage fecal/oocyst availability . For example, folks have had success by \nleaving cage paper down through 22 d to get past the peak cycling peri od.  40% cage floor coverage for 5w was \nhighly effective in a recent study (6). Thick dissolvable paper or paper plates have also pr oven effective in our \nstudies. In addition, any processing of chicks should revolve around oocyst cycling to avoid cycle interruption. For \ninstance, beak trim and move birds around 9- 10 d of a ge rather than at 6 -7 d of age. This pract ice does two \nimportant things. First, it avoids interrupting the cycle at 7  d.  Second, beaks are not sensitive when  needed mo st for \nfecal uptake.  Another practice that influenced oocys t re-cycling was moving birds. Best OPG counts were observed \nwhen birds were moved from upper to lower cages.  Initial chick placement in upper cages is beneficial because this allows for feces to  fall to lower cages and inoculate them for when chicks are later moved down.   \n \nREFERENCES  \n \n1. Chapman, H.D., Biochemical, genetic and applied aspects of drug resistance in  Eimeria  parasites of the \nfowl. Avian Pathol., 26 (1997), pp. 221 \u2013244. \n2. Gordon, H.M., Whitlock, H.V., 1939. A new technique for counting nematode eggs in sheep faeces. J. \nCoun. Sci. Ind. Res. Aust. 12, 50 \u201352. \n3. Hodgson, J.N., 1970. Coccidiosis: oocyst counting technique for coccidiostat evaluation. Exp. Parasitol. \n28, 99\u2013 102. \n4. Long, P.L., Rowell , J.G.. Counting oocysts of chicken coccidia . Lab. Pract., 7 (1958), pp. 515\u2013 518 534  \n5. Peek, H.W., Landman, W.J.M.. Resistance to anticoccidial drugs of Dutch avian  Eimeria  spp. field \nisolates originating from 1996, 1999 and 2001.  Avian Pathol., 32 (4) (2003), pp. 391 \u2013401. \n6. Price K. R., Guerin, M.T., Newman, L., Hargis, B.M. and J.R. Barta. Examination of a Novel Practical \nPoultry Management Method to Enhance the Effect of Live Eimeria Vaccination for Conventionally  \n7. Housed Replacement Layer Pullets . International Journal of Poultry Science 12 (3): 175 -184, 2013.  \n  \n \n  \n 63rd WPDC/XXXIX ANECA  ACKNOWLEDGMENTS  \n \nThis work was sponsored by CEVA Animal Health and could not have been possible without the efforts of the \nCEVA layer sales and product support team.  In addition, huge appreciation goes out to Ms. Nora Johnson , certified \nmedical technologist,  for performing all of  the oocyst counts for this study .   63rd WPDC/XXXIX ANECA  VACCINE PROTECTION OF CHICKENS AGAINST THE 2012 \nMEXICAN H7N3 HIGHLY PATHOGENIC  \nAVIAN INFLUENZA VIRUS  \n \nPROTECCI\u00d3N DE LA VACUNA PARA POLLOS CONTRA EL VIRUS \nMEXICANO DE LA INFLUENZA AVIAR ALTAMENTE PATOG\u00c9NICA  \nH7N3 DEL 2012  \n \nD. KapczynskiA, M. Pantin -JackwoodA, S. GuzmanB, Y. RicardezB, E. SpackmanA, K. BertranA, D. SuarezA,  \nand D. SwayneA \n \nAExotic  and Emerging Avian Disease Research Unit, Southeast Poultry Research Laboratory, Agricultural Research \nService, USDA, 934 College Station Road, Athens, GA 30605  \nBBiosafety Laboratory Level 3, The Mexico -  United States Commission for the Prevention of Foo t and Mouth \nDisease and Other Exotic Animal Diseases (CPA), 2SENASICA -SAGARPA, Palo Alto, Mexico, 05110  \n \nRESUMEN  \n \nEn junio de 2012, se report\u00f3 un brote de influenza aviar altamente patog\u00e9nica (IAAP) H7N3 en aves \ndom\u00e9sticas en Jalisco, M\u00e9xico. Desde entonces  el virus se ha extendido a muchos estados de los alrededores y se \nsiguen reportando nuevos brotes. Se realizaron pruebas de vacunas para determinar la eficacia protectora de una \nvacuna H7 inactivada.  En la primera serie de experimentos, un linaje mexicano  de AI de baja patogenicidad (IABP) \nH7N3 aislado de un pato, con un 98% de similitud de secuencia con el virus de la IAAP, se aplic\u00f3 a dos  pollos de \nuna semana de edad. Las aves vacunadas mostraron una protecci\u00f3n del 100 % cuando se desafiaron. En un segun do \nexperimento, se vacunaron gallinas de postura de 26 semanas de edad, una o dos veces, y se desafiaron con el virus \nde la influenza aviar altamente pat\u00f3geno.  \nLa eliminaci\u00f3n del virus se redujo en todas las aves vacunadas, en comparaci\u00f3n con las aves con trol. Se \ndiscutir\u00e1 el impacto del desaf\u00edo IAAP en la producci\u00f3n de huevos y la transmisibilidad. Estos resultados demuestran que el aislamiento de la vacuna IABP puede proporcionar protecci\u00f3n contra el virus de la influenza aviar H7N3.  \n \nSUMMARY  \n \nIn June of 2012, an outbreak of highly pathogenic avian influenza (HPAI) H7N3 was reported poultry in \nJalisco, Mexico. Since that time the virus has spread into  many surrounding States and new outbreaks continue to be \nreported. The purpose of this study wa s to characterize the Mexican 2012 H7N3 HPAI virus \n(A/chicken/Jalisco/CPA1/2012) and determine protection conferred against the virus by different H7 low pathogenic (LP) inactivated vaccines in chickens.  Both adult and young chickens intranasally inoculate d with the virus be came \ninfected and died between two and four d  post inoculation  (pi). High virus titers and viral replication in many ti ssues \nwas demonstrated at two d pi  in infected birds. The Jalisco virus had high sequence similarity of greater than 9 7% to \nwild bird viruses from North America in all eight gene segments.  The hemagglutinin gene of the virus contained a \n24 nucleotide insert at the hemagglutinin cleavage site which had a 100% sequence identity to chicken 28s ribosomal RNA, suggesting the i nsert was non- homologous recombination with the host genome.  For vaccine \nprotection studies, both U.S. H7 L PAI viruses and a 2006 Mexican H7 LPAI virus were tested as antigen in \nexperimental oil emulsion vaccines and injected into chickens three weeks prio r to challenge. All H7 vaccines tested \nprovided >90 % protection against clinical disease after challenge and decreased the number of birds shedding and the titers of viral shedding. In a second experiment, 26 wk old egg laying hens were vaccinated either singly or \ndoubly and challenged against the HPAI virus.  All vaccinated birds survived challenge and reduced shedding of \nvirus compared to sham vaccinated birds. These results demonstrate the LPAI vaccine isolate can provide protection \nagainst the HPAI H7N3  virus.   \n \n(Manuscript to be published in Avian Diseases .) \n 63rd WPDC/XXXIX ANECA  EV ALUATION OF FOUR DIFFERENT V ACCINATION PROGRAMS \nAGAINST HPAI H5N1 2011 EGYPTIAN VIRUS IN COMMERCIAL \nBROILER CHICKENS REARED UNDER  \nLABORATORY CONDITIONS  \n \nESTUDIO A PRUEBA PARA EV ALUAR CUATRO DIFERENTES PROGRAMAS \nDE V ACUNACI\u00d3N CONTRA EL VIRUS EGIPCIO HPAI H5N1 2011 EN POLLO \nDE ENGORDA COMERCIAL CRIADOS EN  \nCONDICIONES DE LABORATORIO  \n \nW. KilanyA, A. El-H. A. HanafeiB, A. FatouhC, A. SelimA; A. A. ErfanA; M. SafwatA; A. ShawakeA, Soad Abd El-\nAzizA, V. PalyaD, B. Le TallecE, P. CruzE, Y. GardinE, M. PaniagoE, and F. LozanoE \n \nACentral Laboratory for Veterinary  Quality Control , Egypt   \nBAl- Watania Poultry Company, Egypt   \nCeva Animal Health CEgypt, DHungary and EFrance  \n \nRESUMEN  \n \nUn total de 300 de pollos de engorda comercial de un d\u00eda de edad con niveles de anticuerpos maternos (AM) \ncontra la influenza aviar sub -tipo H5, fueron distribuidos en  6 grupos de tratamiento de 50 aves cada uno y \nvacunados como sigue:  Grupo 1 vacunados en la incubadora con la vacuna  Vector rHVT_AI por v\u00eda subcut\u00e1nea. \nGrupo 2 con una vacuna  re-asociada muerta re- H5N1 de origen egipcio. Grupo 3 una vacuna inactivada H5N2 de \ncepa Potsdam. Grupo 4 una vacuna re -asociado inactivada re- H5N3 d e cepa de origen Vietnamita. Grupo 5  no \nvacunado y expuesto ; y Grupo 6 vacunado y no expuesto.  Todas las vacunas inactivadas fueron administradas \nparenteralmente a los siete d  de edad. Todos los pollos de engorda comercial fueron expuestos al d\u00eda 29 de edad con  \nuna variante clade 2.2.1.1 de HPAIV H5N1 (A/Chicken/Egypt/1164D/2011). Se hici eron observaciones a los 14 \nd\u00edas despu\u00e9s de la exposici\u00f3n,  incluyendo signos cl\u00ednicos, mortalidad, detecci\u00f3n de virus,  baja del virus y serolog\u00eda. \nLos resultados ser\u00e1n presentados.  \n \nSUMMARY  \n \nA total of 150 one d old commercial broiler chicks carrying matern ally derived antibody  (MDA) against sub -\ntype H5 of avian influenza and reared in a BSL3 facility  were distributed into 6 treatment groups of 25 birds each , as \nfollows: Group 1 (G1) : Vector rHVT -AI vaccine given by sub -cutaneous route at day-old at the hatchery (0.2 mL ). \nGroup 2 (G2) : A re -assortant inactivated ed vaccine re\u2019H5N1 of Egyptian origin  strain  (0.5 mL ). Group 3 (G3) : An \ninactivated vaccine H5N2 Potsdam strain  (0.5 mL ). Group 4 (G4) : A re -assortant inactivated vaccine re\u2019H5N3 \nVietnam ese origin strain  (0.5 mL ). Group 5 (G5) : Non-vaccinated  and challenged  positive control  and Group 6 \n(G6) : Non-vaccinated and non- challenged  negative control . All inactivated vaccines in G roups 2, 3 and 4  were \nadministered via sub-cutaneous  route  at seven d  of age. All  commercial broiler chi ckens were challenged at 29 d  of \nage with a HPAIV H5N1 variant clade 2.2.1.1 (A/Chicken/Egypt/116AD/2011). An observation  period of 14 d post \nchallenge (dpc) was conducted and the parameters measured were: clinical sig ns, mortality, virus shedding and \nserology.  The percentages  of protection  rate against mortality were: G1: 80%; G2: 66%; G3: 60%; G4: 40%; G5: \n0%; G6: 100% . The p ercentage of virus shedders  by group a t three and six dpc were  respectively : G1: 26% and \n13%; G2: 73% and 42%; G3: 80% and 42%; G4: 60% and 66%; G5: 100% and 100%. The vector rHVT -AI vaccine \nprovided the highest  protection against the HPAIV H5N1 2011 variant virus challenge strain when compared with  \nthe reassortant  and inactivated vaccines evaluated . \n \n \n \n  \n 63rd WPDC/XXXIX ANECA  MATERIALS AND METHODS  \n \nLocation . BSL3 facilities at the National Laboratory for Veterinary Quality Control on Poultry Production \n(NLQP), Cairo, Egypt.  \nBirds . A total of 150 c ommercial broilers from an AI -H5 hyper -immunized broiler breeder parent  flock  were \nused for this study .  \nTreatment g roups . Birds were distributed into six  groups as described in Table 1.  \nChallenge virus . A/Chicken/Egypt/116A/2011 HPAI H5N1 administered at a dose of 106 EID 50/bird in 100 \nuL/bird given via intra -nasal route.  A minimum of 80% mortality at five  d post -challenge in the positive control \ngroup  was considered for the validity of the challenge.  \nBirds challenged . At 29 d of age, 15 broilers with the highest HI titers to a  homologous HA antigen from each \ngroup were selected for the challenge study. O nly 10 birds were used for the two control g roups 5 and 6.  \nParameters measured . Clinical signs  (dyspnea, ruffled feathers, depression) ; Mortality and lesions post -\nmortem; Virus excretion by real time RT -PCR from oro -pharyngeal swabs taken at 3, 6, 10 and 14 dpc ; and \nSerology (HI  test). A 14 d observation period was conducted after the challenge admini stration  at 29 d of age .  \nSerology.  Homologous and heterologous HA antigens from different H5N1 (2006; 2010; 2011 and 2012) and \nH5N2 strains were used for the evaluation of the serological response in each vaccinated group.  \nResults.  Cumulative mortality results by treatment group at the end of the challenge observation period are \npresented in Figure  2. Specific mortality to AI was confirmed by real time RT -PCR in samples of internal organs. \nVirulent challenge was validated in Gr oup 5 with 100% mortality by d six . Birds in G roup 1 had the lowest \nmortality (3/15) and mortality in G roups 2, 3 and 4 were 5/15, 6/15 and 9/15 respectively. No birds were infected \nwith AIV  in the negative control s.  \nDetection of AIV shedding post -challenge . The amount of virus detected in the oro -pharyngeal swabs taken \nat 3, 6, 10 and 14 dpc using a real time RT -PCR showed similar virus levels at three and six  dpc, however the \npercentage of shedder birds at these dpc was lower in the broilers of G roup 1. No virus shedding was detected by \nRT-PCR in any of the groups at 10 and 14 dpc.   \n \nCONCLUSION  \n \nThe highest protection  against mortality  (80%)  and shedding was observed in the vaccinated group with the \nvector rHVT -AI H5 vaccine. Birds in Groups 2 and 3 vaccinated with inactivated vaccines RG H5N1 and H5N2 had \na protection against mortality of 66% and 60% respectively. The Group 4 vaccinated with the inactivated vaccine \nRG H5N3  had 40% protection.  Measurement of virus shedding by real time RT -PCR in the oropharyngeal swa bs \ntaken at 3, 6, 10 and 14 d of age showed detectable shedding at three and six dpc  only in all vaccinated groups , \nbeing the birds in G roup 1 showing the lowest virus excretion  rate. \n \n  \nTable 1. Vaccine group distribution and challenge age . \n \nGroup  Birds  Vaccines  Age Dose / \nbird Challenge HPAIV H5N1  \n106 EID 50/Bird  \n1 25 rHVT -AI H5  1 day  0.2 ml  29 days  \n2 25 Inactivated vaccine - IV H5N1 RG  7 days  0.5 ml  29 days  \n3 25 Inactivated vaccine - IV H5N2  7 days  0.5 ml  29 days  \n4 25 Inactivated vaccine \u2013 IV H5N3 RG  7 days  0.5 ml  29 days  \n5 25 Non-vaccinated -Challenged  ------  ------  29 days  \n6 25 Non-vaccinated -Non-challenged  ------  ------  ------  \n  \n \n  \n \n 63rd WPDC/XXXIX ANECA   \n \n \n \nFigure  1. Cumulative mortality dpc by treatment g roup.  \n  \n \n \n  \nFigure  2. Percentage of shedder birds by treatment group at different dpc.  \n \n                       \n \n 63rd WPDC/XXXIX ANECA  MOLECULAR IDENTIFICA TION OF SELECT SALMONELLA \nSEROTYPES OUT OF MIX ED CULTURES FROM MODIFIED \nSEMISOLID RAPPAPORT -VASSILIADIS MEDIUM  \n \nIDENTIFICACI\u00d3N MOLECULAR DE SEROTIPOS SELECCIONADOS DE \nSALMONELLA ENTERICA DE CULTIVOS MIXTOS A PARTIR DE UN \nMEDIO RAPPAPORT- VASSILIADIS SEMIS\u00d3LIDO MODIFICADO  \n \nU. Klaube  \n \nCobb- Vantress, Inc. , Siloam Springs, AR 72761  \nundine.klaube@cobb -vantress.com  \n \nRESUMEN  \n \nLa serotipificaci\u00f3n cl\u00e1sica de Salmonella  como herramienta epidemiol\u00f3gica requiere cultivos puros de \naislamientos y una biblioteca de antisueros espec\u00edficos para ant\u00edgenos O -y H-. Para determinar el serotipo completo, \nse tiene que hacer un gran esfuerzo en la inducci\u00f3n de fases alternas de ant\u00edge no -H. Hemos desarrollado un \nprotocolo cuantitativo de la reacci\u00f3n en cadena de polimerasa (qPCR), que permite la identificaci\u00f3n de los serotipos \nseleccionados de Salmonella a partir de muestras ambientales de aves, enriquecidas en el medio Rappaport - \nVassiliadis semis\u00f3lido modificado (MSRV, por sus siglas en ingl\u00e9s). Esta prueba basada en SYBR puede identificar \nlas secuencias gen\u00e9ticas \u00fanicas de seis grupos comunes O - (B, C1, C2, D, E, y G), as\u00ed como seis complejos de \nant\u00edgeno flagelar ( i , r , Z10 , G, M , 2 / 5/6/7 , y e, n , x / e, n , Z15 ) de un cultivo crudo de matriz mixto. La \npresencia potencial de aislamientos cr\u00edticos tales como Enteritidis, Typhimurium, Infantis, Heidelberg y Hadar, en una muestra puede entonces confirmarse o descartarse antes de que un cultivo puro est\u00e9 disponible, lo que permite \nuna aplicaci\u00f3n mucho m\u00e1s r\u00e1pida de las medidas de seguimiento que el enfoque tradicional de serotipificaci\u00f3n.  \n \nSUMMARY  \n \nClassical serotyping of Salmonella  as an epidemiological tool requires pure isolate  cultures and a library of O - \nand H -antigen specific antisera. To determine the full serotype, significant effort has to be expended on inducing \nalternate H -antigen phases. We have developed a quantitative polymerase chain reaction (qPCR) protocol that \nallows the identification of select Salmonella serotypes from environmental poultry samples enriched in modified \nsemisolid Rappaport -Vassiliadis medium (MSRV). This SYBR- based assay can identify the unique genetic \nsequences of six common O -groups (B, C1, C2, D, E, and G) as well as six flagellar antigen complexes (i, r, z\n10, \ng,m, 2/5/6/7, and e,n,x/e,n,z 15) from a crude matrix mixed culture. The potential presence of critical isolates such as \nEnteritidis, Typhimurium, Infantis, Heidelberg, and Hadar  in a sample can thus be confirmed or ruled out before a \npure culture is available, allowing for a much swifter implementation of follow -up measures than the traditional \nserotyping approach.  \n \nINTRODUCTION  \n \nEpidemiologists have long relied on serotyping of Salmonella to distinguish strains and track outbreaks of this \nimportant food- borne pathogen. Participation in the National Poultry Improvement Plan (NPIP) and export \nregulations also mandate that certain Salmonella serotypes be identified in the poultry fa rm environment when \npresent  (6).  \nThe White -Kauffmann -Le Minor scheme organizes  the currently known 2,579 Salmonella serovars into \ndistinct groups based on somatic O -antigens and flagellar H -antigens  (3). Determin ing t he complete serotype of a \nSalmonella isolate  requires an extensive library of all possible O - and H -antigen specific antisera as well as a \nsufficient amount of a pure culture . Maintaining the antisera library is expensive, and other challenges such as \nproblems with antisera production and is olates exhibiting abnormal morphology  have given rise to the increasing \npopularity of m olecular serotyping approaches  (4, 5) .  \nWe have developed a protocol t hat uses published primer sequences of six common O -groups (B, C1, C2, D, 63rd WPDC/XXXIX ANECA  E, and G) as well as six flagellar antigen complexes (i, r, z 10, g,m, 2/5/6/7, and e,n,x/e,n,z 15) in a SYBR Green based \nquantitative  PCR (qPCR) application to allow for iden tification of select Salmonella serotypes without having a pure \nculture  (1, 2) . We report here that a crude DNA extraction from a mixed modified semisolid Rappaport -Vassiliadis  \n(MSRV)  culture is sufficient to determine whether certain Salmonella serotypes such as Enteritidis, Typhimurium, \nHeidelberg, Infantis, and Hadar are present in a sample. This enables the user to implement interventions at least one \nday earlier than conventional serotyping procedures.  The approach also works from a pure culture that is not typable \ndue to atypical somatic antigen structure (\u201crough\u201d Salmonella ), problematic p hase inversion,  or limitations of an \nantisera library.  \n \nMATERIALS AND METHODS  \n \nField samples.  Field samples were collected using foot swabs moistened with 2X skim milk and subsequently \nprocessed in tetrathionate broth and MSRV  before streaking on selective agars  upon a positive PCR signal . Field \nisolates were sent to the National Veterinary Services Laboratory to confirm presumptive serotypes.  \nqPCR.  Quantitative PCR was performed using a SYBR Green based reaction mix. Template DNA was \nprepared as a crude boil from MSRV in molecular grade water. Samples were run on a 35 cycle three- step PCR \nprogram with evaluation of fluores cence intensity after every amplification cycle. Following the program, a melt \ncurve analysis was performed . \nData analysis.  Samples were evaluated for a combination of expected cycle threshold (C t) and melt peak (T m) \naccuracy to make positive or negative calls. A Salmonella genus specific primer set was used to establish a C t \nbaseline for each sample. Purified DNA preparations of known isolates w ere used as positive controls.  \n \nRESULTS  \n \nField samples showed characteristic melt peaks corresponding  to the relevant positive control(s). Some  \nunspecific amplification did occur;  it was however easily distinguishable from true positives the due to lack of \nexpected melt peaks and high cycle thresholds. Running a reference well per sample targeting the Salmonella genus \nhelped to establish a range that the molecular serotyping target s would  amplify within should the sample be positive .  \nFor efficiency reasons, we also tested amplification specificity of combinations of primer sets in the same well. \nThe H -antigens could not be combined due to excessive unspecific amplification. However , we were able to \ncombine the six O -group primer sets into three reactions: Grp. B and D, Grp. C1 and C2, and Grp. E and G. The \nmelt temperatures within those combined reactions were signi ficantly different enough that they  could be used to \ndetermine the i dentity of an isolate while de creasing the number of reaction wells  necessary to complete the panel.  \nAfter determining the serotype of field samples molecularly out of MSRV wherever possible, we compared \nthese results to classical serotyping completed from  a pure colony. All isolates tested molecularly were reliably \nshown to contain the same antigens both by our laboratory and the National Veterinary Services Laboratory  when \nusing the serological approach . For example, samples that typed as Grp. B, H:r, and H:2/5/6/7 molecularly were \nsubsequently identified as Salmonella Heidelberg serologically. Samples that were negative on all nine primer sets \nof the panel were later determined to be isolates such as Salmonella Cerro ( 6,14,18:z 4,z23:[1,5]:z 45,z82).  \n \nDISCUSSION  \n \nIn this work we have shown that it is possible to determine the presence or absence of certain critical \nSalmonella serotypes without having to wait for  a pure culture. Instead, we were able to make this determination \nusing merely a crude boil DNA extract from MSRV that also contains significant background flora found in the \npoultry environment. Furthermore, t he nine primer sets used allow for the identif ication  of at least a partial serotype \nof a majority of the commonly isolated Salmonella serovars .  \nWhile this approach is not intended to  replace cultural isolation and purification of a suspected Salmonella , it \ncan serve as an early warning system should  important isolates such as Salmonella Enteritidis, Typhimurium, \nHeidelberg, Infantis, o r Hadar be present in a sample. The sooner a product can be flagged as potentially affected, \nthe earlier intervention decisions can be made to minimize negative impact.  This is true for international export \ndecisions as well as determining whether to depopulate a local flock.  \nThe molecular approach described above reveals itself to be superior when dealing with multiple Salmonella  \nserotypes present in the same sample. NPIP regulations dictate the screening of three to five colonies per sample (6). \nWe have handled several cases where molecular panel results showed the presence of at least two distinct types of \nSalmonella in MSRV, but serological serotyping of five colonies revealed only one serovar present on the selective 63rd WPDC/XXXIX ANECA  agar. Re -culturing from MSRV would eventually produce the second serovar, but only because we kne w to search \nfor it.  \nLastly, this qPCR method is also helpful when conventional serotyping is inconclusive or incomplete due to \nlibrary limitations and abnormal isolate morphology. In fact, using our protocol with a pure colony as template \nrather than a mixed culture MSRV sample reduces background amplification and shows even more clearly that \ntargeting DNA is often quicker, easier, and possibly even cheaper than using the classical serological method.  \n \nREFERENCES  \n \n1. Essam Soliman, S., C. Kilpatrick, S. Mohamed Ahmed, M. Eman Abouelhassan, R. Nimmanapelli, and P. \nG. Reddy. Allelotyping PCR for d etection and s creening of Salmonella enterica serovar Enteritidis  and \nTyphimurium . Int. J. Poult. Sci. 8:156 -160. 2009.  \n2. Fitzgerald, C., M. Collins, S. van Duyne, M.  Mikoleit, T. Brown, and P. Fields.  Multiplex, bead-based \nsuspension array for m olecular determination of c ommon Salmonella  serogroups. J. Clin. Microbiol. 45:3323- 3334.  \n2007.  \n3. Grimont, P. A. D., and F. -X. Weill. Antigenic formulae of the Salmonella serovars. 9th ed. WHO \nCollaborating Centre for Reference and Research on Salmonella, Paris, France. 2007.  \n4. McQuiston, J. R., R. Parrenas, M. Ortiz -Rivera, L. Gheesling, F. Brenner, and P. I. Fields. Sequencing and \ncomparative analysis of flagellin genes fliC , fljB, and flpA from Salmonella. J. Clin. Microbiol. 42:1923- 1932. 2004.  \n5. McQuiston, J. R., R. J. Waters, B. A.  Dinsmore, M. L. Mikoleit, and P. I. Fields. Molecular determination \nof H a ntigens of Salmonella by use of a microsphere- based liquid array. J. Clin. Microbiol.  49:565-573. 2011.  \n6. USDA APHIS. National Poultry Improveme nt Plan and Auxiliary Provisions. 9 CFR 145, 146, and 147. \n2014.  63rd WPDC/XXXIX ANECA  THE IMPACT OF SODIUM AND CHLORIDE LEVELS AND \nRATIOS ON THE PERFORMANCE OF BROILERS FED DIETS \nCONTAINING LASALOCID  \n \nEL IMPACTO DE LOS NIVELES Y PROPORCIONES DE SODIO Y CLORURO \nEN EL RENDIMIENTO DE LOS POLLOS DE ENGORDA ALIMENTADOS \nCON DIETAS QUE CONTIENEN LASALOCID  \n \nM. LaVorgna, T. Barbosa, and J. Dickson  \n \nZoetis Global Poultry, Durham, NC , USA . 27703 \n \nRESUMEN  \n \nLos ion\u00f3foros  son mol\u00e9culas solubles en l\u00edpidos que transportan iones a trav\u00e9s de la membrana de la c\u00e9lula, \nconduciendo a la interrupci\u00f3n de gradientes de concentraci\u00f3n de iones transmembranales de microorganismos. Los \nion\u00f3foros se han utilizado en gran medida en la avicultura para controlar la coccidiosis. Se ha especulado que los \ndiferentes niveles de electrolitos pueden afectar el rendimiento de los pollos de engorda alimentados con ion\u00f3foros. \nSe sabe que los niveles de sodio y cloro var\u00edan en gran medida entre las d ietas de pollos de engorda comerciales, \ndando gran variabilidad a los niveles de electrolitos en las dietas de pollos de engorda, lo que podr\u00eda exacerbar estos \nefectos. El presente estudio tiene como objetivo evaluar los par\u00e1metros de rendimiento de los po llos de engorda \nalimentados con dos niveles diferentes de un ion\u00f3foro divalente (lasalocid) en combinaci\u00f3n con 12 proporciones \ndiferentes de sodio: cloro. El dise\u00f1o del estudio consisti\u00f3 en ocho bloques de veinticuatro corrales cada uno. Un total \nde 4,224 machos Cobb 500 se dividieron en 192 corrales. Los resultados se presentar\u00e1n, incluyendo el aumento de \npeso promedio, la tasa de conversi\u00f3n de alimento, consumo de agua, la mortalidad, la calificaci\u00f3n de lesiones plantares y las puntuaciones de la marcha.  \n \nABSTRACT  \n \nThe study was design ed to evaluate the impact of sodium and chloride levels and relative ratios on the \nperformance of broilers fed diets containing the divalent ionophore l asalocid.  A total of 4224 Cobb 500 male \nbroilers were divided among  192 pens  across 24 treatments . Data collected  includ ed average body weight gain, feed \nconversion rat io, water consumption  and mortality. Weight gain and feed conversion results indicated interactions \nbetween sodium and chloride for a number of treatments.  \n \nINTRODUCTION  \n \nIonophores are lipid- soluble molecules that transport ions across the cell membrane, leading to disruption of \ntransmembrane ion concentration gradients of microorganism. Ionophores have been largely used in poultry to \ncontrol coccidiosis. It has been speculated that different levels of electrolytes may affect performance of broilers fed \nwith ionophor es. It is known that levels of s odium  (Na) and c hlori de (Cl) vary among commercial broiler diets, \ngiving great variability to  dietary  electrolyte  balance (DEB)  levels . The study design  evaluate d the performance \nparameters of broilers fed with two different levels of a divalent ionophore (lasalocid) in  combination with 12 \ndifferent sodium:c hlori de (Na:Cl)  ratios.  \n \nMATERIAL AND METHODS  \n \nAnimals . 4224 Cobb 500 males  were divided into 192 pens at one d  of age. Birds were housed in an \nenvironmentally controlled building in 3\u2019x 5\u2019 concrete floor pens at the sto cking density of 0.75 sq f t/bird. Bir ds \nwere vaccinated for Marek\u2019s d isease in ovo and for Newcastle and infectious b ronchitis by spray application at day \nof hatch.  \nExperimental design.  Table 1 describes the group distribution for the study. The study has 24 different groups \ndivided into two different levels of a divalent ionophore (lasalocid ) in combination with 12 different Na:Cl ratios.  63rd WPDC/XXXIX ANECA  For each Na level, there were three relative  percentage levels of Cl (80%, 100% and 120%).  Each treatment has \neight  replicates distributed in a randomized complete block design, with the pen as the experimen tal unit. Birds were \nkept for 42 d with feed ad libitum  Feed schedule consisted of  3 different diets: Starter  (0-18 d), Grower (19- 28 d) \nand Finisher (29 -42 d).   \nData collection . At the b eginning of each feed phase (d 0, 18, and 28), water  consumpti on was measure for a \nperiod of four d. Feed consumption and body weight gain was me asured at 18, 28, 35 and 42 d. Mortality was \nobserved twice a day and all mortality was necropsied and weighted for feed conversion adjustment.  \nStatistical a nalysis . The model for this study was a randomized complete block with pen as the experimental \nunit and repeated measures. All hypothesis tests were conducted at the 0.05 level of significance using two -sided \ntests. Primary variables were  weight gain per bird, calculated by divi ding pen weight by the number of animals and \nsubtracting D0 pen weight divided by the number of animals  at D0, and  adjusted feed conversion, calculated on \nstudy d 18, 28, 35 and 42 using the total feed consumption for the pen divided by the total weight of  surviving birds  \nwith D0 weight subtracted .  \n \nRESULTS  \n \nPerformance data for birds receiving 90  ppm of Lasalocid  (T1-T12) are shown of Figure 1. Remaining \nsignificant ( p\u22640.05) results are described below. Cumulative  body w eight gains for birds receiving 90  ppm of \nLasalocid  (T1-T12)  were superior to those receiving 125  ppm (T13 -T24)  at d 28, 35, and 42.  Also, b irds receiving \ndiets with 90  ppm of Lasalocid  (T1-T12) exhibited significantly lower feed conversions than did those receiving 125 \nppm (T13 -T24) at d 35 and 42.   \nA number of interactions were identified as related to sodium and chloride levels.  Evaluation of the effect of \nchloride at  the different levels of sodium  found that a t 18 d  of age, for birds receiving high levels of dietary sodium  \n(0.22% ), the high chloride (0.26%) treatments produced significantly lower feed conversions than did the medium \nchloride levels.  Also, a t d 28, 35, and 42, for those birds receiving high dietary sodium levels  (0.22%) , the high \nchloride (0.26%) treatments produced feed  conversions that were lower than either the medium (0.22%) or low \n(0.18%) chloride levels.  Moreover, f or birds receiving low dietary levels of sodium  (0.16%) , those treatments that \nreceived low chloride (0.12%) levels produced feed conversion  ratios at d  28, 35, and 42 that were lower than those \nreceiving high (0.20%) chloride levels.  Evaluati on of the effect of sodium at different levels of chloride  found that  \nfor birds receiving high levels of dietary chloride  (T3/15, T6/18, T9/21 and T12/24 ), those receiving high  (0.22%) , \nmedium  (0.19%) , or progressive  (0.18 to 0.22%)  sodium levels produced significantly lower feed co nversions at 28, \n35, and 42 d than birds receiving low (0.16%) levels of dietary sodium.  Additionally, f or birds receiving medium \nlevel s (100%) of dietary chloride, those that received medium sodium levels  (0.19%)  exhibited lower feed \nconversions at 28, 35, and 42 d than did those birds receiving high sodium levels  (0.22%) . \n \nCONCLUSIONS  \n \nThe trial data indicated that there was interaction between electrolytes (Na & Cl), thus the ratios of these key \nnutrients can be as important as the actual levels. Body weight gain and feed consumption may be affected by \ndifferent levels of ionophores inclusion in the diets. The conditions pres ent in this study, w here coccidial challenge \nwas not taken into consideration suggested that b roilers receiving a high (125 ppm) level of Lasalocid  during the \nlatter stages of the growing cycle had lighter body weights and higher feed conversions than thos e receiving a \nmoderate (90  ppm) level. This appears to be due, at least in part, to a reduction in feed intake.  We also found that , \nfor broilers receiving medium (0.19%) or progressive (0.18% / 0.20% / 0.22%) dietary sodium levels, there was a trend for in creased weight gains and reduced feed conversions when dietary chloride levels were 120% of respective \nsodium levels. Finally, in that ionophores at higher doses tend to restrict feed intake especially in the latter phases of \nthe growth cycle, it is advisa ble to base the dose level on coccidial challenge; utilizing lower levels in the finisher \nphase when prudent.  \n \n \n  \n \n  \n 63rd WPDC/XXXIX ANECA  Table1 . Study design and group distribution.   \n \nTreatme\nnt  Lasaloc\nid \n(ppm)  Starter (0 -18 \ndays)  Grower (19 -28 \ndays)  Finisher (29 -42 \ndays)  Number \nof \nreplicate\ns % Na  % Cl  % Na  % Cl  % Na  % Cl  \n1 / 13  \n90/125  0.16 0.12 \n0.16 0.12 \n0.16 0.12 8 \n2 / 14   0.16 0.16 0.16  8 \n3 / 15  0.20 0.20 0.20  8 \n4 / 16  \n0.19 0.15 \n0.19 0.15 \n0.19 0.15  8 \n5 / 17  0.19 0.19 0.19  8 \n6 / 18  0.23 0.23 0.23  8 \n7 / 19  \n0.22 0.18 \n0.22 0.18 \n0.22 0.18  8 \n8 / 20  0.22 0.22 0.22  8 \n9 / 21  0.26 0.26 0.26  8 \n10 / 22  \n0.18 0.14 \n0.20 0.16 \n0.22 0.18  8 \n11 / 23  0.18  0.20  0.22  8 \n12 / 24  0.22  0.24  0.26  8 \n \n \nFigure 1 . Male broiler performan ce at 42 d  feed with 90ppm of Lasalocid at different levels of Na and Cl. \nNa levels represent percentage (%) levels in the total diet. Cl levels represent the respective percentage (%) of Cl in \nrelation to Na levels.  \n  \n 63rd WPDC/XXXIX ANECA  AN\u00c1LISIS RETROSPECTIVO DE CASOS DE ENFERMEDAD DE \nMAREK EN AVES DE COMBATE REMITIDOS AL \nDEPARTAMENTO DE MEDICINA Y ZOOTECNIA DE AVES  \nDE 2000 A 2013  \n \nRETROSPECTIVE ANALYSIS OF MAREK\u2019S DISEASE CASES IN FIGHTING \nCOCKS SUBMITTED TO THE POULTRY MEDICINE AND POULTRY \nSCIENCE DEPARTMENT (DMZA) FROM 2000 TO 2013  \n \nN. Ledesma,  A. Luisa Garc\u00eda, F.  S\u00e1nchez Godoy  y M. Teresa Casaubon H . \n \nDepartamento de Medicina y Zootecnia de Aves, FMVZ - UNAM , Distrito Federal, M\u00e9xico  \n \nSUMMARY  \n \nMarek\u00b4s disease is one of the main immunosuppressive diseases of  domestic poultry produced by a  \nherpesvirus.  Although there are vaccines that are used successfully in poultry production, in fighting cocks the \nvaccination is limited to vaccines with serotype 3. The goal of the present work i s to analyze the information of \nMarek\u00b4s disease cases submitted to the DMZA of the FMVZ - UNAM  from 2000 to 2013. There were submitted 226 \ncases of fighting cocks from 16 states of Mexico in which 56 (23.89%) had Marek\u2019s disease (MD) alone or in \nassociation  with other pathogens. Visceral development was encountered in 50% of the cases; nervous development \nin 34.6%; and a combination of the two in 25.4%. Twenty -six percent had reported vaccination.  The findings and \npossible causes are under discussion.  \n \nRESUM EN \n \nLa enfermedad de Marek es una de las principales enfermedades inmunodepresoras de las aves dom\u00e9sticas \nproducida por un herpesivrus. Aunque existen vacunas que se han aplicado con \u00e9xito en aves de producci\u00f3n, en aves \nde combate la vacunaci\u00f3n se ve limit ada a vacunas liofilizadas con serotipo 3. El objetivo del presente trabajo es \nanalizar la informaci\u00f3n de casos de enfermedad de Marek remitidos al DMZA de la FMVZ UNAM en el per\u00edodo \ncomprendido de 2000 a 2013.  Se presentaron 226 casos de aves de combate d e 16 estados de la rep\u00fablica mexicana \nen los cuales 56 (23.89%) tuvieron como diagn\u00f3stico EM sola o en asociaci\u00f3n con otras patolog\u00edas. En el 50 % de los casos se encontr\u00f3 la presentaci\u00f3n visceral seguido de la presentaci\u00f3n nerviosa con 34.6% y la combinaci\u00f3n de \ndos o m\u00e1s presentaciones con 25.4%.  En 26% se tienen reportada vacunaci\u00f3n. Se discuten los hallazgos y posibles \ncausas . \nLas aves de combate son de gran importancia en M\u00e9xico debido al impacto econ\u00f3mico (generaci\u00f3n de \nempleos), social y sanitario  sin embargo; es una poblaci\u00f3n poco estudiada . En la Rep\u00fablica Mexicana existen 2,430 \nmunicipios sin contar el Distrito Federal con un promedio de 10 d\u00edas de feria por municipio. Por lo que hay 24,300 \nd\u00edas de fiesta en el pa\u00eds cuyo evento m\u00e1s tradicional s uele ser la pelea de gallos; en M\u00e9xico se realizan 14,000,000 \nde casteos anualmente de aves de combate, y se requieren m\u00e1s de 28,000,000 de gallos de los cuales m\u00e1s del 90% \nson criados en M\u00e9xico. Esto representa la incubaci\u00f3n natural o artificial de alrededor de 133,000,000 huevos, eclosionando aproximadamente el 60%, es decir 80,000,000 pollos de los cuales se estima que el 50% son machos y \nel 50% son hembras, de los 40,000,000 de machos, hay una mortalidad de aproximadamente el 30% por lo que solo \nllegan a la edad adulta 28,000,000 de aves  (1). \nLa mayor\u00eda de los criadores (aproximadamente el 60%) no llevan un control sanitario adecuado debido a que \nno est\u00e1n informados sobre medidas  de bioseguridad, medicina preventiva, requisitos zoosanitarios para la \nmovi lizaci\u00f3n de sus aves, y desconocen el riesgo potencial que conlleva transmitir y difundir enfermedades, que \ncom\u00fanmente afectan a las aves comerciales y que son un riesgo para la avicultura nacional  (2).\n \nDentro de las principales enfermedades que afectan a las aves se puede mencionar : Enfermedades virales como \nla enfermedad de Newcastle (ENC), influenza aviar (IA), enfermedad de Marek (EM), bronquitis infecciosa (BI), \nlaringotraqueitis infecciosa (LTI), infecci\u00f3n de la bolsa de Fabricio (IBF). Bacterianas co mo salmonelosis y \nmicoplasmosis. Parasitarias como la coccidiasis  (3). 63rd WPDC/XXXIX ANECA  Se conoce entre los criadores de aves de combate que la EM es com\u00fan, sin embargo no se conoce la frecuencia \nde enfermedad ni factores asociados, por lo que el objetivo de este trabajo f ue llevar a cabo un an\u00e1lisis retrospectivo \nde casos de enfermedad de Marek en aves de combate remitidos al Departamento de Medicina y Zootecnia de Aves \nde 2000 a 2013.  \nMATERIAL Y M\u00c9TODOS  \n \nSe realiz\u00f3 el estudio retrospectivo de los casos de aves de combate del a\u00f1o 2000 al 2013 presentados en el \nDepartamento de Medicina y Zootecnia de Aves de la Universidad Nacional Aut\u00f3noma de M\u00e9xico. Secci\u00f3n del \nLaboratorio de Diagn\u00f3stico e Investigaci\u00f3n de las Aves, ubicado en Avenida Universidad 3000 CP. 04510 \nDelegaci\u00f3n Coyoac\u00e1n. Distrito Federal . De estos fueron seleccionados los casos cuyo diagn\u00f3stico integral fue \nenfermedad de Marek  o bien la EM estuvo en asociaci\u00f3n con otra enfermedad. Se recabaron los datos de historia \ncl\u00ednica incluyendo el tipo de ave, edad, procede ncia, signos cl \u00ednicos, mortalidad, morbilidad y necropsias de campo \nsi las hubo.   \nRESULTADOS  \n \nSe presentaron 226 casos de aves de combate de 16 estados de la rep\u00fablica mexicana en los cuales 56 (23.89%) \ntuvieron como diagn\u00f3stico EM sola o en asociaci\u00f3n con  otras patolog\u00edas.  \nEl Estado de M\u00e9xico y Distrito Federal fueron las entidades con mayor n\u00famero de casos con 29.6% y 28.3% \nrespectivamente. As\u00ed mismo los estados con menor participaci\u00f3n fueron Guanajuato y Sinaloa con un caso cada uno \nque representa el 0.4 4%. \nEn todos los a\u00f1os estudiados, las necropsias en pollos (se considera pollo el ave de combate menor de 1 a\u00f1o) \nfueron las m\u00e1s frecuentes (50.2%) seguido de necropsias en machos (44.8%). y s\u00f3lo el 5.71% fueron hembras.  \nLa EM fue diagnosticada en 54 casos (23.89%); de esta, la presentaci\u00f3n visceral se encontr\u00f3 en un 50%; seguida de \nla presentaci\u00f3n nerviosa con un 34.6% el porcentaje restante se debi\u00f3 a m\u00e1s de una presentaci\u00f3n en el mismo caso.  \nSe lleg\u00f3 al diagn\u00f3stico de la enfermedad en 51 casos por histopa tolog\u00eda y en tres  de ellos s\u00f3lo con los hallazgos a la \nnecropsia.  \nEn 14 casos la EM fue el \u00fanico diagn\u00f3stico, sin embargo la  asociaci\u00f3n de EM con otras patolog\u00edas  fue \nfrecuente  encontr\u00e1ndose lo siguiente:  \n\u2022 19 casos de EM + coccidiosis siendo esta la asociaci\u00f3n m\u00e1s frecuente.  \n\u2022 3 casos de  EM + Enfermedad bacteriana \n\u2022 2 casos de EM + Heterakis spp. + Ascaridia galli +  Raillietina spp. + Capillaria sp p.  \n\u2022 5 casos de EM + coccidiosis + Heterakis spp. + Ascaridia galli + Raillietina sp p. Capillaria spp. + \nChoanotaenia infundibulum .  \n\u2022 4 casos de EM + coccidiosis + Enfermedad bacteriana.  \n\u2022 1 caso de EM  + coccidiosis + LTI  \n\u2022 5 casos de coccidiosis + EM + Heterakis spp. + Ascaridia galli.  \n\u2022 1 caso de coccidiosis + EM +L eucosis aviar  \nLa presentaci\u00f3n visceral fue la m\u00e1s fr ecuente seguida de la presentaci\u00f3n nerviosa, el C uadro 1 presenta el n\u00famero de \ncasos y porcentaje de cada presentaci\u00f3n . \n \nDISCUSI\u00d3N  \n \nEn los casos estudiados la EM fue frecuente, esto pudiera deberse a las condiciones de crianza de los pollos; \nlos criadores de aves de combate, en su gran mayor\u00eda no vacunan, por desconocimiento, por la disponibilidad de la \nvacuna ya que la presentaci\u00f3n de la vacuna est\u00e1 hecha para 1000 y 2000 dosis que deben ser almacenadas en \nnitr\u00f3geno l\u00edquido lo cual no es costeable para el gallero que aproximadamente incuba 500 cr\u00edas por a\u00f1o.  Otro punto \nimportante a resaltar es que de estos 54 casos diagnosticados con EM en 15 de las historias cl\u00ednicas se comenta que \nsi aplican la vacuna en incubadora por lo que hay que tomar en cuenta todo el proceso desde la preparaci\u00f3n hasta la \naplicaci\u00f3n y que dicho proceso sea llevado de manera adecuada, por otra parte las casas incubadoras que ofrecen el \nservicio de vacunaci\u00f3n contra la EM, utilizan una presentaci\u00f3n liofilizada cuyo porcentaje de protecci\u00f3n es menor \nante cepas muy virulentas de la EM. Est\u00e1 documentado que la vacuna liofilizada \u00fanicamente tiene un 60% de \nprotecci\u00f3n ante cepas muy virulentas  por \u00faltimo algunos criadores son renuentes a vacunar por temor a que los \ngallos pierdan sus faculta des o se reduzca su temperamento.  63rd WPDC/XXXIX ANECA  Los criadores de aves de combate lo traducen en retraso de crecimiento de los pollos; expresando que los \npollos se \u201csecan y se embuchan\u201d  esto se debe a la inmunodepresi\u00f3n y la par\u00e1lisis del nervio vago, con ello aumenta \nla predisposici\u00f3n a enfermedades secundarias bacterianas, coccidiosis, ERCC, parasitosis entre otras.  \nLos brotes de la enfermedad de Marek en aves comerciales de postura se presentan de la semana 3 a la 9 y al \ninicio de la postura,  esto difiere con las av es de combate de este estudio en donde se registraron 29 casos de Marek \nen pollos y 20 casos en aves adultas, esto pudiera explicarse debido a una infecci\u00f3n temprana, el periodo de \nincubaci\u00f3n y el alto grado de estr\u00e9s social, ya que a los 6 u 8 meses es cu ando se va estableciendo la madurez sexual \nde los pollos y estos se encierran en jaulas separadas siendo sometidos al estr\u00e9s por el encierro  \nDe acuerdo a la presentaci\u00f3n de la EM la m\u00e1s com\u00fan fue la visceral (59%), seguida de la presentaci\u00f3n nerviosa \n(35%) . Para ello la cepa gen\u00e9tica y la cepa viral pueden influir en la ubicaci\u00f3n de las lesiones. Los tumores \nviscerales son en particular frecuentes en las formas agudas de la enfermedad y pueden encontrarse en ausencia de \nlesiones nerviosas macrosc\u00f3picas  (4). \nLas lesiones nerviosas es la m\u00e1s caracter\u00edstica desde el punto de vista cl\u00ednico, pero se observa solo en un 20 a \n40 %  de las aves enfermas  (5) lo cual coincide con los resultados de este estudio.  \nSiendo EM una enfermedad inmunodepresora se podr\u00eda inferir que est\u00e1 directamente relacionada con las \ndem\u00e1s enfermedades p resentadas, en especial con la coccidiosis ya que los pollos al ser criados en semilibertad en \npiso de tierra y sin adici\u00f3n de coccidiostato aumenta la probabilidad de las aves de ingerir una gr an cantidad de \noosictos capaces de producir una infecci\u00f3n.  \n  \nCONCLUSI\u00d3N  \n \nLa EM es frecuente en las aves de combate, siendo el principal factor de riesgo las condiciones de crianza con \nausencia de vacunaci\u00f3n o vacunaci\u00f3n deficiente.  Existen pocos estudios espec\u00edficos en aves de combate por lo que \nla informaci\u00f3n recabada contribuye al conocimiento de esta especie. Por otra parte es necesario orientar a los \ncriadores de aves de combate en la medicina preventiva y medidas de bioseguridad.  \n \nREFERENCIAS  \n \n1. Guerrero ZR. Situaci\u00f3n econ\u00f3mica de las aves de combate en M\u00e9xico Memorias del II congreso \ninternacional y III Congreso Nacional de Medicina Veterinaria y Zootecnia en gallos de pelea. Saltillo Coahuila, M\u00e9xico 2006; 16- 18. \n2. Pe\u00f1a RA. Situaci\u00f3n epidemiol\u00f3gica en las galleras de M\u00e9xico. Memorias del II congreso internacional y III \nCongreso Nacional de Medicina Veterinaria y Zootecnia en gallos de pelea. Saltillo Coahuila, M\u00e9xico 2006; 11 -12. \n3. Moreno DR.  Principales enfermedades en las aves de combate. 1\nra ed. M\u00e9xico: Quorum ediciones, 2009.  \n4. Calnek. BW. Enfermedades de las aves Manual Moderno 2a Edici\u00f3n M\u00e9xico D.F. 2000; 297- 309.  \n5. Sistema de Producci\u00f3n Animal I AVES VOLUMEN 2. Divisi\u00f3n Sistema Universidad Abierta y Educaci\u00f3n \na Distancia 2a ed. 20 05. UNAM FMVZ . \n \nCuadro 1 . Presentaciones de la enfermedad de Marek diagnosticadas en aves de combate remitidas al \nDepartamento de Medicina y Zootecnia de Aves de la FMVZ UNAM del a\u00f1o 2000 al 2011.  \n \nEnfermedad de Marek Presentaci\u00f3n:  (n=54)  \ncasos  (%) \nVisceral  27 50 \nNerviosa  18 34.6 \nNerviosa y Visceral  3 5.77 \nOcular y Visceral  2 3.85 \nNerviosa, Muscular y Visceral  2 3.85 \nCut\u00e1nea y Visceral  1 1.92 \nVisceral y Muscular  1 1.92 \n 63rd WPDC/XXXIX ANECA  LACTOBACILLUS CASEI CONSUMPTION PREVENTS \nENTEROCOLITIS INDUCED BY SALMONELLA ENTERIC A \n \nEL CONSUMO DE LACTOBACILLUS CASEI PREVIENE LA ENTEROCOLITIS \nCAUSADA POR SALMONELLA ENT\u00c9RICA  \n \nM. Noto Llana, S. Hern\u00e1n Sarnacki, M.  del Rosario Aya  Casta\u00f1eda, G. Garavello, M.  Nancy Giacomodonato ,  \nand M. Cristina Cerquetti  \n \nInstituto de Microbiolog\u00eda y Parasitolog\u00eda M\u00e9dica (IMPaM -CONICET) and Departamento de Microbiolog\u00eda, \nParasitolog\u00eda e Inmunolog\u00eda, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ar gentina  \nCorresponding autor: Dr Mari\u00e1ngeles Noto Llana, mnotollana@yahoo.com  \nParaguay 2155 Piso 12, Buenos Aires, Argentina. Zip code 1121  \n \nRESUMEN  \n \nSalmonella enterica es un pat\u00f3geno invasivo que causa enterocolitis en el hombre, ganado y en aves de corral. \nAqu\u00ed, utilizamos un modelo murino de salmonellosis para analizar el efecto del consumo L. casei en el desarrollo de \nla infecci\u00f3n.  Encontramos que el probi\u00f3tico ingeri do una semana previa a la infecci\u00f3n reduce significativamente la \ninvasi\u00f3n y persistencia del pat\u00f3geno a nivel del bazo y de placas de Peyer.  L. casei previno el aumento de la \npermeabilidad intestinal y los cambios histol\u00f3gicos que se generan en la enteroco litis. M\u00e1s a\u00fan, la expresi\u00f3n en \nciego y ganglio mesent\u00e9rico de TNF -\u03b1, IL-17, IL -23, IL -1\u03b2 e IL-6 que genera la infecci\u00f3n por Salmonella  se inhibi\u00f3 \ndr\u00e1sticamente en los animales que consumieron el probi\u00f3tico. Estos resultados sugieren que L. casei  mejorar\u00eda la \nbarrera intestinal 002mediante la modulaci\u00f3n de la expresi\u00f3n de citoquinas involucradas en la diferenciaci\u00f3n de c\u00e9lulas inmunes tales como  linfocitos Th17 y c\u00e9lulas \u03b3\u03b4 . \n \nSUMMARY  \n \nSalmonella enterica is an invasive pathogen that causes enterocolitis in  humans , cattle , and poultry. Here, we \nused a murine model of salmonellosis to analyze the effect of L actobacillus  casei  consumption during the \ndevelopment of infection. We found that the  uptake of probiotic for one w k prior to infection significantly redu ces \ninvasiveness and persistence of the pathogen in spleen and Peyer\u00b4s patches. L. casei  prevented the increase of \nintestinal permeability and the histological changes that occur during enterocolitis. Moreover, cecum and mesenteric lymph node augmented exp ression of TNF -\u03b1, IL-17, IL -23, IL -1\u03b2 and IL -6 that occurs during Salmonella infection \nwas drastically inhibited in animals fed with the probiotic. These results suggest that L. casei  would enhance \nintestinal barrier health through modulation of cytokine e xpression involved in immune cell differentiation such as \nlymphocytes T helpers 17 ( Th17 ) lymphocytes and \u03b3\u03b4 cells.  \n \nINTRODUCTION  \n \nSalmonella enterica elicit an acute inflammatory response in the intestinal mucosa that can be modeled usin g \nstreptomycin -pretreated mice (1) . This inflammatory reaction is initiated by direct contact of Salmonella with host \ncells, such as epithelial cells, macrophages or dendritic cells, followed by an amplification of inflammatory \nresponses in tissue (12) . As a  result, changes in gene expression are observed in the intestinal mucosa during \nSalmonella infection, including markedly increased mRNA levels of interleukin  (IL)-17 and IL -23 genes (5) . \nProbiotics are defined as live microorganisms which when administered in adequate amounts, confe r a health benefit \nto the host (10) . Orally administered probiotics exhibit widespread effects on gut homeostasis and \nimmunomodulation of both mucosal and systemic immunity. In the present work, using an animal model of \nintestin al infection we were able to determine the protective role of Lactobacillus  casei  DN-114 001 fermented milk \non the development of Salmonella  enterocolitis.  \n \n \n \n 63rd WPDC/XXXIX ANECA  MATERIALS AND METHODS  \n \nBacteria . Wild -type strain of Salmonella enterica serovar  Enteritidis #5694 ( Salmonella . Enteritidis) was used \nto infect mice.  Bacteria were cultured in trypticase soy broth at 37\u00baC, 200 cycles per minute, then pelleted by \ncentrifugation and suspended to the appropriate density in saline solution. In all cases t he number of bacteria was \ndetermined by plating appropriate dilutions on trypticase soy agar plates.  \nSalmonella  infection and generation of enterocolitis . Six to eight w k old female BALB/c mice were \npretreated with 20 mg of streptomycin (Sigma A ldrich) given intragastrically (6)  and 24 h later they received 3 -4 x \n103 CFU of S. Enteritidis  by the same route. For intragastric i nfection, 0.2 mL  of the bacterial suspension was \nintroduced into the stomach with a 21g blunt needle on a 1.0 mL  plastic sy ringe.  \nProbiotic administration . Commercially -available fermented milk containing Lactobacillus  casei  DN-114001 \n(Danone S.A.) was used in this study. It was given to mice ad libitum, as described elsewhere (3) during seven \nconsecutive days prior to S.  Enteritidis infection. Mice ingested an average dose of 1 x 108 CFU of L. casei  per day.  \nExperimental groups.  1: enterocolitis ( EC): received Streptomycin and Salmonella; 2: L. casei + E C: \nreceived Lactobacillus casei , Streptomycin and Salmonella; 3: Control : untreated animals; and L. casei + Strep : \nmice received the probiotic and Streptomycin only.  \nBacterial colonization and persistence.  At the indicated times post infection mice were sacrificed and \nbacterial loads were analyzed. All Peyer\u00b4s patches l ocated along the large intestine (6 \u2013  8) and one third of the \nspleen were removed aseptically from each animal and homogenized in sterile saline solution.  Salmonella- like \ncolonies appearing on SS plates were grown on triple -sugar -iron agar slants and tested for somatic antigen O9.  \nHistological analysis . Tissue evaluation was performed as previously designed in our laboratory  (8). \nQuantitative real -time reverse transcriptase -polymerase chain reaction . Total RNA was extracted from \ntissues using Trizol reagent (Life Technologies, Inc, Carlsbad, CA) at different time points according to the \nexperiment. Total RNA (1 \u00b5g per sample) was reverse transcribed according to the m anufacturer\u2019s protocol. Primer \nsequences and cycling conditions are described elsewhere (9 ).  \nIntestinal permeability in vivo . The intestinal permeability was measured by determining the amount of \nFITC - dextran in blood after it was orally admini stered as described previously (13) .  \nStatistical analysis . Statistically significant differences between experimental groups were determined by one -\nway analysis of variance (ANOVA) followed by Tukey test for multiple comparisons. P -values less than 0.05 were \nconsid ered statistically significant.  \n \nRESULTS  \n \nWe analyzed the effect of L . casei  consumption on the intestinal inflammatory response to S. Enteritidis . Mice \ntreated with streptomycin only (Strep group), fed with L. casei  and streptomycin ( L. casei  + Strep) and animals \nwithout any treatment (Control group) were included as controls.  Forty -eight h  after infection animals of the EC \ngroup presented signs of disease including diarrhea, rough hair coat, and lethargy. We found that S. Enteritidis \ninduces diffuse enterocolitis, characterized by an epithelium diminished in height, mononuclear infiltration of the \nmucosa and submucosa, and loss of normal villus architecture. Administration of L . casei  for one w k prior to \ninfection prevented  histological changes ( L. casei  + EC group ) as well as the clinical symptoms.  \nThe protective effect of L. casei  observed on intestinal epithelium and clinical features could be related to the \nsignificant  decrease in the bacterial invasion observed in the L. casei  + EC  group.  Our results clearly indicate that \nconsumption of L . casei  drastically diminishes S. Enteritidis invasiveness and shortens splenic persistence of the \npathogen. Preserved intestinal epithelium and diminished bacterial invasiveness induced by L. casei  correlated with \n100% survival rate of animals from L. casei  + EC  group. Approximately 20% of mice with Salmonella enterocolitis \ndie by d seven  post infection (8) ; but no deaths o ccurred among mice fed with L. casei  prior to infection.  \nIt has been shown that intestinal permeability increases during enterocolitis ( 7). To investigate the effect of L. \ncasei  on gut permeability during Salmonella enterocolitis , we administered a single dose of FITC \u2013dextran  by gavage \nto the animals at d two  post infection and measured the inte nsity of fluorescence in serum five  h later. We found \nthat, the augment in gut permeability to macromolecules induced by Salmonella enterocolitis (EC group) was \ndecreased by the consumption of L. casei  to the same extent as found in healthy mice ( L. casei + EC, L. casei  + \nStrep and Control groups).  \nSoon after intestinal infection S. enterica  induces a significant increase in the expression of IL -17 and related \ncytokines such as TNF -\u03b1, IL-1\u03b2, IL-6 and I L-23 (5, 8) . We were able to determine that animals fed with the \nprobiotic ( L. casei  + EC) did not respond to the pathogen burden, since the expression of IL -17 and related 63rd WPDC/XXXIX ANECA  cytokines was similar to that seen in uninfected mice. This anti inflammatory effect of L . casei  was even more \ndrama tic in mesenteric lymph nodes .  \n \nCONCLUSION  \n \nHere we demo nstrate that consumption of L. casei  prior to infection abolishes intestinal inflammation triggered \nby Salmonella enterocolitis; survival rate, invasiveness and persistence of Salmonella were improved.  Also intestinal \nhistological changes and the raise of intestinal permeability were avoided.  \nIn the present work we show that consumption of L . casei  prevents IL -17 intestinal response to Salmonella, \namong other cytokines. In a previous work ( 8), we determined that neutralizing systemic IL -17 inhibited generation \nof enterocolitis. Upon Salmonella  infection, the IL -23/IL -17 axis is triggered in the inte stinal mucosa.  Macrophages \nand dendritic cells infected with Salmonella are a potential source of IL -23, a cytokine that helps to amplify the \ninflammatory response in intestinal tissue. Thus, IL -23 produced by phagocytes stimulates, in turn, T cells to sec rete \nIL-17 (5). Different T cells -like Th17, \u03b3\u03b4 and natural killer T cells ( NKT )- present in the intestinal mucosa and \nlamina propria express the receptor for IL -23 and constitute an important source of IL -17 during Salmonella \ninfection (5, 11) . Th17, \u03b3\u03b4  and NKT cells have been also implicated as a source of IL -17 production in different  \nanimal models of inflammation (4) . On the other hand, differentiation of Th17 and \u03b3\u03b4 T cells requires a specific \ncytokine environment that include s IL-1\u03b2, IL -6 IL-23 and TGF -\u03b2 (2) . Here, we show that the expression of these \ncytokines are induced during Salmonella enterocolitis and are abrogated by consumption of L. casei . Our results \nsuggest that L . casei  consumption alters the intestinal milieu necessary for differentiation of the immune cells.  \n \nREFERENCES  \n \n1. Barthel M et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar \nTyphimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71: 2839\u2013 2858.  \n2. Bi Y , Yang R . (2012)  Direct and indire ct regulatory mechanisms in  TH17  cell differentiation and functions. \nScand J Immunol.  6: 543- 52.  \n3. De Moreno de Leblanc et al. (2010)  Importance of IL -10 Modulation by Probiotic Microorganisms in \nGastrointestinal Inflammatory Diseases. International Scholarly Research Network. doi:10.5402/2011/892971.  \n4. D\u00edaz -Pe\u00f1a R et al. ( 2010) Association of the KIR3DS1_013 and KIR3DL1_004 alleles with susceptibility \nto ankylosing spondylitis. Arthritis Rheum 62: 1000 \u20131006.  \n5. Godinez I et al. (2009) Interleukin -23 Orchestrates Mucosal Responses to Salmonella enterica serotype \nTyphimurium in the Intestine. Infect. Immun 1: 387\u2013 398. \n6. Hapfelmeier S, Hardt W. (2005) A Mouse Model for S. typhimurium -Induced Enterocolitis. Trends \nMicrobiology 13: 497\u2013 503. \n7. Kitajima S, Takuma S, Morimoto M. (1999) Changes in colonic mucosal permeability in mouse colitis \ninduced with dextran sulfate sodium. Exp Anim 48:137\u2013 143. \n8. Noto Llana M  et al. (2012)  Salmonella enterica induces joint inflammation and the expression of IL -17 \nin draining lymph nodes early after the onset of enterocolitis in mice. Infect Immun 6:2231.  \n9. Noto Llana  M et al. ( 2013) . Consumption of Lactobacillus casei Fermented Milk Prevents Salmonella \nReactive Arthritis by Modulating IL -23/IL -17 Expression. PLoS One.  doi: 10.1371/journal.pone.0082588.   \n10. Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin \nPract Gastroenterol Hepatol 3: 390\u2013 407. \n11. Schulz SM  et al (2008)  IL-17A is produced by Th17, gammadelta T cells and other CD4-  lymphocytes \nduring infection with Salmonella enterica serovar Enteritidis and  has a mild effect in bacterial clearance.  Int \nImmunol . 9: 1129- 38.  \n12. Srikanth CV and Cherayil BJ. (2007) Intestinal innate immunity and the pathogenesis of Salmonella \nenteritis. Immunol. Res. 37:61 \u201378.  \n13. Wang Q, Fang CH, Hasselgren PO (2001) Intestinal permeability is reduced and IL -10 levels are increased \nin septic IL -6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281: R1013 \u20131023.   \n63rd WPDC/XXXIX ANECA  SUSCEPTIBILIDAD ANTIMICROBIANA Y GENES DE \nRESISTENCIA EN AISLAMIENTOS DE AVIBACTERIUM \nPARAGALLINARUM  DE PER\u00da  \n \nANTIMICROBIAL SUSCEPTIBILITY AND RESISTANCE GENES IN \nISOLATES OF AVIBACTERIUM PARAGALLINARUM IN PER\u00da  \n \nG. Luna -GalazA,F. Falconi -AgapitoB, V. Morales -ErastoA, L. SaraviaB, Montalvan- AvalosB, E. Soriano -VargasA  \ny M. Fern\u00e1ndez -D\u00edazB \n \nACentro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, \nUniversidad Aut\u00f3noma del Estado de M\u00e9xico, Toluca, 50200, M\u00e9xico  \nBFarmacol\u00f3gicos Veterinarios S.A.C. , Carretera Panamericana Sur # 766, Km 198.5, Ch incha Alta,  \nChincha, Ica \u2013  Per\u00fa \n \nSUMMARY  \n \nIn the present study the antimicrobial susceptibility of 30 isolates of Peru Avibacterium paragallinarum was \nevaluated against 15 different antimicrobials by the disk diffusion test.  The isolates were susceptible to >83% versus \namoxicillin -clavulanic acid and florfenicol. Greater than 73% resistance to trimethoprim -sulfamethoxazole, \nstreptomycin a nd oxacillin was observed . One hundred percent  of the isolates were resistant to lincomycin. The \nneo-Kan, SxT, Lcm, Ox a, and Avilo Str genes were identified by the PCR and sequencing test,  which confer \nresistance to neomycin, sulfamethoxazole -trimethoprim, lincomycin, oxacillin, streptomycin and tetracycline, \nrespectively. In conclusion the isolates showed variability in drug susceptibility and resistance genes, therefore \nsuggesting that the resistance is conferred by other mechanisms.  \n \nRESUMEN  \n \nEn el presente estudio se evalu\u00f3 la susceptibilidad antimicrobiana de 30 aislamientos de Avibacterium \nparagallinarum de Per\u00fa . Se incluyeron un total de  15 antimicrobianos en la prueba de difusi\u00f3n en disco. M\u00e1s del  \n75% de los aislamientos fueron susceptibles a amoxicilina -\u00e1cido clavul\u00e1nico y florfenicol. Se observ\u00f3 m\u00e1s del 73% \nde resistencia a sulfamethoxazole -trimethoprim, estrepto micina y oxacilina. El 100%  de los aislamientos fueron  \nresistentes a lincomicina. Mediante la prueba de reacci\u00f3n en cadena de la polimerasa y secuenciaci\u00f3n , en todos los \naislamientos incluidos en el estudio se identificaron los genes apHA  (confiere resistencia a neomicina)  y los genes \nTet R (B), Tet B  y AviLO C (confieren resistencia a tetraciclina ). En conclusi\u00f3n,  los aislamientos mostraron \nsusceptibilidad antimicrobiana variable y genes de resistencia, lo cual  sugiere que la resistencia es mediada por otros \nmecanismos.  \nLa coriza infecciosa es enfermedad del tracto respiratorio superior de pollos y gallinas, la cual es ocasionada \npor la bacteria Avibacterium paragallinarum . Esta enfermedad se caracteriza por  producir descarga nasal y \nestornudo, infla maci\u00f3n facial y conjunt ivitis . El impacto econ\u00f3mico de esta enfermedad se debe a que produce baja \nconsiderable en producci\u00f3n de huevo  (hasta 40%) ( 4).  \nAv. paragallinarum  se clasifica serologicamente mediante la prueba de inhibici\u00f3n de la hemoaglutinaci\u00f3n en \ntres serogrupos (A, B y C) y nueve  serovariedades ( A-1, A-2, A-3, A-4, B-1, C-1, C-2, C-3, C-4) (3 ). \nEl tratamiento de aves con coriza infecciosa se basa en diversos  antimicrobianos  (2). Sin embargo,  son pocos \nlos reportes que han estudiado la sensibili dad antimicrobiana.  El estudio de esta caracter\u00edstica fenot\u00edpica es  de gran \nvalor, ya que de manera indirecta indican  el posible uso terap\u00e9utico de algunos antimicrobianos en la industria \nav\u00edcola . Adem\u00e1s s on la base de estudios de  eficacia cl\u00ednica y compon entes moleculares que median es ta resistencia.  \n \nMATERIALES Y M\u00c9TODOS  \n \nBacterias.  Se incluyeron 30 aislamientos de Per\u00fa. Todos los aislamientos fueron obtenidos de brotes de coriza \ninfecciosa en gallinas de postura.  \n  \n63rd WPDC/XXXIX ANECA  Medio.  Para el crecimiento de las bacterias se utiliz\u00f3 medio brain -heart infusion BHI suplementado con suero  \nde caballo inactivado  al 1% (w/v) y nicotinamide adenine dinucleotide  reducido  (NAD)  (7). Se utiliz\u00f3 agar TM/SN  \nsuplementado con NAD para la prueba de sensibilidad in vitro  (1). \nSensibilidad antimicrobiana. Se utiliz\u00f3 la t\u00e9cnica de difusi\u00f3n en disco, de acuerdo a las especificaciones del  \nClinical Laboratory Standards Institute  (CLSI ) (6). Se incluyeron  15 ant imicrobianos, generalmente utilizados para \nel control y tratamiento de la coriza infecciosa:  sulfametoxazol -trimetoprim, penicilina,  doxiciclina, ampicilina, \namoxicilina con \u00e1cido clavu l\u00e1nico, colistina, estreptomicina, lincomicina, oxacilina, tetraciclina, neomicina, \nenrofloxacina,  fosfomicina, florfenicol  y gentamicina. Como control de la t\u00e9cnica se utilizaron cepas de referencia \nde E. coli (ATCC 25922) y S taphylococcus  aureus  (ATCC 25923). Cultivos de 24 h  fueron ajustados a una turbidez \nde 0.5 en la escala McFarland y sembrados en agar TM/ SN. Las placas fueron incubadas a 37 \u00baC durante 24 h,  en \nuna atm\u00f3sfera reducida de ox\u00edgeno . Los di\u00e1metros de inhibici\u00f3n fueron clasificados en sensible, intermedio y \nresistente. Los criterios de interpretaci\u00f3n de cad a uno de los antibi\u00f3ticos fuero n basados en puntos de corte \npreviamente reportados  para este microrganismo (6 ,7). \nDetecci\u00f3n de genes de resistencia.  El DNA de los 30 aislamientos fue extra\u00eddo usando el kit DNeasy\u00ae Blood \nand Tissue kit (QIAGEN, Austin, TX, USA). Con base a los  perfi les de resistencia detectados en  la prueba \nsensibilidad in vitro , se investig\u00f3 la presencia de genes de resistencia mediante PCR.  Se identificaron los genes \napHA  (confiere resistencia a neomicina) y los genes Tet R (B), Tet B  y AviLOC (confieren resistenci a a \ntetraciclina).  \n \nRESULTADOS  \n \nLos resultados mostraron que >75% de los aislamientos  son susceptibles a ampicilina, colistina, \namoxicilina+\u00e1cido clavul\u00e1nico y florfenicol; mientras que  los antibi\u00f3ticos que mostraron alta prevalencia ( >73%) a \nser resistentes fueron sulfametoxazol+trimetoprim, estreptomicina, oxacilina y enrofloxacina. El 100 % de los \naislamientos mostr aron resistencia a lincomicina  (Fig. 1). \nLos genes de resistencia identificados en los 30 aislamientos fueron  apHA el cual confi ere resitencia a \nneomicina , Tet R (B) y Tet B, que confieren resistencia a t etraciclina, con un porcentaje de 53 %, 63 % y 70 % , \nrespectivamente.  \nLas diferencias en susceptibilidad y presencia de genes en los aislamientos incluidos en el estudio, indican que \notros mecanismos pueden estar involucrados en la resistencia antimicrobiana de los aislamientos estudiados.  \n \nREFERENCIAS  \n \n1. Blackall, P. J., and G. G. Reid. Further characterization of Haemophilus paragallinarum  and \nHaemophilus avium . Vet. Microbiol.7:359 \u2013367. 1982.  \n2. Blackall, P. J. Antimicrobial drug resistance and the occurrence of plasmids in Haemophilus \nparagallinarum . Avian Dis. 32:742- 747. 1988.  \n3. Blackall, P. J., L. E. Eaves, and D. G. Rogers. Proposal of a new serovar and altered nomenclature for \nHaemophilus paragallinarum  in the Kume hemagglutinin scheme. J. Clin. Microbiol. 28:1185 -1187. 1990.  \n4. Blackall, P. J., and E. V. Soriano. Infectious coryza and related bacterial infections. In: Diseases of \nPoultry, 12th ed. Y. M. Saif, A. M. Fadl y, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. \nBlackwell Publishing, Ames, IA. pp. 789- 803. 2008.  \n5. Chukiatsiri K, Sasipreeyajan A. J., Blackall, P. J , Yuwatanichsampan S., and Chansiripornchai N. Serovar \nidentification, antimicrobial sensitivity, and virulence of Avibacterium paragallinarum isolated from chickens in \nThailand.  Avian Dis.;  56(2):359- 64. 2012.  \n6. (CLSI) Clinical Laboratory Standars Institute. Performance standards for antimicrobial disk and dilution \nsusceptibility tests for bacteria isolated from animals; approved standard 3rd ed. M31 -A3. CLSI, Wayne, PA. 2008.  \n7. Soriano, V. E., G. T\u00e9llez, B. H. Hargis, L. Newberry, C. Salgado -Miranda, and J. C. V\u00e1zquez. Typing of \nHaemophilus paragallinarum  strains by using enterobacterial repetitive intergenic consensus -based polymerase \nchain reaction. Avian Dis. 48:890 -895. 2004.  \n   \n \n  \n63rd WPDC/XXXIX ANECA  Fig. 1 . Porcentajes de susceptibilidad de los aislamientos a los antimicrobianos sulfametoxazol -trimetoprim \n(SxT), penicilina (PE), doxiciclina (D), ampicilina (Am), amoxicilina con \u00e1cido clavuanico (AmC), colistina (CL) , \nestreptomicina ( S), lincomicina ( L), oxacilina ( OX), tetraciclina ( Te), neomicina ( Ne), enrofloxacina ( Enr), \nfosfomicina (FOS), florfenicol (FFC), g entamicina ( Gen) .  \n \n \n63rd WPDC/XXXIX ANECA  EVALUATION OF PULSED -FIELD GEL ELECTROPHORESIS \n(PFGE) PROFILES ON  SALMONELLA ISOLATES OF BROILERS \nAT SLAUGHTER IN ALBERTA CANADA  \n \nEVALUACI\u00d3N DE PERFILES DE ELECTROFORESIS DE IMPULSO DE \nCAMPO EN GEL (PFGE) EN AISLAMIENTOS DE SALMONELLA DE POLLOS \nDE ENGORDA AL SACRIFICIO EN ALBERTA, CANAD\u00c1  \n \nC. Mainali and R.  King  \n \nAnimal Health and Assurance Division, Alberta Agriculture and Rural Development  \nO. S. Longman Building  6909 -116 Street  \nEdmonton, Alberta, Canada T6H 4P2  \n \nRESUMEN  \n \nEl objetivo de este estudio fue evaluar y comparar los perfiles PFGE de aislamientos de Salmonella \nrecuperados del buche, el ciego y la piel de pollos de engorda durante el sacrificio. Los buches y los ciegos \ncoincidieron con cada ave pero las pieles se seleccionaron al azar de cada lote. Un total de 704 aislamientos de \nSalmonella de 23 parvadas positivas a Salmonella se caracterizaron por PFGE usando el protocolo est\u00e1ndar \npublicado por el CDC (Atlanta, GA). Se identificaron cincuenta y seis perfiles de cam po pulsado diferentes (PP). De \nlos 56 perfiles, 3, 7 y 15 fueron la contabilidad de mayor prevalencia de 40,5 %, 10,0 % y 6,3 % de los aislamientos, respectivamente. Hab\u00eda 26 perfiles \u00fanicos que no se compartieron con los aislados de cualquier otra muestra en el \nestudio. De las 23 parvadas, el 65,2 % ten\u00eda al menos un perfil que se encontr\u00f3 en las muestras de buche, ciego y \npiel, lo que indica que es probable que ocurra contaminaci\u00f3n cruzada en la explotaci\u00f3n, durante el transporte o en el \nprocesamiento.  \n \nSUMMARY  \n \nThe aim of this study was to evaluate  and compare the PFGE  profiles of Salmonella isolates recovered from \ncrops, ceca and skins of broiler chickens at slaughter. Crops and ceca were matched by bird but the skins were randomly selected from each flock. A total of 704 Salmonella  isolates from 23 Salmonella  positive flocks were \ncharacterized by PFGE  using the standard protocol published by the C DC ( Atlanta, GA ). Fifty -six different pulsed -\nfield profiles  (PP) were identified.  Out of the 56 profiles , 3, 7, and 15 were the most prevalent accounting for 40.5%, \n10.0% , and 6.3% of the isolates respectively. There were 26 unique profiles that were not shared with isolates from \nany other samples in the study. Of 23 flocks, 65.2%  had at least one profile that was found in the crop,  cecal and \nskin samples indicating that cross contamination is likely to occur on farm, during transport or at  processing .  \n \n(The full length article will be published in peer reviewed journal. ) \n \n 63rd WPDC/XXXIX ANECA  THE ROLE OF ACTIVE SURVEILLANCE AND PRE -MOVEMENT \nBIOSECURITY IN THE MANAGED MOVEMENT OF  BROILERS \nFROM MONITORED FLOCKS DURING A HIGHLY PATHOGENIC \nAVIAN INFLUENZA OUTBREAK  \n \nEL PAPEL DE LA VIGILANCIA ACTIVA Y UN PRE-MOVIMIENTO DE \nBIOSEGURIDAD EN EL MANEJO DEL MOVIMIENTO DE AVES VIVAS EN \nUN BROTE DE INFLUENZA AVIAR ALTAMENTE PATOG\u00c9NICA  \n \n \nS. MalladiA, J. Todd WeaverB, M. BuswellA, J. SlingluffA, C. AlexanderA, and D. HalvorsonA \n \nAUniversity of Minnesota, Center for Animal Health and Food Safety, 136 Andrew Boss Laboratory, 1354 Eckles \nAvenue, St. Paul, MN 55108 \nBUSDA Animal and Plant Health Inspection Service, Veterinary Services, Center  for Epidemiology and Animal \nHealth , Bldg. B MS -2W4 215 0 Centre Avenue, Fort Collins CO 80526  \n \nRESUMEN  \n \nLas decisiones de manejo de riesgos asociados a los movimientos de aves vivas durante un brote de influenza \naviar altamente patog\u00e9nica son de suprema importancia para la industria de la avicultura con un impacto \nconsiderable en el control de brotes y la co ntinuidad del negocio. Un grupo de trabajo en colaboraci\u00f3n con \nparticipantes de USDA APHIS, la Universidad de Minnesota y los veterinarios de la industria av\u00edcola de Estados \nUnidos se reuni\u00f3 para abordar el manejo del movimiento de aves vivas de instalacio nes dentro de una zona de \ncontrol de la IAAP. Esta iniciativa ha dado lugar al desarrollo de un enfoque para mover aves vivas, con la \nconfianza de que no est\u00e9n infectadas. El enfoque se basa en tres  factores clave para la reducci\u00f3n de riesgos: 1) La \nvigila ncia activa, 2 ) Un per\u00edodo de aislamiento previo al movimiento con una mejora de la bioseguridad y 3 ) la \nincorporaci\u00f3n de una distancia de parvadas infectadas conocidas de modo que la propagaci\u00f3n de \u00e1rea local sea poco probable. Destacamos la aplicaci\u00f3n de este enfoque para la evaluaci\u00f3n del riesgo del movimiento de los pollos de \nengorda al rastro durante un brote de influenza aviar altamente patog\u00e9nica.  \n \nABSTRACT  \n \nRisk management  decisions associ ated with live poultry movement  during a highly pathogenic avian i nfluenza \n(HPAI) outbreak  should be carefully considered . Extended  movement r estrictions can disrupt  business  continuity . \nOn the other hand, live bird movements may pose a risk for HPAI disease spread . A collaborative workgroup with \nparticipants from government, industry and academia  was convened to address the managed movement of live \npoultry from clinically healthy flocks  located in a HPAI Control Area. This initiative has led to the development of a  \nrisk based  approach to move live poultry with a high degree of confidence that they are not infectious . The approach \nis based on three key risk mitigation measures: 1) active surveillance; 2) a  pre-movement isolation period with \nenhanced biosecurity ; and 3) incorporation of a distance from known infected flocks such that infection due to l ocal \narea spread is unlikely. T he application of this risk based approach to the risk assessment of the movement of \nbroilers to slaughter during an HPAI outbreak  is highlighted .  \nMovements of l ive poultry have be en implicated in the spread of avian i nfluenza  (AI) in previous outbreaks  \n(3). Therefore, in the event of an outbreak of  highly  pathogenic a vian influenza (HPAI),  emergency response \nmeasures may involve quarantine and movement control for all live poultry and poultry products from premises \nlocated within a Control Area  (CA) . However , response measures that are aimed at controlling th e outbreak may \nalso disrupt continuity of business within the poultry industry with considerable adverse economic consequences  (2). \nMoreover, economic consequences  due to disruptions in the logistical supply chain may be greater for larger  CAs \nwhere a greater number of  uninfected premises would come under movement restrictions. The m anaged movement \nof live broilers from monitored premises (i.e. flocks that are clinically normal) to slaughter has the potential to \nreduce the consequences associated with stop movement orders while  meeting the primary objective of  controlling \nthe outbreak.  63rd WPDC/XXXIX ANECA  To address the managed movement of live poultry from pre mises within a HPAI CA , a Broiler Sector Work ing \nGroup (BSWG ) was convened as a collaborative  initiative  with participants from  the United States Department of \nAgriculture , Animal Plant Health Inspection Service , Veterinary Services ; the University of Minnesota,  Center for \nAnima l Health and Food Safety ; and veterinarians from the U .S. broiler industry . BSWG  members participate as \nstakeholders providing  input into  a scientific risk analysis  process to evaluate HPAI control measures . One of the \nintended outcome s of this initiative is the development of an approach to move broilers to slaughter with increased  \nconfidence that infectious broilers are not moved , reducing the risk to human and animal health . \nMovement of broilers from known infected premises in an HPAI control area is restricted , as they are usually \ndepopulated on site . Hence,  the possibility of movement of infectious broiler s to slaughter only arises  when HPAI \ninfection in the flock is undetected at  the time of movement.  The likelihood of detecting an infected  flock  can be \nenhanced t hrough pre-movement diagnostic testing and monitor ing for clinical signs. T he targeted matrix  gene real -\ntime reverse transcriptase  polymerase chain reaction (rRT -PCR)  test is the primary diagnostic test used in \nconjunction with various sampling protocols.  Protocols  incorporated into HPAI emergency preparedness plans are \nbased on targeted sampling of daily mortality where the prevalence of HPAI diseased birds would be higher.    \nThe likelihood of HPAI detection increases as the length of time post exposure increases. For example, if a \nbroiler house became exposed a week or more before the scheduled movement day, HPAI is likely detected by \nmovement day and unlikely to pose a movement associated risk. Conversely , exposure closer to the time of \nmovement is relatively less likely to be detected due to the reduced time for HPAI to spread within the flock and \ndisease mortality to occur. One managed movement strategy developed with BSWG input is a pre- movement \nisolatio n period (PMIP)  to be  implemented ahead of the scheduled movement date. In essence, this isolation period \nrequires implementing a  higher degree of biosecurity for some days prior to the scheduled movement date.  The \nstrategy is beneficial in minimizing the likelihood of the flock becoming exposed to HPAI close to the scheduled movement date.  \nIn this paper, we first evaluate surveillance protocols by estimating the  probability  of detection under scenarios \nwhere the broiler house becomes  infected on various d ays before the time of movement. We then discuss the \napplication of  these results in considering vario us PMIP s with enhanced biosecurity prior to the movement of \nbroilers to slaughter. Finally , we summarize the qualitative assessment of their combined effectiveness . \n \nMATERIALS AND METHODS  \n \nActive surveillance protocols . The following active surveillance protocols were considered based on BSWG \ninput. Protocol A: RRT -PCR testing of pooled samples  of up to five swabs from the daily mortality c ollected in the \nmorning on  two consecutive days immediately prior to the movement of broilers to slaughter. Protocol B : Similar to \nprotocol A with only change being the testing of pooled samples of up to 11 swabs instead of five swabs. Protocol  \nC: Similar to protocol B, but with the addition of supplementary flock -side Antigen Capture (AC)  testing  used by \nindustry veterinarians as a screening test  close to the time of load -out. \nSimulation methods . A stochastic chain binomial disease trans mission model  was utilized for simulating \ndisease spread and disease mortality on various days post infection of  the flock  (house) (5).  Simulation models of \nactive s urveillance w ere then used  to predict disease detection considering factors such as the HPAI transmissio n \nmodel results, normal daily mortality, and sensitivity of the diagnostic tests . In addition to diagnostic testing a daily \nmortality above 0.3 percent of the house was considered as a trigger for HPAI detection ( i.e. unexplained high \nmortality detected through enhanced passive surveillance).   \nDevelopment and evaluation of pre -movement isolation measures . A set of enhanced biosecurity measures \nwere developed for implementation during the PMIP based upon input from BSWG workgroup members . Broadly, \nthe meas ures involved eliminating non -essential visits to the premises and scheduling some of the routine \noperational visits  to occur outside of t he PMIP . Enhanced biosecurity measures were included for critical \noperational contacts such as feed delivery which have to occur during the PMIP.  Examples of the feed delivery \nbiosecurity measures that were included for further evaluation in the risk assessment are feed vehicle cleaning and \ndisinfection, restricting the driver from entering the poultry house, and protocols for use and proper removal of \npersonal protective equipment (PPE). Other biosecurity measures related to dead bird disposal , catch crews, and \ncompany service personnel  were also included. Qualitative assessment  approaches using  expert opinion, literature \nreview , and past outbreak experiences were used to evaluate the effectiveness of PMIP  measures. Options for the \nduration of the PMIP were evaluated based on the predicted detection probability from quantitative simulation \napproaches .  \n \n 63rd WPDC/XXXIX ANECA  RESULTS  \n \nSimulation model results indicate that a PMIP of five d  or more, in conjunction with the RRT -PCR active \nsurveillance close to the time of movement , increases the probability of HPAI detection  (Table 1).  Recently \nintroduced HPAI infections reduced the likel ihood of HPAI detection for all surveillance protocols, but some of \nthose outbreaks were also detected through Supplementary AC flock side testing.  \n \nDISCUSSION  \n \nEffectiveness of PMIP.  For reducing the overa ll likelihood of moving infectious  broilers, it would be most \nbeneficial to set the duration of the PMIP such that there is a higher likelihood of detecting HPAI by the time of \nmovement. Based on the likelihood of detection presented in Table 1, a consensus w as reached in the BSWG that a \nfive d  PMIP would be appropriate. However , other durations were also included as options for decision makers to \nconsider during an outbreak.  \nManaged movement of clinically healthy birds from monitored flocks to slaughter reduces consequences  \nassociated with  disruption of the logistical supply chain . However, it is important to reduce the likelihood of moving \ninfectious birds, as the unintended consequences of such movement could potentially result in additional HPAI \nspread . Active surveillance is expected to  result in a higher likelihood of detection in cases where disease exposure \noccurred before implementation of the PMIP.  However,  the detection likelihood may be reduced for  recently \nintroduced infections and targeted biosecurity is critical to prevent HPAI introduction  close to the time of \nmovement . Because movement of people and equipment are considered to be the main mechanism of secondary \nspread, enhanced biosecurity duri ng a few days before movement would be effective in reducing exposure  (1). \nHowever, other  local spread mechanisms may occur in  close proximity to an infected farm (i.e. aerosols, flies, \nwildlife scavengers) despite implementation of enhanced biosecurity me asures  (4). Adequate distan ce from an \ninfected premise  could increase confidence that the flock being moved has not been infected through local spread. \nThese risk factors are being further  evaluated through risk assessment. Overall, a combination of active  surveillance, \npre-movement biosecurity, and adequate distance from known infected premises can be considered as a basis for the \nmanaged movement of monitored poultry flocks from within a control area with a higher level of confidence that \nthey are not inf ected.    \nREFERENCES  \n \n1. Alexander, D. J. The Epidemiology and Control of Avian Influenza and Newcastle -Disease. Journal of \nComparative Pathology 112:105- 126. 1995.  \n2. Bowes, V. A. After the Outbreak: How the British Columbia Commercial Poultry Industry Recovered After \nH7N3 HPAI. Avian Diseases 51:313- 316. 2007.  \n3. Halvorson, D. A. Prevention and management of avian influenza outbreaks: experiences from the United \nStates of America. Rev Sci Tech 28:359 -369. 2009.  \n4. Henzler, D. J., D. C. Kradel, S. Dav ison, A. F. Ziegler, D. Singletary, P. Debok, A. E. Castro, H. Lu, R. \nEckroade, D. Swayne, W. Lagoda, B. Schmucker, and A. Nesselrodt. Epidemiology, Production Losses, and Control Measures Associated With an Outbreak of Avian Influenza Subtype H7n2 in Pennsylvania (1996 -98). Avian \nDiseases 47:1022- 1036. 2003.  \n5. Weaver, J. T., S. Malladi, T. J. Goldsmith, W. Hueston, M. Hennessey, B. Lee, S. Voss, J. Funk, C. Der, \nand K. E. Bjork. Impact of Virus Strain Characteristics on Early Detection of Highly Pathogenic A vian Influenza \nInfection in Commercial Table- Egg Layer Flocks and Implications for Outbreak Control. Avian diseases 56:905-\n912. 2012.  \n \n \n  \n \n  \n \n  63rd WPDC/XXXIX ANECA        Table 1. Simulation model results  from 6000 simulation iterations showing the predicted probability of HPAI \ndetection if the flock (house) became exposed to HPAI virus prior to implementation of PMIP biosecurity measures.  \n Predicted detection probability under various PMIPs  \n 3 Days  4 Days  5 days  6 days  \nProtocol A  92.7%  96.4%  98.3%  99.0%  \nProtocol B  95.8%  98.4%  98.8%  99.5%  \nProtocol C  98.3%  99.4%  99.6%  99.9%  \n \n 63rd WPDC/XXXIX ANECA  RETOS Y ESTRATEGIAS PARA EL CONTROL DEL VIRUS DE LA \nENFERMEDAD DE NEWCASTLE  \n \nCHALLENGES AND STRATEGIES IN THE CONTROL OF  \nNEWCASTLE DISEASE VIRUS  \n \nM. Mart\u00ednez- Nu\u00f1ezA, F. Vera -Hern\u00e1ndezA, L. Garc\u00eda- BarreraA, D. Cort\u00e9s -EspinosaA, A. ToscanoB,  \nE. Lucio -DecaniniB, C. AfonsoC y A. Absal\u00f3nA \n \nAInstituto Polit\u00e9cnico Nacional. CIBA Tlaxcala. Carr. Est. Santa Ines -Tecuexcomac Km 1.5, Tepetitla, Tlaxcala; \nM\u00e9xico. Tel. +52 (55) 5729 6000 Ext. 87813 . aabsalon@ipn.mx  \nBInvestigaci\u00f3n Aplicada S.A. de C.V. M\u00e9xico.  \nCDepto. de Agricul tura de Los Estados Unidos. USA  \n \nSUMMARY  \n \nVaccination is the most effective method in the prevention and the most successful in cost \u2013  benefit terms, for \nthe control of the Newcastle disease virus.  However, due to the fact that some problems related with the disease and \nthe persistence of the virus have not been avoided in the vaccinated poultry population, it has been necessary to \ngenerate new strategies to an optimal control of the disease. In this way , producers  try to avoid loses due to the poor \nweight gain, as well as, the low egg production and the poor quality of the eggs in layers. This implicates the antigenic variation and the changes of the NDV in several parts of the world.  Obtain ing a deep knowledge of the \npathogenic mechanisms and immunity before the infection, to stimulate a durable immune response, decrease the \nsecondary reactions and the virus shedding among the birds.  \n \nRESUMEN  \n \nLa vacunaci\u00f3n regulada contra el virus de la e nfermedad de Newcastle (NDV) ha dem ostrado  ser el m\u00e9todo \nm\u00e1s efectivo de prevenci\u00f3n y el m\u00e1s exitoso en t\u00e9rminos de costo -beneficio  para el control de esta enfermedad . Pese \na ello , m\u00faltiples reportes se\u00f1alan  severos brotes en unidades intensivas de producci\u00f3n av\u00edcola  por lo que el NDV  \nsigue representando un riesgo latente para las poblaciones de pollos de engorde y gallinas de post ura. Las aves \nvacunadas poseen t\u00edtulos de anticuerpos capaces de proveer protecci\u00f3n contra mortalidad, sin embargo , la infecci\u00f3n \ny la transmisi\u00f3n del virus pu ede ocurrir todav\u00eda , por lo que es necesario el desarrollo de nuevas estrategias de \nvacunaci\u00f3n. Ello implica tener en cuenta la variaci\u00f3n antig\u00e9nica y los cambios del NDV en varias partes del mundo, \nas\u00ed como adquirir un conocimiento profundo de los mecanis mos de patog\u00e9nesis e inmunidad ante la infecci\u00f3n, pues \nes fundamental estimular una respuesta inmune de larga duraci\u00f3n  que adem\u00e1s de disminuir  las reacciones \nsecundarias  a la vacunaci\u00f3n, controle adecuadamente la excreci\u00f3n viral en las aves.  \n \nINTRODUCCI\u00d3N  \n \nLa enfermedad de Newcastle es uno de los procesos patol\u00f3gicos con mayor impacto en la avicultura mundial . \nSe trata de una enfermedad viral altamente contagiosa causada por un paramixovirus aviar de serotipo 1 (PMVA -1), \nel cual pertenece al g\u00e9nero Avulavi rus dentro de la familia Paramyxoviridae (1,2,3,4 ). El impacto que el Virus de la \nEnfermedad de Newcastle (NDV) tiene a ni vel global es enorme, pues afecta a m\u00e1s de 250 especies de aves tanto \nsalvajes como dom\u00e9sticas . Por ello, varios pa\u00edses han puesto en marcha campa\u00f1as de vacunaci\u00f3n d estinadas a \nprevenir epizootias. E n ellas se emplean vacunas a virus vivo e inactivado ( 5, 6), las cuales son elaboradas en su \nmayor\u00eda a base de cepas lentog\u00e9nicas  de genotipo II ( 7,8,9 ). Es conocido que todos los virus pertenecientes al mismo \nserotipo inducen niveles  \u00f3ptimos  de IgA, IgG, IgM e IgY en el suero de las aves vacunadas por lo que su aplicaci\u00f3n \nofrece un excelente medio para la reducci\u00f3n  del cuadro cl\u00ednico y prevenci\u00f3n de la mortalidad . Sin embargo , pese a \nlos intensos programas de vacunaci\u00f3n, la infecci\u00f3n y la transmisi\u00f3n del virus sigue ocurriendo  durante periodos \nconocidos  como \u201cventana s de susceptibi lidad\u201d. Ello motiva el surgimiento de severos brotes que ocasionan una \ndr\u00e1stica disminuci\u00f3n en la producci\u00f3n , lo cual se ve reflejado en la lentitud en la ganancia de peso, as\u00ed como la baja \nde postura y disminuci\u00f3n de la calidad del huevo en gallinas ponedoras  (10,11,12) . 63rd WPDC/XXXIX ANECA  Reducci\u00f3n de la excreci\u00f3n viral . En a\u00f1os recientes se ha demostrado que vacunas desarrolladas en base a \nNDV\u00b4s filogen\u00e9ticamente cercanos al virus end\u00e9mico de desaf\u00edo , ofrecen un mayor grado de protecci\u00f3n en t\u00e9rminos \nde reducci\u00f3n de excreci\u00f3n viral y propagaci\u00f3n del virus . Sin embargo, tanto pollos de engorda como gallinas de \npostura son rutinariamente vacunados con cepas lentog\u00e9nicas de genotipo II.  (12) Y aun cuando las aves vacunadas \nest\u00e1n protegidas contra mortalidad, el bajo nivel de seroneutralizaci\u00f3n  generado por las cepas vacunales ocasiona \nque el virus se contin\u00fae excretando en ausencia de signos cl\u00ednicos, lo que facilita la transmisi\u00f3n horizontal entre aves \ninmunol\u00f3gicamente suceptibles  (5, 13). La limitada neutralizaci\u00f3n de las part\u00edculas virales est\u00e1 determinada por la \nvariaci\u00f3n antig\u00e9nica y la distancia filogen\u00e9tica  entre las cepas vacunales y los distint os genotipos, lo cual se refleja \nen la cantidad de anticuerpos generados por la cepa vacunal  y los ep\u00edtop os reconocidos en el ant\u00edgeno , as\u00ed como por \nla fuerza de uni\u00f3n o avidez entre ant\u00edgeno y anticuerpo, la cual depende de la secuencia espec\u00edfica de amino\u00e1cidos \nen las regiones hipervariables de los anticuerpos presentes durante la infecci\u00f3n  (14). En relaci\u00f3n a ello, l a estimaci\u00f3n \nde la divergencia gen\u00e9tica entre cepas de los distintos genotipos de la clase II demuestra un bajo porcentaje de similitud en la secuencia de nucle\u00f3tidos y composici\u00f3n de amino\u00e1cidos de las dos pro te\u00ednas m\u00e1s antig\u00e9nicas del \nvirus: hemaglutinina -neuraminidasa (HN)  y prote\u00edna de fusi\u00f3n  (F). El rango de similitud m\u00e1s bajo se reporta entre el \ngenotipo II  y los genotipos V, VI, VII y VIII, reconocidos actualmente como los de m\u00e1s amplia circulaci\u00f3n en varias \npartes del mundo y de los que solo se conocen representantes de alta virulencia ( 12, 15). \nCaract erizaci\u00f3n de la respuesta inmune  y el e mpleo de adyuvantes moleculares . Dada la evidencia \nregistrada, es un hecho que las diferencias a nivel gen\u00e9tico y los continuos cambios fenot\u00edpicos y genot\u00edpicos que \nincrementan la virulencia del NDV deben ser tomadas  en cuenta en el desarrollo de vacunas para el control de la \nEnfermedad de Newcastle. De igual manera, y con el fin de desarrollar estrategias novedosas, se ha despertado el \ninter\u00e9s por comprender los mecanismos de respuesta inmune que se genera ante NDV\u00b4s  de distinto patotipo  (4). Por \ntal raz\u00f3n, la caracterizaci\u00f3n e identificaci\u00f3n de la respuesta transcripcional a inicios de la infecci\u00f3n con NDV\u00b4s de \ndistinta vrulencia , ha permitido identificar  la participaci\u00f3n de una gran variedad de genes implicados en la respuesta \nantiviral y reacciones proinflamatorias de la respuesta inmune innat a. Ello ha evidenciado la importancia de los \nelementos de respuesta  Th1 Y Th2, pues se han identificado como los principales mediadores y reguladores durante \nla infecci\u00f3n ya que definen la magnitud y la naturaleza de la respuesta inmune espec\u00edfica . El entendimiento y la \ncaracterizaci\u00f3n de los mecanismos de la respuesta inmune, ha abierto una amplia gama de posibilidades para \nmodular directa o indirectamente tanto la respuesta inmune innata como la adaptativa. Con ello se busca mantener \nun control adecuado durante  la infecci\u00f3n en aves de corral. Debido a ello, el uso de algunas citocinas como agentes \nterap\u00e9uticos o adyuvantes vacunales ha sido explorado intensamente en la \u00faltima d\u00e9cada.  \n  \nREFERENCIAS  \n \n1. Viruses, I.C.o.T.o., F.A. Murphy, and I.U.o.M.S.V. Division Virus taxonomy: classification and \nnomenclature of viruses : sixth report of the International Committee on Taxonomy of Viruses. Springer -Verlag. \n1995.  \n2. Mayo, M.A. A summary of taxonomic changes recently approved by ICTV. Archives of virology \n147:1655- 1663. 2002.  \n3. de Leeuw, O., and B. Peeters Complete nucleotide sequence of Newcastle dis ease virus: evidence for the \nexistence of a new genus within the subfamily Paramyxovirinae. The Journal of general virology 80 ( Pt 1):131 -136. \n1999.  \n4. Rauw, F., Y. Gardin, V. Palya, S. van Borm, M. Gonze, S. Lemaire, T. van den Berg, and B. Lambrecht \nHumora l, cell -mediated and mucosal immunity induced by oculo -nasal vaccination of one- day-old SPF and \nconventional layer chicks with two different live Newcastle disease vaccines. Vaccine 27:3631 -3642. 2009.  \n5. Kapczynski, D.R., and D.J. King Protection of chickens  against overt clinical disease and determination \nof viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vac cine 23:3424-\n3433. 2005.  \n6. van Boven, M., A. Bouma, T.H. Fabri, E. Katsma, L. Hartog, and G. Koch Herd immunity to Newcastle \ndisease virus in poultry by vaccination. Avian pathology : journal of the W.V.P.A 37:1 -5. 2008.  \n7. Alexander, D.J., E.W. Aldous, and C.M . Fuller The long view: a selective review of 40 years of \nNewcastle disease research. Avian pathology : journal of the W.V.P.A 41:329 -335. 2012.  \n8. Lomniczi, B., E. Wehmann, J. Herczeg, A. Ballagi -Pordany, E.F. Kaleta, O. Werner, G. Meulemans, P.H. \nJorgensen,  A.P. Mante, A.L. Gielkens, I. Capua, and J. Damoser Newcastle disease outbreaks in recent years in \nwestern Europe were caused by an old (VI) and a novel genotype (VII). Archives of virology 143:49- 64. 1998.  63rd WPDC/XXXIX ANECA  9. Miller, P.J., E.L. Decanini, and C.L. Afonso New castle disease: evolution of genotypes and the related \ndiagnostic challenges. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary \ngenetics in infectious diseases 10:26 -35. 2010.  \n10. Miller, P.J., D.J. King, C.L. Afonso, and D .L. Suarez Antigenic differences among Newcastle disease \nvirus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238- 7246. 2007.  \n11. Rue, C.A., L. Susta, I. Cornax, C.C. Brown, D.R. Kapczyn ski, D.L. Suarez, D.J. King, P.J. Miller, and \nC.L. Afonso Virulent Newcastle disease virus elicits a strong innate immune response in chickens. The Journal of general virology 92:931- 939. 2011.  \n12. Absalon, A.E., A. Mariano -Matias, A. Vasquez -Marquez, A. Moral es-Garzon, D.V. Cortes -Espinosa, R. \nOrtega -Garcia, and E. Lucio -Decanini Complete genome sequence of a velogenic Newcastle disease virus isolated \nin Mexico. Virus genes 45:304 -310. 2012.  \n13. Miller, P.J., C. Estevez, Q. Yu, D.L. Suarez, and D.J. King Compariso n of viral shedding following \nvaccination with inactivated and live Newcastle disease vaccines formulated with wild -type and recombinant \nviruses. Avian diseases 53:39 -49. 2009.  \n14. Iorio, R.M., and M.A. Bratt Neutralization of Newcastle disease virus by monocl onal antibodies to the \nhemagglutinin -neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. \nJournal of virology 51:445- 451. 1984.  \n15. Hu, S., H. Ma, Y. Wu, W. Liu, X. Wang, Y. Liu, and X. Liu A vaccine candidate of at tenuated genotype \nVII Newcastle disease virus generated by reverse genetics. Vaccine 27:904 -910. 2009.  \n \n 63rd WPDC/XXXIX ANECA  SAFETY OF CHITOSAN ON HATCHING EGGS  \n \nLA SEGURIDAD DE UN PRODUCTO NATURAL DE QUITOSANO  \nEN LOS HUEVOS PARA INCUBAR  \n \nK. MaschekAC,K. Jones,A, S. HubbardA, and E. David PeeblesB \n \nAPoultry  Research and Diagnostic Lab, Mississippi State University, 3138 HWY 468 West, Pearl, MS 39288  \nBDepartment of Poultry Science, Mississippi State University, 46 Old Bully, Starkville, MS 39762  \nCCorresponding  author. PO Box 97813 Pearl, MS 39288- 7502. E- mail: kmaschek@mvrdl.msstate.edu  \n \nRESUMEN  \n \nEl quitosano es un pol\u00edmero natural que se obtiene industrialmente a partir de la quitina, el componente de \nprincipio de los exoesqueletos de los crust\u00e1ceos e insectos, as\u00ed como las paredes celulares de algunas bacterias y \nhongos. El quitosano tiene beneficios potenciales para su uso en incubadoras comerciales y casetas de reproductoras \npara controlar hongos, bacterias y enfermedades parasitarias. Por estas razones es importante entender el impacto del \nquitosano en los huevos para incubar.  \nEste estudio analiza los efectos de un producto de quitosano sobre huevos para incubar de pollos de engorda \ncomerciales. Los huevos se rociaron con concentraciones diluidas en serie de un producto de quitosano y se \ncompararon co n el grupo de control.  \nLos par\u00e1metros medidos y comparados en todos los grupos fueron: peso fijo del huevo, peso de huevos \nembrionados vivos de 11 y 18 d\u00edas , porcentaje de p\u00e9rdida de peso de los huevos, la fertilidad, incubabilidad, tasa de \nnacimiento, la mortalidad de embriones, la calidad de los pollitos y el peso promedio d e pollitos nacidos a los 21 \nd\u00edas. \n \nSUMMARY  \n \nThe aim of the study was to  determine the safety of a novel chitosan containing product  on commercial \nhatching eggs. Five hundred and forty commercial eggs were sprayed with 5% novel chitosan product at a pH of 5.0. \nFive hundred and twenty -seven control eggs  were sprayed with tap water at pH of 5.0. No statistical difference on \ntotal percent hatch was calculated between the control and treatment groups . These results indicate that the safety of \nthis product at 5% solution does not affect hatchability . \n \nINTRODUCTION  \n \nChitosan is bio -polymer made from the de- acetylation of chitin  a ubiquitous and naturally occurring material \n(2,7). It has been shown to have antibacterial and anti fungal properties in agriculture and medicine  (1,3,4,7,8) . \nChitosan\u2019s ability to be effective  depends on numerous characteristics such as concentration  in solution, pH,  \nmolecular weight  and degree of deacetylation (1,6). \n  Recent trials at Mississippi State University Poultry Research and Diagnostic Lab have  investiga ted the use of \na novel chitosan- containing product as an antifungal in empty commer cial h atchers  against  Aspergillus . It is \nimportant to note that c hitosan forms a film on  the porous surfaces of  egg shells reducing  gas and moisture loss from \ntable eggs whereby preserving  internal egg quality (2,5). Inhibition of m oisture loss and gas exchange may affect  the \nhatch  rate of fertilized  eggs. \n  The aim of this study was  to determine if applying a novel chitosan product to hatching eggs affected  percent \nhatch.   \n \nMATERIALS AND METHODS  \n \nEggs . One thousand and sixty seven commercial hatchery  eggs used in this study were  donated by a \ncommercial broiler company  in Mississippi from 3 9 wk old hens .  \nChitosan source . A 5% solution of a novel c hitosan containing product  (AVIAN -YS, OII -YS Corp, \nCarrollton, GA ) was mixed with tap -water in a 3 gallon hand pump sprayer. The  pH was adjusted to 5.0 using acetic \nacid as suggested by the manufacturer.   63rd WPDC/XXXIX ANECA  Incubator /sprayer/pH meter. A NatureForm NMC -1080 incubator (NatureForm Hatchery Systems, \nJacksonville , FL),  an EcoTest r pH2 by Eutech Instruments (Oakton  Instruments, Vernon Hills, IL ) pH meter and a \nSOLO 457 3 gallon hand pump sprayer (US9456702, Newport News, VA) were used in this experiment.  \nStatistical a nalysis . A chi -square analysis was performed on hatchability data using proc freq (SAS for \nWind ows Version 9.3, SAS Institute, Cary, North Carolina).  \nEggs were evenly divided among 36 thirty -egg capacity flats. Two groups of 18 flats were placed separately on \ntables  for spraying with test solution and  control solution. A single  operator sprayed  one group of  eggs to completely  \ncoat egg shells with a 5% solution  of the chitosan product  adjusted to pH of 5.0 with acetic acid . This same \nprocedure was repeated for the control group using tap water adjusted to a pH of 5.0 using acetic acid. All eggs were \nallowed to dry for 24 h  in a 65 \u00b0F holding room. The eggs were then carefully blotted with paper tow el to remove \nany beading  moisture from the apex of shells. Egg weights were taken  and recorded  before set. Eggs were incubated \nat 99.5 \u00b0F with 55% humidity  for 21 d. At 12 and 19 d  of incubation, eggs  were  weighed,  candled and clear eggs \nremoved . Egg weights  and counts  were repeated after each candling . At 19 d, eggs were moved to  hatching baskets \nand hatch co unt was conducted every 24 h until d  21. A hatch residue breakout  was perf ormed for both groups at 21 \nd of incubation.  \n \nRESULTS  \n \nIn the control group , five hundred and twenty seven eggs were set and 489 eggs hatched equaling a 92.8% total \nhatch rate. In the treatment group, 540  were set and 504 hatched equaling a 93 .3% total hatch rate.  The 0 -12 d \nincubation average weight loss  per egg of control and treatment  group s was 6.2% and 5.8%, re spectively. The 12 -19 \nd incubation average weight loss  per egg was 3.9% and 3.8 % for control  and treatment group, respectively.  \nThe hatch residue breakout had 11 and 10 late hatches, 1 and 0 early dead, 3 and 4 mid dead, 3 and 4 late dead \nand 3 and 1 pipped chick  for control and treatment  groups , respectively. No embryo anomalies were seen in the \ncontrol group. Two chicks had exposed brains and one  had an extra pair of legs in the treatment group.  \n \nDISCUSSION  \n \nThe results of this stu dy show that  a novel chitosan containing product  at 5%  solution  did not  show a \ndetectable difference (p=0.7266)  in hatchability of eggs. W eight loss  per egg  during early and late  incubat ion (0- 12 \nd and 12- 19 d) showed a slight difference but the significance is unknown at this time .  \nIn future studies, the concentration of chitosan and  the possible com plications that may result  from its film \nforming properties need to be made clear. Improving this study would involve using higher  concentrations of the \nproduct and observing for negative changes in embryos and hatching eggs.  \nOther applications for this natural product in the poultry industry are as an antibiotic. Inclusion into water or \nfeed would be highly valuable and feasible to control enteric bacteria. The addition of chitosan to both hatching and \ntable eggs could help co ntrol the spread of Aspergillus  and Salmonella . Future research is needed in order to validate \nthese possible applications.  \n \nREFERENCES  \n \n1. Benhabiles, M.S., R. Salah, H. Lounici, N. Drouchie, M.F.A. Goosen and N. Mameri. Antibacterial \nactivity of chitin, chitosan and its oligomers prepared from shrimp shell waste. Food Hydrocolloids. 29: 48- 56. \n2012.  \n2. Bhale, S., H. K. No, W. Prinyawiwatkul, A. J. Farr, K. Nadarajah, and S. P. Meyers. Chitosan coating \nimproves shelf life of eggs. J. Food Sci. 68 (7): 2378 \u20132383. 2003.  \n3. Chen, Wenxuan, T. Jin, J. Gurtler, D. Geveke and X. Fan. Inactivation of salmonella on whole cantaloupe \nby application of an antimicrobial coating containing chitosan and allyl isothiocyanate. International Journal of Food \nMicrobiology. 155: 165- 170. 2012.  \n4. Islam, M.D Monarul, S.  Md. Masum and K. Rayhan Mahbub. In vitro antibacterial activity of shrimp \nchitosan against salmonella paratyphi and staphylococcus aureus. Journal of Bangladesh Chemical Society. 24(2): 185-190. 2011.  \n5. Jo, C., D.U. A hn, K.H. Kim, K.C. Nam and X.D. Liu. Effects of Chitosan Coating and Storage with Dry \nIce on the  Freshness and Quality of Eggs.  Poultry Science  90: 467- 72. 2011.  \n6. Kim, S.H., H.K. No, and W. Prinyawiwatkul. Effect of Molecular Weight, Type of Chitosan, and \nChitosan solution pH on the shelf -life and quality of coated eggs. J. Food Sci. 72:44- 48. 2007.  63rd WPDC/XXXIX ANECA  7. Raffat, Dina, K. von Bargen, A. Haas, and H.G. Sahl. Insights into the Mode of Action of Chitosan as an \nAntibacterial Compound. Appl. Environ. Microbiol. 74(12):  3764- 3773. 2008.  \n8. Rodriguez -Nunez, Jesus  R., J. Lopez -Cervantes, D. Sanchez -Machado, B. Ramirez -Wong, P. Torres -\nChavez and M.  O. Cortez -Rocha. Antimicrobial activity of chitosan -based films against Salmonella typhimurium \nand Staphylococcus aureus. Intern. Journ. Foo d Sci Tech. 47: 2127- 2133. 2012.  \n \nACKNOWLEDGEMENTS  \n \nThis paper was made possible by the  time, energy and inspiration  of the authors  and staff. Thank you to O2 -YS \nCorporation for their support and vision.  \n \n \n \n 63rd WPDC/XXXIX ANECA  \n PERFORMANCE OF BROIL ER CHICKENS USING A COCCIDIAL \nVACCINE  (COCCIVAC- B) OR AN IONOPHORE ( SALINOMYCIN)  \n \nDESEMPE\u00d1O DE LOS POLLOS DE ENGORDA CON UNA VACUNA CONTRA \nCOCCIDIA (COCCIVAC-B) O UN ION\u00d3FORO (SALINOMICINA)  \n \nG. MathisA, C. HofacreB, C. BroussardC, and L. NewmanC  \n \nASouthern Poultry Research, Inc., Athens, GA  \nBPoultry Diagnostic and Research Center, Athens, GA  \nCMerck Animal Health, DeSoto, KS  \n \nRESUMEN  \n \nSe realiz\u00f3 un estudio de pollo de engorda criado en piso comparando f\u00e1rmacos anticoccidianos en el  alimento \ncon la vacunaci\u00f3n con coccidia viva. Fueron ocho r\u00e9plicas: T1 ninguna vacuna o medicamento, T2 vacuna en \naerosol al nacimiento con Coccivac - B, y T3 s alinomicina  a 60 g / t en el alimento de iniciaci\u00f3n y crecimiento \nsolamente. Se colocaron cincuenta pollos de engorda machos de linaje comercial en cada corral. Se registraron los \npesos de las aves al d  0, d 21, d  35, y en la finalizaci\u00f3n (d  43). En la materia fecal se determinaron ooquistes por \ngramo  (OPG) para T2 y T3, cada 3 d  (D13 - 40). En d  21 las aves vacunadas T2 tuvieron el desempe\u00f1o m\u00e1s bajo. En \nd 35 y d 43, tanto T2 como T3 fueron iguales estad\u00edsticamente y ambos significativamente mejor que T1. El \ndesempe\u00f1 o estuvo correlacionado con OPGs. Los OPGs de T2S alcanzaron su punto m\u00e1ximo al principio y luego \ndisminuyeron de manera constante. Los OPGs de T3 fueron m\u00e1s variables y empezaron a aumentar en d  40. La \nconclusi\u00f3n de este estudio fue que el ciclo de la coccidia ocurri\u00f3 m\u00e1s temprano y con menos variaci\u00f3n con la vacunaci\u00f3n que con el ion\u00f3foro.  \n \nSUMMARY  \n \nA broiler chicken floor -pen study was conducted comparing an in-feed anticoccidial drug to vaccination with \nlive coccidia.  There were eight replications per  treatment. The treatments were:   T1 no vaccine or drug (NM) , T2 \nspray vaccination at hatch with Coccivac -B (CVB) , and  T3 the ionophorous antibiotic s alinomycin (SAL) fed at 60 \ng/t in the starter and grower feeds only.  Fifty commercial strain male broiler s were placed into each pen.   Bird \nweights were recorded at d  0, 21, 35, and termination (d  42). For CVB  and SAL, oocysts per gram (OPG) fecal \nmater ial was determined every 3 d  (d 13-40). T he CVB  vaccinated birds had the poorest performance on d 21. By d  \n35 and d 42 both CVB and SAL  were statistical equal and both significantly better than NM.  Performance closely \ncorrelated with OPGs. CVB \u2019s OPGs peaked early and then steadily lowered. SAL \u2019s OPGs were more variable and \nstarted to increase on d  40.  The con clusion from this study showed  coccidia shedding and related cycling occurred \nearlier and with less variation with Coccivac -B vaccination than wi th the anticoccidial ionophore s alinomycin.  \n  \nMATERIALS AND METHODS  \n \nThe trial was conducted at Southern Poultry Research Inc . in a two sided floor pen house. Each pen was \napproximately 5 x 10 ft in size and all pens had four inches of built up litter with a coating of fresh pine shavings on \ntop. There were ambient humidity and 24 h  lighting throughout the trial.  Each pen was initially stocked with 50 , day \nof hatch , male Cobb 500 chicks with 0.77 sq. ft/ bird floor space. A total of 1200 chicks were allocated to the three \ndifferent treatments with eight replicates per treatment (Tabl e 1). Corn -soy based chicken diets were representative \nof local commercial formulations and calculated analyses met or exceeded National Research Council (1) standards. \nThe rations (crumble/pellet) were fed ad libitum  from the  date of chick arrival until d  42 of the study. Birds were fed \nstarter feed containing the appropriate tr eatment from days 0 \u2013  21, grower feed from d  21 \u2013 35, and finisher feed \nfrom d 35 \u2013  42. All feeds contained no add itional antibiotics other than s alinomycin in T3 starter and grower  feeds. \nAll finisher feeds were non -medicated. Bird weight gain and feed consumption were determined by pen on d 0, 21, \n35, and 42.  \n  63rd WPDC/XXXIX ANECA  \n  \nTo determine timing and amounts of oocysts shedding/ cycling fecal samples were collected. For CVB  and \nSAL, from d  13-40, every 3 d fresh fecal samples w ere collected from each pen. These representative samples w ere \nexamined to determine the number of oocysts per gram fecal material.  \nResults were subjected to ANOVA analysis for a completely randomized experimental desi gn using the PROC \nGLIMMIX procedure of the SAS version 9.2 statistical package (SAS Inst. Inc., Cary, NC).  Statistical differences \nwere declared at P \u2264 0.05.  \n \nRESULTS  \n \nBroiler live performance weight . gain (BWG) (Table 2) and a djusted  feed conversion r atios (FCR) (Table 3) \nwere determined for d  21, 35, and 42.  Feed conversion ratios were calculated as mortality -adjusted feed conversion \nratio calculated as feed weight/ survivor weights + dead bird weights.   D21 results showed that the coccidiosis from the CVB birds affected performance with lower BWG  and higher FCR compared to NM and SAL. The performance \nof NM on d 35 and d  42 were significantly poorer  than CVB and SAL.  Days 35 and 42 performance of CVB was \nstatistically equal to SAL.  \nOPG are presented in Figure 1.  A major OPG peak with the spray -applied CVB  was observed approximately \n13 d of age. This level was signifi cantly higher than SAL  fed birds.   The s harp reduction in OPGs for CVB after \nthis major peak indicated that coccidial im munity was developing, reducing the number of parasites reproducing \nwithin the bird.  By d  25 OPGs were low and at a steady low level throughout the remainder of the study.  SA L \nOPGs were more variable with two  distant peaks ~d  19 and 28.  The OPG level di d decrease after the second peak, \nhowever a rise in OPGs was found aft er the  SAL was removed at d 35.  \n \n \nDISCUSSION  \n \nThe goal of any anticoccidial program is to control severity of coccidiosis and attempt to regulate when the \nprimary damage will occur. Many factors influence oocysts shedding including management, duration of drug \nprogram, vaccine condition and application.  To sustain good coccidiosis management all programs and influences need to be considered.   Poultry anticoccidial programs are eithe r drug or live vaccine. In order to predict coccidiosis \ncontrol and immunity development, performance and related oocysts litter/fecal numbers are valuable  tools. In \nvaccinated broilers , oocysts shedding start ed early with a major peak at 2 -3 wk .  As expected from OPGs, \nperformance was lower for CVB near this OPG peak compared to SAL . An immunity related decline in OPGs \noccurred with CVB. Thus by d  35 performance both FCR and weight g ain were statistically equal between CVB and \nSAL, with both significantly better than NM. Ionophores mode of action is by partial direct control and regulated \nimmunity development.  T hese traits allow some oocysts to be shed over the course of the grow -out with \naccompanying immunity development. According to Chapman ( 2) full immunity to most anticoccidial drugs take s at \nleast 6 -7 wk .  Thus , after removal of the SAL  during the withdrawal period , coccidia oocysts shedding start ed to \nincrease.   In this 42 d study, a loss in performance during the late phase of the grow -out with SAL was not observed . \nHowever , it has been documented that e ven a minor increase in coccidiosis during a late phase of a grow -out can \nsignificantly affect performance ( 3). Th is study con firmed a strong relationship between  performance and OPG.  \nThe conclusion from this study was coccidia shedding and related cycling occurred earlier and with less variation with Coccivac -B vaccination than wi th the anticoccidial ionophore s alinomycin.  \n \nREFERENCES  \n \n1. National Research Council. Nutrient Requirements of Poultry. 9th rev. ed. Natl. Acad. Press. Washington, \nDC. 1994.  \n2. Chapman, H. D. (1999).  Anticoccidial drugs and their effects upon the development of immunity to \nEimeria infections in poultry.  Avian Pathol. 28:521- 535. \n3. R. G. Teeter, (2008). Calorimetry Applications Quantify the Variable Cost of Subclinical Coccidiosis \n(\u201cCoccidiasis\u201d) at Various Points in the Broiler Growth Curve WPC Proceeding 2008: 99-101. \n \n \n \n 63rd WPDC/XXXIX ANECA  \n Table 1 . Treatment groups . \n \n       Treatment  Anticoccidial  \n1. Control (NM)  None  \n2. Coccidia vaccination (CVB)  \n \n \n  Coccivac -B*  \n \n 3. Ionophorus anticoccidial (SAL)  Salinomycin 60 g/t starter and grower \nCFU  *Coccivac- B was spray applied at the recommended commercial dose using a SprayCox 2 machine prior to \nplacement.  Chicks were allowed to pr een for approximately 30 min   \n \n \n \nTable 2 . Broiler weight g ain (kg) at d  21, 35, and 42.  \n \nTreatment  D21 D35 D42  \nNM 0.506 a  1.474 b  1.857 b   \nCoccivac -B 0.457 b   1.522 a  2.005 a   \nSalinomycin 60g/t  0.512 a  1.531 a  2.038 a   \nA,B Means within columns with different superscripts are significantly different (p<0.05)  \n \n \n \nTable 3.  Broiler a djusted for mortality feed conversion ratio at d 21, 35, and 42 . \n \nTreatment  D21 D35 D42  \nNM 1.478 a 1.669 a  1.846 a   \nCoccivac -B 1.485 a  1.590 b   1.705 b   \nSalinomycin 60g/t  1.452 b   1.577 b   1.717 b   \nA,B Means within columns with different superscripts are significantly different (p<0.05)  \n \n \nFigure 1 .  Oocyst shedding patterns for Coccivac B (CVB) vaccination vs s alinmoycin 60 g/t (SAL) starter \nand grower.  \n \n 05000100001500020000\nd13 d16 d19 d11 d25 d28 d31 d34 d37 d40CVB Sal 6063rd WPDC/XXXIX ANECA  USO DE UN ADITIVO ANTI -MICOTOXINAS (A- AM) EN \nREPRODUCTORAS PESADAS PARA EL CONTROL DE LESIONES \nORALES POR MICOTOXINAS DERIVADAS DE HONGOS  \nTIPO FUSARIUM  \n \nUSE OF AN ANTI-MYCOTOXINS ADDITIVE (A- AM) IN HEAVY BREEDERS \nFOR THE CONTROL OF ORAL LESIONS PRODUCED BY  \n FUSARIUM MYCOTOXINS  \n \nM. M\u00e9ndez, E. Camacho,  E. Soto, D. Sarfati  y B. Lozano  \n \nLaboratorio Avimex S.A. de C.V. J.I. Bartola che 1962. Colonia del Valle.  \nDelegaci\u00f3n Benito Ju\u00e1rez. 03100. M\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nDamage caused by some dermonecrotic mycotoxins that affect digestive integrity of reproductive birds can \nalter their performance. The objective of the present work is to present field results of the use of an anti -myco toxins \nadditive (A -AM) in feed contaminated with fusarium toxins in reproductive birds that have damaged mucosa, and \nwere  administered an A -AM during a eight wk  period. The regenerative effect on the digestive mucosa integrity \n(time and degree of the lesio n) was evaluated. Results of mycotoxins tests, immediate changes in oral and tongue \nmucosa regeneration, time of feed intake and improvement in flock performance are presented. It is concluded that \nthe continuous use of the A -AM in reproductive birds will protect their health against the effects of fusarium toxins \nand in turn their performance.  \n \nRESUMEN  \n \nLos da\u00f1os provocados por algunas micotoxinas dermonecr\u00f3ticas  que afectan la integridad digestiva de las aves \nreproductoras pueden alterar su productividad. El objetivo de este trabajo es presentar resultados de campo al uso de \nun aditivo anti -micotoxinas (A -AM) en alimento contaminado con fusiariotoxinas en aves re productoras con da\u00f1o \nen mucosas a las que se les apli c\u00f3 por un periodo de ocho semanas un A -AM, y se valor\u00f3 su efecto regenerativo en \nla integridad de sus mucosas digestivas (tiempo y grado de lesi\u00f3n). Se presentan los resultados de las pruebas de \nmicotoxi nas y la observaci\u00f3n de los cambios inmediatos de regeneraci\u00f3n en la mucosa oral  y lengua, as\u00ed como el \ntiempo de consumo de alimento y mejoras en el desempe\u00f1o productivo de la parvada. Se concluye que el uso continuo de este A -AM en reproductoras proteger\u00e1 la salud de las aves contra los efectos de fusariotoxinas y con \nello su productividad.   \n \nINTRODUCCI\u00d3N  \n \nEl desarrollo y la salud del tracto gastrointes tinal (TGI) es un factor clave en la productividad de las aves  \ndom\u00e9sticas  y en espec\u00edfico de las aves reproductoras, donde se ha documentado ampliamente  que hongos del tipo \nFusarium  spp. que regularmente contaminan a cultivos de granos y oleaginosas en campo, bajo las condiciones \nambientales y micro -ambientales apropiadas de humed ad y temperatura, sintetizan, en campo o en almacenamiento, \nmetabolitos secundarios t\u00f3xicos para los animales denominados m icotoxinas , habiendo caracterizado hasta el \nmomento, por su relevancia desde el punto de vista pecuario, entre otras,  a las siguiente s: zearalenona (ZEA), \nvomitoxina o deoxinivalenol (DON), fumonisina B1 (FB1), t oxina T -2 (T T -2), diacetoxiscirpenol (DAS), \nmonoa cetoxiscirpenol (MAS), triacetoxiscirpenol (TAS) y s cirpentriol (STO) . \nLa contaminaci\u00f3n de los alimentos balanceados de las aves reproductoras en cualquier fase de su vida \nproductiva, especial mente por micotoxinas del tipo t ricotecenos que inducen dermonecrosis, en pico, cavidad oral y \nmucosas digestivas, tiene  el potencial de alterar  la salud y productividad de las parvadas afect adas, de ah\u00ed la \nrelevancia de implantar programas de prevenci\u00f3n . \n 63rd WPDC/XXXIX ANECA  OBJETIVO  \n \nPresentar resultados de campo en el  uso de un aditivo anti -micotoxinas p urificado ( A-AM) en alimento de \nreproductora s pesadas en fase de producci\u00f3n, sospechoso  cl\u00ednicamente  de contaminaci\u00f3n con f usariotoxinas \ndermonecr\u00f3ticas .  \n \nMATERIALES Y M\u00c9TODOS  \n \nEn dos parvadas comerciales de aves reproductoras pesadas de 31 semanas de edad de la misma empresa, en la \nmisma granja  y que consum\u00edan el mismo alimento,  que presentaban lesiones  dermonecr\u00f3ticas en picos y leng uas, \ncl\u00ednicamente causadas por f usariotoxinas  del tipo tricotecenos, s e utiliz\u00f3  en un periodo continuo  de ocho semanas un \nA-AM en el alimento  (Mycoad\u00ae-ZT) y se valor\u00f3 su efecto sobre la presencia de lesiones en cavidad oral , calificando \nel grado de lesi\u00f3n  en picos y lenguas  en una escala de 0 a 3, correspondiendo el 0 a aves sin lesiones, 1 a aves con \nlesiones ligeras, 2 a aves con lesiones moderadas y 3 a aves con lesiones severas. La adici\u00f3n del A -AM se hizo \n\u00fanicamente en uno de los lotes de reproductoras a raz\u00f3n de 1 Kg por tonelada de alimento. La otra parvada \npermaneci\u00f3 como control sin tratamiento alguno de acuerdo a indicaciones del propietario.  \nSe realizaron 4 valoraciones de las lesiones, a las semana 1  (inicio),  2, 5 y 7 de iniciado el tratamiento , \nrevisando 100 aves por parvada en cada ocasi\u00f3n, revisando siempre la misma caseta, a la misma hora del d\u00eda, y fue \nrealizada siempre por la misma persona. Para fines comparativos y con base en el n\u00famero de lesiones observad as y \nseveridad, se calcul\u00f3  un \u00cdndice de Lesiones de cada observaci\u00f3n , derivado de multiplicar el n\u00famero de lesiones por \nel grado observado en cada edad (0 al 3), haciendo la sumatoria y dividiendo el resultado entre 100.  Esto para fines \npr\u00e1cticos comparati vos. \n \nRESULTADOS  \n \nLos resultados de las lesiones en cavidad oral y lengua que fueron evaluados en cuatro ocasiones se resumen \nen el cuadro 1. Se observan diferencias importantes en las lesiones observadas a partir de la segunda observaci\u00f3n, en donde el grupo tratado muestra una importante reducci\u00f3n de las lesiones en cavidad oral y en la lengua.    \nEl an\u00e1lisis comparativo de los \u00cdndices de Lesiones (Cuadro 2), muestra las grandes diferencias encontradas en \nambas parvadas a partir del segundo monitoreo.  \n \nDISCUSI\u00d3N  \n \nComo se puede observar en los resultados , en este estudio de campo se encontr\u00f3 una disminuci\u00f3n muy \nsignificativa en la presencia de lesiones orales en las aves que recibieron el tratamiento en alimento con el A -AM. \nLo anterior fue notorio a part ir del segundo monitoreo que corresponde a una semana de iniciado el tratamiento y se \nhizo m\u00e1s evidente en la quinta semana. En general las lesiones en cavidad oral remitieron un poco m\u00e1s r\u00e1pido que las lesiones en lengua, quiz\u00e1s por el tiempo fisiol\u00f3gico natural de reparaci\u00f3n del organismo de las aves. En el grupo \ncontrol no tratado, se not\u00f3 una mejor\u00eda ligera en la presencia de lesiones a partir de la quinta semana, lo cual puede ser indicativo de que disminuy\u00f3 el grado de contaminaci\u00f3n del alimento con f usariotoxinas, tipo tricotecenos en \nalg\u00fan punto entre la primera y quinta semana de observaci\u00f3n.  \n \nCONCLUSI\u00d3N  \n \nEl A -AM p urificado utilizado en esta prueba demostr\u00f3 su efectividad en el control de lesiones orales inducido \npor micotoxinas en las aves.   \n \nREFERENCIAS  \n \n1. Campbell, M L (1983) Evaluation of imunity of young broiler chickens during simultaneous aflatoxicosis \nand ochratoxicosis.  Poulty Science 62: 2138- 2144.  \n2. Corrier, D E (1991) Mycotoxicosis: mechanisms of immunosuppression.  Vet. Immunol. Immunopathology.  \n30: 73- 87.  \n3. Gimeno A y Martins M L (2000) Problemas de micosis y mycotoxicosis en polllos. In: \nwww.mycotoxin.com  p 1-44. 63rd WPDC/XXXIX ANECA  4. Leeson  S, Diaz G J and Summers J D (1995) Poultry metabolic disorders and mycotoxins. University \nBooks. Guelph, Ontario, Canada.  \n5. Zaviezo D (2004) Impact of molds and mycotoxins in poultry nutrition. Veterinaria Feed Hygiene. \nMonograf\u00eda IV Miedzynarodowa Conferencia Naukowa 29-33 p. Uniwersytet Warminsko -Mazurski.  Olsztynie,  \nPoland.  \n \nCuadro 1 . Lesiones orales (picos y lenguas) .  \n \nEscala de \nLesi\u00f3n  N\u00famero y grado de lesiones orales en grupo control  \nLesiones en Cavidad Oral  Lesiones en Lengua  \n1 sem  2 sem  5 sem  7 sem  1 sem  2 sem  5 sem  7 sem  \nGrado 0  30 22 29 43 0  7 12 \nGrado 1  0 18 27 32 0 3 9 37 \nGrado 2  49 43 31 19 35 34 23 22 \nGrado 3  21 17 13 6 65 63 51 29 \n\u00cdndice  1.61 1.55 1.28 0.88 2.65 2.60 2.08 1.68 \nEscala de \nLesi\u00f3n  N\u00famero y grado de lesiones orales en grupo tratado  \nLesiones en Cavidad Oral  Lesiones en Lengua  \n1 sem  2 sem  5 sem  7 sem  1 sem  2 sem  5 sem  7 sem  \nGrado 0  35 78 95 97 0 4 43 75 \nGrado 1  0 19 5 2 0 71 47 25 \nGrado 2  45 0 0 1 39 20 10 0 \nGrado 3  20 3 0 0 61 5 0 0 \n\u00cdndice  1.50 0.28 0.05 0.04 2.61 1.26 0.67 0.25 \n \n \n \nCuadro 2.  \u00cdndice de lesiones comparativo.  \n \n \nEscala de Lesi\u00f3n  N\u00famero y grado de lesiones orales  \nLesiones en Cavidad Oral  Lesiones en Lengua  \nInicial  1 sem  5 sem  7 sem  Inicial  1 sem  5 sem  7 sem  \n0 P-Tx P-Tx P-Tx 0 P-Tx P-Tx P-Tx \nGrupo Control  1.61 1.55 1.28 0.88 2.65 2.60 2.08 1.68 \nGrupo A -AM 1.50 0.28 0.05 0.04 2.61 1.26 0.67 0.25 \nDiferencia  -0.11 -1.27 -1.23 -0.84 -0.04 -1.34 -1.41 -1.43 \n \n 63rd WPDC/XXXIX ANECA  OLEORESIN BASED FEED ADDITIVE \u2013  A NATURAL GROWTH \nPROMOTER WITH ANTICOCCIDIAL PROPERTIES  \n \nADITIVO DE ALIMENTO BASADO EN OLEORRESINA - UN PROMOTOR DE \nCRECIMIENTO NATURAL CON EFECTOS ANTICOCCIDIANOS  \n \nP. Mishra , A. Casarin , and I. Cabrera  \n \nEuronutec  Premix S.A de CV, Queretaro Mexico  \n \nRESUMEN  \n \nLa creciente preocupaci\u00f3n por el uso de antibi\u00f3ticos en la industria de alimentos para animales y sus efectos \nnocivos relacionados con la salud humana han obligado a la comunidad cient\u00edfica a buscar otras opciones \nsaludables. En el presente trabajo se reporta que el alimento para aves adicionado con una mezcla de dos \noleorresinas naturales presenta un efecto sin\u00e9rgico contra la coccidiosis aviar y tambi\u00e9n mejora el rendimiento de \npollos de engorda. Los efec tos de las oleorresinas naturales se analizaron en la presencia y ausencia de diferentes \ncoccidost\u00e1ticos. Las pruebas muestran que la mezcla de oleorresinas aument\u00f3 la ganancia diaria de peso corporal y \ndisminuy\u00f3 el \u00edndice de conversi\u00f3n alimenticia y la ta sa de mortalidad en los pollos de engorda desafiados con \nCoccidia. Los recuentos de ovocitos para Eimeria  maxima , Eimeria  acervulina  y Eimeria  tenella  fueron los mismos \nen la presencia de diferentes coccidiost\u00e1ticos. El posible mecanismo de acci\u00f3n de estas  oleorresinas es mediante la \nprotecci\u00f3n de los microflora intestinal y la mejora de las respuestas inmunol\u00f3gicas de los animales  \n \nSUMMARY  \n \nGrowing concerns about the use of antibiotic s in animal feed industries and their  related harmful effects on \nhuman health have forced the scientific community to look for other healthy options. In the present work we report that poultry feed added with a mixture of  two natural oleoresins  exhibits a synergic effect against  avian coccidi osis \nand also enhances the performance of broilers.  Effects of the natural oleoresins were analyzed in the presence and \nabsence of  different  coccidostat s. The trials show that the mixture of oleoresins increased the daily body weight gain \nand decreased  the feed conversion ratio and mortality rate in coccidiosis  challenged broilers.  The oocyte counts for \nEimeria  maxima , Eimeria  acervulina , and Eimeria  tenella  were the same as in the presence of different \ncoccidiostats. The possible mechanism of action of these oleoresins is by protecting the gut micro flora and by \nenhancing the immunological responses of the animals.  \n \nINTRODUCTION  \n \nPresent day global poultry industry fin ds it difficult to confront avian coccidiosis as there are fewer \nanticoccidial drugs available. However, the effect of coccidia is reduced to some extent by the use of different \nantibiotics like virginiamycin and flavomycin among others as growth promoters in combination with antico ccidial \nprograms.  Recent studies have clearly shown that indiscriminate uses of antibiotics have deleterious effects in \npoultry industry and thus affecting the human health also. This has resulted ban on the use of different antibiotics in European Union a nd opened debate on the use of antibiotics in other countries also.  In recent years major emphasis \nhas been laid on the use of different alternatives as prebiotics, probiotics and phyt obiotics. Currently, p hytobiotics or \nplant extracts have drawn a lot of attention in animal feed industries. In comparison to synthetic growth promoters or \ninorganic chemicals, these plant extracts ( mainly the essential oils ) have proven to be natural, no or less toxic, and \nresidue free. With evolutionary advances in chemistry and identification of plant compounds which are effective in \ntreatment of certain diseases have renewed interest in different plant extracts as feed additives. Till now several \nbeneficial effects of bioactive plant substance in animal nutrition has been r eported. These include stimulation of \nappetite and feed intake, immune modulation, improved endogenous digestive enzyme secretion, antibacterial, antiviral, antioxidant action and  protection of gut micro flora. S everal plants , like garlic, thyme, clove, a nise, ginger,  \ncinnamon, capsicum, c urcuma etc. have been extensively reported in literature with all the above mentioned \nbeneficial effects. In the present work we investigated the effect of a mixture of two oleoresins  (OR)  in broilers as a \nnatural growth p romoter with anticoccidial effect  in challenged and non challenged chickens with c occidiosis.  63rd WPDC/XXXIX ANECA   \nMATERIALS AND METHODS  \n \nThis trial was conducted at IIIA (International Institute of Animal Research) located in El Marqu\u00e9s, Quer\u00e9taro, \nM\u00e9xico at 1800 m eters above sea level. A total of 1920 one d  old broilers sex mixed from a commercial hatcher y \nwere used in a floor pen of 4 m2. Four hundred and eighty  broilers were trialed per treatment, 10 replicates per \ntreatment were produced with 48 birds  per replicate. Broilers were vaccinated against Marek Disease at d one and \nNCD at d  12 and 24 and a gainst c occidia at d ay one (Coccivac\u00aeB Schering -Plough).  At 14 d age coccidiosis \nchallenge was done by Spray innoculation with a pool of Eimeria culture was used in a litter with 70% moisture. \nEach mL  contained - E. acervulina: 300,000 oocysts, E. maxima  10,000 oocysts,  E. tenella 10,000 oocysts Feeding \nprogram was divided in four diff erent phases - starter (0 -14 d), grower (15 -28 d), finisher (29- 42 d) and withdrawal \n(43-52 d)  with 0.450, 1.50, 2.40 and 1.85 Kg of feed per bird respectively.  The following four  treatment were used - \nwhere NI: 125 PPM, NICARBAZINE, BA:  50 PPM BACITRACINE ZN, SA: 65 PPM, SALINOMYCIN, OR: 100 \nPPM OLEORESIN  Body Weight Gain (BWG), F eed conversion ratio (FCR) and body w eight (BW) were registered \nin two periods -  0 - 14 d old (Pre -Challeng e) and 15 -  52 d old (Post -Challenge)  \n \nRESULTS AND CONCLUSION  \n \nTreatments (T2a and T2b) with OR  showed better results than T1a and T1b for BWG (+8.2%), FCR ( -5.5%) \nand BW (+6.9%), showing the positive effect on stimulating innate immunity on growth performance.  T2a and T2b \nhad similar BWG, FCR and BW, (P>0 .7) confirming that vaccination did not affect growth performance without \nchallenge.  During the post -challenge period:  T2a and T2b showed same BWG, FCR and final BW (p>0.7) as well as \nT1a and T1b (P>0.5).  This demonstrated that OR with vaccination can maintain the performance of challenged birds \nat the same level as non challenged birds. BW in T2a and T2b was 3.7% higher than in T1a and T1b, suggesting that \nusing PF during the whole growing period improved final BW of birds.  The present study clearly shows that plant \noleoresins can be excellent tools to improve performance in pre and post challenge periods  and also can be included \nin coccidia vaccine program.  \n \nREFERENCES  \n \n1. Kim D.K, H.S Lilllehoj y D. Bravo, A bst. Poult.Sci. 2009.  \n2. Mackling K.S y J.B Hess. Abst. Poult. Sci. 2009.  \n3. Reisinger N, Steiner T y TJ Applegate. Abst. Poult. Sci 2009.  \n4. Ricke, et al.. Poultry Sci. 84, 667 -675. 2005.  \n5. Zentek y Mader,. Word Nutrition Forum. Biomin Sept 7th-8th. Pp 75- 86. 2006,  \n6. Sivropoulou A, et.al.. J. Agric. Food Chem. 44, 1202 \u2013  2205.1996.  \n7. Hammer KA, et.al.. J. Appl. Microbiol. 86, 985 \u2013  990. 1999.  \n8. Chami N, et.al.. Oral Microbiol. Immunol. 20, 106 \u2013 111. 2005.  \n  \nTable 1. Different treatments . \n \nTREAT   VACCINATED   CHALLENGED   0-14 \nd  15-28 \nd  29-\n42 d  43-\n52 \nd  \nT1 a   NO  NO  NI + \nBA  SA+BA   \nT1 b   NO  YES   NI + \nBA  SA+ BA   \nT2 a   NO  NO  OR OR \nT2 b   YES   YES   OR  OR  \n 63rd WPDC/XXXIX ANECA   \n \n \n63rd WPDC/XXXIX ANECA  APPLICATIONS FOR A NOVEL COMMERCIAL FOWL \nADENOVIRUS (FAdV) ELISA TEST KIT  \n \nAPLICACIONES EN CAMPO PARA UN KIT DE LA PRUEBA DE ELISA PARA \nEL ADENOVIRUS DE LAS AVES DOM\u00c9STICAS (FADV)  \n \nR. MonleonA, G. SlacumB, and B. van LeerdamA  \n \nABioChek B .V., Fokkerst raat 14, 2811 ER Reeuwijk, The Netherlands  \nBBioChek USA Corp ., 3 Southgate Road, Scarborough, ME 04074, USA  \n \nRESUMEN  \n \nEl adenovirus de las aves dom\u00e9sticas (FadV) es un Adenovirus Grupo 1 que pertenece a uno de los tres g\u00e9neros \nde la familia Adenoviridae. Son ubicuos alrededor del  mundo, infectan una amplia gama de especies y producen \npatolog\u00edas en pollos como la hepatitis con cuerpos de inclusi\u00f3n,  s\u00edndrome de hepatitis con cuerpos de \ninclusi\u00f3n/hidropericardio y erosiones en la molleja. Los s\u00edntomas cl\u00ednicos in cluyen postraci\u00f3n, depresi\u00f3n, anorexia y \nlesiones incluyendo hepatitis, hidropericardio, nefritis y erosiones en la molleja entre otros. La enfermedad \nfrecuentemente se manifiesta con una alta mortalidad y una alta morbilidad. La virulencia es espec\u00edfica d e cada cepa \ny muy variable. El diagn\u00f3stico ha sido tradicionalmente apoyado por histopatolog\u00eda, seroneutralizaci\u00f3n, aislamiento \nviral y herramientas moleculares (por ejemplo PCR y secuenciaci\u00f3n). A trav\u00e9s de los a\u00f1os, ELISA ha sido propuesta \ncomo una alter nativa adecuada dentro de ciertas condiciones; sin embargo, pocos kits de pruebas comerciales han \nestado disponibles a nivel mundial. En este trabajo se presentar\u00e1n aplicaciones de campo para un nuevo kit comercial de la prueba de ELISA para el FadV en una amplia gama de escenarios como exploraci\u00f3n en animales \nlibres de pat\u00f3genos espec\u00edficos (SPF), seroconversi\u00f3n natural e inducida, monitoreo de vacunaci\u00f3n e infecciones de \ncampo.  \n \nSUMMARY  \n \nFowl a denovirus es (FAdV) are Group I Aviadenovirus , belonging to one of the three genus of the family \nAdenoviridae. They are ubiquitous around the world infecting a wide array of species, and  produce economic \ndamage with pathologies  in chickens  such as i nclusion body hepatitis, h epatitis -hydropericardium syndrome and \ngizzard erosions. Clinical symptoms include prostration, depression, anorexia, and lesions that include hepatitis, \nhydropericardium, nephritis, and gizzard erosions among others. The disease often manifests itself with high \nmorbidity and high mortality. Virulence is strain specific and very variable. Diagnosis has been traditionally \nsupported by histopathology, serum neutralization  test, virus isolation,  and molecular tools (i. e. PCR and \nsequencing) . Over the years, ELISA has been proposed as a  suitable alternative within certain conditions ; howe ver \nfew commercial test kits have been made available worldwide . Recently  a novel FAdV  ELISA  test kit (Biochek \nB.V., Reeuwijk, The Netherlands) has become commercially available. To demonstrate the range of applications of  \nthis test, samples were collected  from  four different ly expected  serological groups : specific pathogen free (SPF), \nnatural ly exposed (NE),  vaccinated  (V), and clinically affected  chickens  (CA). Results showed various degrees of \nvariatio n on titer values between serological groups (SPF, NE, V,  CA). Interpretation of these  variations  suggest that \nthis novel FAdV ELISA test kit can be successfully  used for a range of applications such as specific pathogen free \nscreening, monitoring of natural sero -conversion, monitoring of vaccination, and  presumptive  diagnosis of clinical \noutbreaks.  \nThe detailed resu lts will be discussed during the  presentation.\n 63rd WPDC/XXXIX ANECA  EFECTO DEL USO DE GENTAMICINA EN COMBINACI\u00d3N CON \nVACUNA CONTRA LA ENFERMEDAD DE MAREK EN POLLITOS \nDE UN D\u00cdA DE EDAD  \n \nEFFECT OF GENTAMICIN ON THE VACCINE AGAINST MAREK'S DISEASE \nIN CHICKENS VACCINATED AT ONE DAY OF AGE  \n \nL. MontesinosA, N. LedesmaA, R. AlonsoB, \u00c1. AguilarC y F. R\u00edosD \n \nADepartamento de Medicina y Zootecnia de Aves, FMVZ - UNAM , Distrito Federal, M\u00e9xico  \nBDepartamento de Gen\u00e9tica y Bioestad\u00edstica, FMVZ -UNAM , Distrito Federal, M\u00e9xico  \nCUnidad de Investigaci\u00f3n M\u00e9dica en Inmunolog\u00eda,  Hospital de Pediatr\u00eda, Centro M\u00e9dico Nacional Siglo XXI, \nInstituto Mexicano del Seguro S ocial, Distrito Federal, M\u00e9xico  \nDMSD Salud Animal , Estado de M\u00e9xico, M\u00e9xico  \n \nSUMMARY  \n \nIn commercial poultry , it is common to use an antibiotic gentamicin administration in combination with \nMarek's disease vaccine, as well as the use of  half doses of the vaccine. There is inconsistency in the scientific \nliterature regarding the action of this antibiotic on Marek's vaccine , since some authors refer  that genta micin does \nnot affect the vaccine tittles,  while others mention that it does . This project, investigated the  vaccunal virus presence \nand its concentration in feathers  collected at 14, 21 and 28 d  post- vaccination from broilers  vaccinated at one d  old. \nTwo types of vaccines were used; serotype 1 vaccine and bivalent vaccine with serotype 2 and serotype 3, from \nwhic h only serotype 3 was evaluated . The results indicated that both vaccines group which had a smaller number of \npositive samples, a further delay in the maximum value of the relative concentration of viral DNA or a lower \nrelative concentration of viral DNA was the group of half dose with gentamicin , because of this,  the broiler can be \nsusceptible to a field virus.  \n \nRESUMEN  \n \nEn la avicultura comercial es com\u00fan la administraci\u00f3n del antibi\u00f3tico gentamicina en combinaci\u00f3n con vacuna  \ncontra la enfermedad de Marek al igual que el uso de medias dosis de vacuna. Existe inconsistencia en la \npublicaciones cient\u00edficas respecto a la acci\u00f3n de este antibi\u00f3tico s obre la vacuna de Marek, ya que algunos autores \nmencionan que la gentamicina no afecta el t\u00edtulo de la vacuna mientras otros mencionan que si lo hace. En el \npresente estudio se determin\u00f3 la presencia del virus vacunal y su concentraci\u00f3n  de plumas colectad as a los d \u00edas 14, \n21 y 28 post -vacunaci\u00f3n de aves de engorda vacunadas al d\u00eda de edad, se emplearon 2 vacunas; vacuna conteniendo \nel serotipo 1 y vacuna bivalente conteniendo serotipo 2 y serotipo 3. De esta \u00faltima solo se evalu\u00f3 el serotipo 3. Los \nresultados obtenidos en ambas vacunas indicaron que el grupo en el c ual se present\u00f3 un menor n\u00famero de muestras \npositivas, un mayor retraso en alcanzar el valor m\u00e1ximo de la concentraci\u00f3n relativa de ADN viral o bien una menor concentraci\u00f3n relativa de ADN viral fue el grupo de media dosis con gentamicina, por lo que el av e pudiera estar \nsusceptible a la infecci\u00f3n por virus de campo.  \nLa enfermedad de Marek (EM) es causada por un Herpesvirus altamente contagioso, asociado a c\u00e9lulas y  \noncog\u00e9nico. Su distribuci\u00f3n es mundial. En aves susceptibles y expuestas al virus de la enfermedad de Marek \n(VEM) puede resultar en un debilitamiento progresivo llevando a una alta mortalidad, baja en la producci\u00f3n del \nhuevo e inmunodepresi\u00f3n  (1). \nLa eliminaci\u00f3n del virus es mediante descamaciones cut\u00e1neas de aves infectadas formando una parte mu y \nimportante del polvo dentro de las casetas av\u00edcolas por lo que su eliminaci\u00f3n del ambiente es muy dif\u00edcil, debido a esto la vacunaci\u00f3n se utiliza como la mejo r estrategia de control de esta enfermedad  (2). \nEntre las posibles causas de fallas en la vacunaci\u00f3n se menciona a la combinaci\u00f3n de antibi\u00f3ticos con la \nvacuna contra enfermedad de Marek. Petrone et al.  (3) menciona a la gentamicina como un antibi\u00f3tico que \ndisminuye la viabilidad de la vacuna contra EM.  Mientras que Gimeno  (4) menciona a la gentamicina, \noxitetraciclina, eritrom icina y clorotetraciclina como antibi\u00f3ticos capaces de inactivar al virus vacunal e inutilizar la 63rd WPDC/XXXIX ANECA  vacuna. Sin embargo existen otras publicaciones en las que el empleo de  gentamicina  no reporta un efecto negati vo \nsobre el t\u00edtulo de la vacuna (5, 6) . Por lo que no queda del todo claro si la gentamicina afecta o no al virus vacunal.  \nEn el presente estudio se planea evaluar el efecto in vivo  de la gentamicina sobre la vacuna contra enfermedad \nde Marek en dosis completa y media dosis, evaluando la concentraci\u00f3n de ADN del virus vacunal presente en la \npulpa de la pluma mediante t\u00e9cnica de PCR en tiempo real. Se emplearon muestras de pluma debido a que es donde \nel virus de Marek t ermina su ciclo en el hu\u00e9sped y por la relaci\u00f3n que existe entre la concentraciones de ADN viral \nvacunal con protecci\u00f3n contra virus de campo.  \n \nMATERIAL Y M\u00c9TODOS  \n \nSe emplear on 9 0 aves comerciales Ross  308 de un d\u00eda  de edad. Se utilizaron 2 vacunas comerciales, una \nconteniendo el serotipo 1 y otra bivalente recombinante conteniendo los serotipos 2 y 3.  \nLas aves fueron divididas en cuatro  grupos de 10 individuos para cada una de las vacunas y 10 aves m\u00e1s como \ncontrol negativo. Los tratamientos fueron los siguientes: Dosis completa de vacuna  contra la enfermedad de Marek \n(DC), media dosis de vacuna  contra la enfermedad de MD , dosis completa de vacuna  contra la enfermedad de \nMarek con sulfato de gentamicina (DC+G) y m edia dosis de vacuna contra la enfermedad de Marek con sulfato de \ngentamicina (MD+G) . \nCada grupo fue vacunado al d\u00eda de edad v\u00eda subcut\u00e1nea (regi\u00f3n posterior en el tercio medio del cuello), 0.2 mL  \na los g rupos de dosis completa y 0.1 mL  a los grupos de med ia dosis, los grupos con gentamicina a una dosis de 0.25 \nmg/ave. Posteriormente a l os tiempos de 14, 21 y 28 d\u00edas  post-vacunaci\u00f3n fueron tomadas cuatro  plumas de la \nregi\u00f3n del h\u00famero, conserv\u00e1ndolas a - 20\u00b0C hasta su procesamiento.  \nExtracci\u00f3n del ADN . La extracci\u00f3n del ADN a partir de pluma fue mediante modificaci\u00f3n de la t\u00e9cnica de \nHiguchi et al (7).  \nPCR Tiempo Real . Los iniciadores emplea dos fueron las siguientes:  \nSerotipo 1: Regi\u00f3n Meq  \nF: 5\u00b4-GGAGCCGGAGAGGCTTTATG- 3\u00b4 \nR: 5\u00b4-ATCTGGCCCGAATACAAGGAA- 3\u00b4 \nSerotipo 3: Regi\u00f3n SORF1  \nF: 5\u00b4-GGCAGACACCGCGTTGTAT -3\u00b4 \nR: 5\u00b4-TGTCCACGCTCGAGACTATCC -3\u00b4 \nCol\u00e1gena pollo \u03b12 (IV)  \nF: 5\u00b4 -GGGAACTGGAGAACCCAATTTT -3\u00b4 \nR: 5\u00b4-CGTGCCGCTGTCTCTACCAT -3\u00b4  \nLas sondas empleadas fueron las siguientes:  \nSerotipo 1: Regi\u00f3n Meq:  \n5\u00b4(FAM) CGTCTTACCGAGGATCCCGAACAGG(BHQ- 1)3\u00b4 \nSerotipo 3:  Regi\u00f3n SORF1:  \n5\u00b4(FAM)AACCCGGGCTTGTGGACGTCTTC(BHQ- 1)3\u00b4 \nCol\u00e1gena pollo \u03b12(IV):  \n5\u00b4(HEX)CCCTTAACTGAGTTCCCCAGCTACTGCAG (BHQ- 1)3\u00b4 \nEl volumen final por reacci\u00f3n par a el PCR -TR fue de 20 \u00b5L, conteniendo 10 \u00b5L  de la muestra a analizar y 10 \n\u00b5L del master mix. Los componentes del master mix por reacci\u00f3n fueron los siguientes: buffer  Taq Polimerasa 1X, \ndNTP\u00b4s 0.2mm , MgCl 2 3mm,  iniciadores F+R del virus 0.5\u00b5m , sonda del vi rus 0.1\u00b5m , iniciadores F+R del gen de \nreferencia ( col\u00e1gena pollo \u03b12) 0.5\u00b5m , sonda del gen de referencia 0.1 \u00b5m , Taq polimerasa 1u, agua cpb 10\u00b5L . En el \ncaso de la vacuna monovalente se analiz\u00f3 el serotipo 1 y en el caso de la vacuna bivalente solo se  analiz\u00f3  el \nserotipo 3.  \nLa amplificaci\u00f3n -detecci\u00f3n del  ADN se llev\u00f3 a cabo en termociclador de PCR -TR (Corbett Rotor -Gene 6000) \ncon la siguiente p rogramaci\u00f3n: 95\u00b0C por 10 min , 40 ciclos de 95\u00b0C por 15 segundos y 60\u00b0C por 45 segundos.  \nSe llev\u00f3 a cabo la cuantificaci\u00f3n relativa a partir de las concentraciones d e ADN detectadas por el programa del \nequipo del PCR -TR. Para la obtenci\u00f3n de las concentraciones de ADN presente en la muestra se emple\u00f3 el m\u00e9todo \nde la curva est\u00e1ndar .  \n \nRESULTADOS  \n \nEn la vacuna serotipo 1.  En el muestreo a los 14 y 21 d\u00edas  el grupo con menor n\u00famero de muestras positivas \nfue el de media dosis con gentamicina, encontr\u00e1ndose diferencia estad\u00edsticamente significativa respecto a los dem\u00e1s 63rd WPDC/XXXIX ANECA  grupos mediante prueba de ANOVA. (Cuadro 1) . Los grupos que presentaron la media aritm\u00e9tica con los valores \nm\u00e1s bajos de concentraci\u00f3n relativa de ADN vi ral en el muestreo a los 14 d \u00edas fueron los grupos de media dosis y \nmedia dosis con gentamicina  siendo sus valores de 0.14205 y 0.0503 respectivamente, sin encontrarse diferencia \nestad\u00edsticamente significativa. La fecha de muestreo en la cual se encontr\u00f3 el valor m\u00e1ximo de la media aritm\u00e9tica \nde la concentraci\u00f3n relativa de ADN viral fue para el gru po de dosis completa y dosis completa  con gentamicina a \nlos 14 d\u00edas , en el gr upo de media dosis a los 21 d\u00edas  y en el grupo de media dos is con gentamicina a los 28 d \u00edas.  \nEn la vacuna bivalente \u00fanicamente se analiz\u00f3 el serotipo 3.  En todos los muestreos el  grupo con menor \nn\u00famero de muestras positivas fue el de media dosis con gentamicina, encontr\u00e1ndose diferencia estad\u00edsticamente \nsignificativa mediante prueba de ANOVA en l os muestreos a los 21 y 28 d\u00edas  (Cuadro 2) . El grupo que present\u00f3 la \nmedia aritm\u00e9tica con los valores m\u00e1s bajos de concentraci\u00f3n relativa de ADN viral en todos los muestreos fue el de \nmedia dosis con gentamicina, sin embargo, no se encontr\u00f3 diferencia estad\u00edsticamente significativa.  Los valores \nm\u00e1ximos encontrados de las medias aritm\u00e9ticas  de la concentraci\u00f3n relativa de ADN viral fue para el grupo de dosis \ncompleta de 0.00005058 en el muestreo a los 21 d\u00edas , en el grupo de media dosis de 0.00012803 en el muestreo a los \n28 d\u00edas , para el grupo de dosis completa con gentamicina de 0.00012973 en el muestreo a los 28 d \u00edas y para el grupo \nde media dosis con gentamic ina de 0.00001593 a los 28 d\u00edas  (Cuadro 2) . \n \nDISCUSI\u00d3N  \n \nVacuna s erotipo 1 . En un estudio realizado por Baigent et al.  (8) demostr\u00f3 que al diluir una vacuna contra la \nEM se disminuye la concentraci\u00f3n del virus vacunal presente en muestras de pluma y estas aves con una menor \nconcentraci\u00f3n  de virus vacunal en pluma presentaron mayor mortalidad ante un desaf\u00edo por virus de campo.  En el \npresente estudio los grupos que obtuvie ron en el muestreo a los 14 d \u00edas su valor m\u00e1s alto de media aritm\u00e9tica de la \nconcentraci\u00f3n relativa de ADN viral fue el de dosis completa y dosis completa con gentamicina, significando esto, \nque la gentamicina por si sola en dosis completa no parece afectar la viabilidad de la vacuna. El grupo de media \ndosis tuvo su valor m\u00e1ximo de media aritm\u00e9tica a los 21 d \u00edas, este retraso de una semana en relaci\u00f3n a los grupos de \ndosis completa y dosis completa con gentamicina indica que por s\u00ed solo el hecho de aplicar media dosis vacunal \nafecta directamente en la cantidad de virus presente en el fol\u00edculo de la pluma.  \nVacuna bivalente . En un estudio realizado por Islam y Walkden -Brown  (9) estimaron la excreci\u00f3n del A DN \ndel serotipo 3 de aves inmunizadas con vacuna bivalente (serotipos 2 y 3) en la incubadora, reportando que la \nconcentraci\u00f3n m\u00e1xima del ADN viral del serotipo 3 se encuentra alrededor del d \u00eda 28 post -vacunaci\u00f3n . En el \npresente estudio, los grupos que mos traron una cin\u00e9tica similar fueron los grupos de media dosis y dosis completa \ncon gentamicina. El grupo de dosis completa mostro valores en la concentraci\u00f3n de ADN viral por debajo de lo \nesperado, a diferencia de lo encontrado en la vacuna del serotipo 1, en cada uno de los muestreos su media \naritm\u00e9tica estuvo debajo de los grupos de dosis completa con gentamicina y media dosis , sin embargo no se \nencontr\u00f3 diferencia estad\u00edsticamente significativa. El grupo de media dosis con gentamicina al igual que en la vacuna de ser otipo 1, fue el grupo que mostr\u00f3 la menor cantidad en la concentraci\u00f3n de ADN viral y adem\u00e1s fue el \ngrupo que present\u00f3  una menor cantidad de muestras positivas, encontr\u00e1ndose diferencias estad\u00edsticamente \nsignificativas mediante prueba ANOVA en los muestreos a los 21 y 28 d\u00edas , lo que sugiere  mayor susceptibilidad a \ndesaf\u00edo por virus de campo. En este caso aparentemente el uso de la gentamicina por s\u00ed solo no est\u00e1 afectando la excreci\u00f3n del virus vacunal, sin embargo su combinaci\u00f3n con la adminis traci\u00f3n de medias dosis indica lo contrario.   \n \nCONCLUSI\u00d3N  \n \nLa administraci\u00f3n del antibi\u00f3tico gentamicina en combinaci\u00f3n con media dosis de vacuna es una pr\u00e1ctica que \ndebe evitarse debido a los efectos negativos sobre la vacunaci\u00f3n contra la enfermedad de Marek. En el caso de que \nse desee aplicar un antibi\u00f3tico en combinaci\u00f3n con una vacuna debe confirmarse primero que existan estudios de \nlaboratorio y de campo que avalen su eficacia sin interferir con la efectividad de la vacuna.  \n \nREFERENCIAS  \n \n1. Sharma JM. Marek\u00b4s disease. En Swayne DE, Glisson JR, Jackwood, Pearson JE, Reed WM. A \nlaboratory manual for the isolation and identification of avian pathogens. 4ta edici\u00f3n. Kennet Square, Pennsylvania. EU: American Association of Avian Pathologists, 1998: 116 -124.  \n2. Nair V. Evolution of Marek\u00b4s disease \u2013  A paradigm for incessant race between the pathogen and the host. \nThe Veterinary Journal.  2005. 170: 175- 183.  \n3. Petrone GV, Hern\u00e1ndez VX, T\u00e9llez IG. Enfermedad de Marek. Vet. M\u00e9x.2000. 31 (4), 355 -369.  63rd WPDC/XXXIX ANECA  4. Gimeno IM. Actu alidades en el control de la enfermedad de Marek. Asociaci\u00f3n Espa\u00f1ola de Ciencia \nAv\u00edcola. World\u00b4s Poultry Science Association. Disponible en URL: www.wpsa -\naeca.es/aeca_imgs_docs/04_10_37_GIMENO.pdf .   \n5. Eidson CS, Page RK, Kleven SH. In vivo and in vitro studies on the effect of gentamicin sulfate on the  \nefficacy of the turkey herpesvirus vaccine. Poult.  Sci. 1978; 57(6):1519- 1525.  \n6. Chac\u00f3n JL, Pimentel M, Pedroso A, Ferreira AJP, Martinez D, Ruelas C. Evaluaci\u00f3n in vitro del  efecto \nde ceftiofur s\u00f3dico y de  una nueva formulaci\u00f3n de sulfato de gentamicina sobre la viabilidad del virus de la \nenfermedad de Marek. XX Congreso Latinoamericano de Avicultura. Brasil. 2007.  \n7. Higuchi R, von Beroldinger C, Sensabaugh GF, Erlich HA. DNA typing from single hairs . Nature . 1988; \n332, 543- 546. \n8. Baigent SJ, Smith LP, Currie RJW, Nair VK. Correlation of Marek\u00b4s disease herpesvirus vaccine genome \nload in feather tips with protection, using an experimental challenge model. Avian Pathol.  2009; 36:6, 467- 474.  \n9. Islam A, Walkden -Brown SW. Quantitative profiling of the shedding rate of the three Marek\u00b4s disease \nvirus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. \nJ. Gen. Virol . 2007; 88, 2121- 2128.  \n \nCuadro 1 . Porcentaje de  muestras positivas de vacuna serotipo 1 y an\u00e1lisis de varianza entre grupos.  \n \n Muestreo 14 \nd\u00edas Muestreo 21 \nd\u00edas Muestreo 28 \nd\u00edas \nGrupo  % muestras \npositivas  % muestras \npositivas  % muestras \npositivas  \nDC 90a* 90a 90a \nMD 70a 88.8a 90a \nDC+G  90a 70ab 80a \nMD+G  20b 40b 90a \nDC (dosis completa), MD (media dosis), DC+G (dosis completa con gentamicina), MD+G (media \ndosis con gentamicina)  \n*Literales diferentes indican diferencia estad\u00edsticamente significativa. p\u2264 0.05  \n \n \nCuadro 2.  Porcentaje de muestras positivas de vacuna bivalente (serotipo 3) y an\u00e1lisis de varianza entre \ngrupos.  \n Muestreo 14 \nd\u00edas Muestreo 21 \nd\u00edas Muestreo 28 \nd\u00edas \nGrupo  % muestras \npositivas  % muestras \npositivas  % muestras \npositivas  \nDC 40a* 50ab 100a \nMD 20a 60a 80a \nDC+G  50a 70a 75a \nMD+G  10a 10b 30b \nDC (dosis completa), MD (media dosis), DC+G (dosis completa con gentamicina), MD+ G (media \ndosis con gentamicina)  \n   *Literales diferentes indican diferencia estad\u00edsticamente significativa. p\u2264 0.05  \n 63rd WPDC/XXXIX ANECA  USE OF ARTIFICIAL NEURAL NETWORKS  TO CLASSIFY THE \nPATHOGENICITY OF AVIAN PATHOGENIC ESCHERICHIA COLI  \n \nEL USO DE REDES NEURONALES ARTIFICIALES PARA CLASIFICAR LA \nPATOGENICIDAD DE ESCHERICHIA COLI AVIAR PAT\u00d3GENA  \n \nT. Moreira TejkowskiA, B. Guimar\u00e3es de BritoB, S. Luis da Silveira RochaA, G. Fonseca de SouzaA,  \nH. Luiz de Souza MoraesA, and C. Tadeu Pippi SalleA \n \nACenter of Diagnosis and Research in Avian Pathology (CDPA), Veterinary Faculty, Federal University of Rio \nGrande do Sul, Porto Alegre, Brazil;  thiago.mt@veterinario.med.br  \nBVeterinary Research Institute Desid\u00e9rio Finamor, Eldorado do Sul, RS, Brazil; benitobrito@gmail.com  \n \nRESUMEN  \n \nLas Redes Neuronales Artificiales (ANN) han demostrado ser una herramienta de gran alcance para una amplia \ngama de aplicaciones. En este trabajo, el enfoque en las aplicaciones de ANN es en la predicci\u00f3n (\u00edndice de 0 a 10) \nde la patogenicidad de los aislam ientos de Escherichia coli  aviar pat\u00f3gena (APEC). En 489 aislamientos de APEC \nse analizaron: 38 genes asociados con la virulencia, el \u00edndice de patogenicidad (PI) in vivo y la motilidad de las \ncepas. Se contruyeron dos ANNs utilizando el software NeuroShel l clasificador. Se utiliz\u00f3 como capa de entrada, \ninformaci\u00f3n acerca de la presencia o ausencia de los 38 genes asociados con la virulencia y la motilidad de cada una de las muestras, con una capa de salida formada por un PI previamente determinado in vivo.  Los ANNs mostraron \nuna correcta clasificaci\u00f3n de PI por encima de 90 %, siendo que la red 1 ten\u00eda una calificaci\u00f3n de 91,62 % y la red 2 \nde 99,03 %. Esto demuestra que el m\u00e9todo propuesto puede eliminar la inoculaci\u00f3n de los animales en el futuro.  \n \nSUMMARY  \n \nArtificial Neural Networks  (ANN) has shown to be  a powerful tool for  a wide range of applications . In this \npaper, the focus on ANN applications is on  the prediction ( index of 0 -10) of the pathogenicity  of isolates  avian \npathogenic Escherichia coli  (APEC).  Four hundred eighty nine  APEC  isolates were analyzed: 38  virulence -\nassociated genes, the Pathogenicity Index (PI) in vivo  and motility of the strains. Two ANNs were constructed using \nthe so ftware Neuroshell Classifier . We used as input layer, info rmation about the presence or absence of the 38 \nvirulence -associated genes and the motility of each of the samples, with an output layer formed by a previously-\ndetermined PI in vivo. The ANNs showed a correct classification of the PI above of 90%, being th at the network 1 \nhad a rating of 91.62% and the network 2 of 99.03%. This demonstrat es that the method proposed may  eliminate  the \ninoculation of animals in the future.   \n \nINTRODUCTION  \n \nThere is no denying the significant presence that E. coli has in the poultry industry. We know that economic \nlosses measured to date are far from the realities on the field, and present very significant revenue losses . Barnes et \nal. reported that APEC  are the cause of  extraintestinal  diseases  in birds  (1). It has been reported that only specific \nstrains of E. coli are endowed with virulence factors, allowing them to cause disease  (2). This disease manifests \nitself as localized or systemic infections, so -called colibacillosis, as highlighted by Barnes et al. (1). \nThe virulence mechanisms of APEC isolates have been continuously studied and it is supposed that they are of \nmultifactorial cause. Molecular biology has helped us to better understand the mechanisms of the pathogenicity of E. \ncoli, and increasingly, i t has demonstrated the great importance of the interaction of several virulence factors in the \ndetermining of pathogenicity. Delicato et al.  and Ewers et al.  showed that t he factors most frequently associated \nwith pathogenicity include: fimbriae adhesion F 1 and Tsh (Temperature -sensitive hemagglutinin); the system \nsiderophore aerobactin, which enables the capture of Fe\n3+ by the bacteria in poor tissues of this ion; the Iss protein \n(Increased serum survival), purportedly involved in resistance to serum bactericidal effect; the capsule K and the \nproduction of colicin V  (2,3). . \nSalle et al.  showed that the difficulty regarding the E. coli is in their classification as pathogenic  (7); the \ndifferentiation between pathogenic and apathogenic strains remains a problem after the bacteriological diagnosis 63rd WPDC/XXXIX ANECA  and, consequently, in decision -making by the field veterinarian. Most likely this still occurs because of the complex \ninteractions that e xist between the virulence factors of E. coli and the fact that conventional procedures used to \ndetermine the pathogenicity of E. coli, in which animals are inoculated, are time -consuming, expensive and \nethically -challenged by the international community . \nWe believe that one of the tools with the potential to aid in the resolution of ethical problems involving the use \nof animals, as well as the ability to establish a diagnosis that includes the pathogenicity index of E. coli,  is the use of \nmathematical  mod eling, particularly artificial  neural networks. The objective of this paper is to show that it is \npossible to perform pathogenicity prediction through the use of artificial neural networks \u2013 without using animals \u2013  \nand, thus, provide field veterinarians w ith reports that include the degree of pathogenicity of isolates, in order to \nenable their decisions to be more objective and accurate.  \n \nMATERIALS AND METHODS  \n \nDatabase . In this study, 487 APEC isolates were analyzed for the presence of genes responsible for adhesion \ncapacity (afa/draB, crl, fimC, fimH, hra, iha, papC, papG, sfa/focC, tsh, mat e  felA ), invasins ( gimB, ibeA, tia e \ncvaC ), iron acquisition ( chuA, fyuA, ireA, ironA, irp2, iucD, sitD chr, SitD ep e iutA), serum resistance ( cvi/cva, iss, \nneuC, kpsMT II, ompA e  traT), toxins ( astA, cnf1/2,  sat, vat e hlyA), a serin protease autotransporter ( pic) and a \npathogenicity -associated island marker CFT07 3 (malX ). All the genes were studied by six multiplex -PCR protocols, \nwhere the presence of 33 genes was investigated in accordance with four multiplex -PCR protocols developed by \nEwers et al. , three genes were investigated by the multiplex -PCR of the Rocha (2008), and the fimH  and papG  genes \nwere investigated by a multiplex -PCR developed by the CDPA  (4). The reaction mixture of this multiplex is 25\u03bcL, \nincluding 2.5 \u03bcL  10X PCR buffer, 1.25\u03bc L  2,5mM MgCl 2, 1,5U Taq DNA polymerase, 0,5\u03bc L of each 2,5 mM \ndNTP, 2 \u03bcL (20 pmol) oligonucleotide primer pair and 5 \u03bcL template DNA, supplemented with appropriate volumes \nof Mili -Q water.  In addition, each APEC strain was classified according to its pathogenicity i ndex (PI) in vivo (0 -10) \ndeveloped by Souza and motility according Seeley et  al (8). \nArtificial Neural Network (ANN) . An ANN was constructed using the software Neuroshell Classifier 2.1 \n(Ward Systems Group, Inc., Frederick, MD, USA) in two distinct phases: training and vali dation.  Because the 487 \nAPEC strains have shown different PIs in the in vivo  test, we decided to choose 28 random samples per PI, in order \nto build a network with the same number of strains per index, a total of 308 samples. The network shown is \nconstitut ed by an input layer which includes information about the presence or absence of the 38 virulence -\nassociated genes and the motility of each of the strains, with an output layer formed by predetermined PI  in vivo . We \nhave called \u201cinput layer\u201d the set of var iables presented for model calculation and \u201coutput layer\u201d the variable to be \npredicted.  \n \nRESULTS AND DISCUSSION \n \nFor a better understanding of the presented model, we determined sensitivity as \"the ratio of true positives\" and \nspecificity as \"the ratio of true negatives\". The results of our study were surprising: the ANN constructed to \ndetermine the IP of 0 -10 showed a correct classification of 99.03%, a specificity greater than 99.64% in all \ncategories and a sensitivity in 9 of the 11 categories of 100%, and to PI 2 and PI 10, a sensitivity of 96.43% and \n92.86%, respectively. Rocha developed three ANNs with the use o f seven virulence -associated genes to perform the \nprediction and classification of the pathogenicity of 293 E. coli strains  (6). The results obtained were: 54.27% \naccuracy in the network 1, which used 11 categories of PI (0 -10); 80.55% accuracy in the netw ork 2, which used \nthree categories of PI ( apathogenic /low pathogenicity (0 -3.99), intermediate pathogenicity (4 -6.99), high \npathogenicity (7 -10); and 83.96% accuracy in the network 3, with only two categories of PI ( apathogenic /low \npathogenicity (0 -3,99) a nd pathogenicity intermediate/high pathogenicity (4 -10).  \nThis tool is of greater importance, when you consider the experience of veterinarians who work in the field, \nwho, in general, are only offered the name of the bacteria and possibly an antibiogram in  laboratory tests. Thus, the \nvarious technologies represented by the molecular biology, in this case the PCR assays, have remained limited to \nlaboratories and have not represented a useful tool for field work. On top of that, a greater resistance to the us e of \nanimals in experimental models completes the setting. Therefore, the offer of a decision -making support method to \npoultry veterinarians will bring reflections on the cost/benefit ratio of drug treatments, particularly in reducing \nantimicrobial resista nce and residues of those drugs in meat and eggs.  \n \n \n 63rd WPDC/XXXIX ANECA  CONCLUSION  \n \nBy  reaching  correct  classification  percentages  higher  than  99%,  the  method  proposed  here is able to \npredict the pathogenicity of the APEC strains. The characteristics of this model allow the classification of APEC \nisolates pathogenicity with a good degree of reliability, considering the sensitivity and the specificity.  \n \nFINANCIAL SUPPORT  \n \nCNPq ( National Council for Scientific and Techinological Development).  \n \nREFERENCES  \n \n1. Barnes, H. J.; Nolan, L. K.; Vaillancourt, J. P. (2008) Colibacillosis. In. Diseases of Poultry . 12th ed. Ed. \nBlackwell Publishing Professional. pp. 691- 738. \n2. Delicato E. R., De Brito B. G., Gaziri L. C., Vidotto M. C.  (2003) Virulence -associated genes in \nEscherichia coli isolates from poultry with colibacillosis, Veterinarian Microbiology,  94: pp. 97- 103. \n3. Ewers, C., Janssen, T., Kiessling, S., Philipp, H. C. & Wieler, L. H. (2004) Molecular epidemiology of \navian pathogenic Escherichia coli  (APEC) isolated from colissepticemia in poultry. Veterinarian Microbiology , 104, \npp. 91- 10. \n4. Ewers, C., Li, G., Wilking, H., Kiessling, S., Alt, K., Antao, E. M., Lanturnus, C., Diehl, I., Glodde, S., \nHomeier, T., Bohnke, U., Steinruck, H., Philipp, H. C. & Wieler, L. H. ( 2007) Avian pathogenic, uropathogenic, and \nnewborn meningitis -causing Escherichia coli : how closely related are they? International Journal of Medical \nMicrobiology,  297 (3): pp. 163- 176. \n5. Rocha, A. C. G. P. (2006) Utiliza\u00e7\u00e3o de Intelig\u00eancia artificial (redes neurais artificiais) para classifica\u00e7\u00e3o de \npatogenicidade de amostras de Escherichia coli  isoladas de frangos de corte. Tese ( Doutorado em Ci\u00eancias \nVeterin\u00e1rias ), Universidade Federal do Rio Grande do Sul . \n6. Rocha, S. L. S. (2008) Detec\u00e7\u00e3o de fatores de virul\u00eancia de amostras de Escherichia coli  isoladas de \ngranjas av\u00edcolas do RS atrav\u00e9s do Multiplex -PCR. Disserta\u00e7\u00e3o ( Mestrado em Ci\u00eancias Veterin\u00e1rias ), Universidade \nFederal do Rio Grande do Sul.  \n7. Salle, C. T.  P.; Rocha, A. C. G. P.; Souza, G. F.; Salle, F. O.; Moraes, L. B.; Nascimento, V. P.; Moraes, H. \nL. S. (2011) Use of Artificial Intelligence (Artificial Neural Networks) to classify the pathogenicity of Escherichia \ncoli isolates from broilers. 60th Wester n Poultry Disease Conference , March 20 -23, Sacramento, Ca, USA.  \nSeeley, J. R., H. W.; Vandermark, P. J.; Lee, J. J. (1991) Microbes in action. A Laboratory Manual of Microbiology, \n4 th ed. New York: W H. Freeman and Company . \n8. Souza, G. F. (2006) Estabelecimento de uma nova metodologia para c\u00e1lculo do \u00edndice de patogenicidade \nem amostras de Escherichia coli provenientes da produ\u00e7\u00e3o de frangos de corte. Porto Alegre: UFRGS. Disserta\u00e7\u00e3o \n(Mestrado em Ci\u00eancias Veterin\u00e1rias ), Faculdade de Veterin \u00e1ria, Universidade Fed eral do Rio Grande do Sul.  63rd WPDC/XXXIX ANECA  RATIONAL REDUCTION IN ANTIBIOTIC DEPENDENCE BY \nTOTAL MYCOPLASMA  CONTROL  \n \nREDUCCI\u00d3N RACIONAL EN LA DEPENDENCIA DE LOS ANTIBI\u00d3TICOS \nPOR CONTROL TOTAL DE MICOPLASMA  \n \nC.J. Morrow  \n \nBioproperties , 36 Charter St , Ringwood, Vic. 3134 Australia  \nCorresponding author: chris.morrow@bioproperties.com.au    \n \nRESUMEN  \n \nSe pueden producir pollos de engorda sin infecci\u00f3n vertical de MG y MS sin la necesidad de reg\u00edmenes de \nantibi\u00f3ticos de rutina , en especial de medicament os en el per\u00edodo de 18 a 22 d . Esto tambi\u00e9n permite la utilizaci\u00f3n \nde vacunas respiratorias m\u00e1s fuertes (La Sota por ejemplo). La transmisi\u00f3n horizontal en los pollos de engorda no \nparece ser lo suficientemente potente como para requerir antibi\u00f3ticos de rutina. Las gallinas de postura, \nespecialmente las que se cr\u00edan en jaulas, tambi\u00e9n pueden tener reducciones masivas en la dependencia de los \nantibi\u00f3ticos por el control de MG y MS. Esto ayudar\u00e1 a maximizar el rendimiento biol\u00f3gico y satisfacer las \ndemandas emergentes de los clientes. Donde la libertad no es pr\u00e1ctica para MG y MS, la vacunaci\u00f3n contra micoplasma de reproductoras y gallinas de postura se ha utilizado con ts - 11 y vacunas MSH. Otros beneficios \nincluyen expresiones meno s complicadas de diversos virus (virus de influenza aviar, enfermedad de Newcastle, \nAPMV y IBV) y las infecciones bacterianas (coriza y c\u00f3lera aviar), pero es posible la aparici\u00f3n de la enfermedad cl\u00ednica de Brachspira . \n \nSUMMARY  \n \nBroilers without vertical contamination with MG and MS can be produced without the need for routine \nantibiotic regimes , especially  medication in the 18 to 22 d period. This also allows stronger respiratory vaccines (La \nSota for example) to be used. Horizontal transmission to broile rs does not seem to be potent enough to require \nroutine antibiotics. Layers, especially cage layers can also have massive reductions in antibiotic dependence by control of MG and MS. This will help  maximiz e biological performance and meet emerging customer  demands. \nOther benefits include less complicated expressions of various viral (AIV, NDV, APMV and IBV ) and bacterial co -\ninfections (coryza and fowl cholera) but without antibiotics there maybe the emergence of clinical Brachspira \ndisease. Where freedom  by exclusion only  is not practical mycoplasma vaccination of breeders and layers with ts -11 \nand MSH vaccines  can be used .  \n \nINTRODUCTION  \n \nThe simplest approach to decrease dependence on routine antibiotic regimes in animal production is to \nimplement alternat ive methods to control the bacterial challenges that the antibiotics are modulating  (and not look at \nantibiotics as non -specific production enhancers) . The chronic nature of mycoplasma infections and vertical \ntransmission in poultry are the reasons for the strategy of mycoplasma freedom but this is often very difficult to \nimplement at the final production level due to  scale,  the need to source mycoplasma free stock, economic barriers, \nlack of insurance, existing infrastructure  and practises,  and/or current antibiotic usage.  Mycoplasma freedom has a \nfundamental problem  that the birds are totally susceptible to infection (and breaks may require culling).  \nSynergistic effects of mycoplasma infections with other \u201csimple/uncomplicated\u201d infections have been long \nrecognised but perhaps forgotten  (4). The chronic nature of mycoplasma infections in chickens and their propensity \nto make infections with NDV, IBV, AIV (especially H9), and APMV virus to trigger  diseases has  been \ndemonstrated in laboratories. I ndee d it is very hard in the laboratory to produce respiratory disease with \nMycoplasma synoviae  without adding respiratory viruses or vaccines.  The effects of b acterial infections in chickens \nhave also been potentiated by mycoplasma infections.  In the field of ten many potential pathogens are present  and \ncan be identified but their  role in disease is difficult to ascertain.  For example , in b roilers in Germany \u201ccheesy \nbroilers \u201d (airsacculitis in the slaughter house) have been considered to be ORT for a long time but the potentiating 63rd WPDC/XXXIX ANECA  effect of MS has recently been considered.  Thus improvement of mycoplasma status can be seen as a massive \nimprovement in the overall health status o f breeders, layers or broilers  (by eliminating vertical transmission as no \nuseful immunity is passed to the broilers) . \nA good example is  the effect of LaSota NDV in broilers in the field.  The use of LaSota at 10 d  will need \nantibiotic administration at 18 d  in mycopl asma positive chicks  to dampen down post vaccinal reactions.  Obviously \nhere the antibiotics are not directly affecting the viral infection  component . Similarly  in long lived birds  coryza and \nfowl cholera are more chronic in mycoplasma infected b irds. These synergistic effects are seen with either MG \nand/or MS.  \nMG and MS field strain freedom has been successfully achieved by biosecurity in many areas including UK, \nUSA, and NZ.  Usually this has been in broiler segments although MG freedom  in egg production units is seriously \nattempted in some areas.  Some places have only effectively controlled MG including Israel, Iran, Brazil, Germany, \nFrance, the Netherlands and in the field by individual producers  elsewhere. In some areas they have cont rolled MG \nby ts -11 vaccination of breeders (best if they are MG free as DOC). MG only control can lead  to MS potentially \ncausing problems.  The MS status in many operations  is hard to tell because of antibiotic usage especially in lay.   \nMycoplasma vaccines that interfere with wild strain spread and maintenance will be more useful than ones that \njust ameliorate clinical signs (probably vaccines that induce mucosal immunity  are more efficient  than those  \npredominately  inducing  humoral antibody). A useful way to  look at the effects of these vaccines is that they increase \nthe resistance of the birds to infection with field strains. I f some producers are unwilling to participate in pathogen \ncontrol programmes they can  become significant pathogen reservoirs  (example  MS in layers) . Because of the large \nscale of poultry units sterilizing effects (for example total prevention of vertical transmission ) are more useful than \nreduction of vertical transmission  (1). These live mycoplasma vaccines differed from previous gener ations of \nvaccines in that they can di splace wild strains from farms; not always predicted in the laboratory where they can be \noverwh elmed in some challenge systems . Although vertical transmission of ts -11 has been suspected once it is not \nthe usual experience with ts -11(2,1) .  \n \nMATERIALS AND METHODS  \n \nMG and MS control by combined vaccination  with ts -11 and MSH  has been used in Australia , South Africa , \nJapan, Philippines, Argentina (layers only) , and Indonesia.  This strategy is particularly attractive as both \nmycoplasma infections have the same control strategy (antibiotic  strategy  for MS  control  may be incompatible  with \nlive vaccination for MG).   \n \nRESULTS AND DISCUSSION  \n \nIn Australia the strategy to develop mycoplasmal vaccines  was not an active decision to decrease antibiotic \nusage but a response to the emergence of tylosin resistance in MG in some large broiler integrations  in the mid \n1980s  (7). The vaccines ts -11 (MG) and MSH (MS) have been used extensively in layers and breeders in Australia \nfor the last twenty years and now most chickens (layers, breeders or broilers never have antibiotic at therapeutic \nlevels  even when in ovo vaccinated).  Concurrently c oryza was controlled by a vaccine; this vaccine is no longer \navailable but  coryza has not re -emerged as a big problem . Fowl cholera is still a problem on some sites especially \nthose with earthen floors (layers and breeders) and emerging in free range layers. Control of fowl c holera in organic \nbroilers has been done by vaccination with killed vaccine at day old and no antibiotics ( 6). Some other problems are \nre-emerging in free range layers including erysipelas  and spotty liver disease . \nA Japan ese trial successfully controlled egg apical abnormality (EAA) and improved production parameters in \nlayer s by adding MSH to a vaccination programme already containing ts -11 (5). No antibiotic was used.  This was \nmore effective that predicted in a laboratory challenge trial  presumably as the field challenge was lower  (3). \nIn some areas where MG is effectively controlled by a freedom strategy the addition of MSH vaccination has a \nsimilar impact (Arkansas trial, EU, Mexico and Iran) allowing massive antibiotic r eduction.  F strain vaccination of \nbreeders is not done in the USA and the addition of MSH to F strain could still see the vertical transmission of F \nstrain and the continued need for antibiotics around the third week in the broiler progeny.  \nMycoplasma vaccination with  these  live vaccines will only control mycoplasma infection and disease but \nclinicians in Australia, South Africa report that other infections behave more like uncomplicated diseases in \nmycoplasma vaccinated stock.   During a field trial in Indo nesia I saw a ts- 11 and MSH vaccinated flock with an egg \nproducti on drop associated with avian m etapneumovirus  (AMPV) seroconversion that had  minimal other clinical \neffects and did not require antibiotic treatment.  63rd WPDC/XXXIX ANECA  As producers  decrease antibiotic usage sometimes some previously uniden tified problems can emerge.  Most \ncommonly egg production drops that responded to tylosin coming into lay may not be mycoplasma  (in Argentina \nthese egg drops responded to amoycillin  in mycoplasma va ccinated birds ). Avian intestinal spirochaetosis \n(Brachyspira  spp.) infections will do this with little increase in mortality and mild diarrhoea (increase d second \nquality eggs with caramel shell stains).  Indeed I believe that until Brachyspira  in poultry r ecogniz ed in a country \nthen little effective limitation of antibiotic use has been done in layers.  Routine antibiotics  may be \ncontrolling /suppressing mycoplasma, salmonella, E. coli, Pasteurella , Avibacterium , \u201cspotty liver disease ,\u201d and \nother infections  (see Table 1) .  \n \nCONCLUSION  \n \nThe potentiating effect s of MG and MS infections on the impact of respiratory viruses (NDV, APMV and \nAIV) and b acterial respiratory diseases (coryza, EPEC, ORT and fowl c holera) are well recognized.  Effective \ncontrol of wild t ype mycoplasma infections offers chicken and egg producers great advantages in decreasing the \nneed for antibiotics and the impact of these infections. Although antibiotics are initially effective at controlling \nmycoplasma and bacterial respiratory diseases  in poultry , the development of resistance means that this is not \nsustainable even in the medium term.  The best long term strategies for mycoplasma control  in sites with potential \nchallenge  are live vaccines that are safe and prevent vertical transmission.  It is important to have criteria for  judging \nsuccess  of mycoplasma control programme and realize that vaccination must take into account antibiotic \ninterventions and other interactions.  These criteria will include biological and economic parameters.  The m ost \nimportant criteria for successful mycoplasma control in breeder operations is  the ability of the next generation to be  \nreared without  routine antimycoplasmal antibiotics at d  18 to 23.   \nSee http://www.bioproperties.com.au/vaccines/documents/DOC -Bulletin -2012- 01.pdf  \nIncreasingly , customers have an expectation that routine medication with antibiotics will not be used in the \nproduction of  their food. In the Australian egg and poultry industries , MG and MS vaccination facilitated this aim on \na country wide scale. Control of all the bacteria that had previously necessitated routine antibiotic administration \nwas the final piece in the puzzle (often MS being the last) for these industries to really come of age and wean \nthemselves  from routine administration of antibiotics .  \n \nREFERENCES  \n \n1. Barbour , EK, Hamadeh , SK, & Eidt , A. Infection and immunity in broiler chicken breeders vaccinated with \na temperature -sensitive mutant of Mycoplasma gallisepticum  and impact on performance of offspring.  Poult Sci. \n79:1730- 5 2000.  \n2. El Gazzar , M, Laibinis , VA, & Ferguson -Noel , N. Characterization of a ts -11-like Mycoplasma \ngallisepticum  isolate from commercial broiler chickens. Avian Dis .55:569. 2011.  \n3. Feberwee A, Morrow CJ, Ghorashi SA, Noormohammadi A & Landman WJM. Effect of a live \nMycoplasma synoviae vaccine on the production of eggshell apex abnormalities after a dual infection with M. synoviae and IBV D1466.  Avian Path. 38: 333-40. 2009.  \n4. Kleven, S. H., Multicausal Respiratory Diseases  in \u201cDiseases of Poultry \u201d Saif, Y. M., et al editors 12th \nedition  p. 1262- 6. 2008.   \n5. Ouchi, T., Munakata, Y., & Sakamoto, H. Application of Mycoplasma synoviae  vaccine (MSH) in layers \n58\nth WPDC p.111- 4, 2009.  \n6. Remington, B, Blackall,  P. & Turni , C. Control of fowl cholera mortality in a broiler operation . \nProceedings of the 61st WPDC p2  2012.  \n7. Whithear , KG, Bowtell,  DD, Ghiocas , E, & Hughes , KL. Evaluation and use of a micro -broth dilution \nprocedure for testing sensitivity of fermentative avian mycoplasmas to antibiotics. Avian Dis.  27:937-49. 1983 . \n \n \n  \n \n  \n 63rd WPDC/XXXIX ANECA  Table 1. Common reasons for antibiotic therapy in chickens . \n \nDisease/pathogen  Antibiotic use  Alternatives  Comments  \nMycoplasma \ngallisepticum (MG)  \n(CRD & suboptimal \nproduction)  Routine administration in \nlay and day 20- 22 in broilers \n(not penicillins or \nphosphomycin)  MG free replacement \nstock and vaccination \nwhere necessary  ts-11 in Breeders and layers  \n Antibiotic resistance  \nM. synoviae (MS)  \n(CRD, EAA, \nPeritonitis & \nsuboptimal production)  Routine administration in \nlay and day 20- 22 in broilers  \n(not penicillins or \nphosphomycin)  MS free replacement \nstock and vaccina tion \nwhere necessary  MSH in breeders and layers  \n Antibiotic resistance  \nCoryza  \n(A. paragallinarum ) Antibiotics when clinical \nsigns appear.  Vaccination  Synergistic effect with \nmycoplasma  \nFowl cholera  \n (P. multicoda ) Antibiotics supplementing \nvaccination.  Vaccination, concrete \nfloors and rodent \ncontrol. Stress \nminimization  Not all sites have this \nproblem.  Better \nunderstanding and vaccines \nneeded.  \nSalmonella  Suppression  Freedom (Biosecurity) \nand vaccination  Antibiotic resistance is \nproblem  \nE. coli  and ot hers Suppression  Hygiene and perhaps \nvaccination  Antibiotic resistance is \nproblem  \nRespiratory viruses \nand vaccines  \nNDV (esp LaSota), \nAPMV, IBV, H9,  Control of secondary \nbacterial infections including vaccine reactions.  Better or more \nappropriate vaccines  Synergistic effect with \nmycoplasma infections  \nRoutine antibiotics 8 -10 \ndays post vaccination  \nBrachyspira spp. (egg \ndrop and diarrhoea)  Cryptic; often controlled by \nantibiotics targeting other \ninfections.  Water acidification?  Emergence with decreased \nantib iotic usage  \nImmunosuppressive \nviruses  Control of secondary \nbacterial infections  Biosecurity and \nvaccination  MDV, IBD, CAV, REV \nand others.  \n 63rd WPDC/XXXIX ANECA  USO PREVENTIVO DE UN PROGRAMA CON ADITIVO ANTI -\nMICOTOXINAS (A- AM) EN POLLO DE ENGORDA COMERCIAL  \n \nPREVENTIVE USE OF A PROGRAM BASED IN AN ANTI- MYCOTOXINS \nPROGRAM IN COMMERCIAL BROILER CHICKENS  \n \nM. Murillo, E.  Camacho,  E. Soto, D. Sarfati y B.  Lozano  \n \nLaboratorio Avimex  S.A. de C.V. J.I. Bartolache 1862. Colonia  del Valle.  \nDelegaci\u00f3n Benito Ju\u00e1r ez. 03100. M\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nDuring the first 21 days  of life of broiler chickens (PE), important events such as the development of immune \nand digestive systems occur. Damage to these organs and systems produced by the action of mycotoxins can impact \ntheir health and productive efficiency. The objective of t he present work is to present field results of the use of an \nanti-mycotoxins additive (A -AM) in the feed of  PE contaminated with mycotoxins. Results of mycotoxins \nmonitoring, productive development, post -vaccine serological response and histopathological d amage in lymphoid \norgans of birds fed a treated feed compared to birds fed a non -treated feed until 28 d  of age are presented. It is \nconcluded that the use of the A -AM in initial stages of the development of broiler chickens improved birds\u2019 health \nand in t urn their productivity.  \n \nRESUMEN  \n \nDurante los primeros 21 d\u00edas  de vida del pollo de engorda (PE) ocurren eventos importantes como lo son el \ndesarrollo del sistema inmune y del aparato digestivo. Los da\u00f1os a estos \u00f3rganos y sistemas producidos por la acci\u00f3n  \nde las  micotoxinas pueden repercutir en su salud y eficiencia productiva. El objetivo de este trabajo es presentar \nresultados de campo del uso de un aditivo anti -micotoxinas (A -AM) en alimento de PE contaminado con \nmicotoxinas. Se presentan los resultados  del monitoreo de micotoxinas, del desarrollo productivo, de la respuesta \nserol\u00f3gica postvacunal y del da\u00f1o histopatol\u00f3gico en \u00f3rganos linfoides comparando las aves con alimento tratado y \nsin tratamiento hasta los 28 d \u00edas de edad. Se concluye que el uso de  este A -AM en etapas iniciales de desarrollo en \npollo de engorda mejoro la salud de las aves y con ellos su productividad.   \n \nINTRODUCCI\u00d3N  \n \nLas micotoxinas son metabolitos de hongos  toxig\u00e9nicos  que se desarrollan en los cereales y oleaginosas con \nlos que se elaboran los alimentos balanceados de las av es. Estas v ar\u00edan en  toxicidad y tropismo para la afecci\u00f3n de \ntejidos y \u00f3rgano s blanco  de organismo, y existen  factores que i nfluencian  el impacto de las micotox inas en las aves \ndom\u00e9sticas , tales como: el tipo  y concentraci\u00f3n de las micotoxinas en la raci\u00f3n, duraci\u00f3n de la exposici\u00f3n, el \nsinergismo entre ellas, el fin zoot\u00e9cnico, la raza, etapa de producci\u00f3n y otros como la nutrici\u00f3n, el estado de salud, \ncondiciones de producci\u00f3n  y otros. S e ha reportado que las aves j\u00f3venes son m\u00e1s susceptibles a la exposici\u00f3n a \nniveles bajos y continuos de micotoxinas que las aves adultas, quiz\u00e1s debido a la carga metab\u00f3lica a la que est\u00e1 \nsometida este tipo de aves.  \nDurante los primeros 21 a 25 d\u00edas de vida del pollo de engorda  ocurren eventos importantes  en el organismo de \nlas aves , como lo son el desarrollo del sistema  m\u00fasculo -esquel\u00e9tico, del sistema  inmune y del aparato digestivo, por \nlo que si se ocasionan da\u00f1os a estos tejidos, \u00f3rganos y sistem as durante esta fase de desarrollo acelerado, es tos \nrepercutir\u00e1n  en la  salud y eficiencia productiva de las aves y con ello en su rentabilidad . \n \nOBJETIVO  \n \nValorar el efecto de la adici\u00f3n de un aditivo anti -micotoxinas ( A-AM) en el alimento pre -iniciador e iniciador \nde parvadas de pollo de engorda comercial,  sobre la integridad de su s \u00f3rganos linfoides, respuesta sero l\u00f3gica y \npar\u00e1metros productivos .  \n 63rd WPDC/XXXIX ANECA  MATERIALES Y M\u00c9TODOS  \n \nSe trabaj\u00f3 con d os parvadas comerciales de pollo de engorda, dnde  a una de ellas se le adicion\u00f3 un producto \ncomercial aditivo a nti-micotoxinas (Mycoad\u00ae ZT, Special Nutrientes, Inc.), en el alimento. Se consider\u00f3 un grupo \ncontrol n egativo (sin A -AM) con una poblaci\u00f3n de 400,000 aves, as\u00ed como un grupo en tratamiento en s u alimento \ncon una poblaci\u00f3n de 80,000 aves, donde se utiliz\u00f3 el A-AM de 0 a 21 d\u00edas  de edad, equivalente a consumo de  1.0 \nkg de alimento  / ave, a dosis de 0.5 k g de A -AM / Ton de alimento . Se realiz\u00f3 el m anejo zoot\u00e9cnico habitual de la \ngranja y se utilizaron p rogramas preventivos y de inmunizaci\u00f3n similares  para ambos grupos.  \nPruebas de l aboratorio. Muestreo serol\u00f3gico, 15 sueros por grupo a  21 y 28 d\u00edas de edad, para correr pruebas \nde inhibici\u00f3n de la h emoaglutinaci\u00f3n de enfermedad de Newcastle  (HI-EN). Muestreo histopatol\u00f3gico,  de cinco  \naves reci\u00e9n sacrificadas a 7, 14, 21 y 28 d\u00edas  de edad, con muestras de: timo, bolsa de Fabricio, bazo, m \u00e9dula \u00f3sea,  \nh\u00edgado, r i\u00f1\u00f3n y duodeno.  Pruebas de ELISA  para m icotoxinas  (R-biopharm) : ocratoxina  A (OCR A); T2 toxina (T -\nT2); vomitoxina (DON) y fumonisina B1 (FB1) . \nMedici\u00f3n de par\u00e1metros p roductivos . Para cada grupo se pesaron 100 aves de forma semanal y se obtuvo la \nganancia diaria de p eso (GDP) a la tercera y cuarta semanas  de edad . Se registr\u00f3  el consumo de alimento y con el \npeso corporal se determinaron la eficiencia a limenticia (EA) y la conversi\u00f3n a limenticia a la tercera y cuarta \nsemana s de edad .  \n \nRESULTADOS  \n \nLos resultados serol \u00f3gicos a la prueba de HI -EN expresados en L og2, reportaron pa ra el grupo control n egativo \nt\u00edtulos promedio a 21 y  28 d\u00edas  de edad de: 3.7 y 3.6 L og2 respectivamente , mientras que el grupo en tratamien to \ncon el A -AM report\u00f3 t\u00edtulos de 5.6 y 7.1 L og2 a las mismas edades.  \nLos estudios histopatol\u00f3gicos  a 21 d\u00edas de edad reportaron  en el grupo c ontrol n egativo, irregularidad en la \ncantidad del tejido linfoide maduro en los tim os, mientras que  los otros \u00f3rganos muestreados no se observaron \ncambios patol\u00f3gicos aparentes.  El grupo co n tratamiento con A -AM no mostr\u00f3 cambio s patol\u00f3gicos aparentes en \nninguno de  los \u00f3rganos muestreados a las distintas edades.  \nA la prueba de ELISA  con los k its de R -biopharm, se reportaron los siguientes niveles de micotoxinas tanto en \nalimento pre -iniciador como en el iniciador  (Cuadro 1).  \nLos resultados  de los par\u00e1metros productivos entre los distintos grupos , se d escriben en el siguiente cuadro  \n(Cuadro 2).  \n \nDISCUSI\u00d3N  \n \nLos resultados de ELISA  mostraron la presencia de diferentes niveles de micotoxinas  en los alimentos pre -\niniciadores e inicia dores, principalmente del tipo f usariotoxinas , que la literatura tradicionalmente considera como \nniveles bajos o aceptables en los alimentos para l as aves. N o obstante, en nuestra pr\u00e1ctica profesional hemos \nobservado que estos niveles de contaminaci\u00f3n representan riesgos y p\u00e9rdidas para las granjas av\u00edcolas, quiz\u00e1s por no \nanalizar otras micotoxinas presentes en los alimentos, o bien, porque los niveles \u201creales \u201d de micotoxinas en los \nalimentos son superiores a los encontrados en las pruebas. Por lo anterior, cuando encontramos  niveles de \nmicotoxinas de alg\u00fan tipo, lo interpretamos como indicador de que esos insumos o alimentos terminados tuvieron \nlas condiciones  necesarias para la proliferaci\u00f3n f\u00fangica  y para la s\u00edntesis de micotoxinas, por lo que puede  haber \nmayores contaminaciones a las encontradas en los an\u00e1lisis de escrutinio.   \nEn cuanto a los par\u00e1metros zoot\u00e9cnicos medidos, el grupo c ontrol sin A -AM, present \u00f3 menor productividad al \njuzgar por la ganancia diaria de peso, la eficiencia y la convers i\u00f3n alim enticia. As\u00ed mismo, este mismo grupo c ontrol \npresent\u00f3 menor respuesta serol\u00f3gica (HI-EN) y da\u00f1o histopatol\u00f3gico en \u00f3rganos linfoides , especialmente en t imos  a \n21 d\u00edas  de edad . Adicionalmente en las observaciones de campo,  se reportaron lesiones en cavidad oral  (tipo T -T2 o \ntricoticenos ), de moderadas a graves muy evidentes en el  grupo c ontrol desde los 15 d\u00edas  de edad , mismas que n o se \nreportaron en el grupo en  tratamiento con el A -AM. \n \nCONCLUSI\u00d3N  \n \nEl uso del  A-AM empleado en esta prueba de campo en las etapas iniciales de desarrollo en el pollo de \nengorda , previno el da\u00f1o por micotoxinas presentes en alimento y con ello, mejor\u00f3 su productividad.   \n \n 63rd WPDC/XXXIX ANECA  REFERENCIAS  \n \n1. Campbell, M.L. Evaluation of im munity of young broiler chickens during simultaneous aflatoxicosis and \nochratoxicosis.  Poulty Science 62: 2138- 2144.  \n2. Corrier, D .E. Mycotoxicosis: mechanisms of immunosuppression.  Vet. Immunol. Immunopathology . 30: 73-\n87. 1983.  \n3. Gimeno , A. y Martins , M.L. Problemas de micosis y mycotoxicosis en polllos. In: www.mycotoxin.com  p \n1-44. 2000.  \n4. Hoerr, F.J. Micotoxicoses. In: Diseases of Poultry. 12th edition. Edited by Y.M. Saif, A.M. Fadly, J.R. \nGlisson, L.R. McDougald , L.K. Nolan and D.E. Swayne. Iowa State University Press. pp 1197 -1229. 2008.  \n5. Leeson , S, Diaz , G.J. and Summers , J.D. Poultry metabolic disorders and mycotoxins. University Books. \nGuelph, Ontario, Canada. 1995.  \n6. Zaviezo , D. Impact of molds and mycotoxins i n poultry nutrition. Veterinaria Feed Hygiene. Monograf\u00eda \nIV Miedzynarodowa Conferencia Naukowa 29-33 p. Uniwersytet Warminsko -Mazurski. Olsztynie, Poland.  2004.  \n \n \nCuadro 1.  \n \n \nTipo de Alimento  Niveles y tipos de Micotoxinas  \nGrupo Control Negativo  Grupo en tratamiento con A -AM \nT-T2 OCRA  DON  FB1 T-T2 OCRA  DON  FB1 \nppb ppb ppb ppb ppb ppb ppb ppb \nAlimento  \nPre-iniciador  10.37  1.38 760 1250  28.40  2.82 770 1060  \nAlimento \nIniciador  18.12  1.32 520 1050  35.76  5.19 480 2330  \n \n \n \nCuadro 2.  \n \n \nEDAD  \n(d\u00edas)  Resultados Productivos  \nGrupo Control Negativo  Grupo en tratamiento con A -AM \nPeso  GDP  E.A.  C.A.  Peso  GDP  E.A.  C.A.  \ng g   g g   \n21 d\u00edas  755 35.9 0.54 1.41 828 39.4 0.67 1.24 \n28 d\u00edas  1223  43.8 0.71 1.72 1337  47.8 0.85 1.57 \n \n \n   63rd WPDC/XXXIX ANECA  \n INFLUENZA AVIAR A/ H7N3 DE ALTA PATOGENICIDAD EN \nZANATES  (QUISCALUS MEXICANUS ) EN LA R EGI\u00d3N DE LOS \nALTOS DE JALISCO , M\u00c9XICO  \n \nHIGH PATH AVIAN INFLUENZA A/H7N3 IN GREAT-TAILED \nGRACKLES IN THE ALTOS DE JALISCO REGION, MEXICO \n \nNavarro -L\u00f3pez , R.A,  V\u00e1zquez -Mendoza,  L.F.A, Villarreal Ch\u00e1vez,  C. L.A, Casaubon y Hugueni n, M. T.B y \nM\u00e1rquez Ruiz,  M. A.B* \n \nADirecci\u00f3n General de Salud Animal del SENASICA /SAGARPA \nBFacultad de Medicina Vet erinaria y Zootecnia de la UNAM  \n*Autor encargado de la correspondencia \n \nSUMMARY  \n \nThe present report describes by the first time the presence of an infection in wild endemic birds and \nparticu larly in the Great -tailed Grack le (Quiscalus mexicanus ), produced by a high path avian i nfluenza \northomyxovirus Ty pe A, Subtype H7N3, during the avian i nfluenza epizootic occurred in June -October, 2012 \nin Los Altos de Jalisco region, Mexico, which is a highly significant poultry area. The Great -tailed Grackle \npopulation has been l argely increased due to the intense agricultural and livestock activities and by the human \nactivity, situation that has fa cilitated its expansion through out North, Central America and Northern South \nAmerica in diverse ecological systems. The infectious -epidemiological role of the Great -tailed Grackle is \nunknown, as well as, its role as avian i nfluenza virus reservoirs and as other infectious diseases disseminators . \nBecause the huge impact that avian i nfluenza has on fo od production, on the economic  activity  of the effected \ncountries and on the animal and human public health, it is necessary to learn more, in order to clarify the \nsignificance of wild bird population living in the vicinity and around the commercial poultry farms and in the \nbackyard poultry population.  \n                   \nRESUMEN  \n \n El presente reporte cient\u00edfico describe por vez primera la infecci\u00f3n en aves silvestres end\u00e9micas en \nM\u00e9xico, en particular el caso del p\u00e1jaro zanate o quiscal mexicano (Quiscalus mexicanus), por el \northomyxovirus  de Influenza Aviar, Tipo A Subtipo H7N3 de alta patogenicidad (IAAP), durante la epizootia \nde IA de 2012 ocurrida en Los Altos de Jalisco, zona av\u00edcola de gran importancia en M\u00e9xico. La poblaci\u00f3n de zanates ha sido favorecida por las actividades agropecuarias y por la actividad humana, lo que le ha permitido \nextenderse territorialmente en numerosos y diversos ecosistemas de Norte, Centroam\u00e9rica y Sudam\u00e9rica. Se \ndesconoce el papel infecto -epidemiol\u00f3gico de los zanates y de la poblaci\u00f3n de aves nativas no mi gratorias de \nla regi\u00f3n, como posibles reservorios del virus de influenza aviar (IA) y como diseminadores de enfermedades infecciosas. Debido la enorme  importancia que la IA ostenta en la producci\u00f3n de alimentos, la econom\u00eda y la salud p\u00fablica animal y hum ana, es necesario profundizar su conocimiento con nuevos  estudios que permitan \nesclarecer su papel epidemiol\u00f3gico, al igual que el de otras aves residentes silvestres que viven en los alrededores de las granjas y que entran en contacto con aves explotadas  industrialmente y con aves de corral \nde traspatio.  \n \nINTRODUCCI\u00d3N  \n \nEn junio de 2012 se present\u00f3 en M\u00e9xico un brote  muy importante  de influenza aviar altamente pat\u00f3gena \ncausada por el virus H7N3, el cual afect\u00f3 severamente la industria av\u00edcola de la zona co n mayor producci\u00f3n \nde huevo para plato de M\u00e9xico, conocida como Los Altos, en el estado de Jalisco  (1).  \nDespu\u00e9s de un silencio epidemiol\u00f3gico de 17 semanas, en enero de 2013 la epizootia reemergi\u00f3  en una \nsegunda ola epizo\u00f3tica, extendi\u00e9ndose a los estados  de Aguascalientes, Guanajuato, Tlax cala y Puebla \nafectando aves criadas industrialmente y en aves de traspatio, es decir, en parvadas  de pollo de engorde , en   63rd WPDC/XXXIX ANECA  \n gallinas ponedoras de huevo para el plato, reproductoras pesadas, aves de traspatio,  gallos de combate y \ncodornices .  \nLas medidas de control del brote implementadas por los   servicios veterinarios fueron el sacrificio  de \naves y su disposici\u00f3n sanitaria, limpieza, desinfecci\u00f3n, vac\u00edo  sanitario, control de la movilizaci\u00f3n de animales , \nsus productos y subproductos. Adem\u00e1s, de una campa\u00f1a de vacunaci\u00f3n controlada con cepa hom\u00f3loga de \norigen pato inactivada y emulsionada en aceite.  \nLa regi\u00f3n de los Altos de Jalisco comprende 46 municipios  en 19,599 km2 (Figura  2), siendo la zona \nproductora de huevo m\u00e1s i mportante del pa\u00eds . Cuarenta y dos de sus municipios fueron declarados en \nCuarentena Interna  conforme a las disposiciones oficiales  emitidas por la SAGARPA el 8 de junio de 1998  \n(2). Existen en esta zona gran cantidad de granjas av\u00edcolas y abundantes cuerpos de agua, tanto natural como \nartificial, donde aves acu\u00e1ticas migratorias que entre oto\u00f1o y primavera habitan  buscando alimento , \ndirigi\u00e9ndose a territorios de cr\u00eda, o viajando a sitios de invernaci\u00f3n por la ruta migratoria del Pac\u00edfico  (3). De \nigual  forma  existe una poblaci\u00f3n importante de aves residentes silvestres que visitan  las granjas av\u00edcolas en \nbusca de alimento.  \nEn la semana epidemiol\u00f3gica 31 y 36 de 2012, en la poblaci\u00f3n de Tepatitl\u00e1n de Morelos, Jalisco, \nmunicipio donde se presentaron el ma yor n\u00famero de brotes IAAP H7N3 en aves reproductoras y de postura \nde huevo comercial, se present\u00f3 mortalidad de p\u00e1jaros silvestres conocidos como zanate mexicano ( Quiscalus \nmexicanus ). Esta ave se clasifica en el orden paseriforme de la familia icteridae (4). Originaria  de la vertiente \ndel Golfo de M\u00e9xico, s e sabe fue introducid a al centro del pa\u00eds en la \u00e9poca del octavo emperador azteca \nAhu\u00ed zotl, entre los a\u00f1os 1486 y 1502 (5). Dicha especie se ha extendido a toda la Rep\u00fablica Mexicana,  a 21 \nestados de la Uni\u00f3n Americana y a tres provincias Canadienses  (6,7) . Asimismo, se halla a todo lo larg o de \nCentroam\u00e9rica llegando hasta Colombia , Venezuela, Ecuador  y Per\u00fa (8). Existe consenso que su amplia \ndispersi\u00f3n se debe a su gran adaptabilidad y tolerancia a las condiciones urbanas. Otras fuentes de \naccesibilidad a alimento est\u00e1n asociadas con la producci\u00f3n agr\u00edcola y animal, donde hay abundancia de \ngranos y otros alimentos lo cual les permite una alim entaci\u00f3n segura y continua  (9). Otro s lugares donde se \nalimentan son los tiraderos de basura y la comida arrojada en la calle. Los estudios sobre la historia natural \ndel zanate demuestran que es un gran oportunista y que puede alimentarse de vertebrados, invertebrados, \ncrust\u00e1ceos peque\u00f1os y ot ros animales marinos, as\u00ed como de granos y frutos. Tiene preferencia por cuerpos de \nagua como presas, bordos, diques y pantanos, porque les proporcionan una fuente de alimento constante. Se \nha demostrado que el Quiscalus mexicanus  puede ser portadore s de la salmonel la (10) y que presentan \nseroconversi\u00f3n a los virus de influenza aviar de baja patogenicidad  H5 y enfermedad de Newcastle (11). En \nM\u00e9xico, esta especie se vio involucrada en la transmisi\u00f3n del virus del O este del Nilo  (12).  \n \nMATERIALES Y M\u00c9TODOS  \n \nDurante el brote del a\u00f1o 2012 en Jalisco, en la semanas  31 y 36 en un parque deportivo p\u00fablico de la \nciudad de Tepatitl\u00e1n de Morelos , de nombre \u201cUnidad Deportiva Morelos\u201d con Coordenadas LN 20\u00b0 \n48\u00b417.22\u201d LW 102\u00b0 45\u00b448.12\u201d se identific\u00f3 por  las autoridades  veterinarias  del Servicio Nacional de Sanidad \nInocuidad y Calidad Agroalimentaria (SENASICA)  la presencia de aves silvestres muertas y aves enfermas \ncon dificultad para volar. En la investigaci\u00f3n epidemiol\u00f3gica se comprob\u00f3 que las aves correspond\u00edan a la \nespecie Quiscalus mexicanus . De acuerdo a la historia cl\u00ednica con n\u00famero de casos CPA -16126- 12 y 16172-\n12 se encontraron diez aves, de las cuales ocho estaban muertas, una presentaba signos de enfermedad y la \notra solo estaba impedida para volar. Las aves  muertas no se consideraron para la toma de m uestra por su \nestado deplorable de conservaci\u00f3n. El ave enferma present\u00f3 edema en la cabeza, cianosis, tort\u00edcolis y diarrea.  \nAmbas aves se sacrificaron para hacer el estudio post mortem. No se reportaron lesiones macrosc\u00f3picas. Se \ntomaron muestras de \u00f3rganos e hisopos traqueales y cloacales que se remitieron a los laboratorios oficiales de \ndiagn\u00f3stico de sanidad animal del SENASICA en Jalisco y ciudad de M\u00e9xico.  \nEn la semana 36 del 2012, durante una nueva invest igaci\u00f3n oficial en el parque deportivo de Tepatitl\u00e1n \ndonde se hab\u00edan presentado cinco semanas antes casos de IAAP, se detect\u00f3 otro zanate adulto enfermo, el cual \nse encontraba postrado, con incapacidad para volar, incoordinaci\u00f3n, dificultad para respirar ( boqueo) y diarrea \ncolor caf\u00e9 oscuro. En esta investigaci\u00f3n se localiz\u00f3  tambi\u00e9n otra ave muerta conocida como tordo (Molothrus \nsp) del orden Passeriformes  (13) en la cancha de futbol. Ambos ejemplares fueron llevados bajo estrictas \nmedidas de bioseguridad a l Laboratorio de Patolog\u00eda en el municipio de El Salto, en Jalisco para hacer la \nnecropsia y tomar muestras para estudios virol\u00f3gicos e histopatol\u00f3gicos. El zanate muri\u00f3 durante el traslado.  \nPosterior a la necropsia, se remitieron muestras de diez \u00f3rganos en formalina al 10% (enc\u00e9falo, pulm\u00f3n, tr\u00e1quea, h\u00edgado, coraz\u00f3n, proventr\u00edculo,  molleja, duodeno, intestino, p\u00e1ncreas) al Laboratorio de Patolog\u00eda   63rd WPDC/XXXIX ANECA  \n Aviar de la Facultad de Medicina Veterinaria y Zootecnia de la Universidad Nacional Aut\u00f3noma de M\u00e9xico \ncorre spondientes al caso 1056 -12. \nEn entrevista, personas responsables del parque y jardineros se\u00f1alaron la detecci\u00f3n frecuente de zanates \nenfermos y muertos en el parque deportivo y sus inmediaciones desde hac\u00eda seis semanas aproximadamente.  \nEsta instalaci\u00f3n se encuentra cercada en su totalidad y existe un solo acceso principal al p\u00fablico. El parque colinda en su parte posterior con un r\u00edo en donde abundan los \u00e1rboles denominados Ahuehuetes o Sabinos \n(Taxodium mucronatum ). En la cerca del parque existen \u00e1rboles denominados Benjaminas ( Ficus benjaminas ) \ndonde los zanates tienen sus nidos. Entre el r\u00edo y el campo deportivo existe un andador que lleva a una escuela \nde educaci\u00f3n preescolar. En los \u00e1rboles Ficus y en el piso se observaron dep\u00f3sitos abundantes de exc remento \nde zanate y plumas, confirmando que correspond\u00edan a los nidos donde pernoctan estas aves.  \nAl estudiar la relaci\u00f3n epidemiol\u00f3gica de granjas av\u00edcolas en el \u00e1rea perifocal,  existen dos granjas de gallinas \nde postura comercial de huevo para plato y u na de pollo de engorda en un radio menor a dos kil\u00f3metros \n(figura 4). La poblaci\u00f3n de aves de postura en ese momento era de 63 mil aves y 295 mil, ambas vacunadas \ncontra el virus H7N3.  \n  \nRESULTADOS  \n \nSe logr\u00f3 el aislamiento del virus H7N3en embri\u00f3n de pollo a partir de muestras  de \u00f3rganos e hisopo \ntraqueal del ave enferma y de \u00f3rganos del ave impedida para volar de los casos CPA -16126- 12 y 16172- 12 de \nla semana epidemiol\u00f3gica 31. Se llevaron a cabo las pruebas de secuenciaci\u00f3n, identificaci\u00f3n viral e \u00edndice de \npatogenicidad intravenosa, habi\u00e9ndose confirmado que se trat\u00f3 de una infecci\u00f3n por el virus H7N3 de alta \npatogenicidad. El virus result\u00f3 id\u00e9ntico al aislado en gallinas afectadas por la epizootia  de  IAAP.  \nEn el ave de la investigaci\u00f3n de la sem ana 36 caso CPA -19955- 12 y 1056- 12 de histopatolog\u00eda la FMVZ \nde la UNAM. El examen post -mortem revel\u00f3 en el p\u00e1jaro zanate, congesti\u00f3n y sufusiones en coraz\u00f3n y \nenteritis  (figura 3).  El resto de los \u00f3rganos no revelaron lesiones macrosc\u00f3picas . El resultado de la necropsia \ndel p\u00e1jaro tordo evidenci\u00f3 solamente un fuerte traumatismo craneoencef\u00e1lico.  \nLos resultados de los estudios de histopatolog\u00eda en el p\u00e1jaro zanate  determinaron una encefalopat\u00eda no \nsupurati va, hepatosis grasa severa y enteritis supurativa moderada con presencia de coccidias en cantidad \nmoderada. El resto de los \u00f3rganos no presentaron cambios patol\u00f3gicos significativos.  \nLos resultados de los estudios de histopatolog\u00eda en los \u00f3rganos del p\u00e1jar o tordo mostraron un proceso \nlinfoide de probable etiolog\u00eda neopl\u00e1sica en h\u00edgado y proventr\u00edculo. Se encontr\u00f3 obstrucci\u00f3n intestinal por nematodo y pre sencia de coccidias en duodeno.  \nMuestras de los mismos \u00f3rganos conservados en refrigeraci\u00f3n se remitieron  por separado con la \nfinalidad de conocer en que \u00f3rganos se encontraba el virus. Los laboratorios oficiales  LSB2 y LSB3 del \nSENASICA confirmaron el aislamiento viral de IAAP H7N3 de la muestra de coraz\u00f3n del zanate. Los \nresultados de virolog\u00eda del tordo f ueron negativos.  \nLos estudios de laboratorio confirmaron  la infecci\u00f3n por este virus en dos episodios con una diferencia \nde cinco semanas en aves silvestres residentes conocidas como zanate mexicano ( Quiscalus mexicanus ) en un \nparque p\u00fablico en la cabecera municipal de Tepatitl\u00e1n de Morelos de nombre \u201cUnidad Deportiva Morelos\u201d \ncon Coordenadas LN 20\u00b0 48\u00b417.22\u201d LW 102\u00b0 45\u00b448.12\u201d.  \nLos estudios epidemiol\u00f3gicos  no encontraron evidencia que las granjas av\u00edcolas cercanas hubieran \nestado infectadas. La aves de eng orda no se vacunaron contra esta enfermedad y no se reportaron casos en \naves de esta funci\u00f3n zoot\u00e9cnica durante la primera ola epizo\u00f3tica.  \n \nCONCLUSIONES  \n \nSe confirmaron en dos semanas epidemiol\u00f3gicas 31 y 36 que las aves de la especie Quiscalus mexicanus  \nenfermaron y murieron por el virus de influenza aviar H7N3 de alta patogenicidad. No fue posible demostrar que las granjas av\u00edcolas m\u00e1s cercanas fueran la fuente de infecci\u00f3n. Sin embargo el virus H7N3 AP causo una \nsevera epizootia en el municipio, lo que  hace pensar, que los p\u00e1jaros zanates se desplazan muchos kil\u00f3metros \nhacia las granjas o que en basureros se encontrara el virus por desechos de aves entre otras posibilidades \nsabiendo los variados h\u00e1bitos alimenticios del zanate. El \u00faltimo caso registrado  de IAAP H7N3 en 2012 en la \nprimera ola epizo\u00f3tica, se detect\u00f3 en esta especie silvestre (F igura 1).  \nEn general las aves silvestres han sido involucradas en la transmisi\u00f3n de diversas enfermedades, ya sea \ncomo reservorio o simplemente como transmisores mec\u00e1nicos de agentes infecciosos y parasitarios  (14). Pero   63rd WPDC/XXXIX ANECA  \n en el caso de la influenza aviar se ha demostrado que aves silvestres nativas residentes no migratorias pueden \nalbergar orthomyxovirus de baja patogenicidad  (15).  \nEl presente estudio se\u00f1ala por prime ra vez la afectaci\u00f3n por virus de influenza aviar de alta \npatogenicidad en aves de la especie Quiscalus mexicanus . Se demuestr a que el virus hace estados vir\u00e9 micos \npues se pudo aislar de \u00f3rganos y a partir de hisopos traqueales y cloacales. Se asume que la cadena de \ntransmisi\u00f3n de la enfermedad est\u00e1 cerrada, debido a que contiene los elementos necesarios para afirmar que \nexiste el mecanismo adecuado de transmisi\u00f3n de agentes infecciosos de aves enfermas a aves sanas. En este \ncaso, al menos de cinco semanas.  Por lo tanto, el virus de la IA y posiblemente otros agentes infecciosos \ntienen la capacidad para diseminarse por esta especie a las aves dom\u00e9sticas con los riesgos que esto implica \npara la avicultura. El Quiscalus mexicanus , por los h\u00e1bitos y caracter\u00edst icas ya se\u00f1aladas, es un asiduo \nvisitante de las granjas av\u00edcolas en M\u00e9xico junto a otras aves residentes  (16).  \nActualmente persiste la circulaci\u00f3n del virus de IAAP en cuatro entidades del pa\u00eds, por lo que es \nnecesario profundizar en la investigaci\u00f3n del  papel infecto -epidemiol\u00f3gico del zanate y su posible \nparticipaci\u00f3n como reservorio del virus, al igual que otras aves nativas residentes que viven en los alrededores \nde las granjas av\u00edcolas. Se sabe que el riesgo de transmisi\u00f3n de la IA depende de la prev alencia del virus en \nlos hospedadores reservorio (17), por lo que es urgente la necesidad de identificar y entender c\u00f3mo participan \nlos p\u00e1jaros zanates y posiblemente otras aves silvestres residentes en la transmisi\u00f3n de la enfermedad, \nelemento epidemiol\u00f3g ico fundamental para el dise\u00f1o de estrategias de control y erradicaci\u00f3n de la influenza \naviar en M\u00e9xico.  \nREFERENCIAS  \n \n1. UNA. (2013). Uni\u00f3n Nacional de Avicultores. Recuperado el 23 de Agosto de 2013, de Situaci\u00f3n de \nla Avicultura Mexicana: http://una.org.mx/2013/avicultura -mexicana.html  \n2. SAGARPA. (8 de junio de 1998). Establecimiento de cuarentenas para animales y sus productos. Norma Oficial Mexicana NOM -054-ZOO -1996. Diario Ofici al de la Federaci\u00f3n.   \n3. Western Hemisphere Shorebird Reserve Network. (2009). Shorebird migration flyways. Recuperado \nel 22 de Agosto de 2013, de http://www.whsrn.org/western -hemisphere -shorebird -reserve -network.  \n4. CONABIO. (19 de Agosto de 2009). Quiscalus mexicanus (zanate mexicano) residencia \npermanente. Distribuci\u00f3n. Recuperado el 22 de Agosto de 2013, de Cat\u00e1logo de metadatos \ngeogr\u00e1ficos. Comisi\u00f3n Nacional para el Conocimiento y Uso de la Biodiversidad: \nhttp://www.conabio.gob.mx/informacion/metadata/gis/quis_mexigw.xm  \n5. Gurrola Hidalgo, M., S\u00e1nchez Hern\u00e1n, C., & Romero Almaraz, M. (2009). Dos nuevos registros de \nalimentaci\u00f3n de Quiscalus mexicanus y Cyanocorax sanblasianus en la costa de Chamela, Jalisco, \nM\u00e9xico. Acta zool\u00f3gica mexicana, Acta Zool. Mex v.25 n.2 Xalapa.  \n6.  Wehtje, W. (26 de Septiembre de 2003). The range expansion of the great -tailed grackle (Quiscalus \nmexicanus) in North America since 1880. Recuperado el 22 de Agosto de 2013, de Journal of \nBiogeography: http://onlinelibrary.wiley.com/doi/10.1046/j.1365 -2699.2003.00970.x/abstract  \n7. Geoffrey S. LeBaron, What we're learning: Range Expansion of Boat -tailed and Great -tailed \nGrackles, The Christmas Bird Count, National Audubon Society. In \nhttp://web4.audubon.org/bird/cbc/WWL -Grackles.html  \n8. BirdLife International 2012. Quiscalus mexicanus. In: IUCN 2013. IUCN Red List of Threatened Species. Version 2013.1.  www.iucnredlist.org>. Downloaded on 21 October 2013.  \n9. Instituto Nac ional de la Biodiversidad de Costa Rica Quiscalus mexicanus  (Gmelin, 1788) In \nhttp://darnis.inbio.ac.cr/FMPro? -DB=ubipub.fp3& -lay=WebAll& -Format=/ubi/detail.html& -\nOp=bw&id=3393& -Find \n10. Minott Picado P., Caballero Castillo M. Determinaci\u00f3n de Salmonella Spp.  y Endopar\u00e1sitos en \nZanates (Quiscalus Mexicanus) del Parque de Ca\u00f1as, Guanacaste Rev. costarric. salud p\u00fablica, dic. 2007, vol. 16 no. 31 p. 27- 35. ISSN 1409 \u2013 1429.  \n11. Escobar, Luis E. Anticuerpos circulantes contra Influenza Aviar y Newcastle en zanates (Q uiscalus \nmexicanus) de la ciudad de Guatemala. REDVET. Revista electr\u00f3nica de Veterinaria 1695 -7504 \n2011 Volumen 12 N\u00famero 3http://www.veterinaria.org/revistas/redvet/n030311.html  \n12. Guerrero -S\u00e1nchez, S., Cuevas -Romero, S., Nemeth , N. M., Trujillo -Olivera, M., Worwa, G., Dupuis, \nA., y otros. (2011). West Nile Virus Infection of Birds, Mexico. Emerging Infectious Diseases, Vol. 17, No. 12.  \n13. Hub\u00e1lek, Z. (2004). An Annotated Checklist of Pathogenic Microorganisms Associated With \nMigrat ory Birds . Journal of Wildlife Diseases, 40(4), 2004, pp. 639\u2013 659.   63rd WPDC/XXXIX ANECA  \n 14. H\u00e9naux V, Samuel, V., Samuel, M., Dusek, R., Fleskes, J., & Ip, H. (2012). Presence of Avian \nInfluenza Viruses in Waterfowl and Wetlands during Summer 2010 in California: Are Resident Birds  a Potential Reservoir? PLoS ONE, Volume 7 Issue 2 e31471.  \n15. Garc\u00eda Espinoza, G. (2007). Papel de las Aves Silvestres en la Bioseguridad de las Granjas.  M\u00e9xico: \nFMVZ - UNAM.  \n16. CONABIO http://avesmx.conabio.gob.mx/verave?ave=1860 \n17. Garamszegi, L. Z., & Pape M\u00f8ller, A. (2007). Prevalence of avian influenza and host ecology. \nProceedings of the Royal Society . B , 274, 2003 \u20132012.  \n \n \n \nFigura 1.  \n \n \n  \n \n \n  \n \n \n \n \n  \n \n \n \n   63rd WPDC/XXXIX ANECA  \n Figura 2.  \n \n \n \n \n \nFigura 3.  a) H\u00e1bitat del zanate. b) Zanate enfermo. c) Revisi\u00f3n cl\u00ednica. d) Transporte al laboratorio. e) \nInicio de necropsia. f) Toma de muestra con hisopo cloacal. g) Molleja y proventr\u00edculo SCPA. h) Intestino \ndelgado con edema y hemorragia. i) Coraz\u00f3n con conges ti\u00f3n y zonas hemorr\u00e1gicas de donde se aisl\u00f3 IAAP \nA/H7N3.  \n \n \n   63rd WPDC/XXXIX ANECA  \n  \n Figura 4.  Relaci\u00f3n epidemiol\u00f3gica del h\u00e1bitat de zanates infectados con IAAP H7N3 y granjas av\u00edcolas \ncomerciales de Tepatitl\u00e1n de Morelos, Jalisco.  \n  \n \n 63rd WPDC/XXXIX ANECA  CHARACTERIZATION OF BACTERIAL COMMUNITIES AND \nCLOSTRIDIUM PERFRINGENS  POPULATIONS IN THE \nINTESTINES OF BROILER CHICKENS FED DIETS \nSUPPLEMENTED WITH VIRGINIAMYCIN OR BACITRACIN \nMETHYLENE DISALICYLATE USING 454 PYROSEQUENCING \nAND QUANTITATIVE PCR  \n \nCARACTERIZACI\u00d3N DE LAS COMUNIDADES BACTERIANAS Y LAS \nPOBLACIONES DE CLOSTRIDIUM PERFRINGENS  EN LOS INTESTINOS DE \nLOS POLLOS DE ENGORDA ALIMENTADOS CON DIETAS \nSUPLEMENTADAS CON VIRGINIAMICINA O METILENO DISALICILATO \nDE BACITRACINA (BMD) UTILIZANDO 454 PIROSECUENCIACI\u00d3N  \nY PCR CUANTITATIVA  \n \nA. P. Neumann and G. Suen  \n \nDepartment of Bacteriology, University of Wisconsin \u2013  Madison, Madison, WI 53706, United States  \n \nRESUMEN  \n \nQuinientos ( 500) pollos de engorda Cobb se criaron en condiciones simuladas de producci\u00f3n comercial, y \nrecibieron una de tres dietas: control sin medicaci\u00f3n, complementada con BMD o complementada con \nvirginiamicina. Se colectaron tractos gastrointestinales de diez pollos de engorda de cada diet a a los 45 d \u00edas despu\u00e9s \ndel nacimiento durante tres ciclos de engorda consecutivos para obtener un total de 90 aves analizadas. El ADN \ngen\u00f3mico fue extra\u00eddo de contenido intestinal muestreado de una regi\u00f3n de aproximadamente seis pulgadas que \nrodea el divert\u00edculo de Meckel y ambos l\u00f3bulos cecales. PCR se utiliz\u00f3 para amplificar la regi\u00f3n V6 - V8 del gen 16S \nrRNA utilizando primers universales con c\u00f3digos de barras, y Taq polimerasa de alta fidelidad. Los amplicones \nfueron evaluados posteriormente para la cal idad, purificados y utilizados como plantilla para emPCR seguido por la \nrecuperaci\u00f3n de las cuentas (beads) y pirosecuenciaci\u00f3n. Los ADN de las 180 muestras (90 aves x 2 secciones intestinales) tambi\u00e9n fueron analizados mediante PCR cuantitativa espec\u00edfica  de Clostridium perfringens . Se \nobservaron diferencias significativas en la abundancia de los principales g\u00e9neros, as\u00ed como C. perfringens . \n \nSUMMARY  \n \nCobb 500 broiler chickens were raised under simulated commercial production conditions, and received one of \nthree diets; unmedicated  control, BMD supplemented, or v irginiamycin supplemented.  GI tracts were harvested \nfrom ten br oilers from each diet at 45 d  post-hatch during three consecutive grow -out cycles to give a total of 90 \nbirds analyzed.  Genomic DNA was extracted from intestinal contents sampled from an approximately six inch \nregion surrounding the Meckel's diverticulum and both cecal lobes.  PCR was performed to amplify the V6 - V8 \nregion of the 16S rRNA gene  followed by high- throughput DNA sequencing of the resulting amplicons using 454 \npyrosequencing.  DNAs from the samples, 90 birds x 2 gut sections,  were also analyzed using quantitative PCR \nspecifi c for Clostridium perfringens . The feeding of virginiamycin resulted in significant reductions in jejunal \nbacterial community diversity  compared to BMD, and significant reduction s in cecal bacterial community diversity  \ncompared to the unmedicated control.  Additionally, C. perfringens  levels in the ceca of BMD treated broilers were \nsignificantly reduced  compared to those receiving the virginiamycin treatment . \nCommercial broiler chickens are often fed diets supplemented with FDA approved antibiotics in order to \npromote intestinal health and function leading to improvements in production performance  (5). Two such antibio tics \ncommonly in use today are v irginiamycin (VM)  and bacitracin.  Both of these compounds preferentially target \nGram -positive b acteria, but act via entirely different mechanisms ( 1). Recently, a feeding trial was conducted to \nexamine the effects of raising consecutive flocks of broilers under built -up litter conditions where the previous flock \nhad received the same antibiotic as t he current flock ( 7). Although significant increases in feed efficiency associated 63rd WPDC/XXXIX ANECA  with V M compared to bacitracin methylene d isalicylate ( BMD ) were observed during the first flock, a trend toward \ncomparatively better performance associated with BMD supplementation was evident by flock three.  These effects \ncould be explained in part by significantly higher late mortality in the V M fed broilers du ring the third grow -out \ncoinciding with significantly higher levels of C. perfringens  in the litter of those pens.  From these results, it was \nhypothesized that V M has a broader range of activity, compared to  BMD, against bacterial populations that are \nimportant for protecting the host from opportunistic pathogens and that these effects are exacerbated in subsequent \nflocks raised in the same environment.  The purpose of this work was to test that hypothesis by characterizing the \ngastrointestinal tract bacterial community of mature broilers raised under the same conditions as the previous study \nusing 454 pyrosequencing and quantitative PCR . \n \nMATERIALS AND METHODS  \n \nAnimal treatments.  Three consecutive 45 d  simulat ed commercial grow -outs were conducted at Colorado \nQuality Research, Inc. (CQR) (Wellington, CO) between September 2012 and February 2013  with a do wn time of \napproximately two wk between flocks . For each grow -out at da y zero, five hundred and forty one d  old straight -run \nbroiler chickens (Cobb 500) were randomly allocated among three exper imental groups (180 birds/group).  The three \nexperimental groups were maintained in three individual floor pens within one environmentally controlled building.  \nFor all subsequent grow -outs, associations between each pen and its assigned experimental group were strictly \nmaintained and no further manipulations of the litter by the experimenters were performed other than occasional sample collections.  Chickens were fed basal starter (d 0 \u2013  17), grower (d 17 \u2013  30) and finisher (d  30 \u2013 45) diets \nmanufactured at the CQR feed mill using standard CQR formulated corn -soy diets representative of commercial \nbroiler production diets (Agristats Middle 50%).  Experimental groups consist ed of these diets supplemented with \neither; 50 g/ton  bacitracin methylene d isalicylate (BMD 50, Alpharma, Inc., Fort Lee, NJ), 20 g/ ton virginiamycin \n(Stafac, Phibro Animal Health, Teaneck, NJ ), or un -supplemented (unmed) . Feed and water were provided ad \nlibitum throughout  and all groups were administered  Inovocox EM -1 (Zoetis, Florham Park, NJ) vaccine in ovo for \ncoccidia control . \nSample collection.  At d  45 of each grow -out 10 broilers were randomly selected from each of the three \nexperimental groups for s ampling and euthanized via cervical dislocation.  Gastrointestinal tracts, from the duodenal \nloop to just past the ileocecal junction, were removed from each chicken prior to further dissection.  Contents were \ncollected from the jejunum and cecum diluted 5X in sterile 50 mM Tris -HCl + 50 mM EDTA  + 15 % sucrose buffer \n(pH = 8.0), thoroughly mixed, and frozen at - 20\u00b0C . In total, 180 samples (two intestinal sections times 30 birds \ntimes 3 grow -outs) were collected and subjected to further analysis by pyrosequencing and quantitative PCR.  \nDNA extraction.  DNA extraction was performed on 1 mL of diluted intestinal contents  using bead -beating, \nphenol:chloroform, and alcohol precipitation based upon procedures  previously described ( 15). \n16S library preparati on and pyrosequencing.  PCR amplification of the variable V6 -V8 region of the 16S \nrRNA gene for amplicon pyrosequencing was achieved using custom designed primers containing the Roche 454 A \nor B Titanium sequencing adaptors as described previously ( 10). \nQuantitative real -time PCR.  Two distinct probe -based  quantitative real -time PCR (qPCR) assays were \nemploye d to quantify the abundance of bacteria ( 17) and specifically Clostridium perfringens  (16) in each sample of \nintestinal contents in order to estimate the relative abundance of C. perfringens  in each sample.  Relative abundance \nof C. perfringens  in a sample was determined by dividing the average amount of C. perfringens  target observed for a \ngiven sample by the average amount of Bacterial target observed.  \nProcessing and analysis of pyrosequencing data.  Sequence processing was performed using the program \nmothur  v.1.31.2  (11). All subsequent OTU -based analyses were performed using a label of 0.03, meaning that \nsequences represented by a single OTU exhibited greater than or equal to 97% nucleotide identity.  Classification of \nOTUs was achieved using the Greengenes database ( 4) with a confidence level of at least 60 percent.  The following \nanalyses and statistical tests were performed within MOTHUR: Good\u2019s coverage, calculation of Shannon\u2019s and \nInverse Simpson\u2019s diversity indices, Bray -Curtis Index, unweighted pair group method with arithmetic mean \n(UPGMA) clustering , and principal component analysis (PCA) . \nStatistical analysis.  Pairwise comparisons of the mean diversity indices were performed using Student\u2019 s t-test \nin Microsoft\n\u00ae Excel 2010.  Pairwise comparisons of the distributions of C. perfringens  relative abundances were \nperformed using the Mann -Whitney (Sum of Ranks) test with the aid of the online tools at vassarstats.net.  \n \n  \n 63rd WPDC/XXXIX ANECA  RESULTS  \n \nA total of 1, 075,264 analyzable sequences were recovered from 179  total samples after processing using \nmother, with one sample removed due to anomalous results  (11). These sequences were approximately evenly \ndistributed among the three dietary treatments and three different grow -outs.  Average Good\u2019s coverages of 99. 7% \nand 9 8.4% were observed for the jejunum and cecum samples respectively indicating sufficient sampling depth for \nboth anatomical locations.  \nCommunity profile s, consisting of the complete set of sequences and their relative abundances, from each of \nthe 89  jejunum and 90 cecum samples were compared by both constructing a dendrogram using hierarchical \nclustering and a scatterplot based upon principal component an alysis (data not shown).  A clear segregation \ndepending on anatomical origin was observed using both methods indicating distinct bacterial communities in the \njejunum and cecum regardless of any other factor.  Neither method identified an association between community \nprofile and experimental treatment or grow -out. Lactobacillus  was observed to be the most abundant of the major \ngenera observed in the jejunum . Three families of bacteria , classified as Ruminococcaceae , Lachnospiraceae , and \nLactobacillaceae , consistently accounted for approximately 90% of t he total community in the cecum.  \nBacterial community diversity for each individual sample was assessed using two common metrics that \naccount for ecological richness and evenness, the Shannon index and Inverse Si mpson index . These results, in the \nform of m eans for each gut section from each treatment are presented  in table 1 . For both of these indices greater \nvalues correspond to higher diversity, or com munity complexity.  Statistical testing provided evidence in s upport of \ndifferences between certain groups of samples  (Table 1) . One such difference was observed in jejunum samples \nfrom the V M treated groups, mean Shannon = 0. 452, and jejunum samples from the BMD treated groups, mean \nShannon = 0. 704 (p-value = 0.0 45). Strong e vidence for reduced diversity in cecal bacterial communities of broilers \nfed V M compared with those receiving the unmed diet was also observed ( p-values of 0.0 002 and 0.0 012 for \ndifferences in mean Shannon and Inverse Simpson values respectively ). \nDespite the lack of specific community profile associations with particular  experimental treatments, differences \nin C. perfringens  populations among the groups were observed using quantitative PCR ( 16). To determine whether \nthese differences were significant , rank based statistics were performed.  A relative abundance of C. perfringens  was \ndetermined for each sample and the sample distributions for each of the different gut sections and experimental groups can be found in F igure 1 . Strong statistica l evidence for less C. perfringens  in the ceca of broilers fed BMD \ncompared to broilers fed VM  (p-value = 0.0035) was observed.  Weak statistical evidence for less C. perfringens  in \nthe ceca of broilers fed the BMD supplemented diet versus the unmedicated d iet w as also observed ( p-value = \n0.0891) . \n \nDISCUSSION  \n \nIncreased livestock feed efficiency associated with dietary antibiotic administration is well established ( 3, 5-9, \n13, 14), but exactly how this enhanced performance is connected to alterations in the composition of the \ngastrointestinal (GI) microbial community remains an open question.  Furthermore, studies aimed at elucidating the \neffects on subsequent flocks raised under built -up litter conditions are  relatively  rare. These studies are important \nbecau se of the links between the litter and gastrointestinal microbiotas and performance ( 2, 12, 14). In this study, \nseveral interesting differences were observed among the GI bacterial communities of broilers receiving V M, BMD, \nor an unmed  diet. \nAs has been reported previously for mature broilers  (2, 5, 6) , the results of this analysis clearly support distinct \nbacterial communities native to the small intestine compared with the cecum.  These differences were readily \napparent in the abundances of major bacterial  groups, and consisted of the numerical dominance of Lactobacillus  in \nthe jejunum while the cecum harbored two major families of Clostridia as well as a reduction in the abundance of \nLactobacillus .  An increased number of less abundant taxa was  also observed in the ceca of the chickens examined \nproviding further evidence for the greater overall community diversity reported previously for the cecum compared with the more proximal regions of the GI tract ( 6). \nDifferences in total community diversity among the three dietary treatments were observed in addition to the \nanatom ical differences mentioned  above . Based upon previous observations, it was hypothesized that V M has a \nbroader antimicrobial effect on the GI microbiota ( 7). The observations obtai ned here are generally supportive of \nthis prediction as diversity was statistically reduced in the jejuna and ceca of V M fed birds compared with those fed \nBMD  and the unmed diet  respectively . Despite these statistical differences, unique community profiles  associated \nwith either antibiotic or the unmed group were not identified.  This may be explained by the considerable inter -\nindividual variation observed, particularly in the presence and abundance of minor bacterial groups.  63rd WPDC/XXXIX ANECA  An organism of considerable conc ern for poultry producers is the opportunistic pathogen, Clostridium \nperfringens  (14). Previous work examining the effects of V M and BMD on consecutive flocks of broilers implicated \nC. perfringens  as potentially contributing to significantly greater late mortality in the third flock of broilers fed \nvirginiamycin ( 7). We utilized quantitative PCR to specifically detect and quantify this important pathogen in \ncontents from the jejunum and cecum  (16). The results indicated a significant reduction in the relative abundance of \nC. perfringens  in the ceca of BMD treated broilers compared to the unmed and V M groups (F igure 1 ). C. \nperfringens  is believed to reside primarily in the ceca of healthy broilers an d our results are in agreement with what \nhas been reported previously for bacitracin and its effect on C. perfringens  levels in broilers ( 14). \n \nACKNOWLEDGMENTS  \n \nThis study was funded with an industrial grant from Zoetis Animal Health.  The authors would like to thank the \nstaff at Colorado Quality Research who assisted with sample collection and members of the Suen lab, particularly \nKelsea Jewell and Kim Dill -McFarland, who provided advice regarding sequence processing and analysis.  \n \nREFERENCES  \n \n1. Butaye, P., L. A. Devriese, and F. Haesebrouck. Antimicrobial growth promoters used in animal feed: \neffects of less well known antibiotics on gram -positive bacteria. Clin. Microbiol. Rev. 16: 175 \u2013188. 2003.  \n2.   2. Cressman, M. D., Z. Yu, M. C. Nelson, S. J. Moeller, M. S. Lilburn, and H. N. Zerby. Interrelations \nbetween the microbiotas in the litter and in the intestines of commercial broiler chickens. Appl. Environ. Microbiol. \n76: 6572\u2013 6582. 2010.  \n3.   3. Danzeisen, J. L., H. B. Kim, R. E. Isaacso n, Z. J. Tu, and T. J. Johnson. Modulations of the chicken \ncecal microbiome and metagenome in response to anticoccidial and growth promoter treatment. PLoS ONE 6: \ne27949. 2011.  \n4.   4. DeSantis, T. Z., P. Hugenholtz, N. Larsen, M. Rojas, E. L. Brodie, K. Kell er, T. Huber, D. Dalevi, P. \nHu, and G. L. Andersen. Greengenes, a chimera -checked 16S rRNA gene database and workbench compatible with \nARB. Appl. Environ. Microbiol. 72: 5069 \u20135072. 2006.  \n5.   5. Dibner, J. J., and J. D. Richards. Antibiotic growth promoters i n agriculture: history and mode of \naction. Poult. Sci. 84: 634 \u2013643. 2005.  \n6.   6. Dumonceaux, T. J., J. E. Hill, S. M. Hemmingsen, and A. G. Van Kessel. Characterization of \nintestinal microbiota and response to dietary virginiamycin supplementation in the bro iler chicken. Appl. Environ. \nMicrobiol. 72: 2815\u2013 2823. 2006.  \n7.   7. LaVorgna, M., J. L. Schaeffer, D. Bade, J. Dickson, K. Cookson, and S. W. Davis. Performance of \nbroilers fed a broader spectrum antibiotic (virginiamycin) or a narrower spectrum antibiotic ( bacitracin methylene \ndisalicylate) over 3 consecutive grow -out cycles. J Appl Poult Res 22: 574\u2013 582. 2013.  \n8.   8. Lu, J., C. Hofacre, F. Smith, and M. D. Lee. Effects of feed additives on the development on the ileal \nbacterial community of the broiler chicke n. Animal 2: 669\u2013 676. 2008.  \n9.   9. Miles, R. D., G. D. Butcher, P. R. Henry, and R. C. Littell. Effect of antibiotic growth promoters on \nbroiler performance, intestinal growth parameters, and quantitative morphology. Poult. Sci. 85: 476\u2013 485. 2006.  \n10.   10. De O liveira, M. N. V., K. A. Jewell, F. S. Freitas, L. A. Benjamin, M. R. T\u00f3tola, A. C. Borges, C. A. \nMoraes, and G. Suen. Characterizing the microbiota across the gastrointestinal tract of a Brazilian Nelore steer. Vet. \nMicrobiol. 164: 307\u2013 314. 2013.  \n11.   11. Sc hloss, P. D., S. L. Westcott, T. Ryabin, J. R. Hall, M. Hartmann, E. B. Hollister, R. A. Lesniewski, \nB. B. Oakley, D. H. Parks, C. J. Robinson, J. W. Sahl, B. Stres, G. G. Thallinger, D. J. Van Horn, and C. F. Weber. Introducing mothur: open- source, platfo rm-independent, community- supported software for describing and \ncomparing microbial communities. Appl. Environ. Microbiol. 75: 7537\u2013 7541. 2009.  \n12.   12. Stanley, D., M. S. Geier, S. E. Denman, V. R. Haring, T. M. Crowley, R. J. Hughes, and R. J. \nMoore. Identi fication of chicken intestinal microbiota correlated with the efficiency of energy extraction from feed. \nVet. Microbiol. 164: 85 \u201392. 2013.  \n13.   13. Thibodeau, A., S. Quessy, E. Gu\u00e9vremont, A. Houde, E. Topp, M. S. Diarra, and A. Letellier. \nAntibiotic resistan ce in Escherichia coli and Enterococcus spp. isolates from commercial broiler chickens receiving \ngrowth -promoting doses of bacitracin or virginiamycin. Can. J. Vet. Res. 72: 129 \u2013136. 2008.  \n14.   14. Wei, S., A. Gutek, M. Lilburn, and Z. Yu. Abundance of pathog ens in the gut and litter of broiler \nchickens as affected by bacitracin and litter management. Vet. Microbiol. 166: 595 \u2013601. 2013.  63rd WPDC/XXXIX ANECA  15.   15. Weimer, P. J., D. M. Stevenson, D. R. Mertens, and E. E. Thomas. Effect of monensin feeding and \nwithdrawal on populations of individual bacterial species in the rumen of lactating dairy cows fed high -starch \nrations. Appl. Microbiol. Biotechnol. 80: 135\u2013 145. 2008.  \n16.   16. Wise, M. G., and G. R. Siragusa. Quantitative detection of Clostridium perfringens in the broiler \nfowl ga strointestinal tract by real- time PCR. Appl. Environ. Microbiol. 71: 3911\u2013 3916. 2005.  \n17.   17. Yu, Y., C. Lee, J. Kim, and S. Hwang. Group -specific primer and probe sets to detect methanogenic \ncommunities using quantitative real- time polymerase chain reaction . Biotechnol. Bioeng. 89: 670 \u2013679. 2005.  \n \nTable 1.  Mean Shannon and Inverse Simpson diversity among the three dietary treatments and statistical \npairwise comparisons . \n \n \nJ = jejunum, C = cecum  \nVM = virginiamycin (20 g/ton), BMD = bacitracin methylene d isalicylate (50 g/ton)  \np-value \u2264 0.05 in bold font (at least moderate evidence against H 0: \u00b51 = \u00b5 2) \n0.05 < p- value \u2264 0.10 in italicized  font (weak evidence against H 0: \u00b51 = \u00b5 2) \n \n \nFig. 1.  Distributions of C. perfringens  relative abundance in jejunum (J) and cecum (C) samples from broilers \nreceiving unmedicated feed (un med) or feed supplemented with virginiamycin (vir) or bacitracin methylene \ndisalicylate (bmd).  Significant differences were observed between cecal samples from broilers receiving bmd \ncompared to broilers receiving vir or unmedicated feeds (see text for details).  LOW indicates samples for which at \nleast one replicate, but not all three, was positive for C. perfringens  while ND indicates samples where none of the \nthree replicate reactions were positive.  \n \n Index shannon Invsimp shannon Invsimp Index shannon Invsimp shannon Invsimp\nunmedicated 0.47328 1.44804 2.21290 4.14345 unmed vs. VM 0.85814 0.84759 0.00019 0.00120\nVirginiamycin 0.45214 1.41758 2.00021 3.54295 unmed vs. BMD 0.08398 0.06354 0.05021 0.14166\nBMD 0.70435 1.81774 2.09416 3.87130 VM vs. BMD 0.04456 0.02899 0.11237 0.06820J CPairwise Comparisons (p-values)\nJ CMean diversity (All 3 Grow-outs)\n63rd WPDC/XXXIX ANECA  IMPACT OF LATE VS EARLY SUBCLINICAL COCCIDIOSIS ON \nECONOMIC PARAMETERS IN BROILER PRODUCTION  \n \nL. NewmanA, L. EtcharrenA, J. ArceB, R. TeeterC, and J. ArceoA \n \nAMerck Animal Health, Summit, NJ  \nBUniversidad Michoacana de San Nicol\u00e1s  de Hidalgo, Michoac\u00e1n, M\u00e9xico  \nCEmeritus Oklahoma State University, Stillwater , OK \n \nABSTRACT  \n \nThe impact of the timing of a mild, subclinical coccidiosis insult ( average Johnson and Reid lesion  score less \nthan 1.0) on economically significant production parameters was investigated.  Birds subjected to e arly subclinical \ncoccidiosi s (peak lesions prior to 28 d of age) and late subclinical  coccidiosis (lesions at 35 d and older) were \ncompared with respect to weight gain, feed conversion, feed cost per kg , energy utilization per kg, and  the yield of  \nboneless breast  and abdominal fat pad adjusted to target weight.  At a target weight of 2.5 kg (5.5 lbs), the late  \nsubclinical coccidiosis group h ad signi ficantly  lower  body weight,  longer  days to weight, higher  feed conversion, \nand higher  feed cost/kg  compared to the early subclinical coccidiosis group . At a target weight of 2.72 kg (6.0 lbs) \nthe late subclinical coccidiosis group had significantly lower b reast yield (as a percent of live weight) and \nsignificantly higher abdominal fat pad weight compared to the early coccidiosis group.  Very mild coccidiosis lesions \nduring the final weeks before slaughter have an adverse impact on weight gain, feed conversio n, feed cost and breast \nyield.  \n \nINTRODUCTION  \n \nThe ability of the broiler industry to control clinical coccidiosis depends upon either complete or partial \ndevelopment of immunity to important  Eimeria  spp. (E. acervulina, E. maxima, E. tenella ) that are ubiquitous in \nbroiler production.  Complete immunity is developed through live Eimeria  vaccination programs, while ionophore \nanticoccidial programs  often  depend upon a combination of immunity1 and suppression of Eimeria  growth through \ntransmembrane ion conc entration disruption  in the parasite2 to control clinical infection.   \nBoth coccidiosis control methods result in  low-level, subclinical cocci diosis with potential to induce a mild, \ntransient depression of growth and feed efficiency  at different time points in the broiler growth curve . Live Eimeria \nvaccination can subtly slow g rowth during the first three wk, followed by compensatory gain  during the fourth w k \nand beyond, creating a steeper growth curve.  Ionophore medication programs are subject to Eimeria  that escape the \nsuppressive effects of the drugs and build to levels that can slow growth in a portion of the broiler population after \nthe first four wk . The interaction of the timing of a mild, transient subclinical coccidiosis infe ction and broiler \nweight gain and feed efficiency has previously been described by Teeter but the impact on other important \nprofitability v ariables such as carcass quality  has not been previously investigated  (3). \n \nMATERIALS AND METHODS  \n \nNine hundred female Ross 308 broilers were  randomly  divided into two treatment groups in a rando mized \nblock design with nine  replicate  pens of 50 birds per treatment group.  Half of the birds were vaccinated at one d  of \nage with a live coccidiosis vaccine (Coccivac\u00ae-B, MSD Animal Health) to  induce mild, transient, subclinical \ncoccidios is lesions in the first four wk  of growth , and half of the birds were subjected to a very mild mix ed coccidia \nchallenge at 28 d  of age, to slow growth during the final wk before slaughter a t 49 d of age.  All bir ds were fed the \nsame unmedicated starter,  grower  and finisher rations . Early e xposure to coccidiosis  in the late subclinical challenge \ngroup  was prevented by the use of toltrazuril in the drinking wate r until 28 d  of age . \nBody weight and feed consumption were calculated weekly by pen. Coccidiosis lesion scores (Johnson & \nReid4 gross lesions and microscopic E. maxima ) were determined in two random bi rds per pen each wk from d  \nseven through slaughter  (5). At 21, 28, 35 and 42 d  of age, t he same two  birds were also weighed and breast muscle \nand abdominal fat pad grams were determined.  At 49 d of age, all birds were individually weighed.  Two random \nbirds per pen were subjected to yield determination, including the weights of carcass, breast  with and without bone, \nleg and thigh with and without bone, wing, abdominal fat, neck, and head.  \n 63rd WPDC/XXXIX ANECA  STATISTICAL ANALYSIS  \n \nStatistical analysis was performed using Least Squares Means and Duncans Multiple Range Test via SAS \nstatistical software.  Weight and feed efficiency analyses were adjusted to common target weights based upon \nregression analysis of pens over all age groups.  Carcass composition for breast and abdominal fat were adjusted to \ncommon target weights using  regression analysis of bird s selected for carcass composition determination  over \nweekly  age groups beginning at 21 d of age.  \n \nRESULTS AND DISCUSSION \n \nTwo different coccidiosis lesion patterns were successfully induced, with mild peak Eimeria  lesion scores of \nless than 1.0 based upon the Johnson and Reid gross lesion score system, or the Diseases of Poultry  microscopic \nlesion score system (Figures 1 and 2).  Both treatment groups were subjected to a management irregularity that \nresulted i n a suppression of gain from d 14 to d 21 follow ed by compensatory gain from d 21 to d 35. The early \nsubclinical coccidiosis group developed a greater suppression  of gain during the 14 to 21 d period, but by d 35, there \nwas no statistical difference in the weigh t of both treatment groups.  \nFrom d  35 onward, the rate of gain slowed  (p<0.05)  for the late subclinical coccidiosis group compared to the \nearly subclinical coccidiosis group.  The 49 d final weight of the late subclinical cocci group was 97 % of the weight \nof the ear ly subclinical cocci group (2670g vs 2746g).  Data was adjusted to a common target weight of 2.5 kg by \nregression using weekly pen data.  The days to  target weight were significantly longer for the late c occi group (45.8 d  \nvs. 44.9  d), and the feed conversion at the 2.5 kg target weight was significantly higher for the late cocci group (1.83 \nvs 1.78).  Correspondingly, the feed cost per kg was significantly higher for the late cocci group ($0.8442 vs. \n$0.8210).  The energy consumption ( kcal / kg) was s ignificantly higher  for the late cocci group (5867 vs 5845) . \nThe carcass composition was adjusted to a common 2.72 kg (6.0 lb) target weight by regression of the weekly \ndata by the selected birds.  The boneless breast yield in grams was numerically lower for the late cocci group (585g \nvs 637g) , while  the boneless breast as a percent of live weight was significantly lower for the late cocci group \n(20.82% vs 23.32%).  Abdominal fat pad weight was signif icantly higher for the late cocci group (77.87g vs. \n63.88g).  Boneless thigh weight could not be adjusted to a common weight by regression because this fig ure was \nonly analyzed at 49 d . At 49 d, the boneless thigh weight was significantly lower in the  late cocci group (221g vs, \n248g).   \nWhile the body weigh t of the late cocci group was 3% lower than the body weight of the early cocci g roup, the \nlate cocci  group breast  mass was 12 % lower than  of that of the early  cocci  group, reflecting the late onset of breas t \ntissue mass relative to the growth curve.  Even adjusted by regression to the same body weight, the breast mass was \n8% lower in the late subclinical cocci birds.  Thigh mass was 11% lower, while abdominal fat pad was significantly \nheavier in the late cocci  group.  Even very mild late subclinical coccidiosis alters the partitioning between protein \nand fat in the broiler carcass, resulting in lower meat yield and higher fat pad weight.  \nCoccidiosis monitoring and adjustment of coccidiosi s control programs to avoid  mild late subclinical \ncoccidiosis  is essential to maximize the profitability of an integrated broiler company.  Subclinical coccidiosis with \nlesion scores less than 1.0 during the final weeks before slaughter has significant adverse effect on weight g ain, days \nto market, feed conversion, feed cost per kg, breast yield and thigh yield.  \n \nREFERENCES  \n \n1. Chapman , H. D . 1999.  Anticoccidial drugs and their effects upon the development of immunity to Eimeria  \ninfections in poultry.  Av. Path. 28:6, 521- 535. \n2. Kant, Vinjay , P.Singh, P.K. Verma, I. Bais, M. S. Parmar, A. Gopal and V. Gupta. 2013. Anticoccidial \nDrugs used in the Poultry: An Overview. Science International, 1: 261 -265. \n3. Teeter, R.G., A. Beker, C. Brown, C. Broussard, S. Fitz -Coy, J. Radu and L. Newman. 20 10. Production \nand managerial factors influencing the caloric efficiency of growing broilers.  Proceedings of the Poultry Science \nAssociation Joint Annual Meeting, July 11 \u2013  15, Denver, CO.  \n4. Johnson, J., and W. M. Reid. 1970. Anticoccidial drugs:  Lesion scor ing techniques in battery and floor -pen \nexperiments with chickens.  Exp Parasitol 28:30- 36. \n5. McDougald, L. and S.H.  Fitz-Coy.  Chapter 28 Coccidiosis of Chickens. Diseases of Poultry  (13th ed.) (p. \n1149) Ames, IA: John Wiley & Sons, Inc, 2013.  \n \n 63rd WPDC/XXXIX ANECA  Figure 1.  Subclinical coccidiosis lesion scores and timing . \n \n \n \n \n \nFigure 2 . Growth vs. late s ubclinical lesion s core.  \n \n \n \n 00.511.522.533.54\n7 14 21 28 35 42 49Average Lesion Score \nDays of age  Early Subclinical cocci  \nAcerv\nMaxima\nTenella\n00.511.522.533.54\n7142128354249Average Lesion Score \nDays of age  Late Subclinical Cocci  \nAcerv\nMaxima\nTenella\nWeights diverge  63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N DE LA VIABILIDAD DEL VIRUS VACUNAL DE \nMAREK AL COMBINARSE CON ANTIBI\u00d3TICOS COMERCIALES \nA BASE DE GENTAMICINA  \n \nEVALUATION OF THE VIABILITY OF THE MAREK VACCINE VIRUS \nWHEN COMBINED WITH COMMERCIAL ANTIBIOTICS  \nBASED ON GENTAMICIN  \n \nM. Nieto, D. Marrufo y E. Lucio  \n \nInvestigaci\u00f3n Aplicada S. A. Tehuac\u00e1n, Puebla, M\u00e9xico  \n \nSUMMARY  \n \nThe effect of three commercial antibiotics with gentamicin on the viability of the Marek vaccine virus at four \ndifferent  times (0, 30, 45 and 60 min ) was evaluated. In each  case the pH before and after add it to the vaccine was \nmeasured. The pH of gentamicin 1 and 2 was neutral while the pH of gentamicin 3 was more acid. Decreased \nviability of the vaccine virus was ob served when using gentamicin  3 (statistically significant difference), so it \nappears that the pH and time consumption directly affect viability. However, the vaccine remains viable as specified \nby the manufacturer. The use of 10% gentamicin with neutral pH does not affect the viability of the Marek \u2019s vaccine \nvirus significantly, being recom mended for use within 45 min . \n \nRESUMEN  \n \nSe evalu\u00f3 el efecto de tres antibi\u00f3ticos comerciales a base de gentamicina sobre la viabilidad del virus vacunal \nde Marek a cuatro diferentes tiempos (0, 30, 45 y 60 min ). En cada caso se midi\u00f3 el pH antes y despu\u00e9s de \nadicionarlo a la vacuna. El pH de la gentamicina A y B es neutro  mientras que el pH de la gentamicina C es m\u00e1s \n\u00e1cido. Se observ\u00f3 menor viabilidad del virus vacunal al emplear la gentamicina C (diferencia estad\u00edst ica \nsignificativa), por lo que se deduce que el pH y tiempo de consumo influyen directamente en la viabilidad. Sin embargo la vacuna permanece viable de acuerdo a lo especificado por el fabricante. El uso de gentamicina al 10% \ncon pH neutro no afecta la vi abilidad del virus vacunal de Marek de forma significativa, siendo recomen dable su uso \nantes de 45 min . \n \nINTRODUCCI\u00d3N  \n \nLa enfermedad de Marek es causada por un herpes virus que afecta a las aves dom\u00e9sticas y tiene gran \nimportancia en la industria av\u00edcola p orque con la ausencia de medidas de control es capaz de producir grandes \np\u00e9rdidas en lotes de aves comerciales.  La enfermedad de Marek se evita mediante la vacunaci\u00f3n con vacunas mono \no polivalentes de virus vivos, sin embargo a lo largo de estos a\u00f1os se han desarrollado varios tipos de vacunas \ndebido a la aparici\u00f3n de cepas m\u00e1s virulentas y la necesidad de controlarlas. La vacuna de Marek es administrada al nacimiento porque la inmunidad temprana es esencial para prevenir la enfermedad.   \nLos laboratorios productores de la vacuna recomiendan no mezclarla con alg\u00fan antibi\u00f3tico, sin embargo es una \npr\u00e1ctica com\u00fan que en las incubadoras se administre la vacuna de Marek junto con un antibi\u00f3tico para la prevenci\u00f3n \nde infecciones en pollito s de un  d\u00eda de edad.  El uso conjunto de antibi\u00f3ticos como gentamicina, oxitetraciclina, \neritromicina o clortetraciclina con la vacuna de Marek, inactivan al virus y pueden inutilizar la vacuna ( 2). El pH y \nmolaridad de algunos antibi\u00f3ticos como la gentamicina, pueden disminuir el  t\u00edtulo viral de la vacuna (Petrone). Sin \nemba rgo, se han hecho estudios con ceftriaxona, gentamicina y c eftiofur s\u00f3dico en los que se ha probado que el \nt\u00edtulo vacunal no disminuye , en condiciones de laboratorio  (4,5).  \n \nMATERIAL Y M\u00c9TODOS  \n \nSe utiliz\u00f3 la vacuna congelada conteniendo virus vivo de la  enfermedad de Marek  (Serotipo 3) , la cual fue \nreconstituida de acuerdo a las indicaciones del fabricante en 198 mL de diluyente comercial  al cual se agregaron 2 63rd WPDC/XXXIX ANECA  mL de antibi\u00f3tico.  Se midi\u00f3 el pH de cada antibi\u00f3tico antes de su adici\u00f3n al diluente de la vacuna y posteriormente \nen la vacuna reconstituida.  Se utilizaron tres antibi\u00f3ticos comerciales a base de gentamicina al 10%, los cuales \nfueron a dicionados a la vacuna de Marek  (3 tratamientos, 1 control y 2 repeticiones).  Se determin\u00f3 el t\u00edtulo de la \nvacuna de Marek despu\u00e9s de su reconstituci\u00f3n en cuatro tiempos ( min 0, 30, 45, 60). Para determinar el t\u00edtulo de la \nvacuna, se calcularon las Unidades Formadoras de Placa por dosis (UFP ) en del cultivo celular de acuerdo a las \nindicaciones del Supplemental Assay Method 406 (SAM 406) . \nSe utiliz\u00f3 un Dise\u00f1o de factoriales de 4x2 , se realiz\u00f3 el a n\u00e1lisis de varianza y prueba de Tukey para determinar \nsi existe diferencia entre los tratamientos.  \n \nRESULTADOS  \n \nEl tratamiento 1 al ser el  control, tiene el t\u00edtulo m\u00e1s alto  (mayor cantidad de Unidades Formadoras de Placa)  en \ncomparaci\u00f3n con el resto de los tr atamientos.  Los tratamientos A y B  no tienen diferencia estad\u00edstica significativa , el \ntratamiento C si tiene diferencia estad\u00edstica significativa con respecto al resto de los tratamientos presentando el \nmenor t\u00edtulo . \n \nDISCUSI\u00d3N  \n \nLos resultados obtenidos son similares a los encontrados por Eidson et al.,  (4) y Chac\u00f3n et al.,  (5), quienes no \nencontraron reducci\u00f3n significativa del t\u00edtulo de la vacuna de Marek al minuto 60 despu\u00e9s de preparada la soluci\u00f3n \nvacunal. La viabilidad del virus en la vacuna de Marek depende adem\u00e1s de otros factores como  la t\u00e9cnica al \nmom ento de reconstit uir la vacuna, el pH como en este caso, en donde la g entamicina con el pH m\u00e1s \u00e1cido obtuvo el \nmenor t\u00edtulo, as\u00ed como lo demostrado por G eerligs y Hoogendam ( 8), quienes realizaron un estudio en donde \ncompararon el t\u00edtulo de la vacuna de Marek utilizando di luentes a diferentes temperaturas . Existen otros factores \nf\u00edsicos que afectan la viabilidad del virus en la vacuna como el tiempo prolongado de conservaci\u00f3n de la vacuna, \ntemperatura de incubaci\u00f3n elevada, manipulaciones f\u00edsicas, incluyendo la mezcla utili zando una jeringa y aguja, ya \nque tienen un efecto adverso sobre la presi\u00f3n osm\u00f3tica en la vacuna, como lo demostraron Colwell et al.  (7). \n \nCONCLUSIONES  \n \nEn la pr\u00e1ctica es importante que la vacuna tenga un t\u00edtulo alto, se recomienda su aplicaci\u00f3n 45  min posteriores \na su reconstituci\u00f3n. Si el margen del t\u00edtulo es mayor, la vacuna contendr\u00e1 el t\u00edtulo adecuado al momento de la \naplicaci\u00f3n . El uso de los antibi\u00f3ticos en conjunto con la vacuna de Marek reduce la viabilidad del virus, sin embargo \nel pH del antibi\u00f3tico empleado es fundamental como se pudo demostrar en este experimento, el pH neutro del \nantibi\u00f3tico ayuda a mantener la viabilidad del virus por consiguiente cada dosis vacunal tendr\u00e1  el t\u00edtulo adecuado al \nmomento de la aplicaci\u00f3n , capaz de montar una respuesta inmune en los pollitos de un d\u00eda de edad.  \n \nREFERENCIAS  \n \n1. Petrone V, Hern\u00e1ndez X, T\u00e9llez G, Enfermedad de Marek, Departamento de Producci\u00f3n Animal: Aves, \nFacultad de Medicina Veterinaria y Zootecnia, UNAM, M\u00e9xico, D. F. 2000.  \n2. Gimeno I. Actualidades en el control de la Enfermedad de Marek. USDA -ARS Avian Disease and \nOncology Laboratory.  \n3. Petrone V, M\u00e9ndez A, Fehervari T, Evaluaci\u00f3n del efecto de la Ceftriaxona sobre las unidades \nformadoras de placa en diferentes cepas vacunales de Marek. M emorias de la XXIII Convenci\u00f3n Anual ANECA, \n1998 mayo 6- 9, Puerto Vallarta (Jalisco) M\u00e9xico.  \n4. Eidson C, Page R, Kleven S, In vivo and in vitro studies on effect of gentamicin sulfate on the efficacy of \nthe turkey herpesvirus vaccine. Poultry Science 57 (6):  1519 -1525, 1978.  \n5. Chac\u00f3n J, Pimentel M, Pedroso A, Evaluaci\u00f3n in vitro del efecto de Ceftiofur S\u00f3dico y de una nueva \nformulaci\u00f3n de sulfato de gentamicina sobre la viabilidad del virus de la enfermedad de Marek. XX Congreso Latinoamericano de Avicultura Br asil 2007, mayo 25- 28, Porto Alegre, Brasil.  \n6. Supplemental Assay Method for Titration of Monovalent, Cell Associated Marek\u2019s Disease Vaccines of \nSerotypes 1, 2, or 3.  United States Department of Agriculture Center for Veterinary Biologics, Testing Protocol,  \nSAM 406. Marzo 2011.  \n7. Colwell W., Simmons D., Horns V.Influence of Some Physical Factor son Survival of Marek\u00b4s Disease \nVaccine Virus. Avian Diseases 19 (14): 781 -790. 1975.  63rd WPDC/XXXIX ANECA  8. Geerligs H., Hoogendam A. Determination of optimal conditions for thawing and dilu ting cell bound \nCVI988 Marek\u00b4s Disease Vaccine and stability of the diluted vaccine.  Avian Diseases. 51 (4): 969- 973. \n \n \nTabla 1. Lectura del pH de cada antibi\u00f3tico y lectura del pH de la vacuna en combinaci\u00f3n con cada antibi\u00f3tico.  \n \nCon el an\u00e1lisis de varianza se observ\u00f3 que existe diferencia estad\u00edstica signi ficativa entre los tratamientos  \n \n \nGr\u00e1fica 1. Prueba de Tukey . \n \n \n* Diferentes letras son estad\u00edsticamente diferentes (P<0.05)  \n  \n \n \n  I II \nTratamiento  Antibi\u00f3tico  Antibi\u00f3tico+HVT  Antibi\u00f3tico  Antibi\u00f3tico+HVT  \n1.Control HVT  - 7 (S\u00f3lo vacuna)  - 6.95 (S\u00f3lo vacuna)  \n2.HVT+antibi\u00f3tico A  7.08 6.9 6.91 6.84 \n3.HVT+Antibi\u00f3tico B  7.01 6.81 7.36 6.9 \n4.HVT+Antibi\u00f3tico C  5.31 6.81 5.17 6.7 \na \nab \nab \nb 63rd WPDC/XXXIX ANECA  EFFECT OF BIOESTIMULANT ON THE IMMUNE SYSTEM AND \nITS TRANSMISSION TO THE PROGENY BREEDER HENS  \nIN M EXICO  \n \nEFECTO DE UN BIOESTIMULANTE SOBRE EL SISTEMA INMUNE Y SU \nTRANSMISI\u00d3N A LA PROGENIE E GALLINAS REPRODUCTORAS PESADAS \nEN M\u00c9XICO  \n \nL. Ocampo CamberosA and M. G\u00f3mez Dom\u00ednguezB \n \nADepto. de Fisiolog\u00eda y Farmacolog\u00eda, FMVZ , UNAM.  Ciudad Universitaria. D el. Coyoac\u00e1n. CP 04510. Mex. DF  \n \nBDpto. T\u00e9cnico Catalysis M\u00e9xico . Calle La quemada No. 240, Col. Narvarte. D el. B. Ju\u00e1rez CP 03020. Mex. DF  \n \nRESUMEN  \n \nMejorar la respuesta inmune a las vacunaciones y la transmisibilidad al  pollito repercute en parvadas de \npollitos m\u00e1s sanos generando obviamente mayor eficiencia, productividad y beneficios econ\u00f3micos para las \nempresas av\u00edcolas de reproductoras pesadas en M\u00e9xico. Para el estudio se aplic\u00f3 un bioestimulante a 115,514 aves \nreproductoras con su respectivo grupo control (115,165 aves) durante ocho semanas v\u00eda agua de bebida bajo \ncondiciones de ambiente controlado en donde se obtuvo mejor calidad de pollito, mej ores niveles de anticuerpos \npara ENC, BI, Reovirus, IBF y Anemia infecciosa aviar tanto en gallina reproductora como en la progen ie de las \naves tratadas con el b ioestimulante,  medidos por medio de la prueba de ELISA.  \n \nSUMMARY  \n \nEnhance the immune response t o vaccinations and transmissibility of chicken flocks affects healthier chicks \nobviously generating greater efficiency, productivity and economic benefits of heavy poult ry breeding companies in \nMexico . For the s tudy, a bio -stimulant to 28,042  breeding birds was applied to the respective control group ( 28,094  \nbirds) for eight wk  via drinking water under controlled environment conditions where better chick quality , hig her \nlevels of antibodies to ENC , BI were obtained reovirus, IBF and avian infe ctious anemia both breeding hen and the \nchick from birds treated with biostimulant measured by ELISA.  \n \nINTRODUCTION  \n \nPoultry dedicated to th e production of fertile eggs , faces new challenges daily productivity that allow survival \nin a highly competitive ma rket. Some of these challenges involve optimal vaccination programs, transmission of \nantibodies to chick and products that enhance the immu ne response . In this sen se, the bioestimulante  offers the \npossibility to optimize the im mune response of breeding bir ds, efficiency in tran smission of immunity to chicken, \nconsequently improving their health  (2,3). \nThe b ioestimulan te is a nutritional preparation , anti -oxidant s, vitamins , trace elements, an d active product of  \nthe extraction from licorice (glycyrrhizinic acid ) with antiviral activity and  stimul ating the immune system (1,4, 5). \n \nOBJECTIVE  \n \nThe objective of this study was t o evalua te the efficacy of b iostimulant, by measuring its effect on humoral \nimmune level and  its transmission to progeny . \n \nMATERIAL AND METHODS  \n \nInstallation . Commercial poultry f arm locat ed in  Durango, Mexico in broiler breeder hens controlled \nenvironment with automatic  system s. The animals used were 62,079  44 wk  old Cobb 500 strain of FF.  They were  \ndivided into two groups: ( A) with 28,094 birds and (B) with 28,042 birds. The ratio of male/ female was 10.29 %. 63rd WPDC/XXXIX ANECA  All animals received food and so far limited based on age and weight. Water intake was ad libitum. They were also \nvaccinated in accor dance with timetables established on the farm.  \nTreatments.  Control group (A) was  considered the booths , 1, 3 and 5 witho ut application of b iostimulant.  \nTreated group ( B): the houses 2, 4 and 6 biostimu lant treated at a rate of 0.1 mL  product / 1 kg body weight in \ndrinking wate r for 14 wk  were considered.  \nHumoral immune r esponse . Antibodies in chicken b reeder : blood samples were taken at w k 44 and 52 weeks \nof age (18 samples/replication ) and then determine serum antibody titers to the virus of Newcastle (ND ), infectious \nbronchitis (IB) , reovirus (REO ), infection of the bursa (IBF ) and infe ctious anemia (CAV) by ELISA. 5.2 \nAntibodies in c hicken were followed to chicks three d  old and identified by shelter group (A and B). The same tests \nwere det ermined Hen.  \n \nRESULTS  \n \nBreeder , serological results ( Figure 1). ELISA serologic results of c hicks (Figure 2 ). \n \nCONCLUSIONS  \n \nThe b iostimulant stimulates the production of higher titers  of antibodies in breeding: ENC , BI, IBF, REO and \nCAV . 7.2. The biostimulant favors the transmission of a ntibody titers to the progeny: ENC, BI, IBF , REO  and CAV. \n \nREFERENCES  \n \n1. Badam, L. In Vitro Studies of the effect of glycyrrhizin from the Indian Glycyrrhiza glabra Linn on some \nRNA and DNA virus, Indian- J-Pharmacology . 1994.  \n2. Chavali, S.R. et al.  An in vitro  study of immunomodulatory effects of some saponins. Int. J. \nImmunopharmacol 9 (6) 675- 83. 1987.  \n3. Hoever, G. et al. Antiviral activity of glycyrrhizinic acid derivatives against SARS -coronavirus. J. Med. \nChem. 48 (4):1256- 1259. 2005.  \n4. Krausse, R.M. et al. In vitro anti -Helicobacter pylori activity of extractum liquiritae, glycyrrhizin and its \nmetabolites. J. Antimicrob Chemother. 54 (1) 243- 246. 2004  \n5. Lin, J.C. Mechanism of action of glycyrrhizinic acid in inhibition of Epstein -Barr virus replication in \nvitro. Antiviral. Res: 59 (1) 41 -47. 2003.  \n   \n \n  \n \n   \n \n \n \n \n  \n \n \n \n \n \n \nFigure 1 .Humoral immunity breeding hen. Serology results for ENC, BI, IBF, REO and CAV ELISA at 52 \nweeks of age . 63rd WPDC/XXXIX ANECA   \n \n \n \n \n \nFigure 2.  Chicks, serological results ELISA.  \n \n \n \n010000Elisa, unids  \nAntigens  Elisa, breeder  44 y 52 weeks.  \nInitial title\nFinal title\n63rd WPDC/XXXIX ANECA  REOVIRUS AND LEG PROBLEMS IN ONTARIO BROILERS  \n \nREOVIRUS Y PROBLEMAS DE LAS PIERNAS EN  \nPOLLOS DE ENGORDA DE ONTARIO  \n \nE. Martin, M. Brash, S. Hoyland, C. Sandrock , and D. Ojkic  \n \nRESUMEN  \n \nUn mayor n\u00famero de casos de pollos de engorda con problemas de las piernas fue enviado al Laboratorio de \nSalud Animal en Ontario en 2012. Pruebas de m\u00faltiples agentes infecciossos se llevaron a cabo y se identific\u00f3 un \nreovirus aviar (ARV) a partir de articulaciones cerradas del tarso, a menudo en combinaci\u00f3n con otras cau sas de \ncojera ( por ejemplo, bacterias , raquitismo , TD) . Por lo tanto, se considera que la presencia de ARV es una de las \nposibles etiolog\u00edas de la cojera.  \nClinicamente los signos de cojera iban desde una leve dificulad para caminar hasta piernas ensanchada s o \ndeformadas. Para los 14 d \u00edas o m\u00e1s de edad, la parvada afectada se volver\u00eda coja de repente, a menudo con solo un \npiso o una caseta afectada.  M\u00e1s aves se vieron afectadas cuando la cojera se identific\u00f3 m\u00e1s temprano. Las aves \npod\u00edan tener lesiones h istol\u00f3gicas en los tendones y podr\u00edan identificarse ARV, pero los signos cl\u00ednicos pueden o no \nhaber sido evidentes. Las parvadas que fueron afectadas clinicamente podr\u00edan tener p\u00e9rdidas de hasta 15% debido a \nla eliminaci\u00f3n selectiva (desechos) con t\u00edtulos mayores de ELISA ARV a partir de sangre toamada en el \nprocesamiento.    \nSe obtuvo el genotipo de cuarenta y tres aislamientos de ARV del 2012 por medio de la secuenciaci\u00f3n del \nsegmento S1 y se compar\u00f3 con 32 ARVs de a\u00f1os anteriores (2 del 2003, 2007 y 2008,  10 de 2010 y 7 de 2011). \nTreinta y tres ARVs de 2012 formaron dos grupos distintos por genotipo y fueron 40- 50% diferentes de los virus \naislados en los a\u00f1os anteriores. La primera detecci\u00f3n de estas dos variantes de ARV en Ontario se produjo a \nmediados de  2012. Los 10 ARVs  restantes de 2012 fueron similares a los aislamientos de ARV de a\u00f1os anteriores.  \n \nSUMMARY  \n \nAn increased number of cases of Ontario broilers with leg problems  were submitted to the Animal Health \nLaboratory in 2012. Testing for multiple infectious agents was conducted and avian reovirus (ARV) was identified \nfrom closed hock joints, often in conjunction with other causes of lameness (e.g. bacteria, rickets, TD). Therefore, \nthe presence of ARV was considered to be one of multiple possible etiologies of the lameness.  \nClinically, the signs of lameness ranged from slight difficulty walking to splay leg or leg deformity . By 14 d or \nolder an affected flock would become suddenly lame, often with only one floor or one  barn af fected. The earlier the \nlameness was identified the more birds become affected. Birds could have histologic lesions in the tendons and \nARV could be identified but clinical signs may or may not have been evident. Flocks that were clinically affected could h ave losses of up to 15% due to culling  with increased ARV ELISA titers  from blood taken at processing.  \nForty -three ARV isolates from 2012 were genotyped by S1 segment sequencing and compared to 32 ARVs \nfrom previous years (2 from each 2003, 2007 and 2008,  10 from 2010 and 7 from 2011). Thirty -three ARVs from \n2012 formed two distinct clusters by genotyping and were 40- 50% different from viruses isolated in previous years. \nThe first detection of these two ARV variants in Ontario occurred mid -2012. Remaining 10 ARVs from 2012 were \nsimilar to ARV isolates from previous years.  \n 63rd WPDC/XXXIX ANECA  USE OF ARTIFICIAL INTELLIGENCE (ARTIFICIAL NEURAL \nNETWORKS) TO CLASSIFY THE PATHOGENICITY OF \nESCHERICHIA COLI ISOLATED FROM CH AU\u00c1 PARROT \n(AMAZONA RHODOCORYTHA)  \n \nUSO DE INTELIGENCIA ARTIFICIAL (REDES NEURALES ARTIFICIALES) \nPARA ESTABLECER UN \u00cdNDICE DE PATOGENICIDAD A PARTIR DE \nMUESTRAS DE ESCHERICHIA COLI NATIV AS DEL PERICO  \nAMAZONA CORONA ROJA ( AMAZONA RHODOCORYTHA)  \n \nF. de Oliveira SalleA, D. Azeredo BonissiB, D. Tonini da RochaA, S. Lu\u00eds da Silveira RochaA,  \nH. Luiz de Souza MoraesA, and C. Tadeu Pippi SalleB \n \nACenter of Diagnosis and Research in Avian Pathology (CDPA), Veterinary Faculty, Federal University of \nRio Grande do Sul  (UFRGS) , Porto Alegre, Brazil.  \nBUniversitary Center of Esp\u00ed rito Santo (UNESC), Veterinary F aculty, Colatina, Esp\u00edrito Santo, Brazil \n \nRESUMEN  \n \nLa informaci\u00f3n disponible para este estudio fueron 14 muestras de Escherichia coli  aislado de pericos amazona \ncorona roja ( Amazona rhodocorytha). Se crearon redes neurales artificiales haciendo asociaciones entre variables \nintroducidas, con el fin de ajustar mejor el modelo. Los resultados se compararon a la base de datos  real de muestras \naisladas de pollos de engorda. El 85.71% de las muestras se r elacionaron con una resistencia al suero y una \nproducci\u00f3n de toxina; 87.71% de las muestras se relacionaron con la capacidad de adhesi\u00f3n; 57.14% de las muestras \nse relacionaron con la adquisici\u00f3n del hierro. Los resultados obtenidos del \u00edndice de patogenicidad (PI) fueron: \n7.14% (PI=0); 14.2% (PI=1); 7.14% (PI=3); 50% (PI=6); 14.2% (PI=8); 7.14% (PI=10). La capacidad de zoonosis \nde este agente antimicrobiano revel\u00f3 que genes con un alto PI tambi\u00e9n est\u00e1n presentes en humanos con \nmeningococo (gen mat) as\u00ed com o en aves silvestres, con lo cual se refleja la importancia de este estudio.  \n \nSUMMARY \n \nThe data available for this study were 14 samples of Escherichia  coli isolated from Chau\u00e1 parrot ( Amazona \nrhodocorytha ). Artificial neural networks were created making associations between the input variables in order to \nfind the best adjusted model. The results were compared to the actual database of samples isolated from broilers. In 85,71% of the isolates were related to serum resistance and toxin production; 87,71% of the isolates were related to \nresponsible for adhesion capacity; 57,14% of the isolates were related to iron acquisition. The results of \npathogenicity index (PI) obtained were: 7,14%(PI=0); 14,2%(PI=1); 7,14% (PI=3); 50%(PI=6); 14,2% (PI=8); \n7,14%(PI= 10). The potential of zoonosis of this microbial agent unveiled that genes with high PI are also present i n \nhumans with meningitides and in wild birds as well elucidating the importance of this study.  \n \nINTRODUCTION  \n \nE.coli is considered secondary to other agents, and it is the cause of avian extra -intestinal diseases. According \nto Rocha et al. (4), the virulence factors most frequently detected in respiratory isolates of E. coli, isolated in Rio \nGrande do Sul  were serum resistance and colicins production. Virulence mechanisms of E. coli isolates potentially \npathogenic for broilers avian pathogenic  Escherichia coli  (APEC) have been continuously studied and it is supposed \nto be of multifactorial cause. Different pathogens have been associated with food borne diseases, such as E. coli  \nserotype O157: H7, Salmonella, Campylobacte r and Shigella  spp. (3). E.coli O157: H7 causes hemorrhagic colitis in \nhumans and uremic syndrome , a disease of great gravity that leads to renal failure and death ( 2). The results of these \nauthors also support the idea that certain human extraintestinal pathogenic  Escherichia coli  (ExPEC) and APEC may \nbe zoonotic and APEC can be considered as a reservoir for genes associated with the virulence of ExPEC human \nhaving or comprising a high pathogenic potential for humans  (1). \n  63rd WPDC/XXXIX ANECA  MATERIALS AND METHODS  \n \nEach inoculated sample was plated onto eosin methylene blue ( EMB ), incubated in the greenhouse where t hey \nremained for 24 h at 37\u00b0 C. The first part was made with  an aliquot of each sample was reactiv ated directly on \nMacConkey a gar, seeded by  exhaustion and incubated at 37\u00b0 C for 24 h  in a bacteriological incubator.  \nA bacterial colony was solubilized in 200 \u03bc L ultra-pure water in a 1 mL microtube (Eppendor f\u00ae) after it was \ncooled to - 20\u00b0C for 10 min  and then concentrated by centrifugation  (12,000 rpm for two min ). The supernatant \ndiscarded and the pellet resuspended with over 200 \u03bc L ultra-pure water. The material was kept in a water bath at \n100\u00b0 C for 10 min and the supe rnatant transferred to another  microtube (Eppendorf).  \nThis analysi s detected  33 virulence genes, including genes responsible f or the adhesion capacity, invasion, \nacquisition were surveyed iron, serum resistance , toxins  production, a serine protease autotransporter and a \npathogenicity island ass ociated with the marker 73 CFTO.  \nThe detection of 33 virul ence genes was performed in six multiplex  PCRs (4 multiplex -PCR protocols \ndeveloped by  Ewers  et al. (1), 3 genes by multiplex PCR by  Rocha et al. (4) and multiplex 6 for papG and fimH \ngenes were investigated by a multiplex PCR developed by  CDPA. The reaction mixture multiplex contains  25\u03bcL, \nincluding 2.5 \u03bc L buffer 10X, 1.25 \u03bcL of MgCl 2 2.5mM, 0.3 \u03bcL of Ta q DNA polymerase (1.5 U), 0.5 \u03bc L of each \ndNTP ( 2.5 mM ), 2 \u03bc L of each primers (20 pmol) and 5 \u03bc L of bacterial DNA, supplemented with the appropriate \nvolume of ultra-pure water.  \nThe data used in this study were collected in a database, as follows.  Characterization of genes associated with \npathogenicity ( afa/draB, crL, fimC, hrlA, ihA, papC, sfa/focCD , tsH, maT, gimB, ibeA, tiA , chuA, fyuA, ireA, \niroN1, irP 2, iucD, sitD, sitDep, cvi/cvA, isS , neuC, kpsMT II, ompA, traT, cnF1/2, saT, vaT , hlyA, piC , malX , \nEAST1 ); Pathogenicity index (0 to 10);  14 antibiotics (amikacin, amoxicillin/clavulanic  acid, ampicillin, cephalexin, \nceftiofur, cefuroxime, ciprofloxacin , clindamycin, cotrimox azole, enrofloxacin, gentamicin , norfloxac in, ofloxacin \nand tetracycline).   \nThe artificial neural networks (ANN s) were  previously constructed using the Neuroshell  Classifier 2.1  \nsoftware. The results available were transformed into a binary form. The negative results are represented by number \n0 and the positive ones by 1.  The first neural network model ranked the pathogenicity index from the \ncharacterization of 33  genes associated with virulence.  The second neural network model predicted antimicrobial \nresistance and used as inputs characterization of 33  genes associated with virulence and pathogenicity index. This \ncriterion was used for sensitivity 0  or resis tance 1 to the 14 antib iotics studied, to the absence 0 or presence 1  of \ngene s associated with pathogenicity.  The outputs were resistance or sensitivity to l4 antib iotics obta ined by  Salle , \n2009 (5). \n \nRESULTS  \n \nThe 14 strains of E. coli used in this study displayed 0 -10, from 33 virulence genes investigated, with an \naverage of 5.21 for pathogenicity index genes isolated, and a coefficient of variation 55.88. In 87.71% of the isolates \nwas detected at least one related to adhesion  (afa/draB, crL, fimC, hrlA, ihA, papC, sfa/ focCD, ts H and maT ) factor, \nin 57.14%  isolates were detected at least one related to the inva sion (gimB, ibeA and tiA ) factor, in 57.14%  of the \nisolates was detected at least one facto r related to iron acquisition (c huA, fyuA, ireA, iroN1, irP 2, iucD, and sitD \nsitDep), 85.71%  of the isolates was detected at least one r elated to serum resistance (cvi/ cvA, isS , neuC, kpsMT II, \nompA and t raT). In 85,71 % of the isolates was detected at least one factor related t o the production of toxins \n(cnF1/ 2, saT, vaT, EAST1  and hlyA) . \nFrom the results obtained through the joint Multiplex PCR performed in this study, and analysis of the data \nobtained through this on ANNs , it was possible to measure the pathogenicity index (PI) of each sample.  The results \nobtained were PI=0(7% of the isolates); P=1 (14% of the isolates); PI=3(7% of the isolates); PI=6(50% of the \nisolates); PI=8(14% of the isolates) and PI=10 (7% of the isolates).  \nThe antimicrobial analysis of the 14 E.coli strains predicted  the follows results: amikacin (100% of the isolates \nwas sensible);  amoxicillin/clavulanic acid  (100% of the isolates was sensible) , ampicillin  (85,71% of the isolates \nwas sensible and 14,29% of the isolates was intermediate);  cephalexin  (100% of the isolates was sensible);  ceftiofur  \n(85,71% of the isolates was sensible and 14,29% of the isolates was intermediate) ; cefuroxime  (100% of the isolates \nwas sensible);  ciprofloxacin  (92,86% of the isolates was sensible and 7,14% of the isolates was intermediate) ; \nclindamycin (100% of the isolates was resistant);  cotrimoxazole  (64,29% of the isolates was sensible and 35,71% of \nthe isolates was resistant); enrofloxacin (100% of the isolates was sensible) , gentamicin  (92,86% of the isolates was \nsensible and 7,14% of the isolates was res istant); norfloxac in (92,86% of the isolates was sensible and 7,14% of the \nisolates was resistant); ofloxacin  (100% of the isolates was sensible)  and tetracycline (42,86% of the isolates was 63rd WPDC/XXXIX ANECA  sensible, 21,53% of the isolates was intermediate, and 35,71% of the isolates was resistant).  The statistical analysis \nperformed to assess the relationship between PI and resistance to 14 antibiotics also showed that these variables are \nindependent, and the results of the PI obtained using 14 antimicrobials tests were: 7% with PI=0; 14,2% with PI=1; \n7% with PI =3; 50% with PI=6; 14,2% with PI=8; 7% with PI=10.  \n \nDISCUSSION  \n \nThe improvements reached by research in general and the tools which have been used resulted in a better \ncomprehension of the mechanisms of pathogenicit y of E. coli. However, the differentiation of virulent from non -\nvirulent samples is still a problem for veterinarians to come to a diagnosis and, as a consequence, to make decisions . \nBy reaching correct classification percentages higher than 90%, the method proposed here has proved to be a \npowerful to ol to support the veterinarian\u2019s  decisions in the fi eld. The characteristics of these model ing allow ed the \ncorrect classification of the pathogenicity index and antimicrobial profile of the 14 isolates with a good degree of \nreliability, considering the sensitivity and the specificity .  \nFinally, with this methodology, the potential of zoonosis of this microbial agent unveiled that genes with high \npathogenicity index are also present in humans with meningitid es and in wild birds as well elucidating the \nimportance of this study.  Given the repeated references, it was found that E.coli is a normal pathogen of the \nintestinal microbiota of both man and animal , and  deserves greater attention and study about its potential ability to \ntransmit zoonos is. The possibility occurrence of zoonos is shall be a public health problem and end up messing with \nall the financial gearing of a country .  \nThe results were compared to the actual database of samples isolated from broiler (which are part of this \nresearch line) and showed that the artificial neural networks were able of performing correct classification of the \nbehavior of the samples, thereby m aking it possible to predict the antibiotic resistance of E. coli, and pathogenicity \nindex using ANN's modeling, without the need for inoculating animals  or antimicrobial susceptibility testing.  \n \nREFERENCES  \n \n1. Ewers , C. et al. Avian pathogenic, uropathogenic , and newborn meningitis -causing Escherichia coli: how \nclosely related are they? International Journalof Medical Microbiology , v. 297, n. 3, 2007.  \n2. Nataro, J. P., Kaper , J. B. Diarrheagenic Escherichia coli . Clin Microb Rev. v. 11, p. 142- 201, 1998.  \n3. Ribeiro , M. G. et al. De hamb\u00farguer, leite e outros g\u00eaneros aliment\u00edcios \u00e0 colite hemorr\u00e1gica e s\u00edndrome \nur\u00eamico -hemol\u00edtica. Higiene alimentar. v. 13, p. 88 -97, 1999.  \n4. Rocha , A.C.G.P.et al. Genes associated with pathogenicity of avian Escherichia coli (APEC) isola ted \nfrom respiratory cases of poultry. Pesq. Vet. Bras.  v. 28. n. 3. 2008.  \n5. Salle , F.O. Utiliza\u00e7\u00e3o de intelig\u00eancia artificial (redes neurais artificiais) para a classifica\u00e7\u00e3o da resist\u00eancia \na antimicrobianos e do comportamento bioqu\u00edmico de amostras de Escherichia coli  isoladas de frangos de corte.  \nTese (Doutorado em Ci\u00eancias Veterin\u00e1rias) - Universidade Federal do Rio Grande do Sul, Porto Alegre, 2009.   63rd WPDC/XXXIX ANECA \n PROSPECTIVA DE LA AV ICULTURA MEXICANA  \nVISI\u00d3N 2014 -2024  \n \nOrtega S\u00e1nchez de Tagle Jos\u00e9, Ortiz Mu\u00f1iz Ariel, Casta\u00f1o Meneses V\u00edctor, Carmona Medero Miguel \u00c1ngel,  \nGurria Trevi\u00f1o Francisco, Garc\u00eda G\u00f3mez Fern ando  y Z\u00fa\u00f1iga Quintanar Vanessa  \n \nsistemaproductoavesjosdt@live.com.mx  \n \n \nRESUMEN  \n \nProspectiva de la avicultura mexicana visi\u00f3n 2014- 2024.  La metodolog\u00eda m\u00e1s conveniente  y actual para estimar \ny prospectar la avicultura mexicana hacia el 2024 es la t\u00e9cnica de prospectiva en base a modelos econom\u00e9tricos. La \nprospectiva aporta elementos conceptuales y te\u00f3ricos para una mejor comprensi\u00f3n del mundo y sus tendencias m\u00e1s \nrelevantes. Esto permite ampliar el horizonte del pensamiento para actuar individual o colectivamente. En el \u00e1mbito de las actuaciones, posibilita establecer de manera realista qu\u00e9 cosas son ejecutables o no, en horizontes de corto y largo plazo. . \nSobre la definici\u00f3n m\u00e1s simple de Prospectivo, Relativo al futuro: presupuesto prospectivo.  Conjunto de an\u00e1lisis y estudios \nsobre las c ondiciones t\u00e9cnicas, cient\u00edficas, econ\u00f3micas y sociales de la realidad futura con el fin de anticiparse a ello en el \npresente ( Diccionario de la lengua espa\u00f1ola\n\u00a9 2005 Espasa -Calpe ) Algunas semejanzas de la prospectiva con la planeaci\u00f3n \nestrat\u00e9gica son: Pri orizan los elementos relevantes, Planean para la toma de decisiones, Buscan resultados concretos.  Las \ndiferencias m\u00e1s significativas son:  \n \nProspectiva  Planeaci\u00f3n estrat\u00e9gica  \nMarco te\u00f3rico global  Marco te\u00f3rico espec\u00edfico  \nIncorpora Megatendencias  Incorpora  micro tendencias  \nProyecta a largo plazo  Proyecta a mediano plazo  \nMetodolog\u00eda interdisciplinaria  Metodolog\u00eda administrativa  \nVa de lo general a lo particular  Va de lo particular a lo general  \nEs deductiva  Es inductiva  \n \nEconometr\u00eda . La econometr\u00eda como disciplina forma parte de las matem\u00e1ticas aplicadas, al utilizar conceptos \nmatem\u00e1ticos y estad\u00edsticos en la econom\u00eda, ha resultado de gran utilidad para el estudio sobre el comportamiento actual y futuro de los fen\u00f3menos econ\u00f3micos, as\u00ed como para identificar y cuantificar las relaciones estructurales que \u00e9stos mantienen entre s\u00ed, al igual que para expresar matem\u00e1ticamente sus teor\u00edas y para verificarlas con el instrumental que les \nproporciona la estad\u00edstica.  \nAl integrar en forma sistematizada los conocimien tos  sobre esta disciplina; describe los conceptos te\u00f3ricos y la \naplicaci\u00f3n de las t\u00e9cnicas mediante las cuales es posible:  \n1. Realizar el an\u00e1lisis estructural de las relaciones entre variables independientes y  dependientes . \n2. Estimar a partir de informac i\u00f3n hist\u00f3rica la evoluci\u00f3n futura de ciertas variables . \n3. Hacer planeaci\u00f3n micro y macroecon\u00f3mica; y   \n4. Evaluar la aplicaci\u00f3n de pol\u00edticas de producci\u00f3n, comercializaci\u00f3n, legislaci\u00f3n,  etc.  \nComo  se indic\u00f3, dichas t\u00e9cnicas se aplican en la presentaci\u00f3n m atem\u00e1tica y en la verificaci\u00f3n de cierta teor\u00eda \necon\u00f3mica, ya que mediante el an\u00e1lisis funcional se establecen las relaciones entre un fen\u00f3meno y las causas que \nhipot\u00e9ticamente lo determinan, relaciones que posteriormente se comprueban, preferentemente, mediante el uso de los \nm\u00e9todos de la estad\u00edstica inferencial. Una vez  que se comprueba que existen estas relaciones, se puede decir que se est\u00e1 en \ncondiciones de estimar el comportamiento futuro del fen\u00f3meno.  \nDise\u00f1o experimental . Al ser la econometr\u00eda la di sciplina que expresa una teor\u00eda econ\u00f3mica a trav\u00e9s de las \nmatem\u00e1ticas y de verificarse con m\u00e9todos estad\u00edsticos, es conveniente se\u00f1alar que la expresi\u00f3n matem\u00e1tica adopta la forma de modelos.  \nPara su formulaci\u00f3n se requiere metodol\u00f3gicamente de las siguien tes etapas de trabajo:  \n1. Evoluci\u00f3n de la teor\u00eda o hip\u00f3tesis,  \n2. Elaboraci\u00f3n  de la base de datos,  \n3. Variables de modelaje,  \n4. Especificaciones: es la exposici\u00f3n de la teor\u00eda econ\u00f3mica con s\u00edmbolos matem\u00e1ticos, es decir, la definici\u00f3n del  \n    modelo econom\u00e9trico dirigido a probar la teor\u00eda econ\u00f3mica.   63rd WPDC/XXXIX ANECA \n 5. Estimaci\u00f3n: la determinaci\u00f3n del valor num\u00e9rico de los par\u00e1metros del modelo.  \n6. Verificaci\u00f3n: Es la aceptaci\u00f3n o el rechazo de la teor\u00eda econ\u00f3mica mediante el m\u00e9todo de pruebas de hip\u00f3tesis  \n     est ad\u00edsticas.  \n7. Predicci\u00f3n: Se eval\u00faan relaciones estructurales y futuros resultados con base en el modelo establecido.  \n8. Utilizaci\u00f3n del modelo para fines de control, formulaci\u00f3n o evaluaci\u00f3n de  par\u00e1metros.  \n \nMARCO DE REFERENCIA \n \nMegatendencias  en alimentaci\u00f3n. El an\u00e1lisis de la Tendencia en el consumo global de prote\u00edna: El consumo \nmundial de prote\u00edna animal est\u00e1 aumentando en todos lados, se estima un consumo de carne de 43 Kg  per c\u00e1pita a nivel \nmundial, el incremento en ingreso genera demanda de prote\u00edna animal inmediatamente. Actualmente la producci\u00f3n de \nprote\u00edna animal esta en base a ma\u00edz y soya principalmente Con un 35 % de la cosecha de grano del mundo (de 2051, hasta \n2012  se creci\u00f3 a 860 millones de t oneladas), pero se requiere incrementar un 70 % para los pr\u00f3ximos 20 a\u00f1os usada para \nproducir prote\u00edna animal , El consumo de la carne tiene un gran impacto en el consumo final de grano y por tanto en la \nseguridad alimentaria global. En  1961, el 84,7% de la  ingesta media de energ\u00eda alimentaria de la poblaci\u00f3n mundial lleg\u00f3 a \npartir de productos vegetales. En 2013, este porcentaje se redujo al 72,8%. Desouzart. 2012, Las  primeras estimaciones del \n2013 demuestran que ha sido el a\u00f1o cuando la producci\u00f3n mundial  de carne de pollo super\u00f3 los 100 millones de toneladas \nm\u00e9tricas por primera vez en la historia. Organizaci\u00f3n para la Alimentaci\u00f3n y la Agricultura de las Naciones Unidas , Para \nla producci\u00f3n de huevos, un total de 2013 de aproximadamente 74 millones de ton eladas m\u00e9tricas parece probable. Por lo \ntanto, la producci\u00f3n de carne de ave puede decir que ha expandido a nivel mundial en aproximadamente un 43% desde el \na\u00f1o 2000, mientras que la producci\u00f3n de huevos ha crecido en m\u00e1s del 25% durante el mismo per\u00edodo. Organizaci\u00f3n para \nla Alimentaci\u00f3n y la Agricultura de las Naciones Unidas  La industria av\u00edcola mundial debe ser capaz de aprovechar su \nhabilidad de conversi\u00f3n alimenticia superior de mercado en el futuro respecto a sus competidores de carne roja. Pollo \nproporci\u00f3n 2 -a-1 conversi\u00f3n de alimento se compara favorablemente con la de la carne roja, que tienen relaciones de \nalimentaci\u00f3n de conversi\u00f3n de 4 -a-1 y de cerdo 3- a-1, World market projections 2012 A medida que m\u00e1s de la poblaci\u00f3n \nmundial vive en pa\u00edses men os desarrollados comienza a consumir m\u00e1s prote\u00ednas de  ave, ya que cuesta menos. Poultry \nUSDSA, November. \u00a9Copyright 2012, All Rights Reserved . Para ser un actor global, no podemos ignorar las tendencias \nfuturas hacia los productos que requieren menos recursos naturales (tierra, granos, agua, etc. ) como es el caso de aves de \ncorral y de la acuicultura\",  Desouzart. 2012  \n \nABSTRACT  \n \nThe important qu estion is whether this trend will keep 202 4 and relevant activities or strategies; this is obtained by \neconometric modeling technique,  and the variables that can positively or negatively alter this trend. Approaches  to \neconometric forecasting: Generally speaking, there are four approaches to economic forecasting based on time series : ( 1) \nUnlecuacionals regression models , (2) regression models of simultaneous equations , ( 3) autoregressive integrated moving \naverag e ( ARIMA ) And (4 ) autoregressive vector models (VAR ) . They all are used. Publication of E.P.E. Box and G.M. \nJenkins on time series analysis: forecasting and control (Time Series Analysis:  Forecasting and Control Established a new \ngeneration of predict ive tools . Popularly known as Box - Jenkins methodology ( b ) , but technically known as ARIMA \nmethodology , the emphasis of this new method of prediction is unlecuacionals  building or simultaneous equations but in \nthe properties  probabilistic or stochas tic series of economic type themselves under the philosophy of allowing << that the \ninformation speak for itself >> Unlike regression models , in which is explained by the k regressors x1, X3 , X3 ..... Xk , in \ntime series models BJ type,  Y1 can be explained by past or lagged values  of itself and stochastic error terms. Therefore, \nARIMA models are sometimes called -  theoretical models, because they cannot  be derived from any economic theory and \ntheories often economic base of simultaneous equations models. G iven the circumstances the Mexican poultry \nopportunities will be: Determine the growth of the Mexican poultry by 2024, Attend internal demand , Generate quality and \ncompetitiveness to export, , Focus on globalization , Strengthen the habits and customs of the  people , because today is a \npowerful non- tariff barrier .Support  of research institutes .Biosecurity , traceability, food safety , Limit the importation  \n.New marketing , competitiveness and value added niches, Develop  and generate export capacity and skil led human \nresources, Search  for export subsidies and be more competitive , legislate good production practices,  is a priority and \nstrategic resolve health disorders such as avian influenza H7N3.  And use econometric formulation to maximize the profits \nof the  farming . (Econometr\u00eda De Series De Tiempo   Damodan N. Gujarati, P\u00e1gina 718)  Index.  \n \n  \n  63rd WPDC/XXXIX ANECA \n MARCO CONCEPTUAL  \n \nSituaci\u00f3n de la Avicultura Mexicana . La avicultura mexicana durante 2012, aport\u00f3 el 0.77% en el PIB total, el \n19.7% en el PIB agropecuario y el 40.9% en el PIB pecuario.  El sector av\u00edcola mexicano participa con el 63% de la \nproducci\u00f3n pecuaria; 34.6% aporta la producci\u00f3n de pollo, 27.9% la producci\u00f3n de huevo y 0.10% la produc ci\u00f3n de pavo. \nDe 1994 al 2012 el consumo de insumos agr\u00edcolas, ha crecido a un ritmo anual de 2.8%, y cabe destacar que la avicultura \nes la principal industria transformadora de prote\u00edna vegetal en prote\u00edna animal.  Para el 2013, se proyect\u00f3,  que la avicult ura \ngenerar\u00e1 1 mill\u00f3n 188mil empleos, en 2012 la avicultura gener\u00f3 1 mill\u00f3n 167mil empleos. Cabe mencionar que el 60 % de \nlos empleos los genera la rama av\u00edcola de pollo, el 38% la de huevo y solo un 2% la de pavo.  La parvada nacional av\u00edcola \nen M\u00e9xico decreci\u00f3 2.45% en 2012, respecto al crecimiento obtenido en 2011, por lo tanto la parvada es la siguiente: 466 \nmillones de aves, 137 millones de gallinas ponedoras, 270 millones de pollos al ciclo y 512 mil pavos al ciclo.  Producci\u00f3n  \nde carne durante  el 2012:  Se produjeron 3.002 millones de toneladas de carne de pollo, muy por encima de los dem\u00e1s \nc\u00e1rnicos, la producci\u00f3n de huevo fue de 2.386 millones de toneladas y la de pavo 9 mil toneladas. La producci\u00f3n de pollo \nen M\u00e9xico, durante el periodo de 1994 a 2012 ha aumentado a un ritmo de crecimiento anual del 4.3 por ciento.  Durante el \n2012, el 94% de la producci\u00f3n de carne de pollo en M\u00e9xico se concentr\u00f3 en los siguientes estados y regiones de la Rep\u00fablica Mexicana: La Laguna, Veracruz, Quer\u00e9taro, Jalisco, Aguas calientes, Nuevo Le\u00f3n,   Puebla, Chiapas, San Luis \nPotos\u00ed, Michoac\u00e1n, Yucat\u00e1n, Estado de M\u00e9xico, Sinaloa, Guanajuato y Morelos.  Las importaciones mexicanas de carne de \nave, se han incrementado gradualmente. En 2012 se import\u00f3 14.2% m\u00e1s que el a\u00f1o anterior, pero lo doble de los \u00faltimos 15 a\u00f1os, lo que significa que la Tasa de Crecimiento Anual de 1996 al 2010 es de 10.2 por ciento. La comercializaci\u00f3n de pollo en M\u00e9xico se lleva cabo de la siguiente manera:  Vivo 33%, rosticero 26%, mercado p\u00fablico 19%, superm ercado 15%, \npiezas 6% y productos de valor agregado 4 por ciento.  Por lo que se refiere a la producci\u00f3n de huevo, de 1994 a 2012 \ncreci\u00f3 a un ritmo anual de 2.8%, lo que significa que en dicho lapso, su crecimiento fue de 63%. , La producci\u00f3n de huevo \nen M\u00e9x ico durante el a\u00f1o 2012 fue de   2.38 millones de toneladas (108.5 millones de cajas anuales). M\u00e9xico se ubic\u00f3 \ncomo el sexto productor de huevo a nivel mundial, despu\u00e9s de China (1,090 millones de cajas), EUA (218 millones de cajas), La Uni\u00f3n Europea (181 m illones de cajas),   India (178 millones de cajas) y Jap\u00f3n (114 millones de cajas). Cada caja \nde huevo consta de 360 unidades   (30 docenas de huevos se produjo fundamentalmente en los siguientes estados y regiones \ndel pa\u00eds como: Jalisco, Puebla, Sonora, la Laguna, Nuevo Le\u00f3n, Yucat\u00e1n y Guanajuato. La  comercializaci\u00f3n del huevo para \nconsumo humano, conocido tambi\u00e9n como huevo para plato\u2217 , suele hacerse a trav\u00e9s de tres v\u00edas principales: el 80% se \ncomercializa a granel en los mercados tradicionales y centrales de abasto, el 14% en tiendas de autoservicio en envases \ncerrados y el 6% restante, se destina al uso industrial. En los \u00faltimos a\u00f1o s, los precios del huevo han estado por debajo de \nlos \u00edndices de inflaci\u00f3n. La producci\u00f3n de pavo en M\u00e9xico durante 2012:  El 90% de la producci\u00f3n de carne de pavo en \nM\u00e9xico se localiza en 8   estados: Chihuahua (24%), Yucat\u00e1n (21%), Estado de M\u00e9xico (12%), Puebla (11%), Tabasco \n(6%) , Guerrero  (5%),   Veracruz (5%), Hidalgo (5%)   y en otros estados tan solo el 11%. La producci\u00f3n de pavo fue de \n8,190 toneladas anuales en 2012, con una tasa media de crecimiento anual de 1994 -2010 del 0.9%.  \nConsumo  humano.  En la alimentaci\u00f3n del mexicano, el sector av\u00edcola juega un papel importante, ya que 6 de cada \n10 personas incluyen en su dieta productos av\u00edcolas (huevo y pollo), esto se debe, en parte, a que los precios de huevo y \npollo se han reducido en t\u00e9rminos reales en la \u00faltima d\u00e9cada, y tambi\u00e9n a que ambos son alimentos nutritivos y vers\u00e1tiles \nen su preparaci\u00f3n. En  M\u00e9xico el consumo per -c\u00e1pita de pollo ha aumentado de 15.83 Kg. en 1994 a 25.8 kg. Durante  2012, \npara el 2013, se estima que el consumo de pollo alcance los 25.9 kg. El principal consumidor de huevo a nivel mundial es M\u00e9xico. El consumo per c\u00e1pita  del mexicano es de 20.8 Kg de huevo; casi un huevo diario. En segundo lugar se encuentra \nChina con 20.4 Kg;   en tercer lugar Singapur con 18,8 kg; Jap\u00f3n en cu arto lugar con 16.3 Kg, y en quinto Estados Unidos \ncon 15.5 Kg. Por lo que se refiere al pavo, los productores est\u00e1n haciendo esfuerzos para acercar el producto al consumidor, \n(Fuente,  UNA Uni\u00f3n Nacional de avicultores , SIAP , SAGARPA hasta Dic de 2012 elab orado  con datos reales ). \n \nHIP\u00d3TESIS  \n \nI. La rector\u00eda se establece en los procesos enfocados y estimados o calculados hacia el futuro.  \nII. Es factible establecer modelos econom\u00e9tricos que permitan estimar el futuro del sistema producto \u201chuevo para \nplato\u201d  \nIII. Es factible establecer modelos econom\u00e9tricos que permitan estimar el futuro del sistema producto  \u201cCarne de \npollo, gallina y pavo\u201d  \n \nOBJETIVOS  \n \nI. Generar un documento o Plan rector para los sistemas producto \u201cHuevo para plato\u201d y \u201cCarne de ave\u201d con t\u00e9cnicas \nde modelaje econom\u00e9trico   63rd WPDC/XXXIX ANECA \n II. Estimar las variables que permitan generar rector\u00eda en el sector o sistema  \nIII. Identificar y estimular \u00e1reas y m\u00e9todos de difusi\u00f3n que permitan clarificar a los productores y consumidores sobre \ne el beneficio de ingesta  de los producto s del sistema elegido  \n \nPROBLEM\u00c1TICA A ESTIM AR PARA GENERAR RECT OR\u00cdA HACIA EL 2024  \n \nSomos el SEXTO pa\u00eds productor de carne de pollo, Mantenemos un crecimiento  sostenido de 4.1 anual TMA en carne \nde ave. La avicultura  Aporta el 63 % de la prote\u00edna animal que consume un mexicano con huevo. Del 100% de la carne de \nave el pollo aporta el 78 % y aves de desecho el 20  % y pavo 2% . \nDefinici\u00f3n . Econometr\u00eda  es la disciplina que en el \u00e1mbito econ\u00f3mico mide las relaciones que existen entre un \nfen\u00f3meno bajo estudio y las variables que lo explican. La medici\u00f3n se hace con el instrumental matem\u00e1tico y las relaciones \nse verifican, generalmente, con las t\u00e9cnicas de la estad\u00edstica inferencial.El fen\u00f3meno econ\u00f3mico se estudi a a trav\u00e9s de la \nobservaci\u00f3n y su comportamiento, se registra preferentemente con datos cuantitativos (en ocasiones con cualitativos, expresados a trav\u00e9s de variables llamadas categ\u00f3ricas, dicot\u00f3micas, ficticios o dummy). La matem\u00e1tica permite expresar su \ncomportamiento a trav\u00e9s de ecuaciones que pretenden describir determinada teor\u00eda econ\u00f3mica, misma que en turno permite \na la estad\u00edstica indicar si es o no ver\u00eddica. As\u00ed, una vez que se expresa la  teor\u00eda econ\u00f3mica en forma uniecuacional o \nmultiecuacional, la estad\u00edstica proporciona los m\u00e9todos para corroborar s\u00ed se prueba o no con rigor t\u00e9cnico.  \nProp\u00f3sito . Con base en la definici\u00f3n, puede decirse que la econometr\u00eda tiene tres prop\u00f3sitos fundamentales:  \n1. Hacer el an\u00e1lisis estructural de las relaciones econ\u00f3 micas.  \n2. Predecir a partir de valores observados o hist\u00f3ricos de ciertas variables econ\u00f3micas, su evoluci\u00f3n futura.  \n3. Evaluar la aplicaci\u00f3n de pol\u00edticas microecon\u00f3micas (a nivel de empresa) y/o macroecon\u00f3micas (a nivel de los \ngrandes agregados de un pa\u00eds . \n \nEJES RECTORES DE LA POL\u00cdTICA SAGARPA VIS ION 2014 -2024  \n \nI. Prospectiva global y local Tendencias de producci\u00f3n en pollo, huevo y pavo en funci\u00f3n de indicadores de demanda y \nconsu mo y tendencias socioecon\u00f3micas  \nII. Tendencia en el costo y disponibilidad de Materias primas  \nIII. Sustentabilidad, competitividad, Innovacion, cadena de valor, alimentos funcionales y ovoproductos y posicionamiento en \nSistema  producto: \u201cHu evo para plato\u201d, \u201cCarne de Ave\u201d  \nIV. Normas inocuidad alimentaria para exportar y equivalencias para im portar  \nV. Recomendaciones de Bienestar en producci\u00f3n  av\u00edcola y Bienestar humano  \nVI. Campa\u00f1a de desmitificaci\u00f3n para pr oductos av\u00edcolas, huevo y pollo \nVII. Soluci\u00f3n a desordenes de salud y sanitarios en producci\u00f3n av\u00edcola, Financiamiento para contingencias sanitar ias y \nexportaci\u00f3n  \nVIII.  Estimar huella de carne o huella de carb\u00f3n en avicultura  \nIX. Posibles usos de la nanotecnolog\u00eda en producci\u00f3n av\u00edcola  \n \nBIBLIOGRAF\u00cdA Y FUENT ES \n \nI. Damodan N. Gujarati E conometr\u00eda De Series De Tiemp  , P\u00e1gina 718 . \nII. Diccionario de la lengua espa\u00f1ola \u00a9 2005 Espasa -Calpe . \nIII. Econom\u00eda  del Futuro . \nIV. La econom\u00eda del bien com\u00fan: http://www.gemeinwohl -oekonomie.org/es/ . \nV. Servicio de Informaci\u00f3n Agroalimentaria y Pesquera, M\u00e9xico -  \u00a9 - 2014,  http://www.siap.gob.mx/.  \nVI. SAGARPA -SENASICA  Secretaria De Agricultura, Ganader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n \n\u201cPrograma Sectorial  de Desarrollo Agropecuario, Pesquero  y Alimentario 2013- 2018\u201d . http://senasica.gob.mx/.  \nVII. UNA Uni\u00f3n nacional de avicultores http://una.org.mx/2013/.  \nVIII. Am\u00e9rica Latina: Visiones de desarrollo prospectivo . \n 63rd WPDC/XXXIX ANECA  THE EFFECT OF CHICKEN PARVOVIRUS ON SPECIFIC \nPATHOGEN FREE WHITE LEGHORN CHICKENS  \n \nEFECTO DEL PARVOVIRUS AVIAR EN POLLOS WHITE LEGHORN  \n LIBRES DE PAT\u00d3GENOS ESPEC\u00cdFICOS \n \nN. Ortega -HeinlyAB, T. GirshickA, M. KhanB, G. RisattiB, and L. ZsakC \n \nACharles  River Laboratories Avian Vaccine Services, 67 Baxter Road, Storrs, CT 06268  \nBDepartment of Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT  \nCSoutheast Poultry Research Laboratory, USDA -ARS, Athens, GA  \n \nRESUMEN  \n \nLas enfermedades ent\u00e9ricas virales han causado p\u00e9rdidas econ\u00f3micas en la industria aviar a nivel mundial. La \nprincipal enfermedad ent\u00e9rica viral que afecta a los pollos de engorda es el s\u00edndrome runting- stunting (RSS). Los \ns\u00edntomas de RSS incluyen retraso en el crecimiento  y falla para alcanzar el peso al mercado. Estudios previos en \npollos de engorda mostraron que el parvovirus a viar (ChPV) puede ser una de las causas de RSS. Hasta la fecha, el \nChPV no ha sido estudiado por completo en pollos White Leghorn libres de pat\u00f3ge nos espec\u00edficos.  \nPara demostrar el efecto del ChPV en pollos, hembras SPF White Leghorn de 6 semanas de edad fueron \ninfectadas oralmente con el ChPV, y la eliminaci\u00f3n del virus fue medida a diferentes tiempos hasta el d \u00eda 28. Para \nobservar si el virus pod\u00eda ser detectado en secciones del duodeno y el yeyuno por medio de inmunohistoqu\u00edmica, \npollos hembras SPF White Leghorn de 6 semanas de edad fueron  inoculadas con ChPV. A los d\u00edas  7, 14 y 21, las \nsecciones de intestino se removieron y se filtraron para det ectar la presencia del virus. En ambos casos, los \nresultados fueron comparables con aquellos observados en pollos de engorda.  \n \nINTRODUCTION  \n \nViral enteric disease has caused an economic loss in the poultry industry worldwide due to  diseased b irds not \nreach ing proper market weight.  The major viral enteric disease effecting broiler chickens is runting -stunting \nsyndrome (RSS).  Symptoms of RSS include  stunted growth and watery diarrhea.  Birds become stunted due to the \nlack of nutrients absorbed.  Upon necropsy, thin -walled intestines filled with a watery content are seen (1 ). Previous \nstudies in broilers  show  chicken p arvovirus (ChPV)  may be a major factor  in the cause of RSS  (2). More studies are \nneeded in understanding the viral protein roles of ChPV in RSS which can lead to the development of  a proper \nvaccine.  Because most of the specific pathogen free (SPF) broilers have been exposed to ChPV, a proper study \nmodel needs  to be established.  The SPF white leghorn chickens provided by Charles River are ChPV neg ative.  \nAlthough they are layer chickens , viral shedding and immunohistochemistry can be compared to previous studies \nusing broilers infected with ChPV.  \n \nMATERIALS AND METHODS  \n \nTo measure virus shedding, c loacal swabs were collected fr om 10 six w k old female SPF White Leghorn \nchickens.  The inoculum used, ABU -P2, was made from homogenized intestines of ABU -P1ChPV infected chickens.    \nEach bird was inoculated via oral route with 0.1mL  of ABU -P2. Cloacal swabs were collected at  0, 4, 7, 10, 14, 21, \nand 28 d  post inoculation.  Each swab was DNA extracted and amplified by ChPV PCR.  Primers were developed \nfollowing Zsak, et al. publication using PCR for the detection of ChPV  (3). \nTo see whether the virus can be detected in the duodenum and jejunum sectio ns by i mmunohistochemistry, 20 \nsix w k old SPF female chickens were inoculated with 0.1ml ABU -P2, orally . At d 0, 7, 14, and 21, the intestinal \nsections were removed and screened for the p resence of virus  using antibodies against the viral protein VP2 . \n \n \n \n \n 63rd WPDC/XXXIX ANECA  RESULTS AND DISCUSSION \n \nWhen comparing viral  shedding between ChPV infected broilers and SPF white leghorn chickens, 100% of the \nwhite leghorns were shedding at d 10 post inoculation while the broilers we re at d  14 post infection.  At 14 d post \ninoculation,  the SPF white leghorns continued at 100% while the broilers dropped to 80%.  \nDuring harvest of the SPF white leghorn duodenum and jejunum sections, intestinal walls appeared thin and  \nfilled with excessive  amounts of fluid.  Immunohistochemistry  show s presence of ChPV in the intestinal epithelium, \nsimilar to that of infected broilers.  Therefore, when not factoring in differences in bird weight, SPF white leghorn \nchickens can be used in place of SPF broilers when studying the roles of ChPV viral protein s in the cause of RSS.  \n  \nREFERENCES  \n \n1. Zavala, G., and Sellers, H. Runting -Stunting Syndrome. The Poultry Informed Prof. 85:1- 4. 2005.  \n2. Zsak, L., Cha, R.M., and Day, J.M. Chicken parvovirus -induced Runting -Stunting Syndrome in young \nbroile rs. Avian Dis. 57:123 -127. 2013.  \n3.  Zsak, L., Strother, K.O., and Day, J.M. Development of a polymerase chain reaction procedure for \ndetection of chicken and turkey parvoviruses. Avian Dis. 53:83 -88. 2009.  \n 63rd WPDC/XXXIX ANECA  LOS SISTEMAS PRODUCT O AV\u00cdCOLAS MEXICANOS  \n\u201cCARNE DE AVE\u201d Y \u201cHUEVO PARA PLATO\u201d  \n \nOrtega S\u00e1nchez de Tagle Jos\u00e9, Ortiz Mu\u00f1iz  Ariel , Casta\u00f1o Meneses  V\u00edctor , Gurria Trevi\u00f1o  Francisco , Garc\u00eda \nG\u00f3mez  Fernando  y Z\u00fa\u00f1iga Quintanar  Vanessa  \n \nsistemaproductoavesjosdt@live.com.mx  \n \nABSTRACT  \n \nLivestock Committee System Product.  The product systems emerge as a need within livestock development, \nplanning and its integration with the livestock production -consumption chains.  Therefore one of the goals  is to \ndevelop the agriculture sector in economic and financial terms , integrating the primary producer to the supply chain \nthat culminates in the consumer and government efforts to steer producers to offer healthy agroproducts  and quality \nfood for whole society.  \nThe m ission of the livestock section of this program is  \"To design, implement and operate the policy of the \nlivestock sector to promote the consolidation and development of livestock production sector; increase  its \nmodernization , productivity  and competitiveness , and improve producers revenue by promoting , regulating and \norganizing the activity and better linkage with transformation processes , marketing and consumption as well as to \nprevent diseases in this area and ensure that foods are ha ndled with quality procedures and safety , to increase their \nparticipation in national and international markets through the promotion, regulation and certification of production \nprocesses and raw ingredients   that are used in them, and to contribute to th e preservation of the environment \" . \nPart of the livestock section establishes  \"promoting the producer organization and integration of livestock food \nchains  which will be improved by:  Articulating the actions of the various players involved production proc esses and \nconsumption of food and livestock products and increase  Participatory Committees by -  product species and its \nrelationship with the State Committees livestock Promotion and Protection, so to act as  consultation bodies for \nmanagement of livestock development .\u201d \n \nINTRODUCCI\u00d3N  \n \nLos sistemas producto surgen como una necesidad dentro de la planeaci\u00f3n del desarrollo ganadero y av\u00edcola y \nsu integraci\u00f3n con las cadenas de Producci\u00f3n -consumo pecuario.  \nPor lo tanto uno de los objetivos es desarrollar el sector agroalimentario en t\u00e9rminos econ\u00f3micos y financieros, \nintegrando al productor primario a la cadena productiva que culmina en el consumidor as\u00ed como dirigir los esfuerzos \ngubernamentales para que los productores oferten alimentos sanos y agroproductos alimenticios de calidad para toda \nla sociedad. El apartado de ganader\u00eda de este Programa, se establece como Misi\u00f3n para el sector \u201cDise\u00f1ar, instrumentar y operar la pol\u00edtica del sector pecuario para promover  la consolidaci\u00f3n y desarrollo de la producci\u00f3n  \nganadera; elevar su tecnificaci\u00f3n, productividad y competitividad, as\u00ed como mejorar los ingresos de los productores, mediante el fomento, regulaci\u00f3n y organizaci\u00f3n de la actividad y su mejor vinculaci\u00f3n con los procesos de \ntransformaci\u00f3n, comercializaci\u00f3n  y consumo, as\u00ed como la de proteger a este sector de enfermedades y asegurar que \nlos alimentos sean manejados con procedimientos de calidad e inocuidad, a fin de incrementar su participaci\u00f3n e los mercados nacionales e internacionales, a trav\u00e9s de la promo ci\u00f3n , regulaci\u00f3n y certificaci\u00f3n de los procesos \nproductivos y de los insumos que son utilizados en los mismos, as\u00ed como para contribuir a la preservaci\u00f3n del medio \nambiente\u201d . \nComo parte del apartado de ganader\u00eda del Programa Sectorial  establece \u201cPromover la organizaci\u00f3n de \nproductores e integraci\u00f3n de cadenas agroalimentarias pecuarias\u201d lo cual se impulsara \u201cArticulando las acciones de los diferentes agentes econ\u00f3micos que participan e los procesos producci\u00f3n consumo de alimentos y productos pecuarios e impulsando los Comit\u00e9s Participativos por Especie -Producto y su vinculaci\u00f3n con los Comit\u00e9s Estatales \nde Fomento y Protecci\u00f3n Pecuaria, para que funjan como organismos de consulta y gesti\u00f3n de fomento ganadero\u201d.  \n \nMISI\u00d3N \n \nPropiciar la inte graci\u00f3n de los agentes econ\u00f3micos que conforman las cadenas produ cci\u00f3n\u00b4 -proceso -\ncomercializaci\u00f3n consumo de las especies pecuarias y definir acciones consensuadas para su fortalecimiento.  \n 63rd WPDC/XXXIX ANECA  VISI\u00d3N  \n \nSer foros de an\u00e1lisis y concertaci\u00f3n para la vinculaci\u00f3n de los eslabones de las cadenas productivas, as\u00ed como \npara la soluci\u00f3n eficiente y eficaz de la problem\u00e1tica que las afecta, con el fin elevar la producci\u00f3n y productividad a \nlo largo de las cadenas, para ofrecer productos de origen animal suficientes, de calidad y a precios competitivos, \npromoviendo una rentabilidad equitativa.  \n \nOBJETIVO  \n \nPropiciar la integraci\u00f3n de los agentes econ\u00f3micos que participan en las diferentes fases de las cadenas \nproductivas mediante foros permanentes de consulta y an\u00e1lisis de la situaci\u00f3n ganadera que permitan la definici\u00f3n \nde medidas de fomento par a el fortalecimiento de la planta productiva primaria y en los que se establezcan medidas  \nconjuntas para dar soluci\u00f3n a la problem\u00e1tica.  \n  \nFUNDAMENTO JUR\u00cdDICO  \n \nConstituci\u00f3n Pol\u00edtica de  los Estados Unidos Mexicanos , Art\u00edculos 25, 26 y 27, Ley  Org\u00e1nica de la \nAdministraci\u00f3n P\u00fablica Federal . \nArt\u00edculos 9 y 35 ,Ley de Desarrollo Rural Sustentable , Art\u00edculos 149, 150, 151, 152, 153 y 179.  \n \nINTEGRACI\u00d3N DE COMIT\u00c9S POR SISTEMA \u2013 PRODUCTO  \n \nLa ganader\u00eda enfrenta diversos niveles de tecnificaci\u00f3n y productividad, de integraci\u00f3n vertical u horizontal y \nproblem\u00e1ticas espec\u00edficas originadas por la disposici\u00f3n de insumos, caracter\u00edsticas de la demanda y la incidencia de \nla oferta ya sea nacional o  internacional de productos iguales o suced\u00e1neos,  entre otros.  \nPor lo tanto surge la necesidad de impulsar la operaci\u00f3n de Comit\u00e9s Participativos Nacionales que se aboquen \nal an\u00e1lisis y resoluci\u00f3n de problemas de \u00edndole general (programas de fomento, normalizaci\u00f3n de productos, esquemas de r\u00e9gimen comercial y arancelario, entre otros), a la conjunci\u00f3n  y an\u00e1lisis de propuestas emanadas de los \nComit\u00e9s Regionales, as\u00ed como a la definici\u00f3n de esquemas de integraci\u00f3n vertical y apoyos  para su impulso, los que \nser\u00e1n impulsados por los Comit\u00e9s Regionales.  \nPor su parte, cada regi\u00f3n federativa p resenta un diferente potencial de producci\u00f3n pecuaria, as\u00ed como una \nproblem\u00e1tica espec\u00edfica, de acuerdo a las especies que en ella se desarrollan y por ello, debe ser objeto  de atenci\u00f3n \npor las autoridades estatales, Delegaciones del Gobierno Federal, productores y dem\u00e1s agentes locales, cuya injerencia se circunscriba a este \u00e1mbito; de esta manera se apoya el proceso de Federalizaci\u00f3n que impulsa el \nEjecutivo Federal.  \nBajo la premisa d e que en el pa\u00eds existen diversas entidades cuyas caracter\u00edsticas presentan similitudes en los \nsistemas de producci\u00f3n pecuaria, en aspectos zoosanitarios, de complementaci\u00f3n, se efectuar\u00e1 una regionalizaci\u00f3n, \ntomando en cuenta las propuestas de productores, industriales, agentes comerciales y autoridades estatales, a fin \npromover la vinculaci\u00f3n de los grupos o subcomit\u00e9s, para propiciar el intercambio de experiencias, y en su caso, la \ndefinici\u00f3n de acciones conjuntas, bajo la figura de Comit\u00e9s Regionales por Sistema -Producto.  \n \nFUNCIONES DE LOS COMIT\u00c9S POR SISTEMA -PRODUCTO  \n \nConcertar los programas de producci\u00f3n agropecuaria del pa\u00eds  \nEstablecer los planes de expansi\u00f3n y repliegue estrat\u00e9gicos de los vol\u00famenes y calidad de cada producto de \nacuerdo co n las tendencias de los mercados y las condiciones del pa\u00eds.  \nEstablecer las alianzas estrat\u00e9gicas y acuerdos para la integraci\u00f3n de las cadenas productivas de cada sistema.  \nEstablecer las medidas y acuerdos para la definici\u00f3n de normas y procedimientos apl icables en las \ntransacciones comerciales y la celebraci\u00f3n de contratos sin manejo de inventarios f\u00edsicos.  \nParticipar en la definici\u00f3n de aranceles, cupos y modalidades de importaci\u00f3n y generar mecanismos de \nconcertaci\u00f3n entre productores primarios, industr iales y los diferentes \u00f3rdenes de gobierno para definir las \ncaracter\u00edsticas y cantidades de los productos, precios, formas de pago y apoyos del Estado.  \nDifundir informaci\u00f3n sobre producci\u00f3n, comercializaci\u00f3n, transformaci\u00f3n y consumo de productos, \nsubprodu ctos e insumos pecuarios.  \nExaminar la situaci\u00f3n de las cadenas  producci\u00f3n -consumo pecuaria en el \u00e1mbito nacional, regional y estatal.  63rd WPDC/XXXIX ANECA  Analizar los programas de fomento y protecci\u00f3n pecuaria, con la finalidad de proponer su adecuaci\u00f3n y \ncomplementaci\u00f3n, par a la obtenci\u00f3n de mejores resultados.  \nDifundir programas y acciones de apoyo para el fomento ganadero y agroindustrial.  \nDefinir proponer esquemas para la vinculaci\u00f3n de los agentes econ\u00f3micos de las cadenas productivas pecuarias \ne impulsar su aplicaci\u00f3n.  \nConsensar los requerimientos de tecnolog\u00eda ganadera y agroindustrial, con el objetivo de proponer ante las \ninstancias correspondientes, su generaci\u00f3n, validaci\u00f3n y transferencia, as\u00ed como el impulso de sistemas integrales  de \nasistencia t\u00e9cnica.  \nInducir la aplicaci\u00f3n de medidas para la conservaci\u00f3n y mejoramiento de los recursos naturales y de \ndisminuci\u00f3n del impacto ambiental por las unidades de producci\u00f3n pecuaria y agroindustrial.  \nDeterminar e impulsar acciones de apoyo a la transformaci\u00f3n y comercializaci\u00f3n de productos ganaderos.  \nAnalizar la evoluci\u00f3n del intercambio comercial, para proponer las adecuaciones de los reg\u00edmenes comercial o arancelario de productos, subproductos e insumos ganaderos, que propicien una mayor competitividad de la producci\u00f3n nac ional.  \nImpulsar la inversi\u00f3n y capitalizaci\u00f3n de las explotaciones ganaderas, a trav\u00e9s de la promoci\u00f3n de la \ncertificaci\u00f3n de la peque\u00f1a propiedad ganadera. Apoyar la consecuci\u00f3n de los acuerdos y compromisos emanados de los Comit\u00e9s.  \nArt\u00edculo 149.  La Comis i\u00f3n Intersecretarial promover\u00e1 la organizaci\u00f3n e integraci\u00f3n de Sistemas - Producto, \ncomo comit\u00e9s del Consejo Mexicano, con la participaci\u00f3n de los productores agropecuarios, agroindustriales y comercializadores y sus organizaciones, que tendr\u00e1n por objeto:   \nI. Concertar los programas de producci\u00f3n agropecuaria del pa\u00eds;  \nII. Establecer los planes de expansi\u00f3n y repliegue estrat\u00e9gicos de los vol\u00famenes y calidad de cada producto de acuerdo con las tendencias de los mercados y las condiciones del pa\u00eds;  \nIII. Establecer las alianzas estrat\u00e9gicas y acuerdos para la integraci\u00f3n de las cadenas productivas de cada sistema;  \nIV. Establecer las medidas y acuerdos para la definici\u00f3n de normas y procedimientos aplicables en las transacciones comerciales y la celeb raci\u00f3n de contratos sin manejo de inventarios f\u00edsicos;  \nV. Participar en la definici\u00f3n de aranceles, cupos y modalidades de importaci\u00f3n; y  \nVI. Generar mecanismos de concertaci\u00f3n entre productores primarios, industriales y los diferentes \u00f3rdenes de gobierno  para definir las caracter\u00edsticas y cantidades de los productos, precios, formas de pago y apoyos del Estado.  \nLos Comit\u00e9s Sistema -Producto constituir\u00e1n mecanismos de planeaci\u00f3n, comunicaci\u00f3n y concertaci\u00f3n permanente \nentre los actores econ\u00f3micos que forma n parte de las cadenas productivas.  \nLa Comisi\u00f3n Intersecretarial promover\u00e1 el funcionamiento de los Sistemas -Producto para la concertaci\u00f3n de \nprogramas agroindustriales y de desarrollo y expansi\u00f3n de mercados.  \nA trav\u00e9s de los Comit\u00e9s Sistema -Producto, el  Gobierno Federal impulsar\u00e1 modalidades de producci\u00f3n por contrato y \nasociaciones estrat\u00e9gicas, mediante el desarrollo y adopci\u00f3n, por los participantes, de t\u00e9rminos de contrataci\u00f3n y convenios conforme a criterios de normalizaci\u00f3n de la calidad y cotizaci ones de referencia.  \nArt\u00edculo 150. Se establecer\u00e1 un Comit\u00e9 Nacional de Sistema -Producto por cada producto b\u00e1sico o estrat\u00e9gico, \nel cual llevar\u00e1 al Consejo Mexicano los acuerdos tomados en su seno.  \nPara cada Sistema -Producto se integrar\u00e1 un solo Comit\u00e9 Na cional, con un representante de la instituci\u00f3n responsable \ndel Sistema -Producto correspondiente, quien lo presidir\u00e1 con los representantes de las instituciones p\u00fablicas \ncompetentes en la materia; con representantes de las organizaciones de productores; con  representantes de las \nc\u00e1maras industriales y de servicio que est\u00e9n involucrados directamente en la cadena producci\u00f3n -consumo y por los \ndem\u00e1s representantes que de conformidad con su reglamento interno establezcan los miembros del Comit\u00e9.  \nLos comit\u00e9s de S istema -Producto estar\u00e1n representados en el Consejo Mexicano mediante su presidente y un \nmiembro no gubernamental electo por el conjunto del Comit\u00e9 para tal prop\u00f3sito.  \nArt\u00edculo 151. Se promover\u00e1 la creaci\u00f3n de los comit\u00e9s regionales de Sistema -Producto, c uyo objetivo central \nes el de planear y organizar la producci\u00f3n, promover el mejoramiento de la producci\u00f3n, productividad y rentabilidad \nen el \u00e1mbito regional, en concordancia con lo establecido en los programas estatales y con los acuerdos del Sistema -\nProducto nacional.  \nArt\u00edculo 152. Los Sistema -Producto en acuerdo con sus integrantes podr\u00e1n convenir el establecimiento de \nmedidas que, dentro de la normatividad vigente, sean aplicables para el mejor desarrollo de las cadenas productivas en que participan.  \nArt\u00edculo 153. La Comisi\u00f3n Intersecretarial, con la participaci\u00f3n del Consejo Mexicano, establecer\u00e1 los \nlineamientos para el Programa Nacional de Fomento a la Organizaci\u00f3n Econ\u00f3mica del Sector Rural.  63rd WPDC/XXXIX ANECA  Art\u00edculo 179. Se considerar\u00e1n productos b\u00e1sicos y estrat \u00e9gicos, con las salvedades, adiciones y modalidades \nque determine a\u00f1o con a\u00f1o o de manera extraordinaria, la Comisi\u00f3n Intersecretarial, con la participaci\u00f3n del Consejo \nMexicano y los Comit\u00e9s de los Sistemas -Producto correspondientes, los siguientes:  \nI. Ma\u00edz;  \nII. Ca\u00f1a De Az\u00facar;  \nIII. Frijol;  \nIV. Trigo;  \nV. Arroz;  VI. Sorgo;  \nVII. Caf\u00e9;  \nVIII. Huevo;  \nIX. Leche;  \nX. Carne De Bovinos, Porcinos, Aves; y  \nXI. Pescado.  \n \nREFERENCIAS  \n \n1. Lineamientos de Integraci\u00f3n y Operaci\u00f3n, Comit\u00e9s Sistema -Producto Pecuario,  Coordinaci\u00f3n General de \nGanader\u00eda, 2002 . \n2. Reglamento Interno de los Comit\u00e9s Nacionales Sistema -Producto Pecuario, Coordinaci\u00f3n General de \nGanader\u00eda, 2005 . \n3. Plan rector .  \n4. Ley de Desarrollo Rural Sustentable, 7 de Diciembre 2001 . \nANEXO I  Ley de Desarrollo Rur al Sustentable . 63rd WPDC/XXXIX ANECA  HIGH LEVEL OF PROTECTION ACHIEVED BY VACCINATION \nWITH A RECOMBINANT HVT -NDV VECTOR VACCINE AGAINST \nDIFFERENT GENOTYPES OF NEWCASTLE DISEASE VIRUS \nPRESENT IN LATIN AMERICA  \n \nNIVEL ALTO DE PROTECCI\u00d3N ALCANZADO MEDIANTE LA UTILIZACI\u00d3N \nDE UNA V ACUNA RECOMBINANTE VECTOR HVT -NDV CONTRA \nDISTINTOS GENOTIPOS DE VIRUS DE LA ENFERMEDAD DE NEWCASTLE \nPRESENTES EN LATINOAM\u00c9RICA  \n \nV. PalyaA, T. Tat\u00e1r -KisA, T. Mat\u00f3A, B. Felf\u00f6ldiA, E. Kov\u00e1csA, and Y. GardinB \n \nAScientific Support and Investigation Unit, Ceva -Phylaxia, Ceva Animal Health, 5 Sz\u00e1ll\u00e1s utca,  \nBudapest, Hungary, H -1107 \nBCeva Animal Health, Libourne, France  \n \nRESUMEN  \n \nLa enfermedad de Newcastle (ND) es una de las enfermedades m\u00e1s importantes que causan grandes p\u00e9rdidas a \nla industria av\u00edcola. En d\u00e9cadas pasadas, ha habido un cambio importante en los genotipos del virus de la ND \n(NDV) que han sido identificados como los prevalentes en la avicultura. La vacunaci\u00f3n juega un papel importante \nen la prevenci\u00f3n de la enfermedad. Se prob\u00f3 la eficacia de una vacuna recombinante del herpesvirus de pavos \n(HVT) que expresa el gen F de una cepa genotipo I del NDV contra cepas del NDV  velog\u00e9nicas que representan a \nlos genotipos presentes en Latinoam\u00e9rica (Por ejemplo Genotipos V , VII y VIId). Pollos SPF de un d\u00eda de edad \nfueron vacunados y desafiados a las 4 semanas de edad con una de las tres cepas velog\u00e9nicas de NDV pertenecientes \na (A) genotipo V (muestra mexicana), (B) genotipo VIIb (muestra peruana) o (C) genotipo VIId (muestra asi\u00e1tica). \nLa evaluaci\u00f3n de la protecci\u00f3n se realiz\u00f3 en base a la presencia o ausencia de signos cl\u00ednicos y la reducci\u00f3n de la eliminaci\u00f3n del virus. El uso  de la vacuna recombinante previno los signos cl\u00ednicos y redujo de manera significativa \ntanto la eliminaci\u00f3n oro nasal como la cloacal de todas las cepas utilizadas en el desaf\u00edo. Se resultados detallados.   \nSUMMARY  \n \nIn the past decades, there has been a major shift in the genotypes of velogenic NDV strains responsible for \nsevere epidemics in different parts of the world . Vaccination plays an important role in the prevention of the disease. \nEfficacy of a recombinant tu rkey herpesvirus ( rHVT) vaccine expressing the F -gene of a genotype I NDV strain was \ntested against velogenic NDV strains representing the genotypes present in Middle  and South America (i.e.: \ngenotype V and VII). SPF ch icks had been vaccinated at one d old  and challenged at four wk of age with one of \nthree  velogenic NDV strains belonging to (A) genotype V (Mexican isolate), (B) genotype VII b (Peruvian isolate) or \n(C) genotype VIId (Asian isolate). Level  of protection was evaluated  on the basis of clinical s igns and mortality as \nwell as  reduction of challenge virus shedding. Vaccination with the recombinant vaccine prevented clinical signs \nand reduced significantly both oro- nasal and cloacal shedding of all tested challenge strains . \nVelogenic strains of ND virus (NDV) cause a devastating disease of poultry in Middle  and South America, \nAsia, Africa  and Middle East, till today. Considerable genetic diversity has been shown  among NDV strains. The \ngenotype of velogenic NDV strains show s geographical region specific occurrence and temporal distribution with \napparent links to well -defined epizootics ( 2,4). Genotype V, VII and VIII are the predominant genotypes of \nvelogenic NDV causing the recent epidemics in poultry. Among them  genotype VI I is the most widespread, it has \nbeen associated to many outbreaks in Asia, Africa, Middle East and some South America n countries  (3).  \nVelogenic NDV strains from Mexico (1998 -2006) were characterized as members of genotype V ( 7), while the \nstrains detected in  Venezuela and Peru belong to genotype VII . The Venezuelan  isolates are  grouping together with \ngenotype VIId strains from China  (8), while the  Peruvian ones are  most closely related to a Malaysian strain \nBMYBU87078, described as lineage 5b (genotype VIIb) by Aldous et al.  (1). 63rd WPDC/XXXIX ANECA  Control of Newcastle disease, in addition to good biosecurity practices, primarily relies on preventive \nvaccination . Most vaccination programmes for ND include the use of live or inactivated vaccines. The  continuous \noccurrence of ND outbreaks in commercial poultry flocks in many part s of the world indicate s that routine \nvaccination in the field often fails to induce adequate immunity to control ND. The presence of maternally derived \nantibodies (MDA) also interferes with the establishment of an early and persisting immunity after single or even \nrepeated  vaccination during the first 2 to 3 weeks of life.  \nAnother option for vaccinal protection  against ND  is the application  of recombinan t HVT vaccines, expressing  \nthe F gene of NDV  (rHVT -NDV vaccines) . There are several advantages of this type of vaccines, such as safety (i.e. \nlack of post -vaccinal respiratory reactions, go od hatchability after in ovo vaccination)  efficacy even in the presence \nof MDA to  NDV and life -long immunity with a single application ( 5,6).  \nEfficacy of a rHVT -NDV vaccine, expressing F gene from a serotype I NDV strain was tested against three \ndifferent NDV strains representing the genetic groups present in Latin America (ie. g enotype V , VIIb and VIId ) \nunder controlled experimental conditions.  \n \nMATERIALS AND METHODS  \n \nChickens. One d ay old SPF layer -type chickens were used for the experiment.  The chicks were kept in isolated \nanimal rearing house during the immunization period. Challenge infections and post -challenge observations were \nconducted in isolators.  \nVaccine and challenge viruses. The cryo -preserved cell -associated rHVT -NDV vaccine (Vectormune\u00ae ND, \nCeva Animal Health)  expressing the F protein of the avirulent D26/76 genotype I NDV strain was used in the study. \nThe vaccine was diluted to dose in the corresponding diluent. The challenge virus strains were isolated from field \nND cases and propagated in embryonated SPF hen s\u2019 eggs. All of them proved to be free from extraneous agents. \nThe isolate representing genotype V originated from Mexico, 200 8 (identification: D516/1  MX, GenBank accession \nnumber JQ002630, ( 5)). As the representative of g enotype VIIb, a  Peruvian NDV strain from 2005 (D575/6 PE) was \nselected. This challenge strain shows 98% nucleotide homology on the partial F gene sequence with the \nPoultry/Peru/1918 -03/2008 strain ( 3). Genotype VII d strain used in the study , that represents the genotype reported \nfrom Venezuela, was a Chin ese isolate from 2010 (D1500/2/1).  The Venezuelan NDV isolate described by Perozo et \nal. (8) shows high homology with the genotype VIId isolate (BLAST Search)  used in our experiment . \nStudy design.  One d old chicks were assigned to two groups: one was vaccinated with one dose of the rHVT -\nNDV vaccine s.c., the other grou p remained untreated. At 28 d of age, 30 vaccinated and 30 con trol chickens were \nsubmitted to challenge infection ( 3 subgroup s were set from both groups according to the challenge virus used; \nnumber of birds/subgroup was 10). Infection was performed with a dose of 5.0 log 10 ELD 50/chicken via intra -nasal \nroute.  During the post -challenge observation period clinical signs and mortality were monitored daily. Oro -nasal \n(choanal slit) and cloacal swabs w ere collected at 2, 4 , and 7 d post-challenge.  \nMeasurement of NDV RNA load in the swab samples.  RNA was extracted from the swab samples by \nQIAxtractor Virus kit (Qiagen) according to the manufacturer\u2019s instructions. Then quantitative real-time one -step \nRT-PCR, amplifying a fragment of M gene (TaqMan\u00ae NDV reagents and controls, Life TechnologiesTM) was \nperformed . Internal positive control supplied by the manufacturer was included. Tit er equivalent unit was calculated \nby extrapolation from sample Ct to the Ct of standard (total RNA extracted from tenfold dilution series of the relevant challenge virus strain with known ELD\n50 titer).  \n \nRESULTS  \n \nAll non-vaccinated  control chickens died due to the challen ge infection between 4 to 6 d  post-infection , while \nall vaccinated chickens proved to be protected both against clinical signs and  mortality attributable to challenge.  \nChallenge virus RNA load measure ment results a re summarized in T able 1.  \nNDV RNA load in the oro -nasal swabs of the non- vaccinated  control birds was higher compared to the cloacal \nswabs at 2 days post -challenge (dpch), but the level of shedding via the two routes became comparable and very \nhigh at 4 dpch , when mortality started . No data available for the control group since all control birds died by  7 dpch. \nThere was a very strong, significant effect of vaccination on the shedding  of challenge virus. Only limited shedding  \nwas detected via the  oro-nasal route  of vaccinated chickens (3.5 -5.5 log 10 reduction compared to the controls was \nachieved at 4 dpch). Cloacal shedding was more efficiently suppressed resulting in no detectable NDV RNA in the \ncloacal swabs in the great majority of samples (only a few sa mples contained very low level of NDV RNA at a \nsingle sampling date in the subgroup challenged with the genotype VIId strain). C hallenge virus RNA load  of the 63rd WPDC/XXXIX ANECA  cloacal samples in the vaccinated subgroups was by 5. 5-6.6 log 10 lower compared to the correspond ing control \nsubgroup . \n \nDISCUSSION  \n \nEfficacy of a recombinant HVT -NDV vaccine, expressing the F -gene of a NDV strain belonging to genotype I \nwas tested against three different NDV challenge strains. The challenge strains represent all those genetic groups of \nvelogenic NDV which are prevalent  in Middle  and South America. Although the insert in the vaccine was \nheterologous to the challenge strain (the donor strain belongs to a very distinct genotype) , a single vaccination with \none dose at day -old provided not only full protection against clinical signs and mortality , but strongly reduced (by \nthe oro -nasal route) or even totally prevented (by the cloacal route) the shedding of challenge virus.  The strong \nimmunity  which developed in the vaccinated birds was able to prevent  the dissemination of challenge virus in the \nbody  (no cloacal shedding) , and very strong ly suppress ed its local replication  in the oro -nasal mucosa. Our results \nindicate  that very high level of protection can be achieved with the tested rHVT -NDV vaccine against genetically \ndivergent velogenic NDV strains  circulating in Middle  and South America.  \n \nREFERENCES  \n \n1. Aldous, E. W., J. K. Mynn, J. Banks and D. J. Alexander . A molecular epidemiological study of avian \nparamyxovirus  type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of \nthe fusion protein gene.  Avian Pathol. 32 : 239- 257. 2003.  \n2. Czegl\u00e9di, A., D. Ujv\u00e1ri, E. Somogyi, E. Wehmann, O. Werner, B. Lomniczi . Third genome size category \nof avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications . Virus Res. 120: 36\u2013 48. \n2006.  \n3. Diel, D. G., L. Susta, S. C. Garcia, M. L. Killian, C. C. Brown, P. J. Miller  and C. L. Afonso.  Complete \ngenome and c linicopathological characterization of a virulent Newcastle d isease virus isolate from South America. \nJ. Clin. Microbiol. 50:378- 387. 2012.  \n4. Miller, P. J., E. L. Decanini and  C. L. Afonso.  Newcastle disease: Evolution of genotypes and the related \ndiagnostic challenges . Infect. Genet. Evol . 10:26\u2013 35. 2010.  \n5. Palya, V., I. Kiss, T. Tat\u00e1r -Kis, T. Mat\u00f3,  B. Felf\u00f6ldi and Y. Gardin. Advancement in v accination  against \nNewcastle disease: Recombinant HVT NDV p rovides high clinical protection and r educes challenge virus shedding \nwith the a bsence of v accine reactions . Avian Dis. 56:282\u2013 287. 2012.  \n6. Palya, V., T. Tat\u00e1r -Kis, T. Mat\u00f3, B. Felf\u00f6ldi, E. Kov\u00e1cs and Y. Gardin . Onset and long- term duration of \nimmunity provided by a single vaccination with a turkey herp esvirus vector ND vaccine in commercial layers. Vet. \nImmunol. Immunpathol. In press , available online.   \n7. Perozo, F., R. Merino, C. L. Afonso, P. Villegas and N. Calderon. Biological and p hylogenetic \ncharacterization of virulent Newcastle d isease virus circulating in Mexico. Avian Dis. 52:472 \u2013479. 2008.  \n8. Perozo, F., R. Marcano and C. Afonso. Biological and p hylogenetic characterization of a g enotype VII \nNewcastle disease virus from Venezuela: Efficacy of field vaccination. J. Clin. Microbiol. 50: 1204 -1208. 2012.  \n \n \n \n \n \n \n  \n \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA   \nTable 1 . ND challenge virus RNA load in the oro -nasal and cloacal swabs .  \n \nchallenge virus  group  titer equivalent units  \n(lg ELD 50/0.1 ml; mean and STD or  \ndifference between the two groups)  \noro-nasal swab   cloacal swab  \n2 dpch  4 dpch  7 dpch   2 dpch  4 dpch  7 dpch  \nGenotype V  \n(strain D516/1)  vaccinated  0.8b 1.3 b 0.9  0.0 b 0.0 b 0.0 \n\u00b10.9 \u00b11.3 \u00b11.0  \u00b10.1 \u00b10.0 \u00b10.0 \ncontrol  3.9a 6.8 a NA  1.2 a 6.4 a NA \n\u00b10.6 \u00b10.4 -  \u00b11.2 \u00b10.5 - \nreduction by \nvaccination  3.1 5.5 NA  1.2 6.4 NA \nGenotype VII PE  \n(strain D575/6)  vaccinated  2.9 b 3.5 b 1.2  0.0 b 0.0 b 0.0 \n\u00b10.5 \u00b10.5 \u00b11.3  \u00b10.0 \u00b10.0 \u00b10.0 \ncontrol  4.8 a 7.0 a NA  1.1 a 6.6 a NA \n\u00b10.3 \u00b10.3 -  \u00b11.5 \u00b10.4 - \nreduction by \nvaccination  1.9 3.5 NA  1.1 6.6 NA \nGenotype VIId  \n(strain D1500)  vaccinated  2.2 b 1.8 b 0.6  0.0 b 0.2 b 0.0 \n\u00b11.3 \u00b11.4 \u00b11.1  \u00b10.0 \u00b10.5 \u00b10.0 \ncontrol  4.8 a 5.8 a NA  2.3 a 5.7 a NA \n\u00b10.5 \u00b10.5 -  \u00b10.6 \u00b10.7 - \nreduction by \nvaccination  2.6 4.0 NA  2.3 5.5 NA \nDifferent superscript letters indicate statistically significant difference between the vaccinated and the corresponding \ncontrol group  (Kruskal -Wallis test, p<0.05)  \nResults from the same type of samples collected at the same date were compared  \nNA: not applicable  \n  63rd WPDC/XXXIX ANECA  COMPARING THE EFFICACY OF KILLED ND VACCINES \nCONTAINING ANTIGEN PREPARED FROM  \nGENOTYPE II, V OR VII STRAINS AGAINST CHALLENGE WITH \nHOMOLOGOUS OR HETEROLOGOUS  \nVELOGENIC NDV STRAINS  \n \nCOMPARACI\u00d3N DE LA EFICACIA DE VACUNAS MUERTAS DE LA \nENFERMEDAD DE NEWCASTLE QUE CONTIENEN ANT\u00cdGENO \nPREPARADO DE CEPA DE GENOTIPO II, V O VII CONTRA UN DESAF\u00cdO \nCON CEPAS VELOG\u00c9NICAS HOM\u00d3LOGAS O HETER\u00d3LOGAS DEL VIRUS \nDE LA ENFERMEDAD DE NEWCASTLE \n \nV. PalyaA, T. Tat\u00e1r -KisA, T. Mat\u00f3A, B. Felf\u00f6ldiA, E. Kov\u00e1csA, and Y. GardinB \n \nAScientific Support and Investigation Unit, Ceva -Phylaxia, Ceva Animal Health, 5 Sz\u00e1ll\u00e1s utca,  \nBudapest, Hungary, H -1107  \nBCeva Animal Health, Libourne, France  \n \nRESUMEN  \n \nLa enfermedad de Newcastle (ND) es una de las principales enfermedades que causan grandes p\u00e9rdidas a la \nindustria av\u00edcola. Las cepas velog\u00e9nicas de campo en Latinoam\u00e9rica pertenecen a los genotipos V o VII, mientras \nque las vacunas muertas convencionales contienen ant\u00edgenos de cepas vacunales pertenecientes al genotipo II. El \nobjetivo de nuestro estudio fue comparar la inmunogenicidad y la eficacia de tres vacunas muertas experimentales \npreparadas a partir de ant\u00edgenos de los genotipos II, V \u00f3 VII del virus  de la ND. Pollos SPF de un d\u00eda de  edad fueron \nvacunados y a las cuatro  semanas de edad fueron desafiados con el genotipo V (muestra mexicana), o el genotipo \nVII (muestra asi\u00e1tica). La evaluaci\u00f3n de la protecci\u00f3n se llev\u00f3 a cabo en base a la presencia o au sencia de signos \ncl\u00ednicos y la reducci\u00f3n de la eliminaci\u00f3n del virus. Pruebas cruzadas de inhibici\u00f3n de la hemaglutinaci\u00f3n mostraron \npeque\u00f1as diferencias entre las vacunas sin importar la antigenicidad. La inmunizaci\u00f3n con cualquiera de las vacunas \nprevino  la presencia de signos cl\u00ednicos y redujo de manera significativa tanto la carga viral oro nasal como la cloacal \npara las dos cepas utilizadas en el desaf\u00edo. Se presentan resultados detallados.  \n \nSUMMARY  \n \nThe velogenic field NDV strains in Latin  America belong to genotype V or VII, while the conventional killed \nvaccines contain antigen of vaccine strains belonging to genotype II. The aim of our study was to compare the \nimmunogenicity and efficacy of three different experimental killed vaccines prepared from antigens of genotype II, \nor genotype V or genotype VII NDV. SPF chicks vaccinated at day -old with the different experimental vaccines \nwere  challenged either with genotype V, or genotype VII NDV. Evaluation of protection was performed on the basi s \nof the presence or absence of clinical signs and reduction in the level of challenge virus shedding. Cross -\nhaemagglutination -inhibition test showed differences among the vaccines regarding antigenicity. Immunization with \nany of the vaccines prevented cli nical signs and reduced significantly the challenge virus shedding both by the oro -\nnasal and cloacal routes .  \nVelogenic strains of Newcastle disease virus (NDV) cause important economic losses for the  poultry  industry . \nThe predominant genotypes of velogenic NDV causing the recent epidemics are g enotype V, VII and VIII. Among \nthem genotype VII  (G-VII) is the most widespread, it has been associated to many outbreaks in Asia, Africa, Middle \nEast and South America ( 1, 8). The presence of the other two genotypes is restricted to certain geographical areas : \ngenotype V  (G-V) is endemic  in Middle  America and has also been responsible for  exotic ND in North America  (7), \nwhile genotype VIII (G -VIII) is prevalent in South Africa.  \nPreventive vaccination plays a key role in the control of ND. Most of the vaccine strains used belongs  to \ngenotype II  (G-II) or G-I, which are heterologous to the recent field strains. Publications are in agreement regarding \nthe good efficacy of heterologous vaccines in the prevention of clinical signs and mortality  (1,3,4, 8). On the other 63rd WPDC/XXXIX ANECA  side, there are contradictory conclusions on the possibility to improve reduction of challenge virus shedding with \ngenotype -matched vaccines ( 2,3,4,5) .  \nThe aim of our study was to compare the efficacy of killed vaccines prepared from G -II, G-V or G -VII NDV \nantigens against challenge with G -V or G -VII NDV strain in a well -controlled experimental set -up. Evaluation of \nvaccine efficacy was  based on clinical signs, reduction of challenge virus shedding and on the effect of challenge \nvirus spreading  to contact birds . \n \nMATERIALS AND METHODS  \n \nChickens. Day old SPF layer -type chickens were used for the experiment.  The chicks were kept in isolated \nanimal rearing house during the immunization period. Challenge infections and post -challenge observations were \nconducted in isolators.  \nVaccine and challenge viruses. Experimental killed vaccines were prepared either from LaSota strain  or a \nMexican G -V strain  (D516/1 MX , (6)) or a representative G -VII strain  (D1524/1/1,2/MY/10 originated from \nMalaysia). All strains were propagated and titrated in embryonated hens \u2019 eggs.  After inactivation water -in-oil type \nemulsion  vaccine was formulated. Amount of NDV antigen in each vaccine was  set to be the same calculated on the \nbases of the pre -inactivation titer (8.6 log 10 EID 50/dose).  The same strains of velogenic  NDV were used for the \nvaccine preparation  and challenges .  \nStudy design.  Day old chicks were assigned to four groups: three of them were vaccinated with one of the \nkilled vaccines (0.2 mL , s.c.), the fourth  group remained untreated. At 28 d  of age, groups of 20 chickens from each \nvaccinated group and 15 control chickens were submitted to challenge either with the Malaysian strain  (G-VII), or \nwith the Mexican strain  (G-V). Challenge i nfection was performed with a dose of 5.0 log 10 ELD 50/chicken via intra -\nnasal route. During the 14 d long post-challenge observation period clinical signs and mortality were monitored \ndaily. Oro -nasal (choanal slit) and cloacal swabs were collected at 3 , 5, and 7 d post-challenge . In case of the \nMexican strain, two  susceptible SPF sentinels were introduced at five dpch to th e 20 vaccinated and challenged \nchickens to monitor the possible spreading of  challenge virus.  \nMeasurement of NDV RNA load in the swab samples.  Amount of challenge virus RNA was measured by \nreal-time one -step RT -PCR amplifying a fragment of M gene (TaqMan\u00ae NDV reagents and controls, Life \nTechnologiesTM). Positivity limit was set at  less than 36 Ct.  \nHemagglutination inhibition test.  Standard method was used, with four  HA unit of the antigen.  The same \nantigens were used for the HI test and vaccine preparation . Humoral immune response to vaccination was measured \nwith all the three antigen s in the pre -challenge samples.  \n \nRESULTS  \n \nSerological results . HI test results obtained at 28 d post -vaccination with HI antigens homologous to the \nvaccines showed comparable antibody level in all the three vaccinated groups ( log 2 HI titer mean an d STD 8.1\u00b10.7, \n7.9\u00b10.6 or 8.2\u00b10.7 in the groups immunized with G -II, G-VII or G -V antigen, respectively). Cross -HI test revealed \nserological differences among the vaccines. Relatedness (R -value) calculated by  the Archetti -Horsfall formula was \n0.73 between the G-II and the G-VII strains, but  markedly lower  (0.26)  between the G -II and the G -V strains.  \nClinical protection.  All challenged control chickens died due to the challenge infection between four to five d  \nor four to six d  post-challenge (dpch)  in case of the Mexican or Malaysian challenge strain, respectively . On the \ncontrary, each of the vaccinated chickens was protected against clinical signs and  mortality , regardless the vaccine \nand the challenge strain used.  \n \nCHALLENGE VIRUS RNA LOAD MEASUREMENT  \n \nResults are summarized in T able 1.  After challenge with G -VII (Malaysian) NDV strain, very high RNA load \nwas measured in the control group both in the oro- nasal and the cloacal swabs (equivalent to the RNA amount in the \nchallenge virus suspension having a titer  of 7.4 or 8.5- 8.6 log 10 ELD 50/mL at 3 or 5 dpch, respectively). Vaccination \nsuppressed the challenge virus replication significantly. At 5 dpch, when the highest  virus load s were found in the \nbirds , 2.6 -3.6 log 10 reduction was measured in the oro -nasal swabs , while the reduction in th e cloacal swabs was \nmuch stronger (6.2 -7.4 log 10). This resulted in no detectable or very limited virus RNA amount in the cloacal swabs. \nComparison of the different vaccines showed that their efficacy in reducing cloacal shedding was the same and only \nslight difference could be detected in the shedding by the oro -nasal route.  \nIn case of the G -V (Mexican) NDV challenge , the amount of NDV -specific RNA in the control chickens was  63rd WPDC/XXXIX ANECA  equivalent to the RNA content of the challenge virus suspension with a titer  of 6.5/8.2 or 5.8/7.5 log 10 ELD 50/mL at \n3 dpch/5 dpch in the oro -nasal or cloacal swabs, respectively. All the three vaccines reduced challenge virus \nreplication significantly. Cloacal shedding was very efficiently controlled by vaccination, resulting in no p ositive \nresult. Reduction of oro- nasal shedding in the vaccinated groups was 3.1 -5.1 log 10 compared to the control group at \n5 dpch. Significantly stronger suppression of challenge virus shedding through the oro -nasal route was achieved by \nthe homologous vaccine, however the spreading of challenge virus to susceptible chickens was equally controlled by \nall the three vaccines. None of the co -mingled sentinel s showed clinical signs or sero converted and all the oro -nasal \nswabs collected at nine  days post -expo sure proved to be negative with PCR.  \n \nDISCUSSION  \n \nEfficacy of a conventional, LaSota strain -based killed vaccine (G-II) was compared with killed vaccines \nprepared from genotype V  (G-V) and VII  (G-VII) NDV. Cross -serological results showed close relatedness between \nthe LaSota strain and the tested G -VII strain, while the G -V strain differed markedly from both of them.  All the \nvaccines provided complete clinical protect ion against  both challenge virus es (G-V or G-VII). Results indicate \nstrong control on the d issemination of challenge virus in the body  (no cloacal shedding) , regardless the vaccine and \nthe challenge strain  used. Local replication of both challenge virus es in the oro -nasal mucosa was reduced  \nsignificantly  by all vaccines. In case of the challenge with G-VII strain, the homologous vaccine was slightly (not \nsignificantly)  superior to the LaSota vaccine, while in case of G -V challenge there was a marked difference in \nfavour of the homologous vac cine. However,  both the heterologous and the homologous vaccines showed similar \nefficacy in preventin g the G -V challenge virus spreading to sentinels . Our results support published f ield \nexperiences and results of  experiments with conventional live vaccines  (2) or rHVT -NDV vaccines  (6) which \nshowed  that immunization programmes based on genotype I and II NDV strains are suitable for the efficient control \nof ND, including  the suppression of virus shedding , following  field challenge  with any genotype of NDV strains  if \nthe quality of vaccine and its application are adequate.  \n \nREFERENCES  \n \n1. Diel, D. G., L. Susta, S. C. Garcia, M. L. Killian, C. C. Brown, P. J. Miller and C. L. Afonso. Complete \ngenome and clinicopathological characterization of a virulent Newcastle disease virus isolate from South America. \nJ. Clin. Microbiol. 50:378- 387. 2012.  \n2. Dortmans, J. C. F. M., B. P. H. Peeters and G. Koch. Newcastle disease virus outbreaks: Vaccine \nmismatch or inadequ ate application? Vet. Microbiol. 160: 17 \u201322. 2012.  \n3. Hu, S., H. Ma, Y. Wu, W. Liu, X. Wang, Y. Liu and X. Liu. A vaccine candidate of attenuated genotype \nVII Newcastle disease virus generated by reverse genetics. Vaccine 27: 904 \u2013910. 2009.  \n4. Kapczynski, D. R.,  and D. J. King. Protection of chickens against overt clinical disease and determination \nof viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon \nchallenge with highly virulent virus from the California 2002  exotic Newcastle disease outbreak. Vaccine 23:3424 \u2013\n3433. 2005.  \n5. Miller, P. J., D. J. King, C. L. Afonso, and D. L. Suarez. Antigenic differences among Newcastle disease \nvirus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25: 7238 \u20137246. 2007.  \n6. Palya, V., I. Kiss, T. Tat\u00e1r -Kis, T. Mat\u00f3, B. Felf\u00f6ldi and Y. Gardin. Advancement in vaccination against \nNewcastle disease: Recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding \nwith the absence of vaccine reactions. Avian Dis. 56:282 \u2013287. 2012.  \n7. Pedersen, J. C., D. A. Senne, P. R. Woolcock, H. Kinde, D. J. King, M. G. Wise, B. Panigrahy and B. S: \nSeal. Phylogenetic relationships among virulent Newcastle disease vir us isolates from the 2002- 2003 outbreak in \nCalifornia and other recent outbreaks in North America. J. Clin. Microbiol. 42: 2329 -2334. 2004.  \n8. Perozo, F., R. Merino, C. L. Afonso, P. Villegas and N. Calderon. Biological and phylogenetic \ncharacterization of virulent Newcastle disease virus circulating in Mexico. Avian Dis. 52:472 \u2013479. 2008.  \n \n  \n \n \n 63rd WPDC/XXXIX ANECA  Table 1 . ND challenge virus RNA load in the oro -nasal and cloacal swabs .  \n \nchallenge \nvirus  group  Amount of NDV RNA (Ct values; mean and STD)   Reduction by vaccination \ncompared to the corresponding \ncontrol group (log 10 copy \nnumber)  \noro-nasal swab   cloacal swab   oro-nasal \nswab   cloacal swab  \n3 dpch  5 dpch  7 dpch   3 dpch  5 dpch  7 dpch   3 dpch  5 dpch   3 dpch  5 dpch  \nGenotype VII Vaccinated \n1  \n(GII \nantigen)  28.5b 25.7bc 31.0a  40.0b 36.2b 36.4a  \n2.8 3.1  6.3 6.2 \u00b13.5 \u00b11.7 \u00b12.3 \n \u00b10.0 \u00b14.5 \u00b14.2 \nVaccinated \n2 \n(GVII \nantigen)  29.9b 27.1c 35.8b  39.8b 40.0b 35.9a  \n3.3 3.6  6.2 7.4 \u00b12.7 \u00b13.0 \u00b14.3 \n \u00b10.5 \u00b10.0 \u00b15.3 \nVaccinated \n3 \n(GV \nantigen)  26.9b 24.1b 29.7a  40.0b 38.0b 37.3a  \n2.3 2.6  6.3 6.8 \u00b12.4 \u00b11.1 \u00b13.6 \n \u00b10.0 \u00b14.3 \u00b14.5 \ncontrol  19.1 a 15.3 a NA  19.1a 15.5a NA  - -  - - \u00b11.3 \u00b11.6  \u00b11.6 \u00b10.5 \nGenotype \nV Vaccinated \n1  \n(GII \nantigen)  30.6b 26.8b 33.6a  40.0b 40.0b 39.7a  \n2.7 3.1  4.8 6.4 \u00b12.3 \u00b12.8 \u00b15.4 \n \u00b10.0 \u00b10.0 \u00b11.0 \nVaccinated \n2 \n(GVII \nantigen)  30.4b 28.7b 34.8a  39.7b 40.0b 39.4a  \n2.6 3.7  4.7 6.4 \u00b12.5 \u00b12.4 \u00b12.4 \n \u00b10.8 \u00b10.0 \u00b11.4 \nVaccinated \n3 \n(GV \nantigen)  33.4c 33.2c 37.5a  40.0b 40.0b 39.7a  \n3.6 5.1  4.8 6.4 \u00b13.1 \u00b13.7 \u00b12.3 \n \u00b10.0 \u00b10.0 \u00b10.8 \ncontrol  21.6a 16.4a NA  24.0a 18.6a NA  - -  - - \u00b11.9 \u00b10.6  \u00b13.6 \u00b11.4   \nDifferent superscript letters indicate statistically heterologous groups  (Kruskal -Wallis test, p<0.05)  \nResults from the same type of samples collected at the same date were compared among the groups  challenged with \nthe same virus  \n 63rd WPDC/XXXIX ANECA  KINETICS OF THE ANTIBODY  RESPON SE TO VACCINATION \nWITH AN IMMUNE COMPLEX IBD VACCINE IN BROILERS  \nUSING A COMMERCIAL ELISA  \n \nCIN\u00c9TICA DE LA RESPUESTA INMUNE A LA VACUNACI\u00d3N CON UNA \nVACUNA CONTRA EL COMPLEJO INMUNE IBD EN POLLOS DE ENGORDA \nUTILIZANDO UN ELISA COMERCIAL  \n \nM. Paniago , C. Cazaban , F. Lozano , B. Alva , and Y. Gardin  \n \nCeva Sant\u00e9 Animale, 10 Avenue de la Ballasti\u00e8re, Libourne, France  \n \nRESUMEN  \n \nObservaciones de la cin\u00e9tica de la respuesta inmune a la Enfermedad Infecciosa de la Bolsa (IBD) en 2972  \nparvadas saludables de pollos de engorda vacunadas con una vacuna contra el complejo inmune IBD al d\u00eda de edad \ndurante un per\u00edodo de 4.5 a\u00f1os (Febrero/2009 a Julio/2013), y criadas en diferentes regiones del mundo, fueron \nevaluadas para la respuesta de an ticuerpos a diferentes edades d e procesamiento (de 25 a 60 d de vida) utilizando un \nkit comercial de ELISA.  \nLas parvadas vacunadas se convirtieron gradualmente en serol\u00f3gicame nte positivas despu\u00e9s de 26 d de vida lo \ncual refleja el momento en que el virus de la vacuna lleg\u00f3 a la bolsa de F abricio. A partir de los 38 d en adelante casi \ntodas las parvadas vacunadas fueron positivas.  \nEl porcentaje de parvadas serol\u00f3gicamente positivas sacrificadas a edades qu e var\u00edan de 40 a 60 d  fue de 98.4 \n% y la presencia de la cepa de la vacuna (W2512) se confirm\u00f3 al azar por RT -PCR.  \n \nSUMMARY  \n \nObservations of the kinetics of the immune response to infectious bursal disease (IBD) in 2972 healthy \ncommercial broiler flocks va ccinated with an immune -complex IBD va ccine at day of age during a four and a half  \nyear period (February/2009 to July/2013), and raised in different regions of the world, was assessed for antibody response at different processing ages (Ranging from 25 to 60 d of life) using a commercial ELISA test kit.  The \nvaccinated flocks gradually turned serologically positive after 26 d  of age reflecting the timing when the vaccine \nvirus reached the bursa of Fabr icius. From around 38 d onwards, nearly all vaccinated flo cks were positive. The  \npercentage of serologically positive flocks slaughtered at ages varying from 40 to 60 d was 98.4% and the presence \nof the vaccine strain (W2512) was randomly confirmed by RT -PCR.  \n \nINTRODUCTION  \n \nInfectious bursal d isease (IBD) is a disease of chickens caused by an Avi birnavirus. From its first description \nin the early 60\u2019s, the disease  spread out to almost all chicken producing countries in the world and the it still remains \nas one of the major concerns for producers.  \nIts prevention basically depends on the association of biosecurity and vaccination. The introduction of IBD \nvaccines that can be injected through in ovo or subcutaneous routes in the hatcheries has greatly changed the \nvaccination procedures all over the world.  \nThis article summarizes a stud y conducted over a period of four and a half  years in which the kinetics of the \nantibody respons e to IBD was assessed in nearly 3,000  commercial broiler flocks vaccinated with an I mmun e \nComplex IBD vaccine in the hatcheries .  \n \nMATERIAL S AND METHODS  \n \nFlocks . Two thousand nine hundred and seventy two clinically healthy broiler flocks raised in different \ncountries (Spain, Turkey, Malaysia, France, Romania, Ukraine,  and Egypt) and under various conditions were \nincluded in this study  which was carried out from February/2009 to July/2013.  63rd WPDC/XXXIX ANECA  Vaccine.  All flocks included in this study were vaccinated against Gumboro Disease only with an I mmune \nComplex  IBD vaccine either through in ovo or subcutaneous route of injection in the hatcheries.  This vaccine \ncontains the intermediate plus Winterfield 2512 strain of IBD live virus in complex with specific IBD \nimmunoglobulins.  \nSerology.  Serum samples were taken at the depletion time which varied from 25 to 60 d  of age and assessed \nfor antibody response using a commercial ELISA test kit.  The results were expressed as Arithmetic Mean titers \n(AMT) and the cut -off value used was according to the manufacturer's recommendation (\u2265 391). Flocks with AMT \nabove this value  were considered positive.  \nVaccine take.  Bursa samples from randomly chosen flocks were sent to the laboratory for detection and \ncharacterization  of the IBDV. The sequence was b ased on the 408 base pairs long (721- 1128 bp) nucleotide \nsequence of the hypervariable region of the vp2 gene of IBDV . \n \nRESULTS  \n \nThe vaccinated flocks started to become serologically positive at the end of the fourth  wk of age . The \npercentage of positive flocks steadily  increased and, f rom around 38 days onwards, nearly all vaccinated flocks were \npositive by the commercial ELISA test.  Graphic 1 shows the kinetics of the antibody  response to vaccination with an \nImmune Complex  IBD vaccine expressed as Positive/Negative ratio per age.  \nIn or der to assess which IBD virus (field or vaccine) induced the active immunity, bursa samples from \nrandomly selected flocks from each country were sent to the same laboratory for detection and further \ncharacterization of the IBDV. In all flocks evaluated by these methods, the W2512 vaccine strain was detected in the \nbursa samples . \n \nDISCUSSION  \n \nThis large scale serological assessment of broiler flocks vaccinated with an Immune Complex  IBD vaccine \ndemonstrates  that the active antibody  response starts to be detected by a commercial ELISA test between four  and \nfive wk  of age and there is a gradual and steady increase of the percentage of positive flocks as they get older. \nNearly all vaccinated flocks w ere positive from around 38 d onwards.  \nThese results are in agreement with Palya et al.  (3) and Herczeg et al. (1) who demonstrated that,  in controlled \nconditions, an active immune response detected by virus neutralization was evidenced from three to four wk  of age \nonwards . Laboute et al.  (2) working under field conditions, also detected active immune response by a commercial \nELISA test between three to four wk  of age.  In fact, t he gradual increase in the percentage of positive flocks occurs  \ndue to the  mechanism of action of th e Immune Comple x IBD vaccine. The vaccine viruses  which are complexed \nwith the specific immunoglobulins are protected against neutralization by maternally derived antibodies anti -IBDV \n(MDA IBD). However, these exogenous antibodies are progressively catabolyzed  during the first wk  of life and the \nvaccine viruses progressively released. Immunization will occur when the level of the MDA IBD has reached a level \nthat is low enough to permit the vaccine to reach the bursa and start replicating. This process occurs in every chicken so that replication starts at the optimum time in an individual manner.  \nPalya et al.  (3) demonstrated that flocks with lower maternal antibody titer to IBDV at hatch have an earlier \nantibody response than birds with higher maternal antibodies  to IBDV at hatch.  \nFrom all flocks included in this study, 1 ,770 of them were slaughtered with ages varying from 40 to 60 d of \nage. At this age,  the vaccine virus (W2512) from the  Immune Complex vaccine would have already reached the \nbursa of Fabricius and induced measurable levels of antibodies  by ELISA test  irrespective of the level of passive \nimmunity anti -IBDV at hatch. Among these 1,770 flocks, no positive antibody titers  were detected in  only 25 of \nthem, i.e., 1.6% of the total . The reasons might be related to poor vaccine application, problems in the cold chain, \npoor sampling technique, bad  management of the assay, etc.  \n \nACKNOWLEDGMENTS  \n \nThe author would like to thank the Ceva\u2019s  teams in Spain, Turkey, Malaysia, France, Romania, Ukraine,  and \nEgypt for their active participation in this study.  \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Herczeg, J., Nagy, M., Makrans zki, L., Balla, E., Kustos, K., deFoucauld, J., Thevenon , J. Alva, B. \n(2011). Laboratory efficacy testing of subcutaneously administered Cevac Transmune vaccine in broiler chickens. \nProceedings of the XVII Congress of the World Veterinary Poultry Association, Cancun, Mexico, 512 -520, 2011.  \n2. Laboute, M., Albaric,  O., Cazaban, C., Palya, V., Alva, B., Jacquinet, C., Ramon, G., Gardin, Y. Kinetics \nof the development of immunity following the vaccination with an infectious bursal disease immune -complex \nvaccine. Proceedings of the XVIII Congress of the World Veterinar y Poultry Association, Nantes, France, 583, \n2013.  \n3. Palya, V., Forg\u00e1ch, K., S\u00fcveges, T., Kelemen, M., M\u00e9sz\u00e1ros, J., Benyeda, J. Control of infectious bursal \ndisease by an immune complex vaccine. Proceedings of the 22nd World\u2019s Poultry Congress, June 8- 13, Is tanbul, \nTurkey, 2004.  \n \n \nGraphic 1 . Kinetics of the immune response to vaccination with an ICx IBD vaccine.  \n \n \n \n63rd WPDC/XXXIX ANECA  VALIDATION OF A MODIFIED USDA H5 RRT -PCR ASSAY FOR \nDETECTION OF H5N2 LOW PATHOGENIC AVIAN INFLUENZA \n(AI) VIRUSES OF MEXICAN LINEAGE  \n \nVALIDACI\u00d3N DE UNA PRUEBA MODIFICADA H5 RT -PCR DE USDA PARA \nLA DETECCI\u00d3N DEL VIRUS DE LA INFLUENZA AVIAR (IA) DE BAJA \nPATOGENICIDAD H5N2 DE LINAJE MEXICANO  \n \nJ. Pedersen *A, C. PhilibertA, M. Kim TorchettiA, M. Sol\u03afs H\u00e9nandezB, B. Huerta LozanoB, I. Tiburcio SanchezB, J. \nDinorah Lozano AlvaradoB , M. Amalia Mercado PezzatC, and J. Ramirez TorrezC \n \nAU. S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, National \nVeterinary Services Laboratories, Ames, IA, USA  \nBComisi\u00f3n M\u00e9xico -Estados Unidos para la Prevenci\u00f3n de la Fiebre Aftosa y Otras Enfermedades Ex\u00f3ticas de los \nAnimales, Mex ico City, Mexico  \nCEl Centro Nacional de Servicios de Diagn\u00f3stico en Salud Animal, Mexico City, Mexico  \n \nRESUMEN  \n \nLa prueba actual de influenza aviar H5 RT - PCR (RT -  PCR) en tiempo real del departamento de Agricultura \nde los Estados Unidos (USDA) se utiliza  para la detecci\u00f3n de IA H5 en aves comerciales, mercado de aves vivas, \navicultura de patios traseros y aves silvestres. La prueba es un m\u00e9todo semi - multiplex con iniciadores espec\u00edficos \npara la detecci\u00f3n de linajes europeos / asi\u00e1ticos y norteamericanos  de IA H5. Una colaboraci\u00f3n entre laboratorios \npara la armonizaci\u00f3n de los diagn\u00f3sticos de IA identific\u00f3 un linaje de IABP que no fue detectado por la prueba \nactual de USDA H5 RT - PCR.  \nLa alineaci\u00f3n de la secuencia entre los virus de M\u00e9xico y los iniciador es y sondas de USDA identific\u00f3 \ndesajustes m\u00faltiples en los iniciadores y sonda directos resultando en una falta de detecci\u00f3n de los virus mexicanos IA H5. Un iniciador directo y sonda adicionales se multiplexaron en la prueba junto con reactivos de control  \npositivo interno. Las pruebas de validaci\u00f3n que incluyeron l\u00edmite de detecci\u00f3n, eficiencia de la prueba, repetibilidad, \nsensibilidad anal\u00edtica y de diagn\u00f3stico y especificidad se llevaron a cabo en la prueba modificada H5.  Las pruebas de \nvalidaci\u00f3n se realizaron en plataformas de equipos ABI - 7500 y LightCycler.  \n  \nSUMMARY  \n \nThe current United States Department of Agriculture (USDA) H5 AI real -time RT -PCR (rRT -PCR) assay is \nused for the detection of H5 AI in commercial, live bird market, backyard poultry and  wild birds. The assay is a \nsemi -multiplex method with primers targeted for detection of European/Asian and North American lineages of H5 \nAI. An interlaboratory collaboration for the harmonization of AI diagnostics identified a lineage of LPAI that was \nnot detected by the current USDA H5 rRT -PCR assay.  \nSequence alignment between the Mexican viruses and USDA primers and probes identified multiple \nmismatches in the forward primers and probe resulting in a lack of detection for Mexican H5 AI viruses. An \nadditional forward primer and probe were multiplexed i nto the assay along with internal positive control reagents. \nValidation testing including limit of detection, assay efficiency, repeatability, analytical and diagnostic sensitivity \nand specificity has been conducted for the modified H5 assay. Validation testing has been conducted on ABI -7500 \nand LightCycler  equipment platforms.  \n \nINTRODUCTION  \n \nThis report updates the development and validation of an rRT -PCR assay targeting influenza A  subtype H5. \nValidation data include limit of detection, assay efficiency, analytical and diagnostic sensitivity and for the modified \nH5 assay.  Validation testing was conducted on the Life Technologies Applied Biosystems\n\u00ae ABI-7500 Fast real -time \nPCR platfo rm. 63rd WPDC/XXXIX ANECA  The real -time RT -PCR (rRT -PCR) assay currently in  use for the detection of influenza A virus ( IAV) subtype \nH5 in poultry and wild  birds by the United States Department of Agriculture ( USDA ) National Animal Health \nLaboratory Network (NAHLN) and National  Veterinary Services Laboratories  (NVSL)  was developed and modified \nby Spackman et al . (3,4) The assay  is a semi -multiplex procedure  with primers target ing North American  and \nEurasian  lineages of IAV  subtype H5.  The USDA/NAHLN assay  (H5 NA/EA 2008) has been in routine use for both \nwild bird ( U.S. Departments of Agriculture and Interior/State Wildlife Agencies 2 006-2010 surveillance ) and \npoultry samples submitted through the USDA National Poultry Improvement Plan  and Live Bird Market poultry \nsurveillance programs  since 2002.  The assay is routinely  evaluated  by tracking assay control data and evaluat ion of  \nH5 viruses isolated from wild birds and poultry in the U.S .  A lineage of subtype H5 low pathogenic avian influenza \n(LPAI) detected by IAV matrix gene diagnostic s, but not detected by the current H5 assay was identified as the \nresult of a n interlaboratory collaboration for the harmonization of IAV diagnostics  between Mexico, Canada,  and \nU.S. To address this gap , the H5 NA/EA 2008 assay was updated for detection of the  Mexican  (MX)  lineage H5 s by \nthe addition of a forward primer and probe  (H5 AM/EA 2014) , as well the inclusion of an internal positive control \n(IPC).  Validation testing was conducted following NAHLN Methods Technical Working Group and World \nOrgani sation of Animal Health (OIE) guidelines  (1,2). \n  \nRESULTS  \n \nNucleotide analysis was conducted to evaluate 14 H5N2 IAV isolated from MX poultry , to compare to the H5 \nNA/EA 2008 assay primers and probes , and to identify target regions  for a ssay update . The MX viruses had \nincreased variability in the HA2 region of the hemagglutinin (HA) gene segment, a traditionally more conserved \nportion of the HA, and multiple mismatches  were identified in the H5 NA/EA 2008 assay forward primers  and probe  \nresulting in a lack of detection.  No mismatches were identified in the reverse primer.  Major considerations for \nupdating the H5 NA/EA 2008 assay included current  chemistry , thermocycling parameters,  and methodology as \nwell as cost and  ease of implementation into diagnostic laboratory networks . The updated multiplex H5 AM/EA \n2014 assay has an additional forward primer and second probe for detection of MX H5s.  \nConcentration of detection enhancer and  inclusion of  IPC were  optimized  for the assay  by conducting standard \ncurve s using two synthetic constructs for evaluation of limit of detection ( LOD) and amplification efficiency (AE ). \nThe AE and LOD f or the AM/EA 2014 multiplex assay was 104.2%, and 10 copies/\u00b5L  for the MX component  and \n99.1% and 100 copies/\u00b5l  for the NA/EA 2008 component.  No decrease in sensitivity was observed when comparing \nthe LOD for the MX and NA/EA 2008 single -plex and semi -multiplex assays with the H5 AM/EA 2014 multiplex \nassay using standard curve testing with MX and NA reference viruses  (Table 1) . The multiplex assay was 2 -7% \nhigher in efficiency with equal or 1 log 10 increase in LOD when compared to the MX and NA/EA 2008 assays.   \nThe a nalytical specificity was evaluated with 31 different H1 -H16 isolates and 32 different non- influenza avian \nviral pathogens  including avian paramyxovirus type -1, infectious largnotracheitis virus, avian metapneumovirus , \nand infectious bronchitis virus . Diagnostic sensitivity ( SN) and specificity ( SP) testing was conducted with \ntracheal/oropharyngeal and cloacal swabs , tissue and culture specimens  (n=550) from gallinaceous birds  and \ndomestic ducks submitted to the NVSL for confirmation testing, bird movement and active surveillance  testing , and \nswab  material from experimentally infected ducks (wild bird lineage  H5N3 LPAI) and chickens ( three different \nstrains of MX H5 LPAI) . Based upon this testing , the diagnostic  SN and SP were calculated for poultry to be  97.53 \nand 99.34%, respectively.   The analytical and diagnostic sensitivity and specificity for the AM/EA 2014 multiplex \nassay is comparable to the H5 NA/EA 2008 assay, includes an IPC for detection of PCR inhibitors and has been \nupdated for detection of the MX lineage of subtype H5 LPAI.  \n \nREF ERENCES  \n \n1. Principles and Methods of Validation of Diagnostic Assays for Infectious Diseases. In: World \nOrganisation for Animal Health Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Manual 2013, 8th \ned. OIE, Paris, France. Pp 34 -51. 2013.  \n2. Reising, M. M., K. R. Schumann, B. M. Crossley, P. S. Glas, R. H. Jacobson, K. L. Toohey -Kurth, J. C. \nPedersen, D. Siev, B. M. Martin, Methods Comparison, An Alternative Approach for Evaluating the Impact of a Modification to a Validated Assay. Submitted to JVDI for publication.  \n3. Spackman, E, D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber , M. L. Perdue, K. Lohman, L. T. \nDaum,  D. L. Suarez. Development of a real -time reverse transcriptase PCR assay for type A influenza virus and the \navian H5 and H7 hemagglutinin subtypes.  J Clin Microbiol. 2002 Sep; 40 (9):3256- 60. 63rd WPDC/XXXIX ANECA  4. Spackman, E., and D.L. Suarez. Detection and identification of the H5 hemagglut inin subtype by real -\ntime RT -PCR. Methods Mol Biol 436:27- 33. 2008.  \n \nTable 1 . PCR slope, amplification efficiency (AE) , r2 coefficient, and limit of detection (LOD) for the H5 \nNA/EA 2008 semi -multiplex, MX single -plex, and AM/EA 2014 multiplex assays for M X 08- 1433- 1, MX 08- 1433-\n5, and TY/WI/68 H5N9 viruses.  \n \nTarget  Mexican 08 -1433 -1 virus  Mexican 08 -1433 -5 \nvirus  NA TY/WI/68 H5N9  \nvirus  \nPCR  \nfeatures  H5 \nNA/EA \n2008 SMa H5 MX \nSPb H5 \nAM/EA 2014 M P\nc H5 MX \nSPb H5 \nAM/EA 2014 MP\nc H5 \nNA/EA 2008 SM\na H5 \nAM/EA 2014 MP\nc \nslope  -3.4175  -3.4398  -3.3655  -3.5587  -3.3796  -3.4477  -3.3498  \nAE % 96.2%  95.3%  98.2%  90.9%  97.6%  95.0%  98.8%  \nr2\n 0.997619  0.998093  0.99610  0.996937  0.990758  0.997802  0.99448  \nLOD  102\nEID\n50 102\nEID\n50 101\nEID\n50 101\nEID\n50 101\nEID\n50 101\nEID\n50 101\nEID\n50 \naH5 NA/EA 2008 SM \u2013  North American/Eurasian semi -multiplex assay  \nbH5 MX SP \u2013  Mexican single -plex assay  \ncH5 AM/EA 2014 MP \u2013  H5 Americas/Eurasian multiplex assay  63rd WPDC/XXXIX ANECA  NEWCASTLE DISEASES CONTROL: ASSESSMENT OF \nVACCINATION PROTOCOLS  IN PLACE  \nFOR ENDEMIC COUNTRIES  \n \nCONTROL DE LAS ENFERMEDADES DE NEWCASTLE: EVALUACI\u00d3N DE  \nLOS PROTOCOLOS DE VACUNACION QUE SE UTILIZAN  \nEN LOS PAISES ENDEMICOS  \n \nF. PerozoA, R. MarcanoA, M. TrujilloB, F. RojoC, and R. Fern\u00e1ndezC \n \nAUniversity of Zulia Veterinary College. Maracaibo, Zulia Venezuela  \nBInstituto Nacional de Investi gaciones Agropecuarias, Maracay  Venezuela \nCMerial, Gainesville, GA USA  \n \nRESUMEN  \n \nLa enfermedad de Newcastle (ND) es una preocupaci\u00f3n principal para los pa\u00edses end\u00e9micos y se busca su \ncontrol con protocolos m\u00faltiples de vacunaci\u00f3n.  El objetivo de este trabajo fue evaluar la protecci\u00f3n que ofrecen las \nvacunas concomitantes contra ND de virus vivos - m\u00e1s \u2013muertos (Avinew\u00ae y GALLIMUNE ND\u00ae) que se aplican \npor v\u00eda subcut\u00e1nea (SQ) en la incubadora en comparaci\u00f3n con los protocolos que incluyen las vacunas comerciales \nvectorizadas HVT - ND en pollos de engorda. Se utilizaron siete grupos (24 pollos de engorda de un d\u00eda de edad). S e \ndesafiaron los grupos vacunados por v\u00eda SC contra ND vivo y muerto en la incubadora con y sin refuerzo, los de dos \nvacunas comerciales vHVT -  ND con y sin refuerzos de NDV vivo y un grupo control sin vacunar.  La protecci\u00f3n en \nlas aves vacunadas por v\u00eda S C fue de 100 y 95,8 %, respectivamente. Las dos vacunas comerciales contra vHVT -  \nND s\u00f3lo alcanzaron 83,4 y 79,2 %. Despu\u00e9s de dos revacunaciones con NDV vivo, la protecci\u00f3n de vacunas de vector fue de 91,6 %. Los resultados sugieren la conveniencia de la vacunaci\u00f3n por v\u00eda SC con virus vivos y \nmuertos para \u00e1reas end\u00e9micas y la necesidad de ND vivo para complementar la protecci\u00f3n de las vacunas \nvectorizadas comerciales.  \n \nSUMMARY  \n \nNewcastle disease (ND) is a main concern for endemic countries and its control  is attempted with multiple \nvaccination protocols.  The aim of this work was to assess the protection provided by concomitant subcutaneous \n(SQ) hatchery application of live-plus-killed ND vaccines (AVINEW\n\u00ae and GALLIMUNE ND\u00ae, registered \ntrademarks of Merial in the United States of America and elsewhere) compared with protocols including commercial \nvector HVT -ND vaccines in broilers.  Seven groups ( 24 one -day-old broilers) were used. Hatchery  SQ live plus \nkilled ND vaccination with and without boost, two commer cial vHVT -ND vaccines with and without live NDV \nboosts and an unvaccinated control group were challenged.  The protection in the SQ vaccinated birds was 100 and \n95.8%, respectively. The two commercial vHVT -ND vaccines only reached 83,4 and 79,2%. After two live NDV \nrevaccinations the vector vaccines protection was 91.6%. The results suggest the suitability of live plus killed SQ \nvaccination for endemic areas and the need of live ND to increase protection in the commercial vector vaccines.  \nVaccination strateg ies and protocols differ among countries and even among companies with in the same \ngeographical region based on environmental , epidemiological  and technical factors . Hence, the best \nrecommendation is to design and implement a vaccination program suitable fo r each company or region. The \nVillegas -Glisson/University of Georgia (VG/GA) NDV strain included in the AVINEW  vaccine tested here, \nreplicates both in the respiratory and intestinal tract with preference for the intestin al epithelia (2 ). This intestinal \ntropism and the consequent induction of local immunity may be important for protection against virulent \nviscerotropic strains of NDV.  \nHatchery vaccination if of fo remost importance, handling of one d old chicks represents (based on expe cted \nstrict control measures) the most homogenous and controlled segment of the poultry production chain, therefore  it is \nin the industry best interest to take advantage and generate a successful immunization of the birds at this moment. Single needle concomitant SQ application of IBD/MD and killed ND  and/or  the use of novel HVT vector vaccines is \na current trend in the industry.  It has been reported that live in oil vaccines prepared immediately prior to the 63rd WPDC/XXXIX ANECA  vaccination were shown to be 30 to 50 times more  effective than either the same vaccines reconstituted in water or \nkilled in oil vaccines  (1). Additional reports indicate that the use of oil adjuvant together with live viruses potentiate \nthe immune response based on the premise of live virus escaping th e oil induces active immune stimulation at \ntissues, rather than only the killed antigen recognition pathway. This work aims to assess the efficacy of adding live \nSQ ND vaccine (AVINEW) to the hatchery protocol in broilers challenged with a vvNDV  and compar e this protocol \nwith the protection provided by vector HVT -ND vaccination.   \n \nMATERIALS AND METHODS  \n \nA total of seven groups (24 one -day- old broilers) were used. Hatchery  SQ and spray live +  killed ND \nvaccination with and without LaSota boosts at day  10, two commercial vHVT -ND vaccines with and without boost \nand one unvaccinated control group were challenged at 28 days of age with a Venezuelan velogenic viscerotropic \nNDVstrain be longing to genotype VII . Serological response and percentage of survival were used as efficacy \ncriteria.  \n \nRESULTS  \n \nSignificantly higher (P<0.05) ND antibody titers at the challenge age were observed when SQ live ND vaccine \nwas added to the standard vaccination protocol  (Figure 1). The con trol group died within five d after challenge \nvalidating the experiment. The protection in the SQ vaccinated birds was of 100 and 95.8% with and without field boost, respectively  (Figure 2). No adverse effects were observed with concomitant day -old SQ HVT -IBD and killed \n+ live ND vaccination. HVT -ND vector vaccines I and II failed to provide  full protection and reached 83,4 and \n79,2%, respectively. After live revaccinations the vector vaccines group \u2019s protection reached 91.6%.  Overall, the \nuse of the VG/GA strain applied SQ observed im proved the serological response and allowed for 100% protection \n(above 95% without field boost) against a virulent NDV challenge, suggesting the suitability of the vaccine strain to \nbe applied by the SQ route and representing an alternative vaccination pro tocol that showed a robust protection \nagainst NDV provided by Gallimune ND + two doses of AVINEW (spray and SQ), even without field \nrevaccination.  \n \nCONCLUSIONS  \n \nThe observed protection levels and the differences in serological responses suggest the suitability of including \nthe AVINEW strain SQ vaccination for endemic areas with high field challenge and the necessity of live boosts to complement protection in vector the commercially available vector vaccines.  \n \nREFERENCES  \n \n1. Peleg B. Samina I, Brenner J.  Immunization of chickens with live Newcastle disease vaccine adj uvanted \nwith oil. Vaccine. 1993.  11(10):1074- 1076.  \n2. Perozo, F., P. Villegas., L. Purvis., R. Dolz and Afonso, C.L. The VG/GA strain of Newcastle disease \nvirus: mucosal immunity, protection aga inst lethal challenge and molecular analysis. Avian Path.  2008.  \n  \n \n \n  \n \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA  \n \nFigure 1 . Serological response to NDV vaccination.  \n \n \n \nFigure 2 . Protection against lethal challenge.  \n 63rd WPDC/XXXIX ANECA  MULTIDRUG RESISTANCE IN PATHOGENIC AND COMMENSAL \nESCHERICHIA COLI  FROM POULTRY  \n \nRESISTENCIA MULTIDROGAS DE  ESCHERICHIA COLI  \nPAT\u00d3GENA Y COMENSAL EN AVES  \n \nA. PiccirilloA, D. GiovanardiB, M. FranciosiniC, G.GrilliD, C. MontesissaA, and M. Giacomell iA \n \nADepartment of Comparative Biomedicine and Food Science, University of Padua. Vi ale dell\u2019Universit\u00e0,  \n16 - 35020 Legnaro (P D), Italy  \nBLaboratorio Tre Valli, Via le A. Veronesi , 5 - 37132 San Michele Extra (Verona).  \nCDepartment of Biopathologic  Science and Hygiene of Food and Animal Production , University of Perugia. Via San \nCostanzo, 4 -  06126 Perugia , Italy  \nDDepartment of Veterinary Science and Public Health , University of Milan. Via C eloria, 10 -  20133 Milan, Italy  \n \nRESUMEN  \n \nUn total de 355 E . coli ( 299 APEC y 56 AFEC) fueron aisladas en pollos de engorda (110), en pavos (188) y \ngallinas de postura (57), y se les realizaron pruebas de susceptibilidad a 21 antimicrobianos perteneciendo a ocho  \nclases diferentes: Aminoglic\u00f3sidos , cefalosporinas, quinolonas, fenicolas, penicilinas, tetraciclinas, sulfonamidas, \npolimixinas. El m\u00e9todo de difusi\u00f3n de disco se empleo de acuerdo con el est\u00e1ndar  CLSI.  La resistencia a \nMultidrogas(RMD) de tres a siete clases antimicrobianas se detect\u00f3 en  65 cepas resistentes a todos los \nantimicrobianos con la excepci\u00f3n de las polimixinas.  Realmente, el 90.1%de las cepas APEC y AFEC  fueron  RMD \n(APEC 84.5% en pollos, 87.1% en ponedoras, 94.4% en pavos; AFEC 76.9% en ponedoras y 100% en pavos). M\u00e1s \nde 50 pat rones RMD, aminoglic\u00f3sidos + fenicolas + penicilinas + cefalosporinas + fluoroquinolonas + sulfonamidas \npotenciadas + tetraciclinas fueron las m\u00e1s com\u00fanmente detectadas (18.6%) en todas las cepas APEC y AFEC y en todas las especies de aves. Los resultados sugieren que la RMD est\u00e1  muy difundida  en E.coli pat\u00f3genas y \ncomensales  en aves.  \n \nSUMMARY  \n \nA total of 355 E. coli (299 APEC and 56 AFEC) isolated from broilers (110), turkeys (188) and layer hens (57) \nwere tested  for their susceptibility to  21 antimicrobials  belonging to eight  different classes : aminoglycosides, \ncephalosporins, quinolones , phenicols,  penicillin s, tetracyclines, sulphonamides, polymyxins. The disk diffusion \nmethod was performed according to the CLSI standard  (2008) . Multidrug resistance  (MDR)  was detected against \nthree  to eight  antimicrobial classes, with seven strains resistant to all.  Indeed, 90.1% of APEC and AFEC strains was \nMDR (APEC: 84.5% in chickens, 87.1% in layers, 94.4% in turkeys ; AFEC: 76.9% in layers, 100% in turk eys). Out \nof 50 MDR  patterns, AmPhPenCepFluSulTe was the most frequently detected ( 20.6%) . Results suggest that MDR  is \nwidespread  among pathogenic and commensal E. coli from poultry.  \n \nINTRODUCTION  \n \nResistance to multiple classes of antimicrobials, including tetracycline, sulphonamides and streptomycin have \nbeen documented since the earliest studies to demonstrate resistance among E. coli isolates from poultry ( 8,9). In the \nlast years, it has been reported that antimicrobial resistance of avian E. coli has dramatically increased and the \nmultidrug resistance has become widespread  (5,7). Within scientific community , special attention has been \naddressed to the potential transfer of multidru g resistant bacteria from animals to humans  and this is now considered \na real threat for public health  (4). Also poultry have been considered a potential source of resistant bacteria for \nhumans , due to the intensive use of antimicrobial agents to prevent a nd treat bacterial diseases. Therefore, \nmonitoring the antimicrobial resistance of avian E. coli is fundamental to control both  the efficacy of pharmacologic \ntreatments of bacterial infections in poultry flocks and the diffusion of resistant bacteria or genetic determinants of \nresistance from poultry to humans.  \nThe aim of this study was to determine the antimicrobial resistance profiles of avian pathogenic (APEC) and \navian faecal  (AFEC)  Escherichia coli  isolated fro m poultry (i.e. turkeys, chickens , and layer hens) in Italy.  63rd WPDC/XXXIX ANECA   \nMATERIALS AND METHODS  \n \nStrains. A total of 355 E. coli  (299 APEC and 56 AFEC) collected between 2010 and 2012 in industrial \npoultry farms throughout Italy were examined. One hundred and eighty- eight E. coli (156 APEC and 30 AFEC) \nwere from meat turkeys, 110  (APEC) from broilers and 57 (31 APEC and 26 AFEC) from layer hens.  \nAntimicrobial susceptibility testing. All E. coli strains were tested for antimicrobial susceptibility by the disk \ndiffusion method, according to CLSI ( 2) standards, against 21 an timicrobial drugs belonging to eight  classes: \naminoglycosides (apramycin, 15 \u00b5 g, APR; gentamicin, 10 \u00b5 g; streptomycin, 10 \u00b5 g; kanamycin, 30 \u00b5g), \ncephalosporins (cephalotin, 30 \u00b5 g; ceftiofur, 30 \u00b5g; cefotaxime, 30 \u00b5g; ceftazidime, 30 \u00b5g), fluoroquinolones \n(nalidixic acid, 30 \u00b5g; enrofloxacin, 5 \u00b5g; ciprofloxacin, 5 \u00b5g; norfloxacin, 10 \u00b5g), penicillins (ampicillin, 10 \u00b5g; \namoxicillin + clavulanic acid, 30 \u00b5g), phenicols (chloramphe nicol 30 \u00b5g; florfenicol, 30 \u00b5g), potentiated \nsulphonamides ( triple sulphonamides 300 \u00b5g; trimethoprim + sulfamethoxazole, 25 \u00b5g), tetracyclines (tetracycline, \n30 \u00b5g; doxycycline, 30 \u00b5g) and polymyxins (colistin, 10 \u00b5g). All antimicrobial- containing disks were obtained from \nOXOID (Basingstoke, UK).  E. coli ATCC 25922 was used as quality control strain. MDR was defined as resistance \nto \u2265 3 different antimicrobial classes where resis tance was detected to at least one antimicrobial agent.  \n \nRESULTS AND DISCUSS ION  \n \nAntimicrobial resistance testing showed that 90.4% of isolates were resistant to tetracycline, followed by \n85.9% to ampicillin, 80.6% to doxycycline, 80.3% to triple sulphonamides, 74.4% to nalidixic acid, 67.0% to \nstreptomycin, 53.9% to trimethoprim/sulfamethoxazole,  50.1% to cephalotin , 40.3% to chloramphenicol, 31.0% to \nenrofloxacin, 25.1% to amoxicillin/clavulanic acid,  24.5% to norfloxacin,  23.9% to ciprofloxacin, 16.9% to \nkanamycin, 16.1% to gentamicin, 15.2% to ceftiofur, 9 .0% to ce fotaxime, 5.1% to ceftazidime, 3.4 % to apramycin, \n2.8% to colistin, and 1.4 % to florfenicol.  \nThree hundred and twenty  strains  (90.1%)  showed multidrug resistance against  three  up to eight  antimicrobial \nclasses, with seven strains resistant to all classes  (Table 1) . The majority of strains (27.5%) were  resistant to six  \nantimicrobial classes with the predominance of the following pattern: AmPenCepQuSulTet . Resistance to five  \nantimicrobial classes was the second most frequently detected (25.3%), with the AmP enQuSulTet pattern prevalent.  \nOverall, out of 50 multidrug resistance patterns, AmPhPenCepFluSulTe was the most frequently detected ( 20.6%).   \nAmong poultry species, MDR predominated in turkey isolates (95.7%), followed by chicken isolates (84.5%) \nand layers (82.5%). Considering APEC and AFEC, MDR was detected in 94.4% of APEC and all AFEC from \nturkeys, in 87.1% of APEC and 76.9% of AFEC from  layers, and 84.5% of APEC from chickens . In turkey isolates , \nthe most frequent MDR patterns comprised 5 (31.1% of isolates) and 6 (31.1%) antimicrobial classes , of which \nAmPenQuSulTet and AmPenCepQuSulTet  were the most common. In chicken s, the AmPhePenCepQuSu lTet \npattern was predominant  (34.4% of isolates). In layer hens,  MDR to 4 antimicrobial classes (PenQuSulTet) was the \nmost widespread (23.4%  of isolates ). \nA very high level of antimicrobial resistance and multidrug resistance was detected among APEC and AFEC \nfrom Italian poultry. This finding is  in accordance with the resistance situation reported worldwide  (1,5,6 ). Indeed, \nin the current study the highest levels of resistance were detected against tetracyc lines, penicillins and \nsulphonamides , the most commonly antimicrobials  used in the poultry industry worldwide . A decreased \nsusceptibility to cephalosporins  was also detected , whereas  a prevailing susceptibility against colistin and  several \nmembers of the aminoglycoside family  was found . In contrast to nalidixic acid, moderate  levels of resistance to \nfluoroquinolones were detected  in strains examined in this study. Finally, low to m oderate levels of resistance  to \nphenicols were detected.  Resistances against all these antimicrobial classes reflected their usage pattern in the \npoultry industry.  \nIn the present study, MDR was more common in turkey isolates than in those  from the other poultry species. \nThis finding is in accordance to prev ious studies ( 3,10), which showed that multidrug resistance was more frequent \nin APEC and AFEC from turkeys  than those from broilers and layer hens . In contrast, MDR patterns including the \nhighest number of antimicrobial classes were detected mostly among chicken strains.   \nIn conclusion, t he results presented in this study indicate  that poultry may  play a role in the dissemination of \nantimicrobial resistance among bacterial populations and considerable efforts need to be made with regard to the use \nof antim icrobials in poultry  production and to the control of antimicrobial resistance both for animal and human \nhealth concerns.  \n 63rd WPDC/XXXIX ANECA   \nREFERENCES  \n \n1. Apata , D.F. Antibiotic Resistance in Poultry. Int.  J. Poult . Sci. 8:404-408. 2009.  \n2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution \nsusceptibility tests for bacteria isolated from animals ; 3rd Edition. M31- A3, vol. 28:8 . Clinical and Laboratory \nStandards Institute, Wayne, PA.  2008.  \n3. Cormican, M., Buckley, V., Corbett -Feeney G., and  F. Sheridan . Antimicrobial resistance in Escherichia \ncoli isolates from turkeys and hens in Ireland. J . Antimicrob . Chemother . 48:587-595. 2001.  \n4. European Food Safety Authority and European Centre for Disease Prevention and Control. The European \nUnion Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and \nfood in 2011. EFSA Journal 11:3196. 2013.  \n5. Gyles, C.L. Antimicrobial resistance in selected bacteria from poultry. Anim. Health Res. Rev. , 9:149-\n158. 2008.  \n6. L\u00f6hren, U., Ricci, A., and T.S. Cummings. Guidelines for antimicrobial use in poultry. In: Guide to \nAntimicrobial Use in Animals. L. Guardabassi, L.B. Jensen , and H. Kruse , eds. Blackwell Publishing Ltd, Oxford, \nUK. pp. 126- 142. 2008.  \n7. Singer, R.S., and C.L. Hofacre. Potential impacts of antibiotic use in poultry production. Avian Dis . \n50:161-172. 2006.  \n8. Smith, H.W. The incidence of infective drug resistance in strains of Escherichia coli  isolated from \ndiseased human beings and domestic a nimals. J. Hyg. (Lond) , 64:465-474. 1966.  \n9. Sojka, W.J., and  R.B.A. Carnaghan.  Escherichia coli  infection in poultry. Res.  Vet. Sci. 2:340. 1961.  \n10. Van den Bogaard, A.E., London, N., Driessen, C. and  E.E. Stobberingh. Antibiotic resistance of faecal \nEscherichia coli  in poultry, poultry farmers and poultry slaughterers. J. Antimicrob. Chemother. 48: 587-588. 2001.  \n  \n \n \n \n  \n \n \n  \n \n \n \n \n  \n \n \n \n \n  \n \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA  Table 1.  Multidrug resistance of APEC and AFEC in each poultry species.  \n \nNo. of classes  MDR pattern * Total  Turkey  Chicken  Layer hen  \nAPEC  AFEC  APEC  APEC  AFEC  \n3 PenSul Tet 4 1 1 - 1 1 \nPenQuTet  3 3 - - - - \nAmPen Tet 2 - 2 - - - \nAmSul Tet 2 - - 2 - - \nQuSulTet 2 1 - - 1 - \nPenCepQu  2 - - 1 1 - \nPenCepTet  2 - - 1 - 1 \nPheQuTet  1 - - 1 - - \nAmCepSul 1 1 - - - - \nPhePenSul  1 1 - - - - \nPenCepSul 1 - - 1 - - \n4 AmPenSul Tet 13 5 7 1 - - \nPenQuSulTet 11 3 - 4 - 3 \nAmPen QuTet  8 6 1 1 - - \nPheQuSulTet 4 - - - 2 2 \nPenCepQuTet  4 3 - 1 - - \nPenCepSulTet 3 1 - - 2 - \nPhePen CepTet  2 1 - - 1 - \nAmQuSulTet 2 - - 1 1 - \nAmPhe QuTet  1 - - 1 - - \nAmCepSulTet 1 1 - - - - \nAmPheSul Tet 1 - - 1 - - \nAmPen CepTet  1 1 - - - - \nAmPen QuSul 1 - - 1 - - \nPheCepQuTet  1 - - 1 - - \nPhePen QuTet  1 1 - - - - \nPenCepQu Sul 1 1 - - - - \nPhePen CepSul 1 - - 1 - - \n5 AmPen QuSulTet 37 29 1 4 2 1 \nPenCepQu SulTet 14 8 1 5 - - \nAmPhePenSul Tet 7 5 2 - - - \nAmPen CepSulTet 6 2 2 1 - 1 \nPhePen QuSulTet 5 - - 2 2 1 \nAmPen CepQuTet  4 3 - 1 - - \nAmCepQu SulTet 2 1 - 1 - - \nAmPhe QuSulTet 2 - - - 2 - \nAmPhePen QuTet  1 - - - - - \nAmPhePen QuSul 1 1 - - - - \nCepQu SulTetPol 1 - - 1 - - \nPheCepQu SulTet 1 1 - - - - \n6 AmPen CepQu SulTet 44 28 4 10 1 1 \nAmPhePen QuSulTet 23 12 2 8 1 1 \nAmPhePen CepSulTet 10 4 2 1 - 3 \nPhePen CepQu SulTet 5 2 - 1 2 - \nAmPhePen CepQu Sul 2 - - 2 - - \nAmPhe CepQu SulTet 2 - - 1 - 1 \nAmPhePen CepQuTet  1 1 - - - - \nAmPen QuSulTetPol 1 1 - - - - \n7 AmPhePen CepQu SulTet 66 22 5 31 7 2 \nPhePen CepQu SulTetPol 1 - - 1 - - \n8 AmPhePen CepQu SulTetPol 7 - - 4 1 2 \n  320 150 30 93 27 20 \n*Am =  aminoglycosides; Phe = p henicols; Pen = penicillins; Ce p = cephalosporins; Qu  = quinolones;  \nSul = sulfonamides; Te t = Tetracyclines; Pol = polymyxins  63rd WPDC/XXXIX ANECA  A PRACTICAL GUIDE TOWARD USING GIS AND SPATIAL \nSTATISTICS FOR UNDERSTANDING AVIAN DISEASES  \n \nGU\u00cdA PR\u00c1CTICA PARA EL USO DEL SISTEMA DE INFORMACI\u00d3N \nGEOGR\u00c1FICA (SIG) Y LA ESTAD\u00cdSTICA ESPACIAL PARA ENTENDER \nENFERMEDADES AVIARES  \n \nM. PiteskyA, R. GallardoB, M. BlandC, and B. CharltonD \n \nAUniversity of California Cooperative Extension, 1089 Veterinary medi cine Dr. VM3B, Davis, CA, 95616  \nBDepartment of Population Health and Reproduction, School of Veterinary Medicine, University of California, 1089 \nVeterinary Med icine Dr. VM3B, Davis CA, 95616  \nCCulter Associates International, Napa, CA, 94558  \nDCalifornia Animal Health and Food Safety Laboratory, 1550 Soderquest Rd, Turlock, CA 95381  \n \n \nRESUMEN  \n \nLas herramientas de mapeo basadas en el SIG combinadas con la estad\u00edsti ca espacial son herramientas \nrelativamente nuevas que tienen varios usos en la agricultura, la medicina veterinaria y la salud p\u00fablica. En la \navicultura, el SIG es una heramienta ideal para la vigilancia retrospectiva y prospectiva de enfermedades, control  de \nbrotes y manejo de emergencias. Adem\u00e1s, herramientas  nuevas incluyendo el an\u00e1lisis hot -spot, el an\u00e1lisis espacial \nmedio central, la agrupaci\u00f3n espacio -temporal, y el an\u00e1lisis de regresi\u00f3n espacial basado en el SIG pueden ahora ser \nutilizados de manera relativamente f\u00e1cil para lograr un mejor entendimiento de la diseminaci\u00f3n de las enfermedades. \nEl resultado puede entonces ser utilizado para tomar deci siones con una base cient\u00edfica. En esta presentaci\u00f3n \nabordaremos distintos enfoques y t\u00e9cnicas que hemos  utilizado para entender las siguientes enfermedades aviares: \nbronquitis infecciosa, laringotraque\u00edtis infecciosa, enfermedad infecciosa de la bolsa de Fabricio muy virulenta, e \ninfluenza aviar altamente pat\u00f3gena.  \n \nSUMMARY  \n \nGIS based mapping tools coupled with spatial statistics are relatively novel tools that have multiple uses in \nagriculture, veterinary medicine, and public health.  In poultry, GIS is an ideal tool for retrospective and prospective \ndiseas e surveillance, outbreak control  and emergency manag ement.  In addition, newer tools including \u2018hot -spot\u2019 \nanalysis, spatial median center analysis, spatial -temporal clustering, and GIS based spatial regression analysis can \nnow be used relatively easily in order to better understand how diseases spread.  The output can then be used for \nscience based decision making.  In this presentation we will focus on several approaches and techniques that we have \nused to understand the following avian diseases:  infectious bronchitis  (IB), infectious laryngotracheitis  (ILT),  very \nvirulent infectious bursal d isease  (vviBDV) , and hi ghly pathogenic avian i nfluenza  (AI).  \n \nINTRODUCTION  \n \nThe ability to visualize disease outbreaks in space and time are integral toward understanding the epidemiology \nof a disease.  Historically, the analysis tools for this relatively simple visualization were often deemed too \nchallenging with respect to time, cost, and difficulty . While some spatial analysis tools still fit that criteria, easy to \nuse mapping software and free on -line analysis tools now exist that allow mapping of both vector datasets (i.e. \npoints, lines, or polygons representing objects on the map) and raster datasets (i.e. grids of data, which can represent \nimages such as satellite or aerial photography, continuous s urfaces such as elevation models, or thematic classes \nsuch as land cover or habitat maps). Consequently, increased ease and access to these tools could allow for a greater \nunderstanding of the epidemiology of poultry diseases at a local, regional, national and global level.   \nClustering o f disease events in time, space and time and space  simultaneously can provide  clues to the \nepidemiology of a  disease process and may assist in prevention and control programs. These types of analyses  allow \nfor the differentiation of statistically significant disease outbreaks from cases of disease due to chance, and they \nfacilitate the creation of effective containment strategies ( 1,2). Therefore, w hile the above analyses are essential 63rd WPDC/XXXIX ANECA  toward understanding the epidemiology of a disease, f urther analyses  including  hot-spot analysis, and  spatial, \ntemporal, and spatial -temporal  clustering  are essential toward determining focal  areas of disease and  critical time -\nspace boundaries for a disease (1 ). Consequently, opportunities exist for collaborations between stakeholders with a \nmutual interest in utilizing GIS to understand the epide miology of multiple  avian diseases .  \n \nMATERIALS AND METHODS  \n \nGeneral spatial epidemiological approach . In order to v isualize the distribution of IB , ILT, and vvIBDV , \ngeocoding and geospatial mapping was done either via  a licensed  GIS program such as ArcGIS or via the online tool \nGoogle Earth or Google Earth Pro.  For our analysis of IB, ILT, and vvIBDV, affected farms were defined as farms \nin which those diseases were  detected at least once in the flock\u2019s lifetime.  Therefore, multiple positive tests from the \nsame flock were merged into a single accession or case.  Consequently, a premise could be affected more than once \nif a separate or new flock was affected on the same premise that was previously identified as positive.   \nUsing either mapping to ol, the following GIS layer s within California were added: counties, roads, locations of \npoultry operations, backyard operations, locations of flocks that tested negative, locations of flocks that tested \npositive, and locations of flocks that had not been tested. For AI work, layers included rice fields and lakes where \nwater fowl exist.   \nSpatial, temporal, and space -time cluster analysis.  To investigate global clustering (i.e. if any clustering is \noccurring),  a Moran\u2019s I (ArcGIS\u00ae v10) test was applied to the geographical data. To investigate local  clustering  in \nspace and time, statistical tests were performed using SaTScanTM version 9.1.1, (National Cancer Institute, Bethesda, \nMaryland, USA) ( 3). Likelihood functions were applied to various spatial windows in space or time in order to \ncompare the numbe r of observed and expected observations inside and outside the spatial or temporal window. The \nstatistical significance of clusters was evaluated through Monte Carlo simulations (999 replications) and p -values < \n0.05 were considered statistically significa nt to reject the null hypothesis of random distribution in time or space. \nUsing the above described methods buffer analysis was done in order to define geographical risk areas.  \n \nRESULTS AND DISCUSSION \n \nMapp ing of farm premises that tested positive and negative for IB , ILT, and vvIBDV in California was \nperformed. Results show different prevalences of time, space, and time- space clustering.  For example with respect \nto ILT two high rate and one low rate temporal -spatial clusters were identified including one retrospective high rate \nspatial- temporal which accounted for 36.4% of all the ILT positive data Overall the two high rate spatial- temporal \nclusters accounted for 36.9 % of all the positives in the entire stu dy. For vvIBDV spatial clustering was used to \ndefine surveillance buffers during future outbreaks.  In addition, the lack of time -space clustering coupled with \nsurveillance for vvIBDV in peri -domestic birds showed that avian wildlife do not appear to play a  significant role in \nvvIBDV spread in California.  Finally,  spatial and temporal mapp ing of geographical areas where waterfowl \ninterface with domestic poultry was done in order to focus AI surveillance efforts in California.  \n \nCONCLUSION  \n \nThe first step in controlling the spread of a disease is to understand the relationship between the agent, host, \nand the environment.  An understanding of this classic epidemiologic triad is essential toward breaking the \ntransmission cycle of any infectious disease.   Consequ ently, epidemiological tools including GIS and spatial \nstatistics are essential toward understanding risk and how diseases may spread.  Collaborative efforts between \nfarmers, field veterinarians and researchers are essential toward maximizing the potential of these tools for disease \nsurveillance and control.  \n \nREFERENCES  \n \n1. Kulldorff, M., R. Heffernan, J. Hartman, R. Assuncao, and M. F A Space- Time Permutation Scan \nStatistic for Disease Outbreak Detection PLoS Medicien 2:216 -224. 2005.  \n2. Blacker, H.P., N.C. Kirkpatrick, A. Rubite, D. O'Rourke, and A.H. Noormohammadi Epidemiology of \nrecent outbreaks of infectious laryngotracheitis in poultry in Australia. Aust. Vet. J. 89:89 -94. 2011.   \n3. Kulldorff, M. SatScan User Guide for version 9.0. In., http://www.satscan.org/. p 109. July 2010.  \n \n 63rd WPDC/XXXIX ANECA  ATOXOPLASMA IN EUROPEAN GOLDFINCH ( CARDUELIS \nCARDUELIS ) CLINICAL ASPECTS  \n \nATOXOPLASMA EN JILGUERO ( CARDUELIS  CARDUELIS) \n \nM. PizarroA, A. BengoaB, M. Gonz\u00e1lezA, E. TabaneraA, and A. Rodr\u00edguez -BertosA,C \n \nAService of Anatomic Pathology,  Veterinary Clinical Hospital. Veterinary Faculty   \nBService of Exotic Animals; Veterinary Clinic al Hospital. Veterinary Faculty  \nCAnimal Health Surveillance Center (VISAVET), Complutense University of Madrid, 28040 Madrid. Spain  \nmpizarro@ucm.es  \n \nRESUMEN  \n \nLa atoxoplasmosis  es una enfermedad parasitaria que afecta a aves paseriformes. Un criador de jilgueros, \npardillos, verderones y mixtos remiti\u00f3 varios p\u00e1jaros al Servicio de Animales Ex\u00f3ticos. El propietario indic\u00f3 que \nhab\u00eda tenido muertes espor\u00e1dicas de individuos de form a reiterada durante los \u00faltimos cinco o seis  a\u00f1os. El \u00fanico \ns\u00edntoma cl\u00ednico descrito fue una disminuci\u00f3n  de peso. Un jilguero macho de dos  a\u00f1os, con una historia de p\u00e9rdida \nprogresiva de peso, fue enviado para necropsia. Macrosc\u00f3picamente, se observ\u00f3 un es tern\u00f3n m\u00e1s afilado y un \nabdomen distendido. Se observ\u00f3 una discreta hepatomegalia, as\u00ed como un intestino distendido y enrojecido con \ncontenido l\u00edquido. Microsc\u00f3picamente, se observ\u00f3 en el h\u00edgado un infiltrado de c\u00e9lulas mononucleares. Se \nevidenciaron formas parasitarias similares a los merozoitos en el citoplasma de los macr\u00f3fagos. La mucosa intestinal \nmostr\u00f3 una intensa congesti\u00f3n y un moderado infiltrado de c\u00e9lulas redondas en la l\u00e1mina propia, principalmente \nlinfocitos y macr\u00f3fagos con formas parasitaria s en el citoplasma. Se realiz\u00f3 un an\u00e1lisis coprol\u00f3gico que co nfirm\u00f3 un \nresultado positivo a A toxoplasma. Finalmente, se discute el tratamiento con medidas higiosanitarias y terapia \nmedicamentosa.  \n \nSUMMARY  \n \nAtoxoplasmosis is a parasitic disease that affects  passerine birds. A  goldfinc h, linnet, greenfinch,  and crossbred  \nbreeder sent some birds to the Service of Exotic Animals. The owner reported sporadic deaths for five to six  years.  \nWeight reduction was the only cli nical symptom described. A two year old, male goldfinch was submitted for \nnecropsy with previous history of progressive weight loss. Macroscopically, the sternum appeared more  prominent \ndue to muscular atrophy  and the abdomen distended.  A slight hepatomegaly, distended  and reddish intes tine loops \nand fluid content was observed. Microscopically, mononuclear cell infiltrates could be seen in the liver. Parasitic \nforms similar to merozoites were evident in the cytoplasm of macrophages. Intestinal mucosa showed intense \ncongestion and moderat e infiltration of round cells in the lamina propria, mainly lymphocytes and macrophages with \nintracytoplasmatic parasitic forms. A coprologic analysis was performed and was positive to Atoxoplasma. Further \ndiscussion is necessary concerning to  treatment based on  sanitary measures and drug therapy . \n \nCASE REPORT  \n \nAtoxoplasmosis is a parasitic disease that affects passeri ne birds, like  canaries, and it is  caused by a p rotozoan \nof the Coccidium, Atoxoplasma order serini. This p rotozoan is host specific and its transmission is  oro-fecal . In \naddition, oocysts are very resistant to the environmental conditions . A bird breeder  sent some finches t o the Clinical \nService of Exotic Animals of th e HCVC, from Toledo. The owner ha d 40 birds  in total, including goldfinches,  \nlinnets, greenfinches and crossbred. The animals were kept i n the same room, distributed in small individual cages \nand eight  big flying cages with sand substrate. Animals were  fed ad libitum  with commer cial seeds mixture.  \nThe owner refer ed sporadic deat hs for five to six  years. H e had  tried different  treatments with Baycox \n(guideline  unknown) and metronidazo le + sulfatrimethoprim, with no success.  A two-year-old, male goldfinch with \na history of progressive weight loss for a week  and anorexia. On physical examination, there was a marked muscular \natrophy in the breast (prominent sternum) and the abdomen  appeared  distended and congestive . Necropsy show ed a \nslight hepatomegaly and  distended intestine with reddish fluid.  \nMicroscopically, m ild mononuclear infiltrates of lymph ohistiocytic type could be seen. Parasitic p rotozoan  \nforms , similar to A toxoplasma merozoi tes, were evident in the cytoplasm of macrophages. Proventricul us show ed 63rd WPDC/XXXIX ANECA  discrete growth of hyfa  similar to Candida  over the apical areas in th e lining epithelium , with non inflammatory \nreaction  (overgrowth). In the lamina propria of intestine,  marked congestion and abundant inflammatory infiltrates \nof lympho histiocytic type  was observed.  Similar parasitic findings described in the liver, were seen  in the cytoplasm \nof intestinal macrophages.  There were no other significant lesions throughout  the animal body. A coprologic \nanalysis  was performed and was positive  to Atoxoplasma. According to our results, the following were proposed: a ) \nSanitary measure s: general disinfection  including cages  and materials , replacement of the sand of big cages  and \nperiodic cleaning of the facilities . b) Drug therapy: 50 Baycox (t oltrazuril) mg/ml in drinking water during two days \n(rest five days between treatments ). Follow this protocol four times for four  weeks . It is recommended to repeat the \ncoprology  at the end of the treatment.  \n \nREFERENCES  \n \n1. Box E.D. Isopora as an extraintestinal parasite of passerine birds. J Protozool  28: 244- 246. 1981.  \n2. Jamri\u0161ka, J., L. A. Lavilla, A. Thomasson, A. R. Barbon, J. F. Lop\u00e9z, D. Modr\u00fd. T reatment of \natoxoplasmosis in the Blue -crowned Laughing Thrush (Dryonastes courtoisi). Avian Pathol . 42(6): 569\u2013571. 2013.  \n3. Levine, .M.D. The genus Atoxoplasma (Protozoa, Apicomplexa). J Parasitol  68(4):719- 723. 1982.  \n4. Norton, T.M. and col. Atoxoplasma Medic al Protocols Recommended By The Passerine Atoxoplasma \nWorking Group. www.riverbanks.org/subsite/aig/Atoxo -recommendations.htm . \n5. Quiroga, M.I., N. Aleman, S.Vazquez, J.M.Nieto Diagnosis of atoxoplasmosis in a canary ( Serinus \ncanaries ) by histopathologic and ultrastructural examination. Avian Dis . 44:465- 469. 2000.  \n6. S\u00e1nchez -Cord\u00f3n, P.J., J.C. G\u00f3mez -Villamandos, J. Guti\u00e9rrez, M. A. Sierra, M. Pedrera and M. J. Bautista. \nAtoxoplasma spp. Infection in Captive Canaries (Serinus canaria). J. Vet. Med. A 54: 23\u2013 26. 2007.  \n7. Soto Pi\u00f1eiro, C. J. and I. Acosta Guevara. Hallazgo de Atoxoplas ma serini en canarios (Atoxoplasma serini \nfinding on canary birds). REDVET. Revista electr\u00f3nica de Veterinaria 10 (7): 1 -5. 2009.  63rd WPDC/XXXIX ANECA  INCLUSION BODY HEPATITIS IN BROILERS:  \nEVOLUTION OF THE LESIONS  \n \nHEPATITIS CON CUERPOS DE INCLUSI\u00d3N EN POLLOS DE ENGORDA: \nEVOLUCI\u00d3N DE LAS LESIONES  \n \nM. PizarroA, M. Gonz\u00e1lezA, E. TabaneraA, and A. Rodr\u00edguezAB \n \nAPathology Service. Veterinary Clinical Hospital.  Veterinary Faculty  \nBAnimal Health Surveillance Center (VISAVET), Complutense Uni versity of Madrid, 28040 Madrid,  Spain  \nmpizarro@ucm.es  \n \nRESUMEN  \n \nSe realiza la necropsia de broilers (n= 8) de veinte d\u00edas de edad que eran sospechosos de padecer hep atitis \nv\u00edrica. Todos los animales mostraron ascitis, as\u00ed como h\u00edgados p\u00e1lidos con moteado rojizo. Los \u00f3rganos linfoides \n(timo y bolsa de Fabricio) aparec\u00edan atrofiados. El estudio microsc\u00f3pico revel\u00f3 una hepatitis subaguda con necrosis \nmultifocal y presencia de cuerpos de inclusi\u00f3n por adenovirus. La bolsa mostr\u00f3 una extensa y grave necrosis de \nc\u00e9lulas linfoides en cuatro animales. Los hallazgos histol\u00f3gicos sugieren un diagn\u00f3stico final de hepatitis con cuerpos de inclusi\u00f3n (HCI). Fueron remitidas nuevas m uestras de 8 aves del mism o lote de animales a los 42 d\u00edas  de \nedad, que inclu\u00edan h\u00edgados, bazos, bolsas y tr\u00e1queas. El estudio patol\u00f3gico realizado revel\u00f3 una atrofia severa de la bolsa de Fabricio con marcada depleci\u00f3n de tejido linfoide y hepatitis cr\u00f3ni ca en 4/8 h\u00edgados (no se observaron \ncuerpos de inclusi\u00f3n). Discutimos la infecci\u00f3n por adenovirus en pollos como un pat\u00f3geno primario, ya que tambi\u00e9n podr\u00eda ser secundaria a otros agentes infecciosos, tales como el virus de la enfermedad de Gumboro, que pr ovoca \nuna inmunodepresi\u00f3n severa a los animales.  \n \nSUMMARY  \n \nTwenty day- old broilers (n= 8) with viral hepatitis suspected were necropsied. All animals show ascites and \npale mottled reddish livers. Lymphoid tissues (thymus and bursa of Fabricius) were atrophied. Microscopic study \nrevealed subacute hepatitis with multifocal necrosis and presence of inclusion bodies by adenovirus. Burs a displayed \na severe and extensive necrosis of lymphoid cells in four animals. Histological findings suggested the final diagnosis \nof inclusion body h epatitis (IBH). Additional samples from eight  birds (liver, spleen, bursa , and tracheae)  at 42 d  \nold, from the same flock  were submitted . Pathological s tudy revealed  severe atrophy of the bursa of Fabricius with \nmarked depletion of lymphoid tissue and c hronic hepatitis in four of eight  livers (inclusion bodies are not \nappreciated). We discussed the infection by adenovirus in chickens as a primary pathogen; however it can also be \nsecondary with other infectious agents, such as virus of Gumboro disease, caused a severe immunosuppression of \nanimals.  \n \nCASE REPORT  \n \nThe disease inclusion body hepatitis (IBH) is an adenovirus infection described in young chickens, from four \nup to eight wk . Macroscopically, this disease is characterized by  hepatomegaly, ascites and the presence of  white or \nreddish multifocal are as (mottled) . Histologically , multifocal necrosis of hepatocytes with inflammation  is observed. \nBasophilic intranuclear inclusion bodies are often seen in the cellular elements around the necrotic focus. Chicken \ninfection could  be primary or se condary to an immunosuppression p rocess  due to other previous viral infections like \nGumboro disease or infectious anemia , playing a role of secondary pathogen  in these cases . \nEight broilers of 20 d old  with viral hepatitis suspected are received in the Pathology S ervice. Significant \nmortality at 17 -18 d of age  was observed,  reaching 10% of the flock. At necropsy,  all animals displayed ascite s, pale \nkidneys, yellowish  livers with mottled reddish  foci, as well as a b ursa of Fabric ius and thymus atrophy.  \nA subacute hepatitis with multifocal necrosis and presence of  inclusion bodies by adenovirus in all animals \nwere  observed under a microscope. Marked necrosis of  lymphoid tissue were observed in the  bursa  of the four \nanimals.  Therefore, the final diagnosis was a viral inclusion body hepatitis (adenovirus) , possibly  as consequence of \na severe immunosuppression due to Gumboro virus.  63rd WPDC/XXXIX ANECA  Follow -up 42 days  marked a high mortality , reach ing 22% of animals (of a total of 33,000 animals, almost \n7000 die to infectious process ). Additional samples from  livers, spleens, bursa , and tracheae fixed in formalin  were \nsubmitted  for histological examination . Microscopic diagnosis  showed  bursa of Fabricius with marked depletion of \nlymphoid cells and severe a trophy, c hronic hepati tis in four of eight  livers (inclusion bo dies are not appreciated), \nand m ild nonspecific diffuse tr acheitis.  \nOur case described ty pical lesions of a severe immunodeficiency (suspect of Gumboro disease) with chronic \ncourse. Chronic hepatitis  in some animals could be the result of the evolution of the infection by adenovirus  (no \nintranuclear inclusion bodies were observed) . Final conclusion is that of adenovirus induced  hepatitis in chicken as  \nprimary pathogen, and can also be  secondary or  associated with other agents, such as Gumboro virus, giving place to \nclinical pictures with severe immunosuppression in birds.  \n \nREFERENCES  \n \n1. Alemnesh W ., Hair -Bejo M ., Aini I ., Omar AR. Pathogenicity of fowl adenovirus  in specific pathogen free \nchicken embryos.  J Comp Pathol . 146(2- 3):223- 229. 2012.  \n2. Fitzgerald, S.D. Adenovirus infections. In: Diseases of Poultry, 12 th ed. Y.M. Sayf, ed. Blackwell \npublishing, Ames, Iowa, pp. 251- 290. 2008.  \n3. Gomis S ., Goodhope A .R., Ojkic A .D., Willson P. Inclusion body hepatitis  as a primary disease in broilers \nin Saskatchewan, Canada.  Avian Dis . 50(4): 550- 555. 2006.  \n4. Mase M ., Nakamura K ., Minami F . Fowl adenoviruses isolated from chickens with inclusion body hepatitis  \nin Japan, 2009- 2010.  J Vet Med Sci . 74(8): 1087- 1089. 2012.  63rd WPDC/XXXIX ANECA  MATURE OVARIAN TERATOMA IN A DUCK  \n \nTERATOMA OVARICO MADURO EN UN PATO  \n \nM. PizarroA, A. BengoaB, M. Gonz\u00e1lezA, E. TabaneraA, and A. Rodr\u00edguez -BertosAC \n \nAService of Anatomic Pathology Veterinary Clinical Hospital Veterinary Faculty  \nBService of Exotic Animals; Veterinary Clinic al Hospital Veterinary Faculty  \nCAnimal Health Surveillance Center (VISAVET), Complutense University of Madrid, 28040 Madrid. Spain  \nmpizarro@ucm.es  \n \nRESUMEN  \n \nUn pato hembra de 2,5 a\u00f1os de edad, que mostraba distensi\u00f3n abdominal, fue remitido para necropsia. El \nanimal present\u00f3 una gran masa que ocupaba la cavidad cel\u00f3mica. Esta formaci\u00f3n se caracterizaba por una estructura \nmultilobular integrada por n\u00f3dulos de diferentes tama\u00f1os y colores (z onas rojo oscuras y blancas). Al corte de la \nmasa pudimos observar diferentes \u00e1reas que conten\u00edan plumas, cart\u00edlago y vasos sangu\u00edneos. El estudio histol\u00f3gico \nrevel\u00f3 focos de cart\u00edlago hialino maduro con algunos focos de osificaci\u00f3n, as\u00ed como tejido hemato poy\u00e9tico. En otras \n\u00e1reas apareci\u00f3 tejido conjuntivo con abundantes fibras col\u00e1genas maduras y formaciones qu\u00edsticas tapizadas por \nepitelio que recordaba a los fol\u00edculos ov\u00e1ricos, tambi\u00e9n se observaron \u00e1reas vasculares con aspecto cavernoso, tejido \nadiposo y nervioso, fol\u00edculos de plumas, y formaci\u00f3n de perlas de queratina. Se diagnostic\u00f3 un teratoma maduro en \nbase a la presencia de tejidos procedentes de los tres or\u00edgenes embriol\u00f3gicos: epitelio glandular (endod\u00e9rmico), \ncart\u00edlago, hueso y m\u00fasculo (mesod\u00e9rmi co) y tejido nervioso y epitelio plano queratinizado (ectod\u00e9rmico). Este tipo \ntumoral es muy raro en los patos.  \n \nSUMMARY  \n \nA two and a half year old female duck with abdominal distension was submitted for necropsy. The animal \npresented a large mass that occupies the abdominal  cavity. This formation was characterized by a multinodular \nstructure integrated by nodules of different sizes and colors (dark red and white areas). A mass opening was able to  \nbe observed in different areas, which contained feathers, cartilage and blood vessels. Histological examination \nrevealed foci of mature hyaline cartilage with some focal ossification and hematopoietic tissue. Other areas displayed conjunctive tissue with abundant mature collagen fibers a nd cystic formations covered by epithelium that \nresembled ovarian follicles, vascular areas with cavernous appearance, adipose and nervous tissue, feather follicles \nand pearl -like keratin formations were seen. A mature ovarian teratoma was diagnosed based on the presence of \ntissue from three embryonic origins: glandular epithelium (endoderm), cartilage, bone and muscle (mesoderm) and \nnervous tissue and stratified squamous epithelium (ectoderm). This type of tumor is very rare in ducks.  \n \nCASE REPORT  \n \nA two and a half  year old female duck  was cli nically evident abdominal dilatat ion was  sent to the  Service of \nExotic Animal . Clinical suspicion of an abdominal mass was decided to perform echography and aspiration of the \nsame. Ult rasound describes multinodular and hypervascular  mass , however liver show ed normal volume and \nechogenicit y. Cytologically , compact groups of epithelial cells with cytoplasmic vacuoles are described compatible \nwith glandular tissue. Nuclear atypia was  not observed.  \nAbdominal dilatation i s marked on the external survey of the necropsy and opening confirms the presence of a \nlarge mass that occupies the full cavity; the mass showed  a multinodular appearance with spherical formations of \ndifferent sizes and colors. Cut surface displayed a mott led characterized by dark -red and whit ish areas with different \nconsistency; even,  areas similar to feathers, cartilage and vascular or cavernous type were observed . The rest of the \nviscera presented  no alterations, with the  exception of ileum that appeared  very dilated and the heart which was \ndeformed by pressure from the mass. Histologically there were areas with different aspect:  foci of  mature hyaline \ncartilage, occasionally with focal bone ossification and  hematopoietic elements  (bone marrow) . \nConnective tissue compound of mature collagen fibers was able to be observed . Other additional histological  \nfindings were cyst  formations covered by epithelium which  resembles ovarian follicles and vascular areas with \ncavernous appearance. On the other han d, there were areas with evident dermal  component such as  adipose  63rd WPDC/XXXIX ANECA  subcutaneous  tissue , blood vessels, feather follicles, as well as  in the periphery of mass, a squamous stratified \nepithelium with keratin formations (\u201cpearls\u201d).  Structures with morphology si milar to nerves associated with adipose \nand connective tissue were identified. Cellular malignancy criteria were not appreciated.  Therefore, the presence in \nthe mass of tissue from the three embryonic germ  line cell regions, including glandular epithelium (endoderm), \ncartilage, bone and muscle ( mesoderm ) and neural epithelium and stratified squamous epithelium (ectoderm)  is \ncompatible with the final diagnosis of mature ovarian teratoma . These tumor types are very rare in ducks.  \n \nREFERENCES  \n \n1. Bolte A .L., Burkhardt E. A. teratoma in a Muscovy duck (Cairina moschata).  Avian Pathol . 29(3):  237-\n239. 2000.  \n2. Fadly, A.M. Neoplastic Diseases. In: Diseases of Poultry, 12 th ed. Y.M. Sayf, ed. Blackwell publishing, \nAmes, Iowa, pp. 449 -616. 2008.  \n3. Mutinelli F, Vascellari M. Thoracic teratoma  in a white Pekin duck (Anas platyrhinchos domesticus).  Avian \nDis. 46(2):  493-496. 2002.  \n4. Palmieri C , Romanucci M , Loi P , Della Salda L . Intracoelomic teratoma in a domestic duck ( Anas \nplatyrhynchos domesticus ): a case report including immunohistochemistry and electron microscopy.  Res Vet Sci.  \n93(2):  862-864. 2012.  63rd WPDC/XXXIX ANECA  RESPUESTA PRODUCTIVA Y RENDIMIENTO EN CANAL DE \nVARIEDADES DE CODORNIZ ( COTURNIX COTURNIX JAP\u00d3NICA ) \n \nPRODUCTIVE RESPONSE AND CARCASS YIELD IN TWO VARIETIES OF \nJAPANESE QUAIL  \n \nL. Portillo*, R . R\u00edos, T. Castro, M. Angulo , C. Mart\u00ednez y L. Soto  \n \nFacultad de Medicina Veterinaria y ZootecniaUniversidad Aut\u00f3noma de SinaloaCarretera Internacional Km 3.5 Sur, \nApartado Postal 1057, Culiac\u00e1n Sinalo a M\u00e9xico Tel/Fax (667) 718 -1650  \n*Autor para correspondencia: portillo6422@yahoo.com  \n \nSUMMARY  \n \nIn order  to compare the growth performance and carcass yield of the color varieties of the Pharaonic and \nManchuria Japanese quail, 110 chicks of each variety were housed in 10 cages (90x90x60 cm) in conventional \nhousing. The feed was in the form of flour with corn  and soybean meal contributed 2833 kcal / kg ME and 27.96 % \ncrude protein. Weight and consumption wer e recorded weekly and at 32 d of age. At d 33, 20 quails of each variety \nwere slaughtered. Initial weight (9.51, 9.34 g) and final weight  (227.1, 226.6 g),  weight gain (215.8, 211.9 g), feed \nintake  (593.4, 596.8 g), feed conversion (3.21, 3.44 g / g), mortality (7.3,12.7%), hot carcass weight (139.1, 138.1 g) \nand yield (60.8, 60.4 %), were the same in the varieties (P > 0.05). We conclude that the varieties have similar \nproductive response and carcass yield.  \n \nRESUMEN  \n \nPara comparar la respuesta productiva y el rendimiento en canal de dos variedades de codorniz ( Coturnix \ncoturnix japonica ) seg\u00fan el color de la pluma: variedad tipo salvaje (VTS) y variedad tipo  Manchuria (VTM), \nfueron alojados 110 pollitos de cada variedad en 10 jaulas (90x90x60cm) en una caseta convencional. El alimento \nen forma de harina con ma\u00edz y pasta de soya conten\u00eda 2833 kcal/kg de EM y 27.96% de prote\u00edna cruda. Se registr\u00f3 \nel peso y con sumo cada semana y a los 32 d \u00edas de edad. Al d\u00eda 33 fueron sacrificadas 20 codornices de cada \nvariedad. Los resultados de peso inicial ( 9.42) y final ( 226.85g), ganancia de peso ( 213.85  g), consumo de alimento \n(595.1 g), conversi\u00f3n alimenticia ( 3.32g/g), mo rtalidad ( 10%), peso de canal caliente ( 138.6g) y rendimiento \n(60.6%), para VTS y VTM, fueron iguales (P>0.05). Se concluye que estas variedades tienen respuesta productiva y \nrendimiento en canal similar.  \n \nINTRODUCCI\u00d3N  \n \nVarias razas , l\u00edneas y variaciones de color de  codornices son  utilizadas en la producci\u00f3n de huevos, carne o \ncomo aves de ornato . La codorniz amarilla es u na de las variantes  que puede ser muy  atractiva  para la producci\u00f3n a \nescala industrial de huevos y carne de codorniz japonesa. El color result\u00f3 de la mutaci\u00f3n del color tipo salvaje (1). \nLas plumas son de color amarillo trigo pajizo y las codornices son heterocigotas para una mutaci\u00f3n letal dominante \nY (Yellow) (2).  \nMinvielle y col. (3) observaron que el crecimiento inicial  fue m\u00e1s lento  en codornices Manchuria con un peso \ncorporal 2.4 % menor a la  codorniz de tipo salvaje (149.3 g vs. 153.0  g) a 28 d \u00edas de edad.  Sin embrago e l peso \ncorporal  de los machos fue similar  entre variedades  a los 35 d\u00edas de edad y se mantuvo  hasta los 120 d\u00edas. Tarhyel y \ncol. (7) indican efecto significativo del tipo de color en las caracter\u00edsticas de la canal.  \nEl objetivo de este trabajo fue comparar  la respuesta productiva y el rendimiento en canal de la variedad \namarilla con respecto a la variedad com\u00fan utilizada tradicionalmente.  \n \nMATERIALES Y M\u00c9TODOS  \n \nEl trabajo se realiz\u00f3 en la Unidad Av\u00edcola de la Facultad de Medicina Veterinaria y Zootecnia de la \nUniversidad Aut\u00f3noma de Sinaloa, ubicada en Culiac\u00e1n Sinaloa M\u00e9xico.  63rd WPDC/XXXIX ANECA  Se utilizaron 110 pollitos de codorniz japonesa de la variedad com\u00fan o tipo salvaje, que es la que se utiliza \ndesde hace dos d\u00e9cadas en la regi\u00f3n; y 110 pollitos de una variedad de codorniz japonesa con pluma amarilla o \n\u201carena\u201d (tipo Manchuria) que se introdujo recientemente. Se formaron al azar cinco grupos de 22 pollitos de cada \nvariedad que fueron alojados en jaulas de malla met\u00e1lica que miden 90 x 90 x 60 cm, colocadas en el piso de una \ncaseta av\u00edcola tipo convencional. La cama fue de heno de Sud\u00e1n ( Sorghum vulgare var. sudanensis ), sobre la  que se \ncoloc\u00f3 un comedero tipo charola de 30 x 20 cm en los primeros 4 d\u00edas de edad;  a partir del tercer d\u00eda fue colocado \nun comedero tipo tolva de piso semiautom\u00e1tico de 25 x 17.5 x 25 cm (Implementos Huacuja SA de CV, Tonal\u00e1, \nJalisco, M\u00e9xico) y un abast ecedor autom\u00e1tico de agua de 20 x 12 cm (Modelo AA, Sistemas Agropecuarios Jat S.A. \nde C.V., Zapopan, Jalisco, M\u00e9xico). La temperatura en las jaulas se mantuvo de 35 a 37 \u00b0 C en la primera semana, 32 \na 35\u00b0C en la segunda semana, para ello se coloc\u00f3 hule en su per\u00edmetro y fueron utilizadas criadoras el\u00e9ctricas con \nfocos incandescentes de 75 w.  \nLas dietas para iniciaci\u00f3n y finalizaci\u00f3n (Cuadro 1) se formularon con base en los requerimientos nutrimentales \ndel NRC (4). Se prepar\u00f3 en forma de harina y se proporci on\u00f3 ad libitum ; al finalizar cada semana se calcul\u00f3 el \nconsumo de alimento por ave (alimento servido menos alimento no consumido entre el n\u00famero de codornices que finalizaron).  \nCada codorniz se pes\u00f3 a los  1, 7, 14, 21, 28 y 32 d\u00edas  de edad (B\u00e1scula OHAUS U SA 3000 x 0.01 g). La \nganancia de peso promedio por codorniz de cada jaula se calcul\u00f3 con el peso final menos peso inicial entre el n\u00famero de codornices. Se estim\u00f3 la conversi\u00f3n alimenticia por jaula, con base en el total de alimento consumido y la \ngananci a de peso por cada grupo.  \nA los 33 d de edad fueron tomadas al azar cuatro codornices de cada jaula (n=40; 20 hembras y 20 machos), a \nlas que antes del sacrificio se les restringi\u00f3 el alimento durante dos horas. El procesamiento de las aves se realiz\u00f3 \ncon base en la Norma Oficial Mexicana \u201cSacrificio humanitario de los animales dom\u00e9sticos y silvestres\u201d (NOM -\n033-ZOO -1995) (5), previo registro del peso vivo. El faenado inici\u00f3 con el corte de las articulaciones radiocarpiana \ny tibiotarsiana, separaci\u00f3n de la p iel y plumas por tracci\u00f3n mec\u00e1nica, extracci\u00f3n de v\u00edsceras, excepto coraz\u00f3n, \npulmones y ri\u00f1ones; luego la canal se pes\u00f3.  \nPrevio al an\u00e1lisis, los valores se probaron para normalidad e igualdad de las varianzas, con los m\u00e9todos de \nKolmogorov- Smirnov e interv alo de confianza del 95 % para la raz\u00f3n de varianzas. Luego se realiz\u00f3 la prueba de  t \nde Student para la diferencia entre dos medias de muestras independientes. La proporci\u00f3n de mortalidad se analiz\u00f3 \ncon la prueba de Ji cuadrada (6). En todos los an\u00e1lisis se consider\u00f3 el nivel de alfa para aceptar diferencia estad\u00edstica \nigual o menor que 0.05.  \n \nRESULTADOS  \n \nLos resultados para la respuesta productiva y el rendimiento en canal de dos variedades de codorniz japonesa \nse presentan en el Cuadro 2. Los indicadores  de respuesta productiva como el peso final (226.83 g), ganancia de \npeso por codorniz (213.84 g), alimento consumido de 1 a 32 d\u00edas de engorda (595.09 g) y conversi\u00f3n alimenticia (3.33 g/g), no mostraron diferencia estad\u00edstica (P > 0.10). La mortalidad fue  similar entre las variedades (10 %, P = \n0.18). Al realizar el procesamiento, el peso al sacrificio (228.91 g), el peso de la canal caliente (138.62 g) y su \nrendimiento (60.59 %) fueron iguales entre variedades (P > 0.10).  \n \nDISCUSI\u00d3N  \n \nLa utilizaci\u00f3n de la VTM no mejor\u00f3 los par\u00e1metros productivos que se tienen al utilizar la VTS. Minvielle y \ncol. (3) al utilizar las dos variedades obtuvo el mismo resultado, aunque el peso a las cinco semanas de edad fue de \n146.4 g y 148.4 para la VTM y V TS, respectivamente, que son menores a los  registrados en el presente trabajo \n(226.83 g) y a 32 d de edad. Al utilizar el modelo mono molecular para la curva de crecimiento: A \u2013  B exp ( -kt), los \nvalores para los par\u00e1metros de peso asint\u00f3tico (A), rango de peso desde el nacimiento hasta alcanzar el valor de A (B), y el valor para la tasa de crecimiento (k) a la edad en d\u00edas (t), fueron de 0180.3 y 181.7 para A, 192.0 y 193.6 \npara B, y para k de 0.0512 y 0.0520, para VTM y VTS, respectivamente (3), sin observ ar diferencia estad\u00edstica entre \nlos coeficientes de los par\u00e1metros (P > 0.05).  \nPara el consumo de alimento el resultado coincide con el reportado por Minvielle y col. (3) con consumos \ndiarios de alimento promedio de 17.86 y 17.09 g para la VTM y VTS, respe ctivamente.  \nCon respecto al peso al sacrificio en este trabajo (228.91 g), el resultado coincide con lo observado por \nMinvielle y col. (3) con pesos de 178.4 g para VTM y 179.6 g en la VTS, por lo que es posible inferir que el \nrendimiento en canal es simil ar, como se observ\u00f3 en este trabajo.  \n 63rd WPDC/XXXIX ANECA  REFERENCIAS  \n \n1. Genchev, A. Egg production potential of Manchurian golden quail breeders. Agricultural Science and \nTechnology. 3: 73- 80. 2011.  \n2. Homma, K., S. Shumiya, and M. Jinno. 1967. Yellow -feathered Japanese quail ( Coturnix coturnix \njaponica ). Jpn. J. Zootech.Sci. 38:163- 166. 1967.  \n3. Minvielle, F. , D. Gourichon, S. Ito, M. Inoue -Murayama and S. Rivie`re. Effects of the dominant lethal \nYellow mutation on reproduction, growth, feed consumption, body temperature, and body  composition of the \nJapanese quail. Poultry Science 86:1646- 1650. 2007.  \n4. National Research Council (NRC). Nutrient requirements of Ring -Necked Pheasants, Japanese Quail, and \nBobwhite Quail. In: Nutriment requirements of poultry: 9th Rev. Ed. National Academ y Press, Washington, D.C. \nPp. 44- 45. 1994.  \n5. Secretar\u00eda de Agricultura, Ganader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n. Norma Oficial Mexicana \nSacrificio humanitario de los animales dom\u00e9sticos y silvestres. NOM -033-ZOO -1995. M\u00e9xico, D.F. 17 pp. 1995.  \n6. Steel, R. G. D. y J. Torrie H. Bioestad\u00edstica: Principios y Procedimientos. 2da. Edici\u00f3n. McGraw -Hill, \nM\u00e9xico. 539 p.  1986.  \n7. Tarhyel, R., B.K. Tanimomo, S.A. Hena. Effect of sex, colour and weight group on carcass characteristics \nof Japanese quail.  Scientif ic Journal of Animal Science. 1: 22 -27. 2012.  \n \n \nCuadro 1.  Composici\u00f3n y aporte nutrimental calculado de las dietas experimentales.  \n \nIngrediente  Edad de las codornices  \n1 a 14 d\u00edas  15 a 32 d\u00edas  \nMa\u00edz  30.29  46.00  \nPasta de soya  57.83  46.00  \nAceite de soya  5.31 4.00 \nAz\u00facar  3.38 0 \nSal de mar  0.30 0.34 \nMetionina  0.17 0.25 \nLisina  0 0.04 \nTreonina  0 0.15 \nPiedra caliza molida  1.37 1.43 \nOrtofosfato  0.55 0.62 \nVitaminas para pollo de engorda  0.20 0.30 \nMinerales para aves  0.05 0.07 \nAdsorbente de micotoxinas  0.15 0.40 \nFitasa  0.20 0.20 \nPrebi\u00f3tico  0.20 0.20 \nTotal  100 100 \nEnerg\u00eda metabolizable  kcal/kg  2883  2919  \nProte\u00edna cruda %  27.96  24.21  \nMetionina %  0.51 0.52 \nLisina %  1.55 1.30 \nTreonina %  1.08 1.07 \nCa %  0.80 0.80 \nP no fitado %  0.30 0.30 \na Premezcla  de vitaminas y minerales proporciona por kg de dieta: 3.75 mg retinol; 112 \u03bcg colecalciferol; 30 mg \nacetato de tocoferol; 3 mg bisulfuro s\u00f3dico; 1.5 mg tiamina; 6 mg riboflavina; 3 mg piridoxina; 15 \u03bcg \ncianocobalamina; 1.5 mg \u00e1cido f\u00f3lico; 55 mg niacina; 15 mg Ca pantotenato; 180 \u03bcg biotina; 600 mg colina; 75 mg \nMn; 75 mg Zn; 75 mg Fe; 900 \u03bcg Mo; 750 \u03bcg Co; 1.6 mg Cu; 105 \u03bcg Se; 120 mg Banox (BHA +BHT)  \n  \n \n 63rd WPDC/XXXIX ANECA   \nCuadro 2 . Indicadores productivos y de la canal de variedades de codorniz japonesa en engorda.  \n \nIndicador  Variedad  EEM  P Com\u00fan  Amarilla  \nPeso inicial, g  9.51 9.34 0.08 0.13 \nPeso final, g  227.10  226.56  3.47 0.92 \nGanancia de peso, g por ave  215.82  211.86  7.66 0.19 \nAlimento consumido, g por ave  593.41  596.77  6.60 0.67 \nConversi\u00f3n alimenticia, g/g  3.21 3.44 0.22 0.53 \nMortalidad1 % 7.27 (8/110)  12.73 (14/110)   0.18 \nPeso vivo al sacrificio, g  228.59  229.23  5.51 0.91 \nPeso de canal caliente, g  139.10  138.14  1.97 0.63 \nRendimiento en canal, %  60.75  60.43  0.91 0.72 \nEEM = E rror est\u00e1ndar de la media, P  = probabilidad, 1 Muertes de forma natural y por triaje  \n \n \n \n  63rd WPDC/XXXIX ANECA  RESPUESTA PRODUCTIVA Y REPRODUCTIVA DE CODORNIZ \n(COTURNIX COTURNIX JAP\u00d3NICA ) AL INCLUIR EN EL \nALIMENTO HARINA DE JATROPHA CURCAS   \nVARIEDAD NO T\u00d3XICA  \n \nPRODUCTIVE AND REPRODUCTIVE PERFORMANCE OF JAPANESE \nQUAIL WHEN INCLUDING IN THE FEED JATROPHA CURCAS  \nNON-TOXIC VARIETY MEAL  \n \nL Portillo *, A. Estrada, C. Mart\u00ednez, E. Angulo, M. Angulo, y T. Castro  \n \nFacultad de Medicina Veterinaria y Zootecnia Universidad Aut\u00f3noma de Sinaloa  Carretera Internacional Km 3.5 \nSur, Apartado Postal 1057, Culiac\u00e1n Sinaloa M\u00e9xico  Tel/Fax (667) 718- 1650  \n*Autor para correspondencia:  portillo6422@yahoo.com  \n \nSUMMARY  \n \nIn order to evaluate the productive and reproductive performance of Japanese quails when non -toxic Jatropha \ncurcas  (HJCNT) meal was included in their feed, 80 females and 20 males were housed in 20 cages (60X30 cm) in a \nconventional house. The feed (meal) corn and soybean meal -based had 2900 kcal/kg ME, 20% crude protein and \n2.58% Ca. HJCNT without defatting was included at levels of 0% (control), 3% and 6%. Feed intake, number and \nweight of eggs, hatched chickens and their birth weight were registered, and an embryo diagnosis was made. Feed \nintake was similar (76.7%, P =0.06) as well as the birth weight (11.24g, P =0.07). Fertility was 76%, 95% and 77% \nand hatchability was 72 %, 85% and 78% for 0%, 3% and 6% HJCNT groups respectively. It is concluded that the \ninclusion of levels up to 6% of HJCNT without defatting  does not affect the productive and reproductive \nperformance of Japanese quail.  \n \nRESUMEN  \n \nPara valorar la respuesta productiva y reproductiva de codorniz ( Coturnix coturnix japonica) al incluir en el \nalimento harina de Jatropha curcas  no t\u00f3xica (HJCNT), fueron alojadas 80 hembras con 20 machos en 20 jaulas \n(60x30cm) en caseta convencional. El alimento en forma de harina  con ma\u00edz y pasta de soya aport\u00f3 2900 kcal/kg de \nEM, 20% de prote\u00edna cruda y 2.58% de Ca. Se incluy\u00f3 HJCNT sin desgrasar en niveles de 3 y 6 % y el control \n(0%). Se registr\u00f3 el alimento consumido, n\u00famero y peso de huevos, pollitos nacidos y su peso, y se r ealiz\u00f3 \nembriodiagn\u00f3stico. El consumo de alimento fue similar (31.49g, P=0.61), al igual que el porcentaje de postura \n(76.7%, P=0.06) y  el peso del pollito (11.24g, P=0.07). La fertilidad fue de 76, 95 y 77%, y la incubabilidad de 72, \n85 y 78% para 0, 3 y 6% de HJCNT, respectivamente. Se concluye que la inclusi\u00f3n de hasta 6 % de HJCNT sin \ndesgrasar no disminuye  la respuesta productiva y reproductiva de codorniz japonesa.  \n \nINTRODUCCI\u00d3N  \n \nJatropha es un miembro de la familia de las Euforbiaceas, crece en suelos  de regiones tropicales  y es resistente \na la sequ\u00eda. Las semillas en forma de harina contiene n de 22 a 27 % de prote\u00edna y 57 a 63 % de l\u00edpidos ( 1), por ello \nel uso potencial como ingrediente en la alimentaci\u00f3n animal.  Jatropha curcas  se ha identificado en dos variedades: \ntoxica y no t\u00f3xica. La harina y aceite de la variedad t\u00f3xica ha sido incluid a en el alimento de pollos, becerros, \nborregos, cabras y ratas. Los resultados indican que es necesario darle tratamiento para detoxificarla (4). \nLa variedad de Jatropha curcas  de M\u00e9xico seg\u00fan los resultados de Makkar y col (4) no es  t\u00f3xica, ya que \ncontine 0.11 mg/kg de \u00e9steres de forbol. Aunque contiene factores antinutricionales como antitripsina, lectina, \nfitatos y saponinas, algunos de los cuales se inactivan con el calor.  \nEl objetivo del trabajo fue valorar la respuesta productiva y reproductiva de codorniz ( Coturnix coturnix \njaponica ) al incluir en el alimento harina de Jatropha curcas  no t\u00f3xica.  \n \n 63rd WPDC/XXXIX ANECA  MATERIALES Y M\u00c9TODOS  \n \nEl trabajo se realiz\u00f3 en la Unidad Av\u00edcola de la Facultad de Medicina Veterinaria y Zootecnia de la \nUniversidad Aut\u00f3noma de Sinaloa, ubicada en Culiac\u00e1n Sinaloa M\u00e9xico.  \nSe utilizaron 80 hembras y 20 machos de codorniz ( Coturnix coturnix jap\u00f3nica) variedad com\u00fan de 20 \nsemanas de edad, para formar al azar 20 grupos de cuatro hembras con un macho y alojarlos  en 20 jaulas de 60 x 30 \ncm en bater\u00eda para codorniz en producci\u00f3n de huevo (Implementos Huacuja SA de CV, Tonal\u00e1, Jalisco, M\u00e9xico) , en \nuna caseta av\u00edcola convencional. Un comedero de canaleta  se coloc\u00f3 por jaula con un separador entre jaulas, y el \nbebedero de canaleta fue com\u00fan para cuatro jaulas.  Las codornices tuvieron 16 h oras en total  de luz con una hora de \nluz en la noche (1:00 a 2:00 horas).  Durante las horas con t emperatura ambiente elevada en la caseta se utiliz\u00f3 \nventilaci\u00f3n de aire forzada y cortina h\u00fameda con dos equipos tipo cooler.  \nPara la formulaci\u00f3n de las dietas experimentales con HJCNT (Cuadro 1)  se tomaron los valores del an\u00e1lis is \nqu\u00edmico proximal realizado: prote\u00edna cruda 24.64 %, extracto et\u00e9reo 50.32 %, fibra cruda 5.05 %, c arbohidratos \n20.30 % y ELN 15.79 %, c on estos valores se calcul\u00f3 la energ\u00eda metabolizable (5). El contenido de Ca y P fue de \n0.60 % y 0.86 %, respectivamente (2). Los requerimientos nutrim entales se tomaron del NRC (6 ). \nLas codornices de cinco jaulas se asignaron al azar a uno de dos niveles de inclusi\u00f3n (3 \u00f3 6 % de HJCNT) y el \nresto a la dieta control sin HJCNT. El periodo de adaptaci\u00f3n a las dietas y al manejo experimental fue de do s \nsemanas.  \nSe utiliz\u00f3 alimento  en forma de harina ad libitum ; al finalizar cada semana se calcul\u00f3 el consumo de alimento \npor ave (alimento servido menos alimento no consumido entre el n\u00famero de codornices que finalizaron).  \nDurante cinco  semanas cada d\u00eda a las 19 h oras se clasific\u00f3 el huevo en una de tres categor\u00edas: El huevo para \nincubar fue elegido seg\u00fan el tama\u00f1o, forma y color, que estuviera limpio, y sin adherencias  o quebrado. El huevo \nque no cumpli\u00f3 las especificaciones para incubar, limpio y no quebr ado se clasific\u00f3 para consumo, y el resto como \nhuevo de desecho. Los huevos se pesaron seg\u00fan la categor\u00eda.  \nEl huevo para incubar se conserv\u00f3 en filler de pl\u00e1stico entre 6 a 10 \u00b0C y humedad relativa de 40 a 60%. Cada \nlote de huevo incubado fue la colecta de siete d\u00edas, y hubo 23 horas entre la \u00faltima colecta y la colocaci\u00f3n en la \nincubadora.  \nEn cada incubaci\u00f3n el lote de huevo se sac\u00f3 del equipo de refrigeraci\u00f3n  para atemperarlo hasta 23 a 25 \u00b0C \ndurante tres horas, luego se puso  en filler  para huevo de codorniz y se asperj\u00f3 con un desinfectante org\u00e1nico \n(VirkonMR Laboratorios Bayer) a dosis de 50 ppm, y se coloc\u00f3 en la incubadora de volteo autom\u00e1tico (Implementos \nHuacuja SA de CV, Tonal\u00e1, Jalisco, M\u00e9xico)  a temperatura promedio de 37.6\u00b10.3\u00b0C y HR de 67.1\u00b15. 6%. Al \ncumplir 336 h de incubaci\u00f3n el huevo se coloc\u00f3 en  la nacedora (Implementos Huacuja SA de CV, Tonal\u00e1, Jalisco, \nM\u00e9xico)  donde se ma ntuvo a temperatura promedio de  37.2 \u00b1 1 \u00b0C y HR de 68 \u00b1 6 %.  El primer retiro de los \npollitos d e la n acedora se realiz\u00f3  de 11 a 13 h oras a partir de iniciada la eclosi\u00f3n  y cuando el plum\u00f3n estaba seco, y \nse registr\u00f3 el peso de cada pollito (B\u00e1scula OHAUS USA 3000 x 0.01 g).  \nCada huevo no eclosionado se quebr\u00f3 para observar alguna estructura compatible con  el desarrollo de embri\u00f3n \ny considerarlo como hu evo f\u00e9rtil.  \nPara el an\u00e1lisis estad\u00edstico de los valores se comprob\u00f3 la  normalidad y homogeneidad de las v arianzas con los  \nm\u00e9todos de Kolmogorov- Smirnov y Bartlett, respectivamente ( 8), enseguida se realiz\u00f3 el  an\u00e1lisis de la varianza para \nmedidas repetidas con  el Proc MIXED de SAS  (7) que incluy\u00f3 el efecto de semana, nivel de HJCNT y  la int eracci\u00f3n \nentre semana y HJCNT, donde  la jaula (codornices) se consider\u00f3 como efecto aleatorio . Para la incubabilidad y \nfertilidad se realiz\u00f3 una prueba de Ji cuadrada (8). En todos los an\u00e1lisis se consider\u00f3 el nivel de alfa para aceptar \ndiferencia estad\u00edstica igual o menor que 0.05.  \n \nRESULTADOS  \n \nLos resultados para la respuesta productiva y de incubaci\u00f3n se presentan en el Cuadro 2.  La inclusi\u00f3n de hasta \n6% de HJCNT no afect\u00f3 el consumo de alimento (P = 0.61), en promedio las codornices consumieron 31.49 g por \nd\u00eda. La producci\u00f3n de huevo tuvo una tendencia (P = 0.06) a la diferencia estad\u00edstica debido  al valor alto en el niv el \nde 3% de HJCNT. Las codornices en el nivel de 6 % produjeron huevo m\u00e1s pesado (P < 0.01) que el control y 3%, \naunque  el peso del huevo clasificado para consumo no mostr\u00f3 diferencia entre niveles de HJCNT, que en promedio \npeso 14.16 g. El alimento consum ido por huevo producido y huevo incubable, fue diferente entre niveles (P < 0.01), \npero en los niveles de 0 y 6 % no hubo diferen cia (P > 0.05), y el nivel de 3 % tuvo menor consumo. El alimento \nconsumido por pollito nacido fue menor en los nivele con HJCNT (P < 0.01). El peso del pollito de codorniz al salir \nde la nacedora present\u00f3 tendencia a la diferencia entre niveles (P = 0.07), donde el nivel de 6% tuvo el peso m\u00e1s 63rd WPDC/XXXIX ANECA  alto, sin emb argo esto se explica por el mayor peso del huevo incubable. La incubabilidad y fertilidad fue mayor en \nlos huevos de codornices que se alimentaron con HJCNT (P < 0.01).  \n \nDISCUSI\u00d3N  \n \nLos resultados del estudio indican que la HJCNT es un ingrediente que se puede incluir en el alimento de \ncodorniz japonesa reproductora en los niveles utilizados. El primer indicador de ello es que las aves no modificaron \nsu consumo, el peso del huevo incubable y para consumo no disminuy\u00f3. Cuando se incubaron los huevos no fue \nafectada la fertilidad e incubabilidad del huevo, ni el peso del pollito al na cer. Debido a que no se encontraron \ntrabajos con aves reproductoras no es posible comparar los resultados obtenidos. En codornices en engorda Flores (2) utiliz\u00f3 harina de Jatropha curcas  no t\u00f3xica  extrudida en niveles de 10, 20 y 30 %, y observ\u00f3 que el consumo de \nalimento, la ganancia de peso y la conversi\u00f3n alimenticia mostraron diferencias m\u00ednimas con respecto a la dieta con pasta de soya. Gil (3 ) incluy\u00f3 aceite de Jatropha curcas  en el alimento de codorniz japonesa en engorda en \nsustituci\u00f3n de hasta 5 % de aceite de soya, observ\u00f3 que la sustituci\u00f3n no modific\u00f3 la respuesta productiva ni el \nrendimiento de la canal.  \n \nREFERENCIAS  \n \n1. Aderibigbe, A.O., C.O.L.E. Johnson, H.P.S. Makkar, K. Becker and N. Foidl. 1997. Chemical \ncomposition and effect of heat on organic matter and nitrogen- degra dability and some antinutritional components of \nJatropha meal. Animal Feed Science Technology . 67: 223- 243. \n2. Flores, C. R. S., J. B. Valdez T., M. A. Angulo E., J. B. Heredia y J. J. Portillo L. Respuesta productiva \nde codorniz japonesa en engorda alimentada con harina de Jatropha curcas  L no t\u00f3xica extrudida. En: Memorias de \nla XXXVII Convenci\u00f3n Nacional ANECA. Puerto Vallarta Jalisco M\u00e9xico. 2 al 6 de mayo. Pag. 329 -338. 2012.  \n3. Gil. A. M. R. Efecto de la inclusi\u00f3n de aceite de Jatropha curcas  no t\u00f3xica  en el alimento  para codorniz \njaponesa en engorda ( coturnix coturnix japonica). Tesis Maestr\u00eda. Centro de Investigaci\u00f3n en Alimentaci\u00f3n y \nDesarrollo. Culiac\u00e1n Sinaloa M\u00e9xico. 2013.  \n4. Makkar H. P. S. and K. Becker. Potential of J. curcas  seed meal as a protein supplement to livestock fed, \nconstraints to its utilization and possible strategies to overcome constraints. In. G\u00fcbtz, M. Mittelbach, M. Trabi. \nEditors. Symposium \u201cJatropha 97\u201d Biofuels and Industrial Products from Jatropha curcas . Managua Nicaragua. \nFeb. 23- 27. Pages. 190- 205. 1997.  \n5. Moir, K. W., W. J. Yule and J. K. Connor. Energy losses in the excreta of poultry: a model for predicting \ndietary metabolizable energy. Australian Journal Experimental Agricultural Animal Husbandry. 20: 151 -155. \n6. National Research Council (NRC). Nutrient requirements of Ring -Necked Pheasants, Japanese Quail, and \nBobwhite Quail. I n: Nutriment requirements of poultry: 9th Rev. Ed. National Academy Press, Washington, D.C. \nPp. 44- 45. 1994.  \n7. SAS Institute. SAS/STAT: User\u00b4s guide: Version 9.1. SAS Institute Inc. Cary, North Carolina. 2004.  \n8. Steel, R. G. D. y J. Torrie H. Bioestad\u00edstica: P rincipios y Procedimientos. 2da. Edici\u00f3n. McGraw -Hill, \nM\u00e9xico. 539 p. 1986.  \n  \n \n \n \n \n  \n \n \n \n \n   \n \n 63rd WPDC/XXXIX ANECA   \n \nCuadro 1 . Composici\u00f3n y aporte nutrimental calculado de las dietas experimentales.  \n \nIngrediente  Harina de Jatropha curcas  NT, %  \n0 3 6 \nMa\u00edz  51.30  51.38  51.46  \nPasta de soya  35.90  34.26  32.62  \nAceite de soya  4.43 3.12 1.823  \nHarina de Jatropa curcas  0 3 6 \nSal 0.30 0.30 0.30 \nMetionina  0.29 0.24 0.197  \nPiedra caliza molida  6.00 6.00 6.05 \nOrtofosfato  0.98 0.90 0.75 \nVitaminas para gallina en postura  0.15 0.15 0.15 \nMinerales para aves  0.05 0.05 0.05 \nPigmento vegetal  0.10 0.10 0.10 \nPrebi\u00f3tico  0.20 0.20 0.20 \nAdsorbente de micotoxinas  0.10 0.10 0.10 \nFitasa  0.20 0.20 0.20 \nTotal  100 100 100 \nEnerg\u00eda metabolizable, Mcal/kg  2.902  2.903  2.906  \nProte\u00edna cruda, %  20.06  20.06  20.06  \nMetionina, %  0.50 0.50 0.50 \nCalcio, %  2.58 2.58 2.58 \nF\u00f3sforo disponible, %  0.35 0.36 0.35 \nExtracto et\u00e9reo, %  6.67 6.86 7.06 \na Premezcla de vitaminas y minerales proporciona por kg de dieta: 3.75 mg retinol; 112 \u03bcg colecalciferol ; 30 mg \nacetato de tocoferol; 3 mg bisulfuro s\u00f3dico; 1.5 mg tiamina; 6 mg riboflavina; 3 mg piridoxina; 15 \u03bcg cianocobalamina; 1.5 mg \u00e1cido f\u00f3lico; 55 mg niacina; 15 mg Ca pantotenato; 180 \u03bcg biotina; 600 mg colina; 75 mg \nMn; 75 mg Zn; 75 mg Fe; 900 \u03bcg Mo;  750 \u03bcg Co; 1.6 mg Cu; 105 \u03bcg Se; 120 mg Banox (BHA +BHT)  \n \n \n \n  \n  \n \n \n  \n \n \n \n \n 63rd WPDC/XXXIX ANECA   \nCuadro 2.  Indicadores productivos de reproductores de codorniz japonesa con inclusi\u00f3n de harina de Jatropha \ncurcas  variedad no t\u00f3xica en el alimento.  \n \nVariable  HJCNT, %  \nEEM  P \n0 3 6 \nAlimento consumido por d\u00eda,  g 30.97  31.79  31.72  0.58 0.61 \nProducci\u00f3n hembra d\u00eda relativo, %  71.89  83.23  74.89  1.79 0.06 \nPeso del huevo para incubar, g  15.88b 15.85b 16.38a 0.07 0.01 \nPeso del huevo para consumo, g 13.93  13.89  14.67  0.23 0.10 \nAlimento consumido por huevo producido, g  57.36a 49.04b 56.42a 1.33 0.01 \nAlimento consumido por huevo incubable, g 119.98a 98.35b 120.35a 4.29 0.01 \nAlimento consumido por pollito nacido, g  266.51a 162.45b 128.79b 11.90  0.01 \nPeso del pollito, g  11.18  11.15  11.38  0.08 0.07 \nIncubabilidad sobre huevos totales, %  54.46  70.88   0.01 \nFertilidad, %  76.29  86.90   0.01 \nIncubabilidad sobre huevos f\u00e9rtiles, %  71.80  82.39   0.01 \na,b Literales diferentes en rengl\u00f3n indican diferencia estad\u00edstica (P < 0.05) Prueba de Tukey- Cramer  \n \n 63rd WPDC/XXXIX ANECA  P\u00c9RDIDA DE PESO DEL HUEVO INCUBABLE DE CODORNIZ \n(COTURNIX COTURNIX JAPONICA ) DURANTE EL \nALMACENAMIENTO \u00c9 INCUBACI\u00d3N Y SU RELACI\u00d3N  \nCON EL PESO DEL POLLITO  \n \nWEIGHT LOSS OF THE JAPANESE QUAIL HATCHING EGG DURING \nSTORAGE AND INCUBATION AND RELATIONSHIP BETWEEN  \nEGG WEIGHT AND CHICK WEIGHT  \n \nL. Portillo *, C. Mart\u00ednez, T. Castro  y R. R\u00edos  \n \nFacultad de Medicina Veterinaria y Zootecnia Universidad Aut\u00f3noma de Sinaloa  Carretera Internacional Km 3.5 \nSur, Apartado Postal 1057, Culiac\u00e1n Sinaloa M\u00e9xico. Tel/Fax (667) 718- 1650  \n*Autor para correspondencia: portillo6422@yahoo.com  \n \nSUMMARY  \n \nTo know the weight loss of the hatching egg (HI) of the Japanese quail during storage , and incubation and the \nweight ratio of the HI with the chick weight (PP), 1099 eggs in 18 batches (three batches every seven d ays) were \nhatched. The eggs were collected and weighed at 18:30 pm, and were stored for 7 to 10\u00b0C and 40 to 60 % RH. On \nincubation  day, eggs were warmed 3  h at 23 to 25 \u00b0 C, were weighed and sprinkled with organic disinfectant. They \nwere incubated at 37.7 \u00b1  1 \u00b0C and 65 to 70 % RH. On d 14 of incubation were weighed and plac ed in the hatcher at \n37.2 \u00b1 1 \u00b0 C and RH 70 -80 %. When chicks w ere dry they were weighed. Weight loss of egg lots during storage was \n0.58% \u00b1 1.68 and 8.39 \u00b1 0.64% in the incubator. The weight of the HI had an r value of 0.61 with PP (P < 0.01), and \naccounted for 70.1 % of the average egg weight, but this value decrea sed 2.21% per gram of egg weight increase (r \n= -0.62, P <0.01).  \n \nRESUMEN  \n \nPara conocer la p\u00e9rdida de peso del huevo incubable (HI) de codorniz ( Coturnix coturnix japonica) durante el \nalmacenamiento \u00e9 incubaci\u00f3n y la relaci\u00f3n del peso del HI con el peso del pollito (PP), fueron incubados 1099 \nhuevos en 18 lotes (tres lotes cada siete d ). El huevo se colect\u00f3 y pes\u00f3 a las 18:30 horas, fue almacenado de 7 a 10\u00b0C \ny 40 a 60% de HR. El d\u00eda de incubaci\u00f3n se atemper\u00f3 3h entre 23 a 25\u00b0C, fue pesado y se asperj\u00f3 con desinfectante \norg\u00e1nico. Se incubaron a 37.6\u00b10.3\u00b0C y HR 67.1\u00b15.6% y al d\u00eda 14 se pes\u00f3 y coloc\u00f3 en la nacedora a 36.2\u00b10.8\u00b0C y \nHR de 87.8\u00b14.1%. Cuando los pollitos estuvieron  secos fueron pesados. La p\u00e9rdida de peso de los lotes de huevo en \nconservaci\u00f3n fue de 1.68\u00b10.58% y 8.39\u00b10.64% en la incubadora. El peso del HI tuvo un valor de r de 0.61 con PP \n(P<0.01) y represent\u00f3 en promedio 70.1% del peso del huevo, sin embargo, este valor disminuy\u00f3 2.21% por cada \ngramo de aumento de peso del huevo (r = - 0.62, P<0.01).  \n \nINTRODUCCI\u00d3N  \n \nEl peso y la calidad de los pollos para engorde al nacer dependen de factores como la edad de las \nreproductoras, las condiciones de almacenamiento pre incubaci\u00f3n, y las condiciones de incubaci\u00f3n. El \nalmacenamiento del huevo seleccionado para incubar es una pr\u00e1ctica necesaria y su duraci\u00f3n depende del mercado, \nde la capacidad del equipo de incubaci\u00f3n, de la cantidad de pollitos que nacen y la edad de las reproductoras (3). \nDurante el almacenamiento el pH de la alb\u00famina se alcaliniza (9.2 a 9.7), sin embargo el pH \u00f3ptimo para la gastrulaci\u00f3n es de 8.2, otro cambio que ocurre es la desintegraci\u00f3n de la membrana vitelina y las chalazas, lo que afecta el desar rollo del embri\u00f3n  (9). \nDurante el almacenamiento \u00e9 incubaci\u00f3n el huevo pierde peso debido a la p\u00e9rdida de agua, que ocurre \nprincipalmente  durante la incubaci\u00f3n (3). En 18 d\u00edas  de incubaci\u00f3n el  huevo de gallina registra  una p\u00e9rdida de 12% \ndel peso pero se obtienen los mejores \u00edndices de incubaci\u00f3n (7). El peso del pollito al nacimiento es importan te por \nla relaci\u00f3n de \u00e9 ste con los pesos subsecuentes, al tiempo que el peso del huevo determina el peso del pollito al nacer. \nSalah Udinn y col. (5) en huevo de co dorniz estimaron una correlaci\u00f3n de 0.547 y el peso del pollito represent\u00f3 el 63rd WPDC/XXXIX ANECA  70.02 % del peso del huevo. El objetivo del trabajo fue estimar la p\u00e9rdida de peso del huevo en almacenamiento pre \nincubaci\u00f3n de una semana y la relaci\u00f3n entre el peso del huevo con el peso del pollito  al nacimiento . \n \nMATERIALES Y M\u00c9TODOS  \n \nEl trabajo se realiz\u00f3 en la Unidad Av\u00edcola de la Facultad de Medicina Veterinaria y Zootecnia de la \nUniversidad Aut\u00f3noma de Sinaloa, ubicada en Culiac\u00e1n Sinaloa M\u00e9xico. Se utilizaron 1099 huevos  colectados para \nincubar durante seis semanas, agrupados en 18 lotes en seis incubaci ones. Cada d\u00eda a las 18:30 h oras se clasific\u00f3 el \nhuevo en una de tres categor\u00edas: 1) huevo para incubar elegido seg\u00fan el tama\u00f1o, forma y color, limpio y sin \nadherencias o quebrado,   2) huevo que no cumpli\u00f3 las especificaciones para incubar, limpio y no quebrado \nclasificado  para consumo, y 3) el resto  identificado  como huevo de desecho. Los huevos se pesaron seg\u00fan la \ncategor\u00eda. El huevo para incubar fue colocado en filler de pl\u00e1stico entre 7 a 10\u00b0C y humedad relativa de 40 a 60%. \nCada lote de huevo incubado fue  resultado de  la colecta de siete d\u00edas, y hubo 23 horas entre la \u00faltima colecta y la \ncolocaci\u00f3n en la incubadora.  \nEn cada incubaci\u00f3n el lote de huevo se sac\u00f3 del equipo  de refrigeraci\u00f3n, fue pesado y se atemper\u00f3 hasta 23 a \n25 \u00b0C durante tres horas ; al finalizar el proceso se pes\u00f3 , luego fue colocado en filler para huevo de codorniz y  \nasperjarlo  con un desinfectante org\u00e1nico (VirkonMR Laborato rios Bayer) a dosis de 50 ppm , luego se coloc\u00f3 en la \nincubadora de volteo autom\u00e1tico (Implementos Huacuja SA de CV, Tonal\u00e1, Jalisco, M\u00e9xico) a temperatura promedio de 37.61 \u00b1 0.27 \u00b0C y HR de 67.09 \u00b1 5.60%. Al cumplir 14 d\u00edas  de incubaci\u00f3n el huevo fue pesado y se \ncoloc\u00f3 en la nacedora (Implementos Huacuja SA de CV, Tonal\u00e1, Jalisco, M\u00e9xico), donde se mantuvo a temperatura \npromedio de 36.21 \u00b1 0.75\u00b0C y HR de 87.76 \u00b1 4.14 %. El primer retiro de los pollitos de la nacedora fue realizado de \n11 a 13 horas a partir de iniciada la eclosi\u00f3n y cu ando el plum\u00f3n estaba seco, en cada retiro  se registr\u00f3 el peso de \ncada pollito (B\u00e1scula OHAUS USA 3000 x 0.01 g).  \nPara el an\u00e1lisis estad\u00edstico de los valores se comprob\u00f3 la normalidad con el m\u00e9todo de Kolmogorov- Smirnov \n(6). Se calcul\u00f3 la media y desviaci\u00f3 n est\u00e1ndar de la p\u00e9rdida de peso del huevo durante el almacenamiento y en la \nincubaci\u00f3n hasta los 14 d\u00edas. Se realiz\u00f3 an\u00e1lisis de correlaci\u00f3n lineal simple de Pearson y se calcularon los estimadores de los par\u00e1metros para el modelo de regresi\u00f3n lineal simp le, as\u00ed como el valor del coeficiente de \ndeterminaci\u00f3n (6). En todos los an\u00e1lisis se consider\u00f3 el nivel de alfa para aceptar diferencia estad\u00edstica igual o menor \nque 0.05.  \n \nRESULTADOS  \n \nLa p\u00e9rdida de peso de los lotes de huevo en el almacenamiento pre incubaci \u00f3n fue de 1.68 \u00b1 0.58%, mientras \nque en la fase d e incubaci\u00f3n hasta las 336 h oras fue de 8.39 \u00b1 0.64%, por lo que desde la colecci\u00f3n hasta la \ntransferencia la p\u00e9rdida de peso fue de 10.07%.  \nLa relaci\u00f3n entre el peso promedio del huevo a la colecci\u00f3 n con el peso promedio del pollito al retirarlo de la \nnacedora fue positiva (Gr\u00e1fica 1). El modelo de regresi\u00f3n ajustado indica que el peso del pollito se increment\u00f3 en 0.35 gramos por cada gramo de aumento del peso del huevo (r = 0.61), aunque el valor de l coeficiente de \ndeterminaci\u00f3n (R\n2 = 0.38) no es muy bueno.  Con respecto a la proporci\u00f3n del peso del pollito en relaci\u00f3n al peso del  \nhuevo, en promedio fue de 70.1%, aunque este valor disminuy\u00f3 en 2.21 % por cada gramo de aumento del peso promedio del hue vo (r = -  0.62, P < 0.01), como se muestra en la Gr\u00e1fica 2.  \n \nDISCUSI\u00d3N  \n \nDebido al contenido de agua del huevo (75 %), a la necesidad de intercambio de ox\u00edgeno y bi\u00f3xido de carbono \ny la existencia de poros en el cascar\u00f3n, la p\u00e9rdida de peso del huevo es un proceso normal favorecido por el gradiente de concentraci\u00f3n de agua entre el medio interno del huevo y el \u00e1rea donde se almacena, sin embargo , \ncuando la p\u00e9rdida coincide con los valores m\u00ednimos del rango,  implica que la c\u00e1mara de aire no incrementa su \nvolumen y no favorece que el pollito inicie la respiraci\u00f3n pulmonar, en cambio , valores altos de p\u00e9rdida de peso \nresulta n en una deshidrataci\u00f3n del medio. Rahn y Paganelli (2) resaltaron la relevancia  de la  p\u00e9rdida de peso  del \nhuevo como un par\u00e1metro important e para  la incubaci\u00f3n , ya que est\u00e1 relacionada con el intercambio de gases , que se \nha correlacionado  con el metabolismo del  embri\u00f3n y  las tasas de desarrollo  (1). En huevo de codorniz para \nproducci\u00f3n de carne, Romao  y col. (4) estimaron una p\u00e9rdida lineal de peso de 0.2058% por cada d\u00eda de \nalmacenamiento, aunque la p\u00e9rdida de peso duran te la incubaci\u00f3n fue de - 0.8864% durante el mismo periodo, lo que \nindica que estuvo relacionada de forma inversa. Sin embargo , la p\u00e9r dida de peso tanto en almacenamiento como en \nincubaci\u00f3n depende de la temperatura y humedad relativa. As\u00ed  a 20\u00b0C con 60% de HR , la p\u00e9rdida de peso fue de 63rd WPDC/XXXIX ANECA  1.5%, y en la incubaci\u00f3n a 37.6 \u00b0C con 60 % de H R la p\u00e9rdida de peso fue de 4.7% cuando se almacenaron  por siete \nd\u00edas. En el presente trabajo la p\u00e9rdida de peso fue superior a la estimada por Romao y col. (4). Es posible que la \ndiferencia entre los valores de p\u00e9rdida se deba a las condiciones externas al \u00e1rea de conservaci\u00f3n y de incubaci\u00f3n, ya \nque se ha o bservado que los valores registrados var\u00edan conforme lo hacen los valores externos al \u00e1rea donde est\u00e1 el \nhuevo.  \nEn este trabajo el peso  del pollito represent\u00f3 el 70.1 % del peso del huevo. Este valor coincide con el referido \npor Salah Udinn  y col. (5), quienes al almacenar huevo durante siete d\u00edas estimaron una proporci\u00f3n del peso del \npollito de 70.02 % del peso del huevo.  La correlaci\u00f3n entre el peso del huevo con el peso del pollito fue cercana a la \nestimada por Salh Udinn y col. (5) de 0. 547. El peso del pollito al nacer es importante ya que est\u00e1 relacionado con el \ncrecimiento y otros par\u00e1metros como el peso final (8). Por ello es importante el peso del huevo a incubar. El peso \ndel pollito est\u00e1 determinado principalmente por el peso inicia l del huevo, y var\u00eda normalmente de 62 a 78% del peso \ndel huevo, y se determina en segundo lugar por la p\u00e9rdida de peso durante la incubaci\u00f3n, peso de la c\u00e1scara y residuos, la tensi\u00f3n, el tiempo y las condiciones de incubaci\u00f3n, la edad y el sexo de pollo (8).  \n \nREFERENCIAS  \n \n1. Burton F. G. and  S. G. Tullet. A comparison of the effect of eggshell porosity on the respiration and \ngrowth of domestic fowl, duck and turkey embryos. Comparative Biochemistry and Physiology. 75:167- 174. 1983.  \n2. Rahn H. and A. Paganelli  CV. How bird eggs breathe. Scientific American. 240:46 -55. 1979.  \n3. Rocha,  J. S. R. N. C, Bajao, V. M. Barbosa, M. A. Pompeu, M. N. S. Fernandes, L. J. C. Lara, C. F. Q. \nMatias and J. V. M. S. P. Batista. Negative effects of fertile egg storage on the egg an d the embryo and suggested \nhatchery management to minimize such problems. World\u00b4s Poultry Science Journal. 69(1): 35 -44. 2013.  \n4. Romao JM, T. G. V. Moraes, R. S. C. Teixeira, W. M. Cardosoa and C. C. Buxade.  Effect of egg storage \nlength on hatchability and w eight loss in incubation of egg and meat type Japanese quails. Brazilian Journal of \nPoultry Science. 10: 143- 147. 2008.  \n5. Salah -Udinn M., D. C. Paul and Q. M. E. Huque. Effect of weight and pre -incubation holding periods on \nhatchability of Japanese quail egg s in different seasons. Australian Journal of Animal Science. 7: 499 -503. \n6. Steel, R. G. D. y J. Torrie H. Bioestad\u00edstica: Principios y Procedimientos. 2da. Edici\u00f3n. McGraw -Hill, \nM\u00e9xico. 539 p.  \n7. Tullent, S. G. Science and art of incubation. Poultry Science. 69: 1- 15. 1990.  \n8. Wilson, H. R. Interrelationships of egg size, chick size, posthatching growth and hatchability. World\u00b4s \nPoultry Science Journal. 47: 5 -20. 1991.  \n9. Xavier, I. M. C., S. V. Cancado, T. C. Figuereido, T. C. Lara, L. J. C. Lana, M. R. Souza and N . C. Bajao. \nQualidade de ovos de consumo submetidos a diferentes condicoes de armazenamiento.  Arquivo Brasileiro de \nMedicina Veterinaria e Zootecnia. 60: 953 -959. 2009.  \n  \n \n \n  \n \n \n \n \n  \n \n \n \n \n   \n \n 63rd WPDC/XXXIX ANECA  Gr\u00e1fica 1 . Relaci\u00f3n del peso del huevo incubable con el peso del pollito de codorniz ( Coturnix coturnix \njaponica ) al nacimiento.  \n \n \n \nGr\u00e1fica 2.  Relaci\u00f3n entre peso de huevo incubable con peso del pollito  en porcentaje.  \n \n Peso del pollito (g)  = 5.66 + 0.35 (Peso del huevo, g)  \nR\u00b2 = 0.38 \n10.510.710.911.111.311.511.7\n15.4 15.6 15.8 16.0 16.2 16.4 16.6 16.8Peso del pollito, g  \nPeso del huevo incubable, g  \nPorcentaje peso del pollito -  peso huevo  = 105.55 - 2.21 (Peso huevo incubabable, g).  \n R\u00b2 = 0.38 \n68.068.569.069.570.070.571.071.572.072.5\n15.4 15.6 15.8 16.0 16.2 16.4 16.6 16.8Porcentaje \nPeso del huevo incubable, g  63rd WPDC/XXXIX ANECA  EMERGENCE OF VARIANT REOVIRUS SEROTYPES  \nIN NORTH AMERICA \n \nLA APARICI\u00d3N DE VARIANTES DE SEROTIPOS DE REOVIRUS  \nEN AM\u00c9RICA DEL NORTE  \n \nM. PutnamA, A. ReilleyA, K. JonesA, J. RosenbergerB, S. RosenbergerB, and M. MarkisB \n \nACeva Animal Health  8735 Rosehill  Rd. Suite 300 Lenexa, Kansas  66215  \nmarshall.putnam@ceva.com  \nBAviserve LLC  \n \nRESUMEN  \n \nDesde 2010 los productores han estado experimentando signos cl\u00ednicos de artritis viral, tendinitis y sinovitis. \nSe ha determinado que los agentes causales son variantes de serotipos de reovirus claramente diferentes de los \nproductos comerciales disponibles. La presentaci\u00f3n describir\u00e1 los signos cl\u00ednicos, diagn\u00f3stico, caracterizaci\u00f3n viral \ny los esfuerzos para el control.  \n \nSUMMARY  \n \nIn the summer of 2011,  turkey flocks in the upper Midwestern states of the United States began to develop \nclinical signs similar to viral arthritis in chickens.  In the fall of 2011 and early winter of 2012 broiler flocks began to \ndevelop a similar viral arthritis in the US and Canada.  In these cases the clinical signs included edema and rupture of \nthe digital flexor tendons and differed from rupture of the gastrocnemius tendon seen in classical reovirus viral arthritis. In each clinical presentation , variant reoviruses were isol ated that differ antigenically from conventional \nreovirus  S1133 based antigens.   \n \nINTRODUCTION  \n \nClinical signs associated with reovirus infection in turkeys and chickens appeared in progeny from flocks  \nvaccinated with conventional S 1133 based reovirus anti gens. Those clinical signs included  edema and rupture of the \ndigital flexor tendons, edema and rupture of the gastr ocnemius tendons, synovitis, digital flexor tendons causing \nsplayed legs, poor weight gain and increased culling.  In some broiler flocks vira l epicarditis and pericarditis was \nalso see in 3 -5 d old chicks.  \nWhile not indicative of pathogenicity, the reovirus ELISA titers in the parent  flocks  greatly exceed the normal \ntiter associated with a conventional pullet vaccination program. Progeny from all breed crosses were affected but progeny from certain breeder flocks were more heavily affected indicating vertical shed.  Horizontal shed was also \nclinically documented in the hatchery and on the farms.  \n \nMATERIALS AND METHODS  \n \nTendons and joint fluid s were collected for virus isolation.  Pathogenicity of the virus isolates was confirmed \nvia foot pad inoculation test.  Pathogenic isolates were then used to prepare polyclonal antisera in SPF chickens for \nmicro neutralization assays to determine antigenic r elatedness (1).  \n \nRESULTS  \n \nMost of the  reoviruses separated out into three major serologic groups.  Table 1 is a partial list of the antisera \nand reovirus virus isolates that shows the neutralization pattern.  \n \n \n  63rd WPDC/XXXIX ANECA  DISCUSSION  \n \nWhile the reoviruses associated w ith the vir al arthritis tend to fall into three  broad serotype groups, there are \npathogenic isolates that do not fall into these three  groups.  This indicates the reoviruses are continuing to evolve and \nrequires continued monitoring.  Killed vaccines from th ese isolates have been used and are successful in reducing or \neliminating the clinical effects of these variant reoviruses.  \n \nREFERENCES  \n \n1. Aviserve LLC. Delaware Technology Park. 1 Innovation Way, Suite 100. Newwark, DE  1971.  63rd WPDC/XXXIX ANECA   \nTable 1.  Antigenic comparisons of reoviruses  from chicken and turkey tendons . \n \nGroup  Reovirus  Antiserum  \nPA- \n5573  PA-\n7361  PA-\n11733  MTA -\n10015  KF \n111 KF \n112 GP \nSchl Grgs \nBry WF \nCR PA-\n3974  Turke\ny 2011  \nI KF12 -111 + + + + + + - - - - - \nPA 5573  + + + + + + - - - - - \nPA 7361  + + + + + + - - - - - \nPA 11733  +/- +/- + +/- +/- +/- - - - - - \nMTA 10015  + + + + + + - - - - - \nMTA PL  + + + + + + - - - - - \nSMS GL  + + + + + + - - - - - \nPA 5894  + + + + + + - - - - - \nCanada 3088  + + + + + + - - - - - \nCanada 4771  + + + + + + - - - - - \nCanada 4932  + + + + + + - - - - - \nII NJ Bvr  +/- - +/- +/- + + +/- - - - - \nKF12 -112 - - - - + + + - - - - \nGP Schl  - - - - + + + - - - - \nKF Grif  - - - - + + + - - - - \nKF Wal  - - - - + + + - - - - \nKF Srcy - - - - + + + - - - - \nTY P k - - - - + + + - - - - \nTY Earl  - - - - + + + - - - - \nAg St Gunder  - - - - + + + - - +/- - \nAg St Lenth  - - - - + + + - - +/- - \nPA 6500  - - - - + + + - - - - \nIII Canada  \nRed C  - - - - - - - +/- +/- - + \nWF C R - - - - - - - + + - - \nGrgs Bry  - - - - - - - + + - - \nPP G&J  - - - - - - - + + - - \n 63rd WPDC/XXXIX ANECA  EFECTO T\u00d3XICO DEL CONSUMO DE LA SEMILLA DE \nJATROFA (JATROFA CURCAS ) EN POLLOS DE ENGORDE  \n \nTOXIC EFFECTS OF CONSUMING BARBADOS NUT SEED (JATROFA \nCURCAS) IN BROILER CHICKENS  \n \nQuezada- Trist\u00e1n Te\u00f3duloA, Guzm\u00e1n -Maldonado Salvador Horacio , Ortiz -Calder\u00f3n Ana Lilia , Montoya \nNavarrete Ana LuisaA y Ch\u00e1vez Gonz\u00e1lez LeticiaA \n \nADepartamento de Cl\u00ednica Veterinaria del Centro de Ciencias Agropecuarias de la Universidad Aut\u00f3noma de \nAguascalientes, Ags., M\u00e9xico. Av. Universidad 940, Cd. Universitaria CP 20131  \nEmail: tquezada@correo.uaa.mx,tquezadaster@gmail.com  \n \nSUMMARY  \n \nThe Barbados nut seed ( Jatropha curcas ) has a high protein content (24 to 30%). However, its use is \nlimited due to the presence of toxic compounds (phorbol  esters). The objective of the present work was to \nnutritionally characterize and evaluate the toxic effects of Barbados nut seed in broiler chickens. Nutritional and \ntoxic properties of a toxic variety of Barbados seed were evaluated. Forty -five Ross- 308 chickens  one d  old were \nselected and fed a diet with a 10% addition of Barbados nut seed meal. Productive, biochemical and \nhistopathological parameters were evaluated. The seed presented phorbol esters, the birds showed toxic damage, \nALT and AST enzymes in dicated hepatic damage, and the histopathology showed toxic damage. The toxic \nvariety of Barbados n ut seed is not suitable to be used in poultry feeding due to the toxic level of the phorbol \nesters.  \n \nRESUMEN  \n \nLa  semilla de jatrofa ( Jatropha curcas ) posee un alto  contenido de prote\u00edna (24 a 30%), sin embargo, su \nutilizaci\u00f3n es limitada debido a la presencia de compuestos t\u00f3xicos (\u00e9steres de forbol). El objetivo de este trabajo fue realizar una caracterizaci\u00f3n nutricional y evaluar los efectos t\u00f3xicos de  la semilla de j atrofa en pollos de  \nengorda. Se utiliz\u00f3 una semilla de j atrofa variedad t\u00f3xica  y no t\u00f3xica , se le evaluaron las propiedades \nnutricionale s y t\u00f3xicas. Se seleccionaron 135  aves Ross -308 de un d\u00eda  de edad, se alimentaron con alimento \nadicionado con el 10% de harina de j atrofa  t\u00f3xica y no t\u00f3xica . Se e studiaron par\u00e1metros productivos, \nbioqu\u00edmicos e histopatol\u00f3gicos. La semilla presento \u00e9steres de forbol , las aves mostraron da\u00f1o t\u00f3xico, las \nenzimas ALT y AST indicaron el da\u00f1o hep\u00e1tico  y la hi stopatolog\u00eda el da\u00f1o t\u00f3xico. La semilla de j atrofa variedad \nt\u00f3xica no es apta para la alimentaci\u00f3n de las aves por el nivel t\u00f3xico de los \u00e9steres de forbol.  \n \nINTRODUCCI\u00d3N  \n \nLa especie conocida com\u00fanmente como jatrofa (Jatropha curcas) , es un arbusto es  utilizado para el control \nde erosi\u00f3n de suelos, como cerco, le\u00f1a, alimento para ganado, y usos medicinales. Existen dos tipos de jatrofa, la t\u00f3xica y la no t\u00f3xica, la diferencia entre estos dos tipos radica en el contenido de  \u00e9steres  de forbol (compuestos  \nt\u00f3xicos)  (1). La torta de jatrofa es un subproducto obtenido de la semilla una vez que se le extrajo el aceite, el \ncual tiene poco valor comercial debido principalmente a la presencia de compuestos t\u00f3xicos (\u00e9steres de forbol) . \nSin embargo, se sabe que su contenido y calidad de prote\u00ednas es alto ( 3). El contenido de prote\u00edna y grasa en \njatrofa no t\u00f3xica es muy similar a las variedades t\u00f3xicas, pero la variedad toxica posee menor o nula cantidad de \n\u00e9steres de forbol (<0.11  mg/g) ( 4). La toxicidad de los \u00e9st eres de forbol limita el uso de la jatrofa t\u00f3xica como \nalimento humano o animal ya que se ha reportado disminuci\u00f3n del apetito, discapacidad, diarrea, respiraci\u00f3n \nacelerada, dificultad para mantener su posici\u00f3n normal y el pelo rizado. Hallazgos macrosc\u00f3pi cos en el intestino \nmostr\u00f3 enteritis catarral aguda y la extravasaci\u00f3n de sangre en el lumen, se observ\u00f3 h\u00edgado congestionado, los ri\u00f1ones, el coraz\u00f3n y edema de pulm\u00f3n.  Adem\u00e1s de que causan la promoci\u00f3n tumoral, proliferaci\u00f3n celular, \nactivaci\u00f3n de las plaquetas, mitog\u00e9nesis de linfocitos, eritema de la piel,  producci\u00f3n de prostaglandinas y  \nestimulaci\u00f3n de la degranulaci\u00f3n de los neutr\u00f3filos.  \nDada la importancia actual que ha adquir ido el cultivo de la jatrofa para la producci\u00f3n de biocombustible es \nnecesario realizar estudios  en modelos animales para aprovechar de alguna manera la jatrofa como una fuente \nproteica. Es por ello que en este trabajo se propusieron como objetivos el anal izar, evaluar el efecto sobre los \npar\u00e1metros productivos y t\u00f3xico en pollos de engorda incluyendo en su dieta el 10% de la semilla de jatrofa de \nlos dos ecotipos (toxica y no toxica) que se cultivan en M\u00e9xico.  \n \n 63rd WPDC/XXXIX ANECA  MATERIALES  Y MET\u00d3DOS  \n \nEl presente estudio d e laboratorio se llev\u00f3  a cabo en las instalaciones del Instituto Nacional de \nInvestigaciones Forestales Agr\u00edcolas y Pecuarias (INIFAP) de Celaya, Gto., M\u00e9xico y la parte de campo en el \nCentro de Ciencias Agropecuarias de la Universidad Aut\u00f3noma de Aguascal ientes.  Se utilizaron dos ecotipos de \nsemillas de jatrofa una toxica y otra no toxica. Las semillas se descascarillaron y se molieron. La cuantificaci\u00f3n \nde los \u00e9steres de forbol  se determin\u00f3 a trav\u00e9s de cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n (HPLC) seg\u00fan el \nm\u00e9todo descrito por Mart\u00ednez Herrera y col., (2006).  \nSe utilizaron 135  pollos de  engorde raza ROSS -308 de un d \u00eda de edad, procedente de la incubadora Pollitos \nde Aguascalien tes, con un peso promedio de 38.0 \u00b1 3 g. B ajo un dise\u00f1o completamente al a zar (DCA) las aves \nfueron repartidas aleatoriamente en tres tratamientos, tratamiento uno control (alimento normal), tratamiento dos \n(dieta con el 10% de harina de j atrofa no t\u00f3xica)  y tratamiento tres (Dieta con el 10% de harina de j atrofa t\u00f3xica) \ncada tratamiento con tres repeticiones de 15 aves cada uno. Se les administr\u00f3 el agua y alimento at libitum . Se \nmanejaron con dos fases de alimentaci\u00f3n: iniciador del d\u00eda 1 al 28 de edad y finalizador de 28 a 42 d\u00edas , las \ndietas fueron isoprote\u00edcas e isoenerg\u00e9ticas. Una hora despu\u00e9s de su llegada a la caseta, se les suministr\u00f3 agua con \naz\u00facar m\u00e1s amino\u00e1cidos para contrarrestar el estr\u00e9s del transporte.  Semanalmente s e determinaron los \npar\u00e1metros productivos : peso promedio (PP), consuno de alimento  (CA) , ganancia diaria de peso  (GDP) , \u00edndice \nde conversi\u00f3n  (IC)  e \u00edndice de productividad (IP), de acuerdo a lo descrito por Quintana ( 6). Se tomaron \nmuestras de sangre quincenalmente, se centrifugaron y se obtuvo el suero sangu\u00edneo. S e obtuvieron los \npar\u00e1metros bioqu\u00edmicos ( actividades enzim\u00e1ticas de aspartato amino transferasa (AST) y alanino amino \ntransferasa  ( ALT ) y las concentraciones de prote\u00ednas y alb\u00famina  por m\u00e9todos espectrofotom\u00e9 tricos en un \nespectrofot\u00f3metro RA -5O de Bayer  (2). Se sacrificaron al d\u00eda uno y posteriormente  cada 15 d tres aves con \ndislocaci\u00f3n cervical de cada tratamiento, se disecaron los h\u00edgados y ri\u00f1ones .  \nSe tomaron muestras del l\u00f3bulo hep\u00e1tico derecho y el ri\u00f1\u00f3n derecho que, se colocaron en frascos con una \nsoluci\u00f3n fijadora (100 mL de formaldeh\u00eddo al 37%, 900 mL de agua destilada, 4.0 g/L de NaH 2PO 4, 6.5 g/L de \nNa 2HPO 4, pH 7.4) para su conservaci\u00f3n y almacenamiento hasta su an\u00e1lisis histopatol\u00f3gico. Se tomaron \nmuestras de h\u00edgado y ri\u00f1\u00f3n (1 cm3) de cada tratamiento para ser lavadas, deshidratarlas (alcohol al 80 %, 96% y \n100%), aclararlas (Xilol) e infiltrarlas con parafina liquida en un procesador autom\u00e1tico  de tejidos (Histoquinet, \nLeica TP 1020). Se elaboraron los bloques de parafina de cada una de las muestras utilizando un centro de \nembebido de parafina y un enfriador. A partir de los bloques de parafina se realizaron los cortes histol\u00f3gicos de \n5.0 \u03bcm de grosor usando un micr\u00f3tomo de rotaci\u00f3n, los cortes fueron extendidos en un ba\u00f1o de agua caliente (50 \n\u00b1 5\u00b0C) cubiertos portaobjetos y se dejaron secar en la estufa por 24 h oras a una temperatura de 60 \u00b0C. Una vez \nsecos estos fueron te\u00f1idos con hematoxilina/e osina (HE) con un equipo semiautom\u00e1tico. Una vez te\u00f1idos los \ntejidos se procedi\u00f3 a realizar su revisi\u00f3n en un microscopio compuesto con objetivos de 10x y 40x  (5).  \nLos datos del experimento fueron sometidos a un an\u00e1lisis de varianza (AN DEVA ) con un Modelo  Lineal \nGeneral y prueba de comparaci\u00f3n de rangos m\u00faltiples de Tuke y con un nivel de confianza de P< 0.05, en un \nprograma de an\u00e1lisis estad\u00edstico (SAS, 2009) comparando los tratamientos con  la inclusi\u00f3n de  la harina de \njatrofa con respecto al tratamiento control.  \n \nRESULTADOS  \n \nEn el an\u00e1lisis de este compuestos t\u00f3xicos presentes en las semilla s de jatrofa considerada como ecotipo \nt\u00f3xico fue de 1.74 \u00b1 0.17 mg/g de harina . Mientras que p ara el ecotipo no t\u00f3xico el contenido de \u00e9steres de \nforbol  fue de 0.11 mg/g de harina . Los resultados en este estudio demuestran que la adici\u00f3n del 10% de harina de \nsemilla toxica en la dieta comercial para pollos de engorda es altamente t\u00f3xica, ya que presentaron un alto \nporcentaje de mortalidad en las primeras dos semanas de vida  (95.0%). Mientras que en el grupo de animales \nque recibieron la harina de semilla no t\u00f3xica y alimento comercial la mortalidad fue de 4 %.  \nLos principales s\u00edntomas de intoxicaci\u00f3n que se presentaron fueron somnolencia, letargo, postraci \u00f3n, \nataxia, polip nea, diarrea constante, empastamiento de la cloaca, plumas erizadas , p\u00e9rdida de apetito, postraci\u00f3n, \ndespigmentaci\u00f3n, resequedad en los tarsos y signos nerviosos (mostrando algunos ataques  de convulsiones e \nincoordinaci\u00f3n ), coma y muert e de 8 a 10 d\u00edas .  \nNo se encontraron diferencias significativas en el contenido de prote\u00ednas en todos los tratamientos a los 15 \nd\u00edas de vida (3.7 \u00b1 0.4, 4.8 \u00b1 0.4 y 3.7 \u00b1 0.1, control, no t\u00f3xica y t\u00f3xica respectivamente). Sin embargo, si se \nobservaron diferencias en el nivel menor de albumina en las aves que consumieron la j atrofa t\u00f3xica (1.34 \u00b1 0.01, \n0.74 \u00b1 0.15, 1.30 \u00b1 0.16, control, no t\u00f3xica y t\u00f3xica respectivamente).  Igualmente en los grupos de animales que \nconsumieron la dieta con trol y con 10% de la harina de j atrofa no se obse rvaron diferencias a los 28 d  de edad en \nlos valores registrados de prote\u00edna (5.7 \u00b1 0.1 y 4.8 \u00b1 0.4, respectivamente ) y albumina  (1.53 \u00b1 0.1 y 1.47 \u00b1 0.1 \nrespectivamente)  los animales del grupo que reci biero n el 10 % de harina de j atrofa t\u00f3xica en su dieta tuvieron \nque ser sacrificados por sus condiciones de salud que mostraban.   \nSe observ\u00f3 a los 15 d\u00edas  que la actividad enzim\u00e1tica de la ALT no present aron diferencias estad\u00edsticas entre \nlos tratamientos del grupo que recibi\u00f3 alimento cont rol y los que recibieron el 10% de la harina no t\u00f3xica (17 \u00b1 63rd WPDC/XXXIX ANECA  2.0 y 15 \u00b1 1.7 U/L, respectivamente) . Mientras que el grupo de pollos que recibi\u00f3 la dieta con el 10 % de har ina \nde jatrofa t\u00f3xica si mostraron diferencia estad\u00edstic a (35 \u00b1 13.1 U/L) . Por otra parte , la actividad enzim\u00e1tica de \nAST tampoco mostraron diferencias entre los tratamientos del grupo que recibi\u00f3 alimento control y los que \nrecibieron el 10 % de la harina no t\u00f3xica  (121.3 \u00b1 13.5 y 117.7 \u00b1 15.8 U/L, respectivamen te), pero si el grupo de \npollos que recibi\u00f3 la dieta con el 10 % de harina de j atrofa  t\u00f3xica ( 181 \u00b1 1.0 U/L) . \nA los 28 d\u00edas  que la actividad enzim\u00e1tica de la ALT no presentaron diferencias estad\u00edsticas entre los \ntratamientos del grupo que recibi\u00f3 alimento control y los que recibieron el 10% de la harina no t\u00f3xica (12.7 \u00b1 3.5 \ny 12.7 \u00b1 2.1 U/L, respectivamente). Por otra parte a  los 42 d\u00edas  tampoco se presentaron diferencias estad\u00edsticas \nentre los tratamientos del grupo que recibi\u00f3 alimento control y los que recibieron el 10 % de la harina no t\u00f3xica \n(12.7 \u00b1 1.5 y 13.7 \u00b1 5.1 U/L, respectivamente). Mientras que la actividad enzim\u00e1ti ca de AST a los 28 como a los \n42 d, tampoco mostraron diferencias entre los tratamientos del grupo que recibi\u00f3 alimento cont rol y los que \nrecibieron el 10 % de la harina no t\u00f3xica (131.6 \u00b1 9.7 y 130.8 \u00b1 4.2U/L ). \nLos par\u00e1metros productivos evaluados no fueron completados dado a que los animales que consumieron la \nharina de j atrofa  t\u00f3xica al 10 % en la dieta tuvieron que ser sacrificados por sus condiciones de salud. Sin \nembargo, entre los grupos control y dieta con 10 % de harina de j atrofa no t\u00f3xica los resultados fueron muy \nsimilares.  \nA los siete d\u00edas de vida los animales del grupo que recibieron harina t\u00f3xica en la necropsia se encontr aron \nlesiones hep\u00e1tica e infecci\u00f3n del saco vitelino. A  los 15 y 21 d\u00edas  se observ\u00f3 a la necropsia; peritonitis, \npericarditis y perihepatitis fibrinopurulentas, deshidrataci\u00f3n, diarreas, nefromegalia, uratosis, degeneraci\u00f3n grasa \ndel par\u00e9nquima hep\u00e1tico, edema pulmonar, coloraci\u00f3n anormal en tarsos, ulceraciones en molleja y hemorragia \nen diversos \u00f3rgano s. \nEn el h\u00edgado se observaron las siguientes lesiones  histopatol\u00f3gicas : necrosis coagulativa, picnosis, \ncariorrexis o cariolisis  y el citoplasma  intensamente eosinof\u00edlico.  Mientras que en ri\u00f1\u00f3n las lesiones observadas \nfueron: el epitelio tubular impregna do de sales de calcio, carga de calcio excretado, coloraci\u00f3n bas\u00f3fila , \ndisminuci\u00f3n del lumen de los t\u00fabulos, las c\u00e9lulas tumefactas con aspecto granular del citoplasma, c\u00e9lulas \ntubulares con degeneraci\u00f3n , infiltraci\u00f3n intersticial por mocitos, c\u00e9lulas plasm \u00e1ticas y linfocitos.  \n \nREFERENCIAS  \n \n1. Becker , K. and  Makkar, H.  P. S. Jatropha curcas: A potential source for tomorrow\u00b4s  oil and \nbiodiesel. Lipid Technology, 20:104- 107. 2009 . \n2. Gornall , A. G., Bardawill,  C. S. and  David , M. M. Determination of serum proteins  by means of the \nBiuret reaction. Journal of Biological Chemistry, 177:751 \u2013766. 1949.  \n3. Makkar, H.  P. S., Aderibigbe, A. O., Becker, K.  Comparative evaluation  of nontoxic and toxic \nvarieties of Jatropha curcas for chemical composition, digestibility, protein degradability and toxic factors. Food \nChem. 62(2): 207\u2013 215. 1997.  \n4. Makkar, H. P. S., Becker, K., Schmook, B. Edible provenances of Jatropha curcas from Quintana Roo \nstate of Mexico and effect of roasting on antinutrient and toxic factors in seeds. Plant F oods for Human \nNutrition, 52:31 \u201336. 1997.  \n5. Prophet , E. B., Mills , B., Arrington,  J. B., Sobin , L. H. Laboratory methods in histotechnology. The \nAmerican Registry of Pathology. Armed Forces  Institute of Pathology. Washington, D.C.  1994.  \n6. Quintana,  L. J. Avitecnia m anejo de las aves dom\u00e9sticas m\u00e1s comunes. pp. 11  \u2013 36. 2003 . \n                                                                                                                                            6 3rd WPDC/XXXIX ANECA \n \n \u00c1CAROS DE LA FAMILIA MACROCHELIDAE HACIA UN \nCONTROL BIOL\u00d3GICO DE MOSCAS EN GRANJAS AV\u00cdCOLAS  \n \nMITES FROM THE MACROCHELIDAE FAMILY IN CHICKEN FARMS FOR \nA FUTURE BIOLOGICAL CONTROL OF FLIES  \n \nMa. Teresa  Quintero , M.  Elizabeth  Mej\u00eda  Moyo  y Fabiola  Nieto Rabiela  \n \nLaboratorio de Entomolog\u00eda, Departamento de Parasitolog\u00eda Facultad de Medicina Veterinaria y Zootecnia, \nUniversidad Nacional Aut\u00f3noma de M\u00e9xico  \n  \nSUMMARY  \n \nIn this study the presence of mites of the Macrochelidae family found in large numbers in an  egg production \nfarm  is communicated.  Macrochelidae family includes about 20 genera and about 500 species. They have been \nfound in tropical and temperate climates.  Mites from the Macrochelidae family belong to the suborder \nMesostigmata; they belong to a r ange of different genera and species inhabiting various substrates such as feces of \nvarious animals , and poultry manure as well as on various social insects, beetles and flies ( 9). Due to this \ncircumstance,  some countries have tried to use Macrochelidae to  implement a biological control of flies. As a result \nof this finding we are in the beginning of keeping the aforementioned mite cultures to benefit poultry.  \n \nRESUMEN  \n \nEn el presente trabajo se comunica la presencia de \u00e1caros de la familia Macrochelidae hallados en gran n\u00famero \nen una granja productora de huevo.  En la familia Macrochelidae se incluyen cerca de 20 g\u00e9neros y cerca de 500 \nespecies. Se les ha hallad o en climas tropical y templado;  Los \u00e1caros de la familia Macrochelidae pertenecen al \nsuborden Mesostigmata constituyen una gama de diversos g\u00e9neros y especies que habitan en sustratos  muy variados \ntales como excremento de diversos animales y tambi\u00e9n sobre gallinaza as\u00ed como sobre diversos insectos sociales, \nescarabajos  y moscas ( 9) debido a esta circunstancia en algunos pa\u00edses se ha intentado emplear a Macrochelidae para \nimplementar el control biol\u00f3gico de moscas. Por lo que a ra\u00edz del presente hallazgo nos encontramos en el inicio de \nmantener cultivos de los \u00e1caros mencionados par a beneficio de la avicultura.  \n  \nINTRODUCCI\u00d3N  \n \nLos \u00e1caros de la familia Macrochelidae, seg\u00fan la clasificaci\u00f3n moderna  pertenecen  al  orden Mesostigmata, \nCohorte Gamasina, superfamilia Eviphioidea, familia Macrochelidae, en  la que se encuentra el g\u00e9nero M acrocheles,  \ndel que existen diversas especies  reportadas en M\u00e9xico , seg\u00fan  M\u00e9ndez Olivo se reportaron nueve  especies en  \n1973 a saber: Macrocheles dimidiatus ,  M. mex icanus,  M. asutroamericanus,  M. halffteri, M. hechti,   M. boneti,  \nM. hoffmannae,  M. jalisciensis,  todas sobre diferentes especies de escarabajos  y tambi\u00e9n  Macrocheles \nmuscaedomesticae  que s\u00f3lo se  hab\u00eda  mencion ado sobre Musca domestica . \n \nANTECEDENTES  \n \nAxtell (1)  se interes\u00f3 en el control de moscas en granjas de gallinas por medio de los \u00e1caros . Emberson (3) \ncoment\u00f3 que desde hace mucho tiempo  se sabe que los \u00e1caros  Macrochelidae est\u00e1n asociados a moscas \nsinantr\u00f3picas,  lo mismo fu e mencionado por  Krantz (6) .  Con respecto a experimentos:  Halliday y Holm (5) en \nAustralia realizaron  una investigaci\u00f3n a donde comunicaron cuales macroch \u00e9lidos causaban da\u00f1o sobre Musca \nvenustissima ,  comprobando con esto,  que \u00e1caros de la familia Macrochelidae eran capaces de depredar estadios \ninmaduros de la mosca mencionada, asimismo, Walker y Doube (10)  observaron \u00fanicamente a hembras adultas  de \nlos \u00e1caros depredando sobre huevos de moscas.   \nGuanilo  y Cordero (4) realizaron un estudio sobre el comportamiento  depredador de Macrochelidae sobre  \nMusca domestica,   para ello emplearon envases en los que se colocaron  las  moscas y ah\u00ed mismo se  pusieron  \u00e1caros                                                                                                                                            6 3rd WPDC/XXXIX ANECA \n \n Macrocheles muscaedomesticae ;  de este experimento se obtuvieron las siguientes observaciones: los \u00e1caros se \nalimentan de huevos de la mosca d\u00e9j\u00e1ndolos  completamente  vacios,  en cambio las larvas del \u00e1caro no se alimenta n \nde las moscas y si se vuelven  alimentar desde la fase de protoninfa hasta la fase de adulto , por lo que con este \nexperimento se concluy \u00f3 que los \u00e1caros Macrocheles muscaedomesticae  presentan numerosas adaptaciones que los \nconvierten en un eficiente depredador y controlador biol\u00f3gico de Musca dom estica ; Beresford y Sutcliffe (2)  \nestudiaron el efecto de la foresia por Macrocheles muscaedom esticae y M. subbadius  sobre Stomoxys calcitrans  \ncomprobando una hip\u00f3tesis referente a que las moscas que ten\u00edan \u00e1caros macroqu\u00e9lidos  presentaban efectos sobre \nlas poblaciones de moscas reproduci\u00e9ndose menos.   \nEn M\u00e9xico se ha mencionado la presencia de Macrocheles muscaedomesticae  en granjas de gallinas Quintero \n(8, 9)  as\u00ed como tambi\u00e9n se han encontrado sobre otras  moscas como Stomoxys calcitrans  y Ophyra spp. pero esto \nen otros tipos de explotaci\u00f3n pecuaria (8).  \n \nMATERIAL Y M\u00c9TODOS  \n \nEl material consis ti\u00f3 en \u00e1caros colectados  de excremento de gallinas en una granja de postura, se separaron \ncerca de 30 \u00e1caros, de l os cuales se conservaron vivos  10 para inicia r un cultivo, el resto se someti\u00f3 a aclaramiento \ncon hidr\u00f3xido de sodio al 2% despu\u00e9s de este paso se mont aron entre porta y cubre objetos para determinar su  \ng\u00e9nero y especie.  Los \u00e1caros vivos se colocaron en un frasco de boca ancha 7.5 cm en el mismo frasco se colocaron \nlarvas de mosca  para alimentaci\u00f3n de los \u00e1caros, as\u00ed como un algod\u00f3n empapado en agua purificada, el cultivo preliminar se mantuvo por espacio de 40 d\u00edas, siendo este un primer  ensayo para la obtenci\u00f3n masiva de \u00e1caros \nMacrochelidae.  \n  \nDISCUSI\u00d3N Y CONCLUSIONES  \n  \nSe comunica la presencia de \u00e1caros Macrochelidae obtenidos de excre meto de gallinas ponedoras, se \ncomunican  tambi\u00e9n observaciones obtenida s de un ensayo prel iminar de cultivo de los \u00e1caros.  \nSe determin\u00f3 que los \u00e1caros aislados y cultivados correspondieron a Macrocheles muscaedomesticae Se concluye que para inicio de 2014 se principiar\u00e1 a realizar un cultivo  siguiendo  el m\u00e9todo de Guanilo y \nCordero (4).  \n \nREFERENCIAS  \n \n1.Axtell, R. C.  Status and potential of biological control agents in livestock and poultry pest management \nsystems.  In\n:  Biological Control of Muscoid Flies (Patterson, R.S. and D.A. Rutz, editors).  Misc. Publications \nEntomological Society of America. 61, p. 1- 9. 1986.  \n 2.Beresford, D. V., Sutcliffe, J. F. The effect of Macrocheles muscaedomesticae and M. subbadius (Acar ina: \nMacrochelidae) phoresy on the dispersal of Stomoxys calcitrans (Diptera: Muscidae), Systematic & Applied \nAcarology Special Publications 23:1- 30 2009.  \n3.Emberson E. M.    Macrochelid mites in N.Z. (Acarina Mesostigmata, Macrochelidae) New Zeland Entomol  \n205-2-118-127. 1973.  \n4.Guanilo  A.  Cordero  J. Comportamiento depredador de Macrocheles muscaedomesticae (Scopoli)  sobre \nhuevos de Musca domestica  Linneus  (Diptera Muscidae) Rev. Per Ent  43 137 -142 2003.  \n5.Halliday  R.B.   and  Holm  E.  Mites of the family  Macrochelidae as predators of two species of dung-\nbreeding pest flies   Entomophaga  32: 332- 338 1987.   \n6. Krantz, G. W. Observations on five rarely collected genera of Macrochelidae (Acari: Mesostigmata) \nassociated with insects. Acarologia .39: 95-109 1998.  \n7.M\u00e9ndez  O. C., Notas sobre Macrochelidae de M\u00e9xico  (Acari: Macrochelidae)   Anales de la Escuela \nNacional de Ciencias Biol\u00f3gicas M\u00e9xico 15: 135 -183 1968.  \n8.Quintero,  M. M.T.  Current Status of the study of mites associated with flies in Mex ico  Proceedings of  \nAcarology IX Ohio B iiological Survey 125 -127 (1996) . \n9.Quintero , M. M.T. \u00c1caros par\u00e1sitos y de vida libre relacionados con la Avicultura  trabajo p ublicado en \nMemorias del Curso  Tendencias Av\u00edcolas  Facultad de Estudios Superiores Cuautitl\u00e1n U.N.A.M. octubre de 2013  \n10.Walker, J.M., & Doube, B. M. 1984 Susceptibilty to Drowning of eggs of the dung breeding flies \nHaematobia irritans exigua and Musca  venustissima  . Angew Entomology 98, 518- 527. 63rd WPDC/XXXIX ANECA  SENSITIVITY OF FIELD ISOLATES OF EIMERIA MAXIMA, E. \nACERVULINA AND E. TENELLA FROM COMMERCIAL BROILER \nOPERATIONS TO SOME OF THE MOST WIDELY USED \nANTICOCCIDIAL AGENTS IN NORTH AMERICA  \n \nSENSIBILIDAD DE MUESTRAS AISLADAS DE EIMERIA M\u00c1XIMA, E. \nACERVULINA Y E. TENELLA A PARTIR DE OPERACIONES COMERCIALES \nDE POLLO DE ENGORDA A ALGUNOS DE LOS AGENTES \nANTICOCC\u00cdDICOS M\u00c1S UTILIZADOS EN NORTEAM\u00c9RICA \n \nM. Quiroz, S. Clark,  and J. Dickson  \n \nZoetis Inc., 1040 Swabia Court, Durham, NC 27703 \ne-mail: marco.quiroz@zoetis.com  \n \nRESUMEN  \n \nLa coccidiosis es una de las enfermedades m\u00e1s importantes desde el punto de vista econ\u00f3mico en la producci\u00f3n \nav\u00edcola moderna. Los m\u00e9todos de control de la misma incluyen la aplicaci\u00f3n en el alimento de productos \nantococc\u00edd icos, el uso de vacunas vivas in ovo o aplicadas v\u00eda spray al d \u00eda 1 de edad en la incubadora, o la \ncombinaci\u00f3n de ambos m\u00e9todos de control. Debido al uso extensivo de agentes anticocc\u00eddicos  a trav\u00e9s de los a\u00f1os, \nel tema de la resistencia al tratamiento es siempre una preocupaci\u00f3n cuando los profesionales de la avicultura planean estrategias a largo plazo para el control de las coccidias en operaciones de pollos de engorda.  \nEl prop\u00f3sito del presente art\u00edculo fue resumir la eficacia de los anticocc\u00eddicos m\u00e1s ampliamente utilizados en \npollos de engorda en Norteam\u00e9rica, en base a pruebas de sensibilidad anticocc\u00eddicas (AST) conducidas en muestras aisladas en campo de E. acervulina,  E. m\u00e1xima y E . tenella  durante el periodo de 2010 a 2013.  \n \nSUMMARY  \n \nCoccidiosis is one of the most economically important diseases in modern poultry production. Coccidiosis \ncontrol methods include in- feed application of anticoccidial products, the use of live vaccines in ovo or via spray \napplication at one d ay of age  at the hatchery or the combination of both control methods. Due to the extensive use of \nanticoccidial agents through the years, the subj ect of drug resistance  is always a concern when poultry professionals \nplan long term cocci control strategies  in broiler operations .  \nThe purpose of the pres ent paper is  to summar ize the efficacy of the most widely used anticoccidial drugs in \nbroilers in North America, based on anticoccidial sensitivity tests (AST) conducted  for field isolates of E . \nacervulina , E. maxima , and E. tenella  during the period of 2010 to 2013.  \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n PROVENTRICULAR- VENTRICULAR IMPACTION IN A 4 -MONTH \nOLD OSTRICH ( STRUTHIO CAMELUS ): A CASE REPORT  \n \nIMPACTACI\u00d3N PROVENTRICULAR-VENTRICULAR EN UN AVESTRUZ DE \n4 MESES DE EDAD: PRESENTACI\u00d3N DE UN CASO  \n \nA.A. RajiA, M.B. BelloA, Y.S. BarayaA , and S. GarbaB \n \nAA A Raji, Department of Veterinary Pathology, Faculty of Veterinary Medicine, Usmanu Danfodiyo University, \nPMB 2346, Sokoto, Nigeria  \n \nBVeterinary Teaching Hospital, Usmanu Danfodiyo University, Sokoto, Nigeria  \n \nRESUMEN  \n \nLa impactaci\u00f3n es una acumulaci\u00f3n de al imentos o productos no alimentarios (palos, piedras, vidrio, etc) en el \nproventr\u00edculo, con el consiguiente bloqueo de la abertura en la molleja causando una falla en el movimiento del \nalimento a lo largo del tracto gastro -intestinal  (7). La impactaci\u00f3n es  considerada como un s\u00edntoma de problemas de \ncomportamiento tales como el estr\u00e9s por desorientaci\u00f3n, el estr\u00e9s por deserci\u00f3n o la frustraci\u00f3n con respecto a la \nb\u00fasqueda de alimentos ( 7). \n \nSUMMARY  \n \nImpaction is an accumulation of food or non -food items (sticks, stones,  glass, etc) in the proventriculus, with \nthe subsequent blockage of the  opening into the gizzard causing a failure of food to move along the  gastro -intestinal \ntract ( 7). Impaction is regarded  as a symptom of behavioral  problems such as disorientation stress,  desertion stress or \nfrustration with regards to finding food  (7). \n \nABSTRACT  \n \nA four month old ostrich ( Struthio camelus ) was brought to the Veterinary Teaching Hospital of Usmanu \nDanfodiyo University, Sokoto, Nigeria for necropsy examination. The Ostrich was rais ed with its pair in a semi -\nintensive system and it picked up sand and pebbles from a field where it was raised. The affected bird showed \ngradual anorexia, lethargy, weight loss, dehydration, weakness, sternal recumbence and  finally death . Necropsy \nrevealed impaction of gizzard and proventriculus with pebbles. Peritoneal cavity and pericardium contained serosanguineous fluid.  \n \nINTRODUCTION  \n \nOstrich  farming is a rapidly growing enterprise worldwide ( 2). South Africa, Egypt, Italy etc have raised these \nlarge birds intensively for over 100 years ( 1). In Nigeria , ostrich es can be fo und in zoos, parks and farms. Few \ncommercial and demonstration farms can be found in the Northern parts of  the country ( 3). Ostriches are famous for \ncuriosity and especially interest in  bright ly colored materials ( 6). If external materials are swallowed , depending on \nthe size, hardness and neatness of edges could cause intensive troubles ( 6). Ostriches are highly stu rdy, disease \nresistant and can with stand a wide range of climatic temperature. A common problem encountered in ostrich chick s \nis proventricular -ventricular impaction ( 2). Impactions due to ingestion of foreign material have been described by \nmany authors. From Nigeria, such reports were neit her available nor documented. Present case reports pathological \n(gros s) findings in the organs of a four month old ostrich that died due to pebble impaction of proventriculus and \nventriculus.  \n  \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n  \nCASE REPORT  \n \nMortality of a four month old ostrich was reported to Veterinary Teaching Hospital on 18th of August, 2013. \nThe carcass ( Photo 1) was submitted for necropsy at the post -mortem room of the Veterinary Pathology Department, \nFaculty of Veterinary Medicine, Usmanu Danfodiyo University, Sokoto, Nigeria the same day. The necropsy \nprocedure was conducted by the pathologists on duty. Clinical data and information about management was \ncollected and recorded. The clinical signs that persisted for weeks before the death included progressive loss of \nappetite, lethargy, constipation, weight loss, weakness, and abnormal position of the head. Later, the affected bird \nbecame recumbent and died.  \nNecropsy and gross pathology. The bird was subjected to necropsy examination and observed for gross \nalterations.  \nGross lesi ons. The carcass was grossly emaciated ( Photo 2) . The gizzard was markedly enlarged, distended \nand occupied by most of the abdominal cavity. Peritoneal cavity contained serosanguineous fluid of about 40 mL on \nboth sides. P ericardium contained straw -colored thin clear fluid of about 27 mL . Epicardial fat was scanty and \ngelatinized. The proventriculus and ventriculus were completely impacted with a solid mass of sand and pebbles \n(Photo 3) . The inte stines were empty of feed. Colo r was turgid and full of gas.  \n \nDISCUSSION  \n \nIn ostriches, impaction is caused by excessive ingestion of materials which accumulate in the proventriculus \nand gizzard ( 2). Impaction is  classified into three different categories (4). It could be acute (weak birds in a few \ndays) or chronic ( weak birds in weeks to months); hard (caused by hard materials such as pebbles, sand) or soft \n(caused by fibrous materials such as grass); partial or complete. Impaction  occurs in Ostriches less than six  months \nold ( 5). In the present study, the impaction was of hard type and occurred in a four month old Ostrich. The clinical \nsigns seen in this study were similar to that of a previous case (2) . The cause of impaction in the present case was \nmainly due to pebbles. The serosanguineous fluid seen in the perica rdial sac and peritoneal cavity, serous atrophy of \nthe epicardial , and emaciated condition of the carcass clearly indicates the catabolic effect due to starvation. It is \nconcluded that the Ostrich died due to proventricular and  gizzard impaction. Ostriches  reared and maintained in an \narea which is relatively free from  foreign materials and stress easily  avoid this type of impaction.  \n \nREFERENCES  \n \n1. Jenson JM, Johnson JH, Weiner ST. Husbandry and Medical Management of Ostriches, Emus and Rheas. \nWildlife and Exotics Animal Teleconsultants. 1992.  \n2. Nagarajan K, Selvaraj J, Balakrishnan G, Roy P, Selvan ST, Veeramani P, Balachandran C, Thyagarajan \nD, Muralimanohar B. Sand impaction in an ostrich ( Struthio camelus ): pathological and histopathological \nstudy.  IJAVMS. 5(2): 64 -72. 2011.  \n3. Ndelekwute, EK, UK Oke, HO Uzegbu, IR Igwe, UO Inyang, C Nwachukwu. Review of ostrich (Struthio \ncarmelis) production and its adaptability to the Nigerian poultry industry. Animal Production Research Advances \n Vol 5, No 2 (2009)  \n4.  Samson J. Prevalent diseases of ostrich chicks farmed in Canada. Ca nadian Veterinary Journal.; 38: 425 -\n428. 1997.  \n5. Stewart JS. Ratites. In \u2018Avian Medicine: Principles and Application\u2019. (Eds BW Ritchie, GJ Harrison, LR \nHarrison). 1284- 1326. (Fort Worth, Florida: Wingers Publishing Inc., USA). 1994.  \n6. Zakeri, A. and P. Kashefi . Proventricular -ventricular Impaction in Ostrich ( Struthio camelus ). World \nVeterinary Journal of Zoology. 6 (4): 424- 426. 2011  \n7. Huchzermeyer, 1997 . \n \n  \n \n \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n  \n \nPhoto 1.  The o strich carcass at presentation . \n \n \n \n \n \n \nPhoto 2 .  Prominent rib bones, evidence of e maciation .  \n \n \n \n \n \n \n \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n \n Photo 3 . Pebbles in the proventricular and ventricular region.  \n \n \n \n \n63rd WPDC/XXXIX ANECA  FIELD EXPERIENCES IN JUDICIOUS USE OF ANTIMICROBIALS  \n \nEXPERIENCIAS DE CAMPO EN EL USO PRUDENTE  \nDE ANTIMICROBIANOS  \n \nN. Reimers  \n \nCutler Associates International, Gustine, CA  \n \nRESUMEN  \n \nLa Asociaci\u00f3n Americana de Medicina Veterinaria tiene quince Principios del uso prudente de \nantimicrobianos. En el campo, los veterinarios aplican medidas preventivas, eval\u00faan las terapias alternativas y \nsupervisan los protocolos terap\u00e9uticos utilizando la ley y la ciencia actuales. Un plan de prevenci\u00f3n bien desarrollado abor da los retos bacterianos y por protozoarios y detiene la enfermedad cl\u00ednica haciendo la intervenci\u00f3n \nterap\u00e9utica m\u00e1s rara. Planes de prevenci\u00f3n implementados correctamente aseguran la salud y bienestar animal y una abundancia de alimentos seguros y accesib les. \n \nSUMMARY  \n \nField veterinarians orchestrate the disease prevention first line of defense.  Good management practices, \nnutrition, and vaccinations serve critical roles.  Non-antibiotic fe ed and water additives support judicious use \nprogram s, aiding or repl acing the anti microbial\u2019s prevention and control  of disease . \n \nINTRODUCTION  \n \nIn December 2013, the Food and Drug Administration implement ed a new plan concerning anti -microbial use \nin food producing animals.  CVM -GFI209 (1) contains two Principles of Judicious Use:  \nPrinciple 1 : The use of medically important antimicrobial drugs in food- producing animals should be limited \nto those uses that are considered necess ary for assuring animal health  \nPrinciple 2 : The use of medically important antimicrobial drug s in food- producing animals should be limited \nto those uses that include veterinary oversight or consultation.\u201d  \nIn regards to Therapeutic Use of Antimicrobials, t he American Veterinary Medical Association holds this position  \n(2): \u201cWhen the decision is reached to use antimicrobials for therapy, veterinarians should strive to optimize \ntherapeutic efficacy and minimize resistance to antimicrobials to protect public and animal health.\u201d \nAt the State and Federal levels, legislators seek to make Food and Drug Administration  program provisions \nmandatory for all food animal production segments.   \n \nDISCUSSION  \n \nIn poultry production, veterinarians apply preventative measures, evaluate alternative therapies , and oversee \ntherapeutic protocols using the current law and science.  Prevention plans address bacterial and protozoal challenges \nand stop most clinical disease , making therapeutic interventions rare.  Properly -implemented plans ensure poultry  \nhealth and we lfare and abundant,  safe, affordable food.  Before choosing therapeutic antimicrobials, veterinarians \nfollow  several principles (2):  \u201cPreventive strategies, such as appropriate husbandry and hygiene, routine health \nmonitoring, and immunization, should be em phasized.  Other therapeutic options should be considered prior to \nantimicrobial therapy.\u201d  \nJudicious use principles dovetail with preventative medicine practice;  disease prevention eliminates therapeutic \nuse of antimicrobials.  Veterinarians examine field challenges.  Challenges can include unique pathoge ns, worker \npractices , or housing or feeding system limitations.  Some challenges dictate changes  to protocols  or to equipment \ndesign . Others require replacement or augmentation of existing an timicrobial or vaccination programs .  \nWhen prevention measures fail and  laboratory findings and clinical signs dictate, veter inarians choose \nantimicrobials to preserve animal health u nder the following conditions (2):  \n 63rd WPDC/XXXIX ANECA  Judicious use of antimicrobials, when under the dire ction of a veterinarian, should meet all \nrequirements of a veterinarian -client -patient relationship. Prescription, Veterinary Feed Directive, \nand extralabel use of antimicrobials must meet all the requirements of a veterinarian -client -patient \nrelationship.  Extralabel antimicrobial therapy must be prescribed only in accordance with the \nAnimal Medicinal Drug Use Clarification Act amendments to the Food, Drug, and Co smetic Act \nand its regulations.  \n \nDuring antimicrobial therapy, veterinarians ensure treatment success through monitor ing management factors \nand utilizing  diagnostic information (2):  \n \nVeterinarians should work with those responsible for the care of animals to use antimicrobials \njudiciously regardless of the distribution system thro ugh which the antimicrobial was obtained. \nRegimens for therapeutic antimicrobial use should be optimized using current pharmacological \ninformation and principles.  Antimicrobials considered important in treating refractory infections in \nhuman or veterinary medicine should be used in animals only after careful review and reasonable \njustification. Consider using other antimicrobials for initial therapy. Use narrow spectrum \nantimicrobials whenever appropriate.  Utilize culture and susceptibility results to aid in the \nselection of antimicrobials when clinically relevant.  Therapeutic antimicrobial use should be \nconfined to appropriate clinical indications. Inappropriate uses such as for uncomplicated viral \ninfections should be avoided.  Therapeutic exposure to antim icrobials should be minimized by \ntreating only for as long as needed for the desired clinical response.  Limit therapeutic \nantimicrobial treatment to ill or at risk animals, treating the fewest animals indicated.  \n \nAnd finally,  veterinarians promote human an d environmental health through judicious therapeutic application  \n(2): \u201cMinimize environmental contamination with antimicrobials whenever possible.  Accurate records of treatment \nand outcome should be used to evaluate therapeutic regimens.\u201d  \nVeterinarians evaluate treatment success or failure and modify preventative disease plan to reduce future \ntreatment.  \n \nREFERENCES  \n \n1) CVM -GFI209, \u201c The Judicious Use of Medically Important Antimicrobial Drugs in Food -Producing \nAnimal s\u201d 2013.   \n2) AVMA, Judicious Therapeutic Use of Antimicrobials  2013.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n IMPACT OF PRE -ENRICHMENT MEDIA PH  \nON SALMONELLA DETECTION  \n \nIMPACTO DEL PH DE UN MEDIO PRE- ENRIQUECIDO  \nEN LA DETECCI\u00d3N DE SALMONELLA  \n \nK.. RichardsonA, N. CoxB, J. CasonC, D. CosbyB, and L.  DeRomeA \n \nAAnitox Corp., Lawrenceville, Georgia 30043   \n \nBUSDA, ARS, Russell Research Center, Athens, Georgia 30605   \n \nCUSDA Retired, Athens, Georgia 30605  \n \nRESUMEN  \n \nEn un estudio reciente, el pH de los medios pre enriquecidos para Salmonella  se transformaron a \u00e1cidos (pH \n4.0 a 5.0) cuando el alimento/ ingrediente fue incubado por 24 horas. Se ha reportado que las condiciones \u00e1cidas \nda\u00f1an o matan la Salmonella. En el presente estudio, cultivos estresados y no estresados de S. Typhimurium  (ST),  S. \nEnteriditis  (SE),  S. Infantis (SI),  S. Senftenberg  (SS) y S. Montevideo (SM) se incubaron en rangos de pH que iban \nde 4.0 a 7.0. El da\u00f1o celular se determin\u00f3 en agar xilosa -lisina -tergitol 4 (XLT4) y la muerte celular se determin\u00f3 en \nagar nutritivo (NA ). En el caso de la Salmonella no estresada, se observ\u00f3 que ST y SE fueron la que m\u00e1s toleraron  \nlas condiciones \u00e1cidas, y que SS y SM fueron las m\u00e1s sensibles. En el caso de la Salmonella estresada,  se \nobservaron tanto la tolerancia como la sensibilidad opuestas. Estos hallazgos sugieren que el pH de los medios pre enriquecidos puede influenciar el serotipo de Salmonella   recuperado del alimento.  \n \nSUMMARY  \n \nIn a recent study, the pH of commonly used Salmonella pre-enrichment  medias became acidic (pH 4.0 \u2013  5.0) \nwhen feed/ingr edient were incubated for 24 h . Acidic conditions have been reported to injure or kill Salmonella.  In \nthis study, non- stressed and stressed cultures of S . Typhimurium  (ST), S. Enteritidis  (SE), S. Infanti s (SI), S. \nSenftenberg  (SS) and S . Montevideo  (SM), were subjected to incubation pH ranging from 4.0 \u2013 7.0. Cell injury was \ndetermined on xylose lysine tergitol 4 (XLT4) and cell death determined on nutrient agar (NA). In the case of non -\nstressed Salmonella, ST and SE was observed to be the most tolerant to acidic conditions and S S, SM and SI \nobserved to be the most sensitive. In the case of stressed Salmonella, the opposite tolerance/sensitivities among the \nisolates were observed. These finding suggest that the pH of the pre -enrichment media may influence the serotype of \nSalmonella recovered from feed.  \n \nINTRODUCTION  \n \nThe current methodology used for isolating Salmonella from feed and feed ingredients has been derived from \nhuman food methods with minimum consideration to the challenges that occur with dry matrixes and the stressed status of microorganisms. Pre -enrichment media are designed to revive stressed or injured Salmonella  for detection \nin later analytical steps, but recent research has indicated that these media can become acidic during incubation. Cox \net al (1) reported the pH of various pre -enrichment media could decrease from an initial pH of 6.1 -7.2 to a final pH \nof 3.9 -  4.1 depending on the type of pre -enrichment media and feed/ingredient type. These acidic condition s could \nimpact  the isolation and detection of Salmonella.  \nThe influence of pH on Salmonella has primarily focused on Salmonella growth rather than Salmonella \nrecovery. At a pH of 4 - 5, the growth of Salmonella is inhibited ( 2,3,4 ). However, there is limited information on \nthe impact of pH on the isolation and detection of Salmonella. Blankenship ( 5) reported that exposure of viable \n(non-stressed) S. Bareilly to acidic conditions resulted in cell death, cell injury and changes biochemical enzyme \nactivity. The impact of acid injury on the recovery and detection of other isolates of Salmonella is viable and \nstressed stat es were evaluated.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n  \nMATERIALS AND METHODS  \n \nProduction of inoculum . Isolates of S T, SS, SI, SE, and S M were obtained from the American Type Culture \nCollection (ATCC).  Isolates were rehydrated in nutrient broth and transferred to veal infusion agar. Cultures were \nstreaked on XLT -4 agar and the serology of each culture confirmed by somatic antigen agglutination.  A single \ncolony from the XLT -4 agar plate was transferred t o a milk dilution bottle (160 mL) containing 90 mL  of tryptic soy \nbroth ( TSB, Difco) and incubated for 18 \u2013 24 h at 37oC. Broth cultures were utilized for the non -stressed inoculum \nand for the preparation of stressed inoculum as described by Liu et al.  (6). \nAcid exposure . Sterile citrate buffer solutions of pH 4 \u2013  7 were prepared utilizing  sodium citrate and citric \nacid. Aliquots (nine mL ) of the buffer sol utions were transferred to 15 mL  sterile test tubes and 106 cfu Salmonella  \nadded. For the stressed inoculum, one  g of the dried inoculum  was added to each test tube. Test tubes w ere vortex \nfor 15 s  for mixing purposes and then incubated for 24 h  at 37oC. \nCell injury method.  At 6 and 24 h of incubation, one mL  samples from each buffer solution was aseptically \nremoved and serial dilutions prepared. A liquots (0.1 mL ) of the dilutions were plated in duplicate on both NA  \n(Difco) and XLT -4 agar. Plates were counted after 24 h  of incubation at 35oC. Inability to grow on XLT -4 agar was \ntaken to indicate cell injury. The extent of injury was determined as the ratio of tota l counts on XLT -4 to nutrient \nagar. The degree of cell death was determined as the ratio of NA  counts after various treatment times to initial NA  \ncounts.  \n \nRESULTS  \n \nThe effect of the different citrate pH buf fer solutions on cell death/ cell injury was observed to be dependent on \nthe pH of the incubation buffer, the isolate  of Salmonella and the stress stat us of the microorganism. Cell death and \ncell injury of Salmonella was observed to increase in a linear fashion as the pH of the buffer  solution was decreased. \nThis enabled the data to be fitted to a linear regression to compare the acid tolerance of each isolate. T he pH \nrequired for a 50% cell death and 50% cell injury for the non -stressed isolates are presented in Table 1.  This strain \nof ST was the most acid tolerant with respect to cell death. S S, SE and SI were the most acid sensitive. In the case of \ncell injury, S T was the most acid tolerant and S S the most acid -sensitive.  \nSalmonella that had been subjected to stress (dehydration and heat exposure) exhibited different sensitivities to \nacidic conditions than non- stressed Salmonella. Data is presented in Table 2. Of the isolates, S T was the most \naffected. Stressing reduced the pH requir ed for a 50% reduction >1  pH unit. In the case of S S and SI, the opposite \nwas observed. Stressing increased the aci d tolerance of the isolate by a 0.5 to > 1 pH unit.  \nUtilizing XLT4 as the selective media allowed for observing the ability of the different isolates to produce \nhydrogen sulfide. In the case of non -stressed isolates of Salmonella, the ability of S M and SI to produce hydrogen \nsulfide was affected. At a pH of 7, S M, appeared as yellow colonies on XLT4.  However, a t lower pHs, colonies \nwere black (H 2S positive).  It was hypothesized that the colonies may have been immature in the pH 7 treatment and \nplates we re incubated an additional 24 h . No changes in H 2S production were observed. In the case of S I, 46% of the \ncolonies were H 2S negative when incubated in citrate buffer  at pH 7 . Lowering the pH did not appear to increase the \nnumber of H 2S negative colonies. The ability of other isolates of Salmonella to produce H 2S did not appear to be \naffected by pH.  \nDehydration and heat treatment  (stress)  of Salmonella influenced  the ability of S M, SI and SE to produce H 2S. \nIn the case of S M, approximately 50% of the colonies were  H2S negative at a neutral pH without incubation. After \n24 h of exposure to acidic conditions, the pH of the buffer did not appear to affect the percentage of H 2S negative \ncolonies until a pH of 5 was obtained. At this pH, 75% of the colonies had lost their ability to produce H 2S. For SI, \nstressing increa sed the percentage of H 2S negative colonies from 46% to 78%. Reducing pH did not appear to \nincrease the percentage of H 2S negative colonies.  In the case of SE, 100% of the colonies were H 2S positive at a \nneutral pH without incubation. However, incubation in non -acidic conditions (pH 6 -7) appears to result in H 2S \nnegative colonies , whereas incubation in acidic conditions appears to favor H 2S positive colonies  (Figure 1).  \n \n  \n \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n DISCUSSION  \n \nThese results suggest that Salmonella  may go undetected in feed samples due to an assortment of issues.  \nSalmonella may die  as a result of the acidity produced in the pre-enrichment media due to fermentation of substrates \nby background microflora.  Also, acid injury of the Salmonella  may chan ge their biochemical profiles making them \nlook different on plating and screening media.  I n addition, the viable or stressed condition of the Salmonella affects \ntheir sensitivity to acid injury.  Even though certain issues have been raised by this researc h, making broad, \nsweeping conclusions should be avoided until numerous strains of many different serotypes of Salmonella have been \nthoroughly studied.   \n \nREFERENCES  \n \n1. Cox, N.A., J.A. Cason, R.J. Buhr, K.E. Richardson and L.J. Richardson. 2013. J. Appl. Poult. Res. \n22:190- 195. \n2. Chung, K.C. and J.M. Goepfert. 1970. J. Food Sci. 35:326- 328. \n3. Ferreira, M.A.S.S. and B.M. Lund. 1987. Letters Appl. Microbiol 5:67- 70. \n4. McDermid, A.S., A.S. McKee, A.B. Dowsett and P.D. Marsh. 1996. J. Med Microbiol. 45:452 -458. \n5. Blan kenship, L.C. 1981. J. Food Prot. 44(1):73- 77. \n6. Liu, T.S., G.H. Snoeyenbos, and V.L. Carson (1969). Avian Dis . 13:611- 613. \n \n \n \n \n \n \n \nTable 1 . pH Required to Cause a 50% Reduction in the Recovery of Non -Stressed Salmonella  \nIsolate  Cell Death  Cell Injury  \nS. Typhimurium  4.84 5.46 \nS. Montevideo  5.71 6.22 \nS. Infantis  5.88 6.69 \nS. Enteritidis  5.80 6.74 \nS. Senftenberg  5.80 6.88 \n \n \n \nTable 2 . pH Required to Cause a 50% Reduction in the Recovery of Stressed Salmonella  \nIsolate  Cell Death  Cell Injury  \nS. Typhimurium  6.07 6.09 \nS. Montevideo  5.49 6.07 \nS. Infantis  5.12 5.29 \nS. Enteritidis  5.74 6.32 \nS. Senftenberg  4.72 4.85 \n  \n \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n  \n \n \n \n \n0102030405060708090100\n5 5.5 6 6.5 7% Colonies  \npH Figure 1. H2S Production by Stressed S. enteritidis at 24 Hrs  \nH2S Positive\nH2S Negative63rd WPDC/XXXIX ANECA  DETERMINACI\u00d3N DE LA VIABILIDAD DE LA APLICACI\u00d3N DE \nUNA VACUNA RHVT/ND Y UNA VACUNA EMULSIONADA \nINYECTADAS EN FORMA SIMULT\u00c1NEA  \n \nVIABILITY TEST OF THE APPLICATION OF AN rHVT / ND VACCINE AND \nAN EMULSIFIED VACCINE INJECTED SIMULTANEOUSLY \n \nJ. R\u00edos CambreA, L. MontesinosB, R. AlonsoC y N. Lede smaB \n \nAMSD Salud Animal. Paseo de los frailes 22. Parque Industrial.  Santiago Tianguistenco. M\u00e9xico  \nBUniversidad  Nacional Aut\u00f3noma de M\u00e9xico. Facultad de Medicina Veterinaria y Zootecnia. Departamento de  \nMedicina y Zootecnia de Aves . M\u00e9xico  \nCUniversidad Nacional Aut\u00f3noma de M\u00e9xico. Facultad de Medi cina Veterinaria y Zootecnia. Departamento de \nGen\u00e9tica y Bioestad\u00edstica. M\u00e9xico  \n \nSUMMARY  \n \nTo determine if the simultaneous application of a rHVT/ND vaccine with an inactivated emulsion vaccine in \nan oil adjuvant, under different way and temperature of application has an effect on the detection of the recombinant \nvaccine by means of molecular detection methods. Results show that even though the HVT was detected in all \ngroups tested, there are differences in the amount of positive birds.  \n \nRESUMEN  \n \nDeterminar si la aplicaci\u00f3n simult\u00e1nea de una vacuna rHVT/ND con una vacuna inactivada emulsionada en \nadyuvante oleoso bajo diversas condiciones de aplicaci\u00f3n y temperatura afecta la detecci\u00f3n  de la vacuna \nrecombinante por medio de la medici\u00f3n de part\u00edculas virales vacunales utilizando m\u00e9todos moleculares de \ndetecci\u00f3n. Los resultados arrojan que aunque existe detecci\u00f3n   del virus HVT en todos los casos, pueden existir  \ndiferencias en cuanto a la incidencia de individuos positivos . \nUna vacuna recombinante rHVT/ND + SB -1 es aquella en la cual el vector Herpesvirus del pavo (HVT) \nexpresa la prote\u00edna F de fusi\u00f3n del virus de la enfermedad de Newcastle (ENC). Esta vacuna est\u00e1 dise\u00f1ada para que al ser aplicada al d\u00eda de edad en la planta de incubaci\u00f3n, permita la reducci\u00f3n de vacunaciones en el campo, \nincluyendo las vacunas  inactivadas que requieren aplicaci\u00f3n individual  (1,2) . Sin embargo, en zonas av\u00edcolas donde \nse hace necesario vacunar contra otras enfermedades, como la Influenza aviar (IA), no es posible evitar el uso de  \nvacunas emulsionadas. Con el fin de explotar el b eneficio del uso de la vacuna rHVT/ND  al m\u00e1ximo, se sug iere la \naplicaci\u00f3n de estas vacunas emulsionadas en presentaci\u00f3n concentrada, con el fin de inmunizar a los pollitos en la \nplanta de incubaci\u00f3n utilizando vol\u00famenes m\u00e1s reducidos para reducir el estr\u00e9s  causado por la inyecci\u00f3n, para lo \ncual se han dise\u00f1ado diversos equipos de vacunaci\u00f3n autom\u00e1tica que aplican ambas vacunas, una vacuna rHVT/ND \n+ SB -1 (acuosa) y una vacuna inactivada de IA concentrada (emulsi\u00f3n oleosa) en forma simult\u00e1nea.  \nLas vacunas rHV T/ND  son asociadas  a c\u00e9lulas ; la viabilidad de las c\u00e9lulas es fundamental para garantizar la \nfunci\u00f3n biol\u00f3gica de la vacuna misma. Estas c\u00e9lulas son sumamente sensibles  a cualquier variaci\u00f3n adversa del \nambiente en el que se encuentran, por esta raz\u00f3n, siempre que se desarrolla alg\u00fan producto para ser administrado en \nforma simult\u00e1nea, e incluso reconstituido en el mismo diluente de reconstituci\u00f3n de la vacuna asociada a c\u00e9lulas, se \ndeben correr pruebas de compatibilidad.  \nActualmente existen en el mercado varios  tipos de equipos  de vacunaci\u00f3n autom\u00e1ticos con inyecci\u00f3n \nneum\u00e1tica con una sola aguja, dise\u00f1ados para este fin. El m\u00e1s com\u00fan es de tipo asincr\u00f3nico, ya que utiliza dos \ndisparadores de manera que los dos fluidos son inyectados uno despu\u00e9s del otro, y uno de los  cuales es dise\u00f1ado en \ncoordinaci\u00f3n con MSD Salud Animal, denominado tentativamente \u201cDeux -vaccines\u201d.  \nRecientemente se introdujo en M\u00e9xico la prueba de la reacci\u00f3n en cadena de la polimerasa en tiempo real (RT -\nPCR) para el virus HVT, la cual es capaz de emitir resultados cualitativos y cuantitativos. Este recurso p uede \npermitir en primera instancia  determinar en forma directa si la administraci\u00f3n de rHV T/ND en fo rma simult\u00e1nea con \nvacunas oleosas bajo dicha forma de inyecci\u00f3n y condiciones de temperatura variable resulta en una reducci\u00f3n de las \naves positivas  al vector HVT en un lapso considerado est\u00e1ndar para una vacuna de estas caracter\u00edsticas, lo cual \npodr\u00e1 ayu dar a comprobar si existe compatibilidad entre ambos productos . 63rd WPDC/XXXIX ANECA   \nMATERIAL Y M\u00c9TODOS  \n \n40 pollitos de engorda de un d\u00eda  de edad, procedentes del mismo lote de reproductoras y de la misma m\u00e1quina \nnacedora.  Vacuna rHVT/ND + SB -1 (Fusion ND -SB, MSD Salud Animal, Santiago Tianguistenco, M\u00e9xico)  con \ndiluente . Vacuna emulsionada inactivada contra la IA concentrada ( Nobilis Protector Inac , MSD Salud Animal, \nSantiago Tianguistenco, M\u00e9xico).  Vacunador \u201cDeux -vaccines\u201d de tipo asincr\u00f3nico.  Ba\u00f1o Mar\u00eda tipo Pro Heat  con \ntermostato graduable (MSD Salud Animal, Santiago Tianguistenco, M\u00e9xico) . Equipo RT-PCR Corbett Rotor -Gene \n6000 (Departamento de Gen\u00e9tica y Bioestad\u00edstica, UNAM) . Las aves se dividieron en cuatro  grupos de 10 aves cada \nuno, y se identificaron y trataro n de la siguiente manera:  \nGrupo 1.  Fusion ND -SB \nGrupo 2 . Fusion ND -SB + vacuna emulsionada a temperatura de cuarto. Vacunados con equipo \u201cDeux -\nvaccines\u201d.  \nGrupo 3 . Fusion ND -SB + vacuna emulsionada a 40\u00b0C. Vacunados con equipo \u201cDeux -vaccines\u201d  \nGrupo 4 . Fusio n ND -SB + vacuna emulsionada a 45\u00b0C. Vacunados con equipo \u201cDeux -vaccines\u201d  \nTodas las aves fueron vacunadas al d\u00eda de edad y mantenidas en cautiverio.  Al t\u00e9rmino de la vacunaci\u00f3n se envi\u00f3 al \nlaboratorio una muestra de vacuna del mismo lote utilizado sin desc ongelar para su uso en la estandarizaci\u00f3n de la \nprueba.  \nPoster iormente, a los 14, 21 y 28 d\u00edas  de edad se tomaron cuatro  plumas remeras de cada ave. Las plumas \nfueron colocadas en bolsas de pl\u00e1stico limpio (una bolsa por ave). Se tuvo precauci\u00f3n de no presionar los ca\u00f1ones de \nlas plumas para evitar la expulsi\u00f3n de la pulpa. Todas las bolsas fueron mantenidas en congelaci\u00f3n. Cada grupo de \nplumas fue identificado de acuer do al grupo de procedencia y se enviaron al Departamento de Medicina y Zootecnia \nde Aves  de la Universidad Nacional Aut\u00f3noma de M\u00e9xico para el procesamiento de las muestras, las cuales se \nanalizaron  por la t\u00e9cnica de RT -PCR para la determinaci\u00f3n del genoma del Herpesvirus del Pavo (HVT) vacunal.  \nProceso de las muestras. Para determinar la cantidad de ADN viral se emple\u00f3 la sonda que detecta el gen \nSORF1 del Herpesvirus de Pavo. Para la detecci\u00f3n del ADN celular se emple\u00f3 la sonda del gen \u03b12  (IV) de la \ncol\u00e1g ena de pollo, del cual hay una sola copia por c\u00e9lula. Ambas sondas fueron empleadas con anterioridad por \nIslam et al. (3 ). \nLa t\u00e9cnica de extracci\u00f3n del ADN de c\u00e9lulas de pollo se llev\u00f3 a cabo mediante la modificaci\u00f3n de las t\u00e9cnica \ndescrita por Higuchi et al. (4) \nEl volumen final por reac ci\u00f3n para el PCR -TR fue de 20 \u00b5L, conteniendo 10 \u00b5L  de la muestra a analizar y 10 \n\u00b5l del master mix. Los componentes del master mix por reacci\u00f3n fueron los siguientes: buffer Taq Polimerasa 1X, dNTP\u00b4s 0.2mM, MgCl\n2 3mM, inic iadores F+R del virus 0.5\u00b5M, sonda del virus 0.1\u00b5M, iniciadores F+R del gen de \nreferencia (col\u00e1gena pollo \u03b12) 0.5\u00b5M, sonda del gen de referencia 0.1 \u00b5M, Taq polimerasa 1u, agua cpb 10\u00b5L . \nLa amplificaci\u00f3n -detecci\u00f3n del ADN se llev\u00f3 a cabo en termociclador d e PCR- TR con la siguiente p rogramaci\u00f3n: \n95\u00b0C por 10 m inutos , 40 ciclos de 95\u00b0C por 15 segundos y 60\u00b0C por 45 segundos.  \n \nRESULTADOS  \n \nA partir de los resultados obtenidos se consideraron diferentes tipos de muestras: muestras nulas (aquellas en \nlas que no amplifico el ADN celular), muestras negativas (en las cuales no hubo amplificaci\u00f3n viral, pero si \namplificaci\u00f3n celular) y muestras po sitivas (aquellas que amplifico tanto el ADN viral como el ADN celular). En la \nTabla 1 se muestra el porcentaje de muestras positivas de cada grupo.  \n \nDISCUSI\u00d3N  \n \nLos resultados muestran que la detecci\u00f3n del virus vacunal  a los 14 d\u00edas  es un tanto err\u00e1tica, pues \nindependientemente del tratamiento, hay diferencias importantes en la detecci\u00f3n de las copias de los genes entre un \ngrupo y otro. Esto puede coincidir con reportes que indican que en aves vacunadas empleando el vector HVT el \nestablecimiento de la in munidad tarda entre 21 y 28 d\u00edas  (5,6), y esto puede deberse a diferencias individuales en el \ntiempo de la replicaci\u00f3n de las suficientes copias del virus vacunal. A partir del d \u00eda 21 por lo menos el 80% de las \naves analizadas de cada grupo  resultaron positivas al virus HVT, lo cual tambi\u00e9n parece coincidir con la af irmaci\u00f3n \nanterior. En estudios posteriores se reportar\u00e1 el efecto de estos tratamientos en la cantidad de copias por ave y por grupo, medidas por una metodolog\u00eda de cuantifi caci\u00f3n relativa.  \n \n 63rd WPDC/XXXIX ANECA  REFERENCIAS  \n \n1. Morgan, RW; Gelb, Jr., J; Schreurs, CS; L\u00fcticken, D; Rosenberger, JK; Sondermeijer, PJA. (1992). \nProtection of chickens from Newcastle and Marek\u2019s diseases with a recombinant herpesvirus of turkeys vaccine \nexpressing the Newcastle disease virus fusion protein. Avian Diseases 36, 858- 870. \n2. Sondermeijer, PJA; Claessens, JAJ; Jenniskens, PE; Mockett, APA; Thijssen, RAJ; Willemse, MJ; and \nMorgan, RW. (1993). Avian herpesvirus as a live viral vector for the expression of heterol ogous antigens. Vaccine \n11, 349- 358. \n3. Islam A, Harrison B, Cheetham BF, Mahony TJ, Young PL, Walkden -Brown SW. Differential \namplification and quantification of Marek\u00b4s disease viruses using real -time polymerase chain reaction. Journal of \nvirological methods . 2004; 119: 103- 113.  \n4. Higuchi R., von Beroldinger C., Sensabaugh G.F., Erlich H.A. (1988). DNA typing from single hairs. \nNature 332, 543- 546. \n5. Morgan, RW; Gelb Jr., J; Pope, CR; Sondermeijer, PJA. (1993). Efficacy in chickens of a herpesvirus of \nturkeys re combinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of \nmaternal antibodies. Avian diseases 37, 1032- 1040.  \n6. Hein, RG; Slacum, G; Rios, F; Lynch, P. (2008). Onset of immunity in birds with Newcastle disease \nmaternal antibodies vaccinated with a recombinant HVT/F (NDV) vaccine. Proceedings of the XXIII World\u2019s Poultry Congress. Brisbane, Australia.  \n \n \nTabla 1.  El porcentaje de muestras positivas de cada grupo.  \n \n Muestreo a los 14 d\u00edas post -\nvacunaci\u00f3n  Muestreo a los 21 d\u00edas post -\nvacunaci\u00f3n  Muestreo a los 28 d\u00edas post -\nvacunaci\u00f3n  \nGrupo  Positivos/Total \nmuestras  Positivos \n(%) Positivos/Total \nmuestras  Positivos \n(%) Positivos/Total \nmuestras  Positivos \n(%) \n1 4/10 40.0%  10/10  100%  8/10 80.0%  \n2 6/10 60.0%  10/10  100%  9/9 100.0%  \n3 9/9 100%  10/10  100%  8/9 88.8%  \n4 7/10 70.0%  8/10 80.0%  10/10  100%  \n 63rd WPDC/XXXIX ANECA  RENDIMIENTO PRODUCTIVO Y PIGMENTACI\u00d3N DE LA YEMA \nDE HUEVO EN GALLINAS ALIMENTADAS CON DIETAS SORGO-\nPASTA DE SOYA SUPLEMENTADAS CON GRANOS SE COS DE \nDESTILER\u00cdA CON SOLUBLES  BAJOS EN ACEITE  \n \nYIELD AND PIGMENTATION OF EGG YOLK IN HENS FED  \nSORGHUM - SOYBEAN \u2013 DDGS DIETS  \n \nA. Cort\u00e9sA, JF. RiveraA, S. Ram\u00edrezA, C. L\u00f3pezB, J. ArceC y E. \u00c1vilaA \n \nACentro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola, Facultad de Medicina Veterinaria y \nZootecnia, Universidad Nacional Aut\u00f3noma de M\u00e9xico  \nBDepartamento  de Producci\u00f3n Animal, Aves, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional \nAut\u00f3noma de M\u00e9xico  \nCUniversidad Michoacana de San Nicol\u00e1s de Hidalgo FMVZ  \nCorreo electr\u00f3nico: cortescuevasarturo@yahoo.com  \n \nSUMMARY  \n \nIn order to evaluate the use of two samples of distillers dried grains with solubles (DDGS A and B), low in oil \n(5.36 and 6.53 %) to determine the yield and pigmentation of egg yolk in Bovans White hens fed diets based on \nsorghum \u2013soybean, a completely ran domized design with five treatments and six  replicates of 12 chickens each were \nused. The diets were supplemented with 6 % and 12% of low oil DDGS (A and B) and supplemented with 1 and 2 \nppm canthaxanthin per ton of feed. The results showed that the additio n of 6% and 12% of low oil DDGS in \nsorghum -soybean diets for layer hens did not affect (P > 0.05) feed intake, laying rate, average egg weight, egg \nmass , and feed conversion; but their use improved the color of the egg yolk.  \n \nRESUMEN  \n \nLos DDGS (granos s ecos de destiler\u00eda con solubles), son coproductos  del etanol obtenidos a partir de \ningredientes ricos en almid\u00f3n, tienen un alto valor nutritivo. Actualmente existen nuevas variedades, bajas en aceite \n(2.5-7.5%), que las convencionales (10 -12%).  El aceite ext ra\u00eddo de los DDGS, es principalmente utilizado para la \nproducci\u00f3n de biodisel. Diversos autores, han realizado investigaciones acerca de la evaluaci\u00f3n de pigmentaci\u00f3n incluyendo en diferentes porcentajes DDGS e indican que al incluir 5% de DDGS convencionales, con 11.78% de \naceite, en la dieta de gallinas ligeras se tiene impacto significativo en el color de la yema.  En el caso de DDGS bajos \nen aceite, existe informaci\u00f3n escasa sobre la evaluaci\u00f3n de DDGS en la pigmentaci\u00f3n de la yema. El presente estudio, tuvo como finalidad evaluar la inclusi\u00f3n de dos muestras de DDGS bajos en aceite (6.54% y 5.39% de \naceite), en dietas sorgo -soya para gallinas ligeras y su efecto en el rendimiento productivo y pigmentaci\u00f3n en yema. \nCon la finalidad de evaluar la inclusi\u00f3n  de dos muestras (A y B) de granos secos de destiler\u00eda con solubles (DDGS) \nbajos en aceite en dietas sorgo -soya para gallinas de postura y su efecto en la respuesta productiva y pigmentaci\u00f3n \nde la yema del huevo, se realiz\u00f3 el presente estudio. Se utilizar on 360 gallinas de la estirpe Bovans White de 69 \nsemanas de edad. Se utiliz\u00f3 un dise\u00f1o completamente al azar, de 5 tratamientos con 6 repeticiones de 12 gallinas cada una. Los tratamien tos fueron los siguientes: T1. -Dieta testigo sorgo -soya, T2. -6% de DDGS  A, T3. -12% de \nDDGS A, T4. -6% de DDGS B y T5. -12% de DDGS B. Tambi\u00e9n se evalu\u00f3 la pigmentaci\u00f3n de la yema por tres  \nsemanas con la adici\u00f3n de 1 ppm de cantaxantina y tres semanas con 2 ppm en todos los tratami entos. Los resultados \nen 70 d\u00edas  de experimentaci\u00f3n para rendimiento productivo no indicaron diferencia (P>0.05) entre tratamientos. Los \nresultados de luminosidad por colorimetr\u00eda de reflectancia y mediante el abanico colorim\u00e9trico de DSM\n\u00ae no fueron \ndiferentes (P>0.05) entre tratamientos. Sin embargo pa ra el enrojecimiento y amarillamiento de la yema, los datos \nindicaron diferencia estad\u00edstica (P<0.05) entre tratamientos, con menor amarillamiento y enrojecimiento en el \ntratamiento 1 respecto a los tratamientos 2 y 4, seguidos por los tratamientos 3 y 5. De los resultados obtenidos en el \npresente estudio, se puede concluir que la adici\u00f3n de 6 % y 12% de DDGS bajos en aceite en dietas sorgo -soya para \ngallinas de postura, no afect\u00f3 el comportamiento productivo y mejora la pigmentaci\u00f3n de la yema de huevo. La \ninclusi\u00f3n de cantaxantina en 1 y 2 ppm increment\u00f3 la tonalidad amarillo naranja de la yema de huevo.  63rd WPDC/XXXIX ANECA  INNATE IMMUNE RESPON SE OF CHICKEN MACROP HAGES TO \nESCHERICHIA COLI DERIVED -LPS AND PROPIONIBACTERIUM  \nACNES AND GRANULOSUM  CHALLENGE  \n \nLA RESPUESTA INMUNE INNATA DE MACR\u00d3FAGOS  AVIARES AL RETO \nDE LPS -DERIVADO DE E. COLI Y DE  \nPROPIONIBACTERIUM ACNES Y GRANULOSUM  \n \nJ. Rodriguez -LecompteA,*, H. EcheverryB, A. YitbarekC, and M. Parada -GomezD \n \nAAtlantic Veterinary College, University of Prince Edward Island, Canada. 550 University Avenue Ch arlottetown, \nPE, Canada. C1A 4P  \nBMaple Leaf Foods . 15 Aries Court, Hamilton, ON \u2013  Canada . L8W 3C8 \nCUniversity of Manitoba. 12 Dafoe Road. Winnipeg, MB \u2013  Canada. R3T 2N2  \nDLaboratorios Calier de los Andes, Bogot\u00e1 , Colombia  \n* Corresponding Author: jrodriguez@upei.ca 550 University Avenue Charlottetown, PE,  Canada. C1A 4P3  \n \nRESUMEN  \n \nLa primaria funci\u00f3n del sistema inmune innato es el reconocimiento y diferenciaci\u00f3n de lo propio y lo no \npropio; esto se logra por medio de un numero significativo de componentes celulares y sub celulares. En este \ncontexto la esencial importancia de los re ceptores tipo Toll (TLRs) es bien reconocida. Estructuras microbianas ricas \nen carbohidratos o patrones moleculares asociados a pat\u00f3genos (PAMP) tales como el LPS, PG, que interact\u00faan con \nreceptores celulares como los TLRs en el hu\u00e9sped, activan una cascad a de citoquinas pro- inflamatorias. Durante este \nproceso el primer paso las c\u00e9lulas inmunes que recirculan son reclutadas en los sitios de inflamaci\u00f3n por medio de \nun mecanismo que involucra el reconocimientos y uni\u00f3n a carbohidratos propios conocido como s electinas. En este \nestudio hemos usado una l\u00ednea celular de macr\u00f3fagos de aves (HD -11) para caracterizar la respuesta inmune innata \nasociada a la presencia de LPS derivado de E. coli y la bacteria Propionibacterium. La expresi\u00f3n de TLR2b, TLR4, \ninterleuqui nas (IL) -4, IL- 6, IL- 8, IL -10, IL -12p35, IL -13, IL -18 y interfer\u00f3n (IFN)- \u03b3 fueron evaluadas. En general \nnuestros resultados muestran que no hubo diferencias en la expresi\u00f3n de los genes entre los grupos estudiados; sin \nembargo cuando los grupos fueros reta dos a un modelo de LPS la expresi\u00f3n fue estable y en algunos casos fueron \ndecrecidos control\u00e1ndose el gasto de energ\u00eda y posibles reacciones inflamatorias in vitro . \n \nSUMMARY  \n \nThe primary functional theme of innate immunity is the distinction between self a nd non- self, which is \nmaintained by a vast number of cellular and subcellular components. In this context,  the immense importance of the \ntoll-like receptors (TLRs) is well established. Microbial carbohydrate structure or Pathogen associate molecular \npatte rn (PAMP) such as LPS, PG, and y east interact directly with pattern recognition receptors (PRR) such as TLRs \nin the host triggering a pro -inflammatory cytokine cascade. Recirculating immune cells are recruited to \ninflammatory sites by a reaction pathway in volving the self -carbohydrate -binding selectins as initial recognition \nstep. We have used a chicken macrophage cell line (HD -11) to characterize innate immune responses associated  \nwith the presence of E. coli -derived LPS and Propionibacterium. Gene express ion of TLR2b, TLR4, interleukins \n(IL)- 4, IL- 6, IL- 8, IL -10, IL -12p35, IL -13, IL -18 and interferon (IFN)- \u03b3 were assessed. In general, our results show \nthat treatments by themselves did not change the gene expression. Furthermore,  in an LPS challenge model , no \nchange was observed in most genes and in some cases even cause down -regulation controlling energy spend and \npossible inflammatory reaction in vivo.  \n \nINTRODUCTION  \n \nIn order to control microbial agents and promote birds performance the poultry industry has been using \nantibiotics (1); however, costumer concern s about antibiotic  resistance by pathogenic microorganisms is leading \nthem to demand antibiotic -free animal products ( 2).Antigen presenting cells (APC) such as macrophages,  dendritic 63rd WPDC/XXXIX ANECA  cells and B lymphocytes  participate in the initial capture and pr ocessing of microbial antigens a nd later, present \nthem to specific T and B cell s for activation of  their effector mechanisms (3,4). APCs are able to recognize \nconserved structures common to groups of pathogens called  pathogen -associated molecular patterns  (PAMP)  (5). \nThe germline -enconded receptors responsible for recognition of  PAMPs in both non -pathogenic and pathogenic \nmicrobes are called pattern recognition receptors (PRRs) ( 6); Toll- like receptors (TLR) being the most extensively \nstudied type of  these receptors (3). After recognition of the specific PAMP, PRRs initiate a downstream signalling \npathway that will lead to the production  of cytokines and chemokines that will direct the immune response to a pro-\ninflammatory  process (7). Benefic microorganisms such as Propionibacterium acnes and P. granulosum  (gram \npositive bacteria that have thick cell walls  that are rich in peptidoglycans and lipopolysaccharides ) have been used in \nanimal models and productions animals to stimulate their immune s ystem  (8,9,10) Moreover, purified PAMPs such \nas LPS have also been use d for this goal  (11).  \nThe aim of the present study was to determine the immune response of chicken macrophages against P . acnes , \nP. granulosum  (Gram +) , and E. coli derived LPS  (Gram -ve) by measuring gene expression of different TLRs and \ncytokines.  \n \nMATERIALS AND METHODS  \n \nCell culture . HD-11 cell line was grown in RPMI medium supplemented with 10% fetal bovine serum heat \ninactivated, 5% chicken serum heat inactivated in a 5% CO 2 incubator at 370C. Cells were  cultured, harvested and \ndiluted to get a final concentration of 2x106cells/m L in a final volume of 48mL . \nTreatments . I17.5= Inmunai r 17,5 (oral suspension x500ml) , INM= Inmunair (oral suspension x 1000mL ), \nINC= Inmunocel (injectable suspension x50ml) . C= Control (cell culture media) .  \nIn vitro  test. Cell culture 8 -well- plates were used for the experiment. F our 6 -well-plates were used for cells + \ntreatments (Experiment 1) and other four plates for cells + treatments + LPS challenge (Experiment 2). Each \nexperiment contained a control group consisting of cells without any additive . However, in Experiment 2 cells also \ncontain ed LPS.  1mL  of media containing 2x106cells/ml  was added to all wells. Immediat ely, 1mL  of treatment and \ncontrol solutions w as added to the corresponding wells to obtain 10\u03bcL/m L of each treatment as final concentration .  \nAll plates were placed in an incubator at 37oC and 5% CO 2. In Experiment 1, plates 1 and 2 were incubated \nundisturbed for two h  after which RNA extractio n was performed from cells; at four h  of incubation the cells from \nplates 3 and 4 were isolated for RNA extraction.  \nIn Experiment 2, after 30 m of incubation an LPS c hallenge was added to get a final concentration of 10\u03bcg/mL  \nof LPS in each well. Plates 5 and 6 were incubated undi sturbed for additional 1.5 h , then RNA extraction was \nextracted  from cells; and plates 7 and 8 were in cubated for additional 3.5 h  and then cells were isolated for RNA \nextraction.  cDNA conversion was performed followed by qRT -PCR gene expression of TLR2b , TLR4, IL- 4, IL -6, \nIL-8, IL- 10, IL -12p35, IL -13, IL -18 and IFN -\u03b3. \nGene expression . RNA was isolated using Invitrogen Trizol\u00ae Reagent (Life Technologies Inc. Burlington, \nON, Canada) according manufacture\u2019s protocol. cDNA was produce using High Capacity cDNA Reverse \nTranscription Kit (Applied Biosystems, Mississauga, ON, Canada) according manufacture`s protocol. Gene \nexpression w as measured using CFX Connect Real -Time System Bio -Rad (Bio -Rad Laboratories, Mississauga, ON, \nCanada)  in a 96 -well plate using a 10\u03bcL  total reaction volume. Primer concentrations for the target and \nhousekeeping genes were adjusted according to the results  obtained in a standard curve for each specific case. \nSsoAdvancedTM SYBR\u00ae Green Supermix was used according Bio -Rad instruction manual (Mississauga, ON, \nCanada).  \nStatistical analysis . Statistical analysis of the relative gene expression in present study w as done using  REST -\n2009 Software (Technical University Munich. Qiagen, Germantown, MD, USA) which compares each treatment \nindividually with the control group and expresses the relative gene expression as fold change of the target gene taking into considera tion a reference gene (housekeeping gene, \u03b2actin in the present work) and the efficiency of \nreference and target genes. Results from this analysis are given as fold change with a respective p value. For the present work statistical difference is considered  when p value is lower than 0.05. Values of fold change higher or \nlower than 1 with p<0.05 are considered statistical significant in both up -regulated and down- regulated respectively  \n \n   \n \n 63rd WPDC/XXXIX ANECA  RESULTS  \n \nIn Experiment 1, relative gene expression analysis of HD -11 cells treated with immuno -modulatory products \nwas in general  not significantly affected at two h and four h of incubation; just cells treated with  Inmunocel at 2 \nhours of incubation showed  a significant down -regulation of IL -12p35.  \nIn Experiment 2, HD -11 cells treated with INM and challenged with LPS showed significant up -regulation of \nIL-4 and IL -6 at two h of incubation; also at two h  of incubation HD -11 cells showed signific ant up -regulation of \nIL-13. At four h  of incubation HD-11 cells challenged  with LPS had significant down -regulation of IL -18 when \ntreated with I17.5; significant down -regulation of IL -13 when treated with INM and significant down -regulation of \nTLR4, IL -8 and IL -18 when treated with INC.  \n \nREFERENCES  \n \n1. Dibner, J., and J. Richards Antibiotic growth promoters in agriculture: history and mode of action. Poultry \nScience 84:634 -643. 2005.  \n2. Smith, M.A. Antibiotic Resistance. Nursing Clinics of North America 40:63 -75. 2005.  \n3. Siamon, G. Pattern recognition receptors: doublin g up for the innate immune response. Cell 111:927- 930. \n2002.  \n4. Rodr\u00edguez -Pinto, D. B cells as antigen presenting cells. Cellular Immunology 238:67 -75. 2005.  \n5. Uematsu, S., and S. Akira PRRs in pathogen recognition. Central European Journal of Biology 1:299- 313. \n2006.  \n6. Kumar, H., T. Kawai, and S. Akira Pathogen recognition by the innate immune system. International \nReviews of Immunology 30:16- 34. 2011.  \n7. Aderem, A. Phagocytosis and the Inflammatory Response. Journal of Infectious Diseases 187:S340- 345. \n2003.  \n8. Awaad,  M.H.H., A.M. Atta, M.A. Elmenawey, H. B.Gharib, W.A.A. El -Ghany, and A.A. Nada The effect \nof a combination of \u00e2(1 -3) D -Glucan and Propionibacterium granulosum on productive performance and immune \nmodulation of immunocompromised and non- immunocompromised broiler chickens. Vet World 6:31 -38. 2013.  \n9. Dinsmore, R.P., M.B. Cattell, R.D. Stevens, C.S. Gabel, M.D. Salman, and J.K. Collins Efficacy of a \nPropionibacterium acnes Immunostimulant for Treatment of Chronic Staphylococcus aureus Mastitis. J. Dairy Sci. \n78:1932- 1936. 1995.  \n10. Ferrer, L.M., A. Fern\u00e1ndez, A. Loste, A. Ort\u00edn, D. Lacasta, J.J. Ramos, M.T. Verde, and T. Conde Effect of \noral administration of Propionibacterium acnes on growth performance, DTH response and anti -OVA titers in goat \nkids. Pesquisa Veteri n\u00e1ria Brasileira 33:5 -10. 2013.  \n11. Michalek, S.M., H. Kiyono, M.J. Wannemuehler, L.M. Mosteller, and J.R. McGhee Lipopolysaccharide \n(LPS) regulation of the immune response: LPS influence on oral tolerance induction. The Journal of Immunology 128:1992- 1998. 1982.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n THE EFFECTIVENESS OF A BACILLUS LICHENIFORMIS \nPROBIOTIC ON THE REDUCTION IN SALMONELLA \nHEIDELBERG  SHEDDING AND COLONIZATION  \nIN BROILER CHICKENS  \n \nEFICACIA DE UN PROBI\u00d3TICO BACILLUS LICHENIFORM IS, OPTI -BAC L, \nEN LA REDUCCI\u00d3N DE LA EXCRECI\u00d3N Y LA COLONIZACI\u00d3N DE \nSALMONELLA HEIDELBERG EN POLLOS DE ENGORDA  \n \nC. RoneyA, C. HofacreB, R. OwenA, R. BerghausC, and G. MathisC \n \nAHuvepharma, Inc., Peachtree City, GA  \nBPoultry  Diagnostic and Research Center, Athens, GA  \nCSouthern Poultry Research, Inc., Athens, GA  \n \nRESUMEN  \n \nSalmonella Heidelberg  es la tercera causa principal de enfermedades producidas por alimentos contaminados \ncon Salmonella  en los Estados Unidos. Se ha comprobado que la moderaci\u00f3n de la flora intestinal reduce la \ncolonizaci\u00f3n por Salmonella, desde que el Dr. Nurmi en 1972 demostr\u00f3 que dando contenido cecal de una gallina \nadulta a un pollito mejorar\u00eda su capacidad para resist ir la colonizaci\u00f3n por Salmonella. Este informe describe dos \nestudios controlados utilizando un producto comercial con B. licheniformis , Opti - Bac L, en la alimentaci\u00f3n de \npollos de engorda para reducir la colonizaci\u00f3n cecal, as\u00ed como la transferencia de ave a ave, de una cepa de \nSalmonella Heidelberg resistente al \u00e1cido nalid\u00edxico. Los resultados demuestran una reducci\u00f3n significativa en la \nconversi\u00f3n de alimento en pollos de engorda alimentados con el probi\u00f3tico a lo largo de su per\u00edodo de crecimiento, as\u00ed como una reducci\u00f3n de 60 -77 % en la probabilidad de detecci\u00f3n de Salmonella en las aves tratadas.  \nEste nivel de reducci\u00f3n se compara favorablemente con las tasas de reducci\u00f3n de colonizaci\u00f3n por Salmonella  \nen pollos de engorda vacunados con vacunas viva s modificadas de Salmonella o en la progenie de reproductores \nvacunados con Salmonella.  \n \nSUMMARY  \n \nThree groups of one -day-old broilers were vaccinated for coccidiosis. Half the birds in each group were orally \ngavaged with an identifiable strain of Salmonella Heidelberg. Groups were fed rations containing no probiotic, \nprobiotic (Opti -Bac L\n\u00ae) at 1 lb/ton, or a combination of salinomycin (Sacox\u00ae) 50 g/ton plus BMD\u00ae 50g/ton plus \nOpti- Bac L at 1 lb/ton.  \nOpti- Bac L alone,  or in combination with salinomyc in and BMD , resulted in a significant (P <0.05) \nimprovement in feed conversion and weight gain and a significant (P <0.05) reduction in the numbers of infected \nceca in both the seeder and horizontally challenged group.   \nCompared to birds receiving no probiotic, the incidence of Salmonella detection was 60% lower in birds \nreceiving Opti -Bac L and 77% lower in birds receiving salinomycin plus BMD plus Opti -Bac L.   \n \nMATERIALS AND METHODS  \n \nOne-day-old male broiler chicks were obtained from a local hatchery. Routine vaccinations were administered \nin the hatchery and birds were sprayed with a coccidiosis vaccine upon arrival at the research facility. Birds were \nrandomly divided into 24 pens consisting of 50 birds per pen. Twenty -five chicks per pen were tagged for \nidentification and then orally dosed with nalidixic acid resistant Salmonella Heidelberg. The treatments were \nreplicated in eight blocks. Pens were randomly assigned to treatment groups.  \n \nAll treatments were fed for the entire duration of the study. Bi rds received feed appro priate to the treatment \nfrom d ays 0 to 42. Birds were fed starter feed containing the appropriate treatment from d ays 0 to 21, grower feed                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n from d 21 to 35, and finisher feed from d 35 to  42. Birds were weighed by pen on days 0, 35,  and 42. All feeds \ncontained no additional antibiotics other than specified in treatment description.  \nDrag swab samples were collected for Salmonella environmental dete rmination from all pens on d 14 and 42. \nOn d  42, ten birds per pen ( five seeder and five  horizontal challenge) were randomly selected, humanely euthanized, \nweighed, and the ceca aseptically removed and placed in sterile plastic sampling bags for Salmonella isolation. \nSalmonella analysis was performed using standard procedures for selective en richment and enumeration of \nSalmonella.  \n \nRESULTS  \n \nThere was a significant improvement (P < 0.05) in feed conversion and weight gain at 42 d ays of age for the \nbirds fed OBL and the OBL/Sal/BMD combination (Table 1).  \nThere was a reduction in prevalence of Salmonella  positive birds in both directly challenged and contact birds \nfed Opti -Bac L alone (Table 2). The addition of Opti -Bac L plus salinomycin and BMD to the feed further reduced \ncolonization in the contact birds. All drag swab samples were positive for  Salmonella indicating that a strong \nSalmonella Heidelberg challenge had been achieved.  \n \nDISCUSSION  \n \nThe likely pathogenesis for the spread of Salmonella within a population of broilers is, as simulated in this \nstudy, with only a portion of the birds being infected at placement and lateral transmission being responsible for the \nspread of the organism to other birds in the flock. The results of this study i ndicate that the addition of Opti- Bac L \nby itself or in combination with salinomycin and BMD results in a statistically significant reduction in the \nprevalence of positive animals whether by preventing colonization from direct challenge or inhibiting the h orizontal \nspread of the bacteria to pen mates.  \nIn this study, the addition of Opti- Bac L and the addition of salinomycin and BMD to the Opti -Bac L resulted \nin a decrease in the number of S almonella  positive birds detected. There was al so a decrease in the levels of \nSalmonella  counts in the ceca of the positive birds from both treatment groups as compared to the controls. While \nthe reduction numbers were not found to be statistically significant at the p< 0.05 level, cecal bacteria counts were lower for both treatment groups as compared to the controls. If total elimination of Salmonella is not possible, it is \nimportant to reduce the levels of Salmonella in affected animals.  Reduction in Salmonella  levels results in less \nchance of horizontal transmission to negative birds within a house and better efficacy of interventions being used in \nthe processing plant. This study demonstrated that a pelleting temperature tolerant Bacillus licheniformis  probiotic \ncan reduce the prevalence of Salmonella  Heidelberg colonization in br oilers to 42 days  of age.  \n  \n  \n \n \n  \n \n \n  \n \n \n \n \n  \n \n                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n Table 1.  Effect of dietary treatments on performance of broiler chickens at 42 days of age.  \n \n Feed Consumption  Adjusted FC  Ave. Weight Gain  \nControl  4.054AB 1.978A 2.050C \nOpti-Bac L(OBL)  4.035B 1.906B 2.117B \nOBL+Sal+BMD  4.179A 1.886B 2.216A \nA,B,C,Means within cloumns with different superscripts are significantly different (p<0.05)  \n \n \n \nTable 2. Effects of dietary t reatments on Salmonella Heidelberg detection in broiler c hickens at 42 days of age.  \n \nTreatment  Direct Challenge (% pos)  Contact (% pos)  Total (%)  \nControl  62.0A 56.0A 59.0A \nOpti-Bac L  36.0B  (42)* 38.0B  (32) 36.0B   (40) \nOBL+Sal+BMD  30.0B  (52) 16.0C  (71) 24.0B   (59) \nA,B,C Means within columns with different superscripts are significantly different (p<0.05)  \n*Numbers in parenthesis represent percent reduction in prevalence compared to control group  \n \n \n \n  \n \n \n \n \n  63rd WPDC/XXXIX ANECA  EFECTO DE LA CARGA ALOST\u00c1TICA POR MANEJO \nANTEMORTEM SOBRE APARIENCIA Y CALIDAD \nMICROBIOL\u00d3GICA DE LA CANAL DE POLLO CON ADI CI\u00d3N  \nDE UN MODULADOR ALOST\u00c1TICO  \n \nEFFECTS OF THE ALLOSTATIC LOAD BY ANTEMORTEM HANDLING ON \nAPPEARANCE AND MICROBIOLOGICAL QUALITY OF CHICKEN \nCARCASS WITH THE ADDITION OF AN ALLOSTATIC MODULATOR  \n \nM. E. Rubio -Garc\u00edaA*, M.S. Rubio -LozanoB, E. Ponce -AlquiciraC, C. Rosario -CortesD y M. P. Casta\u00f1eda- SerranoA \n \nA Centro de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola (CEIEPAv) \u2013 Facultad de Medicina \nVeterinaria y Zootecnia - Universidad Nacional Aut\u00f3noma de M\u00e9xico (FMVZ -UNAM), Manuel M. L\u00f3pez S/N , Col \nZapotitlan, M\u00e9xico, D.F., C.P. 13209  \nB Laboratorio de Ciencia de la Carne Animal, Secretaria de Producci\u00f3n Animal FMVZ -UNAM,  \nC Departamento de Medicina y Zootecnia de Aves, FMVZ -UNAM,  \nD Departamento de Biotecnolog\u00eda, Universidad Aut\u00f3noma Metropolitana, Unidad Iztapalapa, Av. San Rafael Atlixco \n186, Col Vicentina, M\u00e9xico, D.F. C.P. 09340  \n*Corresponding autor: marielrubiodf@hotmail.com  \n \nSUMMARY  \n \nThe objective of the study was to determine the effect of an allostatic modulator (MA) in reducing allostatic \nload caused by antemortem handling by evaluating the appearance and microbiological quality of the carcass. A \ncombination of 50 g of ascorbic acid, 62.5 g of acetylsalicylic acid and 251 mEq of Na +, K + and Cl  - by L, was \nadministered two d  before shipping to the slaughterhouse. Six hundred chicks were housed in eight  treatments with \nthree  replicates of 25 chickens each, under a factorial 2 x 2 x 2 (lines X and Y, 10 h and 16 h fasting programs with \nand without the addition of MA). The appearance of the carcass was determined by the presence of injuries caused \nby antemorte m handling and the microbiological quality of these by cfu count for coliform and total mesophilic. The \nresults showed association between the frequency of injuries and the use of MA (P = 0,015) with a decrease in injuries from the use of MA. Together, 16 h of fasting and MA reduced col iform counts (0,5 log10 cfu / mL , P = \n0,003) and total  mesophilic (0,25 log10 cfu / mL , P = 0.0004) in unwashed carcasses. The antemortem handling in \nbroilers increase the possibility of damage, reducing their welfare and car cass quality, but in this study it was \ndemonstrated that the use of MA improves these aspects and offers consumers a better product in appearance and quality.  \n \nRESUMEN  \n \nEl objetivo del estudio fue determinar el efecto de un modulador alost\u00e1tico (MA) en la reducci\u00f3n de la carga \nalost\u00e1tica causada por manejo antemortem mediante la evaluaci\u00f3n de la apariencia y calidad microbiol\u00f3gica de la \ncanal. Se administr\u00f3 una combinaci\u00f3n de 50 g de \u00e1cido asc\u00f3rbico, 62,5 g de \u00e1cido acetil salic\u00edlico y 251 mEq de \nNa\n+, K+ y Cl- por L, 2 d\u00edas antes del env\u00edo a rastro. Seiscientos pollitos fueron alojados en 8 tratamientos con 3 \nr\u00e9plicas de 25 pollos cada uno, bajo un arreglo factorial 2 x 2 x 2 (estirpes X y Y,  programas de ayuno 10 h y 16 h, \ncon y sin la adici\u00f3n del MA). La apariencia de la canal se determin\u00f3 por la presencia de lesiones causadas por manejo antemortem y la calidad microbiol\u00f3gica de estas mediante conteo de ufc para coliformes y mes\u00f3filos totales. \nLos resultados mostraron asociaci\u00f3n entre la frecuencia de lesi ones y el uso del MA (P = 0,015) con una \ndisminuci\u00f3n de lesiones por el uso del MA. Juntos, 16 h de ayuno y MA redujeron conteo de coliformes (0,5 log10 \nufc / ml,  P = 0,003) y mes\u00f3filos totales ( 0,25 log10 ufc / mL , P = 0,0004) en canales sin lavar. Los manejos \nantemortem en pollos de engorda aumentan la posibilidad de da\u00f1arlos, reduciendo su bienestar y calidad de las \ncanales; sin embargo, en el presente trabajo se demostr\u00f3 que el uso de MA mejora estos aspectos y ofrece al \nconsumidor un producto mejor e n apariencia y calidad.  \n \n(El art\u00edculo ser\u00e1 publicado en su integridad en Poultry Science.)  63rd WPDC/XXXIX ANECA  LA IMPORTANCIA DEL USO DE VACUNAS VIVAS EN LOS \nPROGRAMAS DE  CONTROL DE SALMONELLA  ENTERITIDIS  \n \nWHY CONTROL PROGRAMS OF SALMONELLA ENTERITIDIS MUST \nINCLUDE LIVE VACCINES (BACTERINS)  \n \nM. Salem  \n \nLohmann Animal Health International  \n \nSUMMARY  \n \nOne of the risk factors for infection with Salmonella Enteritidis is the lack of bird immunity to this infection. \nThe immunization of long -lived birds with inactivated vaccines (bacterins) since the early 90s showed to be a very \neffective tool in the reduc tion of the transmission of this bacterium. However, studies by many researchers and field \nexperiences in many countries showed that live vaccines (bacterins) are more effective in achieving the purpose of \nreducing infection in birds, the transmission to e ggs, chicken and therefore humans. Li ve vaccines administered \norally  mimic the natural route of infection, prevent colonization of internal organs, the transmission to the egg,  and \nprevent infection in the growth phase. They also can be used in combination with bacterins.  \n \nRESUMEN  \n \nUno de los factores de riesgo para la infecci \u00f3n con Salmonella Enteritidis es la falta de inmunidad de las aves a \nesta infecci \u00f3n. La inmunisaci \u00f3n de las aves de larga vida con vacunas (bacterinas) inactivadas desde los inicios  de \nlos 90s mostr\u00f3 ser una herramienta muy efectiva en la reduccci\u00f3n de la trasmisi\u00f3n de esta bacteria. Sin embargo, estudios hechos por muchos investigadores y experiencias de campo en muchos paises,muestran que las vacunas ( \nbacterinas) vivas son mas efe ctivas en el logro del prop\u00f3sito de reducer la infecci\u00f3n en las aves, la trasmisi\u00f3n al \nhuevo, al pollo y por consiguiente a los seres humanos. Las vacunas vivas administradas por via oral: imitan la via \nnatural de infecci\u00f3n, evitan la colonisaci\u00f3n de \u00f3rgan os internos , la trasmision al huevo y evitan la infecci\u00f3n en fase \nde crecimiento . Adem\u00e1s se pueden usar en  combinaci \u00f3n con las bacterinas  \n \nINTRODUCCI\u00d3N  \n \nLos factores de riesgo relacionados con la zoonosis caus ada por Salmonella  Enteritidis (SE) por el consumo y \nmal manejo de huevos y carne contaminadas, fueron dados a conocer desde los a\u00f1os 90s en los EU  (9). Desde \nentonces, una gran cantidad de conocimientos sobre la prevenci\u00f3n de la infecci\u00f3n en las aves, y por consecuencia a \nlos humanos, est\u00e1 a la disposici\u00f3n de profesionales de la avicultura para cualquiera que se interese en adquirir estos \nconocimientos. Dentro de estos  conceptos es ampliamente aceptado que para poder r educir la infecci\u00f3n en las aves y \npor consiguiente en los seres human os, es necesario un p rograma integral que incluye:  \n1. Criar aves limpias de SE de origen;  \n2. Un buen progra ma de bioseguridad en la granja;  \n3. Control de roedores,  insectos y animales silvestres;  \n4 Tratamiento de alimento y agua con productos que eliminen las salmonellas ;  \n5. Muestreo programado de heces;  y \n6. Vacunaci\u00f3n con vacunas vivas, inactivadas o mejor con una combinaci\u00f3n de ambas.  \nTambi\u00e9n es sabido por los que se han educado al respecto, que es necesario que todos los puntos arriba mencionados \nse cumplan de una manera constante,  precisa y auditable para que se obtengan los mejores resultados posibles.  Por \notro lado, a pesar de la disponibilidad de los conocimientos y recursos t\u00e9cnicos y materiales, a\u00fan hay pa\u00edses que no \nhan decidido implementar por parte oficial o particular, programas funcionales y obligatorios que aseguren al p\u00fablico consumidor que los alimentos de origen de avicultura comercial ,est\u00e9 n libres de SE. El p\u00fablico en esos \npa\u00edses, est\u00e1 expuesto a \u00e9sta zoonosis.  Existe adem\u00e1s evidencia que los problemas por SE en aves y en humanos se \nreduce considerablemente cuando se permite legalmente el uso de vacunas vivas y /o bacterinas contra SE en las aves como parte del programa integral (13 ). \n 63rd WPDC/XXXIX ANECA  Cepas de salmonella ente ritidis reportadas para vacunas  \n\u2022 Mutantes auxotr\u00f3ficas de doble marcador  ( mutag\u00e9 nesis qu\u00edmica)  \n\u2022 De mutantes  de deriva metab\u00f3 lica \n\u2022 Mutantes aro A  \n\u2022 De prote\u00edna de membra na externa ( ompR)  \n\u2022 Restringidas de hierro.  \n\u2022 Mutantes espont\u00e1 neas sensibles a temperatura  \n\u2022 Mutantes cya crp ( 11) \nVentajas de las vacunas vivas . La eficacia de vacunas vivas de Salmonella ha sido bien documentada. Babu \net al report\u00f3 que vacunas vivas de Salmonellas reducen considerablemente la excreci\u00f3n de SE cuando se comparan \ncon grupos vacunados con vacunas inactivadas o con grupos no vacunados  (1). Estos resultados est\u00e1n en acuerdo \ncon los resultados obtenidos por  Hassan & Curtis (5 ); Mastroeni et al.  (12); Gast et al.  (3) y Harrison et al.  (4). En \nsus estudios confirmaron la mejor eficacia de las vacunas vivas cuando se comparan con vacunas inactivadas, \nadem\u00e1s de la importancia de la inmunidad mediada por c\u00e9lulas (CMI) en la eliminaci\u00f3n de Salmonellas por las aves. \nAdem\u00e1s, Mastroeni et al.  y, Be al et al. confirmaron que la eliminaci\u00f3n de Salmonella Typhimurium  es \nindependiente de la funci\u00f3n de las c\u00e9lulas B  (10,2) . Sin embargo, Horzinek et a l. (7) report\u00f3 que las vacunas de \nSalmonellas vivas puede tambi\u00e9n elicitar  ambas inmunidad mediada por c\u00e9lulas e inmunidad humoral en el \nsitio deseado (Ej. mucosas) en el animal. Hay tambi\u00e9n evidencia cient\u00edfica de que demuestra que el uso de \ns\u00f3lo un serovar en vacunas vivas atenuadas puede proteger a las aves contra salmonelosi s pro ducida por los  \ngrupos B y D. Esto es  debido a los niveles altos de pr otecci\u00f3n cruzada entre ellos. (2 ).Adem\u00e1s, Holt, Gast, and \nKelly -Aehle  (6). Encontraron que una vacuna viva de ST protegi\u00f3 a aves de 81 semanas  contra el desaf\u00edo con SE \ndurante la muda (pelecha artificial) cuando se vacunaron 17 d \u00edas antes del desaf\u00edo y 13 d\u00edas  antes de iniciar la dieta \nforzada.  Las caracter\u00edsticas \u00f3 ptimas de las  vacunas vivas de  Salmonella Enteritidis  son las siguientes:  \n\u2022 Que estimulen el sistema de inmunidad celular (CD8 ), mecanismo fundamental para controlar las  \nsalmonellas intracelulares.  \n\u2022 Estimular el sistema inmune de mucosas con producci\u00f3n de inmunoglobulina A secretora (SIgA) que \nauxilie en la prevenci\u00f3n de la coloni zaci\u00f3n del intestino por las salmonellas de campo.  \n\u2022 Que las bacterias vacunales se multipliquen por corto tiempo en el tejido intestinal de las aves vacunadas.  \n\u2022 Que se ex creten y desaparezcan r\u00e1pidamente tanto del hospedador como del medio ambiente.  \n\u2022 Que se p uedan aplicar por medios masivos de vacunaci\u00f3n. ( baratos y no afectan el bienestar animal) . \n\u2022 Se apliquen por la misma ruta de infecci\u00f3n natural que las salmonellas de campo.  \n\u2022 Que las bacterias vacunales  puedan diferenciarse f\u00e1cilmente de las salmonellas de campo en pruebas de \nlaboratorio.  \n\u2022 Que no produzcan enfermedad en otras especies dom\u00e9sticas ni en el ser humano.  \n\u2022 Que no revierta n a patogenicidad.  \n\u2022 Que sean seguras para las aves vacunadas a un a 10x o m\u00e1 s la dosis recomen dada. \n \nOtras ventajas de las vacunas  vivas de Salmonella Enteritidis:  \n\u2022 Se pueden aplicar  desde el primer d\u00eda de edad y bloquear la colonizaci\u00f3n de Salmonellas de campo.  \n\u2022 Son compatible  con algunos programas de probi\u00f3ticos . \n\u2022 Evitan la infecci\u00f3n temprana y durante la crianza (levante) evitando as\u00ed la formaci\u00f3n de aves portadoras  \ndurante esta etapa .La infecci\u00f3n temprana puede  difundir la infecci\u00f3n m\u00e1s tarde durante la producci\u00f3n de \nhuevo.  \n\u2022 Se pueden aplicar solas o en comb inaci\u00f3n con vacunas inactivadas.  \n \nLas vacunas disponibles.  Las vacunas que m\u00e1s se usan comercialmente en la avicultura contra SE, son: \nBacterinas monovalentes o polivalentes ; comerciales o aut\u00f3genas  y vacunas vivas: dentro las vivas existen las que \ntienen a lgunos genes removidos o suprimida su funci\u00f3n y algunas otras que son mutantes por deriva metab\u00f3lica. \nTambi\u00e9n se usan vacunas vivas bivalentes (Se y ST) . Dentro de las d iferentes vacunas vivas contra S almonella  \nEnteritidis se encuentran las llamadas vacunas mutantes de deriva  metab\u00f3licas;  \u00e9stas son las m\u00e1 s usadas \nactualmente.  (8,12) Estas han sido usadas desde 1990 y actualment e est\u00e1n registradas y se usan en alrededor de 60 \npa\u00edses, incluyendo muchos de la Comunidad Europea. Sin embargo, algunos pa\u00edses como M\u00e9xico, algunos de \nCentro y Sur Am\u00e9 rica (pocos  ya) a\u00fan no autorizan el uso de vacunas viv as. En  algunos de estos pa\u00edses  (Centro \nAm\u00e9 rica) oficialmente no se reconoce la presencia d e salmonella enteritis como causante de infecci\u00f3n en aves o en \nseres humanos .  63rd WPDC/XXXIX ANECA  REFERENCIAS  \n \n1. Babu, U.; Dalloul, R.A.; Okamura, M.; Lillehoj, H.S.; Xie, H.; Raybourne, R.B.; Gaimes, D.; Heckert, \nR.A. 2004. Salmonella enteritidis clearence  and immune responses in chickens following Salmonella vaccination \nand challenge. Veterinary Immunology and Immunopathology 101:251- 257. \n2. Beal, R.K.; Powers, C.; Davison, T.F.; Barrow, P.A.; Smith, A.L. 2006. Clearance of enteric Salmonella \nenterica serovar  Typhimurium in chickens is independent of B -cell function. Infection and Immunity 74:1442- 1444.  \n3. Gast, R.K.; Stone, H.D.; Holt, P.S. 1993. Evaluation of the efficacy of oil -emulsion bacterins  for reducing \nfecal shedding of Salmonella Enteritidis by laying hens. Avian Diseases 37:1085 -1091.  \n4. Harrison, J.A.; Villareal -Ramos, B.; Mastroeni, P.; DeMarco de Hormaeche, R.; Hormaeche, C.E. 1997. \nCorrelates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model. \nImmunology 90:618- 625. \n5. Hassan, J.O.; Curtiss III, R. 1990. Control of colonization by virulent Salmonella typhimurium by oral \nimmunization of chickens with avirulent delta cya delta crop S. typhimurium. Res . Microbiol 141:839- 850. \n6. Holt, Gast, and Kelly -Aehle. 2003 Salmonella typhimurium vaccine to protect hens against Salmonella \nenteritidis infection while undergoing molt. Avian Dis. 47:656 \u2013661 \n7. Horzinek, MC, Schijns, VECJ, Denis, M, Desmettre, P, Babiuk, LA (1997): Biology of Vaccination. In: \nPastoret, PP, Blancou, J, Vannier, P, Verschueren, C (eds): Veterinary Vaccinology. Elsevier Science B.V., \nAmsterdam, 131- 135. \n8. Linde, K, Fthenakis, GC, Fichtner, A (1998): Bacterial live vaccines with graded level of att enuation \nachieved by antibiotic resistance mutations: transduction experiments on the functional unit of resistance, \nattenuation and further accompaning markers. Vet Microbiol 62, 121 -134. \n9. Mason J. History and Significance of salmonella control in the US  Int. J. Food Microbiol.1994 Jan; 21(1-\n2):155 .  \n10. Mastroeni, P.; Chabalgoity, J.A.; Dunstan, S.J.; Maskell, D.J.; Dougan, G. 2001.Salmonella: immune \nresponses and vaccines. Veterinary Journal 161:132 -164. \n11. Revolledo L, Ferreira A.J.P , Current perspectives in avian salmonelosis: vaccines and immune \nmechanisms of protection. 2012. J. Appl. Poultry. Res. 21:418- 431. \n12. Springer S,.et al, 2000 A new live Salmonella enteritidis vaccine for chickens --experimental evidence of \nits safety and efficacy] Berl Munch Tierarztl  Woc henschr. 2000 Jun;113(6):246- 52 \n13. Williams Mark. The UK Lion Quality Programme for Eggs. Proceedings American College of Poultry \nVeterinarians, Sacramento, USA Sunday 22,  March 2009.  63rd WPDC/XXXIX ANECA  EVALUACI\u00d3N DE UN PROGRAMA DE VACUNACI\u00d3N CONTRA \nINFLUENZA AVIAR (H5N2) Y ENFERMEDAD DE NEWCASTLE \nCONCENTRADA OLEOSA EN POLLO DE ENGORDA \n \nEVALUATION OF A VACCINATION PROGRAM AGAINST AVIAN \nINFLUENZA (H5N2) AND NEWCASTLE DISEASE (CONCENTRATED OIL \nADJUVANT) IN  BROILERS  \n \nJ. S\u00e1nchezA, N. ChristyA y J. CossB \n \nADepartamento t\u00e9cnico av\u00edcola Boehring er Ingelheim Vetmedica SA de CV  \nBRepresentante t\u00e9cnico de ventas Boehring er Ingelheim Vetmedica SA de CV  \njosue.sanchez@boehringer -ingelheim.com  \nCP 44940  \n \nABSTRACT  \n \nThis study evaluated the use  of a vaccine against  AI + ND Conc  KV applied  in broilers  under field conditions . \nTwo groups were formed , group A (new seed strain and  LaSota  Newcastle ) compared to other  vaccination schedule  \ncalled  vaccinated  control , group B. Ten repetitions  for each group  adding  serials  total more than 2.5  million birds  \nwere performed  on the vaccinated  group,  both serological monitoring  for both fractions  was performed  and \nproductive behavior . The statistical evaluation  used to define the difference between  groups was  Kruskal -Wallis and \nStudent T's. Group A  performed better than  the control group  vaccinated  with the highest and  homogeneous  \nserological response, mortality  was 3.8 % less than 130g  and a difference greater  body weight compared with the \ncontrol group  was statistically  significant.  \n \nRESUMEN  \n \nEl presente estudio evalu\u00f3 el uso de una vacuna contra AI + ND Conc. KV aplicada en pollo de engorda bajo \ncondiciones de campo. Donde se  conformaron dos  grupos, el grupo A (nueva semilla m\u00e1s Newcastle cepa LaSota) \ncomparado contra  otro calendario de vacunaci\u00f3n  denominado grupo control vacunado (B), se realizaron 10 \nrepeticiones seriadas para cada grupo sumando en total m\u00e1s de 2,5 millones de aves vacunadas por grupo, en ambos \nse realiz\u00f3 seguimiento serol\u00f3gico para ambas fracciones y comportamiento productivo. La evaluaci\u00f3n estad\u00edstica \nque se utiliz\u00f3 para definir la diferencia entre grupos fue Kruskal -Wallis y T de Student\u00b4s. El grupo A  obtuvo mejores \nresultados  que el grupo control vacunado,  con la m\u00e1s alta y homog\u00e9nea respuesta serol\u00f3gica,  mortalidad de 3.8% \nmenos y una diferencia de 130g en peso corporal mayor comparado con el grupo control siendo estad\u00edsticamente \nsignificativos.  \n \nINTRODUCCI\u00d3N  \n \nLa influenza aviar (AI) y la enfermedad de Newcastle (ND), son dos de las principales enfermedades \nrespiratorias que afectan a las aves y que tienen una repercusi\u00f3n econ\u00f3mica. El control de la influenza aviar en el \nmundo se ha tratado b\u00e1sicam ente de dos formas diferentes. Algunos pa\u00edses han adoptado la posici\u00f3n de erradicar \ntodos los virus que contengan la hemoaglutinina H5 o H7. Para lograr la erradicaci\u00f3n, se opta por el sacrificio de un \ngran n\u00famero de aves y de esta forma mantenerse libres  del virus de Ianfluenza en la regi\u00f3n o regiones. Ejemplo de \nestos pa\u00edses son Estados Unidos, Chile, Australia, Holanda, Italia, etc...  En otros pa\u00edses como M\u00e9xico y pa\u00edses \nasi\u00e1ticos se practica la vacunaci\u00f3n con  biol\u00f3gico inactivados preparados con el tipo de virus causante del problema. \nLa vacunaci\u00f3n disminuye la capacidad de diseminaci\u00f3n del virus a otras aves, reduciendo as\u00ed la cantidad de virus \npresente en el medio ambiente av\u00edcola. A pesar de los esfuerzos realizados por muchos pa\u00edses con planes de \nvacunaci\u00f3n bien establecidos, a\u00fan se presentan brotes de la enfermedad.  \n 63rd WPDC/XXXIX ANECA  En el caso de la enfermedad de Newcastle a pesar de los programas de vacunaci\u00f3n que se aplican en muchos \npa\u00edses, las cepas pat\u00f3genas del virus de Newcastle contin\u00faan apareciendo espor\u00e1dicamente causando tanto \nmortalidades considerables en las parvadas afectadas, como problemas en la exportaci\u00f3n de aves y sus subproductos.  \nAlgunos pa\u00edses eliminan las aves portadoras del virus con el objeto de mantenerse libre de las cepas pat\u00f3genas \no vel og\u00e9nicas del virus, mientras que otros deciden \u201cvivir con los virus pat\u00f3genos\u201d, practicando planes de \nvacunaci\u00f3n para proporcionar diferentes grados de inmunidad y de esta forma controlar los efectos devastadores de este tipo de cepas.   \nLas vacunas a virus  vivo utilizadas en el control del Newcastle incluyen cepas catalogadas como lentog\u00e9nicas \no de baja patogenicidad, siendo las cepas B1 y LaSota las m\u00e1s conocidas. Estas cepas, proporcionan niveles \nadecuados de inmunidad.  \nLas vacunas inactivadas, emulsionadas en aceite y concentradas para su uso en pollos de engorda, tambi\u00e9n se \nhan desarrollado y son de amplio uso en algunos pa\u00edses donde las cepas de virus pat\u00f3g enos son consideradas \nend\u00e9micas (1,2,3,4,5,6,7,8).\n  \n \nMATERIALES Y M\u00c9TODOS  \n \nEn el presente estudio  se utilizaron  pollos de engorda comerciales Ross Ross de un d\u00eda de edad hasta la s\u00e9ptima \nsemana de vida, el estudio se condujo bajo condiciones de campo en casetas tecnificadas, con alimento y \nabastecimiento de agua acorde con los lineamientos establecido s por la empresa. Se utilizaron dos programas de \nvacunaci\u00f3n con dos vacunas diferentes que confieren protecci\u00f3n contra la enfermedad de Influenza aviar y \nNewcastle de laboratorios comerciales conocidos. Las vacunas fueron aplicadas de acuerdo a las recomen daciones \npropias de cada laboratorio a una dosis de  0.2mL  v\u00eda sub cut\u00e1nea en el tercio medio del cuello al d\u00eda cero de edad en \nincubadora con m\u00e1quinas autom\u00e1ticas; as\u00ed mismo, se revacuno con  una vacuna AI + ND KV entre los 8 -12 d\u00edas  con \nuna dosis de 0.5mL  v\u00eda sub cut\u00e1nea en el tercio medio del cuello manualmente, adicionando vacunaci\u00f3n de virus \nvivo cepa La Sota a los ocho v\u00eda ocular, 17 y 30 d\u00edas  de edad v\u00eda aspersi\u00f3n.  \n \nGRUPOS  \n \nGrupo A: Vacuna emulsionada AI + ND Conc. KV (semilla Influenza Aviar tipo A, subtipo H5N2, cepa 2393-\n06 y Newcastle cepa LaSota).  \nGrupo B: Calendario de vacunaci\u00f3n con vacuna AI + ND Conc. KV (semilla H5N2 y La Sota) usada en la \ngranja.  \nSe incluyeron dos  grupos experimentales con 2, 700,000 aves;  el grupo  (A) fue vacunado con el p roducto de \ninvestigaci\u00f3n veterinaria designado y el grupo (B) se consider\u00f3 como el grupo control vacunado; todos los grupos \ntuvieron un muestreo serol\u00f3gico consecutivo desde la semana 1 hasta la semana 7. As\u00ed mismo se tomaron los \npar\u00e1metros productivos de peso y mortalidad semanalmente.  \nDespu\u00e9s de la vacunaci\u00f3n en la incubadora, cada grupo fue ingresado en casetas tecnificadas de una misma \nzona geogr\u00e1fica.  \nLa respuesta inmune fu e monitoreada por la prueba de inhibici\u00f3n de la h emaglutinaci\u00f3n (HI) para AI y ND, la \nprueba usada ha demostrado su efectividad de medici\u00f3n en estudios previos cuando una vacuna con virus muertos es \nutilizada.  \nLa prueba fue analizada por medio de an\u00e1lisis estad\u00edsticos e hip\u00f3tesis.  \nEl seguimiento serol\u00f3gico fue analizado bajo la prueba de Kruskal -Wallis y T de Student\u00b4s para definir si \nexist\u00eda diferencia estad\u00edstica entre los grupos enfocado a mortalidad y peso corporal.  \n \nDISCUSI\u00d3N  \n \nEl grupo A  obtuvo una adecuada respuesta serol\u00f3gica presentes en ambas fracciones, vi\u00e9ndose en \u00e9stas, un \ndesempe\u00f1o ascendente homog\u00e9neo desde una edad temprana, no siendo as\u00ed, para el grupo B el cual present\u00f3 \nresultados aparentemente similares hasta las 35 semanas de vida.  \nEl grupo A presento menor mortali dad que el grupo B, de hasta 3.8% menor comparativamente, siendo \nestad\u00edsticamente significativo, lo que quiere decir que el programa de vacunaci\u00f3n aplicado en el grupo A demostr\u00f3 ser m\u00e1s protectivo bajo mismas condiciones.    \nEn cuanto a peso, si  bien no se  present\u00f3  una diferencia estad\u00edstica significativa entre los grupos, se obtuvo \n130g m\u00e1s  de peso corporal comparado con el grupo B, lo cual dimensionando los gramos a la cantidad de aves \nsometidas al estudio representa 351,000 kg de peso m\u00e1s que el obtenido en el grupo B.  63rd WPDC/XXXIX ANECA   \nREFERENCIAS  \n \n1. Pero F. Actualidades sobre la enfermedad de Newcastle. XXXVII Convenci\u00f3n Nacional Aneca. 2012.  \n2. Alexander D.J. Newcastle Disease, Other Avian Paramyxoviruses, and Pneumovirus Infections Diseases \nof Poultry, 12th ed. Editor -in-chief, Y. M. Saif; associate editors. Iowa State University press, Ames, Iowa. 2008.  \n3. Alexander, D.J. Gordon Memorial Lecture. Newcastle disease. British Poultry Science. 42, 5 -22.  \n2001.  \n4. Ganapathy, K., Cargill, P., Montiel, E. & Jones, R.C. Interaction betw een live avian pneumovirus and \nNewcastle disease virus vaccines in specific pathogen free chickens. Avian Pathology. 34, 297 -302.2005.  \n5. Perozo, F., Nava, J. & Rivera, S. Evaluation of two vaccination programs against Newcastle disease in \nRoss line broiler c hickens reared under field conditions in Zulia state, Venezuela. 2. Immune response and \nprotection against an experimental challenge. Revista cient\u00edfica FCV/LUZ. 14, 387 -394. 2004.  \n6. Senne, D.A., King, D.J. & Kapczynski, D.R. Control of Newcastle disease by vaccination. Developments \nin Biological Standardization (Basel). 119, 165 -70.2004.  \n7. David E. Swayne and David A. Halvorson. Influenza. Diseases of Poultry, 12th ed. Editor -in-chief, Y. M. \nSaif; associate editors. Iowa State University press, Ames, Iowa. 200 8. \n8. European Food Safety Authority. Vaccination against avian influenza of H5 and H7 subtypes in domestic \npoultry and captive birds. The EFESA Journal P.p.1- 64.2007.  \n \n \n \n \nGr\u00e1fica 1.  La mortalidad acumulada (MA) comparativa obtenida para el grupo A, durante e l ciclo, es de \n3.86% menor que la del grupo B y una de T Student\u00b4s = -5.69 (el n\u00famero de aves muertas son diferentes en todos \nlos grupos . \n \n \n \n \n \n \n \n \n \n  \n \n  \n 1 0.91  1.34  1.3 1.2 1.17  1.19  1.62  \n0.96  \n0.80  0.72  0.65  0.70  0.71  0.68  0.65  \n00.511.52\n1 d\u00eda 7 d\u00edas 14 d\u00edas 21 d\u00edas 28 d\u00edas 35 d\u00edas 42 d\u00edas 49 d\u00edas% de mortalidad  % de Mortandad \nGrupo B Grupo A\nEdad 9.73% MA  \n5.87% MA  63rd WPDC/XXXIX ANECA   \n \n \nGr\u00e1fica 2.  La ganancia de peso para el grupo A fue 130g mayor que el g rupo B y una de T Student\u00b4s=0.161 \n(no existe diferencia estad\u00edstica entre el peso de los grupos) . \n \n \n \n \n \n \n \nGr\u00e1fica 3.  El desempe\u00f1o serol\u00f3gico del g rupo A, demostr\u00f3 una respuesta  m\u00e1s alta  en todas l as edades de \nmanera ascendente y sos tenida, no siendo as\u00ed, para el g rupo B el cual obtuvo resultados similares hasta los 35 d\u00edas \nde edad.  \n \n \n \n \n \n \n \n \n  \n \n \n \n 40 147 378 680 1034  1564  2004  2550  \n39 160 386 732.00  1140  1683  2171  2680  \n050010001500200025003000\n1 d\u00eda 7 d\u00edas 14 d\u00edas 21 d\u00edas 28 d\u00edas 35 d\u00edas 42 d\u00edas 49 d\u00edasGramos  Ganancia peso promedio semanal  \nGrupo B\nGrupo A Edad  \n3.8 3.4 4.8 6.9 9.9 10.2 \n5.0 \n2.0 1.6 6.4 9.0 9.0 \n1.03.05.07.09.011.0\n14 D\u00edas 21 D\u00edas 28 D\u00edas 35 D\u00edas 42 D\u00edas 49 D\u00edasTitulo Log2  Comportamiento serol\u00f3gico (HI) influenza aviar   \nGrupo A Grupo B\nEdad  63rd WPDC/XXXIX ANECA   \n \n \n \n \n \nGr\u00e1fica 4.  El desempe\u00f1o serol\u00f3gico del g rupo A, mostr\u00f3 a las edades de 21 y 28 d\u00edas una respuesta  serol\u00f3gica \nm\u00e1s alta, de aproximadamente 1 log2 en comparaci\u00f3n del g rupo B.  \n \n \n \n \n \n \n \n \n 2.8 2.5 4.4 6.3 7.5 \n2.6 1.8 3.2 6.2 6.5 \n0.01.02.03.04.05.06.07.08.09.010.0\n14 D\u00edas 21 D\u00edas 28 D\u00edas 35 D\u00edas 42 D\u00edasT\u00edtulos Log2 Comportamiento serol\u00f3gico (HI) enfermedad de Newcastle   \nGrupo A Grupo B\nEdad  63rd WPDC/XXXIX ANECA  ANALISIS DE LA EFICACIA Y EFICIENCIA DE DIFERENTES \nCUADRILLAS PARA VACUNAR GALLINAS LIGERAS  \n \nANALYSIS OF THE EFFECTIVENESS AND EFFICIENCY OF DIFFERENT \nCREWS IN VACCINATING LIGHT HENS  \n \nJ. S\u00e1nchez and N. Christy  \n \nDepartamento t\u00e9cnico negocio av\u00edcola Boehringer Ingelheim Vetmedica SA de CV  \njosue.sanchez@boehringer -ingelheim.com  \nC.P.44940  \n \nABSTRACT  \n \nThis analysis aimed to assess the number of hens vaccinated per hour in different vaccination crews to measure \nthe effectiveness and efficiency of the same. For the study , measurements were performed in twenty different \ncompanies. Sometimes effectiveness  is often confused with efficiency, and given the same meaning, and the reality \nis that there is  a big difference. In this case,  we can say that a crew is effective if it achieves vaccinate as many birds \nas quickly, however, is not necessarily efficient because if the wrong number of vaccinated birds is high  it isn\u2019t  \neffective. You should always strike a balance between effective and efficient. This paper shows results from \ndifferent vaccination crews that can serve as reference for consolidated vaccination crews and training.  \n \nRESUMEN  \n \nEl presente an\u00e1lisis tuvo como objetivo evaluar el n\u00famero de gallinas vacunadas por hora en diferentes \ncuadrillas de vacunaci\u00f3n para medir la eficacia y la eficiencia de las mismas. Para el estudio se realizaron veinte mediciones en diferentes empresas. A veces se suele confundir la efi ciencia con eficacia, y se les da el mismo \nsignificado; y la realidad es que existe una gran diferencia. En este caso podemos decir que una cuadrilla es eficaz si \nlogra vacunar el mayor n\u00famero de aves en el menor tiempo, sin embargo, no necesariamente es eficiente ya que si el \nn\u00famero de aves mal vacunadas es alto de nada sirve ser eficaz. Siempre se debe lograr un equilibrio entre eficaz y eficiente. El presente trabajo nos muestra resultados de diferentes cuadrillas de vacunaci\u00f3n que pueden servir como referencia para cuadrillas de vacunaci\u00f3n consolidadas y en entrenamiento.  \n \nINTRODUCCI\u00d3N  \n \nEn M\u00e9xico el negocio av\u00edcola se caracteriza por estar altamente tecnificado y en constante mejora, lo que \ndemanda tener los conocimientos que permitan dar un valor agregado a los productos que se consumen. El \ncomportamiento de las aves, as\u00ed como los par\u00e1me tros productivos alcanzados en cada caso particular, son el reflejo \nde las pr\u00e1cticas realizadas por el personal responsable en conjunto con la calidad de las aves, alimento y otros \nfactores. En lo que compete a una buena protecci\u00f3n de las aves contra las enfermedades, es un factor muy \nimportante que los biol\u00f3gicos empleados sean de excelente calidad, contar con un sistema de mejora continua \nbasado en buenas pr\u00e1cticas de vacunaci\u00f3n que nos permita inmunizar correctamente a las aves y que las aves se \nencuentr en sanas con un sistema inmune preparado para montar una respuesta inmune protectora. Debido al gran \nn\u00famero de aves que deben vacunar las cuadrillas se logra ser eficaz y vacunar el mayor n\u00famero de aves en el menor \ntiempo, sin embargo esa misma rapidez puede llevar a cometer errores, llegando a no ser eficiente y lo cual \nrepercute en la salud de las parvadas, es recomendable lograr un equilibrio de ambos. Por tal raz\u00f3n el an\u00e1lisis \nrealizado en este trabajo, pretende aportar rangos de vacunaci\u00f3n basados en l a eficacia y eficiencia obtenidos de \ndiversas cuadrillas de vacunaci\u00f3n en diferentes empresas av\u00edcolas que les permita tener referencias de comparaci\u00f3n con las cuadrillas que actualmente est\u00e1n laborando.  \n \nMATERIALES Y M\u00c9TODOS  \n \nSe visitaron diez empresas a v\u00edcolas, en las cuales se realiz\u00f3 un an\u00e1lisis de cada una de sus cuadrillas de \nvacunaci\u00f3n. Se tom\u00f3 en cuenta el n\u00famero de aves que vacun\u00f3 cada cuadrilla por hora en promedio y el porcentaje de 63rd WPDC/XXXIX ANECA  error al vacunar. La evaluaci\u00f3n fue \u00fanicamente para la v\u00eda de aplicaci\u00f3n subcut\u00e1nea de forma manual en aves \nligeras. Para medir el tiempo se utiliz\u00f3 un cron\u00f3metro Casio HS -3V-1 y los datos resultantes fueron anotados en un \nformato dise\u00f1ado por BIV.  \nAn\u00e1lisis estad\u00edsticos. Para evaluar los datos entre grupos se realiz\u00f3 una prueba de an\u00e1lisis de varianza \n(ANOVA) con un 95% de intervalo de confianza.  \n \nRESULTADOS  \n \nEn la T abla 1 se muestra el promedio del n\u00famero de aves vacunadas por hora en cada una de las empresas y el \npromedio de errores por cada cien aves vacunadas en cada una de las empresas.  \nEn la T abla 2 se muestra el tiempo y los errores por empresa por cada 100 aves.  \nEn la G r\u00e1fica 1 se puede observar la relaci\u00f3n entre el tiempo (eficacia) y los errores en la vacunaci\u00f3n \n(eficiencia).  \nSe tomaron los tres  mejores promed ios grupo A, los tres promedios intermedios B y los tres  promedios bajos C \npara determinar cu\u00e1l es su grado de varianza en forma positiva y negativa en el que se ubican los vacunadores a \ndiferentes n iveles de eficacia y eficiencia (G r\u00e1fica2).  \n \nDISCUSI\u00d3N  \n \nDe acuerdo con la publicaci\u00f3n del Dr. Salleras es importante evaluar la eficacia y la eficiencia de las vacunas, \nsin embargo no \u00fanicamente de la calidad del producto sino de la aplicaci\u00f3n de las mismas. En este estudio se muestra que hay que observar un eq uilibrio para obtener los resultados esperados.  \nEl Dr. Alonso menciona que es importante evaluar a los vacunadores y entrenarlos, para disminuir el riesgo de \nque se presente un problema sanitario por una mala aplicaci\u00f3n de la vacuna, por lo cual, con los r esultados obtenidos \nse puede evaluar a las cuadrillas para evitar los errores en la aplicaci\u00f3n y pueden servir de referencia tambi\u00e9n e n la \ncapacitaci\u00f3n del personal (1,2).  \n \nCONCLUSI\u00d3N  \n \nLos resultados muestran que no necesariamente el ser eficaz quiere decir que se es eficiente en el proceso de \nvacunaci\u00f3n y viceversa.  \nLas empresas que toman m\u00e1s tiempo en vacunar son las m\u00e1s altas en errores de aplicaci\u00f3n de la vacuna. (No \nson ni eficaces ni eficientes).  \nLas empresas que vacunan m\u00e1s r\u00e1pido (son eficaces)  podr\u00edan ser m\u00e1s eficientes al disminuir sus errores aunque \naumenten ligeramente el tiempo destinado a la vacunaci\u00f3n.  \nDe acuerdo con os resultados obtenidos en el an\u00e1lisis de varianza los vacunadores m\u00e1s r\u00e1pidos vacunar\u00e1n  entre \n3535 a 4500 aves por h ora con un promedio de 3915, de tal manera los vacunadores promedio vacunar\u00e1n  entre 1943 \na 2654 aves por h  con un promedio de 2315 y los vacunadores que se toman m\u00e1s tiempo en el proceso, vacunar\u00e1n \nentre 1643 a 1841 con u n promedio de 1752 aves por h ora. \nTomando en cuenta el an\u00e1lisis de v arianza al medir la presencia de errores en la vacunaci\u00f3n, tenemos que los \nvacunadores que cometen menos errores por cada 100 aves vacunadas, presentar\u00e1n de 1 a 3 aves mal vacunadas, con \nun promedio de 2.33, as\u00ed mismo, los vac unadores promedio  presentar\u00e1n de 4 a 5 aves mal vacunadas, con un \npromedio de 4.33 y por \u00faltimo los vacunadores que cometen m\u00e1s errores al vacunar presentar\u00e1n de 6 a 9, con un \npromedio de 8 aves.  \nCabe mencionar que en casos al que denominamos vacunadores de excelencia encontramos tiempos de 3.03 \nminutos por cada 100 aves vacunadas con una eficacia del 100%.  \n \nREFERENCIAS  \n \n1. Salleras L., Dom\u00ednguez A., Navas E., Pratts G. Eficacia y efectividad de la vacunaci\u00f3n antineumoc\u00f3cica en \nlas personas de 65 a\u00f1os o mayor es. Vacunas Elsevier. Volumen 1, Issue2,. Pp. 75 -79. 2000.  \n2. Alonso E., M\u00e9todos de vacunaci\u00f3n. Revista avicultores en Colombia. www. Encolombia.com.  \n \n \n \n 63rd WPDC/XXXIX ANECA  Tabla 1.  El promedio del n\u00famero de aves vacunadas por hora en cada una de las empresas y el promedio de \nerrores por cada cien aves vacunadas en cada una de las empresas.  \n \nEmpresa  Aves \nvac/hr  Mojad\no Sangrado  Total errores/100 aves  \n1 3710  3 0 3 \n2 4500  5 0 5 \n3 2654  2 2 4 \n4 1764  0 1 1 \n5 1851  3 0 3 \n6 1943  4 0 4 \n7 1880  7 2 9 \n8 1643  4 4 8 \n9 2350  7 0 7 \n10 3535  4 3 7 \n \n \n \n \nTabla 2.  El tiempo y los errores por empresa por cada 100 aves.  \n \nEmpresa  Aves vac/hr  Min para vacunar 100 \naves Errores/ 100 aves  \n1 3710  1.62 3 \n2 4500  1.33 5 \n3 2654  2.26 4 \n4 1764  3.40 1 \n5 1851  3.24 3 \n6 1943  3.09 4 \n7 1880  3.19 9 \n8 1643  3.65 8 \n9 2350  2.55 7 \n10 3535  1.70 7 63rd WPDC/XXXIX ANECA  Gr\u00e1fica 1.  La relaci\u00f3n entre el tiempo (eficacia) y los errores en la vacunaci\u00f3n (eficiencia).  \n \n \n \n \n \nGr\u00e1fica 2.  Gr\u00e1fico (CBC) en el eje de la Y muestra el n\u00famero de aves vacunadas, eje de la X los grupos de \nacuerdo a la eficacia (aves vacunadas/hora). En la gr\u00e1fica (AFA) en el eje de la Y tenemos el n\u00famero de aves mal \nvacunadas y para el eje de la X los grupos de acuerdo a su eficacia.  \n \nGrafica de la media entre los grupos  \n \n                                                    Eficacia                  VS                     Eficiencia  \n                                           (aves vacunadas/hora)                      (aves mal vacunadas)  \n \n \n 1.62 1.33 2.26 3.40 3.24 3.09 3.19 3.65 2.55 1.70 \n3 5 4 1 3 4 9 8 7 7 \n0.00 5.00 10.0012345678910\nErrores/ 100 aves\nMin para vacunar\n100 aves\nNo. Aves vacunadas  No. De aves  mal \nvacunadas  3915 \nMean  \n2315.7 \nMean  \n1752.7 \nMean  4.33  \nMean  \n2.33  \n Mean  4.33  \n Mean  63rd WPDC/XXXIX ANECA  \n AVIBACTERIUM  ENDOCARDITIDIS REPORTE DE AISLAMIENTO \nDE GALLINAS LEGHORN COMERCIALES EN M\u00c9XICO  \n \nREPORT OF AVIBACTERIUM ENDOCARDITIS ISOLATION  FROM \nCOMMERCIAL LEGHORN LAYERS  IN MEXICO \n \nJ. S\u00e1nchezA, N. ChristyA\n, E. SorianoB y J. CossC \n \nADepartamento t\u00e9cnico av\u00edcola Boehringer Ingelheim Vetmedica SA de CV  \nBCentro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal Facultad de Medicina Veterinaria y Zootecnia de \nla Universidad Aut\u00f3noma del Estado de M\u00e9xico.  \nCRepresentante t\u00e9cnico de ventas Boehring er Ingelhei m Vetmedica SA de CV  \njosue.sanchez@boehringer -ingelheim.com  \nCP 44940  \n \nABSTRACT  \n \nThis field diagnosis was made in commercial layers between 20 and 35 w eeks of age, whic h was obtained from \nseven isolates fr om trachea, liver and oviduct. T yping was performed by means of molecular biology and \nquantification of 16S rRNA amino acids resulting in the identification of a bacterial infectious agent with 99% \nsimilarity classified as Avibacterium  endocard itidis, which was previously isolated and typified by Dr. Bissgard and \nDr. Christensen in 2007 where they obtained 27 isolates showed breeding bird endocarditis and in 2010 from hens \nthat presented the same picture 43% of the isolates. It is noteworthy tha t birds sampled had a drop production \nbetween 8 and 10 points, in these no evidence of endocarditis was found, however birds showed areas of necrosis in \ncheeks, chins, dehydration, blood clots in periorbital cavity. Also found severe redness in the mucous membrane of \nthe oviduct. While the present work throws the present of Avibacterium  endocarditidis in organs not previously \nreported, finding no references published in Mexico, it is likely that this is the first published work in this country, just as, it is necessary to continue field research (1,3).  \n \nRESUMEN  \n \nEl presente diagn\u00f3stico de campo fue realizado en gallinas de postura comerciales entre las 20 \u2013  35 semanas de \nedad, obtenido a partir de 7 aislamientos provenientes de tr\u00e1quea, h\u00edgado y oviducto. Se  realiz\u00f3 la tipificaci\u00f3n por \nmedio de biolog\u00eda molecular y cuantificaci\u00f3n de amino\u00e1cidos del 16S rRNA  dando como resultado la identificaci\u00f3n \nde un agente infeccioso de origen bacteriano con el 99% de similitud clasificado como  Avibacterium  endocarditidis,  \nmismo que fue aislado y tipificado anteriormente por el Dr. Bissgard y el Dr. Christensen en el 2007,  ellos \nobtuvieron 27 aislamientos procedentes de aves reproductoras que presentaron endocarditis posteriormente en el \n2010 de gallinas que presentaron el m ismo cuadro en un 43% de  los aislamientos. Cabe mencionar que las aves \nmuestreadas presentaban una baja de postura entre 8 y 10 puntos, en estas  no se encontraron indicios de \nendocarditis, sin embargo las aves mostraron  zonas de necrosis en mejillas, barbi llas, deshidrataci\u00f3n, presencia de \nco\u00e1gulos sangu\u00edneos en cavidad periorbitaria. As\u00ed mismo se encontr\u00f3 enrojecimiento severo en la mucosa del oviducto. Si bien el presente trabajo nos arroja la presencia del Avibacterium  endocarditidis en \u00f3rganos no \nreport ados anteriormente, al no encontrar referencias publicadas en M\u00e9xico, es probable que este sea el primer \ntrabajo publicado en este pa\u00eds, de igual manera, es preciso continuar con la investigaci\u00f3n de campo  (1,3).  \n \nINTRODUCCI\u00d3N  \n \nLa familia Pasteurellaceae incluye una gran diversidad  de Gram -negativos anaerobios facultativos y  \nfermentativos. Los principales g\u00e9neros de la familia son la  Pasteurella,  Bibersteinia, Mannheimia, Actinobacillus, y \nHaemophilus . La familia tambi\u00e9n incluye varios otros grupos de age ntes pat\u00f3genos de animales que comparten una \nrelaci\u00f3n gen\u00e9tica fenot\u00edpica.\n Los organismos dentro de esta familia, est\u00e1n involucrados en una amplia gama de \nenfermedades cl\u00ednicas  respiratorias, que afectan a mam\u00edferos, aves (ver cuadro 1), r eptiles e insecto s (6). En los \n\u00faltimos a\u00f1os, la  ARNr: hibridaci\u00f3n de ADN y la secuenciaci\u00f3n del 16S rRNA, se han utilizado para estudiar las \nrelaciones gen\u00e9ticas de estos organismos y sus relaciones con otras bacterias  gram negativas.  El doctor Bisgaard, 63rd WPDC/XXXIX ANECA  \n tipific \u00f3 un nuevo grupo denominado non -V-factor perteneciente a la familia Pasteurellaceae, el cual muestra \ncaracteres fenot\u00edpicos similares a los de Avibacterium , tentativamente llamado tax\u00f3n 50 fue aislado recientemente de \nendocarditis valvular y en forma septic\u00e9mica de l as aves  reproductoras. Basado en resultados fenot\u00edpicos, datos \ngenot\u00edpicos  y secuenciaci\u00f3n del 16S rRNA, proponen dar cabida al  tax\u00f3n 50 dentro del g\u00e9nero Avibacterium  como \nuna especie separada. As\u00ed mismo en un estudio de desaf\u00edo con  Avibacterium endocardi tidis, realizado con 40  aves \nreproductoras, observaron que el agente se aislaba con mayor facilidad del endocardio, sin embargo tambi\u00e9n fue \naislado de h\u00edgado y bazo con escaso crecimiento. Las principales lesiones encontradas fueron las valvulares en \nforma  aguda, que van desde leve engrosamiento de las v\u00e1lvulas a la inflamaci\u00f3n severa. Las lesiones observadas en \nel bazo incluyen diferentes grados de lesiones y necrosis hep\u00e1tica que van desde peque\u00f1os infartos hasta grandes \n\u00e1reas de necrosis coagulativa. La artritis se produjo en 19 aves, 15 de las cuales dieron positivo para Avibacterium  \nendocarditidis. La mayor\u00eda de las aves desarrollaron bacteriemia, pero el escaso crecimiento en  h\u00edgado y el bazo, as\u00ed \ncomo la falta de bacterias demostrado por FISH (fluores cencia de hibridaci\u00f3n in situ) y la histopatolog\u00eda, sugirieron \nuna septicemia que causara la muerte de las aves. No se observ\u00f3 una correlaci\u00f3n significativa entre el tama\u00f1o de la \ndosis inoculada y el desarrollo de endocarditis valvular, sin embargo, los ca mbios regresivos en el ovario, necrosis \ndel h\u00edgado,  hepato -esplenomegalia y nefromegalia fueron significativamente dependientes de la dosis. Donde se \nconcluye que el  Avibacterium  endocarditidis representa un pat\u00f3geno potencial para las aves  (4,5).  \n \nMATERIALES Y M\u00c9TODOS  \n \nEn el presente estudio se evaluaron 50 gallinas ligeras de postura Leghorn White entre 20 a 35 semanas de \nedad en producci\u00f3n, las cuales fueron alojadas en casetas tecnificadas elevadas, con acceso a agua limpia y alimento \nbalanceado.  \nSe realizaron muestreos bacteriol\u00f3gicos, histopatol\u00f3gicos y  PCR de h\u00edgado, ri\u00f1\u00f3n, bazo, tr\u00e1quea, cavidad \nperiorbitaria,  pulm\u00f3n y oviducto.  \nLas muestras fueron remitidas al Centro de Investigaci\u00f3n y Estudios Avanzados en Salud Animal Facultad de \nMedicina Veterinaria y Zootecnia de la Universidad Aut\u00f3noma del Estado de M\u00e9xico.  \nSignos cl\u00ednicos . Las aves muestreadas presentaban una baja de postura entre 8 y 10 puntos con presencia de \nhuevo deforme (imagen 1), en estas  no se encontraron indicios de endocarditi s, sin embargo las aves presentaron \nzonas de necrosis en mejillas, barbillas, deshidrataci\u00f3n, presencia de co\u00e1gulos sangu\u00edneos en cavidad peri orbitaria \n(imagen 2, 3). As\u00ed mismo se encontr\u00f3 enrojecimiento severo en la mucosa del oviducto.  \n \nRESULTADOS  \n \nSe obtuvieron siete aislamientos pertenecientes a la familia  Pasteurellaceae proveniente de tr\u00e1quea, h\u00edgado y \noviducto, las cuales, fueron tipificadas por medio de PCR 16S rRNA,   estas bacterias aisladas correspond\u00edan a un \nAvibacterium endocarditis con un 99% de similitud.  \nLos hallazgos  histopatol\u00f3gicos reportaron  un problema en ri\u00f1\u00f3n con uratosis por deshidrataci\u00f3n, \nglomerulopat\u00eda inespec\u00edfica y zonas de necrosis focales en h\u00edgado.  \nLos otros \u00f3rganos no presentaron cambios patol\u00f3gicos a parentes.  \n \nDISCUSI\u00d3N  \n \nDe acuerdo con las referencias citadas en este trabajo realizadas por el Dr. Bissgard, los hallazgos obtenidos \nmuestran gran similitud con las lesiones encontradas en el h\u00edgado descritas como \u00e1reas  de necrosis.  \nCabe la posibilidad que  los sitios donde se aisl\u00f3 el  Avibacterium  endocarditidis, tr\u00e1quea, h\u00edgado y oviducto, \nfuera por un estado septic\u00e9mico presente en las aves, evidenciando que la bacteria puede replicarse en otros \u00f3rganos adem\u00e1s de los descritos en la literatura.  \nPor otro l ado, la identificaci\u00f3n y metodolog\u00eda que se utiliz\u00f3 para la tipificaci\u00f3n molecular del agente coincide \ncon los trabajos referidos, lo cual asegura la correcta identificaci\u00f3n del Avibacterium  endocarditidis siendo este de \nun 99% de similitud  (2). \nCabe la po sibilidad de que otros agentes infecciosos de etiolog\u00eda viral puedan estar interactuando en el cuadro \ncl\u00ednico, es necesario seguir la investigaci\u00f3n de campo para descartar la presencia de dichos agentes, as\u00ed mismo, reproducir la enfermedad bajo condiciones  controladas con el fin de realizar   el agente del endocardio y replicar  el \ncuadro cl\u00ednico referido por la literatura, esto ayudar\u00eda a integrar el cuadro para determinar si en alguna forma se ve involucrada la ca\u00edda de producci\u00f3n por el Avibacterium  endocarditidis.  63rd WPDC/XXXIX ANECA  \n Haciendo referencia a los estudios reportados, por el Dr. Bissgard y Christensen realizados en su mayor\u00eda en el  \nDepartment of Veterinary Disease Biology, Faculty of Health and Medical Sciences, de la University of \nCopenhagen, en Frederiksberg C, Denmark y al no encontrar referencia bibliogr\u00e1fica de la bacteria aislada en \nM\u00e9xico, es probable que sea el primer caso reportado en este pa\u00eds.  \n \nREFERENCIAS  \n \n1. Horne. M. B., y  M Bisgaard. Pathology and Localization of Avibacterium endocarditidis in Experimentally \nInfected Broiler Breeders. Journal of Comparative Pathology . Department of Veterinary Disease Biology, Faculty of \nHealth and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark. 2013.  \n2. Bisgaard M., y H. Christensen. Multilocus sequence phylogenetic analysis of Avibacterium. . Department \nof Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark. 2012.  \n3. Bisgaard M.,y   H. Christensen . Avibacterium endocarditidis sp. nov., isolated from valvular endocarditis in \nchickens. International Journal of Systematic and Evolutionary Microbiology. Department of Veterinary Disease \nBiology, Faculty of Health and Med ical Sciences, University of Copenhagen, Frederiksberg C, Denmark. 2007.  \n4. Bisgaard M ., y  H. Christensen Observations on the incidence and aetiology of valvular endocarditis in \nbroiler breeders and detection of a newly described taxon of Pasteurellaceae, Avibacterium endocarditid is. \nDepartment of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C, \nDenmark. Avian Patology. 2010.  \n5. John R. Glisson.,  B. W. Calnek. Diseases of Poultry. Pasteurella. 12 nd. Blackwell Publishing, 2008: 657-\n690. \n6. A.R. Wooolums. Pasteurellaceae: Avibacterium, Bibersteinia, Mannheimia, and Pasteurella. Veterinary \nMicrobiology, 3rd edition, Edit. Wiley -Blackwell. P.p. 101 -107. 2013.  63rd WPDC/XXXIX ANECA  \n  \nCuadro 1.  Algunos miembros de la Familia Pasteurellaceae de importancia en enfermedades aviares.  \n \n \n \n63rd WPDC/XXXIX ANECA  EFFICACY  AND FIELD  SAFETY  OF A  COMBINED AVIAN  \nENCEPHALOMYELITIS  \u2013 FOWL POX  \u2013 PIGEON  POX  \nLIVE VIRUS  VACCINE IN CHICKENS  \n \nEFICACIA Y SEGURIDAD DE CAMPO DE UNA VACUNA COMBINADA DE \nVIRUS VIVO LIOFILIZADO COMBINADO DE ENCEFALOMIELITIS AVIAR, \nVIRUELA AVIAR Y VIRUELA DE LA PALOMA EN POLLOS  \n \nG. Sarma, B. Kersting, and G. Spina  \n \nHygieia Biological Laboratories, 1785 East Main Street #4,  P. O. Box 8300, Woodland, CA 95776  \n \nRESUMEN  \n \nLa encefalomielitis aviar (AE) causa una reducci\u00f3n marcada en la producci\u00f3n de huevo, disminuci\u00f3n de la \nincubabilidad de los huevos y una mortalidad alta en pollitos. El virus de la viruela aviar (FP) provoca lesiones \ncut\u00e1neas (viruela seca) o lesiones dif t\u00e9ricas  (viruela h\u00fameda) en pollos infectados. La viruela h\u00fameda causa una \nmortalidad m\u00e1s alta lo que resulta en graves p\u00e9rdidas econ\u00f3micas. La vacuna contra la viruela de la paloma (PP) \nparece proporcionar una mejor protecci\u00f3n cruzada contra algunas cepas  de campo de la viruela h\u00fameda. Aunque han \nhabido informes de aumento de la eficacia asociado con diversas mezclas de campo de vacunas de FP y PP, el \nproceso de vacunaci\u00f3n es laborioso y requiere mucho tiempo. En este estudio se evalu\u00f3 una combinaci\u00f3n de l a \nvacuna contra PP + FP y AE para su seguridad y eficacia en pollos de ocho  semanas o m\u00e1s. Se vacun\u00f3 un total de \n124 pollos con la vacuna de AE + FP + PP a trav\u00e9s de la membrana del ala y se desafiaron con cepas virulentas de \nvirus de AE y FP. La protecci\u00f3n en contra del desaf\u00edo con FP y AE fue de 100 % y 97 % respectivamente. La  \nvacuna ha demostrado ser segura cuando se prueba bajo condiciones tanto de laboratorio como de campo.  \n \nABSTRACT  \n \nAvian e ncephalomyelitis  (AE) causes a marked drop in egg production, decrease in egg hatchability and high \nmortality in young chicks. Fowl pox  (FP) virus causes cutaneous lesions (dry pox) or diptheritic lesions (wet pox) in \ninfected chickens.  Wet pox causes higher mortality resulting in severe economic loss. Pigeon pox (PP) vaccine \nappears to provide better cross protection against some wet pox  field strains. Although there have been reports of \nincreased efficacy associated with various field mixtures of FP and PP vaccines, the process of vaccination is labor \nintensive and time consuming. In the present study, we evaluated a combination of AE + FP + PP vaccine for its \nsafety  and efficacy in chickens aged eight wk  or older.  A total of 124 chickens were vaccinated with AE + FP + PP \nvaccine through wing web and challenged against virulent strains of AE and FP viruses. Protections against FP and \nAE c hallenge were 100% and 97% respectively. The vaccine was demonstrated to be safe when tested under both \nlaboratory and field conditions.  \n  \nINTRODUCTION  \n \nFowl pox virus causes cutaneous lesions (dry pox) or diptheritic lesions (wet pox) in infected chickens . Dry \npox produces scabs and lesions around the comb, wattle, ear lobes, and eyes. Wet pox lesions are mostly seen in the \noral cavity and the upper respiratory tract, especially the larynx and trachea. Wet pox causes higher mortality in \ninfected flocks resulting in si gnificant economic loss. Avian e ncephalomyelitis virus infection in laying and \nbreeding flocks causes a marked drop in egg production, decrease in egg hatchability and high mortality in young infected chicks.  \nVaccination of poultry with eith er FP or PP vaccines appears to generate cross -protective immune response \nagainst the other ( 1,3,4 ). However, the immunity induced by either vaccine alone may not be sufficient enough to \nprotect against variant strains.  Outbreaks of FP have emerged in some previously vaccinated flocks leading to \nvirulent field strains (variant strains) that were not controlled by use of commercial FP vaccine alone ( 2). The \nvirulent strains often cause increased mortality due to respiratory obstruction (wet pox or diphtheritic form of the \ndisease). Vaccinating chickens with both FP and PP vaccines appears to provide better protection against the 63rd WPDC/XXXIX ANECA  virulent field strains of the virus.  Therefore, poultry producers in pox endemic areas routinely vaccinate their flocks \nwith both FP  and PP vaccines so as to obtain a greater spectrum of protection against the disease. For vaccinating \nchickens, poultry producers mix various FP containing products with PP vaccine and administer the mixed product \nvia wing web route. However, mixing of se parate products has some disadvantages including preparation error, \nlonger time requirement for vaccine rehydration and mixing and eventual loss of virus titer, inconsistency in vaccine \npotency and product contamination during preparation and processing. I n the present study, we evaluated the \nefficacy and safety of a freeze dried live virus vaccine containing AE, FP and PP viruses in a singl e preparation in \nchickens aged eight w eeks or older.  \n \nMATERIALS AND METHODS  \n \nSpecific pathogen free (SPF) chickens aged eight wk  or older were used for vaccination. For Hygieia AE -FP-\nPP vaccine, a total of 124 chickens were vaccinated via wing web using a double needle wing web stab. For \ncomparison, another group of 30 chickens were vaccinated with a field mixture of c ommercial AE -FP and PP \nvaccine through wing web. The freeze dried vaccines were rehydrated with sterile diluent following the directions \nfor use circular accompanying the product. The experiment consisted of three trials. In each trial, a group of \nchickens  originating from the same source and flock was kept as unvaccinated ch allenged controls. At 4 \u2013  6 d post \nvaccination, all vaccinated and control chickens were checked for vaccine induced \u201cTake\u201d at the site of vaccination.   \nAll vaccinated chickens  were obs erved daily for 21 d post vaccination (DPV) for development of any vaccine \nassociated adverse reactions, mortality, and appearance of pox lesions on the comb, wattle, eyelids and other n on-\nfeathered areas of the body. Chickens were also observed for development of clinical signs of avian \nencephalomyelitis including ataxia, circling, depression, paralysis, sudden death, tremors, or torticollis.  \nVaccinated and positive control chickens were challenged against AE and FP at 21 DPV. The AE challenge \nwas do ne intracerebrally and Fowl pox challenge virus was administered through wing web route using a double \nneedle stab. The AE challenged chickens were observed for 21  DPC for AE clinical signs such as ataxia, circling, \ndepression, paralysis, sudden death, tre mors, or torticollis. Any chicken showing clinical signs of AE and/or \nmortality was considered positive or unprotected.  The FP challenged chickens were observed for 10 DPC for clinical \nsigns of FP such as appearance of nodular lesions at the site of challe nge virus inoculation, as well as lesions or \nscabs at the non -inoculated, non -feathered areas of the body including the comb, wattles, eyelids and oral mucosa. \nAny chicken showing lesion at the challenge virus inoculation site or elsewhere was considered p ositive or \nunprotected.   \nThe safety of the vaccine was evaluated by vaccinating a total of 186,768 eight to eleven wk  old chickens \n(LSL, Cobb and HY -W36) in three different geographical areas of the country. Dail y mortality was recorded up to \nthree wk  post-vaccination and compared with the control birds which were vaccinated with other commercially \navailable vaccines . One hundred randomly selected birds each from the vaccin ated and control groups in all three  \ntrial sites were also examined for pox \u201ctake\u201d at  7 \u2013 8 d post vaccination.  \n \nRESULTS AND DISCUSSION \n \nHygieia AE -FP-PP vaccine was found to be safe for wing web a dministration in chickens aged eight wk  or \nolder  both under laboratory and field conditions . This was evidenced by the absence of any vaccine associated \nadverse reactions, absence of secondary pox lesions at the non -inoculated sites, and absence of AE clinical  signs or \nmortality during the three wk post vaccinat ion observation period. Under field situations, the post vaccination \nmortality was co mparable to the co ntrol groups.  \nWhen examined for pox \u201ctake\u201d , 100% of the vaccinated chickens (both under laboratory and field conditions) \nrevealed good vaccine \u201ct ake\u201d at the site of vaccination. With other commercially available vaccines, the pox takes in  \nvaccinated chickens under field conditions averaged 86%. The percentages of protection against AE and FP \nchallenge under laboratory conditions are shown in Table 1.  The Hygieia AE -FP-PP vaccine induced 100% \nprotection against FP challenge in the vaccinated chickens. Protection in the unvaccinated challenged controls was \n0%. The average percentage protection against AEV challenge with Hygieia AE -FP-PP vaccine was 97% in the \nvaccinated chickens an d 0% in the unvaccinated challenged controls.  \n \nCONCLUSION  \n \nHygieia\u2019s  avian encephalomyelitis \u2013  fowl pox \u2013  pigeon pox vaccine , when tested in chickens aged eight w eeks \nor older , was found to be safe and efficacious against both fowl pox and avian encephalomyelitis virus challenge. 63rd WPDC/XXXIX ANECA  The vaccine was also proved to be safe when tested in commercial chickens under field situations. Hygieia AE -FP-\nPP vaccine was distinctly advantageous over the commercial vaccines due to the fact that it contained both FP and \nPP v iruses in a single preparation.  \n \nREFERENCES  \n \n1. Beaudette, F.R. Twenty Years of Progress in Immunization Against Virus Diseases of Birds, Journal of \nthe American Veterinary Medical Association, 115:232 -244, and 116:367- 377. 1949.   \n2. Fatunmbi, O.O. and Reed, W.M. Evaluation of a commercial modified live virus fowl pox vaccine for the \ncontrol of \u201cvariant\u201d fowl poxvirus infections, Avian Diseases, 40:582- 587. 1996.   \n3. Tripathy, D.N. and Hanson, L.E. Pathogenesis of Fowlpox in Laying Hens, Avian Diseases, 22:259- 265. \n1978.   \n4. Winterfield, R.W. The response of chickens to vaccination with different concentrations of pigeon pox \nand fowl pox viruses, Avian Diseases, 9:237 -241. 1965.   \n \n \n  \n \nTable 1 . Efficacy of Hygieia AE -FP-PP vaccine against challenge with AE and f owl po x viruses . \n \nTreatment \ngroups  No. of birds \nvaccinated  No. of birds challenged  % Protection (average)  Post vaccination  \n\u201cTake\u201d at the site of \nvaccination  \n         (%) AE FP AE FP \nHygieia    AE -\nFP-PP vaccine   \n124  \n60  \n62  \n97  \n100  \n100 \nCommercial AE -\nFP vaccine \nmixed with PP \nvaccine   \n \n30  \n \n15  \n \n15  \n \n93  \n \n100  \n \n100 \nUnvaccinated \nchallenged \ncontrols   \n0  \n76  \n77  \n0  \n0  \n0 \nThe numbers in the table represent data from three  trials  \n 63rd WPDC/XXXIX ANECA  \n \n CHICKEN ANEMIA VIRUS AND IMMUNOSUPPRESSION: \nIMPACT ON MAREK\u2019S DISEASE VACCINE PROTECTION  \n \nK. A. Schat  \n \nDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornel l University,  \nIthaca, NY 14853  \nEmail: kas24@cornell.edu  \n \nABSTRACT  \n \nSubclinical immunosuppression caused by chicken infectious anemia virus (CIAV) is an important \ncontributing factor to Marek\u2019s disease (MD) vaccine breaks.  Infection with CIAV results in reduced T helper and \ncytotoxic T lymphocyte  activity affecting antibo dy and cell -mediated immune responses. CIAV infection is \ncontrolled by the development of virus -neutralizing antibodies, which can be compromised by poorly controlled \ninfectious bursal disease virus (IBDV) infection. MD virus (MDV), es pecially the very vir ulent (vv+)  strains, is also \nhighly immunosuppressive. When fi eld strains of MDV infect properly vaccinated birds or reactivate from latency, \nmemory CTL will be activated to control virus replication . These CTL are also dividing thus providing target cells \nfor CIAV replication. In conclusion,  when CIAV is actively replicating during infection with or reactivation of \nMDV, CTL responses are suboptimal and MDV infection is poorly controlled leading to vaccine breaks.  \n \nINTRODUCTION  \n \nAltho ugh MD is in general well controlled by vaccination in ovo or at one d  of age, MD remains a concern for \nseveral reasons. First of all, vaccination practices are often suboptimal resulting in some vaccine breaks. Proper use \nof standard operating procedures at the hatchery remains essential for optimal protection and has been the topic of \nmany presentat ions. The short -term financial gain by using vaccines diluted beyond the recommendations by the \nmanufacturer results in suboptimal protection when very virulent (vv) or vv+ strains of MDV are present (4).  T he \nsecond reason is the continuous evolution of  MDV. Over the last 100 years MDV has increased significantly in \nvirulence (10). The first increase in virulence occurred in the mid 1950\u2019s when the poultry industry changed from a \nrather extensive to a more intensive production system. Subsequent increases in virulence are, at least in part, caused \nby the fact th at none of the vaccines prevent  infection with field strains thus allowing for the development of esca pe \nmutants ( 1). In addition, Atkins et al. (1) suggest ed that the reduction in age of broilers to processing also favors an \nincrease in virulence. Unfortunately, there are no good options to change th ese development s. Without vaccination , \nlosses would be s taggering in breeder and layer flocks and in many countries in broilers as well. Thorough cleaning \nof broiler houses after each cycle may alleviate the need to vaccinate as is the case in some countries, but this will be \nimpractical in the USA and Mexico. A third important factor is immunosuppression especially by chicken infectious \nanemia virus (CIAV), which is difficult to control in commercial production systems.  \nIn this review I will briefly discuss the pathogenesis of CIAV and its impact on immune res ponses, MD \nvaccine -induced immune responses, and how CIAV can influence MD vaccine -induced immune responses. With \nfew exceptions only references for book chapters and review papers are used for these three sections.  \n \nPATHOGENESIS OF CHICKEN INFECTIOUS ANEMIA VIRUS  \n \nCIAV, currently the only member of the Gyrovirinae  of the Circoviridae , is characterized by its small size \n(\u00b125 nm), single -stranded, circular, covalently closed, negative sense DNA genome of 2,298 nt, and very important \nfrom a practical poin t of view the extreme resistance of CIAV to many commercial disinfectants (7, 9) . The genome \ncodes for only three  proteins: VP1 (the capsid protein), VP2 (essential for the proper folding of VP1) and VP3, \nwhich is also known as apoptin. VP3 is essential fo r virus replication and mutation of the start codon will prevent \nvirus replication. VP3 is also important because it causes apoptosis of infected cells. The replication of the viral \ngenome requires the formation of double -stranded (ds)DNA, which resembles in some respects a mini -chromosome \nor a bacterial plasmid.  Because CIAV does not code for the necessary enzymes to generate new DNA, and thus \ninfectious virus particles, it needs to infect dividing cells using the cellular enzymes to generate viral DNA. T he \ndividing cells which are susceptible to infection with CIAV are the hemocytoblasts , the precursor cells for 63rd WPDC/XXXIX ANECA  \n \n erythrocytes, heterophils and thrombocytes,  in the bone marrow, thymocytes and T cells. Destruction of the \nhemoc ytoblasts by CIAV results in lowe r hematocrit values, decreased phagocytosis of bacteria by a lack of \nheterophils and thrombocytes, and increased hemorrhages. Infection of the thymocyte series results in a loss of \nthymocytes (thymus atrophy), T helper (Th) and cytotoxic T lymphocytes (CTL ). The loss of Th lymphocytes and \nCTL impacts negatively the antibody and cell -mediated immune responses. Virus -neutralizing (VN) antibodies \ndevelop within six wk post infection (pi) eliminating virus replication. However, CIAV can remain present in \ngonads  and lymphocytes probably as dsDNA fulfilling the characteristics of latency (7). Latent CIAV can be \ntransmitted vertically and be reactivated. Infection with CIAV only causes clinical disease if infection o ccurs during \nthe first one to ten d  of age in mat ernal antibody -negative chickens. However o lder chickens can develop clinical \ndisease when humoral antibody responses are severely compromised for example after infection with vv infectious \nbursal disease virus (IBDV). Control of vvIBDV  using appropriate vaccines without causing damage to the bursa of \nFabricius is therefore an important component for the control of CIAV infections.  \n \nMAREK\u2019S DISEASE VACCINE -INDUCED IMMUNITY  \n \nInfection of na\u00efve chickens with MDV causes first a lytic infec tion of B lymphocytes followed by a lytic \ninfection of mostly CD4+ T cells. The lytic phase of infection can cause severe atrophy of the thymus and bursa of \nFabricius resulting in  immunosuppression. Latent infections are established in CD4+ T cells startin g around seven d  \npi but infection with vv+ strains may cause permanent damage to the primary lymphoid organs and early mortality. \nLatency can be permanent or temporarily depending on the genetic resistance and immunocompetence of the birds  \nand the virulenc e of the MDV strain . Ultimately, MDV -positive CD4+ cells may transform in which case tumors \ndevelop.  \nTo protect against MD , chickens are vaccinated in the USA at 18 d  of embryonati on (broilers) or directly after \nhatching (layers and breeders). The latter two groups of birds receive sometimes a second vaccination between 1 \u2013  \n14 d of age. If a second vaccination is given , it has to be done within the first one to two d  of age before chickens are \nexposed to field virus. Vaccination induces both innate and acq uired immune responses . The former include the \nproduction of nitric oxide and interferons as well as the activation of natural killer cells  which are important to \nreduce early MDV infections . Innate responses are short -lived, lack memory, and are therefore only important \nduring the first 7 \u2013  10 d pi. However, innate responses are of crucial importance for the development of acquired \nimmunity. Antibodies play only a minor role in protective immunity because MDV infection is strictly cell -\nassociated. In contr ast to antibodies, CTL responses are a key component of vaccine -induced acquired immunity.  \nProtective immunity is primarily antiviral reducing but not preventing replication of field virus. The \nimportance of antitumor immunity is controversial and immune responses to tumor cells may be directed to viral \nantigens rather than true tumor antigens.  (8). \n \nIMPACT OF CIAV INFECTION ON MAREK\u2019S DISEASE  \n \nCIAV infection in maternal antibody -positive chickens typically occurs once maternal antibodies have weaned \nand flocks typically  seroconvert between 4 \u2013  10 wk of age. During this time birds may also become infected with \nMDV field strains . CTL responses are  the key component to control virus replication and memory CTL against \nMDV antigens will be rapidly activated and start dividing thus presenting target cells for CIAV replication. MD \nvaccine breaks have been linked directly or indirectly to the presence of  CIAV infection in several instances (2, 3) . \nSimilarly, CIAV infection has also been implicated in in fectious bronchitis breaks ( 5). The effect of CIAV on CTL \nwas clearly shown by Markowski -Grimsrud and Schat (6)  using reticuloendotheliosis virus (REV) as a model. \nChickens hatched from antibody- positive and -negative hens were infected at four wk  of age with CIAV with or \nwithout exposure to REV at the same time. At seven d  pi CIAV replication was measured by quantitative (q)PCR \nand qRT -PCR and CTL responses to REV -transformed lymphocytes was measured by chromium release assays \n(CRA). In the case of maternal antibody -positive chickens, qPCR and qRT -PCR showed lack of CIAV replication \nand a strong CTL response to REV. Residual maternal antibodies we re apparent ly still present at four wk  of age, \neven while the Iddex ELISA was negative. In contrast, maternal antibody -negative chicks showed high levels of \nCIAV DNA and RNA, the latter indicating active virus replication. The CTL response to REV was significantly reduced in these birds.  \n \n  63rd WPDC/XXXIX ANECA  \n \n  \n \nCONCLUSIONS  \n \nCIAV is an important pathogen causing subclinical immunosuppression and can be an important co -factor in \nvaccine breaks against MD and may other diseases. Development of vaccines to protect chickens to CIAV infectio n \nearly in life will be an important addition to disease control programs.   \nREFERENCES  \n \n1. Atkins, K. E., A. F. Read, N. J. Savill, K. G. Renz, A. F. Islam, S. W. Walkden -Brown, and M. E. \nWoolhouse. Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture. Evolution 67:851 -860. 2013.  \n2. Davidson, I., M. Kedem, H. Borochovitz, N. Kass, G. Ayali, E. Hamzani, B. Perelman, B. Smith, and S. \nPerk. Chicken infectious anemia virus infection i n Israeli commercial flocks: virus amplification, clinical signs, \nperformance, and antibody status. Avian Dis. 48:108\u2013 118. 2004.  \n3. Fehler, F., and C. Winter. CAV infection in older chickens, an apathogenic infection? In: II. International \nSymposium on inf ectious bursal disease and chicken infectious anaemia. Institut fur Geflugelkrankheiten, Justus \nLiebig University, Giessen, Germany, Rauischholzhausen. pp 391 -394. 2001.  \n4. Gimeno, I. M., A. L. Cortes, E. R. Montiel, S. Lemiere, and A. K. R. Pandiri. Effec t of diluting Marek's \ndisease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's \ndisease viruses. Avian Dis. 55:263 -272. 2011.  \n5. Hoerr, F. J. Clinical aspects of immunosuppression in poultry. Avian Dis . 54:2- 15. 2010.  \n6. Markowski -Grimsrud, C. J., and K. A. Schat. Infection with chicken anaemia virus impairs the generation \nof pathogen -specific cytotoxic T lymphocytes. Immunology 109:283- 294. 2003.  \n7. Schat, K. A. Chicken anemia virus. Curr. Top. Microbi ol. Immunol. 331:151- 184. 2009.  \n8. Schat, K. A., and V. Nair. Marek's disease. In: Diseases of Poultry, 13 ed. D. E. Swayne, J. R. Glisson, L. \nR. McDougald, J. V. Nolan, D. L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 515- 552. 2013.  \n9. Schat, K. A., and V. L. van Santen. Chicken infectious anemia. In: Diseases of Poultry, 13 ed. D. E. \nSwayne, J. R. Glisson, L. R. McDougald, J. V. Nolan, D. L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames. IA. \npp 248- 264 and 276- 284. 2013.  \n10. Witter, R. L. Inc reased virulence of Marek's disease virus field isolates. Avian Dis. 41:149 -163. 1997.  \n \n  63rd WPDC/XXXIX ANECA  CLOSTRIDIAL ENTEROPATHIES: MITIGATING THEIR EFFECTS \nIN AN ANTIBIOTIC FREE PRODUCTION SYSTEM  \n \nENTEROPAT\u00cdAS CLOSTRIDIALES: MITIGACI\u00d3N DE SUS EFECTOS EN UN \nSISTEMA DE PRODUCCI\u00d3N LIBRE DE ANTIBI\u00d3TICOS  \n \nJ. Schleifer, T. Lohrmann, and S. Johnson  \n \nQuality Technology International (QTI) Inc. 1707 N. Randall Rd. Suite 300, Elgin, IL. 60123  \n \nRESUMEN  \n \nLas enteropat\u00edas clostridiales siguen afectando a la producci\u00f3n av\u00edcola comercial en los Estados Unidos. \nInformes recientes indican un aumento de enfermedades co mo la enteritis necr\u00f3tica en pollos de engorda.  Los \nresultados de estas enfermedades son disminuci\u00f3n en el rendimiento de producci\u00f3n, mayor costo de producci\u00f3n y \naumento de la mortalidad. En correspondencia con el aumento de las enfermedades clostridiales  se reduce el uso de \nantibi\u00f3ticos. Esta din\u00e1mica de producci\u00f3n est\u00e1 siendo impulsada por la demanda del mercado y las iniciativas \nregulatorias. Por lo tanto, se est\u00e1n investigando alternativas a los agentes terap\u00e9uticos com\u00fanmente utilizados. \nEstudios reci entes han informado que el uso de microbios alimentados directamente (DFMs) puede mejorar los \nefectos de las enfermedades clostridiales.  \nLos objetivos de esta presentaci\u00f3n son delimitar la incidencia actual de enteropat\u00edas clostridiales . Se discutir\u00e1 \nel examen de la literatura publicada que describe la eficacia y el modo de acciones que tienen los DFMs en la mejora \nde las enteropat\u00edas clostridiales. Por \u00faltimo, se discutir\u00e1 un estudio de la investigaci\u00f3n actual sobre el efecto \natenuante que tienen los DFMs en las enteropat\u00edas clostridiales.  \n \nSUMMARY  \n \nClostridial enteropathies continue to plague commercial poultry  production in the United States. Recent reports \nindicate an increase in  diseases such as necrotic enteritis in broilers. The results of these  diseases are decreased \nproduction performance, heightened cost of  production , and increased mortality. Corresponding to the rise of  \nclostridial diseases is reduced antibiotic usage. This production dynamic  is being driven by market demands and \nregulatory initiatives. Thus,  alternatives to commonly used therapeutic agents are being investigated.  Recent studies \nhave reported that the use of direct fed microbials (DFMs)  can ameliorate the effects of clostridial diseases.  \nThe objectives of this presentation are to delineate the current incidence of clostridial enteropathies. An \nexamination of published literature  describing the efficacy and mode of actions that DFMs express toward  the \namelioration of clostridial enteropathies will be discussed. F inally, a  survey of current research regarding the \nmitigating effect DFMs have on  clostridial enteropathies will be addressed.  \n \nINTRODUCTION  \n \nClostridial enteropathies  continue to plague commercial poultry production in the United States. Recent reports \nindicate an increase in diseases such as  necrotic enteritis in broilers and focal duodenal necrosis in commercial \nlaying hens.  The results of these diseases are decreased production performance, heightened cost of production and \nincreased mortality.  \n  \nNECROTIC  ENTERITIS  \n \nNecrotic enteritis  (NE) in broilers is caused by Clostridium perfringens  and is characterized by acute morbidity \nand mortality. The clinical signs are identified as sudden depression, loss of appetite and relucta nce to move. \nMortality often accompanies clinical symptoms. Gross lesions are  observed in the jejunum and ileum. Initial lesions \ninclude petechial hemorrhaging of the mucosal layer of the intesti ne with muco -fibrinous inflammation.  As the \ndisease progresses, necrosis proliferates and a pseudo -fibrinous membrane may be found on the mucosal layer  (5). \nThe economic impact of necrotic enteritis is pronounced. Current estimates are that there is an 80 % incidence \nof subclinical NE in broilers produced in an antibiotic free production system. Skinner et al.  (10) showed a 12% 63rd WPDC/XXXIX ANECA  reduction in body weight and a 10.9% increase in feed conversion rates in birds with subclinical NE. An economic \nanalysis by the sa me authors showed that NE resulted in a loss to producers ranging from $878 to over $1,400 per \nflock. When feed loss co mpensation costs were analyzed, an  additional loss  of approximately $400 to $740 per flock \nwas additive  (10).  \nNE is often com plicated or  predisposed by jejunal or ileal coccidiosis, caused by Eimeria maxima . Because of \nthe pathogenic nature of Eimeria maxima , the two diseases are often linked. However, the two diseases may occu r \nseparately and may not be in trinsically  concurrent . Yet, the producer should examine for coccidiosis if the incidence \nof NE is increasing  within the respective production system.  \n \nFOCAL DUODENAL NECROSIS  \n \nFocal duodenal n ecrosis ( FDN ) is an emerging disease in commercial layer hens. It was first reported in 1997. \nIt is a unique disease in that the affected animal most often presents with no clinical symptoms. The only common \nsymptom reported is \u201cpale combs\u201d.  The disease has been reported in hens as earl y as 15 wk old and cases have been \nidentified through out the lay  cycle. The hallmark sign is a drop in case weights. C ase weight reductions of up to two  \nlbs. per case have been reported. Also , in approximately 50% of the outbreaks, a drop in egg production has been \nreported. The production drop  may be  as much as 1 0%. Y et in most cases, production  has been rep orted to not be \naffected.  \nThe disease seems to be restricted to the duodenum of the hen. The lesions are characterized by gray -green foci \nin the mucosa. Microscopic ulcerations have been observed correspo nding to the gross lesions. Gram positive \nbacteria have been identified in association with the lesions. Diagnostic laboratory analyses generally result  in the \nisolation  of Clostridium colinum. H owever a report from the Netherlands indicates that Clostridium perfring ens may \nalso be a pathogen  (1). \nThe incidence of FDN also appears to be on the increase. There i s no substantive indication as to the incidence \nof the disease in the early 2000\u2019s;  however veterinarians now believe that the incidence could be in excess of 80%  \n(2). \nAs with  NE, there  currently  are no preventative measures that can be taken for FDN. The only approved \nantibiotic for use in commercial layer hens is bacitracin at 25 g/ton. Reports indicate that recurrences of the disease \nare common after treatment with the antibiotic.  \n \nANTIBIOTIC FREE PRODUCTION  \n \nThe use of antibiotics in broilers to treat NE is more commonplace and reports indicate that commonly used \ntherapeutic antibiotics are generally still effective. However, increased resistance to these  antibiotics continue s to be \nobserved and re fracto ry cases appear to be on the rise.  Corresponding to the increased incidence of both NE and \nFDN is consumer and regulatory pressure to reduce their usage.  \nThe exact incremental increase in antibiotic free meat production in the United States is difficult to assess. \nHowever, in 2009 Organic Trade Association reported a 20% per year growth in organic meat sales since 1997 (3). \nIndications are that organic and antibiotic free meat sales will continue to increase based on projections by major US food retai lers in this market segment  (4). \n \nDFM EFFECTIVENESS  \n \nWith increased pressure to reduce antibiotic usage in some poultry production segments, produc ers are seeking  \nalternative products that will reduce the effects of clostridial diseases. One of the initial  papers showing that DFMs \ncan have an effect against clostridial enteropathies was  reported by Fukata et al.  (6). These researchers orally dosed \nyoung chickens with Lactobacillus acidophilus  or Streptococcus faecalis  one d  prior to challenging the birds with C. \nperfringens  and observed a reduction in the recovery of  C. perfringens  in the duodenum . Maruta et al. (8 ) showed a \nreduction in C. perfringens  in the feces of broilers that were fed Bacillus subtilis  C-3102 from one d of age. Hofacre \net al. (1998) found that the undefined bacterial culture,  marketed as Avigard , resulted in a significant reduction in  \nthe incidence of NE  and lesion expression in subsequently challenged broilers.  Additional research indicated that \nthere may be a direct r elationship with a reduction in fecal shedding of C. perfringens  in broilers and an increase in  \nthe percent of Lactobacillus  as a component of the total anaerobic microbiota of the chicken\u2019s intestine (7). \nCurrent research has centered on the effectiveness  of Bacillus subtilis  C-3102 either by itself or in combination \nwith another product to reduce NE pathologies. Data indicates that there is a dose response to decreasing the effects \nof NE by C. perfringens  with increasing levels of B.  subtilis  C-3102. Addi tionally, an additive effect o f C. 63rd WPDC/XXXIX ANECA  perfringens  reductions has  been reported when B. subtilis  C-3102 is combined with an oral one -time dosage of \nproprietary Lactobacillus reuteri  (9). Finally, an additive effect in the reduction of NE was observed with the \ncombination of B. subtilis  C-3102 and the yea st cell wall preparation, IMW50TM . \n \nCONCLUSIONS  \n \nDFMs have been shown to reduce the effects of Clostridium perfringens  infections in young chickens for over \n20 years. During this time the incidence of cl ostridial enteropathies  in populations not treated with DFMs have  \nsteadily increased. Current indications suggest  that clostridia l enteropathies are becoming more refractive to \nconventional antibiotic therapies. Additionally, consumer demands have placed more pressure on producers to use \nless antibiotic intervention  during t he production phase. T hus t he uses of specific direct fed microbials appear  to be \nan effective option for produce rs toward reducing the effects of  clostridial e nteropathies . \n \nREFERENCES  \n \n1.  Allaart, J.G., N.D. deBruijn, A.J.A.M. vanAsten, T.H.F. Fabri and A. Grone.  NetB -producing and beta2-\nproducing Clostridium perfringens associated with subclinical necrotic enteritis in laying hens in the Netherlands. \nAvian Pathol. 41:541- 546. 2012.  \n2. Anonomys.  An Overview of Focal Duodenal Necrosis (FDN). Technical Update. Hy -Line International, \nDallas Center, IA.  2013.  \n3. Anonomys.  The Organic Trade Association 2009 Organic Industry Survey.  Organic Trade Association, \nGreenfield, MA.  2009.  \n4. Anonomys.  Whole Foods Market 2013 Annual Report.  Whole Foods Market, Inc.  Austin, TX.  2013.  \n5. Ficken, M.D., D.P. Wages. Necr otic Enteritis. Diseases of Poultry 10th Ed., Calnek et al. eds. 1997.  \n6. Fukata, T., Y. Hadate, E. Baba and A. Arakawa. Influence of bacteria on Clostridium perfringens  \ninfections in young chickens. Avian Dis. 35:224- 227.  1991.  \n7. Kato, M., N. Otomo, K. Nishimura, Y. Tadano, T. Marubashi, H. Miyazaki, K. Maruta and D.M. Hooge.  \nDietary Bacillus subtilis  C-3102 spores influence intestinal (excreta) populations of Lactobacilli, Clostridium \nperfringens, Enterobacteeriaceae (coliforms), and Salmonella, and live performance of broiler chickens.  Poult. Sci. \n86:216- 217.  2007.  \n8. Maruta, K ., H. Miyazaki, S. Masuda, M. Takahashi, Y. Tadano and H. Takahashi.  Exclusion of intestinal \npathogens by continuous feeding with Bacillus subtilis  C-3102 and its influence on the intestinal microflora in \nbroilers. Anim. Sci. Technol. 67:271- 280.  1996.  \n9. Schleifer, J., T. Lohrmann, N. Otomo, T. Hamaoka, G. Mathis, B. Lumpkins and D.M. Hooge.  Dose \nresponses to dietary Bacillus subtilis  C-3102 plus Lactobacillus reuteri .  2013 AAAP Convention, Chicago, IL.   \n2013.  \n10. Skinner JT, S. Bauer, V. Young, G. Pauling and J. Wilson.  An economic analysis of the impact of \nsubclinical (mild) necrotic enteritis in broiler chickens.  Avian Dis. 54:1237 -1240.  2010.  \n (IMW50 is a trademark of ICC, Brazil .) \n 63rd WPDC/XXXIX ANECA  REDUCING EXPERIMENTALLY INDUCED NECROTIC \nENTERITIS LESIONS IN BROILERS USING DIETARY  \nBACILLUS  SUBTILIS  C-3102 (CALSPORIN)  \n \nREDUCCI\u00d3N DE LAS LESIONES DE ENTERITIS NECR\u00d3TICA INDUCIDA \nEXPERIMENTALMENTE EN POLLOS DE ENGORDA MEDIANTE EL USO \nDE BACILLUS SUBTILIS C-3102 (CALSPORIN) EN LA DIETA \nJ. Schleifer, T. Lohrmann, N. Otomo, T. Hamaoka, G. MathisA, B. LumpkinsA, and D. M. HoogeB \n \nQuality Technology International (QTI) Inc. 1707 N. Randall Rd. Suite 300, Elgin, IL.  60123  \n ASouthern Poultry Research Inc., Athens, GA.  30607  \nBHooge Consulting Service Inc. Eagle Mountain, UT.   87529  \n \nRESUMEN  \n \nLa enteritis necr\u00f3tica (NE) en pollos de engorda comerciales ocurre con mayor frecuencia entre las edades de \n14 a 30 d y es causada por Clostridiu m perfringens . Los productores av\u00edcolas est\u00e1n limitando o eliminando cada vez \nm\u00e1s el uso de antibi\u00f3ticos en el control de NE. Se est\u00e1n investigando productos alternativos para controlar las \ninfecciones de NE. El objetivo de este estudio es exami nar la efectividad de Calsporin\u00ae (Bacillus subtilis  C -3102) \ncontra un desaf\u00edo con NE. En este estudio, NE se reprodujo por medio del desaf\u00edo de  pollos de engorda a los 14 d  de \nedad con Eimeria maxima , seguido de una sonda oral con C. perfringens  a partir de los 19 d de edad. Las \npuntuaciones de las lesiones de NE se evaluaron a los 21 d  de la edad. Los par\u00e1metros de mortalidad y de \nprodu cci\u00f3n se evaluaron a los 28 d  de la edad. Dosificaciones variables de Calsporin se analizaron para determinar \nlas capacid ades correspondientes de mejora de NE. La eficacia de Calsporin en este modelo de desaf\u00edo de NE se \ncompar\u00f3 con un grupo control no tratado y uno que recibi\u00f3 niveles terap\u00e9uticos de Stafac\u00ae. Se obtuvieron \nreducciones significativas en mortalidad y en las pu ntuaciones de lesiones con Calsporin frente a un desaf\u00edo con NE \ncomparado con el grupo sin tratar/infectado. Todos los resultados de calificaci\u00f3n de las lesiones para los grupos de tratamiento que recibieron Calsporin fueron estad\u00edsticamente equivalentes a  los grupos alimenta dos con las dietas \nStafac. Los resultados indican que hay evidencia de respuesta a la dosis con tratamientos con Calsporin en lo que respecta a la reducci\u00f3n de lesiones de enteritis necr\u00f3tica, la mortalidad y las influencias de producci \u00f3n \n \nSUMMARY  \n \nNecrotic enteritis (NE) in commercial broilers most often occurs between  the ages of 14 to 30 d of age and is \ncaused by Clostridium perfringens . Poultry producers are increasingly limiting or eliminating the  use of antibiotics \nin the control of NE. Alternative products to control NE  infections are being investigated. The objective of this study \nis to examine  the effectiveness of Calsporin\n\u00ae (Bacillus subtilis  C-3102) against an NE  challenge. In this trial, NE \nwas reproduced by challenging broil ers at 14  d of age  with Eimeria  maxima , followed by an oral gavage of \nC.perfringens  starting at 19 d of age . NE lesion scores were assessed  at 21 d of age . Mortality and production \nparameters were assessed at  28 d of age . Varying dosages of Calsporin were analyzed to  determine corresponding \ncapabilities of NE amelioration. The  effectiveness of Calsporin in this NE challenge model was compared to  a non-\ntreated control group and one that received therapeutic levels of  Stafac\u00ae. Significant reductions in mortal ity and \nlesion scores were attained with Calsporin against an NE challenge compared to the non-treated/infected group. All \nlesion score results for the treatment  groups receiving Calsporin were statistically equivalent to the groups  fed the \nStafac diets. T he results indicate that there is evidence of dose response with the Calsporin treatments in regard to \nthe reduction of NE  lesions, mortality and production influences.  \n  \n \n \n 63rd WPDC/XXXIX ANECA  INTRODUCTION  \n \nNE is a pervasive disease in 1 4 to 28 d old chickens which can often result in high levels of morbidity and \nmortality. The etiologic agent is typically Clostridium  perfringens . However, Eimeria maxima  infections are \nconsidered a significant predisposing factor for NE (1). There is a need for alternatives to therapeutic antibiotics in \nthe control of NE as producers decrease antibiotic usage.  DFMs (d irect fed microbials), particularly Calsporin , as a \nfeed additive has shown an effect on reducing C. perfringens in fecal samples ( 2,4). Recent studies ind icate that \nswine fed Calsporin resulted in significantly less C. perfringens in fecal samples (3 ). The purpose of this study was \nto examine the  effect of various levels  of Calsporin in reducing NE.   The various dosages were also compared to \nnon-treated con trols and to conventional therapeutic antibiotic effectiveness.   \n \nMATERIALS AND METHODS  \n \nA battery trial was conducted from 0 to 28 d of age, using Cobb male broiler chicks.  Except for Treatment 1, \nall birds were challenged with ~5,000 oocysts of Eimeria maxima  on d 14 and with 1x108 cfu of Clostridium \nperfringens  per bird on d 19, 20, and 21. No coccidiostat was used in the feed and no coccidia vaccine was \nadministered to bird s. Each treatment consisted of eight cages (rep) of eight  birds each per treatment with each bird \nhaving 0.62 ft2/bird.  Birds were randomly assigned to cages and given ad libitum  access to feeders and water via \nnipple drinkers. Treatments were randomized by pen prio r to the start of the study.  \nBirds were weighed by cage on d  0, 14, 2 1, and 28.  Feed was weighed in on d 0 and r emaining feed was \nweighed on d 14, 21, and 28.  The trial was terminated on d  28. \nThe six treatments used in this study were:  \n1. Non -infected chicks, non -medicated diets  \n2. Infected chicks, non- medicated diets   \n3. Infected chicks, 20 gm/ton Stafac\u00ae \n4. Infected chicks, CALSPORIN  300,000 cfu/g  diet \n5. Infected chicks, CALSPORIN  600,000 cfu/g diet  \n6. Infected chicks, CALSPORIN  900,000 cfu/g diet  \n \nNecrotic enteritis intestinal lesion sco ring (0 to 3) was performed on  three birds per cage on d  21. T hree birds \nfrom each cage were selected, sacrificed, weighed, and examined  for the degree of presence of necrotic e nteritis \nlesions. If less than three birds were present at time of scoring, all remaining birds within the cage were scored. The \nscoring was based on a 0 to 3 score, with 0 identified as the absence of gross NE lesions and 3 identified as the \npresence of severe gross NE lesions.  \n \nRESULTS  \n \n \nAn NE mortality of 12.5% and an average NE score  of 1.04 were  attained in the infected/non -treated (positive \ncontrol) group. When comparing  the two control groups,  to the four f eed additive treatments , BWG  (body weight \ngain)  was not significantly different.  However , as expected, those birds that were infected and r eceiving no feed \nadditive had the lowe st BWG at d  28.  Similarly, the infected non -treated control group  had significantly poorer \nmortality  adjusted F/G  (feed -to-gain, 0 -28 d)  compared to other treatments.   \nWhen comparing the four  feed additive treatments , birds fed Calsporin had similar BWG, F/G, NE mortality % \nand NE score to birds fed diets supplemented with Stafac at 20 g/t.  Compared to the infected and non- treated \ncontrol group , birds fed diets contai ning Calsporin at 600,000 to 900,000 cfu/g of feed  had significantly better \nlivability. Correspondingly, the birds treated with the highest level of Calsporin had the lowest NE scores.  \n \nDISCUSSION  \n \nThe NE challenge in this trial can be considered mild -moderate based on mortality levels and lowered body \nweights.  All feed additive treatments provided significant reductions in mortality levels compared to the untreated \ncontrol.  The greatest reduction in NE - related mortality was achieved with Stafac with no mortality.  The greatest \nreduction in NE lesion sco res was achieved wi th Calsporin at 900,000 cfu/g treated feed.  The treatment reductions \nin lesion scores were not statistically significant.  The 28 d body weight gain and feed/gain ratios generally 63rd WPDC/XXXIX ANECA  corresponded numerically, however no feed additive treatment provided a significant improvement in each of these \nparameters.  \nThe weight gain, feed/gain ratios and reduction in lesion scores with increasing inclusion rates of Calsporin \ncorrespond with additional studies.  \n \nREFERENCES  \n \n1. Ficken, M.D. and D. Wages. Necrotic enteritis.  Diseases of Poultry 10th Edition.  1997.  \n2. Kato, M., N. Otomo, K. Nishimura, Y. Tadano, T. Marubashi, H. Miyazaki, K. Maruta, and D. M. Hooge. \nDietary Bacillus  subtilis C-3102 spores influence intestinal (excreta) populations of  Lactobacilli, Clostridium \nperfringens , Enterobacteriaceae (coliforms), and Salmonella, and live performance of broiler chickens. Poult. Sci. \n86:216- 217 (Abstr.).  2007.  \n3. Knudson B.K., N. Otomo, T. Hamaoka, B. Lee, and S.C. Johnson. Effects of commercial diets with or \nwithout CALSPORIN\u00ae (Bacillus subtilis C-3102 spores) on fresh fecal microbial profiles of sows from breeding \nthrough lactation. J An Sci, Vol 91 (e -suppl 2):46.  2013.  \n4. Maruta, K., H. Miyazaki, S. Masuda, M. Takahashi, T. Masrubashi, Y. Tadano, and H. Takahashi. \nExclusion of intestinal pathogens by continuous feeding with Bacillus subtilis C -3102 and its influence on the \nintestinal microflora in broilers. An im. Sci. Technol.  67:273 -280. 1996.  \n (Calsporin is a registered trademark of Calpis Co., L td., Tokyo, Japan ) \n(Stafac is a registered trademark of Phibro Animal Health Corporation ) \n  \nTable 1.  \n \nTreatment  NE Mortality%  \n28 Days  NE Lesion Score  \n21 Days  Body wt. 0 -28 \nDays lbs  Body wt. 21 -28 \nDays lbs  Adj.Feed/gain  \n0-28 Days  \nNonInfected/Non -\ntreated  0 b 0 c 1.77 0.75 1.93 b  \nInfected/Non -treated  12.50 a  1.04 a  1.59 0.69 2.13 a  \nStafac 20 g/ton  0 b 0.29 b  1.76 0.77 1.97 ab  \nCalsporin 300,00/g  4.69 ab  0.67 ab  1.71 0.72 2.06 ab  \nCalsporin 600,00/g  3.13 b  0.67 ab  1.68 0.77 2.08 a  \nCalsporin 900,000/g  3.13 b  0.17 bc  1.71 0.80 2.09 a  \n \nP value  0.001  <0.001  0.371  0.14 <0.001  \na, b, c Within data set, values with different superscript letters, differ significantly  \n 63rd WPDC/XXXIX ANECA  \n MOLECULAR AND ANTIGENIC CHARACTERIZATION OF \nVARIANT REOVIRUSES FROM  \nCLINICAL CASES OF TENOSYNOVITIS  \n \nCARACTERIZACI\u00d3N MOLECULAR Y ANTIG\u00c9NICA DE VARIANTES  \nDE REOVIRUS DE CASOS CL\u00cdNICOS DE TENOSINOVITIS \n \nH. Sellers, E. Linnemann, and V.  Gauthiersloan  \n \nPoultry Diagnostic and Research Center, Department of Population Health  \nCollege of Veterinary Medicine, University of Georgia  \n953 College Station Road  \nAthens, GA 30602 USA  \n \nRESUMEN  \n \nUn aumento dram\u00e1tico en el n\u00famero de casos cl\u00ednicos de tenosinovitis  inducida por reovirus ha sido reportado \nen los \u00faltimos dos a\u00f1os. Variantes de reovirus se han aislado de 70% de las muestras presentadas a la PDRC. El \nan\u00e1lisis genot\u00edpico del reovirus sigma C ha identificado dos grupos de variantes de los reovirus que tie nen desde 50 \nhasta 80% de similitud con las cepas vacunales comerciales. Actualmente se desconoce el origen de las variantes. An\u00e1lisis moleculares y antig\u00e9nicos adicionales de las variantes de reovirus est\u00e1n en marcha para proporcionar una mejor comprensi\u00f3 n del  posible origen de estos virus.  \n \nSUMMARY  \n \nA dramatic increase in the number of clinical cases of reovirus induced  tenosynovitis has  been reported over \nthe past two years. Variant  reoviruses have been isolated from 70% of the samples submitted to the  PDRC. \nGenotypic analysis of the reovirus sigma C has identified two  variant groups o f reoviruses that range from 50 to \n80% similarity to  commercial vaccine strains. The origin of the variants is currently  unknown. Additional molecular \nand antigenic analysis  of the variant  reoviruses is underway to provide a better understanding to the possible  origin \nof these viruses.  \n \nABSTRACT  \n \nAvian reoviruses are ubiquitous in poultry and usually not a major concern for poultry producers.  While \nreoviruses can be isolated from healthy birds, they have been associated with several diseases including malabsorption syndrome and runting and stunting syndrome (RSS), although their role as primary pathogens in the clinical syndromes is not clear.  In contrast, the association of some reoviruses with clinical cases of viral arthritis (VA)/tenosynovitis is quite clear especially when reoviruses are isolated from the tendons of affected birds. Control \nof reovirus -induced VA can be achieved by vaccination of broiler breeders with a co mbination of live and/or \ninactivated vaccines with maternal immunity passed on to progeny for early protection against field challenge.  In \nbroilers, live attenuated vaccines are available for use at day -of-hatch and some even used in ovo.  Current \ncommercial vaccine strains (S1133, 1733, 2408 and 2177 to name a few) have been used for decades to control \ndiseases associated with reovirus.  In addition, autogenous vaccines have been produced, on a company by company \nbasis, with field isolates for use in breeder s. A dramatic increase in the number of clinical cases of reovirus induced \ntenosynovitis and/or lameness in br oilers, ranging in age from two and a half to eight w eeks, were submitted to the \nPoultry Diagnostic and Research Center.  Here, w e report the molec ular and antigenic characterization of field \nisolates associated with VA.   \nReoviruses were isolated , from the tendons submitted , in primary chicken embryo liver cells.  Cytopathic effect \ncharacteristic of reoviruses was ob served in most cases by 72 h  post inoculation.  Cells were frozen and thawed three \ntimes and RNA was extracted from the supernatant.  RNA was used for RT -PCR to amplify a region of the S1 \nsegment encoding the entire sigma C protein ( Kant,  et al ., 2003).  RT-PCR products were sequenced directly for \nmost of the cases; however, in some cases, the products were cloned and sequenced.  Multiple alignments were 63rd WPDC/XXXIX ANECA  \n generated using ClustalW (Lasergene 11.0, DNAstar) followed by phylogenetic analysis using Neighbor Joining \nalgorithm with 1,000 bootstr ap replicates.  \nGenotypic analysis of the reovirus sigma C identified two variant groups of reoviruses isolated from clinica l \nVA cases submitted from 2011 to present. The amino acid similarity of the group 1 VA variants was <50% similar \nto reovirus vaccine strains S1133, 1733, 2408 and 2177.  Serological evaluation of several representativ e isolates \nfrom this group was performed  using one way virus neutralizations in primary chicken embryo liver cells.  \nHyperimmune serum against  a group 1 variant was generated in SPF chickens and used as a positive control along \nwith antiserum against S1133 and 2408.  VN titers of 2-4 (log 2) were observed with S1133 and 2408 antiserum , \nsuggesting that antibodies generated against the vaccine strai ns would not provide sufficient protection against \nchallenge.  Several challenge experiments were performed in progeny from vaccinated breeders that support this \nfinding (data not shown).  Similarity of the group 2 VA variants was 80% similar to reovirus vac cine strains and 50% \nsimilar to the group 1 variants.  In one -way VNs , using hyperimmune serum against group 1 variants and vaccine \nstrains S1133 and 2408, VN titers of  <16 were observed suggesting that antibodies generated against vaccine strains \nand group  1 variants poorly neutralize group 2 variants.   \nThe origin of the variants is currently unknown. Additional molecular and antigenic analysis of the variant \nreoviruses is underway to provide a better understanding to the possible origin of these viruses.  63rd WPDC/XXXIX ANECA  \n   2009 -2013 RETROSPECTIVE STUDY ON NECROTIC ENTERITIS \nIN CHICKENS AND TURKEYS IN THE CENTRAL VALLEY  \nOF CALIFORNIA  \n \nESTUDIO RETROSPECTIVO DEL 2009 AL 2013 SOBRE ENTERITIS \nNECR\u00d3TICA EN POLLOS Y PAVOS DEL VALLE CENTRAL \nDE CALIFORNIA  \n \nC. Gabriel Sent\u00edes -Cu\u00e9A, B. R. CharltonA, H. L. ShivaprasadB, R. P. ChinB, and F. A. UzalC \n \nCalifornia Animal Health & Food Safety Laboratory System (CAHFS),  \nSchool of Veterinary Medicine,  \nUniversity of California, Davis  \n \nATurlock Branch, 1550 N. Soderquist  Road, Turlock, CA 95381  \nBTulare Branch, 18830 Road 112, Tulare, CA 93274  \nCSan Bernardino Branch, 105 West Central Avenue, San Bernardino, CA 92408 \n \nRESUMEN  \n \nEntre enero del 2009 y octubre del 2103, 199 casos de enteritis necr\u00f3tica (NE) en pollos y pavos f ueron \ndiagnosticados en el CAHFS. Todas las aves fueron alojadas en el Valle Central de California. 134, 50 y 15 casos de \nNE fueron diagnosticados en pollos de engorda, pavos y gallina ponedoras respectivamente. E l rango de edades fue \nde 12 d\u00edas  a 29 semanas, y 16 d\u00edas  a 12 semanas en pollos y pavos respectivamente. Los factores asociados m\u00e1s \nfrecuentemente con la NE fueron coccidiosis, reducci\u00f3n  del tejido linfoide en la b olsa de Fabricio, infecciones por \nSalmonella spp., e infecciones por enter itis hemorr\u00e1gica viral. Entre enero y octubre del 2013 se registr\u00f3 un aumento \nen el n\u00famero de casos de NE observados en comparaci\u00f3n con los a\u00f1os previos. El diagn\u00f3stico se bas\u00f3 en \nexaminaci\u00f3n macrosc\u00f3pica e histol\u00f3gica, as\u00ed como descartar otros agentes de enteritis necrotizantes. En algunas \nocasiones tambi\u00e9n se utiliz\u00f3 el cultivo de anaer\u00f3bicos como una ayuda en el diagn\u00f3stico.  \n \nSUMMARY  \n \nBetween January of 2009 and October of 2013, 199 cases of necrotic enteritis (NE) in chickens and turkeys \nwere diagnosed at CAHFS. All the birds were housed in the Central Valley of California. One hundred and thirty \nfour, 50, and 15 NE cases were diagnose d in meat type chickens, turkeys and layers, respectively.  Age ranges for \nNE presentation were 12 d to 29 wk, and 16 d to 12 wk in chickens and turkeys, respectively. The most frequent \nfactors associated with NE were coccidiosis, lymphoid depletion in the bursa of Fabricius, Salmonella spp. infection, \nand hemorrhagic enteritis virus infection. Between January and October of 2013 t here has been an increase in the \nnumbers of NE cases observed in comparison with previous years. Diagnosis was based on gross and histological \nexamination coupled with ruling out other agents of necrotizing enteritis. Anaerobic culture was also occasionall y \nused as a diagnostic aid.    \n  \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n \n FIELD SAFETY AND EFFICACY OF VECTOR \nMAREK\u2019S/INFECTIOUS BURSAL DISEASE VACCINES  \n(RHVT \u2013 IBD) AS ASSESSED BY CLINICAL AND PRODUCTIVE \nPERFORMANCE IN COMMERCIAL LAYERS IN ARGENTINA  \n \nSEGURIDAD DE CAMPO Y EFICACIA DE LAS VACUNAS VECTORIZADAS \nCONTRA LA ENFERMEDAD DE MAREK/ENFERMEDAD INFECCIOSA DE \nLA BOLSA  (RHVT/IBD) SEG\u00daN LA EVALUACI\u00d3N DEL DESEMPE\u00d1O \nCL\u00cdNICO Y PRODUCTIVO EN GALLINAS COMERCIALES DE POSTURA  \nEN ARGENTINA  \n \nL. SestiA, L. SaraB, R. van OortC, F. LozanoD, M. PaniagoD, and C. CazabanD \n  \nCeva  Animal Health  \nABrazil,  BArgentina, CUnited States,  DFrance  \n \n \nRESUMEN  \n \nLa seguridad de campo y la eficacia de dos vacunas vectorizadas HVT - IBD (Cepa de la vacuna recombinante \ncontra Marek HVT [rHVT ] que expresa el gen VP2 del virus de la enfermedad infecciosa de la bolsa [IBD]) se \nevaluaron en una prueba de campo que involucr\u00f3 varias parvadas de gallinas de postura comerciales en Argentina. Tres lotes de gallinas de postura comerciales fueron vacunados (d\u00eda 1, SQ) con un rHVT \u2013  IBD expresando el VP2 \nde la cepa variante E IBDV (Grupo 1) y otras tres parvadas recibieron otra vacuna rHVT -  IBD expresando el VP2 \nde IBDV de la cepa Lukert cl\u00e1sica (Grupo 2). Se compararon los par\u00e1metros de salud y crecimiento, serolog\u00eda de IBD, histolog\u00eda de la bolsa de Fabricio y datos de rHVT -  IBD PCR durante la fase de crianza entre los dos grupos. \nTodas las parvadas de gallinas de postura en los grupos 1 y 2 fueron contempor\u00e1neas y tuvieron el mismo manejo, \nnutrici\u00f3n, tipo de alojamiento y desaf\u00edo de la enfermedad ambiental.  \nLos datos cl\u00ednicos, de laboratorio y de crecimiento de todas las parvadas de ambos grupos no mostraron \ndiferencias estad\u00edsticas entre los dos vacunas rHVT -  IBD utilizadas en esta prueba de campo, para todos los \npar\u00e1metros evaluados.  \n \nSUMMARY  \n \nField safety and efficacy of two vector HVT -IBD vaccines (recombinant  Marek\u2019 s HVT [rHVT] vaccine strain \nexpressing the VP2 gene of the  infectious bursal d isease [IBD] virus) were assessed in a field trial  involving several \nflocks of commercial layers in Argentina. Three commercial layer  flocks were vaccinated (day 1 SQ) with an rHVT -\nIBD expressing the VP2 of the variant E IBDV strain (Group 1) and three  other flocks received another rHVT -IBD \nvaccine expressing the VP2 of  Lukert classical IBDV strain (Group 2). Health and growth parameters,  \nIBD serology, Bursa of Fabricius histology and rHVT -IBD PCR data  during the rearing phase were compared \nbetween the two groups. All  layer flocks in groups one and two were contemporaneous and had the same  \nmanagement, nutrition, type of houses and environmental disease  challenge.  \nThe clinical, laboratory and growth data from all flocks in both groups  showed no statistical differences  \nbetween the two rHVT -IBD vaccines  used in this field trial for all parameters evaluated.  \n \nINTRODUCTION  \n \nInfectious bursal disease (IBD) was first described in 1962 and since then has been described throughout the \nworld. The socio- economic significance of this poultry disease is considerabl e worldwide. Various clinical forms of \nthe disease can occur but the true incidence of those different forms is quite difficult to determine. IBD is present worldwide in all countries with modern poultry production systems. Depending on the age of the infe cted chicken  \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n \n and the virulence of the infecting IBD virus, immunosuppression (very difficult to diagnose and measure) and/or \nhigh rates of morbidity and mortality will ensue in the infected flock ( 3). Therefore, it is indispensable to vaccinate \nbroilers, c ommercial layers and light and heavy breeders against IBD wherever field challenge exists. Currently, \nmany types of vaccines against IBD are available worldwide, ranging from conventional live vaccine strains of different invasiveness rates to molecular biology derived vaccines (recombinant/vector vaccines)  (2). \nThe objective of this field trial was to investigate the safety and efficacy of vector rHVT -IBD vaccines in one \ncommercial layer farm in Argentina located in an area of medium to low classic IBDV ch allenge and/or local \nvariants challenge.  \n \nMATERIAL AND METHODS  \n \nTesting vaccines . The new IBD commercial vaccine tested was a turkey herpesvirus -based recombinant \nvaccine ( rHVT) expressing a key protective antigen (VP2 viral protein of the variant E strain ) of the IBD virus \n(rHVT -IBD-1; Vectormune\n\u00ae IBD, from Ceva Animal Health -  Lenexa, Kansas, USA).  \nA second HVT recombinant vaccine ( rHVT -IBD-2) from a different manufacturer was also used.  \nExperimental groups . The trial was carried out in one commercial layer company located in the eastern part \nof Argentina, a region of medium to low field challenge from classic IBDV and local variants.  \nGumboro vaccination program was used.  \nVaccination program .  rHVT -IB-1 at d  1 SQ (69,000 layers) vs . rHVT -IBD-2 at d 1 SQ  (63,900 layers).  \nBoth groups were also vaccinated with a Marek\u2019s Rispens strain mixed with r HVT -IBD vaccines.  \nSampling for laboratory analysis . Blood samples for Gumboro E LISA  serology (Idexx \u2013 IBD classic kit) \nfrom all flocks were taken at 1,  21, 42 and 105 d of age. In order to confirm rHV T vaccination \u201ctake\u201d, at 21 d  of age, \nfive chickens were euthanized and clinical samples taken from spleen and wing feathers for PCR (Polymerase Chain \nReaction) analysis for detection of r HVT. Five BF from each flock w ere also taken at 21 and 42 d of age for \nhistopathology (lymphoid depletion analysis).  \nGrowth and clinical data . Key flock parameters (average weekly bird weight, weekly flock uniformity and \nweekly mortality) were collected from each flock and statisticall y analyzed for differences between the vaccines \ntested programs throughout the rearing period.  \nStatistical analysis . All productivity, clinical and laboratory results were statistically analyzed by completely \nrandom analysis of variance and means compared by Tukey HSD All -Pairwise test at p<0.05 level. (Statistix\u00ae 9.0 \nsoftware \u2013 www.statistix.com)  \n \nRESULTS AND DISCUSSION \n \nSerology.  Gumboro seroconversion measured by E LISA  serology (Idexx IBD classic kit) indicated a slow and \nuniform Ab production (Table 1) from rHVT -IBD vaccinated chickens, although the commercial kit utilized is not \nrecommended for appropriate detection of VP2 specific Ab production.  \nrHVT PCR / Histopathology score . All rHVT vaccinated flocks were positive at PCR indicating that the \nrHVT  vaccines were properly applied at the hatchery (Table 2). No BF histopathology lesion was found in chickens \nvaccinated with both rHVT -IBD-1 and r HVT -IBD-2 vaccines indicating no early IBD challenge in the farm.  \nGrowth and clinical data.  The measured growth (average weight and body weight uniformity) and clinical \n(mortality) data are d epicted in Table 3. In group two, mortality rate during rearing in chickens vaccinated with \nrHVT -IBD-1 was significantly lower from that observed in r HVT -IBD-2 vaccinated  chickens. The final etiology for \nthat mortality was not assessed.  \n \nCONCLUSIONS  \n \nThe results from this field trial indicate that both rHVT -IBD vaccines equally protected the chickens against \nIBD and Marek \u2019s disease in this farm.  \n   \n \n   \n                                                                                                                                           63rd WPDC/XXXIX ANECA \n \n  \nREFERENCES  \n \n1. Eterrado ssi, N & Saif, YM (2013) Infectious Bursal Disease. In: D. E. Swayne, J. R. Glisson, L. R. \nMcDougald, L. K. Nolan, D. L. Suarez  and V. Nair (editors) -  Diseases of Poultry, 13th edition \u2013 2013. Published by \nWiley -Blackwell \u2013 John Wiley and Sons Inc., Ames , Iowa, USA.  \n2. M\u00fcller, H; Mundt, E;  Eterradossi, N and Islam, MR (2012) Current status of vaccines against infectious \nbursal disease. Avian Pathology 41(2):133- 139. \n3. van den Berg, TP (2000) Acute infectious bursal disease in poultry: a review. Avian Pathology 29:175-\n194. \n \n \nTable 1.  Gumboro E LISA  serology (Idexx classic kit; GMT [%CV]) during the rearing phase in layer flocks \nvaccinated with different Gumboro  vaccination programs (means of each vaccination program in each company \nfollowed by different letter in the same age are statistically different, p<0.05).  \n \nAge Gumboro Serology  \nrHVT -IBD-1 rHVT -IBD-2 \n1 d 8741 a [29] 7209 a [27] \n21 d 410 a [48] 462 a [87] \n42 d 157 a [92] 331 a [70] \n105 d  2968 a [34] 3994 a [28] \n \n \nTable 2.  Bursa of Fabricius\u2019 histopathology lesion scores (lymphoid depl etion) at 21, 28, 35,  and 42 d of age \nfrom detected in layer vaccinated with different Gumboro  vaccination programs (means of each vaccination \nprogram in each company followed by different letter in the same age are statistically different, p<0.05). Data from IBDV and r HVT PCR are also depicted.  \n \nAge Histopathology & rHVT PCR  \nrHVT -IBD-1 rHVT -IBD-2 \nHistopathology score    \n21 d 0 0 \n42 d 0 0 \nrHVT PCR (spleen \nand/or wing feather pulp    \n21 d Positive  Positive  \n  \nTable 3.  Clinical and growth performance during the rearing phase in layer flocks vaccinated with different \nGumboro vaccination programs (means of each vaccination program in each company followed by different letter \nare statistically different, p<0.05).  \n \n Clinical and Growth Performance  \nrHVT -IBD-1 rHVT -IBD-2 \nTotal mortality in rearing  4.03 % a 4.01 % a \nClinical signs  No clinical signs and lesions of IBD and Marek\u2019s was observed in all \nchickens.  \nWeight gain in rearing  There was no statistical difference (p>0.05) in weekly body weight \ngain and uniformity between the groups of chickens vaccinated with \nboth rHVT -IBD vaccines.  Body weight uniformity in rearing  \n \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n FIELD PERFORMANCE OF DIFFERENT VACCINATION \nPROGRAMS AGAINST INF ECTIOUS BURSAL DISEASE (IBD) \nUSING CONVENTIONAL L IVE AND DIFFERENT RHVT -IBD \nVECTOR VACCINES IN COMMERCIAL LAYERS IN BRAZIL  \n \nRENDIMIENTO DE CAMPO DE DIFERENTES PROGRAMAS DE \nVACUNACI\u00d3N CONTRA LA ENFERMEDAD INFECCIOSA DE LA BOLSA \n(IBD) QUE UTILIZAN VACUNAS VIVAS CONVENCIONALES Y DIFERENTES \nVACUNAS VECTORIZADAS  RHVT - IBD EN GALLINAS DE POSTURA \nCOMERCIALES EN BRASIL  \n \n \nL. SestiA, F. ResendeA, M. OizumiA, C. KneippA, R. van OortB, F. LozanoC, M. PaniagoC, and C. CazabanC \n  \nCeva Animal Health  \nABrazil, BUnited States, CFrance  \n \nRESUMEN  \n \nVarias  parvadas de gallinas de postura comerciales en dos empresas diferentes en Brasil fueron vacunadas \ncontra la enfermedad infecciosa de la Bolsa (IBD) con diferentes programas de vacunaci\u00f3n. Las vacunas utilizadas \nfueron: a) vacuna vectorizada rHVT -  IBD que  expresa el gen VP2 de la cepa variante E IBDV combinada con la \ncepa de la vacuna convencional Rispens de Marek (rHVT -  IBD + Rispens; 234.162 gallinas de postura), b) vacuna \nvectorizada rHVT -  IBD expresando el gen VP2 de la cepa cl\u00e1sica Lukert IBDV (rHVT  - IBD; 24.698 gallinas de \npostura), y c) vacunas vivas convencionales de IBD (LIVECONV; cepa intermedia; 74.037 gallinas de postura). Los datos de par\u00e1metros de salud y crecimiento, serolog\u00eda de IBD, histolog\u00eda de la bolsa de Fabricio y los datos rHVT \u2013 \nIBD PCR se compararon entre los tres programas diferentes de vacunaci\u00f3n durante la fase de crianza.  Todas las \nparvadas de gallinas de postura en cada compa\u00f1\u00eda eran contempor\u00e1neas y tuvieron el mismo manejo, nutrici\u00f3n, tipo \nde alojamiento y desaf\u00edo de la en fermedad ambiental.  \nGallinas de postura vacunadas con rHVT -  IBD + Rispens mostraron una mortalidad total menor (p < 0.05) \ndurante la fase de crianza y una calificaci\u00f3n menor de lesiones de histopatolog\u00eda de la b olsa de Fabricio (p < 0,05) a \nlas 3 semanas de edad, en comparaci\u00f3n con las gallinas de postura vacunadas con la vacuna rHVT \u2013 IBD. El resto de \nlos datos cl\u00ednicos, de laboratorio y de crecimiento de todas las parvadas en ambas empresas, no mostraron \ndiferencias estad\u00edsticas entre los tres programas de vacunaci\u00f3n utilizados en esta prueba de campo.  \n \nSUMMARY  \n \nSeveral commercial layer flocks in two different companies in Brazil were vaccinated against infectious bursal \ndisease (IBD) with different  vaccination programs. Vaccines used were: a) vector rHVT -IBD vaccine expressing the \nVP2 gene of the variant E IBDV strain combined with  conventional Marek\u00b4s Rispens vaccine strain (rHVT -\nIBD+Rispens;  234.162 layers); b) vector rHVT -IBD vaccine expressing the VP2 gene of  the classical Lukert IBDV \nstrain (rHVT -IBD; 24.698 layers); and c)  conventional live IBD vaccines (LIVECONV; intermediate strain; 74.037  \nlayers). Health and gr owth parameters, IBD serology, b ursa of Fabricius  histology and rHVT -IBD PCR data during \nthe rearing phase were compared between the three different vaccination programs. All layer  flocks in each \ncompany were contemporaneous and had the same  management, nutrition, type of houses and environmental disease  \nchallenge.  \nLayers vaccinated with the rHVT -IBD+Rispens showed lower (p<0.05)  total mortality during the rearing phase \nand lower (p<0.05) b ursa of  Frabricius histopathology lesion score at three wk  of age when compared  with layers \nvaccinated with the rHVT -IBD vaccine. All other clinical,  laboratory and growth data from all flocks in both \ncompan ies showed no  statistical differences between the three vaccination programs used is  this field trial.  \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n INTRODUCTION  \n \nInfectious  bursal disease (IBD) is an acute, highly contagious viral infection of young chickens that has \nlymphoid tissue,  especially the cloacal bursa (b ursa of Fabricius - BF) as its primary target. IBD is present \nworldwide in all countries with modern poultry production systems. Depending on the age of the infected chicken \nand the virulence of the infecting IBD virus, immu nosuppression and/or high rates of morbidity and mortality will \nensue in the infected flock ( 3). \nTherefore, it is indispensable to vaccinate broilers, commercial layers and light and heavy breeders against IBD \nwherever field challenge exists. Currently, ma ny types of vaccines against IBD are available worldwide, ranging \nfrom conventional live vaccine strains of different invasiveness rates to molecular biology derived vaccines \n(recombinant/vector vaccines ) (2). \nThe objective of this field trial was to inves tigate the safety and efficacy of a vector rHVT -IBD + Rispens \nvaccine in comparison with different IBD vaccination programs with conventional live vaccines and another r HVT -\nIBD vaccine in two different commercial layer farms in Brazil located in areas of m edium to low very virulent \nIBDV challenge and/or local variants challenge.  \n \nMATERIAL S AND METHODS  \n \nTesting vaccines . The new IBD commercial vaccine tested was a turkey herpesvirus -based recombinant \nvaccine ( rHVT) expressing a key protective antigen (VP2 vi ral protein of the variant E strain) of the IBD virus \ncombined (same ampoule) with a conventional Marek\u2019s Rispens vaccine strain ( rHVT -IBD-1; Vectormune\u00ae \nIBD/Rispens, from Ceva Animal Health - Lenexa, Kansas, USA).  A second HVT recombinant vaccine ( rHVT -IBD-\n2) from a different manufacturer was also used as well as a conventional live  intermediate strain Gumboro vaccine.  \nExperimental groups . The trial was carried out in two commercial layer companies located in southeast \nBrazil, a region of medium to low field challenge from very virulent IBDV and local variants.  Vaccination programs \nused by the two companies were as follow s: \nCompany 1 \u2013 rHVT -IBD-1 at d  1 SQ (192,000 layers) vs  conventional live IBDV intermediate vaccine strain \napplied via drinking water at, 12, 17, 22 and 27 d of age (46,000 layers \u2013  these chickens also received a \nconventional HV T+Rispens Marek\u2019s vaccine at d  1 SQ at the hatchery).  \nCompany 2 \u2013 rHVT -IB-1 at d 1 SQ (52,000 layers) vs  rHVT -IBD-2 at d  1 SQ (25,000 layers) mixed with a \nmonovale nt Marek\u2019s Rispens strain vaccine.  \nSampling for laboratory analysis . Blood samples for Gumboro E LISA  serology (Idexx \u2013 IBD classic kit) \nfrom all flocks were taken at 1 , 21, 35, 42, 49,  and 105 d of age. In order to  confirm rHVT vaccination \u201ctake,\u201d five \nchickens were euthanized and clinical samples taken from spleen and wing feathers for PCR (polymerase chain \nreaction) analysis for detection of rHVT. Five BF from each flock were taken at 21, 28, 35,  and 42 d of age for \nhistopathology and IBDV PCR analysis.  \nGrowth and clinical data . Key flock parameters (average weekly bird weight, weekly flock uniformity and \nweekly mortality) were collected from each flock and statistically analyzed for differences between the vaccination \nprograms throughout the rearing peri od. \nStatistical analysis . All productivity, clinical and laboratory results were statistically analyzed by completely \nrandom analysis of variance and means compared by Tukey HSD All -Pairwise test at p<0.05 level. (Statistix\u00ae 9.0 \nsoftware \u2013 www.statistix.co m) \n \nRESULTS AND DISCUSSION \n \nSerology. Gumboro seroconversion measured by ELISA  serology (Idexx IBD classic kit) indicated a slow and \nuniform Ab production (Table 1) from rHVT -IBD vaccinated chickens, although the commercial kit utilized is not \nrecommended for appropriate detection of VP2 specific Ab production. On the other hand, chickens vaccinated with \nconventional live vaccines had not seroconverted even at 49 d  of age clearly indicating failure in vaccine \u201ctake.\u201d  The \nstrong ser oconversion observed at 105 d of age in live conventional vaccines vaccinated chickens was most certainly \ndue to field IBDV challenge.  \nrHVT PCR / IBDV PCR / Histopathology score . All rHVT vaccinated flocks were positive at PCR \nindicating that the r HVT vaccines were properly appl ied at the hatchery (Table 2). BF histopathology lesion scores \nindicated that rHVT -IBD-2 vaccinated chickens were challenged very early when the vaccine had not yet \nestablished full protection. Conventional live vaccine vaccinated chickens were never PCR p ositive for the vaccine \nvirus nor showed any histological lesion in the BFs indicating no vaccination \u201ctake\u201d whatsoever.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n Growth and clinical data . The measured growth (average weight and body weight uniformity) and clinical \n(mortality) da ta are depicted in  Table 3. In C ompany 2, mortality rate during rearing in chickens vaccinated with \nrHVT -IBD-1 was significantly lower from that observed in r HVT -IBD-2 vaccinated chickens. The final etiology for \nthat mortality was not assessed.  \n \nCONCLUSIONS  \n \nThe results fro m the this field trial indicate that both r HVT -IBD vaccines performed quite similarly, except for \nthe higher mortality during rearing and earlier BF histopathological lesions presented by the flocks vaccinated with \nrHVT -IBD-2 vaccine. On the other hand, it  seems clear that field Gumboro vaccination is not a reliable strategy to \nprotect commercial layers against IBD.  \n \nREFERENCES  \n \n1. Eterradossi, N & Saif, YM (2013) Infectious Bursal Disease. In: D. E. Swayne, J. R. Glisson, L. R. \nMcDougald, L. K. Nolan, D. L. Suarez  and V. Nair (editors) -  Diseases of Poultry, 13th edition \u2013 2013. Published by \nWiley -Blackwell \u2013 John Wiley and Sons Inc., Ames, Iowa, USA.  \n2. M\u00fcller, H; Mundt, E;  Eterradossi, N and Islam, MR (2012) Current status of vaccines against infectious \nbursal disease. Avian Pathology 41(2):133- 139. \n3. van den Berg, TP (2000) Acute infectious bursal disease in poultry: a review. Avian Pathology 29:175-\n194. \n \n \n  \n \nTable 1.  Gumboro ELISA  serology (Idexx  classic kit; GMT [%CV]) during the rearing phase in layer flocks \nvaccinated with different Gumboro vaccination programs (means of each vaccination program in each company followed by different letter in the same age are statistically different, p<0.05).  \n \nAge \nCompany 1  Company 2  \nrHVT -IBD-1 Field vaccination  rHVT -IBD-1 rHVT -IBD-2 \n1 d 8663 a [19] 7159 a [26] 6913 a [26.9]  5608 a [32] \n21 d 1738 a [62.5]  1189 a [64] 1118 a [64] 953 a [50.7]  \n35 d 444 a [67.8]  69 b [70] 405 a [80.4]  386 a [75.1]  \n42 d 586 a [69.7]  36 b [106.2]  2513 a [46.9]  1555 a [63.7]  \n49 d 1112 a [58.5]  58.5 b [81.9]  2553 a [32.1]  2268 a [47.9]  \n105 d  4278 a [50.4]  8819 b [21.1]  5026 a [28] 6648 a [31.1]  \n \n \n \n   \n \n \n \n \n  \n \n \n \n \n                                                                                                                                            63rd WPDC/XXXIX ANECA \n \n  \nTable 2.  Bursa of Fabricius\u2019 histopathology lesion scores (lymphoid depl etion) at 21, 28, 35,  and 42 d of age \nfrom detected in layer vaccinated with different Gumboro vaccination programs (means of each vaccination \nprogram in each company followed by different let ter in the same age are statistically different, p<0.05). Data from \nIBDV and r HVT PCR are also depicted.  \n \nAge Company 1  Company 2  \nrHVT -IBD-1 Field vaccination  rHVT -IBD-1 rHVT -IBD-2 \nHistopathology score      \n21 d 0 0 0 a 2.2 b \n28 d 0 0 0 0 \n35 d 0 0 0 0 \n42 d 0 0 3 a 3 a \nIBDV PCR      \n21 d VP2 gene insert  Negative  VP2 gene insert  VP2 gene insert  \n28 d  Negative  Negative  VP2 gene insert  VP2 gene insert  \n35 d Negative  Negative  VP2 gene insert  \nMixed infection  VP2 gene insert  \nMixed infection  \n42 d VP2 gene insert  Negative  VP2 gene insert  \nMixed infection  VP2 gene insert  \nMixed infection  \nrHVT PCR (spleen \nand/or wing feather \npulp      \n21 d Positive  not done  Positive  Positive  \n28 d Positive  not done  Positive  Positive  \n \n \n \nTable 3.  Clinical and growth performance during the rearing phase in layer flocks vaccinated with different \nGumboro vaccination programs (means of each vaccination program in each company followed by different letter \nare statistically different, p<0.05).  \n \n Company  1 Company 2  \nrHVT -IBD-1 Field vaccination  rHVT -IBD-1 rHVT -IBD-2 \nTotal mortality in rearing  2.6 % a 2.8 % a 1 % a 1.9 % b \nWeight gain in rearing  There was no statistical difference (p>0.05) in weekly body weight gain and \nuniformity between the vaccination programs when compared to the target \nstandard curve of the birds\u2019 genetic brand in both companies.  Body weight uniformity in \nrearing  \n  \n 63rd WPDC/XXXIX ANECA  PATHOGENESIS OF TURKEY ARTHRITIS REOVIRUS (TARV)  \n \nPATOG\u00c9NESIS DE LA ARTRITIS CAUSADA POR REOVIRUS EN PAVOS  \n \nT. Sharafeldin, S. Mor, S . Goyal, and R . Porter  \n \nMinnesota Veterinary Diagnostic Laboratory, 1333 Gortner Ave., Saint Paul, MN 55108  \n \nRESUMEN  \n \nEl reovirus aviar ha sido aislado y caracterizado a partir de pavos de 16 semanas de edad con \ntenosiniovitis/artritis y tendones con rupturas desde el 2011 en Minnesota. Estos virus han demostrado ser \ngen\u00e9ticamente diferentes a los reovirus del pollo. Dos de los virus aislados produjeron tenosinovitis cuando se \ninocularon de manera experimental en pavitos de una semana de edad via oral, intratraqueal y/o v\u00eda cojinete plantar \n1 a 2 semanas post inoculaci\u00f3n. De las 7 a las 16 semanas post inoculaci\u00f3n, los pavitos presentaron un andar \nseveramente afectado, fibrosis y adhesi\u00f3n y ruptura del tend\u00f3n gastrocnemio. En el presente trabajo se estudi\u00f3 la \npatog\u00e9nesis y la diseminaci\u00f3n en el tejido del reovirus causante de la artritis a trav\u00e9s de la inoculaci\u00f3n del virus  en \npavitos de una semana de edad. El virus ser\u00e1 detectado por medio de la localizaci\u00f3n de la determinaci\u00f3n de la copia \ndel gen utilizando qRT -PCR e inmunohistoqu\u00edmica.  \n \nABSTRACT  \n \nAvian reovirus has been isolated and characterized from 16 wk  old tom turkeys with tenosynovitis/  arthritis \nand raptured tendons since 2011 in Minnesota. These viruses showed to be genetically different from chicken \nreoviruses. Two isolated reoviruses showed tenosynovitis when it was e xperimentally inoculated in one  wk old \nturkey poults via oral, intratrache al and/or footpad route from one to two wk post inoculation. At seven wk post \ninoculation until 15 wk  post inoculation, poults showed severely disturbed gait, fibrosis, adhesion and rapture in \ngastrocnemius tendon. In this work, we study the pathogenesis and tissue spread of turkey arthritis reoviruses \nthrough inoculation of the TARV -O\u2019Neil via oral route to  one w k old turkey poults. Virus  was detected in intestine, \ngastrocnemius tendon, bursa of Fabricius, spleen liver and kidney at 12, 2 4, 48, 72, 96, 168,  and 331 h  post \ninoculation PI. Virus gene copy determination using quantitative RT -PCR used to quantify the virus multiplication. \nTARV -O\u2019Neil showed the highest multiplication (more than 1000 c opies) in intestines at 96 h  in jejunum, and bursa \nof Fabricius.  In cloacal swab, 100 virus copy numbers were detected. Internal organs and tendons did not have this \nhigh copy number as shown in i ntestines and bursa of Fabricius. These results tells that TARV -O\u2019Neil mul tiply \nmostly in intestines and b ursa of Fabricius. Furthermore, a turkey may shed the virus at 96 h PI.  \n \nINTRODUCTION  \n \nAvian reovirus was first  identified in tendons of 15 -wk-old tenosynovitis/arthritis turkeys in 1980  (3). Page et \nal., (6) described  cases of lameness in five and eight wk old turkeys.  \nIn 2011, Minnesota Veterinary Diagnostic Laboratory isolated and characterized novel turkey arthritis reovirus \n(TARV) strains from tendons of turkeys with tenosynovitis/arthritis  (4). When some of these strains inoculated \nexperimentally via oral, intra tracheal and footpad routes in one w k old turkey poults, they induced tenosynovitis in \ngastrocnemius tendon while chicken reovirus and reovirus isolated f rom turkey intestines did not (7 ). \nIn this work, we study the pathogenesis of TARV -O\u2019Neil; virus multiplication, tissue spread and shedding. \nThis should tell how virus behaves in turkeys and this will lead to understand how the virus uni quely produces the \ndisease.   \nMATERIAL AND METHODS  \n \nBirds.  Eighty commercial one d  old male turkey poults were divided int o two groups; 40 birds that were  \ninoculated with TARV -O\u2019Neil orally and 40 birds  inoculated with virus free MEM orally. Birds were supplied with \nfood and water ad libitum . \nVirus.  TARV -O\u2019Neil that was grown and titrated in QT -35 cell culture. The virus had the following titer 105.5 \nTCID 50/mL.  63rd WPDC/XXXIX ANECA  Experimental design.  Poults were kept in air filtered isolators in RAR facility in University of Minnesota, \nTwin cities campus. Birds were supplied with food and water ad libitum. Birds were th en inoculated with either 0.2 \nmL of virus or 0.2 mL of virus free MEM at one w k of age. At 12, 24, 48, 72, 96, 168,  and 331 h  post inoculation \nPI, five birds from each group were euthanized and samples from duodenum, jejunum, cecum, bursa of Fabricius, \ncloacal swab, kidney, liver, heart, spleen and gastrocnemius tendon were collected.  \nSamples processing.  Samples were homogenized in Hank\u2019s balanced salt solution (HBSS) with 2% donor \nhorse serum (DHS), antibiotics and antifungal drugs. The homogenates were centrifuged for 2500 rpm for 25 \nminutes then supe rnatant were kept frozen ( -20) until  RNA extraction.  \nVirus gene copy determination.  Samples that were kept frozen were subjected to RNA extraction using \nQIAamp Viral RNA Mini Kit (Qiagen, Valencia, CA). The extracted RNA was subjected to quantitative RRT -PCR \nto determine the S4 gene copy number. Previously de veloped turkey reovirus specific rRT -PCR was used \n(Unpublished data).  Forward primer 5\u2019 - ATCATGGCT GGGTTTGTGCC \u20133\u2019 and reverse primer 5\u2019 - \nAGAACGAATTTGTARGCGACCA -3\u2019 were designed to amplify 99 bp fragments from S4 gene. A TaqMan probe, \n5\u2019- FAM -TGAG MGTGATGACTTTACYCC \u2013TAMRA -3\u2019 was similarly selected. The Real time PCR reactions \nwere set up in 96 -well format and carried out in Mastercycler\u00ae ep realplex2 (Eppendorf, Hamburg, Germany) using \nOne-step RT - PCR Kit (Q iagen, Valencia, CA). Each 25 \u00b5L  of reaction mixture contained 5\u03bcL, 5X reaction buffer, \n1.0 \u03bcL enzyme mix, 0.2 \u03bcL  RNase inhibitor (Promega, Madison, USA), 300nM of each primer and  200 nM of \nTaqMan probe and 2 \u00b5L  of RNA. Two no template control (NTC) wells were included in each run. Wells were \nsealed with  optical lids. The PC R cycling conditions were 30 min at 50\u00baC, 15 min  at 95\u00baC and then 45 cycles each of \ndenaturation at 95\u00baC for 15 s and annealing and extension at 56\u00baC for 45 s. Ampli fication data were analyzed by \nsoftware version (Eppendorf). The software generated standard quantitation curves by plotting the threshold cycle \n(Ct) values against the logarithm of the input copy number.  \n \nRESULTS  \n \nVirus gene copy determinatio n. In intestines and bursa of F abricius (Fig . 1), the virus multi plication was low \nuntil 48 h PI. The virus gene copy number in cecum  exceeded 100 copies at 48 h PI. At 72 h  the virus gene copy \nnumber in bursa of Fabricius was more than 100 copies. At 96 h  PI, the virus gene copy numbers exceeded 10 00 \ncopies in jejunum, cecum and bursa of Fabricius. The virus multiplication in duodenum was lower and in virus gene \ncopy number w as around 100 copies at 96 h  PI. \nIn internal organs and gastrocnemius tendon (Fig. 2), the virus gene copy number was lower than 100 copies \nduring all times PI.  \n \nDISCUSSION  \n \nPrevious experiments showed that TARV -O\u2019Neil causes significa nt histologic tenosynovitis at four wk  post \ninoculation ( 7). No lamenes s we seen on these birds until four wk  PI. Only histologic inflammation was observed on \nthe tendons of  birds that were inoculated at one wk  of age via oral, intratracheal or footpad route. Normally in the \nfield we always find reovirus induced l ameness at 10 wk  and older birds. For that hypothe sized for another \nexperiment that the bird got infected at young age and the virus causes tendon sheath inflammation and fibrosis and \nwhen bird gets older and heavier problems starts. In the other experiment, birds were inoculated by TAR V-O\u2019Neil \nthrough or al route at one w k of age then followed until 16 wk  of age. We start to see disturbed gait in infected group \ncompared with control one from eight wk of age (seven wk  PI). This gait disturbance increased until 16 wk  of age \n(Unpublished data). This raised cu riosity to study the pathogenesis of TARV -O\u2019Neil and how this virus uniquely \ncauses histologic inflammation scores that lead to lameness while other avian reovirus (Turkey enteric reov irus and \nchicken reovirus ) does not.  \nThe virus showed high S4 gene copy  number in cecum, jejunum and bursa of Fabricius compared with liver, \nspleen, kidne y, heart and tendons at 96 h  PI. These results (Fig.1 and Fig.2) show that the virus multiplies mostly in \nthe first two wk  in intestines and bursa of Fabricius. The virus st art to sheds at 96 h  PI as cloacal swabs sho wed 100 \nvirus copies at 96 h  PI. This tells some facts about the virus but we still need to understand more about how the virus \ncauses inflammation in gastrocnemius tendon sheath though it is not a main site of v irus replication. Further work in \ncontinuing with blood samples, tendon samples and intestines. This work is investigating cytokine expression.  \n \n \n \n 63rd WPDC/XXXIX ANECA  REFERENCES  \n \n1. Afaleq, A.A . and Jones, R.C. (1 989). Pathogenicity of three turkey and three chicken reoviruses for \npoults and chicks with particular reference to arthritis/tenosynovitis. Avian Pa thology,  18, 433- 340. \n2. Jones, R.C. (2000). Avian reovirus infection. Rev. sci. tech. Off. int. Epiz., 19, 614 -625.  \n3. Levisohn, S ., Gur-Lavie, A. and Weisman, J . (1980). Infectious synovitis in turkeys: Isolation of \ntenosynovitis virus -like agent. Avian Patholology,   9, 1 -4. \n4. Mor, S.K., Sharafeldin, T.A., Por ter, R.E., Ziegler, A., Patnayak, D.P. and Goyal, S.M. (2013) Isolation \nand characterization of a turkey arthritis reovirus. Avian Diseases, 57, 97 -103. \n5. Olson, N.O. and Solomon, D.P. (1968). A natural outbreak of synovitis caused by the viral arthritis age nt. \nAvian Diseases, 12, 311- 316. \n6. Page, R.K., Fletcher, O.J., Villegas, P. (1982). Infectious tenosynovitis in young turkeys. Avian Diseases, \n26, 924- 927.  \n7. Sharafeldin T.A., Mor S.K., Bekele A.Z., Verma H., Goyal S.M. and Porter R.E. (2014). The role of \navian reoviruses in turkey tenosynovitis/arthritis. Submitted to Avian Pathology  \n \n  \n \nFigure 1. Virus gene copy number in intestines and bursa of Fabricius . \n \nA  \n \n \n \nFigure 2.  Virus gene copy number in internal organs and gastrocnemius tendon.  \n \n \n \n \n63rd WPDC/XXXIX ANECA  INCREASED INCIDENCE OF  GIZZARD EROSIONS   \nIN TURKEY POULTS AND  BROILER  CHICKENS  \n \nAUMENTO EN LA INCIDENCIA DE EROSIONES EN LA MOLLEJA  \nDE PAVOS Y POLLOS DE ENGORDA  \n \nH. Shivaprasad and R . Chin  \n \nCalifornia Animal Health and Food Safety Laboratory System, Tulare branch, University of California, Davis  \n \nRESUMEN  \n \nLas erosiones en la capa de la koilina de la molleja que en ocasiones resultan en \u00falceras est\u00e1n teniendo una \nmayor ocurrencia en pavos j\u00f3venes y en pollos de engorda. Existen muchas causas que provocan las erosiones de la \nmolleja. Aminas como la mollerosina, un subproducto del pescado o de la harina de carne se sabe que causa \nirritaci\u00f3n g\u00e1strica, lo cual resulta en erociones en la molleja. Los adenovirus Grupo I tambi\u00e9n se han asociado con erosiones en la molleja de pollos. El estr\u00e9s, cuerpos externos, metales pesados y en ocasiones nem\u00e1todos t ambi\u00e9n \nhan sido asociados con erosiones en la molleja.  \nRecientemente existe un aumento en la incidencia de estas erosiones en pavitos y en pollos libres de \nantibi\u00f3ticos. Para mantener la flora bacteriana en cantidades bajas en el agua, se utilizan \u00e1cidos org\u00e1nicos y cloro. El \nsulfato de cobre tambi\u00e9n se utiliza para contolar la presencia de hongos en el alimento. Es probable que si estos productos son utilizados en exceso, pudieran causar irritaci\u00f3n g\u00e1strica la cual resultar\u00eda en erosiones de la molleja.  \n \nSUMMARY  \n \nErosion of the koilin layer of the gizzard , sometimes resulting in ulcers , is becoming a common occurrence in \nyoung turkeys and broiler chickens. There are many causes for gizzard erosions. Amines such as gizzerosine a byproduct of fish or meat me al, has been known to cause gastric irritation resulting in gizzard erosions. Group I \nadenovirus has also been associated with gizzard erosions in chickens. Stress, foreign bodies, heavy metals and occasionally nematode parasites have also been as sociated with gizzard erosions.  \nRecently there is increased incidence of gizzard erosions more commonly in turkey poults and chickens raised \nas antibiotic free. To keep the bacterial flora down in the water, organic acids and chlorine are being used. Copper \nsulfate  is also being used to control mold in the feed. It is probable that if these products are used in excess they can \ncause gastric irritation resulting in gizzard erosions.  \n \nABSTRACT  \n \nGizzard , also called the ventriculus , is the muscular stomach of most spec ies of birds that functions in grinding \nof feed and helps in digestion. It is made up of smooth muscles rich in myoglobin and is  arranged in four semi - \nautonomous regions, two thick and two thin muscles.  Lining the inner surface of the gizzard is hardened membrane \ncalled koilin or cuticle. The  cuticle or most commonly called koilin layer is rich in carbohydrate complex es and is \nsecreted by the glands underneath.  The koilin layer protects the gizzard from acid and proteolytic enzymes secreted \nby the proventr iculus and from injury during grinding of hard feed  or ingredients. The pH of gizzard is low , 2.5 to \n4.74. The mean retention time of solid phase markers in the proventriculus  and gizzard is about 35 min . In general , \nfeed containing grains spend more time than those made up of crumble s and mash.  Even though gizzard does not \ncontribute any enzymes or  gastric  juice , it is the o rgan where the main proteolysis takes place.  Therefore,  any \ndamage to the gizzard lining or the underlying mucosa and muscular layers can cause maldigestion  resulting in poor  \nabsorption of nutrients  in the intestine. This in turn can result in decreased weight gain and other health \nconsequences  in broilers and turkeys .  \nIt has been observed th at in the past several years  that there is an  increased incidence of gizzard erosions  in \npoult s and broi lers grown as \u201c antibiotic free \u201d or \u201corganic .\u201d However, there are many causes which can causes  \ngizzard erosions. Biogenic amines such as gizzerosine a byproduct of fish or meat meal has been known to cause \ngastric irritation resulting in gizzard erosions. Group I adenovirus has also been associated with gizzard erosions in chickens. Stress, foreign  bodies, heavy metals and occasionally nematode parasites have also been associated with 63rd WPDC/XXXIX ANECA  gizzard erosions.  Others , such as organic acids  to decrease pH in the water,  chlorine dioxide , hydrogen peroxide \nused to control bacteria  in the drinking water , and Co pper sulfate to control mold in feed if used in excess , have the \npotential to cause gizzard erosions.  \nIn order to study the incidence and pathology of gizzard erosions in turkey poults and broiler chickens routine \ndiagnostic submissions to the laboratory were used.  Various parameters such as a ge of the birds  (1 d to 56 d) , \nhistory , clinical signs, use of any substances to control bacteria such as organic acids, chlorine, hydrogen peroxide,  \nnumber of birds submitted and number of birds with gizzard erosions  and the nature and consistency of the feed in \nthe gizzard  were recorded. In addition , gross and microscopic examination of gizzard s in all cases, pharynx, \nesophagus and proventriculus in most cases and tongue and crop in some cases were performed . Feed and gizzard \ncontents were also analyzed for biogenic amines such as histamine, putrescine, cadaverine, spermidine, spermine, \ntyramine, tryptamine and phenylethylamine.  \nThe earliest incidence of gizzard erosions observed in turkey poults and chicks were at  three d  of age but were \nmost common around 10 to 19 d of age.  The incidence of gizzard erosions ranged from a few birds to as many as six \nto eight  in a standard submission of eight to eleven  birds  per submission . The feed in the gizzard of birds with \ngizzard erosions were often coarse and also contained litter.   \nGross lesions of t he koilin layer ranged  from focal pale yellow streaks to diffuse pale roug h appearing  koilin \nthroughout. Often the koilin layer had peeled off  from the underlying mucosa  and occasionally there were \nhemorrhages and ulcers.  Microscopically the lesions consisted of mild  to severe,  focal to multifocal or  diffuse  \ndegeneration, necrosis  and ulceration  of the koilin. This was accompanied by a thin to thick layer of \nfibrinosuppur ative exudate mixed with bacteria either replacing or overlying the koilin and the mucosa . There was \ninfiltration of heterophils and lymphocytes in the mucosa and the crypts were often dilated. Occasionally there was \nextension of inflammation in to the sub mucosa and muscular layers . In the upper digestive tract there were lesions \nsuggestive of caustic changes of the mucosa characterized by hypertrophy and pale epithelial cells several layers \nthick most commonly in the pharynx but also in the tongue, esophag us and crop.  Occasionally there was candidiasis \nof the mucosa  in these organs . \nNo viral inclusions suggestive of adenovirus were found in the mucosa of the gizzard or the upper digestive \ntract. Feed and gizzard contents analyzed for biogenic amines either were  negative  or were  in non-toxic \nconcentrations . The cause of gi zzard erosions in turkey poults and broiler chickens could not be determined. But \nthere was history of using organic acids, chlorine dioxide, and hydrogen  peroxide in the water to control bacteria in \nmost of these cases. Therefore, it is probable that the se products if used  in excess  and in combination of  a low pH in \nthe gizzard  might have  cause d gastric irritation resulting in gizzard erosions  and ulcerati ons as well as lesions in the  \nupper  digestive tract.   63rd WPDC/XXXIX ANECA  COMMON NUTRITIONAL  DISEASES  SEEN  IN COMMERICAL \nCHICKENS AND TURKEYS IN C ENTRAL CALIFORNIA  \n \nENFERMEDADES NUTRICIONALES COMUNES OBSERVADAS  \nEN POLLOS Y PAVOS EN CALIFORNIA CENTRAL  \n \nH. ShivaprasadA, R. ChinA, S. CarnacciniB, B. CharltonB, and G. SentiesB \n \nCalifornia Animal Health and Food Safety Laboratory System, TulareA and TurlockB branch es,  \nUniversity of California, Davis  \n \nRESUMEN  \n \nA pesar de los grandes avances hechos en la nutrici\u00f3n aviar, se siguen observando casos de desnutrici\u00f3n de \nforma com\u00fan en pollos y pavos. Varios factores como errores humanos, interacciones nutricionales, mala digesti\u00f3n \ny mala absorci\u00f3n debido a enfermedades, etc. pueden tener influencia sobre la presencia de las enfermedades o la \ndesnutrici\u00f3n. Estas enfermedades incluyen ded os torcidos y par\u00e1lisis debido a deficiencias de vitamina B2, \nencefalomalacia debida a deficiencias de vitamina E, ricketsia/osteomalacia debida a deficiencias de calcio, f\u00f3sforo y vitamina D3 o una ambibalencia en la relaci\u00f3n calcio:f\u00f3sforo, as\u00ed como lesi ones oculares, en el sistema digestivo \nanterior, sistema respiratorio y lesiones bursales debidas a deficiencias de vitamina A. La perosis puede deberse en \ngran parte a la deficiencia de magnesio y la discondroplasia tibial puede deberse a factores gen\u00e9ticos y a desbalances \nde electrolitos. El raquitismo en pavos puede deberse a una mala absorci\u00f3n como resultado de enfermedades \nintestinales causadas por virus ent\u00e9ricos. Las enfermedades ocasionadas por desnutrici\u00f3n pueden ser diagnosticadas \ntentativamente e n base a los signos cl\u00ednicos y la patolog\u00eda en aves, y confirmarse por medio de an\u00e1lisis del alimento, \nserol\u00f3gicos y evaluaciones hep\u00e1ticas.  \n \nSUMMARY  \n \nIn spite of vast advances made in poultry , nutrition diseases of malnutrition are still observed rather co mmonly \nin chickens and turkeys. Various factors such as human errors, nutritional interactions, maldigestion and malabsorption due to diseases etc. can influence diseases of malnutrition. These diseases include curly -toe paralysis \ndue to vitamin B2 defic iency , encephalomalacia due to vitamin E deficiency,  rickets/osteomalacia due to calcium, \nphosphorus and vitamin D3 deficiency or an imbalance in the ratio of calcium to phosphorus and ocular, upper \ndigestive, respiratory and bursal lesions due to vitamin  A deficiency. Slipped tendon most likely due to deficiency of \nmanganese and tibial dyschondroplasia probably due to genetics and electrolyte imbalance are also observed. Field rickets in turkey poults due to  malabsorption as a result of intestinal disease s due to enteric viruses also occurs. \nDiseases of malnutrition can be tentatively diagnosed based on clinical signs and pathology in birds and confirmed by feed, serum and liver evaluations.  \n \nABSTRACT  \n \nNutrition is the process of furnishing the cells insid e the animal with that portion of the external chemical \nenvironment needed for optimum functioning of the many metabolic and chemical reactions (Scott  1971). It \ninvolves procurement, digestion, and absorption of nutrients. Nutrients including amino acids, carbohydrates, fats, vitamins, inorganic chemical elements, energy, water and oxygen are essential for normal growth and development, \nlivability, work and reproduction. These nutrients should be in proper concentration and balance to be effective.  \nIn spit e of vast advances made in poultry nutrition , diseases of malnutrition are still observed rather commonly \nin chickens and turkeys. Various factors can influence nutritional diseases in birds in general. It is important to \nunderstand these factors as they are necessary for taking corrective steps. These include human errors such as \nomission of an ingredient or two of  groups of vitamins (water soluble and fat soluble), improper mixing, improper \nstorage, miscomputations in feed formulations and misfeeding to wrong species or sex or age of the birds. Other \nimportant factors that can influence nutritional diseases include poor nutritive value of an ingredient, nutrient and \nmineral interactions, poor shelf life and insufficient feed availability. Poor health of the birds due to bacteria, 63rd WPDC/XXXIX ANECA  viruses, parasites and other causes can result in anorexia, dysphagia, maldigestion, malabsorption , decreased storage \nor utilization, increased excretion or secretion and increased requirements that can also cause malnutrition.  \nMalnutrition in poultry can result in a general ized or a specific disease. Specific disease conditions such as \nencephalomalacia or rickets are easy to diagnose and treat. But generalized or subclinical disease or signs such as \nloss of weight or failure to thrive due to marginal deficiencies of nutrients are very difficult to diagnose and treat. \nThe latter are probably more common in the field than realized. Malnutrition can also suppress immune system, \ndecreased reproductive performance, decrease weight gain, can cause feather problems and cause decreas ed \nresponse to therapeutic agents.  \nDiagnosis of malnutrition in poultry can generally be based on history such as recent feed change, clinical \nsigns, gross and microscopic lesions, analysis of feed if available, liver and serum, serum chemistry, radiograph y of \nthe birds and estimating peroxide levels in the feed which indicates rancidity. Feeding trials with suspected feed can \nalso be performed but it can be time consuming, expensive and sometimes disappointing. Treatment is another \noption of diagnosing dis eases; for example, curled  toe paralysis due to riboflavin (vitamin B2) deficiency where the \nbirds will respond to supplementation of riboflavin or multiple B vitamins if the condition is diagnosed and treated \npromptly.  \nSome of the common diseases of malnutrition seen in chickens and turkeys were  rickets, \nosteomalacia/osteoporosis, encephalomalacia,  curled toe paralysis, vitamin A deficiency , and occasionally slipped \ntendon.  \nOne of the m ost common disease s of malnutritio n seen in poultry w as rickets, most likely due to calcium, \nphosphorus , and vitamin D3 deficiency or an imbalance in the r atio of calcium to phosphorus. Another \nmanifestation of rickets , a condition called \u201cfield rickets\u201d was also observed in turkey poults  most likely due to \nmalabsorption caused by damage to the tips of the intestinal villi by enteric viruses.  Similar condition can also take \nplace in broiler chicks such as in runting stunting syndrome but it has not been well documented.  In cases of ricket s, \nchickens and poults were often presented with clinical signs of being down on legs and increased mortality in the \nflock.  Gross lesions include crooked keels, soft , pliable  and bowing of  long bones , beading of ribs and enlarged \nparathyroid glands. Similar lesions  were  also seen in adult laying chickens due to osteoporosis.  Microscopic lesions \ndue to rickets were quite characteristic in the physis of long bones in young birds and hyperplasia of chief cells in \nthe parathyroid glands.  Feed analysis co nfirmed rickets in some cases.  \nEncephalomalacia due to vitamin E deficiency has been  observed in young chicks and turkey poults \ncharacterized by neurological signs of ataxia, head tilt and sudden death. Gross lesions of soft and enlarged \ncerebellum with petechiae and hemorrhage and microscopic lesions of malacia, hyalin thrombi , and hemorrhages \nwere characteristic lesions of encephalomalacia.  \nCurled toe paralysis  due to vitamin B2 (riboflavin) deficiency was pri marily seen in young 9 to 27 d old broiler  \nand pullet chicks  characterized by ataxia, curled or non -curled toes , and increased mortality as high as 50 % in one \ninstance . Gross and microscopic lesions in the nerves consist ed of enlarged sciatic nerves, loss of cross striations, \ndemyelination , and infiltration of lymphocytes. P rompt diagnosis followed by s upplementation with multivitamins \nhad a dramatic and positive effect on th is condition.  \nMany cases of vitamin A deficiency w ere diagnosed primarily in turkey s at different ages : 3 to 6 and 11 to 19 \nwk old. Droopy birds with ruffled feathers, ocular discharge, failure to gain weight , and increased mor tality were the \nprimary clinical signs. Gross and microscopic lesions included caseous exudate in the o cular, upper d igestive, \nrespiratory systems , and in the bursa of Fabricius accompanied by squamous metaplasia of the cuboidal and \ncolumnar epithelial cells.  Analysis of feed samples revealed either very low or no vitamin A.   \nSlipped tendon most likely due to deficiency of manganese was occasionally  seen in a few turkeys and pullets \ncharacterized by swelling of the hock joint and slippage of the gastrocnemius tendon.  \n 63rd WPDC/XXXIX ANECA  DETECTION OF CYTOLETHAL DISTENDING TOXIN \n(CDT)  GENES IN  CAMPYLOBACTER JEJUNI   \nISOLATED FROM CHICKEN CARCASSES  \n \nDETECCI\u00d3N DE GENES DE LA TOXINA DISTENSORA CITOLETAL (CDT) \nEN CEPAS DE CAMPYLOBACTER JEJUNI  \nAISLADAS  DE POLLO EN CANAL  \n \nY. Sierra -ArguelloA*, M. TrinidadeA, G. PerdonciniA, and V. Pinheiro do NascimentoA \n \nA Center for Diagnostics and Research in Avian Pathology (CDPA), Av. Bento Gon\u00e7alves, 9090. CEP 91540- 000. \nFederal University of Rio Grande do Sul (UFRGS). Faculty of Veterinary Medicine (FAVET). Porto Al egre, Rio \nGrande do Sul, Brazil  \n*Corresponding author  E-mail: yuli_melisasierra@yahoo.com  - Fax: +55 (51) 3308- 6130.  \n \nRESUMEN  \n \nUno de los principales factores de virulencia relacionados a la patogenicidad de Campylobacter jejuni  en \ninfecciones humanas y animales es la toxina distensora citoletal (CDT), conduciendo a arresto del ciclo celular en \nG2/M y posterior muerte celular. Su actividad est\u00e1 codificada por el complejo de genes cdt, que consiste en tres \ngenes adyacentes ( cdtA, cdtB, cdtC). El objetivo del presente trabajo fue aislar e identificar cepas de C. jejuni a \npartir de carcasas refrigeradas de tres plantas de sacrificio d el estado de Rio Grande del Sur, Brasil; detectar \nmediante la t\u00e9cnica de PCR la presencia del complejo de genes cdt . Treinta cepas de Campylobacter jejuni  fueron \naisladas e identificadas por m\u00e9todos fenot\u00edpicos y genot\u00edpicos.  La presencia del complejo cdt  fue detectada en el \n63,33% de las cepas aisladas, demostrando la alta posibilidad de la presentaci\u00f3n de la toxina que est\u00e1 relacionada \ncon la patog\u00e9nesis de la diarrea inflamatoria en humanos.  \n \nSUMMARY  \n \nOne of the major virulence factors related to the pathogenicity of Campylobacter jejuni  in human and animal \ninfections is the cytolethal distending toxin (CDT ), leading to cell cycle arrest in G2/M and subsequent cell death . \nIts activity is encoded by the cdt gene operon , which consists of three adjacent genes ( cdtA , cdt B , cdt C). In this \nwork we isolated and identified strains of Campylobacter jejuni  from refrigerated carcasses  of three slaughter plants \nin the stat e of Rio Grande do Sul, Brazil and detected using PCR the presence of cdt genes  operon . Thirty strains of \nCampylobacter  jejuni were isolated and identified by phenotypic an d genotypic methods . The cdt  complex was \ndetected in 63.33 % of the isolates,  showing a high possib ility of the introduction of this  toxin which is linked to the \npathogenesis of inflammatory diarrhea in humans.  \n \nINTRODUCTION  \n \nCampylobacteriosis is a zoonosis of worldwide distribution, with sign ificant impact on public health.  In recent \nyears Campylobacter  has been recognized as an emerging foodborne organism, which is widely distributed in the \nenvironment, well as acting as a p athogen or commensal bacteria of the gastrointestinal tract of domestic and wild \nanimals. Campylobacter  is widespread in nature  and the principal reservoirs of these microorganisms are the \nalimentary tract of wild and domesticated birds ( 19). This microorganism is the principal cause of human \ngastroenteritis worldwide, but the disease can present as a spectrum from  asymptomatic to  severe bloody diarrhea. \nIn rare instances this infection may be followed by sequelae including septicaemia (5) and neuropathies such as \nGuillain -Barr\u00e9 syndrome  (GBS) (3 ). \nThe pathogenesis of Campylobacter jejuni  (C. jejuni)  is poorly unders tood as compared to other enteric \npathogens. Various pathogenic mechanisms like production of cholera like enterotoxin and cytotoxin and ability to \nadhere and invade epithelial cells have been proposed to play a role in the cases of enteritis (7 , 15). CDT is encoded \nby three adjacent genes, cdt A, cdtB, and cdt C, and expression of all three cdt  genes is required in order to produce \nactive CDT (14). Thus, CDT toxin can act as a virulence factor in pathogens that produce this toxin, since genes are 63rd WPDC/XXXIX ANECA  active.  Abuoun et al. (1) suggested that cdt B encodes the active/toxic component of the toxin, while cdt A and cdt C \nare involved with binding to and internalization into the host cell.  \nAt that time, Pe res et al. ( 13) first reported that the mechanism of mammalian  cell intoxication by E. coli CDT  \ninvolved arrest of the cell cycle at the G2/M phase. Soon after, these observations were extended to CDT produced \nby Aggregatibacter  (formerly Actinobacillus ) actinomycetemcomitans (17). Finally, Gelfanova et al.  (10) \ndemo nstrated that the underlying mechanism of  CDT -induced cell death involving  apoptosis.  It has been observed \nthat CDT causes cell cycle blockage in several cell types ( 18) indicating that the action of CDT diff ers from other \nbacterial toxins. Thus, as Campylobacter  may be transferred from animals to human , it is important to know whether \nall Campylobacter isolates obtained from different sources are equally viru lent. To address this matter, thirty  C. \njejuni isolates from three slaughter plants in the st ate of Rio Grande do Sul, Brazil  were selected and tested in the \npresent study.  \n \nMATERIALS AND METHODS  \n \nProcessing of carcasses . The refrigerated carcasses are rinsed in sterile polyethy lene bags containing 400 mL \nof buffered peptone w ater ( BPW  1%). 1 mL aliquot of each sample was removed and homogenized in 9 mL of \nBolton broth supplemented with antibiotics and incubated in microaerophilic conditions ( 10% CO 2, 2% H 2, 5% O 2, \nand 80% N 2.) for 48 h  at a temperature of 41.5\u00b0C. 100\u00b5L of the suspension was filtered on a membrane with a 0.65 \nmM pore acetate, this membrane was spread on the surface of a charcoal cefoperazone deoxycholate agar (CCDA) \nplate  (CM739, Oxoid\u00ae, with cefoperazone selective su pplement SR 155E) for 30 min . The plate was incubated in \nmicroaerophilic  conditions at 41.5 \u00b0C for 48 h.  Colonies  suspected as being Campylobacter  spp. were examined for \ncell morphology  by phase -contra st microscopy (Olympus  B201). The isolates were purified further on blood agar \nplates (BA; Blood Agar Base N.2, Oxoid, supplemented with sterile defibrinated ovine blood 5%).  Single colonies \nwere picked and streaked on to wet BA plates, and further characterized to species level by thei r catalase reaction \nability to hydrolyze hippurate and indoxyl acetate.  For the final identification of the suspect samples Multiplex -PCR \ntechnique ( 9) was used. The colonies were  collected and resuspended in 1 mL of ultrapure water, transferred to \nmicrotub es, and later frozen at - 20\u00b0C until DNA extraction. Isolates were stored with glycerol 15% at - 80\u00b0C until \nrequired for further investigations.  \nDetection of cdt  genes from Campylobacter  isolates by PCR.  Thirty  Campylobacter jejuni  isolated and \nidentified  by polymerase chain reaction ( PCR) were used. As a positive control tests, was used the standard strain \nATCC 29428 Campylobacter jejuni.   \nStandardization of protocols: Three pairs of primers for detection of CDT complex in Campylobacter  jejuni , \nwas selected based on  Datta et al. (8) and Wieczorek et al. (19). The primers were: cdtA F: \n5\u2019CCTTGTGATGCAAGCAATC3\u2019 and cdtA R: 5\u2019ACACTCCATTTGCTTTCTG3\u2019,  cdtB F: \n5\u2019CAGAAAGCAAATGGAGTGTT3\u2019 and cdtB R: 5\u2019AGCTAAAAGCGGTGGAGTAT3\u2019;  cdtC F: \n5\u2019CGATGAGTTAAAACAAAAAGATA3\u2019 and cdtC R: 5\u2019TTGGCATTATAGAAAATACAGTT3\u2019.  The PCR \nconditions were adapted from Datta et al.(8). All PCR ampli\ufb01cations were performed in a mixture (30\u00b5L) consisting \nof 3 \u00b5L of the PCR buffer (10 \u2013  fold concentrated),  0.2 (5 U) of the Taq thermostable DNA polymerase  \n(Invitrogen\u00ae), 1.25 \u00b5l of MgCl2 (25 mM), 2.4 \u00b5L dNTPs (dATP, dCTP, dGTP and dTTP, each at 2.5 mM), 0.5 \u00b5L \nextracted template DNA and 1 \u00b5L of a 20 pM solution of each primer. Sterile  Milli- Q water  was added q.s.p 30 \u00b5L . \nAll amplification reactions are performed in thermal cycler (Peltier Thermal Cycler Biocycler -MJ96 + / MJ96G). \nThe 30 cycles was performed  as follows: denaturation at 94oC for 1 min, annealing at a temperature speci\ufb01c to the \nprimer pair ( cdtA 47oC, cdtB 51oC and cdt C 49oC) for 1 min and extension at 72oC for 1 min. Part of this ampli\ufb01ed \nsample was  analyzed by electrophoresis  in 2% agarose gels ( Invitrogen\u00ae). DNA bands were stained with ethidium \nbromide and visualized with a UV transilluminator (ATTO\u00ae). \n \nRESULTS  \n \nThe primary goal of this work was to determine the frequency of cdt  genes in C. jejuni isolates from chicken \ncarcasses. The cdt  gene cluster was detected in 63.33% isolates.  Of the samples tested, 83.33% (25/30) were positive \nfor cdtA, 63.33% (19/ 30) positive for cdtB and 86.66% (26/30) positive for cdt C. The high prevalence of toxin \ngenes demonstrated that these putative pathogenic determinants are widespread among Campylobacter  isolates from \npoultry. These results varied in agreement with the lit erature, which reports frequencies usually near 100% for all \nthree genes. Datta et al. (8) reported a frequency of 100% for the genes in the studied samples, which included \nchicken, chicken feces, cattle feces and human clinical samples. Rozyneketal et al. (16) found 100% of prevalence \nin isolates from broiler carcasses. Wieczorek et al.  (19) reported in  samples of bird feces, 87.5% positive for cdt A, 63rd WPDC/XXXIX ANECA  75% and 90% for cdt B cdtC, respectively. In Brazil, there are few studies about  CDT in Campylobacter jejuni . \nCarvalho et al. (6) searching  Campylobacter jejuni  in poultry carcasses reported CDT complex in only 36.4% of the \nsamples.  According to Martinez et al.  (11), essentially all strains of C. jejuni have the cdt  genes, and most have toxin \nactivity. But ther e are exceptions of isolates that mutate and do not express the toxin activity. Asakura et al.  (2) also \nobserved that some cdt  genes are not identified due to mutations as deletion, insertion or substitution of nucleotides, \nand suggest that these mutations  may affect the activity of the toxin. Bang et al. (4) reported that toxin production is \nlow or absent when mutations in regions of the cdt  gene occur, however, according to Park (12), and even some \nstrains are CDT negative, mutants retain some toxigenic activity. Our understanding of the ecology of CDT -\nproducing bacterial species has greatly expanded and the molecular biology of CDT -induced cellular genotoxicity \nhas improved significantly. However, the natural history and contribution of CDT produced by in dividual bacterial \npathogens in the context of mucocutaneous colonization, initiation and persistence of infection and disease in their \nrespective host niches remain incompletely understood.  \n \nREFERENCES  \n \n1. Abuoun, M., G. Manning, S. A. Cawthraw , A. Ridley, I. H. Ahmed , T. M. Wassenaar , D. G.  Newell . \nCytolethal distending toxin (CDT) -negative  Campylobacter jejuni  strains and anti -CDT neutralizing antibodies are \ninduced during human infection but not during colonization in chickens . Infect Immun . 73, 3053 \u2013\n3062.10.1128/IAI.73.5.3053- 3062.  2005 . \n2. Asakura, M., W. Samosornsuk, M. Taguchi, K. Kobayashi, N. Misawa, M. Kusumoto, K. Nishimura, A. \nMatsuhisa, S. Yamasaki. Comparative analysis of citolethal distending toxin ( cdt) genes among  Campylobacter \njejuni,  C. coli  and C. fetus  strains.  Microb. Pathog . v.42, p.174- 183. 2007An g, C. W., M. A. De Klerk,  H. P. Endtz, \nB. C. Jacobs , J. D. Laman, F. G. A. Van Der Meche, P. A. Van Door n. Guillain -Barr\u00e9 syndrome - and Miller Fisher \nsyndrome - associated  Campylobacter  jejuni Lipopolysaccharides induce anti -GM 1 and anti -GQ 1b antibodies in \nrabbits.  Infect. Immun.  69, 2462 -2472.  2001 . \n5. Bang, D.  D., E. M. Nielsen, F. Scheutz, M. Madsen. PCR detection of seven virulence and toxin genes of  \nCampylobacter jejuni  and Campylobacter coli  isolates from Danish pigs and cattle and citolethal distending toxin \nproduction of the isolates.  J. Appl. Microbiol . v.94, p.1003- 1014.  2003.   \n6. Blaser, M. J., I. D. Berkowitz, M. LaForce, J. Cravens, B. Reller, W.-L. L. Wang.  Campylobacter  \nenteritis clinical and epidemiologic features. Ann. Int. Med.  91, 179-185. 1979 . \n7. Carvalho , A. F. et al. Detec\u00e7\u00e3o  dos genes  da toxina  citoletal distensiva  em estirpes  de Campylobacter  \njejuni isoladas  de carca\u00e7as  de frangos.  Arq. Bras.  Med.  Vet. Zootec . v.62,  n.5, pp.1054- 1061.  2010.  \n8. Crushell , E., H. Sinead, F. Sharif, B. Bourke . Enteric Camplylobacter : Purging its secrets? Review. \nPediatr. Res. 55, No.1.  2004.  \n9. Datta, S. H. N iwa, K. Itoh. Prevalence of 11 pathogenic genes of Campylobacter jejuni by PCR in strains \nisolated from humans, poultry meat and broiler and bovine faeces . J. Med.  Microbiol . v.52, p.345- 348. 2003.  \n10.  Denis , M., C. Soumet , K. Rivoal , G. Ermel , D. Blivet,  G. Salvat,  P. Colin . Development  of m-PCR assay  \nfor  simultaneous  identi\ufb01cation  of Campylobacter  jejuni and C. coli. Letters  in Appl.  Microbiol . 29, 406\u2013410. 1999.   \n11.  Gelfanova,  V., E. J. Hansen,  S. M. Spinola.  Cytolethal distending toxin of  Haemophilus  ducreyi  induces \napoptotic death of Jurkat T cells.  Infect . Immun . 67, 6394 -6402.  1999 .  \n12.  Martinez, I., E. Mateo, E. Churruca, R. Alonso, A. Fern\u00e1ndez -Astorga . Detection of cdt A, cdtB, and \ncdtC genes in  Campylobacter jejuni by multiplex PCR.  Int. J. Med. Microbiol . v.296, p.45- 48. 2006.   \n13.  Park, S.F. The physiology of  Campylobacter  species and its relevance to their role as foodborne \npathogens.  Int. J.  Food Microbiol.  v.74, p.177 -188. 2002.   \n14.  Peres,  S. Y., O. Marches,  F. Daigle,  J. P. Nougayrede,  F. Herault,  C. Tasca,  J. De Rycke , E. Oswald . A \ncytolethal distending toxin (CDT) from  Escherichia  coli producing CNF2 blocks HeLa cell division in G2/M \nphase.  Mol. Microbiol . 24, 1095 -1107. 1997 .  \n15.  Pickett, C.L., C.A. Whitehouse.  The cytolethal distending toxin family. Trends in Microbiol. 7: 292 -297. \n1999.  \n16.  Rizal , A., A. Kumar, A. S. Vidyarthi.  Prevalence of pathogenic genes in Campylobacter jejuni isolated \nfrom poultry and human. Int . J. Food Saf . 12: 29- 34. 2010.  \n17.  Rozynek, E.  et al.  Prevalence of potential virulence markers in Polish Campylobacter jejuni  and \nCampylobacter coli isolates obtained from hospitalized children and from chicken carcasses. J . Med. Microbiol . \nv.54, p.615- 619. 2005.  63rd WPDC/XXXIX ANECA  18.  Sugai, M., T. Kawamoto, S. Y. Peres, Y. Ueno, H. Komatsuzawa, T. Fujiwara, H. Kurihara, H. \nSuginaka,  E. Oswald.  The cell cycle -specific growth -inhibitory factor produced by  Actinobacillus \nactinomycetemcomitans  is a cytolethal distending toxin.  Infect . Immun . 66, 5008- 5019.  1998.   \n19. Whitehouse,  C. A., P. B. Balbo,  E. C. Pesci,  D. L. Cottle,  P. M. Mirabito,  C. L. Pickett.  Campylobacter  \njejuni  cytolethal distending toxin causes a G2 -phase cell cycle block.  Infect.  Immun.  66, 1934 -1940.  1998 . \n20. Wieczorek , K., J. Osek . Comparison of two molec ular methods for genotyping of Campylobacter  sp. \nisolated from poultry.  Bull. Vet. Inst. Pulawy . 52, 523- 528. 2008.  \n \nACKNOWLEDGMENTS  \n \nWe would like to acknowledge CAPES Coordination of Qualification  of Higher Education Faculty for their \nfinancial support . 63rd WPDC/XXXIX ANECA  THE INTERFACE OF SCIENCE AND POLICY IN DETERMINING \nSALMONELLA  OUTBREAKS ATTRIBUTABLE TO POULTRY  \n \nEL PUNTO DE CONTACTO ENTRE LA CIENCIA Y LA POL\u00cdTICA EN LA \nDETERMINACI\u00d3N DE BROTES DE SALMONELLA  \nATRIBUIBLES A LA AVICULTURA  \n \nR. Singer  \n \nDepartment of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota,  \n1971 Commonwealth Ave., St. Paul, MN 55108  \n \nRESUMEN  \n \nSalmonella sigue siendo un problema importante de salud humana, y si bien las enfermedades causadas por \nalgunas bacterias transmitidas por los alimentos han disminuido, los casos de salmonelosis se han mantenido \nestables. Muchos de los casos de salmonelosis humana s on atribuibles al consumo de aves. Muchas pol\u00edticas \nrecientes implementadas para reducir los riesgos para la salud humana asociados con aves contaminadas con \nSalmonella se basan en la detecci\u00f3n de brotes causados por subtipos de los serotipos de Salmonel la. Una \ndeterminaci\u00f3n del brote objetiva y basada en la ciencia es esencial para que estas pol\u00edticas proporcionen un beneficio \nreal para la salud humana. Esta presentaci\u00f3n explorar\u00e1 un evento reciente de salmonelosis que fue definido por el \nCDC como un brote causado por siete patrones diferentes de electroforesis en gel en un campo de pulsos (PFGE) de \nSalmonella Heidelberg. El objetivo de la presentaci\u00f3n ser\u00e1 entender la ciencia detr\u00e1s de la determinaci\u00f3n del brote y \nc\u00f3mo la industria de la avicultura podr\u00ed a verse afectada en el futuro si esta definici\u00f3n se sigue utilizando.  \n \nSUMMARY  \n \nSalmonella continues to be a significant human health problem, and while illnesses due to some foodborne \nbacteria have decreased, salmonellosis cases have remained steady. Many  human salmonellosis cases are \nattributable to the consumption of poultry. Many recent policies being implemented to reduce the human health risks \nassociated with  Salmonella- contaminated poultry are based on the detection of outbreaks caused by subtypes of  \nSalmonella  serotypes. A science- based and objective outbreak determination is essential if these policies are to \nprovide a real benefit to human health. This presentation will explore a recent salmonellosis event that was defined \nby the CDC as an outbreak  caused by seven  different pulsed -field gel electrophoresis (PFGE) patterns of Salmonella  \nHeidelberg. The objective of the presentation will be to understand the science behind the outbreak determination and how the poultry industry might be impacted in the future if this definition continues to be used.  \n \nABSTRACT  \n \nSalmonella continues to be a significant human health problem, and while illnesses due to some foodborne \nbacteria have decreased, salmonellosis cases in the U.S. have remained steady (1).  Many human salmonellosis cases \nare attributable to the consumption of poultry, with certain mathematical models of attribution in the U.S. estimating that as many as 48% of sporadic salmonellosis cases are  attributable to poultry consumption (2).  One possi ble \nexplanation for the disconnect between Salmonella reductions in poultry over the past decade and the st able \nincidence rate of salmonellosis in humans is the continued reliance on  prevalence -based performance standards (3).   \nCurrent policies being imple mented to reduce human health risks associated with Salmonella- contaminated \npoultry are based on the detection of outbreaks caused by subtypes of Salmonella  serotypes.  For example, pulsed -\nfield gel electrophoresis (PFGE) is commonly used to link illnesses due to Salmonella, to identify possible sources of these illnesses, and to determine if a possible outbreak of specific Salmonella subtypes is occurring.  A science -\nbased and objective outbreak determination is essential if these policies are to provide a r eal benefit to human health.  \nThis presentation will explore a recent salmonellosis event that was defined by th e CDC as an outbreak caused by \nmultiple  different pulsed- field gel electrophoresis (PFGE) patterns of Salmonella Heidelberg.  The objective of the  \npresentation will be to understand the science behind the outbreak determination.  Of critical importance, data that \nmight be used to estimate the number of expected illnesses will be explored.  Without a solid understanding of the 63rd WPDC/XXXIX ANECA  biases in the U.S. survei llance systems and of the number of illnesses that might be expected under normal \nconditions, outbreaks will be declared that might actually represent nothing more than the expected number of \nillnesses.  If there is a desire to have performance standards pr edict public health risks, changes must be made in \ninspection practices so that they have a real relationship to public health outcomes.  \n \nREFERENCES  \n \n1. Centers for Disease Control and Prevention (CDC). Foodborne Diseases Active Surveillance Network \n(FoodNet): FoodNet Surveillance Report for 2011 (Final Report). Atlanta, GA:  U.S. Department of Health and \nHuman Services, CDC . 2012.  \n2. Guo, C., R.M. Hoekstra, C.M. Schroeder, S.M. Pires, K.L. Ong, E. Hartnett, A. Naugle, J. Harman, P. \nBennett, P. Cieslak, E. Scallan, B. Rose, K.G. Holt, B. Kissler, E. Mbandi, R. Roodsari, F.J. Angulo, and D. Cole Application of Bayesian techniques to model the burden of human salmonellosis attributable to U.S. food commodities at the point of processing: adaptation of a Dan ish model. Foodborne Pathog. Dis. 8:509- 516. 2011.  \n3. Williams, M.S., and E.D. Ebel Estimating changes in public health following implementation of hazard \nanalysis and critical control point in the United States broiler slaughter industry. Foodborne Pathog. D is. 9:59 -67. \n2012.  \n  \n(A full -length article will be published. ) \n 63rd WPDC/XXXIX ANECA  FIELD UTILIZATION OF AN  \nINFECTIOUS LARYNGOTRACHEITIS ELISA \n \nUSO EN CAMPO DE UNA PRUEBA DE ELISA CONTRA  \nLA LARINGOTRAQUE\u00cdTIS INFECCIOSA \n \nG. SlacumA, R. MonleonB, and B.  van LeerdamB \n \nABioChek USA Corp., 3 Southgate Road, Scarborough, ME 04074, USA  \nBBioChek B.V., Fokkerstraat 14,  2811 ER  Reeuwijk,  Netherlands  \n \nRESUMEN  \n \nLa laringotraque\u00edtis  infecciosa (LTI), causada por el Herpesvirus aviar, es una infecci\u00f3n respiratoria aguda y \naltamente contagiosa que afecta principalmente a los pollos. Los signos cl\u00ednicos pueden variar desde tos, \nexpectoraciones sanguinolentas,  disnea rara a severa, y mor talidad por asfixia. Puede causar p\u00e9rdidas econ\u00f3micas \nsignificativas debido a aumentos en la tasa de conversi\u00f3n alimenticia, mortalidad elevada y disminuci\u00f3n en la \nproducci\u00f3n de huevo. Los signos cl\u00ednicos y las lesiones, de las cuales la traque\u00edtis es la p rincipal, pueden ser \nutilizados para realizar un diagn\u00f3stico presuntivo. Pruebas como histolog\u00eda, PCR y serolog\u00eda (ELISA y \nneutralizaci\u00f3n viral) son utilizadas com\u00fanmente para confirmar el diagn\u00f3stico de LTI. Existe un debate sobre la efectividad de ELISA para el diagn\u00f3stico de LTI,  ya que se presume que muy pocos anticuerpos humorales contra el \nvirus de LTI  se pueden detectar despu\u00e9s de un desaf\u00edo, debido a que la protecci\u00f3n contra la LTI est\u00e1 regulada \nprincipalmente por la inmunidad mediada por c\u00e9lulas. A dem\u00e1s, se ha presumido que el nivel de inmunidad humoral \nmedido por los anticuerpos detectados en ELISA no se puede correlacionar con el nivel de protecci\u00f3n en una \nparvada. M\u00e1s a\u00fan, existe la percepci\u00f3n de que los t\u00edtulos medidos por ELISA no son capaces d e diferenciar entre una \nparvada vacunada y una no vacunada. Esta presentaci\u00f3n resume lo que sabemos sobre la prueba BioChek ELISA en \ncampo. En particular, se discutir\u00e1 la utilidad de la prueba de ELISA para el diagn\u00f3stico de LTI,  y c\u00f3mo puede \nutilizarse pa ra diferenciar entre parvadas vacunadas y no vacunadas y entre parvadas vacunadas y desafiadas.  \n \nSUMMARY  \n \nInfectious l aryngotracheitis (ILT), caused by avian Herpesvirus, is an acute, highly contagious viral respiratory \ninfection, principally affecting chickens.  Clinically the signs can vary from coughing, bloody expectorations, and \nrales to severe dyspnea and mortality due to asphyxiation.  It can cause significant economic losses due to increased \nfeed conversion rates, elevated mortality, and decreased egg production.  Clinical signs and lesions, of which \ntracheitis is the primary lesion, can be used for presumptive diagnosis.  Histology, PCR and serology (ELISA and \nVN) are often used to confirm ILT diagnosis.  There has been debate over the effectiveness o f ELISA for ILT \ndiagnosis as it has been presumed that very little humoral antibody against ILTV can be detected after challenge because protection for ILT is predominantly regulated through cell -mediated immunity.  In addition, it has been \npresumed that th e level of humoral immunity as measured by the antibodies detected in the ELISA cannot correlate \nwith the level of protection in a flock.  Furthermore, there is the perception that titers as measured by the ELISA are \nnot capable of differentiating between a vaccinated and a non -vaccination flock.  Interpretation of ILT ELISA \n(Biochek B.V., Reeuwijk,  Netherlands) results has been shown to be most effective when all parameters, such as \nmean titer, percent positives, and vaccination index (VI) are evaluated simultaneously. With live TCO vaccines and recombinant vector vaccines, experimental data has shown that vaccine responses can be clearly distinguished from \nchallenged flocks on the basis of mean titer response, percent positives and VI index.  However, thi s is not true for \nlive CEO vaccines. The main reason for this could be that CEO vaccines mimic field strains in immunogenicity and \nspreading capacity. Field data taken from non ILT vaccinated and non clinical br oiler flocks at the age of 39 to 50 d  \nhave shown the ILT  ELISA  test to be highly specific (> 99%).  Comparison data with other diagnostic methods show \nthat the ELISA can be useful as a screening test.  Because of the specificity of the test, d etection of one  or more \npositives in a n unvaccinated  broiler  flock can be interpreted as suspect infection, but further confirmation with \nclinical symptoms and other laboratory tests such as histology and/or PCR is needed to confirm an ILT diagnosis.  \n 63rd WPDC/XXXIX ANECA  AISLAMIENTO E IDENTIFICACI\u00d3N DEL VIRUS H7N3 EN \nHIRUNDO RUSTICA  (GOLONDRINA COM\u00daN)  \nEN EL ESTADO DE JALISCO  \n \nISOLATION AND IDENTIFICATION OF THE AVIAN INFLUENZA VIRUS \nSUBTYPE H7N3 IN THE COMMON SWALLOW (HIRUNDO RUSTICA)  \nIN THE STATE OF JALISCO  \n \nE. SotoA, J. Mar\u00eda WenceA, R. ViguerasB, J. Luis BorregoA, D. SarfatiA y B. LozanoA \n \nALaboratorio Avimex, S.A. de C.V.  J.I. Bartolache 18 62. Colonia del Valle, Delegaci\u00f3n Benito Ju\u00e1r ez. 03100. \nM\u00e9xico, D.F., M\u00e9xico  \nBDiagn\u00f3sticos Cl\u00ednicos V eterinarios , S.A. de C.V. Campesinos 224, Colonia Granjas Esmeralda,  \nDelegaci\u00f3n Iztapalapa. 09810, M\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nIt has been demonstrated that the avian influenza v irus (AIV) in wild birds is a constant threat for poultry \nproduction due to the close relation that some wild birds like swallows ( Hirundo rustica) and grackles ( Quiscalus \nmexicanus ) have with poultry farms. The recent outbreaks of the avian influenza (AI) virus H7N3 in different states \nof Mexico have  caused large economic losses and it has been ver y important in some municipalities of the state of \nJalisco.  \nThis work has the objective of bringing information about the virus isolation and the AIV subtype H7N3 \nidentification in swallows in the state of Jalisco, with the aim of documenting it, so in oth er affected zones by the \ndisease the epidemiology surveillance in wild birds will be reinforced.  \n \nRESUMEN  \n \nLos virus de influenza aviar (VIA) en aves silvestres han mostrado ser una amenaza constante para la \nproducci\u00f3n av\u00edcola debido a la cercan\u00eda que algunas aves silvestres como las golondrinas ( Hirundo rustica) y \nzanates ( Quiscalus mexicanus ) tienen con granjas av\u00edcolas. Los recientes eventos del brotes del virus H7N3 de \nInfluenza Aviar (IA) en diferentes estados de la rep\u00fablica mexicana han causo grandes p\u00e9rdidas econ\u00f3micas y esto \nse ha visto de manera muy importante en algunos municipios del estado de Jalisco.  \nEl presente trabajo pretende informar del aislamiento viral e identificaci\u00f3n de VIA subtipo H7N3 en \ngolondrinas en el estado de Jalisco, con l a finalidad de documentarlo y que en zonas afectadas por este virus se \nfortalezca la vigilancia epidemiol\u00f3gica de la enfermedad en aves silvestres.  \n \nINTRODUCCI\u00d3N  \n \nLos virus de influenza aviar (VIA) infectan principalmente a las aves acu\u00e1ticas de vuelo libre como virus de \nbaja patogenicidad , pero cuando infectan especies av\u00edcolas terrestres com\u00fanmente cambian en su patogenicidad y \ncausan la muerte de las aves dom\u00e9sticas criadas de manera intensiva, afectando tambi\u00e9n a otras especies av\u00edcolas e \nincluso a mam\u00edferos. Durante el brote de VIA de alta patogenicidad (VIAAP) subtipo H5N1 que inici\u00f3 en Asia en el \na\u00f1o 2004 se detect\u00f3 la infecci\u00f3n y muerte de cuervos silvestres, as\u00ed como de gatos dom\u00e9sticos, tigres y leopardos en cautiverio.  \nEl virus de inf luenza aviar de alta patogenicidad (VIAAP) subtipo H7N3 fue detectado en granjas av\u00edcolas de \nM\u00e9xico  y reportado el d\u00eda 21 de junio de 2012. La afectaci\u00f3n de parvadas por este virus fue observada primeramente \nen los municipios de Acatic y Tepatitl\u00e1n en el e stado de Jalisco, en donde predomina la producci\u00f3n de gallinas \ncomerciales productoras d e huevo para plato, causando la muerte de gallinas y codornices comerciales con \nimportantes da\u00f1os econ\u00f3micos en la avicultura nacional.  \n \n  63rd WPDC/XXXIX ANECA  OBJETIVO  \n \nPresent ar el halla zgo de golondrinas comunes (Hirundo rustica)  que enfermaron y murieron durante el brote de \nVIAAP subtipo H7N3 en el estado de Jalisco, de las cuales se obtuvo el aislamiento de este virus.  \n \nDESCRIPCI\u00d3N  \n \nDurante el mes de septiembre de 2012  se observ\u00f3 la muerte repentina de golondrinas  que se encontraban en los \nestacionamientos de las casas, iglesias y edificios de la ciudad de Tepatitl\u00e1n, estado de Jalisco. En una sola ma\u00f1ana \namanecieron alrededor de 40 a 50 golondrinas en el piso de una sola calle, repiti\u00e9ndose esto en toda la ciudad. \nAlgunas aves estaban muertas, mientras que otras presentaban i ncoordinaci\u00f3n, inc apacidad para caminar y \nepist\u00f3tonos. Las aves que estaban en la calle e intentaban volar, \u00fanicamente sub\u00edan alrededor de tres metros de altura y luego de cinco  metro s de distancias ca\u00edan nuevamente al piso.  \nDado que es en esta \u00e9poca en que las aves anidan, e n el piso se encontraron muertas aves  adultas pero tambi\u00e9n \nlos polluelos que ca\u00edan de los nidos.  Esta mortalidad solamente f ue observada en esa semana de septiembre.  \nSe tomaron golondrinas que acababan de morir y se congelaron completas  para su env\u00edo,  en cajas t\u00e9rmicas \nherm\u00e9ticas y desinfectadas al laboratorio de Diagn\u00f3stico s Cl\u00ednicos Veterinarios , S.A. de C .V. ubicado en la ci udad \nde M\u00e9xico  y debido a  que el brote de VIAAP subtipo H7N3 en gallinas de postura se encontraba activo en la regi\u00f3n, \nse solicit\u00f3  el aislamiento de VIA  en esos animales . El n\u00famero de caso de recepci\u00f3n en el laboratorio fue el 12 -3868, \ndonde l os resultados  de las pruebas de virolog\u00eda de las golondrinas fueron  positivos al aislamiento de VIAAP \nsubtipo H7N3, identificado con anticuerpos monoclonales.  \nInmediatamente se realiz\u00f3 el reporte correspondiente a la SAGARPA (25 de septiembre de 2012), quienes \nverifica ron los hallazgos en el laboratorio de alta seguridad nivel 3 de CPA y finalmente lo reportaron a la \nOrganizaci\u00f3n Mundial de Sanidad Animal (OIE).    \n \nCONCLUSI\u00d3N Y COMENTARIOS  \n \nEl VIAAP subtipo H7N3 fue aislado en este caso de golondrinas comunes ( Hirundo rustica ), causando su \nmuerte , lo que demuestra  que este virus tiene el potencial de infectar a las aves de vuelo libre que habitan en los \nalrededores de las granjas av\u00edcolas, por lo que es conveniente  reforzar las medidas de bio -seguridad y de aislamiento  \nsanitario  de las mismas  para evitar el contacto de las aves dom \u00e9sticas con la fauna silvestre.  \n \nREFERENCIAS  \n \n1. http://www.oie.int/wahis_2/public/wahid.php/Countryinformation/Countryreports  \n2. http://www.birdlife.org/datazone/speciesfactsheet.php?id=7116&m=1  \u00abBarn Swallow ( Hirundo rustica ) \u2013 \nBirdLife species facsheet \u00bb (en ingl\u00e9s). BirdLife I nternational . \n3. http://www.repository.naturalis.nl/document/46434  Dickinson, Edward C.; Dekker, Ren\u00e9 W. R. J. (2001). \n\u00abSystematic notes on Asian birds. 13. A preliminary review of the Hirundinidae \u00bb. Zoologische Verhandelingen  \n(Leiden : Rijksmuseum van Natuurlijke Historie ) 335: pp. 127\u2013144. ISSN  0024- 1652 .  \n4. Turner, Angela K.; Rose, Chris . Swallows & martins: an identification guide and handbook . Boston : \nHoughton M ifflin . pp. 164\u2013169. ISBN  0-395-51174- 7.1989.  \n5. L.D. Sims and I.H. Brown. Multicontinental epidemic of H5N1 HPAI virus (1996- 2007).  In: Avian \ninfluenza. Edited by. D.E. Swayne. Blackwell Publishing. 251- 286. 2008.  \n6. D.E. Swayne. Influenza. In: Diseases of Poultry. 12th edition. Edited by Y.M. Saif, A.M. F adly, J.R. \nGlisson, L.R. McDougald, L.K. Nolan and D.E. Swayne. Iowa State University Press. pp 153 -184. 2008.  \n 63rd WPDC/XXXIX ANECA  CALIFORNIA SHELL EGG FOOD SAFETY (SEFS)  \nREGULATION CCR \u00a7 1350  \n \nREGULACI\u00d3N CCR \u00a71350 DE LA SEGURIDAD ALIMENTARIA DEL \nCASCAR\u00d3N DEL HUEVO (SEFS) EN CALIFORNIA  \n \nK. Takeshita  \n \nCDFA, ESQM program  \n \nRESUMEN  \n \nCalifornia (CA) instituy\u00f3 una nueva regulaci\u00f3n SEFS en su c\u00f3digo de regulaci\u00f3n \u00a7 1350 para todas las \nparvadas mayores de 3000 gallinas de postura, incubadas el 1\u00ba de julio del 2013 o despu\u00e9s y que vendan huevo en \nCalifornia. Las parvadas que cumplan con la  SEFS deber\u00e1n conocer los requerimientos la regla del huevo  FDA del \nc\u00f3digo federal de regulaci\u00f3n \u00a7 118 para el control de Salmonella Enteriditis  (SE) incluyendo registros, pollos \nprovenientes de granjas reproductoras limpias de SE en E.U., pollitas que es t\u00e9n monitoreadas contra SE, premisas \npositivas para limpiar SE, bioseguridad, control de roedores, control de mosca, pruebas ambientales de SE y pruebas de SE en huevo. Adem\u00e1s de los requerimientos de la regla FDA del huevo, CA SEFS CCR \u00a7 1350, se requiere  de un \ndocumento que certifique que a los pollos se les realizan pruebas contra SE, pruebas contra SE antes de despoblar y dos vacunaciones con vacuna viva y una con vacuna muerta de SE.  \nComenzando el 1\no de enero del 2015, SEFS CRC \u00a71350, se requerir\u00e1 que las gallinas ponedoras sean alojadas \nen un espacio por ave utilizando la f\u00f3rmula ( 322 + [(n-1) x 87.3])/n, en donde \u201cn\u201d es el n\u00famero de gallinas. Por \nejemplo, se requerir\u00e1 un m\u00ednimo de 116 pulgadas2 por ave para 9 gallinas en un corral. Las parvadas que cumplan \ntodos los requerimientos mencionado podr\u00e1n vender huevo en California (CA), y los empaques deber\u00e1n tener la leyenda \u201cCA SEFS compliant\u201d.  \n \nSUMMARY  \n \nCalifornia (CA) instituted a new  SEFS regulation CCR (California Code of Regulation)  \u00a7 1350 for all flocks \nwith greater than 3000 laying hens, hatched July 1 2013or later and selling eggs into CA. Flocks that are SEFS compliant must meet the FDA egg rule CFR (Code of Federal Regulation)   \u00a7 118 requirement for Salmonella \nEnteriditis (SE) control including records, chicks from US SE clean breeders, pullets that are SE monitored, cleaning \nSE positive premise, biosecurity, rodent control, fly control, environmental SE testing and SE egg test ing. In \naddition to the FDA egg rule requirements, CA SEFS CCR \u00a7 1350 requires chick paper SE testing, pre -depopulation \nSE testing and 2 live plus 1 killed SE vaccination.  \nBeginning in January 1, 2015, SEFS CRC \u00a7 1350 requires that layers be housed at a space per bird using \nformula ( 322+[(n -1) x 87.3])/n, where \u201cn\u201d equals the number of birds. For example a minimum 116 square inches \nper bird are required with a 9 birds in an enclosure. Flocks which meet all of the above requirements can sell eggs in \nCA and  containers must be labeled \u201cCA SEFS compliant .\u201d \nTo support the consumption of high quality, safe eggs, the California  Department of Food and Agriculture \n(CDFA) adopted a new Section 1350 (Shell Egg Food Safety) and amended Section 1354 (Product Labeling) of \nTitle 3 of the California Code of Regulations. These regulations require  any in -state or out- of-state egg producer or \negg handler selling chicken eggs in California to implement Salmonella enterica serotype Enteritidis  reduction \nmeasures and label produ cts accordingly. These requirements  will be implemented in phases beginning on July 1, \n2013.  \n \nPhase 1, Effective July 1, 2013  \nEnhanced Salmonella  Enteritidis (SE) Testing and Vaccination  \n \n\u2022 Applies to all flocks with 3,000 or more laying hens and a hatch date of 7/1/2013 or  later, whose eggs are sold \nin California.  \n\u2022 Laying hens whose shell eggs are pasteurized or otherwise processed to reduce the risk of SE consistent with \nFood and Drug administration (FDA) regulations (5  log reduction) are exempt.  63rd WPDC/XXXIX ANECA   \nNew California Shell Egg Food Safety Regulations  \nIn Addition to the FDA Standards  \n \n1. Environmental SE Tests (Title 3, Section 1350)  \na) While there may be various effective methods for environmental testing  related to chicks being placed, \nthe California Egg Safety rule requires that ten  (one paper for every ten boxes of chicks) of chick papers be \ntested for  Salmonella  Enteriditis . Check with the laboratory you use for SE testing to  determine the best \nway to submit samples. Currently the California Animal  Heal th and Food Safety Laboratory is accepting \nthree types of specimens:  \n1. Chick papers that are swabbed with pre- moistened (double strength skim  milk or commercially \navailable evaporated milk) 3x3 gauze pads at the farm  after the chicks have been removed. One \ngauze pad is rubbed across the surface of the five papers and placed into a sterile plastic bag. After \ncollection  of up to ten papers (two gauze pads pooled), add approximately 15- 30 ml  double \nstrength skim milk and deliver to laboratory within 48 hour s after  collection. Samples may be \nfrozen if unable to deliver to laboratory within 48 hours.  \n   2. Portions of chick papers totaling 25 grams should be cut out using disinfected scissors or torn \nout with sterile gloves, pooled in a sterile container  and d elivered to the laboratory from the farm . \n  3. Chick papers (one paper for every ten boxes of chicks) are removed at the farm and placed into \na clean plastic trash bag and submitted to the laboratory  within 48 hours of collection. Samples \nsubmitted by this  method will be charged  an additional processing fee and only samples from one \nproducer will be set up  per day \nb) End of Production Testing: should take place at 2 -4 weeks prior to the end of  production and should \ninclude a minimum of sixteen swabs per flo ck that can be pooled in four swabs per bag.  \n \n2. SE Vaccination Program (Title 3, Section 1350)  \na) Protocol includes a minimum of two attenuated live vaccinations and one killed or inactivated \nvaccination or a demonstrated equivalent SE vaccination  program  approved by CDFA. Vaccines are \navailable through livestock supply  companies or directly through the manufacturer.  \n \nPhase 2, Effective January 1, 2015  \nReduced Stocking Density and Product Labeling  \n \n1. Reduced Stocking Density (Title 3 Section 1350)  \na) Stocking density requirements apply to all chickens whose eggs are sold in  California, regardless of \nflock size.  \nb) Requires a minimum floor space per hen dependent on the number of hens  in the enclosure:  \n \n# Hens 1 2 3 4 5 6 7 8 >9 \nIn2/Hen 322 205 166 146 135 127 121 117 116 \n \n2. California Product Labeling (Title 3 Section 1354)  \na) Grade and Size Designation: Where eggs are no t produced by the person  whose name appears on the \nlabel, the name shall be qualified by a phrase that  reveals the connection such person has with such eggs; \nsuch as, \u201cProduced for  _____ ,\u201d \u201cDistributed by _____\u201d or any other wording the expresses the facts.   \nb) The principal display panel for containers for all eggs sold in California must  have the following \nstatement: \u201cCalifornia She ll Egg Food Safety Compliant\u201d or  equivalent approved by CDFA. The Statement \nshall be legible and plainly marked  on each container in letters not less than \u00bc inch in height.  \n \n \n \n \n \n  63rd WPDC/XXXIX ANECA  FDA Production, Storage and Transportation  \nof Shelled Eggs Regulation Guidance  \nTitle 21 CFR Section 118  \n \nFDA Egg Safety Standards require you create and implement a written SE prevention  plan that is specific to \neach farm where eggs are produced and includes at minimum  the SE prevention measures outl ined in this guidance \ndocument.   \nOne or more supervisory personnel must be appointed responsible for ensuring  compliance with each farm's \nSE prevention plan. This person must have successfully completed training on SE prevention measures for egg \nproduction  under a  standardized curriculum recognized by the FDA or must be qualified through job experience.  \n \nThis person is responsible for:  \n\u2022 Development and implementation of an SE prevention plan that is appropriate  for your specific farm, \nreassessing and modifyi ng the SE prevention plan as  necessary to ensure that the requirements are met and \nreviewing records (does  not need to have performed the monitoring or created the records).  \n The following records documenting your SE prevention plan must be maintained:  \n\u2022 Written SE prevention plan, with records of review, modification & corrective  actions taken  \n\u2022 Documentation that pullets were \u201cSE Monitored\u201d or raised under \u201cSE  Monitored\u201d conditions  \n\u2022 Records documenting compliance with SE prevention measures:  \n\u00b0 Biosecurity measures  \n\u00b0 Rodent and other pest control measures  \n\u00b0 Cleaning & disinfection procedures performed \n\u00b0 Refrigeration requirements  \n\u00b0 Environmental and egg sampling procedures  \n\u00b0 Results of SE testing  \n\u00b0 Diversion of eggs  \n\u00b0 Egg treatment records  \nAll records must include:  \n\u2022 Your name and location of farm  \n\u2022 Date and time of activity that the records reflects  \n\u2022 Signature/initials of person performing operation or creating records  \n\u2022 Data and information reflecting compliance activities  \n1. SE Prevention Measures (Title 21 CFR Section 118.4):  \na) Pullets: obtain pullets that are from SE -monitored breeder flocks or raised  under SE -monitored \nconditions. SE -monitored means pullets are raised under SE  Control conditions, which include:  \n\u2022 Chicks obtained from SE -monitored breeder flocks that meet the National  \n\u2022 Poultry Improvement Plan\u2019s standards for \u201cUS SE Clean\u201d status.  \n\u2022 Pullet environment is tested for SE when pullets are 14 to 16 weeks old  \n\u2022 If test positive for SE take proper cleaning and disinfection steps, which  \n\u2022 include removal of all visible manure, dry cleaning to remove dust, feathers  \n\u2022 and old feed and disinfection with appropriate disinfection method \nb) Biosecurity: limit visitors\u2019 contact with poultry, protect against cross  contamination between poultry \nhouses through people and equipment, preven t stray  poultry, wild birds, cats and any other animals from \nentering poultry houses and  restrict employees from housing poultry at their personal homes. These \nbiosecurity  measures can be achieved by:  \n\u2022 Maintaining fencing and locked gates  \n\u2022 Providing a visito r log or a closed facility to visitors  \n\u2022 Dedicated cleaning and disinfection of poultry houses, clothing and hands  \nc) Rodents, Flies & Other Pest Control: perform rodent and fly counts on a regular  basis and increase \ncontrol as indicated by counts and remove  vegetation in and  around poultry houses to reduce harborage for \npests   \nd) Cleaning & Disinfection: Performed before new laying hens are added to house  and/or after positive \nenvironment or positive egg SE test. This can be accomplished  by: 63rd WPDC/XXXIX ANECA  \u2022 removing all vis ible manure  \n\u2022 dry cleaning poultry house to remove dust, feathers, old feed  \n\u2022 following proper disinfection protocol of the poultry house following cleaning  \ne) Refrigeration: eggs must be held or transported at 45 degrees F ambient  temperature or below beginni ng \n36 hours after time of lay \n2. Environmental Testing for SE (Title 21 CFR Section 118.5): \na) As one indicator of the effectiveness of your SE prevention plan, you must  perform environmental \ntesting within the poultry house for SE when the flock has  reached 40 to 45 weeks of age and each time a \nflock is molted, beginning 4 to 6 weeks after the end of the molting process.  \nb) The environmental test must utilize sampling techniques appropriate to the  poultry house layout  \n3. Options for Positive SE Enviro nmental Test: \na) 14 to 16 Week Test  \n\u2022 you must begin egg testing within two weeks of the start of egg laying  \nb) 40 to 45 Week and Post Molt Test  \n\u2022 review and make any necessary adjustments to your SE prevention plan  to ensure that all measures \nare being proper ly implemented  \n\u2022 begin egg testing or divert egg to treatment  \n4. Testing Eggs from SE Positive Flock (Title 21 CFR Section 118.6)  \na) You must conduct four tests (each test requires a collection of 1,000 intact  eggs representative of a day\u2019s \nproduction), at t wo week intervals. If all four tests  are negative  no further egg tests are required.  \nb) However, if any of the egg tests are positive  you must divert* all eggs from  that flock to treatment and \nrepeat the testing protocol until all tests are negative.  \nc) A monthly egg test  (each test requires a collection of 1,000 intact eggs  representative of a day\u2019s \nproduction) must be conducted if:  \n\u2022 you have a positive egg test;  \n\u2022 divert eggs for treatment;  \n\u2022 later meet the negative test result requirement; and  \n\u2022 return  to table egg production.  \nc) If you have a positive monthly test you must divert all eggs from that flock  for treatment for the life of \nthe flock or until four egg tests conducted in two week intervals are all positive  \n \n*NOTE: If you are diverting eggs, the pallet, case or other shipping container  must be labeled and all \ndocuments accompanying the shipment must contain the  following legible and conspicuous statement: \n\u201cFederal Law requires that these eggs must be treated to achieve at least a 5- log destructi on of \nSalmonella  Enteriditis  or processed as egg products in accordance with the Egg  Products Inspection \nAct, 21 CFR 118.6(f).\u201d  \n \n5. Treatment of Eggs from SE Positive Flock (Title 21 CFR Section 118.3)  \na) Requires utilizing a technology or process that achieves at least 5 -log destruction of SE for shell eggs or \nthe processing of egg products in accordance  with the Egg Products Inspection Act  \n(http://www.fda.gov/RegulatoryInformation/Legislation/ucm148752.htm).  \n6. Registration of Farms with FDA (Title 21 CFR Section 118.11)  \na) Shell egg producers are required to register their farms with FDA within 30  days of becoming an egg \nproducer. Producers may register their farms by:  \n\u2022 Electronic Registration at http://www.access.fda.gov . \n\u2022 Mail or Fax using FDA Form no.  3733. The form can be requested by  writing to the US Food and \nDrug Administration, 5600 Fishers Lane,  (HFS -681), Rockville, MD 20857 or by calling 1- 800-\n216-7331.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n AN\u00c1LISIS DE LOS RESULTADOS DE SENSIBILID AD \nANTIMICROBIANA REALI ZADOS EN ESCHERICHIA COLI   \nDE AVES DE M\u00c9XICO  DURANTE EL PERIODO 2 005 A 201 3 \n \nANALYSIS OF THE RESULTS OF ANTIMICROBIAL SUSCEPTIBILITY IN \nESCHERICHIA COLI IN BIRDS FROM MEXICO   \nDURING THE PERIOD 2005- 2013  \n \n \nE. TapiaA, L. SantiagoA, R. ViguerasA, E. SotoB, D. SarfatiB y B. LozanoB \n \nADiagn\u00f3sticos Cl\u00ednico s Veterinarios SA de CV. M\u00e9xico  \nCampesinos 224, Colonia Granjas Esmeral da, 09810, M\u00e9xico, D.F., M\u00e9xico  \n \nBLaboratorio AVI -MEX SA de CV. M\u00e9xico  \nBartolache 1862, Colonia Del Val le, 03100, M\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nAntimicrobial susceptibility testing were performed on 371 Escherichia coli  purified isolates obtained from \nbird\u2019s clinical cases from 2005 to 2013 using the disk diffusion method (s ensidiscs) and following standardized \nguidelines approved by the National Committee for Clinical Laboratory Standards. The antimicrobials tested included amoxicillin, enrofloxacin, florfenicol, fosfomycin, furaltadone, gentamicin, neomycin, norfloxacin,  and \ntrimethoprim sulfacloropiridicina sodium. The results for the period indicate a high resistance of Escherichia coli  to \namoxicillin and trimethoprim sulfacloropiridicina sodium , and resistance to enrofloxacin, florfenicol , and \nfosfomycin , which begins to appear from 2010.  \n \nRESUMEN  \n \nSe realizaron pruebas de sensibilidad antimicrobiana en 371 aislamientos de Escherichia coli  purificados \nobtenidos de casos cl\u00ednicos de aves del a\u00f1o 2005 al 2013 utilizando el m\u00e9todo de difusi\u00f3n con disco (sensidiscos) y siguiendo los lineamientos estandarizados y aprobados por el National Commitee for Clinical Laboratory Standards. \nLos antimicro bianos probados incluyen amoxicilina, enrofloxacina, florfenicol, fosfomicina, furaltadona, \ngentamicina, gentamicina combinada con \u00e1cido nalid\u00edxico, neomicina, norfloxacina y sulfacloropiridicina s\u00f3dica \ncon trimetoprim. Los resultados en el per\u00edodo indican que existe una gran resistencia de Escherichia coli  hacia \namoxicilina y sulfacloropiridicina s\u00f3dica con trimetoprim y que a partir del 2010 comienza a presentarse resistencia \na enrofloxacina, florfenicol y fosfomicina.  \n \nINTRODUCCI\u00d3N  \n \nLa realizaci\u00f3n de pruebas de sensibilidad antimicrobiana a los aislamientos bacterianos de casos cl\u00ednicos de los \nanimales resulta en una excelente herramienta para conocer la resistencia que desarrollan los microorganismos hacia los diferentes antimicro bianos utilizados en el campo, por lo que el objetivo de este trabajo es presentar los \nresultados de sensibilidad antimicrobiana a Escherichia coli  (E. coli) realizados en el laboratorio de Diagn\u00f3sticos \nCl\u00ednicos Veterinarios durante nueve  a\u00f1os en el periodo comprendido entre 2 005 y 201 3. \n \nMATERIALES Y M\u00c9TODOS  \n \nLa prueba de susceptibilidad antimicrobiana se realiz\u00f3 por el m\u00e9todo de difusi\u00f3n con disco, bajo los \nlineamientos y directrices del National Committee for Clinical Laboratory Standards  (NCCLS) .  \nLas 371 cepas utilizadas en este estudio corresponden a aislamientos obtenidos a partir de aves enfermas que \nllegan de toda la Rep\u00fablica Mexicana al Laboratorio de Diagn\u00f3sticos Cl\u00ednicos Veterinarios. Las bacterias fueron aisladas , purificadas  e identificadas por pruebas bioqu\u00edmica s, reacciones enzim\u00e1ticas o pruebas de PCR.                                                                                                                                             63rd WPDC/XXXIX ANECA \n \n Los antimicrobianos utilizados fueron amoxicilina (Amoxi), enrofloxacina (Enro), florfenicol Flor), \nfosfomicina (Fosf), furaltadona (Fural), gentamicina (Genta), gentamicina combinada con \u00e1cido nalid\u00edxico \n(Genta+Naldix), neomicina (Neo), norfloxacina (Nor) y sulfacloropiridicina s\u00f3dica  con trimetoprim (SCP+TMP).  \nSe consider\u00f3 sensible al antimicrobiano a las cepas con un di\u00e1metro del halo inhibitorio de 8 mm en adelante. El \nporcentaje de sensibilidad anual se cons ider\u00f3 bajo con menos de 33% de cepas sensibles, medio entre 33%  y 66% y \nalto con m\u00e1s de 66%.  \n \nRESULTADOS  \n \nTabla 1. Resultados de las pruebas de sensibilidad antimicrobiana.  \n \n \n \n* ND: No disponible  \n \n\u2022 Bajo: menos de 33% de cepas sensibles.  \n\u2022 Medio: entre 33 y 66% de cepas sensibles.  \n\u2022 Alto: m\u00e1s del 66% de cepas sensibles.  \n \nCONCLUSIONES  \n \nLos antibi \u00f3ticos en los cuales se present\u00f3  mayor resistencia a las cepas evaluadas durante el periodo de 9  a\u00f1os \nfueron amoxicilina y sulfaclopiridazina + t rimetroprim. Los antibi\u00f3ticos que presentaron un mayor sensibilidad \nfueron fosfomicina , furaltadona  (prohibida en M\u00e9xico) , gentamicina, gentamicina + \u00e1 cido nalixidico, neomicina y \nnorfloxacina . \nA partir del a\u00f1o 2010 s e observ \u00f3 un decremento  en la sensibilidad  de E. coli hacia Enrofloxacina, ya que de un \n79% obtenido en el periodo 2005 - 2009, bajo a un 53% en el periodo 2010 - 2013; a florfenicol de un 66% en el \nperiodo de 2005 a 2009 disminuyo a un 42% en 2010 -  2013 y hacia fosmomicina  que de un 85% obtenido en el \nperiodo 2005 - 2009, baj\u00f3 a un a 5 4% en el periodo 2010 a  2013 . \n \nREFERENCIAS  \n \n1. Gail L. Woods & John A. Washington. Antimicrobial Susceptibility Tests: Dilution and Disk Diffusion \nMethod. In \u201cManual of Clinical Microbiology\u201d. Edi ted by Patrick R. Murray. 6th .Ed. 1995.  \n2. Jorgensen, J, H., Ferraro, M.J., Craig, W.A., Doren, G.V., Finegold, S.M., Fung -Tomc,J., Hansen, S.L., \nHindler, J., Reller, L.B., Swenson, J.M., Tenover, F.C., Testa, R.T., & M.A. Wikler. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standar d. M2 -A6, Vol 17, No. 1. The National Committee for \nClinical Laboratory Standards. Approved by the American National Standards Institute. 6th ed. 1997.  \n2005 2006 2007 2008 2009 2010 2011 2012 2013\n41 38 26 17 53 33 61 72 30\nAmoxicilina 20 \u00b5g 29% 42% 27% 0% 36% 4% 15% 22% ND 22%\nEnrofloxacina 5 \u00b5g 71% 79% 77% 75% 79% 45% 61% 54% 53% 66%\nFlorfenicol 5 \u00b5g 78% 68% 78% 27% 77% 48% 47% ND 30% 57%\nFosfomicina 200 \u00b5g 85% 88% 69% 100% 83% 55% 54% 55% 53% 71%\nFuraltadona 300 \u00b5g 90% 100% ND 100% 84% 85% 95% 92% ND 92%\nGentamicina 10 mg ND ND ND ND ND ND ND 83% 77% 80%\nGentamicina + \nAc nalixidico10 \u00b5g + \n30 \u00b5g100% 87% 96% 86% 94% 73% 59% 61% 59% 79%\nNeomicina 30 \u00b5g 100% 97% 100% 100% 100% 94% 98% 97% 100% 98%\nNorfloxacina 10 \u00b5g 67% 65% 78% 87% 91% 67% 79% 74% 50% 73%\nSulfacloropiridazina + \nTrimetoprim27.75 \u00b5g +\n1.25 \u00b5g 13% 40% 19% 21% 58% 27% 17% 19% 20% 26%Concentraci\u00f3n \nen \u00b5gAntimicrobianoResultados: Porcentaje Anual de Sensibilidad Antimicroniana de  Escherichia coli\nPromedio63rd WPDC/XXXIX ANECA  CHITOSIN- ARGININE (CA) AS A BIOFILM -REDUCING  \nWATER LINE TREATMENT  \n \nPOLI (ACETIL ARGINIL) GLUCOSAMINA COMO MEDIO PARA REDUCIR \nLA BIOPEL\u00cdCULA EN LAS L\u00cdNEAS DE AGUA  \n \nS. TilleyA, S. BakerB, M. BerrangC, and C. HofacreA \n \nAUniversity of Georgia, PDRC , 953 Coll ege Station Rd. Athens, GA 30602  \nBSyndegen, Inc. 1420 N Claremont Blvd. Suite 105D. Claremont, CA 91711  \nCUSDA , ARS, RRC, 950 College Station Rd . Athens, GA, 30605  \n \nRESUMEN  \n \nLa biopel\u00edcula que se forma en las l\u00edneas de agua de granjas av\u00edcolas son  el sitio ideal para que los organismos \nresidan, se repliquen y eviten la desinfecci\u00f3n. La Salmonella es una preocupaci\u00f3n siempre creciente en la sanidad \nalimenticia, por lo que se realizan esfuerzos cada vez mayores para controlar la exposici\u00f3n inicial. L a poli (acetil \narginil) glucosamina (PAAG) es un pol\u00edmero derivado del chitos\u00e1n natural que tiene propiedades antimicrobianas \ninnatas y se sabe que las bacterias no desarrollan resistencia contra \u00e9l. En otros estudios, la PAAG ha removido de \nmanera exitosa biopel\u00edculas ya establecidas y ha prevenido la formaci\u00f3n de las mismas. Tambi\u00e9n se ha demostrado \nque las aves lo pueden consumir de manera segura. Utilizando un modelo de laboratorio para l\u00edneas de agua, una \nsoluci\u00f3n de PAAG redujo de manera efectiva el n \u00famero de organ ismos de Salmonella adheridos.  \nEl objetivo del presente estudio es cuantificar la dosis ideal para que se produzca el m\u00e1ximo efecto anti -\npel\u00edcula. Se propone el uso de la PAAG como un tratamiento intermitente para las l\u00edneas de agua con el fi n de \ndisminuir la presencia de biopel\u00edculas, especialmente de Salmonella.  \n \nSUMMARY  \n \nBiofilms in poultry water lines are an ideal place for infectious organisms  to reside, replicate, and avoid \ndisinfection. Salmonella is an ever  increasing food safety concern; increased efforts are being made to  control initial \nexposure. Poly (acetyl, arginyl) glucosamine (PAAG) is a  natural chitosin derivative polymer that has innate \nantimicrobial properties  and bacteria are not known to develop chitosin resistance. In  other trials,  PAAG has \nsuccessfully removed established biofilms and prevented the  formation of biofilms. It has also been shown to be safe \nfor consumption  by poultry. Using a laboratory model for water lines a solution of PAAG  has effectively reduced \nthe number of attached Salmonella organisms.  \nThe aim of this study is to quantify the ideal dose for maximum  anti-biofilm effect. PAAG is proposed for use \nas an intermittent water line  treatment to decrease the presence of biofilms, specifically Salmonella.  \n \n \nABSTRACT  \n \nBacteria attach to a surface forming a biofilm which can  hinder  removal by common disinfectants (1). Some \nbacteria are better than others at forming biofilm s but once it is formed many pathogens can reside in the matrix. \nSalmonella spp. have been shown to have some biofilm forming capabilities but will also dwell, replicate, and \npotentially infect poultry via water lines  (1, 2, 3, 4) . The aim of this study was to investigate the effect of a natural \nchitosan derivative polymer, Chitosan -arginine (CA)  on the prevention and breakdown of biofilms with Salmonella \nEnteriditis. Varying concentrations of CA were used with an experimental design of poultry water lines colonized \nwith S. Enteriditis for two  waterline  experiments. The P oly Vinyl Chloride  (PVC)  fittings were allowed to incubate \nwith S. Enteriditis before CA  addition and then permitted to incubate for another period of time before sampling. In \nboth experiments the control , brain heart i nfusion  (BHI ) only groups showed S . Enteriditis  levels of over 108 \nCFU/mL whereas the CA  treated groups all decreased with the greatest  decrease in 500 -1000ug/mL CA.  \n   63rd WPDC/XXXIX ANECA  INTRODUCTION  \n \nFood safety is an ever -growing concern for consumers and therefore the poultry industry , especially with \nSalmonella spp. Commercial p oultry species can be exposed to pathogens by many methods including aerosol, \nenvironment, and water line contamination  (4). The sanitation of poultry water lines can be difficult due to the \nlimited options of disinfectants  that can be used while the birds are drinking  and varying success against biofilms (1, \n2, 3). Common bacteria su ch as Pseudomonas spp., E. coli , and other s are  biofilm forming organisms. Water lines \ncan harbor many organisms such as Salmonella spp.,  Campylobacter  spp., and various viruses ( 4, 5). Limited \neffectiveness of disinfectants that can be used while birds are in the house has been seen as bioiflm  build -up of \nminerals and debris  in poultry water lines. Disinfectants used after birds have left the farm can be very effective but \nhave to be administered correctly  and have a  narrow influence on the other six wk  when birds are on the farm.  \nChitosan -arginine  is a natural product that has been demonstrated to have antibiofilm activity against a range of \norganism  including Gram positive and Gram negative bacteria including Escherichia coli , Pseudomonas \naeruginosa, Salmonella typhi , Staphlococcus aureus,  and Listeria myonocytogenes . The purpose of this study was to \ndetermine the effectiveness of a natural chitosan derivative polymer, Chitosan -arginine (CA) , as a water line \ndisinfectant against biofilm formation and degradation of biofilms . \n \nMATERIALS AND METHODS  \n \nExperimental design . Polyvinyl chloride pipe (PVC) fittings were used as models for in -house poultry water \nlines.  One portion of the experiment dealt with preventing biofilm formation on the PVC fittings while the other was \ntesting the effect of breaking down pre- formed biofilms.  A monoculture of Salmonella Enteriditis  was inoculated in \nPVC f ittings and allowed to attach. The S. Enteriditi s was provided growth medium with treatments added of \nvarying concentrations of Chitos an-arginine (CA)  and allowed to incubate for variable times before sampling.  \nS. Enteriditis culture . A monoculture of Salmonella enterica serovar E nteriditis  (Culti -Loop ATCC 13076) \nwas cultivated on 5% sheep blood agar plates (Remel, Lenexa, Kans.) and grown to  a conflue nt lawn of the bacteria. \nThe bacteria were collected and added to sterile p hosphate buffered s aline (PBS) until a  McFarlan d standard  of \napproximately 0.5 was reached , indicating a concentration of  approximately  108CFU/mL , this served as the S. \nEnteriditis  solution .  \nTreatment groups . Chitos an-arginine  solution  (5mg/mL) was diluted by adding  to 1/10 strength  sterileBHI  to \nachieve the following concentrations : A) No CA , B) 50ug/mL CA, C) 100ug/mL CA , D) 250ug/mL CA, E) \n500ug/mL CA, and F) 1000ug/mL CA .  \nBiofilm development.  The first portion of the experiment  50mL of  S. Enteriditis  solution was added to \nsterilized PVC fittings and incubated for 2 h at 25 \u00b0C (6). After incubation the solution was poured off and the \nfittings were rinsed three times  with sterile water using a 10mL syrin ge with slight force  to remove non- adhering \ncells. Each fitting was then refilled with  50mL  of 1/10 strength sterile BHI broth mixed with CA solution at the \npreviously described concentrations . The treatment sol ution was incubated for 24 h  at 25 \u00b0C. After incubation the \ntreatment solutions were poured off and the fittings were again rinsed three times with sterile water as described \nabove .  \nThe second portion of the experiment involved PVC pipe water lines from an experimental poultry house . \nThey  had a visible biofilm present and Pseudomonas spp. was cultured. These pipes were cut into 10 cm pieces  and \ninoculated in the same fashion as previously described  but only treatments A (no CA), E (500ug/mL  CA) and F \n(1000ug/mL  CA) were tested  in the same fashion as before . After the initial 24 h incubation with treatment mixture \nthe solution was poured off and new treatment mixture was added, incubated for another 24 h period at 25\u00b0 C, this \nwas repeated a third time for one of the replicates.  \nSampling . Assessment of preventing biofilm development involved sampling fittings 24 h after treatment \nmixture was added.  Testing for biofilm breakdown involved two replicates being sampled 48 h post inoculation and \none 72 h post inoculation.  \nFolding 4x4 pads into quarters, moistening with water, and wrapping in foil before autoclaving created \nsterilized gauze pads. After rinsing to remove non-adherent cells  with sterile water , the pipes were sampled with \nsterilize gauze pads  by using aseptic t echnique and wiping internal surface three  consecutive times. The sample \ngauze was  placed in  sterile Whirl -Pak\u00ae bags with 5mL of sterile PBS. The samples were stomached  for 60 seconds  \nand 100uL of fluid was removed for diluting . Ten fold serial dilutions w ere made on each sample with sterile PBS \nand each dilution was plated (10uL in triplicate for each sample \u2013  30uL total) on 5% blood agar plates.  The plates \nwere allowed to incubate at 37 \u00b0C for 24 h before enumeration. The number of colonies for each was co unted and \naveraged for each dilution. Only attached cells were recorded . 63rd WPDC/XXXIX ANECA   \nRESULTS/DISCUSSION  \n \nPreventing biofilm formation . In the control group (A) , more than 108 CFU/mL were detected. Each \ntreatment group lowered the log of colonies per mL but it varied based on the CA  concentration. In treatment groups \nE (500ug/mL CA ) and F (1000ug/mL CA ) there was about a  103 CFU/mL reduction.  \nBreaking down biofilm . The control group (A) averaged  the highest  concentration  of S. Enteriditis  (109 \nCFU/mL)  and groups E and F were lower  concentrations, 103 CFU/mL and 0 CFU/mL respectively . It could be \ntheorized that a water line treatment of CA  on a weekly or biweekly basis from the time the birds are placed until \nprocessing may prevent the development of a biofilm and act to break down any newly developed biofilms.  \n \nREFERENCES  \n \n1. Costerton, J.W., et al., Microbial Biofilms.  Annual Review of Microbiology, 1995. 49 (1): p. 711 -745. \n2. Schonewille, E., et al., Biofilm building capacity of Salmonella enterica strains from the poultry farm \nenvironment.  FEMS Immunology & Medical Microbiology, 2012. 65 (2): p. 360- 365. \n3. Marin, C., A. Her nandiz, and M. Lainez, Biofilm development capacity of Salmonella strains isolated in \npoultry risk factors and their resistance against disinfectants.  Poultry Science, 2009. 88 (2): p. 424- 431. \n4. Amaral, L.d., Drinking water as a risk factor to poultry health. . Revista Brasileria de Ciencia Aviocola, \n2004. 6(4): p. 191- 199. \n5. Zimmer, M., et al., Detection of Campylobacter jejuni Strains in the Water Lines of a Commercial Broiler \nHouse and Their Relationship to the Strains That Colonized the Chickens.  Avian Dise ases, 2003. 47 (1): p. 101 -107. \n6. Berrang, M.E., J.F. Frank, and R.J. Meinersmann, Effect of Chemical Sanitizers with and without \nUltrasonication on <i>Listeria monocytogenes</i> as a Biofilm within Polyvinyl Chloride Drain Pipes.  Journal of \nFood Protection, 2008. 71(1): p. 66 -69. \n \n(The full -length article will be published in the Journal of Applied Poultry Research.)  \n 63rd WPDC/XXXIX ANECA  USE OF ARTIFICIAL NEURAL NETWORKS TO CLASSIFY THE \nANTIMICROBIAL RESISTANCE AND THE RELATIONSHIP OF 38 \nGENES ASSOCIATED WITH THE VIRULENCE OF  \nESCHERICHIA COLI  ISOLATES FROM BROILERS  \n \nUSO DE REDES NEURALES ARTIFICIALES PARA CLASIFICAR LA \nRESISTENCIA ANTIMICROBIANA Y LA RELACI\u00d3N DE 38 GENES \nASOCIADOS CON LA VIRULENCIA DE ESCHERICHIA COLI  \nAISLADA DE POLLOS DE ENGORDA  \n \nD. Tonini da Rocha, F.  de Oliveira Salle, S.  Luis da Silveira Rocha, H. Luiz de Souza Moraes,   \nand C. Tadeu Pippi Salle  \n \nCenter for Diagnosis and Research in Avian Pathology (CDPA) of the Veterinary School, Federal University of Rio \nGrande do Sul (UFRGS), Porto Alegre, Brazil  \n \nRESUMEN  \n \nEscherichia coli es responsable de varios procesos patol\u00f3gicos en los pollos de engorda. Este estudio \ndemuestra que es posible predecir el uso de antimicrobianos evaluando 38 genes distintos responsables de factores \nde virulencia, a trav\u00e9s de redes neurales artificiales (A NN). Adem\u00e1s, se encontr\u00f3 la relaci\u00f3n entre el \u00edndice de \npatogenicidad y la resistencia a 14 antimicrobianos que formaban parte de la base de datos utilizada para este \nestudio (muestras aisladas de parvadas de pollos de engorda, lesiones de celulitis y s\u00ednt omas respiratorios). Los \nresultados muestran que la ANN es capaz de llevar una correcta clasificaci\u00f3n del comportamiento de las muestras? \ncon una amplitud de 74.22% a 98.44%, haciendo posible predecir la resistencia al antibi\u00f3tico. El an\u00e1lisis estad\u00edstico \nllevado a cabo para evaluar la relaci\u00f3n entre el \u00edndice patog\u00e9nico (PI) y la resistencia a 14 antibi\u00f3ticos demostr\u00f3 que \nestas variables son independientes. Esto es, su m\u00e1ximo puede ocurrir en PI sin que ocurra un cambio es la resistencia \nal antimicrobiano,  o incluso lo opuesto, cambios en la resistencia al antimicrobiano sin cambios en el PI.  \n \nSUMMARY  \n \nEscherichia coli is responsible for various pathological processes in poultry  (1). Thi s study demonstrated that it \nis possible to predict the antimicrobials\u2019s use, testing thirty -eight distinct genes responsible for virulence factors, \nthrough artificial neural networks  (ANN). Also , it was found the relationship between pathogenicity index and \nresistance to fourteen antimicrobial forming part of the database used for the development of this study (samples \nisolated from broiler litter, lesion of cellulitis and respiratory symptoms). The results show that the ANN is cap able \nof performing correct classification of the samples\u2019 behavior with an amplit ude of 74.22% to 98.44%, making it \npossible to predict the antibiotic resistance. The statistical analysis performed to assess the relationship between \npathogenic i ndex (PI) and resistance to 14 antibiotics showed that these variables are independent. That  is, peaks can \nhappen in PI without change in antimicrobial resistance, or even the opposite, changes in antimicrobial resistance without changes in PI.  \n \nINTRODUCTION  \n \nThe avian pathogenic Escherichia coli  (APEC), belonging to the family Enterobacteriacea, is responsible for \nvarious pathological processes in poultry, acting as an agent in the primary or secondary lesion such as: \naerosaculitis , pericarditis, perihepatitis, peritonitis, salpingitis, omphalitis, cellulitis, among others  (1). This study \naddres ses the antimicrobial resistance of E. coli (APEC) strains in an innovative way, using tools such as artificial \nneural networks, methodology embedded in the CDPA \u0301s research line (Center for Diagnostics and Research in \nAvian Pathology). The use of artificial intelligence, specifically AN Ns, is being increasingly used as a tool for data \nanalysis and nonlinear multivariate, common feature in biological phenomena  (2). The objective of this study was  to \ndemonstrate that it is possible to predict the use of anti microbials, using thirty -eight distinct genes responsible for \nvirulence factors, derived from Escherichia coli  isolates from broiler, through ANNs . Also , it was found the 63rd WPDC/XXXIX ANECA  relationship between pathogenicity index (PI) and resistance to fourteen antimicrobial forming part of the database \nused for the development of this study.  \n \nMATERIALS AND METHODS  \n \nThe data used in this study was collected in a database generated at the CDPA Veterinary Faculty, Federal \nUniversity of Rio Grande do Sul. Informatio n on 246 isolates of Escherichia coli  was used as follows:  \n\u2022 Characterization of 38 genes associated with pathogenicity ( crl, ireA, cnf1/2, tia, sat, fyuA, mat, \nsfa/focCD, malX, afa/drab, neuC, iha, hrlA, fimC, pic, hlyA, kpsMTII, sitDep, ompA, iroN1, gimB, sitD, tratT, \nibeA, chuA, vat, tsh, iucD, cvi/cva, papC, irp2, iss, EAST1, felA, iutA, cvaC, papG, fimH )  \n\u2022 Antimicrobial resistance to 14 antibiotics (amikacin, amoxicillin/clavulanic acid, ampicillin, cephalexin, \nceftiofur, cefuroxime, ciprofloxacin, clinda mycin, cotrimoxazole, enrofloxacin, gentamicin, norfloxacin, \nofloxacin , and tetracycline)  \nThe artificial neural networks were constructed using the Neuroshell Classifier 2.1 software (Ward Systems \nGroup, Inc., Frederick, MD, USA, 1997 - 2000).  \nThe results a vailable were transformed into a binary form. Thus, the negative results are represented by \nnumber 0 and the positive ones by 1. This criterion was used for sensitivity (0) or resistance (1) to the 14 antibiotics \nstudied, to the absence (0) or presence (1)  of genes associated with pathogenicity, to the absence (0) or presence (1) \nof the different lesions observed in the chicks. Non -motile isolates were represented by 0 and motile isolates by 1. \nAs to the origin of isolates, it was necessary to add one more value and the data was noted as follows: litter (0), \ncellulitis (1) and respiratory cases  (2). \nIn this study, based on  the met hodology used by Salle (3 ), the inputs chosen to construct the artificial neural \nnetworks were  the 38 genes associated with pathogenicity . The outputs used were the behavior of Escherichia coli  \nstrains against 14 antibiotics.  \nThe significant difference between the mean levels of pathogenicity and the sensitive and resistant to the 14 \nantibiotics used in this study was observed when samples was performed statistical analysis with the aid of JMP \u00ae 9.0.1 software (SAS Institute Inc., 2010).  \n \nRESULTS AND DISCUSSION \n \nTable 1 shows the characteristics of artificial n eural networks constructed with the  inputs  38 genes associated \nwith virulence. The outputs were  the resistance or sus ceptibility to 14 antibiotics  studied by Salle (3 ).  \nAcco rding to the results of Table 1, it was  observed that the correct ratings had a range of 74.22 % to 98.44 % . \nNow with regard to sensitivity and spe cificity of the classifications , the results showed that the range of sensitivities \nof ratings was from 0% to 100 % for the intermediate samples , 0 % to 87 % for resistant , and 62 % to 100% \nsensit ive. Referring to the specificity , the results were 98 % to 100 % for the intermediate samples , 50 % to 99 % for \nresistant a nd 0 % to 87 % for the sensitivity . \nThis study agreed with the conclusions obtained by Salle et al . (4) has shown that it is possible, in a simplified \nway, using only the  38 genes associated with virulence obtain conclusive results regarding antimicrobial resistance. \nAlso it is possible to conclude that: if there is suspicion of infection by Escherichia coli , and this sample was \nidentified through traditional microbiological technique s, now using technologies like polymerase chain r eaction \n(PCR), tool that elucidated the genes associated with virulence factors combined with the use of Artificial Neural \nNetworks, is possible to define what is the best treatment to that sample.  \nThe results obtained from statistical analysis of the pathogenicity index and the 14 antimicrobials t hat were \nanalyzed in this study showed no significant differences between the averages: Pathogenicity index (PI) and the antimicrobial resistance of the samples. Also , it was noticed that these variables were independent, namely, it is \npossible to observe peaks of PI without any changes in antimicrobial resistance or the contrary.  \n \nREFERENCES  \n \n1. KABIR, S.M.L. Avian colibacillosis and salmonellosis: a closer look at epidemiology, pathogenesis, \ndiagnosis, control and public health concerns. Int. Environ. Res. Health. 2010.  \n2. 2. FACELI, K. et al. Intelig\u00eancia artificial uma abordagem de aprendizado  de m\u00e1quina. Rio de Janeiro: \nLTC, 2011.  \n3. 3. SALLE, F. O. Utiliza\u00e7\u00e3o de Intelig\u00eancia Artificial (Redes Neurais Artificiais) para a classifica\u00e7\u00e3o da \nresist\u00eancia a antimicrobianos e do comportamento bioqu\u00edmico de amostras de Escherichia coli isoladas de frango s 63rd WPDC/XXXIX ANECA  de corte. Tese (Doutorado em Ci\u00eancias Veterin\u00e1rias), Universidade Federal do Rio Grande do Sul. 2009.  \n4. 4. SALLE, F.O. et al. Use of artificial intelligence (artificial neural networks) to classify antimicrobial \nresistance from Escherichia coli samples isolated from broilers. In: 60th Western Poultry Disease Conference, 2011, \nSacramento. Proceedings 60th Western  Poultry Disease Conference.   \n \n \n \nTable 1.  Classification of bacterial resistance (intermediate, resistant or sensitive) of 256 samples of \nEscherichia coli  to 14 antibiotics using artificial neural networks, as input the 38 genes associated with virulence . \n \nOutputs  Inputs  Correct classifications \n(%) S (i)*  \n E (i) \n S (r) \n E (r) \n S (s) \n E (s)  \n \nAmikacin  Genes  97,27  0,0 1,0 0,0 1,0 1,0 0,0 \nAmoxicillin  + \nClavulanic acid  Genes  98,05  1,0 1,0 0,0 1,0 1,0 0,37 \nAmpicillin   Genes  82,42  0,72 1,0 0,36 0,98 0,98 0,41 \nCephalexin   Genes  94,92  0,6 1,0 0,41 0,99 0,99 0,5 \nCeftiofur   Genes  96,88  0,57 1,0 0,71 1,0 1,0 0,61 \nCefuroxime   Genes  96,09  0,0 1,0 0,28 1,0 1,0 0, 16  \nCiprofloxacin   Genes  85,94  0,75 1,0 0,55 0,97 0,97 0,61 \nClindamycin   Genes  98,44  0,5 1,0 1,0 0,5 0,5 1,0 \nCotrimoxazole   Genes  74,22  1,0 1,0 0,72 0,75 0,74 0,73 \nEnrofloxacin   Genes  75,78  0,42 0,98 0,53 0,94 0,94 0,55 \nGentamicin   Genes  88,67  - - 0,35 0,99 0,99 0,35 \nNorfloxacin   Genes  88,28  0,55 1,0 0,34 1,0 1,0 0,42 \nOfloxacin   Genes  89,45  1,0 1,0 0,24 0,99 0,99 0,5 \nTetracycline   Genes  77,73  1,0 1,0 0,87 0,63 0,62 0,87 \n* S (i): sensitivity for isolates with intermediate resistance  \n   E (i):  specificity for isolates with intermediate resistance  \n   S (r): sensitivity to resistant isolates  \n   E (r): spe cificity for resistant isolates  \n   S (s): sensitivity for sensitive isolates  \n   E (s): spe cificity for sensitive isolate  63rd WPDC/XXXIX ANECA  TENOSYNOVITIS IN BROILERS IN QUEBEC:  \nTHE COMPLEX RELATIONSHIP WITH REOVIRUS  \n \nTENOSINOVITIS EN POLLOS DE ENGORDA EN QUEBEC:  \nLA COMPLEJA RELACI\u00d3N CON REOVIRUS  \n \nJ.P. VaillancourtA and D. TremblayB \n \nADepartment  of Clinical Sciences, Faculty of Veterinary Medicine, University of Montreal, CP 5000, St -Hyacinthe, \nQc, Canada J2S 7C6  \nBLaboratoires de diagnostic mol\u00e9culaire et virologie, Faculty of Veterinary Medicine, University of Montreal, \nCDEVQ, 3220 Sicotte, St -Hyacinthe, Qc, Canada J2S 2M2  \n \nRESUMEN  \n \nEn 2012 y 2013, un gran n\u00famero de parvadas se han visto afectadas con tenosinovitis  la cual se ha observado \ndurante el sacrificio de pollos de engorda en Quebec. Se realiz\u00f3 un estudio comparando 13 parvadas afectadas (del 5 \nal 20 % de las aves con lesio nes) con 27 parvadas control  (no se observaron aves con lesiones) de la misma regi\u00f3n y  \nsacrificados en el mismo d\u00eda como casos. Se recogieron muestras de tejido de 5 aves de cada parvada, as\u00ed como \nmuestras de sangre (ELISA). El trabajo de diagn\u00f3stico incluy\u00f3 PCR, aislamiento viral y secuenciaci\u00f3n; tambi\u00e9n se recopil\u00f3 informaci\u00f3n sobre rendi miento de la parvada. Los t\u00edtulos serol\u00f3gicos fueron significativamente mayores en \nlas aves de las parvadas con casos en comparaci\u00f3n con las parvadas control. Pero lo m\u00e1s probable es que se \ndiagnosticara la infecci\u00f3n por reovirus tanto en los casos como en  los controles, bas\u00e1ndose en PCR y / o cultivo. Se \nidentificaron siete cepas diferentes de reovirus, y algunas de estas cepas se aislaron a partir de parvadas casos y \ncontroles. Tambi\u00e9n se discutir\u00e1n otros factores de riesgo (incluyendo nutricional).  \n \nSUMM ARY  \n \nIn 2012 and 2013, a large number of flocks were  affected with tenosynovitis observed at slaughter in broilers \nin Quebec. A study was conducted comparing 13 affected flocks (5 to 20% of birds with lesions) to 27 control flocks (no birds with lesions ob served) from the same region and slaughtered on the same day as cases. Ti ssue sampling \nwas collected on five  birds  per flock as well as blood samples (ELISA). Diagnostic work included PCR and virus \nisolation and sequencing. Information was also collected a bout flock performances. Serological titers were \nsignificantly higher in birds from case flocks compared to control flocks, but reovirus infection was just as likely to \nbe diagnosed in cases and controls based on PCR and/or culture. Seven different strains  of reovirus were identified, \nand some of these strains were isolated from case and control flocks. Other risk factors (including nutritional) will also be discussed.  \n \nABSTRACT  \n \nTenosynovitis is one of the clinical manifestations of avian reovirus infectio n in chickens, particularly in meat -\ntype chickens. In 2012 and 2013, a large number of chicken broiler flocks were  affected with tenosynovitis and \nobserved at slaughter in broilers in Quebec. Observed lesions included swollen shanks and hocks, excessive synovial fluid, enlargement of gastrocne mius/digital flexor tendon area,  rupture of tendons resulting in subcutaneous \nhemorrhages leading to a greenish discoloration over the site of the rupture.  \nA series of variants, much different from vaccine strains and associated with leg problems in broilers, has also \nbeen identified in different regions of North America since 2012  (1). The emergence and reemergence of reovirus -\nrelated diseases over the years in poultry make this virus a pathogen of interest as primary or secondary agent.  \nAt the request of two slaughter plants from different companies, a study was designed based on discussions \nwith field veterinarians and a poultry pathologist (Drs Ghislain H\u00e9bert, Louise Mercier, Mona Morin, and Daniel \nVenne). A case-control study was conducted comparing 13 affected flocks (5 to 20% of birds observed with lesions  \nat slaughter ) to 27 control flocks ( no birds observed with similar lesions ) from the same region and slaughtered on \nthe same day at the same slaughter plant. The case and control flocks came from the two slaughter plants that had \nrequested the work.  63rd WPDC/XXXIX ANECA  Shanks and blood samples (for reovirus ELISA testing) were collected from 11 birds  from  each flock . Six of \nthe 11 shanks were stored at \u2013  76\u00b0C, and tendons from the  other five shanks were sampled for PCR and virus \nisolation . Information was also collected about flock performances.  \nViruses were isolated and/or detected at the Facult\u00e9 de m\u00e9decince v\u00e9t\u00e9rinaire of the University of Montreal \n(FMV -UdeM) virology and molec ular diagnostic laboratories.  Brief ly, 200 mg of fresh tissues was  grinded with the \nBiospec Mini Bead -beater (BioSpec Products Inc., Bartlesville, OK ). Viruses were propagated by serial passage into \nbursal reticuloepithelial (REP) cells with Hanks medium supplemented with 10% fetal bovine serum (FBS) and 1% \npenicillin/streptomycin . Extraction of nucleic acid was performed with 200 \u00b5L of viral suspension\u00b8 using the fully \nautomated sample preparation Qiacube and the QIAamp cado r Pathogen Mini Kit ( QIAGEN Inc., Valencia, CA ) \naccording to the manufacturer\u2019s instructions. Amplification of partial S1 gene was then executed. Viral dsRNA was \nfirst denaturated 10 min  at 95\u00b0C in presence of primers Foward -Reo-SEQ -S1: 5\u2019 \nTGATACTGTCATTGAC TTCGAACGTG- 3\u2019 and Reverse -REO -SEQ -S1: 5\u2019ATCCCCGTACGGCGCGCCACAC-\n3\u2019. Reverse transcription of the RNA and amplification of the cDNA were performed with Qiagen One -Step RT -\nPCR kit. PCR products were purified with the Omega Bio -Tek E.Z.N.A. Cycle -Pure Kit (Ome ga Bio -Tek Inc., \nNorcross, GA). Sequencing was performed using the same primer sets used in the reverse transcription -PCR, with \nstandard automated sequencing methods (FMV Sequencing Laboratory, BigDye Terminator sequencer version 3.1 \n[ABI 310]; Applied Biosystems, Foster City, CA). The resulting sequences were compared with sequences of \nvaccines strains and strains available in the GenBank database. Software (BioEdit sequence alignment editor version \n7.0.9; Ibis Therapeutics, Carlsbad, CA) using the CLUSTAL  W alignment method was utilized and an unrooted \nphylogenic tree of the S1 gene was constructed by using the distance -based neighbor -joining method. Bootstrap \nvalues were calculated for 1,000 repeats of the alignment.  \nAlthough mortality was slightly higher  on average in case flocks (2.52%) compared to controls (1.81%), the \ndifference was only marginally significant (p = 0.08). Total carcass  condemnations (excluding parts condemned) did \nnot differ statistically between the two groups (cases: 1.33% versus controls: 1.52%).  \nOn average, s erologic  titers were higher in birds from case flocks (2264) compared to controls  (1279) . \nHowever, reovirus infection was as likely to be diagnosed in cases as in  controls  based on PCR and/or culture . \nIndeed, of 13 cases, eight were PCR positive and/or culture positive, while 17 of the 27 control flocks were PCR \nand/or culture positive.  In fact, when comparing flocks with tissue samples showing typical m icroscopic lesions \nassociated with reovirus infection to flocks with no such lesions, no significant difference could be found.  \nSix different strains of reovirus were identified, and some of these strains were isolated from case and control flocks.  \nThey were all significantly different from vaccine strains. Some isolates were very similar to strains previously \nidentified  in the neighb oring province of Ontario,  some were similar  to strains isolated in Georgia,  and others were \nclosely related to strain s previously sequenced in Israel. T able 1 below summarizes the information for isolates that \nappeared very similar, yet were found in case as well as control flocks.  \nResults from this small study confirm that reoviruses can be isolated from normal and affected birds  (2). \nAlthough reovirus may certainly play a role in the presence of gross lesions observed at slaughter, it was not \npossible to clearly identify a strain responsible for the problem.  There was also no clear relationship between \nreovirus stra in and the hatchery of origin. Altho ugh reovirus may persist in bird s longer than processing age ( 3), it is \npossible that the virus may no longer be isolated by that time. Therefore, without sequencing, diagnostic efforts \n(serology, virus isolation, PCR) a re of little value when investigating such problems. Further work is being carried \nout to sequence  the whole genome of the virus strains  equally found in case and control flocks in order to determine \nwhether they are identical or not. If this proves to be the case, the question would be which risk factors are required \nto allow these viruses to cause disease. Some of these factors may be related to the environment of the affected \nflocks. Nutritional factors should also be considered. For example, Timms ( 4) demonstrated that a 12.5% rapeseed \ndiet had an impact on the production of leg abnormalities caused by avian reovirus in male broiler chickens. The \ncurrent emergence of reovirus strains that are much different from vaccinal strains shows that the problem is  likely \nmultifactorial with risk factors that have yet to be identified.  \n \nREFERENCES  \n \n1. Rosenberger J.K. et al. 2013. Novel reovirus in broilers associated with arthritis/tenosynovitis  : viral \ncharacterization and research. Proceedings of the National Meeting on Poultry Health, Processing and Live \nProduction. Ocean City, October 2013.  \n2. Jones , R.C., Reovirus Infections. In:  Diseases of Poultry, 13th ed. D. Swayne , J.R. Glisson, L.K. Nolan, \nD.L. Suarez, V.L. Nair, eds. Wiley -Blackwell. pp.  351-370. 2013.  \n3. Islam,  M.R. Reovirus infection in chickens. PhD Thesis. University of Liverpool. 1988 . 63rd WPDC/XXXIX ANECA  4. Timms, L.M., Influence of a 12.5 per cent rapeseed diet and an avian reovirus on the production of leg \nabnormalities in male broiler chickens. Res. Vet. Sci. 38 (1): 69 -76. 1985.  \n \n \n \n \nTable 1.  \n \nSimilarity \nwith Flock \nstatus  LesionsA Bacterial \nculture  Serologic \ntiterB Hatchery  \nIDC  Slaughter \nplant ID  Gross  Histo  \nOntario \nvariant  Case  Yes Yes StaphD 2716  3 2 \nControl  No No - 346 2 1 \n \nIsrael \nvariant  Case  No Yes - 2139  4 2 \nControl  No No - 958 5 1 \nControl  No Yes - 1243  3 1 \nControl  No Yes - 980 4 1 \nControl  No No - 756 3 1 \nALesions compatible with reovirus infection (yes versus no) for macroscopic (gross) and microscopic  \n  (histo) lesions  \nBAverage  ELISA titer for reovirus  \nCID: identification number  \nDStaphylococcus  isolated from lesion  \n \n \n \n  63rd WPDC/XXXIX ANECA  AN\u00c1LISIS DEL SEGUIMIENTO EPIDEMIOL\u00d3GICO DE FOCOS DE \nENFERMEDAD DE NEWCASTLE EN EL ESTADO  \nDE M\u00c9XICO, 2013  \n \nEPIDEMIOLOGIC FOLLOW- UP OF FOCAL POINTS OF NEWCASTLE \nDISEASE IN THE STATE OF MEXICO, 2013  \n \nA. Valadez Sanabria \n \nM\u00e9dico Veterinario Zootecnista \nIndependencia 1327 Col. Reform a y Ferrocarriles Nacionales, C.P. 50070  \nToluca, Estado de M\u00e9xico  \nemail: alicia_valadez@yahoo.com  \n \nSUMMARY  \n \nIn 2013 Mexico was declared free of velogenic Newcastle d isease (VND) wi th vaccination . The present work \ndescribes the epidemiologic follow -up that took place in three foci  of VND occurring  in fighting cocks in the State \nof Mexico in 2013 until it was resolved  using the  official format from SENASICA. It was concluded that fighting \ncocks  and backyard poultry represent a hi gher risk for foci of VND because this type of  production often lacks  \nproper biosecurity measures and established annual vaccination programs.  Also, the constant movement  of fighting \ncocks to \u201cpalenques\u201d and fairs  represents an additional threat . \n \nRESUMEN  \n \nM\u00e9xico fue declarado libre de la enfermedad de Newcastle v elog\u00e9nico (ENCV) con vacunaci\u00f3n, en el a\u00f1o \n2013. En el presente trabajo, se describen los seguimientos epidemiol\u00f3gicos en tres focos que se presentaron en la \navicultura de combate del Estado de M\u00e9x ico durante el a\u00f1o 2013, hasta su cierre, utilizando el formato oficial del \nServicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (SENASICA). Se concluy\u00f3 que la avicultura de \ncombate y la de traspatio, representan mayor riesgo para la presentaci\u00f3n de focos de la ENCV, por el tipo de \nproducci\u00f3n, carencia de medidas de bioseguridad y de calendarios de vacunaci\u00f3n establecidos anualmente, as\u00ed como \nla constante movilizaci\u00f3n de gallos de pelea a palenques y ferias.  \n \nINTRODUCCI\u00d3N  \n \nLa ENC, es clasificada por la Organizaci\u00f3n Mundial de Sanidad Animal (OIE), como una enfermedad de \ndeclaraci\u00f3n obligatoria debido a su elevada contagiosidad y por su importante impacto econ\u00f3mico y social (1). La avicultura comercial es un sector importante  en la producci\u00f3n pecuaria del Estado de M\u00e9xico. Las explotaciones de \ngallos de pelea y traspatios, componen una parte importante del sector av\u00edcola, preocupante desde el punto de vista \ndel movimiento de aves y el potencial de \u00e9stas como portadoras y trans misoras de enfermedades que pudieran llegar \na afectar la industria av\u00edcola estatal. Dentro de las enfermedades aviares m\u00e1s importantes que pueden diseminarse, \nse encuentra la Enfermedad de Newcastle (ENC ), considerada como una de las patolog\u00edas de alta transmisi\u00f3n y que \ncausa mayor impacto econ\u00f3mico a la avicultura por las p\u00e9rdidas que ocasiona, representadas por elevadas morbilidades y mortalidades, bajas en la producci\u00f3n, altos costos de los tratamientos de infecciones secundarias y cuantiosas inversiones  en los programas para su control y erradicaci\u00f3n (2). Para prevenir y controlar la diseminaci\u00f3n \nde esta enfermedad se deben implementar medidas como planes de vacunaci\u00f3n en aves de traspatio y de combate (3); desarrollar planes de vigilancia epidemiol\u00f3gica  activa, hacer seguimiento de casos sospechosos (vigilancia \npasiva); llevar a cabo capacitaciones constantes y educaci\u00f3n a los propietarios, cuidadores y responsables de este \ntipo de aves, para en un futuro no muy lejano poder erradicar la enfermedad. Auna do a lo anterior, se identifica que \nlas explotaciones con aves de combate que mantienen medidas de bioseguridad regulares o malas y los predios de \ntraspatio con nulas medidas de bioseguridad, se encuentran expuestos a una mayor probabilidad de ocurrencia d e la \nenfermedad. El objetivo del presente trabajo, fue analizar tres focos de la ENCV a trav\u00e9s de la vigilancia \nepidemiol\u00f3gica pasiva realizada en el Estado de M\u00e9xico, que constituy\u00f3 una herramienta muy importante para la \noportuna detecci\u00f3n de la enfermedad e implementar estrategias de control en aves de combate y de traspatio.  63rd WPDC/XXXIX ANECA   \nMATERIAL Y M\u00c9TODO  \n \nCon informaci\u00f3n proporcionada por el Comit\u00e9 de Fomento y Protecci\u00f3n Pecuaria del Estado de M\u00e9xico S.C. \n(CFPPEM ), se analizaron las actividades epidemiol\u00f3gicas realizadas en tres focos diagnosticados por la Comisi\u00f3n \nM\u00e9xico Estados Unidos para la Prevenci\u00f3n de la Fiebre Aftosa y otras Enfermedades Ex\u00f3ticas de los Animales \n(CPA ) como positivos a ENCV en predios de tra spatio con aves de combate durante el a\u00f1o 2013, utilizando el \nformato oficial emitido por la DEAR. Los focos identificados como 1 y 2 corresponden a los que se presentaron en \nToluca y el foco n\u00famero 3, es el de Ixtlahuaca.  \n \nRESULTADOS  \n \nA trav\u00e9s del formato : Lista de verificaci\u00f3n de documentos para el cierre de focos de la Enfermedad de \nNewcastle en el Estado de M\u00e9xico, emitido por la DEAR, se analizaron tres focos de la ENCV, dos registrados en el \nmunicipio de Toluca y uno en Ixtlahuaca. La poblaci\u00f3n total registrada en los tres focos, fue de 345 aves (combate y \ntraspatio), la mortalidad global por enfermedad fue del 40% con un rango de 40 a 94. En los tres focos se registr\u00f3 \nsimilar signolog\u00eda: diarrea amarillenta -verdosa, secreci\u00f3n nasal, crestas moradas y edema en p\u00e1rpados.  \nSe sacrificaron un total de 191 aves en los dos predios de Toluca, indemnizando a los productores. Se concluy\u00f3 \nel seguim iento epidemiol\u00f3gico, integrando la informaci\u00f3n solicitada por la DEAR: Formatos SIVE 01 y 02, \nresultados de laboratorio, oficios de cuarentena, actas de despoblaci\u00f3n o sacrificio, muestreos perifocales y \nresultados, oficio de levantamiento de cuarentena, entre otros. Actualmente, los tres predios se mantienen sin aves.  \n \nDISCUSI\u00d3N  \n \nEn la actualidad la OIE, sigue considerando a la ENC, una de las principales enfermedades virales de las aves; \npor ser altamente contagiosa y por las p\u00e9rdidas econ\u00f3micas que ocasiona.  \nM\u00e9xico se considera libre de la ENC a partir del a\u00f1o 2013, sin embargo, se siguen presentando eventos de la \nenfermedad en aves de traspatio y de combate.  \nLa densidad de la poblaci\u00f3n aviar y su distribuci\u00f3n en el Estado de M\u00e9xico, var\u00eda seg\u00fan la regi \u00f3n geogr\u00e1fica y \nel tipo de UPP. El establecimiento de una granja o UPP en M\u00e9xico no se regula con fines de la salud y la producci\u00f3n \nanimal; solo se hace por el reglamento del Bando Municipal, en funci\u00f3n del uso de suelo y la zona seg\u00fan sea urbana o rural; lo que representa un riesgo para transmisi\u00f3n de enfermedades a granjas tipo comercial. Estudios previos \nrealizados en porcinos, encontraron que la ubicaci\u00f3n de granjas a menos de 1 -0 km de radio de la granja foco, es \nconsiderado como riesgo, sin especificar el nivel (3).  \n \nREFERENCIAS  \n \n1. Organizaci\u00f3n Mundial de Sanidad Animal (OIE). Technical Disease Card. Newcastle Disease. October \n2009. www.oie.int.  \n2. Moreno, Ch. R. La Enfermedad de Newcastle y algunos avances recientes de diagn\u00f3stico. Ciencia \nVeterinaria 6: -50-51.1994.   \n3. Estrada, S. E., Diosdado, V. F., Arriaga, R. E., \u00c1vila, S.E., Hern\u00e1ndez CA, Morilla GA. Evaluaci\u00f3n de \nalgunos factores que pudieron influir en el incremento de la fiebre porcina cl\u00e1sica en el Estado de M\u00e9xico, M\u00e9xico, \ndurante 1997. Vet. M\u00e9x., 2001; 32 (1): 47- 53. \n 63rd WPDC/XXXIX ANECA  EVALUATION OF THE REDUCTION OF AVIBACTERIUM  \nPARAGALLINARUM  COLONIZATION IN VACCINATED SPF \nCHICKENS USING QUANTITATIVE PCR  \n \nEVALUACI\u00d3N DE LA REDUCCI\u00d3N DE LA COLONIZACI\u00d3N DE \nAVIBACTERIUM PARAGALLINARUM EN POLLOS LIBRES DE PAT\u00d3GENOS \nESPEC\u00cdFICOS VACUNADOS UTILIZANDO PCR CUANTITATIVA  \n \nM. Pietraszewski , N. Downs, and M. Vazquez \n \nResearch and Development Department, Lohmann Animal Health International, Winslow, ME, USA  \nCorresponding author: mjpietraszewski@lahinternational.com  \n \nRESUMEN  \n \nLa coriza infecciosa aviar es una enfermedad respiratoria altamente contagiosa causada por Avibacterium \nparagallinarum . La infecci\u00f3n se caracteriza por conjuntivitis espumosa, sinusitis, descarga nasal, depresi\u00f3n y \nletargia. El objetivo de este estudio fue evaluar la reducci\u00f3n  de la colonizaci\u00f3n de la coriza infecciosa en pollos \nlibres de pat\u00f3genos espec\u00edficos (SPF) utilizando PCR cuantitativa. Los pollos SPF  se vacunaron en las semanas 12 y \n16 utilizando dos v\u00edas de vacunaci\u00f3n. Los pollos fueron desafiados a las 20 semanas de edad contra los serotipos A, \nB y C. Despu\u00e9s de tres d\u00edas post desafio, se tomaron muestras del paladar hendido y la carga bacteriana fue evaluada \nmediante PCR cuantitativa. Los resultados mostraron una reducci\u00f3n significativa (prueba de chi cuadrada, P =0.05) \nen la carga bacteriana del paladar hendido de los pollos vacunados comparados con los pollos no vacunados. Estos \nresultados sugieren que la PCR cuantitativa puede ser un m\u00e9todo confiable para evaluar la eficacia de la vacuna.  \n \nSUMMARY  \n \nAvian c oryza is a highly contagious respiratory disease caused by Aviba cterium  paragallinarum . The infection \nis characterized by foamy conjunctivitis, sinusitis, nasal discharge, depression , and lethargy. The goal of this study \nwas to evaluate the reduction of coryza colonization in SPF chickens using quantitative PCR. SPF chickens were \nvaccinated at 12 and 16 wk  of age  using two vaccination routes. Chickens were challenged at 20 wk  of age  against \nseroty pes A, B and C. After three d  post challenge, swabs samples were taken from the chickens palatine cleft and \nthe bacterial loads were assessed by quantitative PCR. Results showed a significant reduction ( ANOVA  test, \nP=0.05) of bacterial loads in  the palatine cleft of vaccinated chickens in comparison with unvaccinated ch ickens. \nThese results suggest that quantitative PCR ( qPCR)  may be a feasible method to evaluate vaccine efficacy . \n \nINTRODUCTION  \n \nThe causal organism of infectious coryza is  Avibacterium paragallinarum . Infection is highly contagious and \nrapidly spreads thr ough flocks and chicken houses. The emergence of secondary infections during the course of the \ndisease prolongs the clinical signs dramatically impacting flock performance. The disease is characterized by depression, facial swelling, conjunctivitis, mucus discharge, and in very acute cases there is low rate of mortality  \n(1). The highest impact in the flock is the economic losses due to the decreased productivity. Vaccination practices \nhave shown to help reduce risk of contamination. In zones with high incid ence of coryza , vaccines do not always \nprotect against all field isolates; in these cases proper biosecurity and improving vaccination programs is generally \nthe best way to prevent outbreaks . The efficacy of  coryza vaccines is usually evaluated by the analysis of the type \nand intensity of clinical signs developed  after challenge with virulent c oryza strains.  The differences in clinical signs \nobserved  between vaccinated and non -vaccinated chickens  after infection  are scored  and expect ed to result in \nsignificant differences between  groups.  The results obtained with  this type of analysis are subjective and therefore \nthe method lacks statistical power and leads to inconsistent results (2). The development of a more reliable and \nquantitative method to evaluate  with a simpler approach the performance of coryza  vaccines  would be ideal.  The \naim of this study was to evaluate the feasibility of qPCR as a potential method to measure the reduction  of coryza  \ncolonization in challenge d birds after two administrations o f three different commercial c oryza vaccines .   63rd WPDC/XXXIX ANECA   \nMATERIALS AND METHODS  \n \nExperimental design.  A total of 130 White Leghorn SPF chickens (12 wk  of age) were included in this study.  \nChickens were randomly distributed into 13 treatment groups . Three commercial  vaccines were administered to th e \nbirds and they were identified as  Vaccine A, B, and C . (Table 1).  \nVaccination . The groups were vaccinated with the vaccine randomly assigned to them using the IM route with \na dose of 0.5 mL  at 12 wk  of age and then again at 16 w k of age. Control groups received injections of placebo in \nthe same manner.   \nPreparation of t he challenge i noculum . Challenge seeds of coryza 0083, Modesto and Spross were thawed \nand 0.5 mL of seed was inoculated into 200 mL of c oryza media supplemented with 0.1% NADH (10%), 3% \ndextrose and 6% horse serum. The culture w as incubated overnight (18 h ) at 37\u2070C. Culture media was transferred \ninto 30 mL sterile vials, stoppered, crimped, and held at room temperature until use in the  challenge (no m ore than 2 \nh). A plate count was c onducted to determine the CFU/mL  of the challenge culture. Plate counts resulted in titers of: \n0083= 6.71 log10 CFU/0.2mL, Modesto= 6.55 log10 CFU/0.2mL, and Spross= 6.67 log10 CFU/0.2mL.  \nChallenge . At 20 wk  of age the birds were inoculated with a 0.20 mL intranasal challenge (0.10 mL in each \nnasal orifice) of one of the three challenge strains . The birds in the negative control group were kept in a separate \nisolation room and inoculated with sterile PBS and considered a s the non -challenged controls.  \nPalatine cleft swabs . At the pe ak of clinical signs (three d  post-challenge) the palatine cleft of each challenged \nbird was swabbed with a flocked micro swab. The swabs were placed in 1 mL sterile water in falcon tubes for \nprocessi ng. Each tube was vortexed then a sample of 100 \u00b5L was taken from each tube and placed into a 96 -well \nmicroplate. The samples were then boiled at 100 \u2070C for 20 min  to lyse the cells. Boiled samples were processed  \nusing qPCR to quantify the amount of c oryza present in  each sample.   \nqPCR . Primers and probes were designed to amplify and detect a 143bp, 128bp, and 128bp region of 0083, \nSpross, and Modesto, respectively. Quantitative PCR was conducted using the Bio- Rad CFX96TM Real-Time PCR \nDetection System (Bio -Rad, Hercules, CA).  Reactions were carried out in 20uL containing:  1x SsoFastTM Probes \nSupermix (Bio -Rad, Hercules, CA), 0.5 uM each qPCR Fwd and Rev primer, 0.25 uM probe, and 1uL of template.  \nThe cycling conditions were as follows: 1  cycle at 95oC for 2 min. and 40 cycles at 95oC for 5 sec. and 60oC for 10 \nsec. Standards were generated through PCR amplification of each region.  The DNA was purified using the Wizard\u00ae \nSV Gel and PCR Clean -up System (Promega, Madison, WI) and quantified using the QubitTM fluorometer \n(Invitrogen, Carlsbad, CA).  The DNA was diluted to a stock concentration of 1x109 copies/uL.   \nData analysis. All qPCR was analyzed using ANOVA  with significance level set at P\u22640.05.   \n \nRESULTS  \n \nReduction of bacterial colonization was determined at the peak of clinical signs (3 d  post-challenge). Swab \nsamples were taken from the palatine cleft of each bird and the average copy number was assessed by qPCR . There \nwas no detectable coryza present on the swabs for any of the vaccinated birds challenged  with coryza serotype A \n(0083), while controls had an average bacterial loads  of 1.3x105 copy#/mL  (Figure 1). Birds challenged with c oryza \nserotype B (Spross) had average  bacterial loads  of 1.1 x106, 9.7 x104, 9x104, and 2.0 x105 copy#/mL for controls, \nvaccine A, vaccine B, and v accine C groups, respectively. Birds challenged with c oryza serotype C (Modesto ) had \naverage bacterial loads of 5.4 x105, 1.5 x104, and 8.6 x102 copy#/mL for controls, v accine A, and vaccine B, \nrespectively.  Birds that received Vaccine C were free of any detectable levels of Modesto  strain . There was a \nsignificant re duction of the colonization of c oryza 0083, Spross, and Modesto between all va ccinated groups  \nregardless the type of adjuvant utilized in the formulation.  \n \nDISCUSSION  \n \nTraditional methods for determining vaccine efficacy  of coryza vaccines  rely on the use of clinical signs  as an \nanalytical measure.  Due to the nature of the readout, significant differences can be difficult to observe  and may not \nreflect true  vaccine perfo rmance . In addition, the method of observing for clinical signs is highly subjective and can \nvary depending on the technician conducting the test. This study was set forth to deter mine the feasibility to detect \ncoryza colonization using a more practical qu antitative method than bacterial re -isola tion. It was demonstrated that  \nqPCR was not only able to detect c oryza colonization at three  d post-challenge, but also able to detect statistically  \nsignificant differences between vaccinated and non -vaccinated grou ps. The three commercial vaccines were able to  \ncompletely eliminate  colonization  of coryza serotype A  at three  d post-challenge . For serotype B , chickens showed 63rd WPDC/XXXIX ANECA  0.90- 1.2 times  less colonization than the control group.  Chickens  challenged wit h serotype C had 5.7 (Vac -C), 1.9 \n(Vac -B), and 1.3 (Vac -A) less bacterial load than the control group. Based on these results, qPCR may provide an \nalternative/supplemental  approach in determining  the effica cy of coryza vaccines  based on reduction of colonization \nafter challenge . \n \nREFERENCES  \n \n1. Blackall P.J. Infectious Coryza: Overview of the Disease and New Diagnostic options. Clinical \nMicrobiology Reviews. 12(4):627- 632. 1999.  \n2. Sim, Julius and Wright, Chris C. The kappa statistic in reliability studies: use, interpretation, and sample \nsize requ irements. J. Amer. Phys ical Therapy. 85: 257 -268. 2005.  \n \n \nTable 1.  Treatment groups . \n \n \nGroup  Adjuvant  Treatment  Birds #  Challenge  \n1 \nWO Vaccine A  10 0083  \n2 Vaccine A  10 Spross  \n3 Vaccine A  10 Modesto  \n4 Al(OH) 3 \nGel Vaccine B  10 0083  \n5 Vaccine B  10 Spross  \n6 Vaccine B  10 Modesto  \n7 \nWOW  Vaccine C  10 0083  \n8 Vaccine C  10 Spross  \n9 Vaccine C  10 Modesto  \n10 \nWOW  Placebo  10 0083  \n11 Placebo  10 Spross  \n12 Placebo  10 Modesto  \n13 Placebo  10 No challenged  \nTotal birds in test:  130    \nFigure 1 . Coryza colonization as determined by qPCR.  Statistically significant (P\u22640.05) differences are \nindicated by different letter designation.   \n \n63rd WPDC/XXXIX ANECA  DIFFERENCES IN SECONDARY REACTIONS INDUCED BY \nWATER -OIL-WATER ( WOW ) AND WATER -OIL ( WO) \nAVIBACTERIUM  PARAGALLINARUM  VACCINES  \n \nDIFERENCIAS EN LAS REACCIONES SECUNDARIAS INDUCIDAS POR \nV ACUNAS CONTRA AVIBACTERIUM PARAGALLINARUM EN ADYUV ANTES \nAGUA/ACEITE/AGUA Y AGUA/ACEITE \n \nM. Vazquez  and N. Downs  \n \nResearch and Development Department, Lohmann Animal Health International, Winslow, ME, USA  \nCorresponding author: mvazquez@lahinternational.com  \n \nRESUMEN  \n \nCon la nueva generaci\u00f3n de aceites y surfactantes, la tecnolog\u00eda de emulsi\u00f3n para el sistema de suministro de \nant\u00edgenos tuvo una mejor\u00eda considerable. Dependiendo de la formulaci\u00f3n de la vacuna y el tipo de ant\u00edgeno,  la \nseveridad de la reacci\u00f3n puede variar y en algunos casos causar granulomas. La meta de este estudio fue evaluar el \nnivel de reacci\u00f3n en el sitio de vacunaci\u00f3n inducido por vacunas contra coriza agua/aceite/agua y agua/aceite. Pollos \nlibres de pat\u00f3genos  espec\u00edficos (SPF) fueron  vacunados a las 12 y 16 semanas de edad v\u00eda intramuscular y \nsubcut\u00e1nea. Los pollos fueron sacrificados y se evalu\u00f3 el nivel de reacci\u00f3n en el sitio de la vacuna. Las lesiones \nobservadas se calificaron de acuerdo a un sistema de pu ntuaci\u00f3n establecido y las diferencias entre las dos vacunas \nen los distintos puntos de observaci\u00f3n se evaluaron utilizando la prueba de chi cuadrada ( P=0.05). Los resultados \nmostraron diferencias significativas entre las vacunas agua/aceite/agua y agua/aceite para ambas v\u00edas de administraci\u00f3n.  \n \nSUMMARY  \n \nWith the new generation of oils and surfactants the emulsion technol ogy for antigen delivery system s has \nconsiderably  improved. Depending on the  vaccine formulation and the type of antigen , the severity of the reaction \nmay vary and in some cases can induce granulomas. The goal of this study was to evaluate the level of reaction at  \nthe vaccination site induced by water \u2013oil-water ( WOW ) and water -oil (WO) infectious coryza vaccines.  SPF \nchicke ns were vaccinated at 12 and 1 6 wk  using the intramuscular and subcutaneous routes. Chickens were \neuthanized and the level of reaction at  the vaccination sites was evaluated.  The observed lesions were scored \naccording an established scoring system and diff erences between both vaccines were assessed by  the C hi square test \n(P=0.05). Results showed that i nfectious c oryza, WOW bacterin is two  times less reactive th an the WO bacterin \nwhen a 0.5 mL  dose is applied twice by both IM and SQ route.  The WOW vaccine ad ministered by the SQ route \ninduced milder reactions than when it was applied by the IM route.  \n \nINTRODUCTION  \n \nThe efficacy of  emulsion vaccines is related to the capacity of the vaccine to  reduce to a certain degree and \nunder specific criteria the level of  disease  in the host  when they are compared with an unvaccinated group , while \nsafety is mostly associated with  the degree of reaction at the vaccination site. A properly developed emulsion \nvaccine must maintain an adequate balance between efficacy and safet y. The oil quality, the immunogenic capacity \nof the antigen(s), formulation components, and  the emulsification process are factors directly involved  in the \nachievement of this balance . The kinetics of the antigen release varies according  to the tolerance of the host to the \noil, the  type of  antigen or a  combination of both (1, 6 ). WOW  emulsions are designed to have the same \nimmunogenic characteristics as the WO  formulations with the advantage of having minimal or no adverse reactions \nat the application site . Avibacterium  paragallinarum  is the causative agent of infectious coryza.  The disease is \nmainly characterized by facial edema, nasal  discharge and conjunctivitis. Infectious  coryza has a considerable \neconomic impact in poultry mostly in regions where the disease is endemic or with the prevalence of a high diversity \nof serotypes (A, B and C) or serovars (A1 -A4, B1, C1 -C4) (2). Available  infectious c oryza c ommercial vaccines are 63rd WPDC/XXXIX ANECA  commonly formulated as WO type or in other cases the antigen is usually adjuvanted with an aluminum hydroxide \ngel.  There is little  information evaluating the differences  between  the level of reactivity of WOW  vs WO infectious \ncoryza bacterins  (3, 4, 5). The goal of this study was to assess if WOW bacterins  are less reactive than the WO \nbacterins  when they are administered by the subcutaneous or intramuscular routes . \n \nMATERIAL AND METHODS  \n \nExperimental design. This study was conducted  in two parts ; each part  was performed with three \nexperimental groups with a total of 30 chickens each. The experimental groups were identified as WOW , WO,  and \nplacebo groups.  \nBirds. White Leghorn SPF chickens were included in this study. Chickens in both stages  were randomly \nhoused in floor pens where water and feed were  supplied ad libitum . \nVaccines.  WOW and WO  commercial infectious coryza bacterins were included in the study, both products \ncontained A, B and C serotypes of Av. paragallinarum . The placebo was experimentally f ormulated (WO and \nWOW) at Lohman n Animal Health International, Research and D evelopment facilities.  \nVaccination.  Chickens  in both parts  of the study were vaccinated at 12 and 16  wk of age with 0.5 mL  of their \nrespective WOW, WO or placebo . For  part one, the chickens were vaccinated by the intramuscular route while for  \npart two a subcutaneous vaccination  was performed . \nEvaluation of the lesions in the vaccination site.  Chickens were humanely sacrificed at five wk  post-last \nvaccination and the injection  site was analyzed in order to id entify  and classify  the type of  reaction  present  in the \nbreast or neck  of the chicken. The lesions were identified  and scored according to the characteristics  described in \nTable 1.   \nData analysis.  To assess the degree of reaction presented at the injection site, the scores obtained per each \nchicken were added in order to have a representative value per category and per experimental group.  A Chi square \n(P\u22640.05)  analysis was conducted to determine significant differences between  the type of vaccine applied and \nseverity  of the lesions produced by the vaccination.  \n \nRESULTS  \n \nAs was previouly indicated , five categories of lesion s were indentified  (Table 1)  to determ ine the \u201creactivity\u201d \nof the WO and WOW commercial infectious c oryza bacterins  at the injection site.  \nChickens vaccinated with WOW -SQ route  induced  2.4 times  less encapsulation and  six times  less changes in \nthe internal  tissue of the  chicken neck than the WO -SQ bacterin . Granulomas were not observ ed with the WOW \nbacterin while four of the 30 chickens  vaccinated with WO  developed a small size granuloma.  In general , both WO \nand WOW bacterins pr esented a normal level of absorption  after five wk  post second vaccination  by the SQ route . \nChickens vaccinated with the WOW -IM route showed three times less changes in the breast tissue than the \nchickens vaccinat ed with the WO bacterin. Only one of the 30 chickens vaccinated with the WOW bacterin \ndeveloped  a certain type of  grano ulomatouse tissue in the breast . In comparison , the breast s of seven  chickens \nvaccinated with the WO -IM presented  different degrees of granulomatouse tissue.  No residual vaccine was observed \n(100% of absorp tion) in 30% of the chickens vaccinated with WOW -IM, while all the chickens vaccinated with \nWO-IM had different leve ls of remaining vaccine a fter 5 w k post-last vaccination . \nNone of the p lacebo groups showed a ny degree of reaction in the inj ection site with both (IM, SQ) vaccination \nroutes.  \n \nDISCUSSION  \n \nLicensed emulsion vaccines in USA as  in other  parts of the world are required to ensure safety before they are \nreleased for its sale.  In this study it was proven  that infectious c oryza , WOW bacterin is two  times less reactive than \nthe WO bacterin when  a 0.5 mL  dose is applied  twice  by both IM and SQ route (Fig. 1) . Fukanoki et al.  (4, 5), \nprepared  several WOW vaccines  including different components in the formulation and their reactivity was \ncompared against a standard WO formula. Fukanoki showed that the variation of the components included in the \nformulation  of these WOW vaccines  had a direct impact on  the intensity of the reaction  and some of those \nformulations  were more reactive than the WO vaccine. Blackall ( 3) studied the efficacy and the reactivity of WOW \ninfectious c oryza experimental vaccines. He found that WOW vaccines  formulated for his  study  did not  conferred a \nsatisfactory level of protection after  challenge , but he remarked that the toxicity of these WOW vaccines was \nevidently reduced. In conclusion,  the reactivity of vaccines is essential to trigger an adequate immune response but 63rd WPDC/XXXIX ANECA  at the same time this res ponse must be mediated to avoid the presence of  strong adverse reactions.   \n \nREFERENCES  \n \n1. Aucouturier J., Dupuis L. and Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine \n19: 266- 2672. 2001.  \n2. Blackall  P.J. Infectious Coryza: Overview of the Disease and New Diagnostic options. Clinical \nMicrobiology Reviews. 12(4):627- 632. 1999.  \n3. Blackall P.J. Further Comparison of Adjuvants for an Inactivated Infectious Coryza Vaccine. Avian \nDiseases. 32:831- 835.1998.  \n4. Fukanoki Shin -ichi, Matsumoto Kohei, Mori Hajime and Takeda Reiji. Relationship between antigen \nrelease and antibody response of Infectious  Coryza Water -in-Oil-in Water Emulsion Vaccines. Avian Diseases. \n44:869- 873.2000.  \n5. Fukanoki Shin- ichi, Iwakura Tadashi , Iwaki Shuki, Matsumoto Kohei, Takeda Reiji, Ikeda Keiko, Shi \nZhe and Mori Hajime. Safety and efficacy of water -in-oil-in-water emulsion vaccines containing Newcastle disease \nvirus haemagglutinin -neuraminidase glycoprotein. Avian Pathology. 30:509- 516. 2001. \n6. Marciani D.J. Vaccine adjuvants, role and mechanisms of action in vaccine immunogenicity. Drug \ndiscovery today. 8(20):934- 943. 2003.  \n \n \nTable 1. Scoring system to classify the reactions in the injection site.  \n \nDescription of the lesion  Score  \n0 1 2 3 \nChanges on the internal skin \ntissue of the neck  Normal  Engrossed  Severely \nengrossed   \nChanges in the breast tissue  Normal  Other    \nVaccine encapsulation  None  Partial Severe   \nVaccine absorption  Absorbed No absorbed    \nGranuloma  None  Small  \n(0.3-0.4 cm)  Medium  \n(0.5-1.4 cm)  Large  \n(\u22651.5 cm)  \n \n \nFigure 1. Comparison of reactions induced by WOW and WO in the chicken injection site. Different letters \nindicates significant differences between groups by Chi square test (P\u22640.05).  \n \n \n \n \n63rd WPDC/XXXIX ANECA  ASSESSMENT OF q PCR AS A METHOD TO EVALUATE \nSALMONELLA  ENTERITIDIS SHEDDING  \n \nEV ALUACI\u00d3N DE LA PCR CUANTITATIV A COMO M\u00c9TODO PARA \nEV ALUAR LA ELIMINACI\u00d3N DE SALMONELLA ENTERITIDIS  \n \nM. Pietraszewski  and M . Vazquez \n \nResearch and Development Department, Lohmann Animal Health International, Winslow, ME, USA  \nCorresponding author: mjpietraszewski@lahinternational.com  \n \nRESUMEN  \n \nLa PCR cuantitativa se ha vuelto muy popular y ha sido un m\u00e9todo muy eficiente para detectar pat\u00f3genos de \nmanera cuantitativa. Los iniciadores espec\u00edficos de la PCR cuantitativa fueron dise\u00f1ados para ampliar una porci\u00f3n \ndel gen transportador del ant\u00edgeno O (Wzx) de la Salmonella  Enteritidis  (SE). El objetivo de este estudio fue evaluar \nla confiabilidad del uso de la PCR cuantitativa c omo un m\u00e9todo para evaluar la eliminaci\u00f3n de SE. Pollos libres de \npat\u00f3genos espec\u00edficos fueron desafiados con una cepa virulenta de SE a las 20 semanas de edad. Los pollos se \nsacrificaron a diferentes tiempos y se tomaron muestras individuales del ciego y de heces, las cuales fueron \nanalizadas con PCR cuantitativa y re- aislamiento bacteriano. Los resultados demostraron que la prueba de PCR \ncuantitativa puede utilizarse para discriminar la carga bacteriana en muestras de ciego y fecales, aunque el resultado \nm\u00e1s confiable fue observado en las muestras del ciego despu\u00e9s de siete  d\u00edas post infecci\u00f3n.  \n \nSUMMARY  \n \nQuantitative PCR (qPCR) has become a popular and efficient means for detecting and quantifying pathogens. \nSpecific qPCR primers were designed to anneal to  and amplify a portion of the O -antigen transporter (Wzx) gene of \nSalmonella Enteritidis (SE). The goal of this study was to assess the feasibility of the use of quantitative polymerase \nchain reaction ( qPCR)  as a method to evaluate SE shedding. SPF chickens were challenge wit h a SE virulent strain \nat 20 wk  of age. Chickens were euthanized at different time points and individual samples of ceca and fecal swabs \nwere taken and analyzed by qPCR and bacterial re- isolation. The results showed that qPCR assay can be used to \ndiscriminate bacterial loads in ceca and fecal samples, although the most reliable outcome was seen in the ceca \nsamples after seven d  post infection.  \n \nINTRODUCTION  \n \nOne of the primary modes of Salmonella transmission is through the excretion of feces in chicken houses in \nwhich the bacteria are released into the environment. With fecal transmission still an inevitable mode of contamination, it is critical to evaluate the degree that  shedding occurs naturally and if vaccination may result in a \nsignificant decrease following challenge.  Reliable quantitative assays can be used to determine the true bacterial \nload released into the environment. This information can be used in determining more accurately the direct impact vaccination programs have on the reduction of Salmonella contamination via the oral -fecal route.  Some of the \ncurrent bacterial shedding methodologies utilize c loacal swabbing and drag swabs  (1, 3) . Depending on the sample \ntype, time of collection, pre -enrichment procedures, and other experimental conditions, these methods may lead to \nincon sistent and/or inaccurate results. Cloacal swabbing relies on the assumption that each sample is equal; \nhowever,  this is typically not the case.  Drag swabs may provide a better idea of the overall shedding, but is limited \nto groups of chicken s contained in any given area. We suggest an alternative method which may provide a more \nconsistent approach which allows for accurate quantification of bacterial shedding on an individual chicken basis.  \n \nMATERIAL AND METHODS  \n \nExperimental design. At total of 36 SPF chickens were divided into groups of 6 and randomly assigned cages \n(six chickens per cage). All chickens were challenged at 20 wk of age. Bacterial enumeration of the cecal content \nand qPCR  analysis of the cecal and fecal content was determined for a single group of chickens  at 24, 48, 72, 96, 63rd WPDC/XXXIX ANECA  168, and 216 h  post challenge ( hpc). \nChicken  housing . All chickens were maintained in colony houses at the Lohmann Animal Health facility \n(Winslow, ME). Chickens were individually assigned to cages by computer generat ed randomization (random.org). \nAll chicken s had access to feed and water ad libitum for the duration of the experiment. No biological or \npharmaceuticals, other than the specific challenge strain (described below), was administered to the test animals.  \nChallenge culture preparation . A seed of ME 76 SE naladixic acid resistant strain was streaked onto TSA \nagar supplemented with naladixic acid (100 \u00b5g/mL) and incubated at 37\u00b0C overnight. Colonies were scraped and \nsuspended in 12 mL of tryptose broth to an O.D. 600nm of 0.902. The culture was diluted 1:10 with 1X PBS to a titer \nof 8.32 x 107 CFU /mL (as determined  by traditional plating methodology) and immediately administered to all \nchicken s in a 1.0 mL oral dose.   \nFecal sample collection . The day prior to each sample date, paper under each cage was changed to ensure \nsamples were no more than 17 h  old. On the day of sampling, approximately 1.0g of fecal material was collected \nfrom each cage, homogenized, and 0.2g used for extraction using the QIAmp DNA stool Mini Kit (Qiagen, \nMaryland)  following manufacture\u2019s recommendations . \nNecropsy . On each sampling date  (24, 48, 72, 96, 168, and 216 hpc)  the appropriate group of chickens (six  \nchickens per time point)  were euthaniz ed by cervical dislocation. Using proper aseptic technique, both ceca were \nremoved from each chicken. One cecum was placed in a sterile Whirl -Pak bag and frozen. The contents of the \nremaining ceca were removed and 0.2g set aside for total DNA extraction using the QIAmp DNA stool Mini Kit \n(Qiagen, Maryland).  The remaining contents were weighed and bro ught up to 10mL using sterile 1X  phosphate \nbuffered saline (PBS).  \nCecal bacteriological enumeration . Following necropsy, cecal samples placed in PBS were titered following \nthe traditional plating method.  In short, samples were vortexed vigorously for 20 sec.  then serially diluted through to \n10-7. From each dilution, 100\u00b5L was plated onto brilliant green (BG) plates  supplemented with naladixic acid (100 \n\u00b5g/mL), in duplicate.  Plates were incubated overnight (18 to 24 h) at 37\u00b0C then evaluated  for typical Salmonella \ngrowth (red/pink colonies on a red/pink field) following incubation.  Salmonella colonies were counted to determine \nthe titer of SE contained in each gram of cecum.    \nQuantitative PCR for Salmonella  fractions . The O -antigen transporter ( Wzx) gene of S . Ent eritidis was used \nto design qPCR primers specific for S . Enteritidis  (2). These primers were designed to amplify a 172bp fragment of \nthe O -antigen transporter gene of S . Enteritidis. Quantitative PCR was conducted using the Bio -Rad CFX96TM Real-\nTime PCR De tection System (Bio -Rad, Hercules, CA).  Reactions were carried out in 20uL containing: 1x SsoFastTM \nEvagreen\u00ae Supermix (Bio -Rad, Hercules, CA), 0.5 uM each qPCR Fwd and R ev primer, and 1uL of template.  The \ncycling  conditions were as follows: 1  cycle at 98oC for 2 min. and 40 cycles at 98oC for 5 sec. and 65oC for 5 sec . \nStandards were generated through PCR amplifi cation of the O -antigen gene. The DNA was purified using the \nE.Z.N.A Cycle Pure Kit (Omega Biotek, Norcross, GA) and quantified using the QubitTM fluorometer (Invitrogen, \nCarlsbad, CA).  The DNA was diluted to a stock concentration of 1x109 copies/uL.   \nCecal and fecal quantitative analysis . Fecal and cecal samples were processed using the QIAmp DNA stool \nMini Kit (Qiagen, Maryland) following the manu facture\u2019s recommendations. After extraction, samples were \nquantified and presented as copy#/mL of Salmonella Enteritidis DNA.   \n \nRESULTS  \n \nBacterial enumeration . In order to determine the pattern of SE shedding, cecal content  was sampled at 24, 48, \n72, 96, 168, and 2 16 hpc . Results demonstrate that Salmonella Enteritid is can be re -isolated as early as 24 hpc and \npeaks by 72 hpc at 3.55x108 CFU/g of feces  (Figure 1).  Titers remained high throughout the remaining  time points  \n(7x106-1x109 CFU/mL) .    \nFecal and cecal qPCR t iters . Both fecal and cecal samples, from the same chickens  used to determine viable \nbacterial enumeration, were process ed for qPCR analysis. Only two of six and one of six chickens showed \ndetectable levels of bacterial DNA at 24 hpc in the cecal an d fecal samples, respectivel y. Levels of detectable DNA \npeaked at 96 hpc and began to decrease at 168 hpc in  both cecal and fecal samples  (Figure 1). Quantitative PCR \nresults of cecal and fecal contents reveal a high correlation demonstrating that cecal colonization and bacterial shedding through feces are similar.   \n \nDISCUSSION  \n \nThe aim of this study was to evaluate the point at which shedding/colonization is maximal and may yield the \nbest results in demonstrating a shedding reduction in chicken s recei ving a Salmonella vaccinati on program. The 63rd WPDC/XXXIX ANECA  results of this study demonstrate that colonization and excretion of Salmonella Enteritidis can be detected by viable \nbacterial count and qPCR as ear ly as 24 hpc. Peak of Salmonella colonization, based on viable bacterial counts of \nthe cecum, appears to occur around 72 h  and remains high out to 216 h , with titers fluctuating around 1x107 CFU/g \nof feces and never appear ing to significantly decrease. The difficulty of processing the cecal samples for \ndetermining viable bacterial titers may be the cause of the fluctuating  titers after 72 h .  \nQuantitative PCR analyses of cecal and fecal samples reveal a close correlation between the two.  This \ndemonstrates that colonization and sheddin g occur at a similar rate. Peak of bacterial colonization and shedding, \nbased on qPCR results, occur s around 96- 168 hours post challenge. Quantitative PCR analysis reveals a significant \ndecrease in the amount of bacterial DNA present in fecal and cecal samples  by 216 hpc, suggesting that bacterial \ncolonization and shedding begins to decline shortly after peaking. This finding is important for the evaluation of SE \nvaccine performance where the samples must be taken before clearance in order to provide evidence o f the true \neffects of vaccination.  However, further studies mus t be conducted to verify this  hypothesis . Quantification of cecal \nsamples is suggested as they are easily obtained at necropsy and may be taken following the regular necropsy schedule (168 hpc ). \n \nREFERENCES  \n \n1. Barrow, P.A, Bumstead, N., Marton, K., Lovell, M.A., and Wigley, P. Faecel shedding and intestinal \ncolonization of Salmonella eterica in in -bred chickens:the effect of host -genetic backg round. Epidemiol. Infect. \n1132: 117-126. 2003  \n2. Herrera -Leon, Silvia, et al. Blind comparison of traditional serotyping with three multiplex PCRs for the \nidentification of Salmonella serotypes. Research in Microbiol. 158:122 -127. 2007.  \n3. Riemann, H., et al. A survey for Salmonella by drag swabbing manure piles in California egg ranches. \nAvian Disease. 42:67 -71. 1998.  \n \n \n \n \nFigure 1.  Average qPCR and bacterial enumeration titers. Chickens were challenge with Salmonella \nEnteritidis and then cecal and fecal samples were obtained at 24, 48, 72, 96, 168, and 216 hpc. Viable bacteria enumeration was determined following the traditional plating method (a). Quantitative PCR was performed on fecal \nand cecal DNA extracts to determine copy#/g of feces (b).   \n \n \n \n \n63rd WPDC/XXXIX ANECA  UTILIZACI\u00d3N DE ENZIMAS XILANASAS, \u0392 -GLUCANASAS Y \nFITASAS EN DIETAS MA\u00cdZ -PASTA DE SOYA  \nPARA GALLINAS EN POSTURA  \n \nUSE OF XYLANASES, BETA- GLUCANASES, AND PHYTASES  \nIN CORN -SOY IN LAYER DIETS  \n \nD. V\u00e1zquez, I. Miguel, C. Cortes y G. \u00c1vila  \n \nACentro  de Ense\u00f1anza, Investigaci\u00f3n y Extensi\u00f3n en Producci\u00f3n Av\u00edcola -FMVZ \u2013UNAM  \nmvzalmavazquez@gmail.com  \n \nSUMMARY  \n \nThe present experiment evaluated the addition of a mixture of xylanases, beta-  glucanases and phytases in \ncorn-soy diets for laying hens with nutri ents reduction, on productive performance. Three hundred thirty six Bovans \nWhite 53 wk old distributed in two  treatments were used. Each treatment had 27 repetitions and 24 hens per \nrepetition. Enzymes were added in a ratio of 100g/ton of feed. Results indicated there was no difference ( P>0.05) \nbetween treatments. The yellow color of the yolk (50.8a and 52.6b) increased ( P<0.05) with the enzyme addition. \nBased on the results, it can be concluded that inclusion of xylanases, beta -glucanases and phytases  in corn- soy diets \nallow for nutrient reduction without affecting productive performance of hens, and improves yolk yellow \npigmentation.  \n \nRESUMEN  \n \nEl presente estudio se realiz\u00f3 con la finalidad de evaluar la adici\u00f3n de una mezcla de enzimas xilanasas, \u03b2 -\nglucanasas y fitasas en dietas ma\u00edz -pasta de soya con reducci\u00f3n de nutrientes para gallinas de postura, sobre las \nvariables productivas. Se emplearon 336 gallinas Bovans White de 53 semanas de edad en un dise\u00f1o completamente \nal azar con 2 tratamientos. Cad a tratamiento cont\u00f3 con 7 repeticiones de 24 gallinas cada una. Los tratamientos \nfueron: 1) dieta testigo con 17.5% de prote\u00edna cruda (PC), 2893 kilocalor\u00edas (kcal) de energ\u00eda metabolizable \n(EM)/kg, 4.1% de calcio y 0.4% de f\u00f3sforo disponible; 2) dieta con  reducci\u00f3n de nutrientes, 16.80 % de PC 2823 \nkcal de EM/kg,  4.0% de calcio y 0.3% de f\u00f3sforo + enzimas. Las enzimas se adicionaron a raz\u00f3n de 100 g por \ntonelada de alimento.  La duraci\u00f3n del experimento fue de 70 d\u00edas. Los datos obtenidos de las variables e n estudio, se \nsometieron a un an\u00e1lisis de T de Student. Los resultados obtenidos al final del estudio para porcentaje de postura, peso de huevo, masa de huevo/ave/d\u00eda, consumo de alimento ave/d\u00eda, conversi\u00f3n alimenticia, grosor de cascar\u00f3n y porcentaje de huevo roto y en f\u00e1rfara para los tratamientos 1 y 2 respectivamente, indicaron que no existi\u00f3 diferencia \n(P>0.05) entre ellos. El  amarillamiento de la yema (50.8a y 52.6 b), se increment\u00f3 (P<0.05) con la adici\u00f3n de las \nenzimas. Con base en los resultados o btenidos, se puede concluir que la inclusi\u00f3n de enzimas xilanasas, \u03b2 -\nglucanasas y fitasas en dietas ma\u00edz -soya permite reducir nutrientes, sin afectar el comportamiento productivo de las \ngallinas,  adem\u00e1s de que se mejora la pigmentaci\u00f3n amarilla de la yema.  \n \nINTRODUCCI\u00d3N  \n \nDe acuerdo con Buchanan et al. ( 1) las enzimas hidrolizan los polisac\u00e1ridos no amil\u00e1ceos que pueden ser \nusados potencialmente por el animal e incrementa la utilizaci\u00f3n de la energ\u00eda de la dieta. Adem\u00e1s,  la liberaci\u00f3n del \ncontenido celular permite que exista una digesti\u00f3n enzim\u00e1tica; y por lo tanto, una mayor digestibilidad de todos los nutrientes.  De igual forma las fitasas hidrolizan el fitato encontrado en todos los ingredien tes de origen animal. El \nfitato  es una mol\u00e9cula con el potencial  de ligarse a nutrientes de carga positiva (Na, Mg, K, Ca y Zn) lo que se \nconsidera una propiedad antinutricional ya que compromete la utilizaci\u00f3n de prote\u00edna, energ\u00eda, calcio y minerales traza.  \nCon base en estos antecedentes, se plante\u00f3 el presente estudi o con la finalidad de evaluar el efecto de la \ninclusi\u00f3n de enzimas xilanasas, \u03b2 -glucanasas y fitasas en dietas ma\u00edz -pasta de soya, sobre el comportamiento \nproductivo de gallinas de postura.  \n 63rd WPDC/XXXIX ANECA  MATERIAL Y M\u00c9TODOS  \n \nSe utilizaron 336 gallinas de la l\u00ednea Bov ans White de 53 semanas de edad.  Las aves se distribuyeron al azar en \n14 grupos de 24 aves cada uno Los tratami entos (dietas) experimentales fueron  tipo pr\u00e1ctico o comercial ma\u00edz -pasta \nde soya y se balance\u00f3 una dieta testigo seg\u00fan las especificaciones del man ual de la estirpe Bovans White, con 17.5% \nde PC, 2893 Kcal/Kg de EM, 4.1% de calcio y 0.4% de f\u00f3sforo disponible. Se formul\u00f3, tambi\u00e9n, una dieta similar \nreducida en nutrientes, empleando el aporte de nutrientes indicados en la matrix del  complejo enzim\u00e1tico , a 2823 \nkcal/kg de EM, 16.80 % de PC, 4.0% de calcio y 0.3% de f\u00f3sforo.  \nLas enzimas que se utilizaron conten\u00edan xilanasas, \u03b2 -glucanasas y fitasas, producidas por el microorganismo \nPenicillium funiculosum , a una dosis de 100 g por tonelada de alimento. La s enzimas utilizadas conten\u00edan una \nactividad m\u00ednima de:  \nA. endo -1,4-xilanasa: 1400 unidades AXC/g.  \n\u2022 1 unidad de AXC se define como la liberaci\u00f3n de los olig\u00f3meros no precipitables en etanol a partir \nde un xilano asociado a un crom\u00f3foro, correspondiente a una absorbancia de 1.23 unidades a 590 nm.  \nB. endo -1-3(4)-\u03b2-glucanasa: 200 AGL unidades/g \n\u2022 1 unidad de AGL se define como la liberaci\u00f3n, de los olig\u00f3meros no precipitables en etanol, a partir \nde un glucano asociado a un crom\u00f3foro, correspondiente a una absorbancia de 0.82 unidades a 590 nm.  \nC. Glucanasa y fitasa en cantidades no definidas.  \nD. Los tratamientos fueron como se se\u00f1ala a continuaci\u00f3n:  \n\u2022 Tratamiento 1.  Dieta testigo sin inclusi\u00f3n de complejo enzim\u00e1tico.  \n\u2022 Tratamiento 2.  Dieta baja en nutrientes m\u00e1s complejo enzim\u00e1tico.  \nSemanalmente, durante 10 semanas,  se resumieron los datos de porcentaje de postura, peso promedio del \nhuevo, porcentaje de huevos con cascar\u00f3n roto y huevo en f\u00e1rfara, consumo de alimento, masa de huevo por ave por \nd\u00eda, porcentaje de mortalidad  y conversi\u00f3n alimenticia. Los pesajes del huevo se realizaron por r\u00e9plica. Al final del \nexperimento se evalu\u00f3 la pigmentaci\u00f3n de la yema del huevo con un color\u00edmetro de reflectancia Minolta CR -400; \nas\u00ed como el grosor del cascar\u00f3n con un micr\u00f3metro electr\u00f3 nico marca Mitutoyo, para lo cual se utilizaron  30 huevos \nde cada tratamiento.  \n \nRESULTADOS  \n \nLos resultados obtenidos en 10 semanas de experimentaci\u00f3n, para porcentaje de postura, peso promedio del \nhuevo, \u00edndice de conversi\u00f3n, consumo de alimento y masa de huevo, se encuentran resumidos en el  Cuadro 1. Se \npuede apreciar que no hubo diferencia (P>0.05) entre tratamiento en las variables en estudio . Por otro lado, en el \nCuadro 2, se muestran los resultados promedio de amarillamiento  (b), grosor de cascar\u00f3n, porcentaje de cascar\u00f3n \nroto y porcentaje de huevo en f\u00e1rfara. Se puede observar que en las variables grosor de cascar\u00f3n, porcentaje de \nhuevo roto y en f\u00e1rfara, no hubo diferencia significativa (P>0.05) entre tratamientos. Los resu ltados de \namarillamiento en la yema del huevo indicaron efecto ben\u00e9fico (P<0.05) a la adici\u00f3n de enzimas, es  decir,  el color \namarillo  en la yema del huevo, se increment\u00f3 con la inclusi\u00f3n de enzimas.  \n \nREFERENCIAS  \n \n1. Buchanan NP, Kimbler LB, Parsons AS. The ef fects of nonstarch polysaccharide enzyme addition and \ndietary energy restriction on performance and carcass quality of organic broiler chickens. J Appl Poult Res 16:1 -12. \n2007.  \n2. Hughes AL, Dahiga JP, Wyatt CL, Classen HL. The efficacy of quantum phytase in a forty -week \nproduction trial using white leghorn laying hens fed corn- soybean meal -based diets. Poult Sci 87:1156- 1161. 2008.  \n3. Liu N, Liu GH, Li FD, Sands JS, Zang S, Zheng AJ, Ru J. Efficacy of phytases on egg production and \nnutrient digestibility in laye rs fed reduced phosphorus diets. Poult Sci 86:2337- 2342. 2007.  \n \n \n \n \n  \n \n 63rd WPDC/XXXIX ANECA   \nCuadro 1.  Resultados promedio de variables productivas en gallinas de postura durante 70 d\u00edas de \nexperimentaci\u00f3n.  \n \nTratamiento  Postura \n(%) Peso del \nhuevo (g)  Masa de \nhuevo (g)  Consumo de \nalimento (g)  Conversi\u00f3n \nalimenticia  \n1 90.8a  63.9a  58.1a  111.3a  1.920a  \n2 90.7a  63.8a  57.9a  111.1a  1.910a  \na,b valores con distinta literal son diferentes (P<0.05)  \n \n  \n \nCuadro 2.  Resultados promedio de pigmentaci\u00f3n amarilla en el huevo, grosor de cascar\u00f3n y porcentaje de \nhuevo roto y en f\u00e1rfara.  \n \nTratamiento  Amarillamiento (b)  Grosor de cascar\u00f3n (mm)  Huevo roto y en f\u00e1rfara \n(%) \n1 50.8a  0.364  1.21 \n2 52.6b  0.369  1.67 \na,b valores con distinta literal son diferentes (P<0.05)  \n \n \n \n \n 63rd WPDC/XXXIX ANECA  GENOMA COMPLETO DE UNA CEPA DE ADENOVIRUS AVIAR \nSEROTIPO 4 CAUSANTE DE S\u00cdNDROME DE HIDROPERICARDIO \nY HEPATITIS EN M\u00c9XICO  \n \nCOMPLETE GENOME OF A STRAIN OF AVIAN ADENOVIRUS  \nSEROTYPE 4 ISOLATED IN MEXICO  \n \nP. F. Vera -Hern\u00e1ndezA, L.J. Garc\u00eda- BarreraA, D. Cort\u00e9s- EspinosaA, A. Galiote -FloresB, A. Morales -Garz\u00f3nB,  \nA. ToscanoB, E. Lucio -DecaniniB y A. Absal\u00f3nA \n \nAInstituto Polit\u00e9cnico Nacional. CIBA Tlaxcala. Carr. Est. Santa Ines -Tecuexcomac Km 1.5, Tepetitla, Tlaxcala; \nM\u00e9xico. Tel. +52 (55) 5729 6000 Ext. 87813. aabsalon@ipn.mx \nBInvestigaci\u00f3n Aplicada S.A. de C.V.  Tehuac\u00e1n, Puebl a \n \nSUMMARY:  \n \nAdenoviruses have been isolated from a variety of species of animals , including birds. Based on their genome \norganization, their serological properties, and growth in cell culture, these viruses have been grouped into four \ndifferent genus under the Adenoviridae family. The major clades correspond to the four accepted genus. Two genus (Mastadenovirus and Aviadenovirus) come from mammals or birds, respectively, and the ot her two genera \n(Atadenovirus and Siadenovirus) have a wider range of host organisms. In this paper the complete genome of an avian adenovirus serotype 4 isolated in Mexico in 1994 that showed higher virulent characteristics is presented. \nSimilarly, certain  assumptions of the reasons for the virulence of adenovirus based on the nucleotide sequence of the \ncomplete genome are discussed.  \n \nRESUMEN  \n \nEl s\u00edndrome de hidropericardio y  hepatitis es un padecimiento severo de las aves. En este trabajo se presenta el \ngenoma completo de un Adenovirus aviar del serotipo 4 aislado en M\u00e9xico en el a\u00f1o 1992 que present\u00f3 \ncaracter\u00edsticas virulentas superiores. De igual forma, se discuten algunas hip\u00f3tesis de las razones de la virulencia del \nadenovirus basados en la secuencia de nucle\u00f3tidos del genoma completo.  \n \nINTRODUCCI\u00d3N  \n \nEl s\u00edndrome de h idropericardio y  hepatitis (hepatitis \u2013hydropericardium s yndrome o HHS, por su nombre y \nsiglas en ingl\u00e9s ) tambi\u00e9n conocida como enfermedad de Angara,  es una padecimiento  severo de los pollos que \nalcanza tasas de mortalidad que han sido reportadas  hasta de un 100 %. (1, 2) \nGeneralmente las aves infectadas no muestr an signos cl\u00ednicos aparentes asociados con la enfermedad , sin \nembargo, en la necropsia se observa la acumulaci\u00f3n de l\u00ed quido en el saco peric\u00e1rdico de apariencia clar a o de color \n\u00e1mbar , de consistencia acuosa o gelatinosa y un coraz\u00f3n deforme, o tros cambios observados son  h\u00edgado friable , \ndescolorido  e hinchad o con necrosis focal , hemorragias petequiales en la musculatura del coraz\u00f3n y otros \u00f3rganos , \nadem\u00e1s de congesti\u00f3n y edema en los pulmones y por ultimo ri\u00f1ones p\u00e1lidos con t\u00fabulos prominentes.  El h\u00edgado es  \nel \u00f3rgano que muestra los cambios histopatol\u00f3gicos  m\u00e1s notables  tales como peque\u00f1as \u00e1reas multifocales de \nnecrosis, la infiltraci\u00f3n de c\u00e9lulas mononucleares y la presencia de inclusiones intranucleares bas\u00f3fil as en los \nhepatocitos . (1, 3-5) \nAlgunos estudios realizados en divers os laboratorios, indican que la mayor\u00eda de los agentes causales  del HHS \npertenecen al sero tipo 4 de  adenovirus a viares del grupo I  (2, 3, 6-10). A pesar de que la Hepatitis con cuerpos de \nInclusion (IBH) es causada por algunos serotipos de adenovirus aviares del grupo I  y que  esta condici\u00f3n es  tambi\u00e9n \ncaracterizada por da\u00f1o hep\u00e1tico, la IBH generalmente no es grave y sus tasas de mortalidad fluct\u00faan entre el 0  al \n10% pudiendo alcanzar hasta un 30% . (3) \nEl HHS fue reportado por primera vez a finales de 1987 en Angara, Pak ist\u00e1n (11). En M\u00e9xico  el HHS fue \ndescrito por primera vez en 1990 ( 12) y en 1992 Lucio y cols. aislaron  un virus de campo que reproduce el cuadro \ndel HHS que denominan como  cepa SHP92 que  experimentalmente alcanza tasas de mortalidad de hasta 100% 63rd WPDC/XXXIX ANECA  cuando  se administran macerados de h\u00edgados de pollos infectados  en aves libres de pat\u00f3genos e spec\u00edficos (SPF) de \nun d\u00eda de edad por v\u00eda oral y subcut\u00e1nea.  \n \nRESULTADOS  \n \nEl genoma completo del adeno virus  SHP92  tiene una longitud de 45,642  pares de bases, con un contenido de \nG+C  de 54.72% y pose e una organizaci\u00f3n similar a la de otros adenovirus aviares . \nEl an\u00e1lisis de los genomas por un alineamiento con Clustal W seguida de la generaci\u00f3n de una matriz de \nidentidad, indica que la cepa SHP92  tiene un porcentaje de similitud con la cepa KR5 de 98.84% y un 98.77% de \nidentidad con la cepa ON1.  \nComo se muestra en la F igura 1, el alineamiento global de las secuencias completas de los genomas de \nadenovirus del serotipo 4, muestra que la regi\u00f3n izquierda y central del genoma contienen  pocas variaciones  en \ncomparaci\u00f3n con el genoma de las cepas KR5 y ON1, y de manera general los marcos abiertos de lectura (ORF\u00b4s) \nencontrados en estas regiones en la cepa SHP92 tienen una similitud important e con respecto a los adenovirus cuyo \ngenoma esta reportado.  \nPor otra parte la  regi\u00f3n derecha del genom a result\u00f3 ser m\u00e1s variable encontrando regiones que alcanzan una \ndiferencia de hasta un 50%.  \n \nCONCLUSIONES  \n \nLos genomas de los adenovirus aviares son m\u00e1s  grandes (~45 kb) que los de adenovirus pertenecientes a los \ng\u00e9neros Atadenovirus, Siadenovirus, o los de los aislados de mam\u00edferos, serpientes o ranas. El contenido de G+C es \ngeneralmente un buen criterio de demarcaci\u00f3n de especies para los adenovirus. Su  valor para el genoma de la cepa \nSHP92 (54,72%) fue muy similar a las de las otras cepas de adenovirus aviares (53,8% a 57,9%).  \nLa longitud del genoma de la cepa SHP92 es muy similar al de las cepas no patog\u00e9nicas KR5 y ON1 (45,810 y \n45,667 pb respectivame nte) por lo que se descarta la idea que el tama\u00f1o del genoma pudiera estar relacionado con la \nvirulencia.  \n \nREFERENCIAS  \n \n1. Ganesh, K., and R. Raghavan Hydropericardium hepatitis syndrome of broiler poultry: current status of \nresearch. Resear ch in veterinary science 68:201 -206. 2000.  \n2. Mase, M., K. Nakamura, and T. Imada Characterization of Fowl adenovirus serotype 4 isolated from \nchickens with hydropericardium syndrome based on analysis of the short fiber protein gene. Journal of veterinary \ndiagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, \nInc 22:218- 223. 2010.  \n3. Mittal, D., N. Jindal, A.K. Tiwari, and R.S. Khokhar Characterization of fowl adenoviruses associated \nwith hydroperic ardium syndrome and inclusion body hepatitis in broiler chickens. Indian journal of virology : an \nofficial organ of Indian Virological Society 25:114 -119. 2014.  \n4. Chandra, R., S.K. Shukla, and M. Kumar The hydropericardium syndrome and inclusion body hepatit is in \ndomestic fowl. Tropical animal health and production 32:99- 111. 2000.  \n5. Mazaheri, A., C. Prusas, M. Voss, and M. Hess Some strains of serotype 4 fowl adenoviruses cause \ninclusion body hepatitis and hydropericardium syndrome in chickens. Avian pathology  : journal of the W.V.P.A \n27:269- 276. 1998.  \n6. Asthana, M., R. Chandra, and R. Kumar Hydropericardium syndrome: current state and future \ndevelopments. Archives of virology 158:921- 931. 2013.  \n7. Schonewille, E., A. Singh, T.W. Gobel, W. Gerner, A. Saalmuller, and  M. Hess Fowl adenovirus (FAdV) \nserotype 4 causes depletion of B and T cells in lymphoid organs in specific pathogen -free chickens following \nexperimental infection. Veterinary immunology and immunopathology 121:130- 139. 2008.  \n8. Shivachandra, S.B., R.L. Sah, S.D. Singh, J.M. Kataria, and K. Manimaran Immunosuppression in broiler \nchicks fed aflatoxin and inoculated with fowl adenovirus serotype -4 (FAV -4) associated with hydropericardium \nsyndrome. Veterinary research communications 27:39 -51. 2003.  \n9. Dahiya, S., R.N. Srivastava, M. Hess, and B.R. Gulati Fowl adenovirus serotype 4 associated with \noutbreaks of infectious hydropericardium in Haryana, India. Avian diseases 46:230- 233. 2002.  63rd WPDC/XXXIX ANECA  10. Balamurugan, V., J.M. Kataria, R.S. Kataria, K.C. Verma, and T. Nanthakumar Char acterization of fowl \nadenovirus serotype -4 associated with hydropericardium syndrome in chicken. Comparative immunology, \nmicrobiology and infectious diseases 25:139- 147. 2002.  \n11. KHAWAJA, D.A., S. AHMED, A.M. RAUF, M. ZULFIGAR, and S.M. MAHMOOD Isolation of a n \nadenovirus from hydropericardium syndrome in broiler chicks. Pakistan Journal Veterinary Research 1:2 -17. 1988.  \n12. Altamirano, R.R., A. Retamo, and J. Zurita Hepatitis por Cuerpos de Inclusi\u00f3n y su relacion con alta \nmortalidad en pollo de engorda en M\u00e9xico.  Memorias XV Convenci\u00f3n Anual ANECA:279- 287. 1990.  \n \n \n \n \nFigura 1.  Alineaci\u00f3n global de las secuencias de los genomas de adenovirus del serotipo 4.  \n \n \n  \n63rd WPDC/XXXIX ANECA  AN\u00c1LISIS DE LOS RESULTADOS DE MICOTOXINAS POR EL \nM\u00c9TODO DE ELISA EN ALIMENTOS DE M\u00c9XICO  \nDURANTE EL PERIODO 2011 A 2013  \n \nANALYSIS OF RESULTS OF MYCOTOXINS BY ELISA IN MEXICO\u2019S FOOD \nDURING THE PERIOD 2011 TO 2013  \n \nR. ViguerasA, G. AguilarA, E. TapiaA, E. SotoB, D. SarfatiB y B. LozanoB \n \nADiagn\u00f3sticos Cl\u00ednicos Veterinarios SA de CV. M\u00e9xico.  Campesinos 224, Colonia Granjas Esmeral da, 09810, \nM\u00e9xico, D.F., M\u00e9xico  \nBLaboratorio AVI -MEX SA de CV. M\u00e9xico.  Bartolache 1862, Colonia Del Val le, 03100, M\u00e9xico, D.F., M\u00e9xico  \n \nSUMMARY  \n \nCompetitive ELISA tests on samples of raw materials and different phases of finished feed were conducted \nduring the period 2011 to 20 13 from different regions of Mexico. Analyzed mycotoxins incl ude aflatoxin, T -2, \nfumonisin, d eoxynivanelol , ochratoxin and zearalonone . The effect of mycotoxins can vary depending on the age, \ngender, species, interaction with other mycotoxins or agents, etc.; therefore  the minimum acceptable level for a food \nis variable. This analysis considered minimum levels reported in various bibliographies that have been associated \nwith any effect on birds in production. The results indicate that in the period more than 20% of the analyzed s amples \nhave elevated levels of d eoxynivanelol,  ochratoxin and T -2. Regarding z earal enone, aflatoxin and f umonisin they \nwere lower than 10% of the samples with high levels.  \n \nRESUMEN  \n \nSe realizaron pruebas de ELISA competitiva en muestras de materi as primas y alimento terminado de \ndiferentes fases durante el periodo 2011 al 2013 provenientes de diferentes regiones del pa\u00eds. Las m icotoxinas \nanalizadas incluyen aflatoxina, T -2, fumonisina , deoxynivanelol, ocratoxina y z earelonona. El efecto de las \nmicotoxinas puede variar por la edad, sexo, especie, interacci\u00f3n con otras micotoxinas o agentes, etc., por lo que los \nniveles m\u00ednimos aceptables para un alimento son variables. En este an\u00e1lisis se consideraron niveles m\u00ednimos \nreportados en diferentes bibliog raf\u00edas que se han relacionado con alg\u00fan efecto sobre las aves en producci\u00f3n. Los \nresultados en el per\u00edodo indican que m\u00e1s del 20% de las muestras analizadas  presentan niveles elevados de \ndeoxynivanelol, T -2 y ocratoxina. Con respecto a zearalenona, fumonis ina y a flatoxina fueron menores al 10% de la \nmuestras con niveles elevados.  \n \nINTRODUCCI\u00d3N  \n \nLa m icotoxicosis es una enfermedad que afecta los par\u00e1metros productivos de las aves y es causada por la \ningesta de micotoxinas contaminantes de  granos y alimentos. Las micotoxinas son metabolitos t\u00f3xicos producidos \npor diferentes especies de hongos. Existen diferentes pruebas en el mercado para la identificaci\u00f3n y cuan tificaci\u00f3n \nen donde destaca el e nsayo por inmunoabsorci\u00f3n ligado a e nzimas (ELISA) ya que no requier e de equipos \nespecializados y su costo es menor compar ado con otras t\u00e9cnicas como la cromatograf\u00eda l\u00edquida de alta eficacia \n(HPLC). El monitoreo de alimentos a partir de la prueba de ELISA permite conocer el grado de contaminaci\u00f3n por \nmicotoxinas y de esta forma contribuir en la toma de decisiones para su control, por lo que el objetivo de este trabajo \nes presentar los resultados de determinaci\u00f3n de la concentraci\u00f3n de micotoxinas obtenidos en el Laboratorio de \nDiagn\u00f3sticos Cl\u00ednicos Veterinarios durante tre s a\u00f1os en el periodo comprendido entre 2011 y 2013.  \n \nMATERIALES Y M\u00c9TODOS  \n \nLas 423 muestras analizadas en este estudio corresponden a materias primas  (n=148) conformadas por granos \nsecos de destiler\u00eda, ma\u00edz, sorgo, pasta de soya y semilla de alg od\u00f3n , as\u00ed como de alimento balanceado de aves \n(n=285) de diferentes fases incluyendo inicio, desarrollo, finalizaci\u00f3n, crianza y postura; todas provenientes de \ndistintas  zonas  av\u00edcola s de M\u00e9xico .  63rd WPDC/XXXIX ANECA  La determinaci\u00f3n de la concentraci\u00f3n de micotoxinas se realiz\u00f3 por el m\u00e9todo de ELISA competit iva para \naflatoxina  B1 (AF), toxina T -2 (T-2), ocratoxina A  (OTA) , zearalenona (Z), deoxinivalenol o vomitoxina  (DON)  y \nfumonisina  (F) siguiendo las indicaciones recomendadas por el fabricante de los reactivos (R -Biopharm\u00ae, \nAlemania), del equipo (Biotek\u00ae, EUA ) y trabajando bajo los lineamientos y est\u00e1ndares de Buenas Pr\u00e1cticas de \nLaboratorio.  \n \nRESULTADOS  \n \nLos resultados se agruparon por a\u00f1o y de acuerdo al tipo de muestra (materia prima y alimento terminado) , en \ndonde se calcul\u00f3 el porcentaje de muestras que presentaron resultados mayores a los reportados en la bibliograf\u00eda \ncomo causantes  de da\u00f1o en las aves de producci\u00f3n  intensiva (l\u00edmite), as\u00ed como se determinaron los valores de \nconcentraci\u00f3n m\u00ednima y m\u00e1xim a de micotoxinas.  \n \nDISCUSI\u00d3N  \n \nDe acuerdo a los resultados obtenidos, las materias primas contienen mayores niveles de aflatoxina  B1, toxina  \nT2, ocratoxina A y z earalenona, mientras que l os alimento s terminado s con tienen niveles m\u00e1s elevados de \ndeoxinivalenol y f umonisina.  Durante los tres a\u00f1os evaluados , la micotoxina predominante en las muestras de \nmateria prima y alimento terminado fue t oxina T2 , seguida por o cratoxina  A, deoxinivalenol y z earalenona.  \nEn las muestras de alimento terminado del a\u00f1o 2013 no  se encontraron resultados que fueran superiores al l\u00edmite \npara aflatoxina  B1, zearalenona y f umonisina.  \nLas micotoxinas que presentaron mayores niveles de inclusi\u00f3n con respecto a su propio l\u00edmite fueron la toxina \nT2 con un nivel de 4975.5 ppb  en materia prima y de 350.7 en alimento terminado; la zearalenona con un nive l de \n991.6 ppb en materia prima y de 602.2 ppb en alimento terminado; la a flatoxina B1 con un nivel d e 400 ppb en \nmateria prima y de 177.9 en alimento terminado; deox inivalenol con un nivel de 35 ppm en alimento terminado y \nfumonisina con un nivel de 36 ppm en alimento terminado.  \n \nREFERENCIAS  \n \n1. Shivaprasad, H.L.  Mycotoxicosis . In \u201c Avian Disease Manual \u201d. Edited by Bulianne, M . 7th Ed. 2013.  \n2. Hoerr, F.J. Micotoxicoses . In: Diseases of Poultry. 12th edition. Edited by Y.M. Saif, A.M. Fadly, J.R. \nGlisson, L.R. McDougald, L.K. Nolan and D.E. Swayne. Iowa State University Press. pp 1197 -1229. 2008.  \n3. Cuevas , P.G. Niveles M\u00e1ximos Permitidos en la Legislaci\u00f3n Nacional e Internacional . III Encuentro \nNacional de Laboratorios de Control de Calidad de la Industria Alimenticia Animal. M\u00e9xico, 2012 . \n   \n \nTabla 1. Resultados de las pruebas de ELISA en materia prima.  \n \n \n \n \n \n \n \n \n % muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo% muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo% muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo\nAF > 20 ppb ( \u00b5g/Kg) 4.9 21.6 - 231.4 9.5 20.1 - 123.1 6.6 20.21 - 400\nT-2 > 50 ppb ( \u00b5g/Kg) 41.0 59.9 - 4975.5 31.0 57.1 - 224.6 44.4 50.8 - 178.6\nOTA > 10 ppb ( \u00b5g/Kg) 51.4 11.6 - 97.6 10.0 10.4 - 33.4 24.1 10.5 - 94.7\nZ > 250 ppb ( \u00b5g/Kg) 18.4 288.1 - 991.6 0.0 - 15.4 310.6 - 354.7\nDON > 0.3 ppm (mg/Kg) 33.3 0.3 - 3.5 14.8 0.3 - 0.8 15.9 0.3 - 1.9\nF > 5 ppm (mg/Kg) 4.2 8.3 5.9 6.8 0.0 -L\u00edmite2011 ( n=45 ) 2012 ( n=42 ) 2013 ( n=61 )63rd WPDC/XXXIX ANECA  Tabla 2. Resultados de las pruebas de ELISA en alimento terminado.  \n \n \n \n \n \n \n % muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo% muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo% muestras \n> l\u00edmite[Micotoxina] \nM\u00ednimo - M\u00e1ximo\nAF > 20 ppb ( \u00b5g/Kg) 3.9 25.0 - 35.9 23.3 23.4 - 177.9 0.0 -\nT-2 > 50 ppb ( \u00b5g/Kg) 34.0 51.7 - 257.6 14.8 51.7 - 350.7 21.4 50.5 - 105.7\nOTA > 10 ppb ( \u00b5g/Kg) 33.7 10.2 - 52.91 10.2 10.3 - 34.8 14.9 10.1 - 20.0\nZ > 250 ppb ( \u00b5g/Kg) 2.2 254.7 13.7 267.3 - 602.2 0.0 -\nDON > 0.3 ppm (mg/Kg) 24.1 0.31 - 35.0 31.9 0.30 - 2.36 8.8 0.3\nF > 5 ppm (mg/Kg) 9.8  6.0 - 36.0 3.6 5.1 - 5.9 0.0 -L\u00edmite2011 ( n=106) 2012 ( n=114 ) 2013 ( n=55 )63rd WPDC/XXXIX ANECA  MAREK'S DISEASE IN BACKYARD AND SPECIALTY FLOCKS, \nCURRENT STATUS  \n \nESTADO ACTUAL DE LA ENFERMEDAD DE MAREK EN  \nPARVADAS DE PATIO TRASERO Y PARVADAS ESPECIALIZADAS  \n \nP. Wakenell and Y.  Sato \n \nPurdue ADDL  \nWest Lafayette, IN  \n \nRESUMEN  \n \nLa enfermedad de Marek  (MD) ha ido en aumento en parvadas peque\u00f1as tanto de traspatio como comerciales, \nprincipalmente debido a la falta de vacunaci\u00f3n. Las incubadoras peque\u00f1as y el internet a menudo aconsejan a los \npropietarios de aves novatos que no existe la necesidad de vacu naci\u00f3n contra MD. Se presentar\u00e1n cuatro casos \nrecientes y los escenarios que llevaron a los productores a buscar ayuda.  \n \nSUMMARY  \n Marek's disease (MD) has been increasing in small flocks both backyard and commercial, predominantly due \nto lack of vaccinatio n. Novice poultry owners are often advised by small hatcheries and the web that there is no need \nfor MD vaccination. We will be presenting four recent cases and the scenarios that led to the farmers seeking \nassistance.  \n \nABSTRACT  \n \nMarek\u2019s disease (MD) is a ubiquitous herpesvirus that has been well controlled by vaccination in the \ncommercial poultry industry.  In ovo vaccination and increased improvement of vaccines have contributed to the \nsuccess, but concern remains that new strains may not be easily control led. Research on improving the genetics of \ncommercial poultry and on improving vaccines are ongoing in hopes of staying ahead of the increasing virulence of \nMDV.  \nBackyard poultry rearing has been exploding in popularity in the last decade.  The desire to h ave fresh eggs and \nthe ability to choose attractive strains has  driven this trend.  Many communities are considering allowing a limited \nnumber of hens to be reared in urban and suburban settings.  Unfortunately, many new poultry owners have limited \nknowledge  of biosecurity and disease, and the information available on the internet is often incorrect.  Poultry are \nusually purchased at auctions, swap meets, farm stores and at shows where multiple species are housed together and \nthere is no information on flock history, vaccination or disease exposure.  Most online poultry supplies offer MD \nvaccination, but purchasers usually do not know the necessity or are counseled not to have the chicks vaccinated.  \nAt Purdue University\u2019s Animal Disease Diagnostic Laboratory, we  are seeing an increase in the number of MD \ncases from backyard flocks in the last five  years.  Most of the birds are unvaccinated adults, and it is unknown \nwhether the exposure was early in life or recent.  Flock mortality ranges from 10 -80% and is devastat ing to the \nowners.  There is also concern that if the MDV is circulating unchecked in backyard poultry, new strains may \nemerge that will be difficult to control in commercial poultry industry.  We are presenting MD cases that we have \nrecently seen at Purdue ADDL.  63rd WPDC/XXXIX ANECA  A COLLECTION OF COMMON AND UNUSUAL NEUROLOGICAL \nDISORDERS IN COMMERCIAL CHICKENS  \n \nRECOPILACI\u00d3N DE DES\u00d3RDENES NEUROL\u00d3GICOS COMUNES E \nINUSUALES EN POLLOS COMERCIALES  \n \nG. Zavala  \n \nDepartment of Population Health, College of Veterinary Medicine  \nUniversity of Georgia , Athens, GA 30602  \navianhealth@gmail.com  \ngzavala@uga.edu  \n \nRESUMEN  \n \nLos des\u00f3rdenes neurol\u00f3gicos en los que se presentan signos cl\u00ednicos significativos incluyen una variedad de \ncondiciones de origen infeccioso, t\u00f3xico, metab\u00f3lico y nutricional. En el presente estudio se reporta una recopilaci\u00f3n \nde signos del sistema nervioso central comunes e inusuales, incluyendo varios casos de encefalitis f\u00fangica, \nbacteriana y viral. Casos de signos neurol\u00f3gicos inusuales o casos en los que se sospecha de la presencia de signos \nneurol\u00f3gicos  que indican una afectaci\u00f3n importante en el sistema nervioso central incluyen reovirus y encefalitis por \nla enfermedad de Marek; una encefalopat \u00eda hep\u00e1tica putativa causada por el adenovirus aviar; intolerancia a las \nbacterinas de Salmonella y toxicosis por ion\u00f3foros.  \n \nSUMMARY  \n \nNeurological disorders with significant clinical signs include a variety of conditions of infectious, toxic, \nmetabolic and nutritional origin. A collection of common and unusual central nervous system signs are herein \nreported, including various cases of fungal, bacterial and viral encephalitis. Cases of unusual neurological signs or \nsuspect neurological signs indicating a  significant insult to the central nervous system include reovirus a nd Marek's \ndisease encephalitis,  a putative hepatic encephalo pathy caused by fowl adenovirus,  intolerance to Salmonella \nbacterins,  and ionophore toxicosis.  \n \nABSTRACT  \n \nVarious forms of rela tively common neurological disorders of chickens have been well documented. The \nsource of some neurological disorders may be (not exclusively) infectious, toxic, nutritional or idiopathic.  \nViral infections  may result in a septic encephalitis as is the case in infections caused by West Nile virus (WNV)  \n(3), Newcastle disease virus (NDV)  (4), avian influenza virus (AIV)  (8), avian encephalomyelitis virus (AEV)  (7), \nand Marek\u2019s disease virus (MDV)  (6). With the exception of MDV, all such viruses frequently  induce clinical signs \nreflecting involvement the central nervous system (CNS), including tremors, torticollis, and a variety of disorders  \nincluding alteration of the normal gait of birds, posture, eye sight, and incoordination or ataxia a nd other \nmanifestations of brain involvement.  MDV most commonly induces flaccid paralysis of the limbs and neck ( 6), but \non occasion and in only a relatively small number of affected chickens it may induce blindness, or head tremors \nindistinguisha ble from those produced by AEV.  Other viral infections may rarely involve infection of the brain. \nSuch is the case of some reovirus strains that apparently can cause encephalitis with CNS relat ed clinical signs, \nincluding incoordination and tremors  (10). Reoviruses causing encephalitis are uncommon in commercial chickens \nbut have been reported in mammals ( 9). Severe cases of adenovirus -induced inclusion body hepatitis (IBH) often \nresult in massive hepatic necrosis associated with neurological signs. Although this is a relatively common clinical \nfinding in individual chickens in the field , it has not been described in the scientific literature as a problem in \nchickens and may be reflect a syndrome similar to hepatic encephalopathy occurring in mammals  (2). \nNutritiona l deficiencies causing neurological signs are most commonly represented by vitamin A/E deficiency \nresulting in avian encephalomalacia in young chicks  (1). Complex B vitamin deficiencies have been described but \nare extremely rare and very difficult and expensive to document in commercial poultry.   \nFeed ingredient toxicities  may also result in clinical signs resembling neurological involvement.  Severe sodium 63rd WPDC/XXXIX ANECA  toxicosis may result in clinical signs resembling thos e associated with encephalitis, and is most likely observed in \nvery young chickens intoxi cated with sodium  (5). \nIonophore toxicities  have been reported in chickens and turkeys among other animal species and humans  (11). \nAlthough monensin and s alinomycin have been most commonly implicated, other ionophores have the potential of \ncausing toxicities, particularly in adult chickens or turkeys that accidentally receive ionophores in their diet without \nhaving been exposed to the drug earlier in life.  \nBotulism  is an infrequent but well documented source of overt neurological signs in chickens. Affected flocks \nmay express sudden death and paralysis of the neck, limbs and the third eyelid. Cases of botulism may be associated with a history of increased litte r moisture, sudden changes in weather resulting in overheating and an unusual bloom \nof insects.  \nOther intoxications  are rare but may occur in regions or countries where potentially toxic pesticides or \ninsecticides may be used  around poultry or in agricultural fields ; organophosphate poisoning , for example,  results in \nthe inhibition of acetylcholinesterase in nerve cells.  \nCertainly there may be many more sources of neurological signs in commercial poultry but the ones listed \nabove are the most common and should be considered as possibilities in a differential diagnosis.  This work describes \nrecent common and uncommon cases of neurological disease of various etiologies.  \n \nREFERENCES  \n \n1. Bartholomew, A., D. Latshaw, and D.E. Swayne Changes in bl ood chemistry, hematology, and histology \ncaused by a selenium/vitamin E deficiency and recovery in chicks. Biol. Trace Elem. Res. 62:7 -16. 1998.  \n2. Gow, A.G., A.I. Marques, D.A. Yool, K. Crawford, S.M. Warman, P.D. Eckersall, R. Jalan, and R.J. \nMellanby Dogs with congenital porto -systemic shunting (cPSS) and hepatic encephalopathy have higher serum \nconcentrations of C -reactive protein than asymptomatic dogs with cPSS. Metab. Brain Dis 27:227 -229. 2012.  \n3. Guy, J. West Nile Virus. In: Diseases of Poultry. J.R. Glisson, L.R. McDougald, L.K. Nolan, D.L. Suarez \nand V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 479- 482. 2013.  \n4. Miller, P.J., and G. Koch Newcastle Disease. In: Diseases of Poultry. J.R. Glisson, L.R. McDougald, L.K. \nNolan, D.L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 89- 133. 2013.  \n5. Sander, J.E., S.I. Savage, and G.N. Rowland Sodium sesquicarbonate toxicity in broiler chickens. Avian \nDis. 42:215- 218. 1998.  \n6. Schat, K.A., and V. Nair Marek's Disease. In: Diseases of Poultry. J.R. Glisson, L.R. McDou gald, L.K. \nNolan, D.L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 515- 552. 2013.  \n7. Suarez, D.L. Avian Encephalomyelitis. In: Diseases of Poultry. J.R. Glisson, L.R. McDougald, L.K. \nNolan, D.L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. p p 486- 493. 2013.  \n8. Swayne, D.E., D.L. Suarez, and L.D. Sims Influenza. In: Diseases of Poultry. J.R. Glisson, L.R. \nMcDougald, L.K. Nolan, D.L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 181- 218. 2013.  \n9. Tyler, K.L., J.S. Leser, T.L. PHang, and P. C larke Gene expression in the brain during reovirus \nencephalitis. J. Neurovirol. 16:56 -71. 2010.  \n10. VandeZande, S., and E.M. Kuhn Central nervous system signs in chickens caused by a new avian \nreovirus strain: a pathogenesis study. Vet. Microbiol. 25:42 -49. 2006.  \n11. Zavala, G., D.A. Anderson, J.F. Davis, and L. Dufour -Zavala Acute monensin toxicosis in broiler breeder \nchickens. Avian Dis. 55:516- 521. 2011.  \n \n 63rd WPDC/XXXIX ANECA  THE IMPACT OF AVIAN RETROVIRUSES IN  \nPOULTRY PRODUCTION  \n \nG. Zavala  \n \nDepartment of Population Health, College of Veterinary Medicine  \nUniversity of Georgia  \navianhealth@gmail.com  \ngzavala@uga.edu  \n \nAvian retroviruses affecting chickens include the avian leukosis sarcoma group of retroviruses (ALSV), \ncommonly known as avian leukosis viruses (ALV)  (7, 8); the reticuloendotheliosis viruses (REV)  (11, 15); and \nlymphoproliferative disease virus of turkeys (LPDV)  (1). ALVs are generally classified into exogen ous and \nendogenous viruses. The latter are  transmitted genetically in the germ line cells, and th e exogenous viruses are  \ntransmitted congenitally, ho rizontally or iatrogenically.  The exogenous viruses are economically important whereas  \nthe endogenous viruses are considered  normal genetic components of the chicken genome and usually do not cause \nclinical disease or performance problems  (8). Exogenous ALVs are sub classified into five subgroups infecting \nchickens, namely subgroups A, B, C, D and J  (9). Subgroups A and B were the first ALVs to be recognized as \npathogenic and detrimental for poultry production  (9).  These two subgroups happened to be the most common in \ncommercial poultry several decades ago.  Both are capable of inducing  a variety of tumors , with lymphoid leukosis \nbeing the most common form of neoplasia represented by B cell lymphomas  (20). The commercial layer industry \nbenefited from the eradication efforts of breeding companies specializing in the genetic selection of chickens for \ntable egg production.  Thus, subgroups A and B causing lymphoid leukosis were once a very significant economic \nand pathologic problem, and both were the first avian retroviruses to be effectively eradicated from breeding stock  \n(21, 24). It is important to mention that ALVs, including subgroup A (ALV -A) have been contaminants of specific \npathogen free chickens used to produce fert ile eggs for vaccine production.  Thus, vaccine contamination with ALVs \nhas been at times a serious problem that has required eradication and the withdrawal of contaminated vaccines from \nthe market  (2, 29, 30). The meat type chicken industry was also affected by lymphoid leukosis years ago but to a \nlesser extent.  Eradication of ALV -A and ALV -B in meat type chickens was possible in all major primary breeding \ncompanies thanks to the experience gained during the years of eradication efforts in egg type breeding stock.  \nSubgroups C and D (ALV -C, ALV -D) have never been a problem in commercial chickens  (9), perhaps due to the \nfact that the original breeding stock used to generate egg type and meat type breeding stock was f ree of both \nsubgroups.  \nIn or around 1988 there was a novel emerging subgroup identified in the United Kingdom  (14, 16, 17, 23, 18, \n19, 22). This new subgroup, classified as ALV -J (or subgroup J avian leukosis virus) found its way to virtually all \nmeat type primary breeding companies of the world  and by the mid 1990s there was hardly no ALV -J-free meat type \nbreeding stock in the world  (31). By 1998 ALV -J-associated mortalit y and loss of production reached unprecedented \nlevels.  The meat type chicken industry witnessed a serious shortage of eggs due to high mortality in hens and low \nfertility associated with male mortality.  Eradication programs were put in place and by the ear ly 2000s and most \nbreeding companies had succeeded in eradicating ALV -J from their pure line breeding stock  (14). While the \nWestern world was in the process of eradicating ALV -J, some Asian countries suffered the infection of their \nindigenous breeds of chickens  preferred for their meat texture and the color of their plumage.  A prime example of \ninfected breeding stock of indigenous chickens is represented by the Chinese \u201cYellow\u201d chicken, which is \noverwhelmingly preferred in Southern and South East China, and in T aiwan  (5, 6, 12). Today, China is in the \nprocess of eradicating ALV -J from its local indigenous breeds and also from some egg type breeding stock that was \nalso contaminated.  \nRecently, our laboratory discovered a population of rustic colored slow -growing chickens bred to supply the \nethnic markets of the United States and thus this virus, which had been considered completely eradicated from \nchickens in the Western World, still circulates and is now in the process of being eradicated  (32). \nThe economic impact of ALV infection results primarily from increased mortality associated with tumors  (9, \n19), reduced egg production  and egg weight  (25), loss of uniformity in the progeny, inability to sell and export \ninfected breeding stock and other forms of economic losses.  It can easily be understood that ALV contamination of \ncommercial vaccines must be avoided at all costs because conta minated vaccines injected into embryos or very \nyoung chickens can induce very severe losses.  Thus, SPF breeding stock must be ALV -free and therefore the cost of \ntesting for ALV infection in SPF stock is substantial as it is for primary breeding companies.  Likewise, all vaccine 63rd WPDC/XXXIX ANECA  companies must demonstrate that their Marek\u2019s disease vaccines are free of ALV and thus they are forced to invest \nin testing vaccines for ALV detection among other potential contaminants  (29, 30). \nOther viruses related to ALSV include fowl glioma virus found in commercial chickens in Japan  (13, 26, 27); \nand myelo blastosis -associated virus (MAV) types 1, 2 and 1/2, of which MAV -1 has been found in commercial egg \nlayers  as recently as 2006 (33). \nAnother avian retrovirus that has caused serious economic losses is reticuloendothelio sis virus (REV)  (15). \nLike ALV -A and ALV -B, REV induces bursal lymphomas and increased mortality, and it has been found as a \ncontaminant of fowl poxvirus vaccines  (10). Besides being an oncogenic virus, REV is a powerful \nimmunosuppressor as it induces cytokine dysregulation and it has been proven to significantly increase the \nconsequences of viral, bacterial and parasitic infections , and it also induced delayed growth, stunting, poor \nfeathering and decreased flock uniformity ( 2, 3, 4 , 28). \nFinally, lymphoproliferative disease virus of turkeys (LPDV), which had only been detected in turkeys of the \nOld World an the Middle East until recently, is now known to circulate in wild turkeys of the United States ( 1) and \neven more recently it has been detected in domestic turkeys of the North Eastern United States.  LPDV has not been \ndetected yet in commercial turkeys and it remains to be known whether it circulates in commercial turkeys.  LPDV \ninduces increased mortality and tumors in infected individuals, but little is known about its pathogenesis since so far \nisolation and propagation methods have not been developed and thus diagnostic reagents  are scarce.  \nIn summary, avian retroviruses have inflicted a very significant economic damage to the poultry industry at \nvarious intervals, but luckily it has been possible to control, reduce and eradicate such viruses in most cases.   \n \nREFERENCES  \n \n1. Allison, A.B., M.K. Keel, J.E. Phillips, A.N. Cartoceti, B.A. Munk, N.M. Nemeth, T.I. Welsh, J.M. \nThomas, J.M. Crum, A.B. Lichtenwalner, E.M. Bunting, A.M. Fadly, G. Zavala, E.C. Holmes, and J.D. Brown \nAvian oncogenesis induced by lymphoprolifera tive disease virus: a neglected or emerging retroviral pathogen? \nVirology In Press. 2014.  \n2. Barbosa, T., G. Zavala, and S. Cheng Molecular characterization of three recombinant isolates of avian \nleukosis virus obtained from contaminated Marek's disease vacci nes. Avian Dis 52:245- 252. 2008.  \n3. Barbosa, T., G. Zavala, S. Cheng, and P. Villegas Full genome sequence and some biological properties \nof reticuloendotheliosis virus strain APC -566 isolated from endangered Attwater's prairie chickens. Virus Res \n124:68- 77. 2007.  \n4. Barbosa, T., G. Zavala, S. Cheng, and P. Villegas Pathogenicity and transmission of reticuloendotheliosis \nvirus isolated from endangered prairie chickens. Avian Dis 51:33 -39. 2007.  \n5. Cui, Z., S. Sun, Z. Zhang, and S. Meng Simultaneous endemic infections with subgroup J avian leukosis \nvirus and reticuloendotheliosis virus in commercial and local breeds of chickens. Avian Pathol 38:443 -448. 2009.  \n6. Cui Z., Y. Du, Z. Zhang, and R.F. Silva Comparison of Chinese field strains of avian leukosis subgroup J \nviruses with prototype strain HPRS -103 and United States strains. Avian Dis 47:1321- 1330. 2003.  \n7. Fadly, A. Avian retroviruses. Vet Clin North Am Food Anim Pract. 13:71- 85. 1997.  \n8. Fadly, A.M. Neoplastic Diseases. In: Diseases of Poultry, 12th ed. Y.M. Saif, A. M. Fadly, J. R. Glisson, \nL. R. McDougald, L. K. Nolan, and D. E. Swayne, ed. Blackwell Publishing, Ames, IA. pp 449 -588. 2008.  \n9. Fadly, A.M., and V. Nair Leukosis/Sarcoma Group. In: Diseases of Poultry. J.R.G. Saif Y. M., L. R. \nMcDougald, L. K. Nola n, D. E. Swayne., ed. Blackwell Publishing Professional, Ames, Iowa. pp 514- 568. 2008.  \n10. Fadly AM, W.R., Smith EJ, Silva RF, Reed WM, Hoerr FJ, and Putnam MR An outbreak of lymphomas \nin commercial broiler breeder chickens vaccinated with a fowlpox vaccine co ntaminated with reticuloendotheliosis \nvirus. Avian Pathol. 25:35 -47. 1996.  \n11. Fadly, A.M., G. Zavala, and R.L. Witter Reticuloendotheliosis. In: Diseases of Poultry. F.A.M. Saif \nY.M., Glisson J.R., McDougald L.R., Nolan L.K., Swayne D.E., ed. Blackwell Publis hing Professional. pp 568- 588. \n2008.  \n12. Guo, G., S. Sun, and Z. Cui [Sequence analysis for the complete proviral genome of avian leukosis virus \n(subgroup J) strain SD07LK1 isolated from layers]. Wei Sheng Wu Xue Bao 49:400- 404. 2009.  \n13. Hatai, H., K. Ochiai, K. Nagakura, S. Imanishi, A. Ochi, R. Kozakura, M. Ono, M. Goryo, K. Ohashi, and \nT. Umemura A recombinant avian leukosis virus associated with fowl glioma in layer chickens in Japan. Avian Pathol 37:127- 137. 2008.  \n14. McKay, J.C.a.A.G.R. Control and eradication o f ALV -J. In: International Symposium on ALV -J and \nother avian retroviruses. E.F. Kaleta, L. N. Payne, and U. Heffels -Redmann, ed. World Veterinary Poultry 63rd WPDC/XXXIX ANECA  Association and Institut fur Geflugelkrankheiten, Justus Liebig University, Rauischholzhausen, German y. pp 248-\n255. 2000.  \n15. Nair, V., G. Zavala, and A.M. Fadly Reticuloendotheliosis. In: Diseases of Poultry. J.R. Glisson, L.R. \nMcDougald, L.K. Nolan, D.L. Suarez and V. Nair, eds. Wiley -Blackwell, Ames, IA. pp 593- 604. 2013.  \n16. Payne L. N., A. M. Gillespie, and K. Howes Myeloid leukaemogenicity and transmission of the HPRS -\n103 strain of avian leukosis virus. Leukemia 6:1167- 1176. 1992.  \n17. Payne, L.N. History of ALV -J. In: International Symposium on ALV -J and other avian retroviruses. E.F. \nKaleta, L. N. Payne, and U.  Heffels -Redmann, ed. World Veterinary Poultry Association and Institut fur \nGeflugelkrankheiten, Justus Liebig University, Rauischholzhausen, Germany. pp 3 -12. 2000.  \n18. Payne, L.N. HPRS 103: a retrovirus strikes back.  The emergence of subgroup J avian leukosi s virus. \nAvian Pathology 27:S36- S45. 1998.  \n19. Payne, L.N. Myeloid leukaemogenicity and transmission of a new strain of avian leukosis virus. In: New \nand Evolving Virus Diseases of Poultry. M.S. McNulty, McFerran, J.B., ed. Community Research and \nTechnological  Development Programme in the Field of \"Agriculture and Agro -Industry, Including Fisheries,1990-\n1994,\" (AIR), Brussels, Belgium. pp 311- 325. 1992.  \n20. Payne, L.N. Viral lymphomagenesis in the domestic fowl: a review. Proceedings of the Royal Society of \nMedicin e 70:559- 563. 1977.  \n21. Payne, L.N., and K. Howes Eradication of exogenous avian leukosis virus from commercial layer breeder \nlines. Veterinary Record 128:8 -11. 1991.  \n22. Payne, L.N., S.R. Brown, N. Bumstead, K. Howes, J.A. Frazier, and M.E. Thouless A novel subgr oup of \nexogenous avian leukosis virus in chickens. Journal of General Virology 72:801 -807. 1991.  \n23. Payne, L.N., K. Howes, A. M. Gillespie, and L. M. Smith Host range of Rous sarcoma pseudotype RSV \n(HPRS -103) in 12 avian species: support for a new avian retrovirus envelope subgroup, designated J. Journal of \nGeneral Virology 73:2995- 2997. 1992.  \n24. Spencer, J.L. Progress towards eradication of lymphoid leukosis viruses -  a review. Avian Pathology \n13:599- 619. 1984.  \n25. Spencer, J.L., J. S. Gavora, and R. S. Gowe Effect of selection for high egg production in chickens on \nshedding of lymphoid leukosis virus and gs antigen into eggs. Poultry Science 58:279- 284. 1979.  \n26. Tomioka, Y., K. Ochiai, K. Ohashi, T. Kimura and T. Umemura In ovo infection with an avian leukosis \nvirus ca using fowl glioma: viral distribution and pathogenesis. Avian Pathol. 32:617 -624. 2003.  \n27. Toyoda, T., K. Ochiai, H. Hatai, M. Murakami, E. Ono, T. Kimura, and T. Umemura Cerebellar \nhypoplasia associated with an avian leukosis virus inducing fowl glioma. Vet Pathol 43:294- 301. 2006.  \n28. Zavala, G. Virus -Induced Immunosuppression: Reticuloendotheliosis and Other Immunosuppressive \nViruses. In: Immunosuppressive Diseases of Poultry. I.M. Gimeno, ed. Grupo Asis Biomedia, S.L., Zaragoza, Spain. pp 153- 160. 2013.  \n29. Zavala , G., and S. Cheng Detection and characterization of avian leukosis virus in Marek's disease \nvaccines. Avian Dis 50:209- 215. 2006.  \n30. Zavala, G., and S. Cheng Experimental infection with avian leukosis virus isolated from Marek's disease \nvaccines. Avian Dis 5 0:232- 237. 2006.  \n31. Zavala, G., S. Cheng, and M.W. Jackwood Molecular epidemiology of avian leukosis virus subgroup J \nand evolutionary history of its 3' untranslated region. Avian Dis 51:942- 953. 2007.  \n32. Zavala, G., S. Cheng, S.M. Williams, and P. Dunn A natural outbreak of ALV -J in U.S. slow growing \nspecialty chickens. In: American Veterinary Medical Association American Association of Avian Pathologists, \nChigago, IL. p Electronic Proceedings. 2013.  \n33. Zavala, G., B. Lucio -Martinez, S. Cheng, and T. Barbosa Sarcomas and myelocytomas induced by a \nretrovirus related to myeloblastosis -associated virus type 1 in White Leghorn egg layer chickens. Avian Dis 50:201-\n208. 2006.  \n \n ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}